Citrus Sinensis ID: 003438
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 820 | 2.2.26 [Sep-21-2011] | |||||||
| Q54QV3 | 1458 | Probable serine/threonine | yes | no | 0.518 | 0.291 | 0.495 | 1e-121 | |
| Q9P6P3 | 534 | Serine/threonine-protein | yes | no | 0.481 | 0.739 | 0.512 | 1e-117 | |
| P14680 | 807 | Dual specificity protein | yes | no | 0.501 | 0.509 | 0.482 | 1e-114 | |
| Q8BI55 | 632 | Dual specificity tyrosine | yes | no | 0.387 | 0.503 | 0.410 | 2e-70 | |
| P49657 | 908 | Serine/threonine-protein | no | no | 0.459 | 0.415 | 0.367 | 5e-70 | |
| Q9Z188 | 629 | Dual specificity tyrosine | no | no | 0.486 | 0.634 | 0.359 | 3e-69 | |
| Q9Y463 | 629 | Dual specificity tyrosine | yes | no | 0.486 | 0.634 | 0.357 | 5e-69 | |
| Q8WQL7 | 882 | Dual specificity tyrosine | yes | no | 0.423 | 0.393 | 0.383 | 8e-69 | |
| Q9NR20 | 520 | Dual specificity tyrosine | no | no | 0.382 | 0.603 | 0.409 | 1e-68 | |
| Q09690 | 1087 | Dual specificity protein | no | no | 0.413 | 0.311 | 0.360 | 7e-68 |
| >sp|Q54QV3|YAKA_DICDI Probable serine/threonine-protein kinase yakA OS=Dictyostelium discoideum GN=yakA PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 212/428 (49%), Positives = 292/428 (68%), Gaps = 3/428 (0%)
Query: 45 VVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVN 104
++ LTK+++ Y+ CN F Y LNP+R LT PS + NDGYDNVNSD I+ VN ++ N
Sbjct: 139 IIHLTKNLLHFYKKCNSNFNYISSLNPRRVLTHPSEPLSNDGYDNVNSDYIVYVNDIITN 198
Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
E+ ++Y V D LG GTFGQV KC + + + VA+KI+KN+ AY+QQ +E+ L +LN
Sbjct: 199 NESGQKYKVLDSLGQGTFGQVVKCKNCDTDELVAIKILKNKQAYFQQGRLEIQTLKSLND 258
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
++D EDK+HI+R+ + F+ + HLCI FELL NL+ELIK N+FRGLS +++++F QIL
Sbjct: 259 QHDPEDKNHILRLLDSFIHKMHLCIVFELLSVNLFELIKQNNFRGLSTNLIKVFLIQILD 318
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
L +L +A IIHCDLKPENILL PA IKIIDFGSAC E T+Y+YIQSR+YRSPEV
Sbjct: 319 ALIVLANANIIHCDLKPENILLQNVNSPA-IKIIDFGSACYEKSTLYTYIQSRHYRSPEV 377
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
L+G Y +IDMWS GCI AELFLGLPLFPG SE++ + R++ + G P D + K +T
Sbjct: 378 LVGTVYCASIDMWSLGCISAELFLGLPLFPGNSEYNQISRIVEMRGIFPSDLLDKGKSST 437
Query: 345 SKFFKCIG-SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLI-GKEYFHHKHLEEIV 402
F + +G + + N + G+ Y L E R+ K L+ K+YF++K L EI+
Sbjct: 438 RYFHRHLGSNSDDNNNNNNNNNGKPYYYTLKSEEDYQRDSKTTLLPSKKYFNYKTLPEII 497
Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
NY ++K++S +DI KE Q R+ DF+ GL++ DP +RWSP QA HPF+TG+P+ P+
Sbjct: 498 QNYGFKKSMSPQDIEKEKQHRIVFTDFINGLLQLDPNERWSPMQAKEHPFITGQPYNGPF 557
Query: 463 QPPPETPR 470
P P R
Sbjct: 558 IPDPSKKR 565
|
General sensor of environmental conditions, such as heat stress, effecting changes through pkaC. Essential for survival to nitrosoative and oxidative stresses. Required for cell cycle control, not only at the onset but also during development (aggregation process and postaggregative development). Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|Q9P6P3|PPK15_SCHPO Serine/threonine-protein kinase ppk15 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1086), Expect = e-117, Method: Compositional matrix adjust.
Identities = 212/414 (51%), Positives = 283/414 (68%), Gaps = 19/414 (4%)
Query: 48 LTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAET 107
+T + +TY ICNP F++S E NP+R LT PS GV N G+DNVN D +L VN L+ +
Sbjct: 68 MTVKLADTYSICNPKFQFSSEQNPRRPLTKPSEGVHNHGFDNVNHDYVLYVN-DLLGTDE 126
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
R+Y++ D LGHGTFGQVA+C D + VA+K+IKN+PA+Y Q ++EVSIL LN KYD
Sbjct: 127 GRKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILELLNNKYD 186
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
EDK H++R+Y+ F+ + HLC+ FELL NLYELIK N FRGL LS+V+ F+ Q+L S
Sbjct: 187 PEDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRGLHLSLVRSFATQLLSCTS 246
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
LLK A IIHCDLKPENILL P +K+IDFGSAC E +TVY+YIQSR+YRSPEV+LG
Sbjct: 247 LLKQARIIHCDLKPENILLQDLSSPI-VKVIDFGSACHERQTVYTYIQSRFYRSPEVILG 305
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
Y IDMWS GCI+AELFLGLPLFPG SE++ L R++ +LG PP ++L+ KN+ K+
Sbjct: 306 LHYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLG-NPPTWMLEMGKNSKKY 364
Query: 348 FKCIGSVHNIENGEVSIGGRSAYQ--ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405
+ + GR Y+ ++ + E + ++P GK+YF K L+ IV NY
Sbjct: 365 Y-----------NSGFVNGRKTYELKSIEQFSIENNKTEQP--GKQYFGEKTLDAIVLNY 411
Query: 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459
P RK + + +E + RL +DF+K +E +P KRW+P QA HPF+TG F+
Sbjct: 412 PRRKT-TPKLTPEEHEERLCFIDFIKQFLELNPLKRWTPDQAKNHPFITGASFS 464
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P14680|YAK1_YEAST Dual specificity protein kinase YAK1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=YAK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1064), Expect = e-114, Method: Compositional matrix adjust.
Identities = 204/423 (48%), Positives = 285/423 (67%), Gaps = 12/423 (2%)
Query: 45 VVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVN 104
+V +TK ++ TY +C+P F Y NPKR LT PS G N+G+DN+NSD IL VN VL
Sbjct: 304 LVSVTKSLITTYSLCSPEFTYQTSKNPKRVLTKPSEGKCNNGFDNINSDYILYVNDVL-G 362
Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
E R+Y+V D+LG GTFGQV KC + +AVK++K++ Y Q++ E IL LN+
Sbjct: 363 VEQNRKYLVLDILGQGTFGQVVKCQNLLTKEILAVKVVKSRTEYLTQSITEAKILELLNQ 422
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
K D +KHH +R+Y+ FV + HLC+ FELL +NLYEL+K N F GLS+ +++ F+ QIL
Sbjct: 423 KIDPTNKHHFLRMYDSFVHKNHLCLVFELLSNNLYELLKQNKFHGLSIQLIRTFTTQILD 482
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEV 284
L +LK++ +IHCDLKPENILLC KP E+KIIDFGS+C E RTVY+YIQSR+YR+PE+
Sbjct: 483 SLCVLKESKLIHCDLKPENILLCAPDKP-ELKIIDFGSSCEEARTVYTYIQSRFYRAPEI 541
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
+LG Y+T+IDMWS GCIVAELFLG+P+FPGASE++ L R+I LG PP +++ KN+
Sbjct: 542 ILGIPYSTSIDMWSLGCIVAELFLGIPIFPGASEYNQLTRIIDTLGY-PPSWMIDMGKNS 600
Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
KF K + + + + + + + E E ++KP K+YF + L +I+ N
Sbjct: 601 GKFMKKLAPEESSSSTQ-----KHRMKTIEEFCREYNIVEKP--SKQYFKWRKLPDIIRN 653
Query: 405 YPYRKNL--SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
Y Y K++ S E I +E Q R L+ FL G++ +P +RW+P QA HPF+T + FT +
Sbjct: 654 YRYPKSIQNSQELIDQEMQNRECLIHFLGGVLNLNPLERWTPQQAMLHPFITKQEFTGEW 713
Query: 463 QPP 465
PP
Sbjct: 714 FPP 716
|
Negative regulator of the cell cycle acting downstream of the cAMP-dependent protein kinase. Part of a glucose-sensing system involved in growth control in response to glucose availability. Phosphorylates POP2. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8BI55|DYRK4_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Mus musculus GN=Dyrk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 150/365 (41%), Positives = 214/365 (58%), Gaps = 47/365 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY V +++G G+FGQVAKC D + N VA+KII+N+ ++ QALVE+ IL L +K D++
Sbjct: 218 RYEVLEMIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHHQALVELKILEALRRK-DKD 276
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ H++V + ++F + HLCI FELL NLYEL+K N F G +LSIV+ F+ IL+ L +L
Sbjct: 277 NNHNVVHMKDFFYFRNHLCITFELLGINLYELMKNNSFHGFNLSIVRRFTFSILKCLHML 336
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
IIHCDLKPENI+L + +K+IDFGS+C E + VY+YIQSR+YRSPEV+LG+
Sbjct: 337 YVEKIIHCDLKPENIVLYQRGQ-VTVKVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHP 395
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
Y AIDMWS GCI+AEL+ G PLFPG +E + L ++ +LG PP + + A FF
Sbjct: 396 YNMAIDMWSLGCIMAELYTGYPLFPGENEVEQLACIMEVLGL-PPAHFTQTASRRQVFFD 454
Query: 350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409
G NI N GG+ YP K
Sbjct: 455 SKGLPKNINNNR---GGK------------------------------------RYPDSK 475
Query: 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETP 469
+L+M + +S + +DFL+ + ++P+ R +P QA +H ++ EP +P P+
Sbjct: 476 DLTMVVKTYDS----SFLDFLRRCLVWEPSLRMTPEQALKHAWI-HEPRKFKPRPKPQIL 530
Query: 470 RVPVA 474
R P A
Sbjct: 531 RKPGA 535
|
Possible non-essential role in spermiogenesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49657|MNB_DROME Serine/threonine-protein kinase minibrain OS=Drosophila melanogaster GN=mnb PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 5e-70, Method: Compositional matrix adjust.
Identities = 152/414 (36%), Positives = 233/414 (56%), Gaps = 37/414 (8%)
Query: 47 RLTKDIVETYQICNPLFKYSEELNPKRYL------TSPSVGVLNDGYDNVNSDLILAVNL 100
+L+ D+++TY+ N ++ ++ ++ + NDGYD+ N D I+
Sbjct: 99 KLSVDLIKTYKHINEVYYAKKKRRAQQTQGDDDSSNKKERKLYNDGYDDDNHDYIIKNGE 158
Query: 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILT 160
++ RY + L+G G+FGQV K +D E VA+KIIKN+ + QA +EV +L
Sbjct: 159 KFLD-----RYEIDSLIGKGSFGQVVKAYDHEEQCHVAIKIIKNKKPFLNQAQIEVKLLE 213
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
+N+ D E+K++IV++ +F+ + HLC+ FELL NLY+L++ +FRG+SL++ + F++
Sbjct: 214 MMNRA-DAENKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQ 272
Query: 221 QILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
Q+ L L + IIHCDLKPENILLC + A IKI+DFGS+C + +Y YIQSR+
Sbjct: 273 QLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYHYIQSRF 331
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
YRSPEVLLG QY AIDMWS GCI+ E+ G PLF G +E D + +++ +LG PP Y+L
Sbjct: 332 YRSPEVLLGIQYDLAIDMWSLGCILVEMHTGEPLFSGCNEVDQMNKIVEVLG-MPPKYLL 390
Query: 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL 398
+A T KFF I + +G + R+ K P G H +
Sbjct: 391 DQAHKTRKFFDKI-----VADGSYVLKKNQ----------NGRKYKPP--GSRKLH--DI 431
Query: 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
+ T P + L S ++ D + +++FDP R +P+ A +H F
Sbjct: 432 LGVETGGPGGRRLDEPGHSVSDYLKFK--DLILRMLDFDPKTRVTPYYALQHNF 483
|
Role in the specific control of proper proliferation of optic lobe neuronal progeny. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9Z188|DYR1B_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Mus musculus GN=Dyrk1b PE=1 SV=3 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 160/445 (35%), Positives = 245/445 (55%), Gaps = 46/445 (10%)
Query: 25 GPYLVQKDAPSLRVVVRK-PLVVR---------LTKDIVETYQICNPLF-----KYSEEL 69
GP + P +R++ R+ PL R L+ D+++TY+ N ++ + +++
Sbjct: 15 GPQEHTQVLPDVRLLPRRLPLAFRDAASAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQA 74
Query: 70 NPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCW 129
P+ T VLN GYD+ N D I V RY + L+G G+FGQV K +
Sbjct: 75 PPQDSSTKKEKKVLNHGYDDDNHDYI-----VRSGERWLERYEIDSLIGKGSFGQVVKAY 129
Query: 130 DAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189
D + VA+KIIKN+ A+ QA +E+ +L +N+ +D E K++IV + +F+ + HLC+
Sbjct: 130 DHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ-HDTEMKYYIVHLKRHFMFRNHLCL 188
Query: 190 CFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLC 247
FELL NLY+L++ HFRG+SL++ + ++Q+ L L + IIHCDLKPENILLC
Sbjct: 189 VFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLC 248
Query: 248 TSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+ A IKI+DFGS+C + +Y YIQSR+YRSPEVLLG Y AIDMWS GCI+ E+
Sbjct: 249 NPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMH 307
Query: 308 LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGR 367
G PLF G++E D + R++ +LG PP +L++A K+F+ + GG
Sbjct: 308 TGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPKARKYFE-----------RLPGGGW 355
Query: 368 SAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALV 427
+ + +EL+K G + + + T P + S +R
Sbjct: 356 TLRR--------TKELRKDYQGPGTRRLQEVLGVQTGGPGGRRAGEPGHSPADYLRFQ-- 405
Query: 428 DFLKGLVEFDPAKRWSPFQASRHPF 452
D + ++E++PA R SP A +H F
Sbjct: 406 DLVLRMLEYEPAARISPLGALQHGF 430
|
Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activity. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9Y463|DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (671), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 159/445 (35%), Positives = 243/445 (54%), Gaps = 46/445 (10%)
Query: 25 GPYLVQKDAPSLRVVVRK-PLVVR---------LTKDIVETYQICNPLF-----KYSEEL 69
GP + P +R++ R+ PL R L+ D+++TY+ N ++ + +++
Sbjct: 15 GPQEHTQVLPDVRLLPRRLPLAFRDATSAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQA 74
Query: 70 NPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCW 129
P+ VLN GYD+ N D I V RY + L+G G+FGQV K +
Sbjct: 75 PPQDSSNKKEKKVLNHGYDDDNHDYI-----VRSGERWLERYEIDSLIGKGSFGQVVKAY 129
Query: 130 DAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189
D + VA+KIIKN+ A+ QA +E+ +L +N+ +D E K++IV + +F+ + HLC+
Sbjct: 130 DHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ-HDTEMKYYIVHLKRHFMFRNHLCL 188
Query: 190 CFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLC 247
FELL NLY+L++ HFRG+SL++ + ++Q+ L L + IIHCDLKPENILLC
Sbjct: 189 VFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLC 248
Query: 248 TSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+ A IKI+DFGS+C + +Y YIQSR+YRSPEVLLG Y AIDMWS GCI+ E+
Sbjct: 249 NPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMH 307
Query: 308 LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGR 367
G PLF G++E D + R++ +LG PP +L +A K+F+ + GG
Sbjct: 308 TGEPLFSGSNEVDQMNRIVEVLGI-PPAAMLDQAPKARKYFE-----------RLPGGGW 355
Query: 368 SAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALV 427
+ + +EL+K G + + + T P + S +R
Sbjct: 356 TLRR--------TKELRKDYQGPGTRRLQEVLGVQTGGPGGRRAGEPGHSPADYLRFQ-- 405
Query: 428 DFLKGLVEFDPAKRWSPFQASRHPF 452
D + ++E++PA R SP A +H F
Sbjct: 406 DLVLRMLEYEPAARISPLGALQHGF 430
|
Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activities. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8WQL7|MBK1_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis elegans GN=mbk-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 8e-69, Method: Compositional matrix adjust.
Identities = 153/399 (38%), Positives = 228/399 (57%), Gaps = 52/399 (13%)
Query: 81 GVLNDGYDNVNSDLILAVNLVLVNAETQRRYIV--KDLLGHGTFGQVAKCWDAEMNSFVA 138
G N+GYD+ N D IL + +RY++ +G G+FGQV K +D VA
Sbjct: 301 GPYNNGYDDQNYDYILKNGEIF-----DKRYVILSDTPVGKGSFGQVTKAYDTLNKEEVA 355
Query: 139 VKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNL 198
+KIIKN+ ++ QA +E+ +L L +D+++K++IV + +FV + HLC+ FELL NL
Sbjct: 356 IKIIKNKKTFFDQAQIEIHLLE-LTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNL 414
Query: 199 YELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIK 256
Y+L+K FRG+SL++ + F++Q+ + L L + IIHCDLKPEN+LL + K ++I+
Sbjct: 415 YDLLKNTSFRGVSLNLARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNA-KRSQIR 473
Query: 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
+IDFGS+C +Y YIQSR+YRSPEVLLG Y T IDMWS GCI+ E+ G PLF G+
Sbjct: 474 VIDFGSSCQTGHRIYQYIQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGS 533
Query: 317 SEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENG-----EVSIGGRSAYQ 371
SE D + +++ +LG PP +L T K+F E+G + G R Y+
Sbjct: 534 SEVDQMMKIVEVLGM-PPKEMLDIGPKTHKYFD------KTEDGIYYCKKTRDGYRHTYK 586
Query: 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL-----SMEDISKESQIRLAL 426
A AR+L + ++G + + P + L S+ED SK
Sbjct: 587 APG-----ARKLHE-ILG-----------VTSGGPGGRRLGEPGHSVEDYSK-------F 622
Query: 427 VDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP 465
D +K +++FDP +R SP+ RHPF+ + P QPP
Sbjct: 623 KDLIKRMLQFDPKQRISPYYVVRHPFLKQKEERVPSQPP 661
|
Possible role in the function of olfactory neurons. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9NR20|DYRK4_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 4 OS=Homo sapiens GN=DYRK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 261 bits (668), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 148/361 (40%), Positives = 213/361 (59%), Gaps = 47/361 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY V + +G G+FGQVAKC D + N VA+KII+N+ ++QQAL+E+ IL L KK D++
Sbjct: 103 RYEVLETIGKGSFGQVAKCLDHKNNELVALKIIRNKKRFHQQALMELKILEALRKK-DKD 161
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ +++V + ++F + H CI FELL NLYEL+K N+F+G SLSIV+ F+ +L+ L +L
Sbjct: 162 NTYNVVHMKDFFYFRNHFCITFELLGINLYELMKNNNFQGFSLSIVRRFTLSVLKCLQML 221
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
IIHCDLKPENI+L + A +K+IDFGS+C E + VY+YIQSR+YRSPEV+LG+
Sbjct: 222 SVEKIIHCDLKPENIVLYQKGQ-ASVKVIDFGSSCYEHQKVYTYIQSRFYRSPEVILGHP 280
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
Y AIDMWS GCI AEL+ G PLFPG +E + L ++ +LG PP ++ A FF
Sbjct: 281 YDVAIDMWSLGCITAELYTGYPLFPGENEVEQLACIMEVLGL-PPAGFIQTASRRQTFFD 339
Query: 350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409
G NI N GK+ YP K
Sbjct: 340 SKGFPKNITNNR---------------------------GKK------------RYPDSK 360
Query: 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETP 469
+L+M + ++ + +DFL+ + ++P+ R +P QA +H ++ P QP P+T
Sbjct: 361 DLTMVLKTYDT----SFLDFLRRCLVWEPSLRMTPDQALKHAWIHQSRNLKP-QPRPQTL 415
Query: 470 R 470
R
Sbjct: 416 R 416
|
Possible non-essential role in spermiogenesis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q09690|POM1_SCHPO Dual specificity protein kinase pom1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pom1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 144/399 (36%), Positives = 224/399 (56%), Gaps = 60/399 (15%)
Query: 84 NDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK 143
N G+D+ D V++ RY V D LG G+FGQV +C D E VA+KII+
Sbjct: 677 NFGFDDERGDY-----KVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETGKLVALKIIR 731
Query: 144 NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIK 203
N+ ++ QALVE IL + +++D D++ +V+ ++F + HLC+ ELL NLYELIK
Sbjct: 732 NKKRFHMQALVETKILQKI-REWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIK 790
Query: 204 INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
N F+GL + +++ ++Q+++ L+LL + +IHCDLKPENILLC K +++K+IDFGS+
Sbjct: 791 SNGFKGLPIVVIKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFK-SQVKVIDFGSS 849
Query: 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
C E VY+YIQSR+YRSPEV+LG Y T ID+WS GCI+AE++ G PLFPG +E + L
Sbjct: 850 CFEGECVYTYIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTGFPLFPGENEQEQLA 909
Query: 324 RMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEAREL 383
++ I G PPD+ L + + K F +++
Sbjct: 910 CIMEIFG--PPDHSLIDKCSRKKVF-----------------------------FDSSGK 938
Query: 384 KKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS 443
+P + + V+ P+ K+L K+ ++ + F+ +++DP +R +
Sbjct: 939 PRPFVSSKG---------VSRRPFSKSLHQVLQCKD----VSFLSFISDCLKWDPDERMT 985
Query: 444 PFQASRHPFVTGE-----PFTCP----YQPPPETPRVPV 473
P QA++H F+TG+ P T P + PP P+
Sbjct: 986 PQQAAQHDFLTGKQDVRRPNTAPARQKFARPPNIETAPI 1024
|
Involved in localization of polarized growth and cytokinesis. May interact with both the actin and microtubule cytoskeleton. Requires tea1 for localization to the cell ends but not to the cell center. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 820 | ||||||
| 225454595 | 957 | PREDICTED: uncharacterized protein LOC10 | 0.970 | 0.831 | 0.781 | 0.0 | |
| 297737219 | 909 | unnamed protein product [Vitis vinifera] | 0.937 | 0.845 | 0.794 | 0.0 | |
| 255566076 | 848 | ATP binding protein, putative [Ricinus c | 0.862 | 0.833 | 0.801 | 0.0 | |
| 356559112 | 951 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.841 | 0.727 | 0.0 | |
| 449451775 | 963 | PREDICTED: uncharacterized protein LOC10 | 0.968 | 0.824 | 0.712 | 0.0 | |
| 356523832 | 969 | PREDICTED: uncharacterized protein LOC10 | 0.941 | 0.796 | 0.735 | 0.0 | |
| 297801134 | 956 | kinase family protein [Arabidopsis lyrat | 0.956 | 0.820 | 0.684 | 0.0 | |
| 42568145 | 956 | YAK1-like protein 1 [Arabidopsis thalian | 0.956 | 0.820 | 0.680 | 0.0 | |
| 79329054 | 787 | YAK1-like protein 1 [Arabidopsis thalian | 0.909 | 0.947 | 0.689 | 0.0 | |
| 224285202 | 1070 | unknown [Picea sitchensis] | 0.917 | 0.702 | 0.576 | 0.0 |
| >gi|225454595|ref|XP_002267912.1| PREDICTED: uncharacterized protein LOC100240775 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1291 bits (3342), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 640/819 (78%), Positives = 701/819 (85%), Gaps = 23/819 (2%)
Query: 17 WRPKGFSFGPYLVQKDAPS----LRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPK 72
WRP F PY +A + LRVVVR+PLV RLTKDIVETYQICNP FKYSEELNPK
Sbjct: 34 WRPSKLVFAPYSPSLEAATKSQALRVVVRRPLVARLTKDIVETYQICNPQFKYSEELNPK 93
Query: 73 RYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAE 132
R+LTSPS+GVLNDG+DNVNSDLILAVN VLVN+ETQRRYI+KD+LGHGTFGQVAKCW E
Sbjct: 94 RFLTSPSIGVLNDGHDNVNSDLILAVNSVLVNSETQRRYIIKDILGHGTFGQVAKCWVTE 153
Query: 133 MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192
NSF AVKIIKNQPAYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YFV QRHLCI FE
Sbjct: 154 TNSFTAVKIIKNQPAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFVHQRHLCIAFE 213
Query: 193 LLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252
LLD+NLYELIKINHFRGLSLSIVQLFSKQILRGL+L+KDAGIIHCDLKPENILLCT VKP
Sbjct: 214 LLDTNLYELIKINHFRGLSLSIVQLFSKQILRGLALMKDAGIIHCDLKPENILLCTRVKP 273
Query: 253 AEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL 312
AEIKIIDFGSAC EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL
Sbjct: 274 AEIKIIDFGSACMEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL 333
Query: 313 FPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQA 372
FPGASEFDLLRRMI+ILG QPPDYVLKEAKNTSKFFKCIGS H++ENG+VS+GGRSAY A
Sbjct: 334 FPGASEFDLLRRMIQILGGQPPDYVLKEAKNTSKFFKCIGSFHHVENGDVSMGGRSAYLA 393
Query: 373 LTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKG 432
L+E +YEARELKKP IGKEYF HK+LE IVTNYPYRKNL+ EDI KES++RLAL+DFL+G
Sbjct: 394 LSEEDYEARELKKPSIGKEYFIHKNLEAIVTNYPYRKNLAEEDIVKESRVRLALIDFLRG 453
Query: 433 LVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAG 492
LVEFDPAKRWSPFQAS+HPFVTGEPFTCPY+PP ETPRVPVAQN KVDHHPG GHWFAAG
Sbjct: 454 LVEFDPAKRWSPFQASKHPFVTGEPFTCPYRPPAETPRVPVAQNVKVDHHPGGGHWFAAG 513
Query: 493 LSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFA 552
LSPNI GR++ ++HNSPHFQVVPY + +SYGS+GS+GSYNDGTGLGSSYGSYGD N FA
Sbjct: 514 LSPNIPGRNRATLHNSPHFQVVPYAHASSYGSLGSHGSYNDGTGLGSSYGSYGDNSNMFA 573
Query: 553 YFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQ 612
Y+SP GPS MN+HAQ GVS+ G+SPDAR+ I + GNGLGVSPSAG F PLPLGTSPSQ
Sbjct: 574 YYSPAGPSAMNIHAQGGVSMLGTSPDARRRIIPFPHGNGLGVSPSAGNFAPLPLGTSPSQ 633
Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
FTPP+SY QVS+GSPGHYGPTSPAR SCHGSPLGKM A + +NRRK+WGYSG+ QSQES
Sbjct: 634 FTPPNSYSQVSTGSPGHYGPTSPARGSCHGSPLGKMAAVSQFNRRKSWGYSGSLQSQESS 693
Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNM 732
SS HWQG F DG SS Q+E N Q G + LHL SN +ATS KQQRGGSGI A N+
Sbjct: 694 SSAHWQGHFTDGTSSNQSEGNSQAFGGSPLHLQSNSNATSWKQQRGGSGI-----AFQNI 748
Query: 733 PSSLTRGPAI-----AEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFS 787
PSS T G + A H+KPE+SL +PDPGDWDPNYSDE LLQ+DGSD + TEFS
Sbjct: 749 PSSFTLGSNVQFAQTAGVVHEKPESSLLLPDPGDWDPNYSDELLLQDDGSD---MATEFS 805
Query: 788 KAMHL----SSADSSVGVGRFNRTSSASSNI--PIQSFA 820
K MHL SA+ VGVGRF SS SSN PIQ F+
Sbjct: 806 KGMHLGQNFGSAEPLVGVGRFGHASSTSSNTSRPIQPFS 844
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737219|emb|CBI26420.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1265 bits (3273), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 626/788 (79%), Positives = 684/788 (86%), Gaps = 19/788 (2%)
Query: 44 LVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLV 103
LV RLTKDIVETYQICNP FKYSEELNPKR+LTSPS+GVLNDG+DNVNSDLILAVN VLV
Sbjct: 17 LVARLTKDIVETYQICNPQFKYSEELNPKRFLTSPSIGVLNDGHDNVNSDLILAVNSVLV 76
Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
N+ETQRRYI+KD+LGHGTFGQVAKCW E NSF AVKIIKNQPAYYQQALVEVSILTTLN
Sbjct: 77 NSETQRRYIIKDILGHGTFGQVAKCWVTETNSFTAVKIIKNQPAYYQQALVEVSILTTLN 136
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
KKYD EDK+HIVRIY+YFV QRHLCI FELLD+NLYELIKINHFRGLSLSIVQLFSKQIL
Sbjct: 137 KKYDPEDKNHIVRIYDYFVHQRHLCIAFELLDTNLYELIKINHFRGLSLSIVQLFSKQIL 196
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
RGL+L+KDAGIIHCDLKPENILLCT VKPAEIKIIDFGSAC EDRTVYSYIQSRYYRSPE
Sbjct: 197 RGLALMKDAGIIHCDLKPENILLCTRVKPAEIKIIDFGSACMEDRTVYSYIQSRYYRSPE 256
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI+ILG QPPDYVLKEAKN
Sbjct: 257 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIQILGGQPPDYVLKEAKN 316
Query: 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVT 403
TSKFFKCIGS H++ENG+VS+GGRSAY AL+E +YEARELKKP IGKEYF HK+LE IVT
Sbjct: 317 TSKFFKCIGSFHHVENGDVSMGGRSAYLALSEEDYEARELKKPSIGKEYFIHKNLEAIVT 376
Query: 404 NYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQ 463
NYPYRKNL+ EDI KES++RLAL+DFL+GLVEFDPAKRWSPFQAS+HPFVTGEPFTCPY+
Sbjct: 377 NYPYRKNLAEEDIVKESRVRLALIDFLRGLVEFDPAKRWSPFQASKHPFVTGEPFTCPYR 436
Query: 464 PPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYG 523
PP ETPRVPVAQN KVDHHPG GHWFAAGLSPNI GR++ ++HNSPHFQVVPY + +SYG
Sbjct: 437 PPAETPRVPVAQNVKVDHHPGGGHWFAAGLSPNIPGRNRATLHNSPHFQVVPYAHASSYG 496
Query: 524 SVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMF 583
S+GS+GSYNDGTGLGSSYGSYGD N FAY+SP GPS MN+HAQ GVS+ G+SPDAR+
Sbjct: 497 SLGSHGSYNDGTGLGSSYGSYGDNSNMFAYYSPAGPSAMNIHAQGGVSMLGTSPDARRRI 556
Query: 584 IQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGS 643
I + GNGLGVSPSAG F PLPLGTSPSQFTPP+SY QVS+GSPGHYGPTSPAR SCHGS
Sbjct: 557 IPFPHGNGLGVSPSAGNFAPLPLGTSPSQFTPPNSYSQVSTGSPGHYGPTSPARGSCHGS 616
Query: 644 PLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLH 703
PLGKM A + +NRRK+WGYSG+ QSQES SS HWQG F DG SS Q+E N Q G + LH
Sbjct: 617 PLGKMAAVSQFNRRKSWGYSGSLQSQESSSSAHWQGHFTDGTSSNQSEGNSQAFGGSPLH 676
Query: 704 LPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAI-----AEAAHDKPETSLSVPD 758
L SN +ATS KQQRGGSGI A N+PSS T G + A H+KPE+SL +PD
Sbjct: 677 LQSNSNATSWKQQRGGSGI-----AFQNIPSSFTLGSNVQFAQTAGVVHEKPESSLLLPD 731
Query: 759 PGDWDPNYSDEQLLQEDGSDESSITTEFSKAMHL----SSADSSVGVGRFNRTSSASSNI 814
PGDWDPNYSDE LLQ+DGSD + TEFSK MHL SA+ VGVGRF SS SSN
Sbjct: 732 PGDWDPNYSDELLLQDDGSD---MATEFSKGMHLGQNFGSAEPLVGVGRFGHASSTSSNT 788
Query: 815 --PIQSFA 820
PIQ F+
Sbjct: 789 SRPIQPFS 796
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255566076|ref|XP_002524026.1| ATP binding protein, putative [Ricinus communis] gi|223536753|gb|EEF38394.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1183 bits (3060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/711 (80%), Positives = 621/711 (87%), Gaps = 4/711 (0%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
YIVKD+LGHGTFGQVAKCW AE NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD ED
Sbjct: 14 YIVKDVLGHGTFGQVAKCWVAETNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDPED 73
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
KHHIVRIY+YFV QRHLCICFELL +NLYELIK+N FRGLSLSIVQLFSKQIL GL+LLK
Sbjct: 74 KHHIVRIYDYFVFQRHLCICFELLYTNLYELIKLNQFRGLSLSIVQLFSKQILHGLALLK 133
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC EDRTVYSYIQSRYYRSPEVLLGYQY
Sbjct: 134 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACMEDRTVYSYIQSRYYRSPEVLLGYQY 193
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKC 350
TT+IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI ILG QPPDY+LKEAKNTSKFFKC
Sbjct: 194 TTSIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIEILGGQPPDYLLKEAKNTSKFFKC 253
Query: 351 IGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410
IGSVHN+++G++S+G +SAYQALT EYE RELKKP IGKEYFHHK+LE IVTNYPYRKN
Sbjct: 254 IGSVHNVDHGDMSLGSKSAYQALTVDEYEVRELKKPSIGKEYFHHKNLEAIVTNYPYRKN 313
Query: 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPR 470
L EDI KESQIRLAL+DFL+GLVEFDPAKRWSPFQASRHPFVTGEPFTCPY+PPPE+PR
Sbjct: 314 LPQEDIMKESQIRLALIDFLRGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYKPPPESPR 373
Query: 471 VPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGS 530
+PVAQNFKVDHHPG GHWFAAGLSPNI GR++ S+HNSPHFQVVPY +GNSYGS+GS+GS
Sbjct: 374 MPVAQNFKVDHHPGGGHWFAAGLSPNIPGRTRASLHNSPHFQVVPYAHGNSYGSIGSHGS 433
Query: 531 YNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGN 590
YNDG GLGSSYGSYGDG N FAY+SPVGPSGMN+H Q+G+S+ GSSPDAR+ FI YS N
Sbjct: 434 YNDGIGLGSSYGSYGDGSNMFAYYSPVGPSGMNMHPQAGLSMLGSSPDARRRFIPYSHPN 493
Query: 591 GLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTA 650
G+G+SPS G F PLPLGTSPSQFTPP+SY QVS+GSPGHYGPTSPARS+CHGSPLGKM A
Sbjct: 494 GIGMSPSTGNFAPLPLGTSPSQFTPPNSYSQVSAGSPGHYGPTSPARSNCHGSPLGKMAA 553
Query: 651 ATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSA 710
T +NRRK+WGYSG+ Q+QESP S HWQGQF DG SS Q E NP +LGS+ H SN S
Sbjct: 554 VTQFNRRKSWGYSGSSQNQESPQSSHWQGQFADGTSSSQPEGNPPILGSSPSHRQSNSST 613
Query: 711 TSSKQQRGGSGIAASYSAMPNMPSSL----TRGPAIAEAAHDKPETSLSVPDPGDWDPNY 766
S QQ GG GI A +SA+ NMP S + P A A DKPE SLS+PDPGDWDPNY
Sbjct: 614 ASWMQQHGGGGITAGHSAIQNMPGSFKPSSMQFPQNAGPAFDKPEASLSLPDPGDWDPNY 673
Query: 767 SDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQ 817
SDE LLQEDGSD SSI TEF+K MHL S D SV GR NR S+ SS+ +Q
Sbjct: 674 SDELLLQEDGSDVSSINTEFNKGMHLGSGDPSVTFGRSNRASNQSSSSLVQ 724
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356559112|ref|XP_003547845.1| PREDICTED: uncharacterized protein LOC100792777 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1175 bits (3040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 594/817 (72%), Positives = 672/817 (82%), Gaps = 17/817 (2%)
Query: 13 FGASWRPKGFSFGP-----------YLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNP 61
+ WRP+G F P +K L VVVRKPLV RLTK+IVETYQICNP
Sbjct: 17 LASGWRPRGSVFSPCKPKGEEEASAAAGKKPQQPLHVVVRKPLVARLTKEIVETYQICNP 76
Query: 62 LFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGT 121
FKYSE+LNPKR+LTSPSVGVLNDGYDNVNSDLIL VN VL++ E +RYIVKDLLGHGT
Sbjct: 77 QFKYSEDLNPKRFLTSPSVGVLNDGYDNVNSDLILTVNFVLIHLEKNKRYIVKDLLGHGT 136
Query: 122 FGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181
FGQVAKCWD++ NSFVAVKIIKNQPAYYQQALVEV+ILTTLNKKYD EDKHHIVRIY+YF
Sbjct: 137 FGQVAKCWDSDTNSFVAVKIIKNQPAYYQQALVEVTILTTLNKKYDPEDKHHIVRIYDYF 196
Query: 182 VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKP 241
V QRHLCICFELLD+NLYELIK+NHFRGLSL IVQLFSKQIL GL+LLK+AGIIHCDLKP
Sbjct: 197 VYQRHLCICFELLDTNLYELIKMNHFRGLSLGIVQLFSKQILYGLALLKEAGIIHCDLKP 256
Query: 242 ENILLCTS-VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG 300
ENILLCTS VKPAEIKIIDFGSAC E+RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG
Sbjct: 257 ENILLCTSTVKPAEIKIIDFGSACMENRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG 316
Query: 301 CIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENG 360
CIVAELFLGLPLFPGASEFDLL+RMI ILG QPPDYVL++AKNTSKFFKCIGS+ NIE+
Sbjct: 317 CIVAELFLGLPLFPGASEFDLLKRMIEILGGQPPDYVLRDAKNTSKFFKCIGSLQNIESS 376
Query: 361 EVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420
E S GRS YQ LT EYEARELKKP IGKEYF+ +LE IVTNYPYRKNL EDI KES
Sbjct: 377 ESSKNGRSVYQTLTVEEYEARELKKPSIGKEYFNQLNLEAIVTNYPYRKNLPKEDILKES 436
Query: 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVD 480
QIRLAL+DFLKGLVEFDPAKRWSPFQAS+HPFVTGEPFT PY+PPPETP +PV QN KVD
Sbjct: 437 QIRLALIDFLKGLVEFDPAKRWSPFQASKHPFVTGEPFTHPYKPPPETPHMPVVQNIKVD 496
Query: 481 HHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSS 540
+HPG GHWFAAGLSPN+SG+S+ S+++SPHFQ+V + NSYGSVGS+GSYND GLGSS
Sbjct: 497 NHPGGGHWFAAGLSPNVSGKSRASLYSSPHFQMVQHPPANSYGSVGSHGSYNDSVGLGSS 556
Query: 541 YGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGM 600
YGSYG+ N FAY+SP+GPSGMN+H Q +S+ G+SPDAR+ ++Y GNGLG+SPSAG
Sbjct: 557 YGSYGESSNMFAYYSPIGPSGMNMHNQGSMSMLGNSPDARRR-VKYQPGNGLGISPSAGN 615
Query: 601 FVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNW 660
F PLPLG SPSQFTPPSSY QVS SPGHYGPTSPAR + HGSPLGK A + +NRRKNW
Sbjct: 616 FAPLPLGASPSQFTPPSSYSQVSVSSPGHYGPTSPARGTSHGSPLGKTAAVSQFNRRKNW 675
Query: 661 GYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGS 720
G+SG+PQ+QE+ SS HW GQ+ D S+ E Q LGS+ +L SN S + +QRG
Sbjct: 676 GHSGSPQTQETFSS-HWPGQYPD--STSHTEGTSQALGSSPSYLQSN-SNPGNWKQRGSG 731
Query: 721 GIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDES 780
G++A+ + M S + P E HD ET +S+PDPGDWDPNYSDE LLQEDGSDES
Sbjct: 732 GLSANQNISSLMKPSASMNPQSTEVVHDNAETGISLPDPGDWDPNYSDELLLQEDGSDES 791
Query: 781 SITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIPIQ 817
S+TTEF ++M+L S ++ G GRFN SS S+ I +Q
Sbjct: 792 SLTTEFGRSMNLGSTETWAGFGRFNHVSSTSTPIIMQ 828
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451775|ref|XP_004143636.1| PREDICTED: uncharacterized protein LOC101210441 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1165 bits (3015), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 587/824 (71%), Positives = 661/824 (80%), Gaps = 30/824 (3%)
Query: 14 GASWRPKGFSFGPYLVQKDAPSLR-----VVVRKPLVVRLTKDIVETYQICNPLFKYSEE 68
G+ W P+ F PYL +++A + R PLV RLTKDIVETY+ CNP FKYSEE
Sbjct: 36 GSLWHPRQLGFSPYLQRENAAAKPPQDSCFAARIPLVARLTKDIVETYRKCNPEFKYSEE 95
Query: 69 LNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKC 128
LN KR+LTSPS+GVLNDGYDNVNSDLILAVN VL+N E QRRY+VKDLLGHGTFGQVAKC
Sbjct: 96 LNLKRFLTSPSIGVLNDGYDNVNSDLILAVNSVLLNFEMQRRYVVKDLLGHGTFGQVAKC 155
Query: 129 WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188
W AE NSFVAVKIIKNQPAYYQQALVEVSILT LN+KYD EDKHHIVRIY+YFV QRHLC
Sbjct: 156 WFAETNSFVAVKIIKNQPAYYQQALVEVSILTLLNQKYDPEDKHHIVRIYDYFVYQRHLC 215
Query: 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248
ICFELLD+NLYELIKINHFRGLSLSIVQ+ SKQIL GL+LLKDAGIIHCDLKPENILLCT
Sbjct: 216 ICFELLDTNLYELIKINHFRGLSLSIVQMLSKQILCGLALLKDAGIIHCDLKPENILLCT 275
Query: 249 SVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308
S KPAEIKIIDFGSAC EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL
Sbjct: 276 SAKPAEIKIIDFGSACLEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 335
Query: 309 GLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRS 368
GLPLFPGASEFDLLRRMI ILGAQPPDYVLKEAK+TSKFFK IG HN ENGE+ GRS
Sbjct: 336 GLPLFPGASEFDLLRRMIDILGAQPPDYVLKEAKHTSKFFKFIGGFHN-ENGEIYSSGRS 394
Query: 369 AYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVD 428
++QAL EYEARE+KKP IGKEYF+ LE IVTNYPYRKNL+ EDI KESQ+RLAL+D
Sbjct: 395 SFQALKADEYEAREMKKPSIGKEYFNRMDLEAIVTNYPYRKNLAEEDIRKESQVRLALID 454
Query: 429 FLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKV-DHHPGAGH 487
FLKGLVEFDPAKRWSPFQAS+HPFVTGEPFTCPY PPPET R+PV++N KV DHHPG GH
Sbjct: 455 FLKGLVEFDPAKRWSPFQASKHPFVTGEPFTCPYTPPPETRRLPVSKNIKVDDHHPGGGH 514
Query: 488 WFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDG 547
WFAAGLSPN++GR++ + +SPHFQ+VPY + NSYGSVGS+GSYN+ G G+SYGSYGD
Sbjct: 515 WFAAGLSPNLAGRNRV-LQSSPHFQMVPYPHANSYGSVGSHGSYNESIGFGNSYGSYGDN 573
Query: 548 GNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLG 607
G AY+SPVGPSGMN+H Q +SV SSPD R+ Q S NG+GVSPS G F PLPLG
Sbjct: 574 G-MLAYYSPVGPSGMNMHPQGRISVLASSPDTRQRIFQLSHSNGIGVSPSTGNFAPLPLG 632
Query: 608 TSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQ 667
TSPSQFTPPSSYGQVS GSPGHYGPTSPAR SC GSPLGKM +NRRK W Y P
Sbjct: 633 TSPSQFTPPSSYGQVSMGSPGHYGPTSPARGSCQGSPLGKMATVGQFNRRKYWDY---PG 689
Query: 668 SQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYS 727
+ + SS HWQGQ +G S QA+ N + G + HLP + +ATS KQQ+ GSG +A Y
Sbjct: 690 THDGSSSSHWQGQSTEGTSYSQADGN-SLHGCSPSHLPPSSNATSWKQQQVGSGSSAGYP 748
Query: 728 AMPNMPSSLTRGPAI-----AEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDG-SDESS 781
+ +MP S GP + + A +K E +PDPGDWDPNYSDE LLQ+DG S+ SS
Sbjct: 749 TIQSMPGSHLPGPNMQFSQSTDVARNKSE----LPDPGDWDPNYSDELLLQDDGDSNVSS 804
Query: 782 ITTEFSKAMHLSSADSSVGVGRFN------RTSSASSNIPIQSF 819
++T+FS MH+ S++ S G+GRF+ SS P+Q+F
Sbjct: 805 MSTDFSN-MHVGSSNPSTGIGRFSVPSPSLNLSSQRKTGPVQAF 847
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523832|ref|XP_003530538.1| PREDICTED: uncharacterized protein LOC100786931 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1160 bits (3001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 578/786 (73%), Positives = 658/786 (83%), Gaps = 14/786 (1%)
Query: 44 LVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLV 103
LV RLTK+IVETYQICNP FKYSE+LNPKR+LTSPSVGVLNDGYDNVNSDLIL VN VL+
Sbjct: 76 LVARLTKEIVETYQICNPQFKYSEDLNPKRFLTSPSVGVLNDGYDNVNSDLILTVNFVLI 135
Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
+ E +RYIVKDLLGHGTFGQVAKCWD++ NSFVAVKIIKNQPAYYQQALVEV+ILTTLN
Sbjct: 136 HLEKNKRYIVKDLLGHGTFGQVAKCWDSDTNSFVAVKIIKNQPAYYQQALVEVTILTTLN 195
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
KKYD EDKHHIVRIY+YFV QRHLCICFELLD+NLYELIK+NHFRGLSL IVQLFSKQIL
Sbjct: 196 KKYDPEDKHHIVRIYDYFVYQRHLCICFELLDTNLYELIKMNHFRGLSLGIVQLFSKQIL 255
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSP 282
GL+LLK+AGIIHCDLKPENILLCTS VKPAEIKIIDFGSAC E+RTVYSYIQSRYYRSP
Sbjct: 256 YGLALLKEAGIIHCDLKPENILLCTSTVKPAEIKIIDFGSACMENRTVYSYIQSRYYRSP 315
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
EVLLG QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL+RMI ILG QPPDYVL++AK
Sbjct: 316 EVLLGCQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLKRMIEILGGQPPDYVLRDAK 375
Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
NTSKFFKCIGS+ NI+N E S GRS YQALT EYEARELKKP IGKEYF+H +LE IV
Sbjct: 376 NTSKFFKCIGSLQNIDNSESSKNGRSVYQALTVEEYEARELKKPSIGKEYFNHMNLEAIV 435
Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
TNYPYRKNL EDI KESQIRLAL+DFLKGLVEFDPAKRWSPFQAS+HPFVTGEPFT PY
Sbjct: 436 TNYPYRKNLPKEDILKESQIRLALIDFLKGLVEFDPAKRWSPFQASKHPFVTGEPFTHPY 495
Query: 463 QPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSY 522
+PPPETP +PV QN KVD+HPG GHWFAAGLSPN+ G+S+ S+++SPHFQ+V + NSY
Sbjct: 496 KPPPETPHMPVVQNIKVDNHPGGGHWFAAGLSPNVPGKSRASLYSSPHFQMVQHPPANSY 555
Query: 523 GSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKM 582
GSVGS+GSYND GLGSSYGSYG+ N FAY+SP+GPS MN+H Q +S+ G+SPDAR+
Sbjct: 556 GSVGSHGSYNDSVGLGSSYGSYGESSNMFAYYSPIGPSVMNMHNQGSMSMLGNSPDARRR 615
Query: 583 FIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHG 642
++Y GNGLG+SP+AG F PLPLG SPSQFTPPSSY QVS GSPGHYGPTSPAR + HG
Sbjct: 616 -VKYQPGNGLGISPAAGNFAPLPLGASPSQFTPPSSYSQVSVGSPGHYGPTSPARGTSHG 674
Query: 643 SPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASL 702
SPLGK AA+ +NRRKNWG+SG+PQ+ E+ SS HWQGQ++D S+ E Q LGS+
Sbjct: 675 SPLGKTAAASQFNRRKNWGHSGSPQTLEAFSS-HWQGQYLD--STSHTEGTSQALGSSPS 731
Query: 703 HLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDW 762
+L SN S + +QRG G++A+ + M S + E +D ET +S+PDPGDW
Sbjct: 732 YLQSN-SNPGNWKQRGSGGLSANQNISSLMKPSASMNSQSTELVYDNAETGISLPDPGDW 790
Query: 763 DPNYSDEQLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASS--------NI 814
DPNYSDE LLQEDGSDESS+TTEF ++M+L + ++ G GRFN SS ++ N
Sbjct: 791 DPNYSDELLLQEDGSDESSLTTEFGRSMNLGATETWAGFGRFNHVSSTNTPPIIMQRLNG 850
Query: 815 PIQSFA 820
P Q+F
Sbjct: 851 PSQAFT 856
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297801134|ref|XP_002868451.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297314287|gb|EFH44710.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1083 bits (2800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/795 (68%), Positives = 629/795 (79%), Gaps = 11/795 (1%)
Query: 17 WRPKGFSFGPYLVQKDAPS-LRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYL 75
W+P F YL QK + S +RV V+KP+VVRLT+D+VETY+IC+P FKY ELNPKRYL
Sbjct: 27 WKPIQLVFKRYLPQKGSDSKVRVAVKKPVVVRLTRDLVETYKICDPQFKYRGELNPKRYL 86
Query: 76 TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
T+PSVGV NDG+DNVN DLILAVN ++++++RYIVKDLLGHGTFGQVAKCW E NS
Sbjct: 87 TTPSVGVHNDGFDNVNFDLILAVNDDFCSSDSRQRYIVKDLLGHGTFGQVAKCWVPETNS 146
Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD 195
FVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YF+ HLCICFELLD
Sbjct: 147 FVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFLYHGHLCICFELLD 206
Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255
NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIHCDLKPENILLC SVKP EI
Sbjct: 207 MNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIHCDLKPENILLCASVKPTEI 266
Query: 256 KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
KIIDFGSACTED+TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG
Sbjct: 267 KIIDFGSACTEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 326
Query: 316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTE 375
SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN+ NG + G +SAY ALTE
Sbjct: 327 GSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHNLGNGGTNGGFKSAYMALTE 386
Query: 376 IEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVE 435
E+EARE KKP IGKEYF+HK+LEEIV YPY+ NL +D+ KE+QIRLAL+DFL+GLVE
Sbjct: 387 EEFEAREKKKPEIGKEYFNHKNLEEIVKGYPYKINLPEDDVVKETQIRLALIDFLRGLVE 446
Query: 436 FDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSP 495
FDPAKRWSPFQA++HPF+TGEPFTCPY P PETPRV V QN KVDHHPG GHWFAAGLSP
Sbjct: 447 FDPAKRWSPFQAAKHPFITGEPFTCPYNPAPETPRVHVTQNIKVDHHPGGGHWFAAGLSP 506
Query: 496 NISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFS 555
N+SGR++ MHNSPHFQ++PY + NSYGS+GSYGSYNDG SSYGSYG GN FAY+S
Sbjct: 507 NVSGRTRIPMHNSPHFQMIPYSHANSYGSIGSYGSYNDGNIQESSYGSYGGTGNMFAYYS 566
Query: 556 PVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQG---NGLGVSPSAGMFVPLPLGTSPSQ 612
PV G+ + SGVS+ G+SPDAR+ +QY G NGLG SPSAG F PLPLGTSPSQ
Sbjct: 567 PVNHPGLYMQNNSGVSMLGTSPDARRRVMQYPHGYGPNGLGTSPSAGNFAPLPLGTSPSQ 626
Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
FT P++ Q +GSPGH+GPTSP R+S HGSPLGKM A + NRR + GYSG QSQ+ P
Sbjct: 627 FT-PNTNNQFLAGSPGHHGPTSPVRNSSHGSPLGKMAAFSQINRRMSAGYSGGSQSQD-P 684
Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSA---M 729
S QG +D + ++ Q GS S + + KQ +GG+ ++ YS
Sbjct: 685 SLSQAQGHGMDNFYQNEG-YSGQFSGSPSRRQ-LDSGGKNRKQTQGGTTLSTGYSTHNNS 742
Query: 730 PNMPSSLTRGPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKA 789
+ S P+ + P+T+LSVPDPGDWDPNYSD+ LL+ED +DESS+ FS+
Sbjct: 743 NSSLRSNMSNPSSTAHHLENPDTALSVPDPGDWDPNYSDDLLLEEDSADESSLANAFSRG 802
Query: 790 MHLSSADSSVGVGRF 804
M L S D+S RF
Sbjct: 803 MQLGSTDASSYSRRF 817
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42568145|ref|NP_198447.2| YAK1-like protein 1 [Arabidopsis thaliana] gi|20260382|gb|AAM13089.1| unknown protein [Arabidopsis thaliana] gi|34365721|gb|AAQ65172.1| At5g35980 [Arabidopsis thaliana] gi|110741197|dbj|BAF02149.1| protein kinase like protein [Arabidopsis thaliana] gi|332006652|gb|AED94035.1| YAK1-like protein 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 541/795 (68%), Positives = 627/795 (78%), Gaps = 11/795 (1%)
Query: 17 WRPKGFSFGPYLVQKDAPS-LRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYL 75
W+P F YL Q + S + V V+KP+VVRLT+D+VETY+IC+P FKY ELNPKRYL
Sbjct: 27 WKPIQLVFKRYLPQNGSASKVHVAVKKPVVVRLTRDLVETYKICDPQFKYRGELNPKRYL 86
Query: 76 TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
T+PSVGV NDG+DNVN DLILAVN ++++++RYIVKDLLGHGTFGQVAKCW E NS
Sbjct: 87 TTPSVGVNNDGFDNVNYDLILAVNDDFCSSDSRQRYIVKDLLGHGTFGQVAKCWVPETNS 146
Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD 195
FVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YF+ Q HLCICFELLD
Sbjct: 147 FVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFLHQSHLCICFELLD 206
Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255
NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIHCDLKPENILLC SVKP EI
Sbjct: 207 MNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIHCDLKPENILLCASVKPTEI 266
Query: 256 KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
KIIDFGSAC ED+TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG
Sbjct: 267 KIIDFGSACMEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 326
Query: 316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTE 375
SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN+ NG G +SAY ALT
Sbjct: 327 GSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHNLGNGGTYGGLKSAYMALTG 386
Query: 376 IEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVE 435
E+EARE KKP IGKEYF+HK+LEEIV +YPY+ NL +D+ KE+QIRLAL+DFLKGL+E
Sbjct: 387 EEFEAREKKKPEIGKEYFNHKNLEEIVKSYPYKINLPEDDVVKETQIRLALIDFLKGLME 446
Query: 436 FDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSP 495
FDPAKRWSPFQA++HPF+TGEPFTCPY PPPETPRV V QN KVDHHPG GHWFAAGLSP
Sbjct: 447 FDPAKRWSPFQAAKHPFITGEPFTCPYNPPPETPRVHVTQNIKVDHHPGEGHWFAAGLSP 506
Query: 496 NISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFS 555
++SGR++ MHNSPHFQ++PY + NSYGS+GSYGSYNDGT +SYGSYG GN FAY+S
Sbjct: 507 HVSGRTRIPMHNSPHFQMMPYSHANSYGSIGSYGSYNDGTIQDNSYGSYGGTGNMFAYYS 566
Query: 556 PVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQG---NGLGVSPSAGMFVPLPLGTSPSQ 612
PV G+ + Q GVS+ G+SPDAR+ +QY G NGLG SPSAG F PLPLGTSPSQ
Sbjct: 567 PVNHPGLYMQNQGGVSMLGTSPDARRRVMQYPHGNGPNGLGTSPSAGNFAPLPLGTSPSQ 626
Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
FT P++ Q +GSPGH+GPTSP R+SCHGSPLGKM A + NRR + GYSG +
Sbjct: 627 FT-PNTNNQFLAGSPGHHGPTSPVRNSCHGSPLGKMAAFSQINRRMSAGYSGG-SQSQDS 684
Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNM 732
S QG +D + ++ Q GS S + + KQ +GG+ ++ YS N
Sbjct: 685 SLSQAQGHGMDNFYQNEG-YSGQFSGSPSRRQ-LDSGVKNRKQTQGGTTLSTGYSTHNNA 742
Query: 733 PSSLTR---GPAIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITTEFSKA 789
SSL P+ + P+T+LSVPDPGDWDPNYSD+ LL+ED +DESS+ FS+
Sbjct: 743 NSSLRSNMYNPSSTAHHLENPDTALSVPDPGDWDPNYSDDLLLEEDSADESSLANAFSRG 802
Query: 790 MHLSSADSSVGVGRF 804
M L S D+S RF
Sbjct: 803 MQLGSTDASSYSRRF 817
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|79329054|ref|NP_001031970.1| YAK1-like protein 1 [Arabidopsis thaliana] gi|9758801|dbj|BAB09254.1| protein kinase-like [Arabidopsis thaliana] gi|332006653|gb|AED94036.1| YAK1-like protein 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1044 bits (2699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/757 (68%), Positives = 601/757 (79%), Gaps = 11/757 (1%)
Query: 17 WRPKGFSFGPYLVQK-DAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYL 75
W+P F YL Q A + V V+KP+VVRLT+D+VETY+IC+P FKY ELNPKRYL
Sbjct: 27 WKPIQLVFKRYLPQNGSASKVHVAVKKPVVVRLTRDLVETYKICDPQFKYRGELNPKRYL 86
Query: 76 TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
T+PSVGV NDG+DNVN DLILAVN ++++++RYIVKDLLGHGTFGQVAKCW E NS
Sbjct: 87 TTPSVGVNNDGFDNVNYDLILAVNDDFCSSDSRQRYIVKDLLGHGTFGQVAKCWVPETNS 146
Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD 195
FVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVRIY+YF+ Q HLCICFELLD
Sbjct: 147 FVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVRIYDYFLHQSHLCICFELLD 206
Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255
NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIHCDLKPENILLC SVKP EI
Sbjct: 207 MNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIHCDLKPENILLCASVKPTEI 266
Query: 256 KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
KIIDFGSAC ED+TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG
Sbjct: 267 KIIDFGSACMEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 326
Query: 316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTE 375
SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN+ NG G +SAY ALT
Sbjct: 327 GSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHNLGNGGTYGGLKSAYMALTG 386
Query: 376 IEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVE 435
E+EARE KKP IGKEYF+HK+LEEIV +YPY+ NL +D+ KE+QIRLAL+DFLKGL+E
Sbjct: 387 EEFEAREKKKPEIGKEYFNHKNLEEIVKSYPYKINLPEDDVVKETQIRLALIDFLKGLME 446
Query: 436 FDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSP 495
FDPAKRWSPFQA++HPF+TGEPFTCPY PPPETPRV V QN KVDHHPG GHWFAAGLSP
Sbjct: 447 FDPAKRWSPFQAAKHPFITGEPFTCPYNPPPETPRVHVTQNIKVDHHPGEGHWFAAGLSP 506
Query: 496 NISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFS 555
++SGR++ MHNSPHFQ++PY + NSYGS+GSYGSYNDGT +SYGSYG GN FAY+S
Sbjct: 507 HVSGRTRIPMHNSPHFQMMPYSHANSYGSIGSYGSYNDGTIQDNSYGSYGGTGNMFAYYS 566
Query: 556 PVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQG---NGLGVSPSAGMFVPLPLGTSPSQ 612
PV G+ + Q GVS+ G+SPDAR+ +QY G NGLG SPSAG F PLPLGTSPSQ
Sbjct: 567 PVNHPGLYMQNQGGVSMLGTSPDARRRVMQYPHGNGPNGLGTSPSAGNFAPLPLGTSPSQ 626
Query: 613 FTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESP 672
FT P++ Q +GSPGH+GPTSP R+SCHGSPLGKM A + NRR + GYSG +
Sbjct: 627 FT-PNTNNQFLAGSPGHHGPTSPVRNSCHGSPLGKMAAFSQINRRMSAGYSGG-SQSQDS 684
Query: 673 SSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNM 732
S QG +D + ++ Q GS S + + KQ +GG+ ++ YS N
Sbjct: 685 SLSQAQGHGMDNFYQNEG-YSGQFSGSPS-RRQLDSGVKNRKQTQGGTTLSTGYSTHNNA 742
Query: 733 PSSLTR---GPAIAEAAHDKPETSLSVPDPGDWDPNY 766
SSL P+ + P+T+LSVPDPGDWDPNY
Sbjct: 743 NSSLRSNMYNPSSTAHHLENPDTALSVPDPGDWDPNY 779
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224285202|gb|ACN40327.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 465/807 (57%), Positives = 569/807 (70%), Gaps = 55/807 (6%)
Query: 17 WRPKGFSFGPYLVQKDA-------------PSLRVVVRKPLVVRLTKDIVETYQICNPLF 63
W+P F Y A +LRV+V KPLVVRLTK+I+ETYQICNP F
Sbjct: 30 WKPGALVFKAYASSTGAVNRSPNGGTMNRPGALRVIVAKPLVVRLTKEIIETYQICNPTF 89
Query: 64 KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFG 123
YS+ NPKRYLT+PS GVLNDG DN NSDLILAVN VLVN+++ RRYIVKD+LG GTFG
Sbjct: 90 TYSDAFNPKRYLTNPSTGVLNDGTDNENSDLILAVNAVLVNSDSNRRYIVKDILGQGTFG 149
Query: 124 QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183
QVAKCW E N+ VA+K+IKNQPAYY QA+VE+SILT LN+ +D EDKHHIVRI ++FV
Sbjct: 150 QVAKCWVPETNNHVAIKVIKNQPAYYHQAVVEISILTMLNQNFDPEDKHHIVRILDHFVF 209
Query: 184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN 243
QRHLCI FE+L NLYEL+K+N +RG+SL +++LF+KQIL L +L+DA +IHCDLKPEN
Sbjct: 210 QRHLCISFEMLGVNLYELLKLNQYRGISLKLLRLFAKQILDALLVLRDARVIHCDLKPEN 269
Query: 244 ILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIV 303
ILL T ++ AEIK+IDFGSAC E+RTVYSYIQSR+YRSPEVLLG+ YTTAIDMWSFGCIV
Sbjct: 270 ILLTTRLQSAEIKMIDFGSACMENRTVYSYIQSRFYRSPEVLLGHPYTTAIDMWSFGCIV 329
Query: 304 AELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVS 363
AELFLGLPLFPGASE+DL++RMI IL QPPD++L+ AKNTSK+FK +G ++
Sbjct: 330 AELFLGLPLFPGASEYDLIKRMIEILRDQPPDHILRSAKNTSKYFKHVGVSSRLDENRTG 389
Query: 364 IGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPY--RKNLSMEDISKESQ 421
G +SAY+ LTE EYEARE+KKP GK YF+ LE+IV NYP+ RK ++ E+I+KE+Q
Sbjct: 390 EGQQSAYRFLTESEYEAREMKKPESGKRYFNFDTLEDIVVNYPHLNRKKMTEEEIAKENQ 449
Query: 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDH 481
RLA +DFL+GLVEFDP KRW+P QA+RHPFVT E FTCPY P PETPR PV+Q VDH
Sbjct: 450 SRLAFIDFLRGLVEFDPEKRWTPGQAARHPFVTEEAFTCPYMPAPETPRKPVSQIVTVDH 509
Query: 482 HPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSY 541
+PG+GHWF AGLSP + +K NSP +Q+ P+ Y +SYGS+GS+GSY DG GLGSS+
Sbjct: 510 NPGSGHWFGAGLSPQVVNMNKGIHFNSPQYQMAPFSYASSYGSLGSHGSYGDGVGLGSSF 569
Query: 542 GSYGDGGNTFAYFSPVGPSGMNL--HAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAG 599
GSYGD N + + P+ PSG+N+ H G + G+SPD R Q G+ LG+SPS+G
Sbjct: 570 GSYGDTSNAYMGYCPITPSGLNIQNHGTPGGTSLGASPDTRWRLSQAPPGHALGISPSSG 629
Query: 600 MFVPLPLGTSPSQFTPPSSYGQVSS----GSPGHYGPTSPARSSCHGSPLGKMTAATHYN 655
M P+ LG SPSQFTPPSS QVSS GSPG YGPTSPARS H + LGK A Y+
Sbjct: 630 MLRPMSLGASPSQFTPPSSQIQVSSGSPIGSPGRYGPTSPARSGIHVTGLGKAAAVGQYH 689
Query: 656 RRKNWGYSGNPQSQESPSS---QHWQGQ--------------FIDGASSGQAEWNPQVLG 698
+R+ + SG+ S SP QHWQG F+DG + G +P+
Sbjct: 690 KRRGFSISGS--SHLSPQDNIPQHWQGHQNNLGVNMDVGAGSFVDGNTRGGYPGSPRNSQ 747
Query: 699 SASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRG-------PAIAEAAHDKPE 751
+ S PS +QRGG+GIA + + +S G P E + E
Sbjct: 748 ATSHLQPS--------RQRGGNGIATASMVSNHQKNSSVYGSGLFGESPTAMETCSEGLE 799
Query: 752 TSLSVPDPGDWDPNYSDEQLLQEDGSD 778
+S S PDPGDWDPNYSDE L QEDGSD
Sbjct: 800 SSSSPPDPGDWDPNYSDELLFQEDGSD 826
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 820 | ||||||
| TAIR|locus:2162868 | 956 | YAK1 "yeast YAK1-related gene | 0.986 | 0.846 | 0.631 | 2.1e-274 | |
| ASPGD|ASPL0000065013 | 885 | AN7104 [Emericella nidulans (t | 0.492 | 0.456 | 0.501 | 1.1e-115 | |
| DICTYBASE|DDB_G0283605 | 1458 | yakA "protein kinase, CMGC gro | 0.512 | 0.288 | 0.494 | 9.3e-115 | |
| POMBASE|SPAC823.03 | 534 | ppk15 "serine/threonine protei | 0.480 | 0.737 | 0.510 | 1.2e-106 | |
| SGD|S000003677 | 807 | YAK1 "Serine-threonine protein | 0.496 | 0.504 | 0.472 | 4.2e-102 | |
| FB|FBgn0259168 | 908 | mnb "minibrain" [Drosophila me | 0.313 | 0.283 | 0.475 | 4.9e-73 | |
| RGD|1307223 | 629 | Dyrk1b "dual-specificity tyros | 0.354 | 0.462 | 0.424 | 2e-70 | |
| UNIPROTKB|D4A382 | 689 | D4A382 "Uncharacterized protei | 0.354 | 0.422 | 0.424 | 2e-70 | |
| MGI|MGI:1330302 | 629 | Dyrk1b "dual-specificity tyros | 0.354 | 0.462 | 0.424 | 2.5e-70 | |
| ZFIN|ZDB-GENE-091015-3 | 634 | dyrk4 "dual-specificity tyrosi | 0.303 | 0.392 | 0.496 | 9.8e-70 |
| TAIR|locus:2162868 YAK1 "yeast YAK1-related gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2638 (933.7 bits), Expect = 2.1e-274, P = 2.1e-274
Identities = 522/826 (63%), Positives = 607/826 (73%)
Query: 2 DEGSPSNGGQV--FGAS--WRPKGFSFGPYLVQKDAPSXXXXXXXX-XXXXXTKDIVETY 56
D + + G++ G S W+P F YL Q + S T+D+VETY
Sbjct: 8 DGAAAARAGEIGSIGVSTPWKPIQLVFKRYLPQNGSASKVHVAVKKPVVVRLTRDLVETY 67
Query: 57 QICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQRRYIVKDL 116
+IC+P FKY ELNPKRYLT+PSVGV NDG+DNVN DLI ++++RYIVKDL
Sbjct: 68 KICDPQFKYRGELNPKRYLTTPSVGVNNDGFDNVNYDLILAVNDDFCSSDSRQRYIVKDL 127
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
LGHGTFGQVAKCW E NSFVAVK+IKNQ AYYQQALVEVSILTTLNKKYD EDK+HIVR
Sbjct: 128 LGHGTFGQVAKCWVPETNSFVAVKVIKNQLAYYQQALVEVSILTTLNKKYDPEDKNHIVR 187
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIH 236
IY+YF+ Q HLCICFELLD NLYELIKIN FRGLSLSIV+LFSKQIL GL+LLKDAGIIH
Sbjct: 188 IYDYFLHQSHLCICFELLDMNLYELIKINQFRGLSLSIVKLFSKQILLGLALLKDAGIIH 247
Query: 237 CDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDM 296
CDLKPENILLC SVKP EIKIIDFGSAC ED+TVYSYIQSRYYRSPEVLLGYQYTTAIDM
Sbjct: 248 CDLKPENILLCASVKPTEIKIIDFGSACMEDKTVYSYIQSRYYRSPEVLLGYQYTTAIDM 307
Query: 297 WSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHN 356
WSFGCIVAELFLGLPLFPG SEFD+LRRMI ILG QPPDYVLKEAKNT+KFFKC+GSVHN
Sbjct: 308 WSFGCIVAELFLGLPLFPGGSEFDILRRMIEILGKQPPDYVLKEAKNTNKFFKCVGSVHN 367
Query: 357 IENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416
+ NG G +SAY ALT E+EARE KKP IGKEYF+HK+LEEIV +YPY+ NL +D+
Sbjct: 368 LGNGGTYGGLKSAYMALTGEEFEAREKKKPEIGKEYFNHKNLEEIVKSYPYKINLPEDDV 427
Query: 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQN 476
KE+QIRLAL+DFLKGL+EFDPAKRWSPFQA++HPF+TGEPFTCPY PPPETPRV V QN
Sbjct: 428 VKETQIRLALIDFLKGLMEFDPAKRWSPFQAAKHPFITGEPFTCPYNPPPETPRVHVTQN 487
Query: 477 FKVDHHPGAGHWFAAGLSPNISGRSKFSMHNSPHFQVVPXXXXXXXXXXXXXXXXXXXXX 536
KVDHHPG GHWFAAGLSP++SGR++ MHNSPHFQ++P
Sbjct: 488 IKVDHHPGEGHWFAAGLSPHVSGRTRIPMHNSPHFQMMPYSHANSYGSIGSYGSYNDGTI 547
Query: 537 XXXXXXXXXXXXNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKMFIQYSQGNG---LG 593
N FAY+SPV G+ + Q GVS+ G+SPDAR+ +QY GNG LG
Sbjct: 548 QDNSYGSYGGTGNMFAYYSPVNHPGLYMQNQGGVSMLGTSPDARRRVMQYPHGNGPNGLG 607
Query: 594 VSPSAGMFVPLPLGTSPSQFTPPSSYGQVSSGSPGHYGPTSPARSSCHGSPLGKMTAATH 653
SPSAG F PLPLGTSPSQFTP ++ Q +GSPGH+GPTSP R+SCHGSPLGKM A +
Sbjct: 608 TSPSAGNFAPLPLGTSPSQFTPNTN-NQFLAGSPGHHGPTSPVRNSCHGSPLGKMAAFSQ 666
Query: 654 YNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVLGSASLHLPSNPSATSS 713
NRR + GYSG QSQ+S SQ QG +D + ++ Q GS S + +
Sbjct: 667 INRRMSAGYSGGSQSQDSSLSQA-QGHGMDNFYQNEG-YSGQFSGSPSRR-QLDSGVKNR 723
Query: 714 KQQRGGSGIAASYSAMPNMPSSLTRG---PAIAEAAH-DKPETSLSVPDPGDWDPNYSDE 769
KQ +GG+ ++ YS N SSL P+ + A H + P+T+LSVPDPGDWDPNYSD+
Sbjct: 724 KQTQGGTTLSTGYSTHNNANSSLRSNMYNPS-STAHHLENPDTALSVPDPGDWDPNYSDD 782
Query: 770 QLLQEDGSDESSITTEFSKAMHLSSADSSVGVGRFNRTSSASSNIP 815
LL+ED +DESS+ FS+ M L S D+S RFN +S SS+ P
Sbjct: 783 LLLEEDSADESSLANAFSRGMQLGSTDASSYSRRFNSNASTSSSNP 828
|
|
| ASPGD|ASPL0000065013 AN7104 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 1059 (377.8 bits), Expect = 1.1e-115, Sum P(4) = 1.1e-115
Identities = 211/421 (50%), Positives = 285/421 (67%)
Query: 49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXET- 107
T + TY+ICNP F Y NP+R LT PS GV NDGYDN +SD I E
Sbjct: 277 TNHLPATYRICNPNFHYESSRNPRRVLTKPSKGVKNDGYDNEDSDYILYVNDILGSEEAG 336
Query: 108 -QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
+ RY++ D+LG GTFGQV KC + + VAVK+IKN+ AY+ Q+++EVS+L LN +Y
Sbjct: 337 HKNRYLILDVLGQGTFGQVVKCQNLKTQEVVAVKVIKNKTAYFNQSMMEVSVLDLLNSRY 396
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
D+ D HH++R+ + F+ ++HLC+ FELL NLYELIK N FRGLS ++V++F++Q+L L
Sbjct: 397 DKNDDHHLLRLKDTFIHRQHLCLVFELLSVNLYELIKQNQFRGLSTTLVRVFAQQLLNAL 456
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
SLL A +IHCDLKPENILL P IK+IDFGSAC E +TVY+YIQSR+YRSPEVLL
Sbjct: 457 SLLNKAHLIHCDLKPENILLKNLESPI-IKVIDFGSACDERQTVYTYIQSRFYRSPEVLL 515
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
G Y++AIDMWS GCIV ELFLGLPLFPG+SE++ + R++ +LG PP ++L+ K + +
Sbjct: 516 GLPYSSAIDMWSLGCIVVELFLGLPLFPGSSEYNQVCRIVEMLGL-PPTWMLEMGKQSGE 574
Query: 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELK-KPLIGKEYFHHKHLEEIVTNY 405
FF E + G R +Y+ L +E +RE K K+YF LEEI+ +Y
Sbjct: 575 FF---------EKTQDEFG-RKSYR-LKSLEQYSREHNTKEQPSKKYFQASTLEEIIRSY 623
Query: 406 PY-RKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP 464
P RKN+ +I +E R+A +DF++GL+ +P +RWSP QA HPF+T + FT P+ P
Sbjct: 624 PMPRKNMKQAEIEREVNNRVAFIDFVRGLLSINPLERWSPQQAKLHPFITQQKFTGPFVP 683
Query: 465 P 465
P
Sbjct: 684 P 684
|
|
| DICTYBASE|DDB_G0283605 yakA "protein kinase, CMGC group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 9.3e-115, Sum P(3) = 9.3e-115
Identities = 210/425 (49%), Positives = 287/425 (67%)
Query: 49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQ 108
TK+++ Y+ CN F Y LNP+R LT PS + NDGYDNVNSD I E+
Sbjct: 143 TKNLLHFYKKCNSNFNYISSLNPRRVLTHPSEPLSNDGYDNVNSDYIVYVNDIITNNESG 202
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
++Y V D LG GTFGQV KC + + + VA+KI+KN+ AY+QQ +E+ L +LN ++D
Sbjct: 203 QKYKVLDSLGQGTFGQVVKCKNCDTDELVAIKILKNKQAYFQQGRLEIQTLKSLNDQHDP 262
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
EDK+HI+R+ + F+ + HLCI FELL NL+ELIK N+FRGLS +++++F QIL L +
Sbjct: 263 EDKNHILRLLDSFIHKMHLCIVFELLSVNLFELIKQNNFRGLSTNLIKVFLIQILDALIV 322
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
L +A IIHCDLKPENILL PA IKIIDFGSAC E T+Y+YIQSR+YRSPEVL+G
Sbjct: 323 LANANIIHCDLKPENILLQNVNSPA-IKIIDFGSACYEKSTLYTYIQSRHYRSPEVLVGT 381
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
Y +IDMWS GCI AELFLGLPLFPG SE++ + R++ + G P D + K +T F
Sbjct: 382 VYCASIDMWSLGCISAELFLGLPLFPGNSEYNQISRIVEMRGIFPSDLLDKGKSSTRYFH 441
Query: 349 KCIGS-VHNIENGEVSIGGRSAYQAL-TEIEYEARELKKPLI-GKEYFHHKHLEEIVTNY 405
+ +GS + N + G+ Y L +E +Y+ R+ K L+ K+YF++K L EI+ NY
Sbjct: 442 RHLGSNSDDNNNNNNNNNGKPYYYTLKSEEDYQ-RDSKTTLLPSKKYFNYKTLPEIIQNY 500
Query: 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP 465
++K++S +DI KE Q R+ DF+ GL++ DP +RWSP QA HPF+TG+P+ P+ P
Sbjct: 501 GFKKSMSPQDIEKEKQHRIVFTDFINGLLQLDPNERWSPMQAKEHPFITGQPYNGPFIPD 560
Query: 466 PETPR 470
P R
Sbjct: 561 PSKKR 565
|
|
| POMBASE|SPAC823.03 ppk15 "serine/threonine protein kinase Ppk15 (predicted)" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 1.2e-106, P = 1.2e-106
Identities = 211/413 (51%), Positives = 280/413 (67%)
Query: 49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQ 108
T + +TY ICNP F++S E NP+R LT PS GV N G+DNVN D + E
Sbjct: 69 TVKLADTYSICNPKFQFSSEQNPRRPLTKPSEGVHNHGFDNVNHDYVLYVNDLLGTDEG- 127
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
R+Y++ D LGHGTFGQVA+C D + VA+K+IKN+PA+Y Q ++EVSIL LN KYD
Sbjct: 128 RKYLILDTLGHGTFGQVARCQDLKTQQIVAIKVIKNKPAFYNQCVMEVSILELLNNKYDP 187
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
EDK H++R+Y+ F+ + HLC+ FELL NLYELIK N FRGL LS+V+ F+ Q+L SL
Sbjct: 188 EDKRHLIRLYDQFMHKNHLCLVFELLSINLYELIKQNQFRGLHLSLVRSFATQLLSCTSL 247
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
LK A IIHCDLKPENILL P +K+IDFGSAC E +TVY+YIQSR+YRSPEV+LG
Sbjct: 248 LKQARIIHCDLKPENILLQDLSSPI-VKVIDFGSACHERQTVYTYIQSRFYRSPEVILGL 306
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
Y IDMWS GCI+AELFLGLPLFPG SE++ L R++ +LG PP ++L+ KN+ K++
Sbjct: 307 HYNCGIDMWSLGCILAELFLGLPLFPGNSEYNQLCRIVDMLG-NPPTWMLEMGKNSKKYY 365
Query: 349 KCIGSVHNIENGEVSIGGRSAYQ--ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP 406
+G V+ GR Y+ ++ + E + ++P GK+YF K L+ IV NYP
Sbjct: 366 N---------SGFVN--GRKTYELKSIEQFSIENNKTEQP--GKQYFGEKTLDAIVLNYP 412
Query: 407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459
RK + + +E + RL +DF+K +E +P KRW+P QA HPF+TG F+
Sbjct: 413 RRKT-TPKLTPEEHEERLCFIDFIKQFLELNPLKRWTPDQAKNHPFITGASFS 464
|
|
| SGD|S000003677 YAK1 "Serine-threonine protein kinase" [Saccharomyces cerevisiae (taxid:4932)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
Identities = 198/419 (47%), Positives = 277/419 (66%)
Query: 49 TKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXXETQ 108
TK ++ TY +C+P F Y NPKR LT PS G N+G+DN+NSD I E
Sbjct: 308 TKSLITTYSLCSPEFTYQTSKNPKRVLTKPSEGKCNNGFDNINSDYILYVNDVLGV-EQN 366
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
R+Y+V D+LG GTFGQV KC + +AVK++K++ Y Q++ E IL LN+K D
Sbjct: 367 RKYLVLDILGQGTFGQVVKCQNLLTKEILAVKVVKSRTEYLTQSITEAKILELLNQKIDP 426
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+KHH +R+Y+ FV + HLC+ FELL +NLYEL+K N F GLS+ +++ F+ QIL L +
Sbjct: 427 TNKHHFLRMYDSFVHKNHLCLVFELLSNNLYELLKQNKFHGLSIQLIRTFTTQILDSLCV 486
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
LK++ +IHCDLKPENILLC KP E+KIIDFGS+C E RTVY+YIQSR+YR+PE++LG
Sbjct: 487 LKESKLIHCDLKPENILLCAPDKP-ELKIIDFGSSCEEARTVYTYIQSRFYRAPEIILGI 545
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
Y+T+IDMWS GCIVAELFLG+P+FPGASE++ L R+I LG PP +++ KN+ KF
Sbjct: 546 PYSTSIDMWSLGCIVAELFLGIPIFPGASEYNQLTRIIDTLG-YPPSWMIDMGKNSGKFM 604
Query: 349 KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408
K + + + + + + + E E ++KP K+YF + L +I+ NY Y
Sbjct: 605 KKLAPEESSSSTQ-----KHRMKTIEEFCREYNIVEKP--SKQYFKWRKLPDIIRNYRYP 657
Query: 409 KNL--SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP 465
K++ S E I +E Q R L+ FL G++ +P +RW+P QA HPF+T + FT + PP
Sbjct: 658 KSIQNSQELIDQEMQNRECLIHFLGGVLNLNPLERWTPQQAMLHPFITKQEFTGEWFPP 716
|
|
| FB|FBgn0259168 mnb "minibrain" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 639 (230.0 bits), Expect = 4.9e-73, Sum P(4) = 4.9e-73
Identities = 127/267 (47%), Positives = 176/267 (65%)
Query: 84 NDGYDNVNSDLIXXXXXXXXXXETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK 143
NDGYD+ N D I RY + L+G G+FGQV K +D E VA+KIIK
Sbjct: 142 NDGYDDDNHDYIIKNGEKFLD-----RYEIDSLIGKGSFGQVVKAYDHEEQCHVAIKIIK 196
Query: 144 NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIK 203
N+ + QA +EV +L +N+ D E+K++IV++ +F+ + HLC+ FELL NLY+L++
Sbjct: 197 NKKPFLNQAQIEVKLLEMMNRA-DAENKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLR 255
Query: 204 INHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
+FRG+SL++ + F++Q+ L L + IIHCDLKPENILLC + A IKI+DFG
Sbjct: 256 NTNFRGVSLNLTRKFAQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSA-IKIVDFG 314
Query: 262 SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
S+C + +Y YIQSR+YRSPEVLLG QY AIDMWS GCI+ E+ G PLF G +E D
Sbjct: 315 SSCQLGQRIYHYIQSRFYRSPEVLLGIQYDLAIDMWSLGCILVEMHTGEPLFSGCNEVDQ 374
Query: 322 LRRMIRILGAQPPDYVLKEAKNTSKFF 348
+ +++ +LG PP Y+L +A T KFF
Sbjct: 375 MNKIVEVLG-MPPKYLLDQAHKTRKFF 400
|
|
| RGD|1307223 Dyrk1b "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 635 (228.6 bits), Expect = 2.0e-70, Sum P(3) = 2.0e-70
Identities = 130/306 (42%), Positives = 193/306 (63%)
Query: 51 DIVETYQICNPLF-----KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXX 105
D+++TY+ N ++ + +++ P+ T VLN GYD+ N D I
Sbjct: 51 DLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKEKKVLNHGYDDDNHDYIVRSGERWL-- 108
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
RY + L+G G+FGQV K +D + VA+KIIKN+ A+ QA +E+ +L +N+
Sbjct: 109 ---ERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ- 164
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+D E K++IV + +F+ + HLC+ FELL NLY+L++ HFRG+SL++ + ++Q+
Sbjct: 165 HDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTA 224
Query: 226 LSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
L L + IIHCDLKPENILLC + A IKI+DFGS+C + +Y YIQSR+YRSPE
Sbjct: 225 LLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPE 283
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
VLLG Y AIDMWS GCI+ E+ G PLF G++E D + R++ +LG PP +L++A
Sbjct: 284 VLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPK 342
Query: 344 TSKFFK 349
K+F+
Sbjct: 343 ARKYFE 348
|
|
| UNIPROTKB|D4A382 D4A382 "Uncharacterized protein" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 635 (228.6 bits), Expect = 2.0e-70, Sum P(3) = 2.0e-70
Identities = 130/306 (42%), Positives = 193/306 (63%)
Query: 51 DIVETYQICNPLF-----KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXX 105
D+++TY+ N ++ + +++ P+ T VLN GYD+ N D I
Sbjct: 111 DLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKEKKVLNHGYDDDNHDYIVRSGERWL-- 168
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
RY + L+G G+FGQV K +D + VA+KIIKN+ A+ QA +E+ +L +N+
Sbjct: 169 ---ERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ- 224
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+D E K++IV + +F+ + HLC+ FELL NLY+L++ HFRG+SL++ + ++Q+
Sbjct: 225 HDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTA 284
Query: 226 LSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
L L + IIHCDLKPENILLC + A IKI+DFGS+C + +Y YIQSR+YRSPE
Sbjct: 285 LLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPE 343
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
VLLG Y AIDMWS GCI+ E+ G PLF G++E D + R++ +LG PP +L++A
Sbjct: 344 VLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPK 402
Query: 344 TSKFFK 349
K+F+
Sbjct: 403 ARKYFE 408
|
|
| MGI|MGI:1330302 Dyrk1b "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 635 (228.6 bits), Expect = 2.5e-70, Sum P(3) = 2.5e-70
Identities = 130/306 (42%), Positives = 193/306 (63%)
Query: 51 DIVETYQICNPLF-----KYSEELNPKRYLTSPSVGVLNDGYDNVNSDLIXXXXXXXXXX 105
D+++TY+ N ++ + +++ P+ T VLN GYD+ N D I
Sbjct: 51 DLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKEKKVLNHGYDDDNHDYIVRSGERWL-- 108
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
RY + L+G G+FGQV K +D + VA+KIIKN+ A+ QA +E+ +L +N+
Sbjct: 109 ---ERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIKNKKAFLNQAQIELRLLELMNQ- 164
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+D E K++IV + +F+ + HLC+ FELL NLY+L++ HFRG+SL++ + ++Q+
Sbjct: 165 HDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRNTHFRGVSLNLTRKLAQQLCTA 224
Query: 226 LSLLK--DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
L L + IIHCDLKPENILLC + A IKI+DFGS+C + +Y YIQSR+YRSPE
Sbjct: 225 LLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPE 283
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
VLLG Y AIDMWS GCI+ E+ G PLF G++E D + R++ +LG PP +L++A
Sbjct: 284 VLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMSRIVEVLGI-PPAPMLEQAPK 342
Query: 344 TSKFFK 349
K+F+
Sbjct: 343 ARKYFE 348
|
|
| ZFIN|ZDB-GENE-091015-3 dyrk4 "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 650 (233.9 bits), Expect = 9.8e-70, Sum P(2) = 9.8e-70
Identities = 125/252 (49%), Positives = 177/252 (70%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY V +++G G+FGQV KC D + N VA+KII+N+ ++ QALVE+ IL + ++ DR+
Sbjct: 211 RYEVLEVIGKGSFGQVLKCLDHKTNETVAIKIIRNKKRFHHQALVELKILDAVRRR-DRD 269
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ H+++ + EYF + HLCI FELL +NLYELIK N+F+G SL +++ F+ +L+ L +L
Sbjct: 270 NCHNVIHMKEYFYFRNHLCISFELLGANLYELIKKNNFQGFSLGLIRRFAHSLLKCLQML 329
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ 289
IIHCDLKPENILL + IK++DFGS+C E + VY+YIQSR+YRSPEV+LG+
Sbjct: 330 HKEKIIHCDLKPENILLSQRGQ-GNIKVVDFGSSCYEQQRVYTYIQSRFYRSPEVILGHP 388
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
Y+ AIDMWS GCI+AEL+ G PLFPG SE + + ++ I+G P D+V + A FF
Sbjct: 389 YSMAIDMWSLGCILAELYTGYPLFPGESEVEQIACIMEIMGLPPNDFV-QTASRRRLFFD 447
Query: 350 CIGSVHNIENGE 361
G+ NI N +
Sbjct: 448 SKGNPRNITNSK 459
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 820 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-66 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-54 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-53 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-53 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-48 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-45 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-42 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-40 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-39 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-39 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-38 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-37 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-37 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-37 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-36 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-36 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-35 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-35 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-34 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-34 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-33 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-33 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-33 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-33 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-33 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-32 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-32 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-31 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-31 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-31 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-30 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-30 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-29 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-29 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-29 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-29 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-29 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-28 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-27 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-27 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-27 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-27 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-27 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-27 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-25 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-25 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-24 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-24 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-04 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 0.002 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.002 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 1e-66
Identities = 75/222 (33%), Positives = 114/222 (51%), Gaps = 17/222 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDR 168
Y + + LG G+FG+V D + VA+K+IK + ++ L E+ IL L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHP--- 57
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
+IVR+Y+ F + L + E + +L++L+K LS + + +QIL L
Sbjct: 58 ----NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFYLRQILSALE 111
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVL 285
L GI+H DLKPENILL + +K+ DFG A + +++ + Y +PEVL
Sbjct: 112 YLHSKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
LG Y A+D+WS G I+ EL G P FPG + L + I
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 1e-56
Identities = 85/232 (36%), Positives = 130/232 (56%), Gaps = 28/232 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNK 164
Y + LG GT+G V K D + VA+K I+ P+ AL E+S+L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS---TALREISLL----- 52
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
+E KH +IV++ + +R L + FE D +L + + LS ++++ Q+L
Sbjct: 53 ---KELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLD-KRPGPLSPNLIKSIMYQLL 108
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSY-IQSRYY 279
RGL+ I+H DLKP+NIL+ + +K+ DFG A RT Y++ + + +Y
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILI--NRDG-VLKLADFGLARAFGIPLRT-YTHEVVTLWY 164
Query: 280 RSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
R+PE+LLG + Y+TA+D+WS GCI AE+ G PLFPG SE D L ++ +ILG
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 4e-54
Identities = 82/233 (35%), Positives = 116/233 (49%), Gaps = 22/233 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKYD 167
Y + LG G+FG V K VAVKI+K + Q A E+ IL L+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS---- 56
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
H +IVR+ + F + HL + E + +L++ + LS + + QILRG
Sbjct: 57 ----HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRG 110
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSP 282
L L GIIH DLKPENILL + +KI DFG A ++ +++ + +Y +P
Sbjct: 111 LEYLHSNGIIHRDLKPENILL---DENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 283 EVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
EVLLG Y +D+WS G I+ EL G P F G + D L+ + RILG
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE 220
|
Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 1e-53
Identities = 90/244 (36%), Positives = 134/244 (54%), Gaps = 27/244 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
+G GT+G V K D VA+K IK + AL E+ +L LN
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPN------- 59
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
I+++ + F + L + FE +D++LY+LIK RGL S+++ + Q+L+GL+ G
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-------YIQSRYYRSPEVLL 286
I+H DLKPEN+L+ T +K+ DFG A R+ S Y+ +R+YR+PE+LL
Sbjct: 119 ILHRDLKPENLLINT---EGVLKLADFGLA----RSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 287 G-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345
G Y+T +D+WS GCI AEL PLFPG SE D L ++ R LG P V + + +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT-PDPEVWPKFTSLA 230
Query: 346 KFFK 349
+ +K
Sbjct: 231 RNYK 234
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 4e-53
Identities = 104/391 (26%), Positives = 155/391 (39%), Gaps = 92/391 (23%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKY 166
RY + +G G +G V D VA+K I N ++ L E+ +L L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL---- 56
Query: 167 DREDKH-HIVRIYEYFV-----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
+H +I+ + + + I EL++++L+++IK L+ +Q F
Sbjct: 57 ----RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQP--LTDDHIQYFLY 110
Query: 221 QILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG---SACTEDRTVY--- 271
QILRGL L A +IH DLKP NIL+ C ++KI DFG ++
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNC------DLKICDFGLARGVDPDEDEKGFLT 164
Query: 272 SYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
Y+ +R+YR+PE+LL YT AID+WS GCI AEL PLFPG D L ++ +LG
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
+ K I S +AR K L K
Sbjct: 225 TPSEE-----------DLKFITSE------------------------KARNYLKSLPKK 249
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
K L ++ A+ D L+ ++ FDP KR + +A H
Sbjct: 250 P---KKPLSKLFPGAS----------------PEAI-DLLEKMLVFDPKKRITADEALAH 289
Query: 451 PFVTGEPFTCPYQPPPETPRVPVAQNFKVDH 481
P++ P P P +
Sbjct: 290 PYL--AQLHDPEDEPVAKPPFDFDFFDDDEL 318
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 8e-50
Identities = 85/226 (37%), Positives = 126/226 (55%), Gaps = 16/226 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ--ALVEVSILTTLNKKYDR 168
Y V LG GTFG V + E VA+K +K + +++ L EV L LN+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE---- 56
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
H +IV++ E F L FE ++ NLY+L+K + S S+++ QIL+GL+
Sbjct: 57 ---HPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVY-SYIQSRYYRSPEVL 285
+ G H DLKPEN+L+ +KI DFG A R Y Y+ +R+YR+PE+L
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170
Query: 286 LGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
L Y++ +D+W+ GCI+AEL+ PLFPG+SE D L ++ +LG
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG 216
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 1e-48
Identities = 74/219 (33%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG V D + VA+KIIK + + ++ L E+ IL LN +I
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP-------NI 53
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
V++Y F + HL + E + +L +L+K + LS + QIL GL L G
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSNG 112
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVLLGYQ- 289
IIH DLKPENILL ++K+ DFG + ++ + + + + Y +PEVLLG
Sbjct: 113 IIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEF-DLLRRMIR 327
Y+ D+WS G I+ EL E DL+R+M++
Sbjct: 171 YSEKSDIWSLGVILYEL----------PELKDLIRKMLQ 199
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 79/249 (31%), Positives = 122/249 (48%), Gaps = 33/249 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ------ALVEVSILTTLN 163
RY LG GT+ V K D E VA+K IK + AL E+ +L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL---- 56
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+E KH +I+ + + F + ++ + FE ++++L ++IK L+ + ++ +
Sbjct: 57 ----QELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV-LTPADIKSYMLMT 111
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSY-IQSRYY 279
LRGL L I+H DLKP N+L+ +K+ DFG A + ++ + +R+Y
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168
Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG-------- 330
R+PE+L G Y +DMWS GCI AEL L +P PG S+ D L ++ LG
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228
Query: 331 --AQPPDYV 337
PDYV
Sbjct: 229 GVTSLPDYV 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 81/244 (33%), Positives = 126/244 (51%), Gaps = 23/244 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
+Y V ++G G +G V KC + VA+K K + + AL EV +L L
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL---- 57
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+H +IV + E F + L + FE ++ L EL++ + GL V+ + Q+L+
Sbjct: 58 ----RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQA 112
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSA----CTEDRTVYSYIQSRYYR 280
++ IIH D+KPENIL V + +K+ DFG A + Y+ +R+YR
Sbjct: 113 IAYCHSHNIIHRDIKPENIL----VSESGVLKLCDFGFARALRARPASPLTDYVATRWYR 168
Query: 281 SPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
+PE+L+G Y +D+W+ GCI+AEL G PLFPG S+ D L + + LG PP +
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL 228
Query: 340 EAKN 343
+ N
Sbjct: 229 FSSN 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 101/356 (28%), Positives = 155/356 (43%), Gaps = 81/356 (22%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
RY + +G G G V K D E VA+K + + + QAL E+ L Y
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+V++ + F + E + S+L E+++ + R L + V+ + + +L+G+
Sbjct: 61 -------VVKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGV 112
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSY-IQSRYYRSP 282
+ + GI+H DLKP N+L+ +KI DFG A E+ +YS+ + +R+YR+P
Sbjct: 113 AYMHANGIMHRDLKPANLLISAD---GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
Query: 283 EVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
E+L G + Y +D+W+ GCI AEL G PLFPG ++ + L + R LG
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE------- 222
Query: 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK---HL 398
E L P K F L
Sbjct: 223 ---------------------------------ETWPGLTSL--PDYNKITFPESKPIPL 247
Query: 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454
EEI P D S E+ +D LKGL+ +DP+KR S +A RHP+ T
Sbjct: 248 EEIF---P--------DASPEA------LDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 110/388 (28%), Positives = 163/388 (42%), Gaps = 97/388 (25%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
RY +G G +G V VA+K I + Q+ L E+ IL
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF----- 60
Query: 168 REDKH-HIVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
KH +I+ I + + I EL++++LY+LIK H LS +Q F
Sbjct: 61 ---KHENIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQH---LSNDHIQYFLY 113
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED------RTVYSYI 274
QILRGL + A ++H DLKP N+LL T+ ++KI DFG A D + Y+
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 275 QSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
+R+YR+PE++L YT AID+WS GCI+AE+ PLFPG D L ++ ILG
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK---DYLHQLNLILG--- 224
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
VL + + CI S+ AR K L
Sbjct: 225 ---VLGTP--SQEDLNCIISL------------------------RARNYIKSL------ 249
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF- 452
P++ + + + AL D L ++ F+P KR + +A HP+
Sbjct: 250 ------------PFKPKVPWNKLFPNAD-PKAL-DLLDKMLTFNPHKRITVEEALAHPYL 295
Query: 453 ----------VTGEPFTCPYQPPPETPR 470
V EPF ++ + P+
Sbjct: 296 EQYHDPSDEPVAEEPFPFDFELFDDLPK 323
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 108/381 (28%), Positives = 168/381 (44%), Gaps = 111/381 (29%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQP-AYYQQALVEVSILTTLN 163
R+Y + LG G +G V K D VA+K I +N A Q+ E+ L L
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA--QRTFREIMFLQELG 64
Query: 164 KKYDREDKHHIVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK- 220
D +IV++ + + + + FE ++++L+ +I+ N I++ K
Sbjct: 65 ------DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN--------ILEDVHKR 110
Query: 221 ----QILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS- 272
Q+L+ L + +IH DLKP NILL C +K+ DFG A R++
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR------VKLADFGLA----RSLSEL 160
Query: 273 -----------YIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320
Y+ +R+YR+PE+LLG +YT +DMWS GCI+ E+ LG PLFPG S +
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220
Query: 321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEA 380
L ++I ++G PP S +IE SI S + A T ++
Sbjct: 221 QLEKIIEVIG--PP------------------SAEDIE----SIK--SPFAA-TMLDSLP 253
Query: 381 RELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAK 440
+KP L+E++ +D +D LK L+ F+P K
Sbjct: 254 SRPRKP-----------LDELLPKAS-------DDA----------LDLLKKLLVFNPNK 285
Query: 441 RWSPFQASRHPFVTGEPFTCP 461
R + +A HP+V F P
Sbjct: 286 RLTAEEALEHPYV--AQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 83/251 (33%), Positives = 127/251 (50%), Gaps = 28/251 (11%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDR 168
Y + +G GTF +V K + + A+K +K +Q L E+ L L+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----- 55
Query: 169 EDKHHIVRIYEYFVCQRH--LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+I+R+ E ++ L + FEL+D NLYELIK R L V+ + Q+L+ L
Sbjct: 56 -PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIK-GRKRPLPEKRVKSYMYQLLKSL 113
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS------YIQSRYYR 280
+ GI H D+KPENIL+ K +K+ DFGS R +YS YI +R+YR
Sbjct: 114 DHMHRNGIFHRDIKPENILI----KDDILKLADFGSC----RGIYSKPPYTEYISTRWYR 165
Query: 281 SPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
+PE LL GY Y +D+W+ GC+ E+ PLFPG +E D + ++ +LG + +
Sbjct: 166 APECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224
Query: 339 KEAKNTSKFFK 349
K K+ +
Sbjct: 225 KFRKSRHMNYN 235
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 77/235 (32%), Positives = 118/235 (50%), Gaps = 27/235 (11%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYD 167
Y +G G +G V K D FVA+K ++ ++ L E+++L K+ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALL----KQLE 56
Query: 168 REDKHHIVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+ +IVR+ + R L + FE +D +L + GL ++ +Q+
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR----- 277
LRG+ L I+H DLKP+NIL+ + ++KI DFG A +YS+ +
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLA-----RIYSFEMALTSVVV 168
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
+YR+PEVLL Y T +DMWS GCI AELF PLF G SE D L ++ ++G
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 82/235 (34%), Positives = 125/235 (53%), Gaps = 32/235 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
+Y L+G G++G V KC E VA+K ++ + A+ E+ +L L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL---- 57
Query: 167 DREDKHH--IVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
H +V + E F ++ L + FE +D L +L K + GL S V+ + QIL
Sbjct: 58 -----RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQIL 110
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS-------YIQS 276
RG+ IIH D+KPENIL+ S +K+ DFG A RT+ + Y+ +
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFA----RTLAAPGEVYTDYVAT 163
Query: 277 RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
R+YR+PE+L+G +Y A+D+W+ GC+V E+ G PLFPG S+ D L +I+ LG
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 6e-37
Identities = 80/272 (29%), Positives = 119/272 (43%), Gaps = 67/272 (24%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
E RY +G G +GQV +D + VA+K K
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------------------------K 47
Query: 166 YDR--EDKHHIVRIYEYFVCQRHLC----ICF--------------------ELLDSNLY 199
R + H R Y +H+ I L+ ++L
Sbjct: 48 LSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLN 107
Query: 200 ELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIK 256
++K + LS +Q QILRGL + AGIIH DLKP NI + C E+K
Sbjct: 108 NIVK---CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC------ELK 158
Query: 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPG 315
I+DFG A D + Y+ +R+YR+PE++L + Y +D+WS GCI+AEL G LFPG
Sbjct: 159 ILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
Query: 316 ASEFDLLRRMIRILGAQPPDYVLK----EAKN 343
+ D L+R++ ++G + + K A+N
Sbjct: 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARN 250
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 77/247 (31%), Positives = 114/247 (46%), Gaps = 55/247 (22%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNK 164
Y +G GT+GQV K + + VA+K I+ + P A+ E+ +L L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP---ITAIREIKLLQKLRH 57
Query: 165 KYDREDKHHIVRIYE----------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
+IVR+ E Y V FE +D +L L+ + +
Sbjct: 58 P-------NIVRLKEIVTSKGKGSIYMV--------FEYMDHDLTGLL---DSPEVKFTE 99
Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
Q+ + KQ+L GL L GI+H D+K NIL+ +K+ DFG A R
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND---GVLKLADFGLA----RPYTK 152
Query: 273 YIQSRY--------YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
+ Y YR PE+LLG +Y +DMWS GCI+AELFLG P+F G++E + L
Sbjct: 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212
Query: 324 RMIRILG 330
++ + G
Sbjct: 213 KIFELCG 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-37
Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 20/241 (8%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDREDK 171
+ + +G G FG+V K VA+K+IK ++ + E+ IL
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPN----- 58
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
IV+ Y ++ + L I E +L +L+K + + L+ S + K++L+GL L
Sbjct: 59 --IVKYYGSYLKKDELWIVMEFCSGGSLKDLLK-STNQTLTESQIAYVCKELLKGLEYLH 115
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGY 288
GIIH D+K NILL + E+K+IDFG + ++ + + + + Y+ +PEV+ G
Sbjct: 116 SNGIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348
Y D+WS G EL G P + SE ++ + +I A L+ + S F
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKI--ATNGPPGLRNPEKWSDEF 227
Query: 349 K 349
K
Sbjct: 228 K 228
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 104/392 (26%), Positives = 167/392 (42%), Gaps = 92/392 (23%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKY 166
RY + +G G +G V D VA+K I + P ++ L E+ IL
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKIL------- 58
Query: 167 DREDKH-HIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSK 220
R KH +I+ I + + + + +L++S+L+ +I H L+ ++ F
Sbjct: 59 -RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII---HSDQPLTEEHIRYFLY 114
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CT--EDRTVY--SY 273
Q+LRGL + A +IH DLKP N+L+ + E++I DFG A + + + Y
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 274 IQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
+ +R+YR+PE+LL +YTTAIDMWS GCI AE+ LFPG + L+ ++ +LG
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG-S 230
Query: 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY 392
P + VL IGS + + I +
Sbjct: 231 PSEEVLNR----------IGS----------------------------DRVRKYI--QN 250
Query: 393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
K +P S E+ +D L +++FDP +R + QA +HPF
Sbjct: 251 LPRKQPVPWSKIFP--------KASPEA------LDLLSQMLQFDPEERITVEQALQHPF 296
Query: 453 VTGEPFTCPYQPPPETPRVPVAQNFKVDHHPG 484
+ Y P + P P +F +
Sbjct: 297 LAQ------YHDPDDEPTCPPPFDFDFEAIEL 322
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 84/251 (33%), Positives = 129/251 (51%), Gaps = 21/251 (8%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
E RY+ +G G FG V D VA+K I P ++ E+ +L L
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 163 NKKYDREDKHHIVRIYEYFVCQRH-LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
+ +I+ + + F+ + ELL ++L+ L+ R L +Q F Q
Sbjct: 67 RHE-------NIISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQ 116
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
ILRGL + AG++H DLKP NIL+ + ++KI DFG A +D + Y+ +RYYR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINEN---CDLKICDFGLARIQDPQMTGYVSTRYYRA 173
Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
PE++L +Q Y +D+WS GCI AE+ G PLFPG + + +LG PPD V+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG-TPPDDVINT 232
Query: 341 --AKNTSKFFK 349
++NT +F +
Sbjct: 233 ICSENTLRFVQ 243
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 100/345 (28%), Positives = 155/345 (44%), Gaps = 77/345 (22%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKH- 172
+G G++G V KC + E VA+K ++ P + AL E+ +L L KH
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL--------KHP 60
Query: 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
++V + E F +R L + FE D + L EL K + RG+ +++ Q L+ ++
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLG- 287
IH D+KPENIL+ K +IK+ DFG A Y+ +R+YR+PE+L+G
Sbjct: 119 HNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
QY +D+W+ GC+ AEL G PL+PG S+ D L + + LG P + ++ +T++F
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH--QQIFSTNQF 233
Query: 348 FKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPY 407
FK L+ E E RE LE N
Sbjct: 234 FK----------------------GLSIPEPETREP--------------LESKFPNISS 257
Query: 408 RKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
+ FLKG ++ DP +R S + HP+
Sbjct: 258 PA-----------------LSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 72/244 (29%), Positives = 118/244 (48%), Gaps = 31/244 (12%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVK---IIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
LLG G+FG V D + +AVK + + + E+ IL++L
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHP------- 59
Query: 173 HIVRIY--EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+IVR Y E + L I E + +L L+K F L +++ +++QIL GL+ L
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTRQILEGLAYL 117
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRSPE 283
GI+H D+K NIL+ + +K+ DFG A T + T S + Y+ +PE
Sbjct: 118 HSNGIVHRDIKGANILVDSD---GVVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPE 173
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP----PDYVLK 339
V+ G +Y A D+WS GC V E+ G P P + + + + +I + P+++ +
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKP--PWSELGNPMAALYKIGSSGEPPEIPEHLSE 231
Query: 340 EAKN 343
EAK+
Sbjct: 232 EAKD 235
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 74/222 (33%), Positives = 125/222 (56%), Gaps = 19/222 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
LG GT+ V K + VA+K I + A+ E+S++ +E KH +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLM--------KELKHEN 59
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKIN-HFRGLSLSIVQLFSKQILRGLSLLKDA 232
IVR+++ + L + FE +D +L + + + L + V+ F+ Q+L+G++ +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLGYQ 289
++H DLKP+N+L+ K E+K+ DFG A T + + + +YR+P+VLLG +
Sbjct: 120 RVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 290 -YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
Y+T+ID+WS GCI+AE+ G PLFPG + D L ++ RI+G
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 87/269 (32%), Positives = 127/269 (47%), Gaps = 39/269 (14%)
Query: 105 AETQRRYIVKD-LLGHGTFGQVAKCWDAEMNSFVAVKIIKN-----QPAYYQQALVEVSI 158
RYI K LG GT+G+V K +D VA+K +K +Q + I
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 159 -LTTLNK-KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
TTL + K E KH +I+ + + +V + + +++ S+L +++ L+ S V
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR--LTESQV 121
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--- 272
+ QIL GL++L +H DL P NI + KI DFG A R Y
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLA---RRYGYPPYS 175
Query: 273 -------YIQSR----------YYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFP 314
+Q R +YR+PE+L+G + Y A+DMWS GCI AEL G PLFP
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235
Query: 315 GASEFDLLRRMIRILGAQPPDYVLKEAKN 343
G +E D L R+ +LG P + +AK
Sbjct: 236 GENEIDQLGRIFELLGT-PNEDNWPQAKK 263
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 77/225 (34%), Positives = 122/225 (54%), Gaps = 25/225 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDRED 170
+G GT+G V K D VA+K I+ + P+ A+ E+S+L +E
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS---TAIREISLL--------KEL 55
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
H +IVR+ + + L + FE LD +L + + + GL +++ + Q+L+G++
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLL 286
++H DLKP+N+L+ +K+ DFG A V +Y + + +YR+PE+LL
Sbjct: 116 HSHRVLHRDLKPQNLLIDRE---GALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 172
Query: 287 G-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
G QY+T +D+WS GCI AE+ PLFPG SE D L R+ R LG
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 135 bits (339), Expect = 3e-34
Identities = 84/339 (24%), Positives = 138/339 (40%), Gaps = 42/339 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
Y + LG G+FG+V D VA+K++ ++ ++ L E+ IL +LN
Sbjct: 2 YRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLN--- 55
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG-LSLSIVQLFSKQILR 224
+IV++Y++F + L + E +D +L +L+K +G LS S QIL
Sbjct: 56 ---HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---------TEDRTVYSYIQ 275
L L GIIH D+KPENILL +K+IDFG A + + +
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDR--DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 276 SRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
+ Y +PEVLLG +++ D+WS G + EL GLP F G + ++I+
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230
Query: 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY 392
P + + +S + L + + R + +
Sbjct: 231 PTPSLASP-------------LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLK 431
H L+E + + + S AL+ L
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLN 316
|
Length = 384 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 82/231 (35%), Positives = 125/231 (54%), Gaps = 23/231 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
+Y + +G GT+G V K + E + VA+K ++ + AL E+ +L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL------- 53
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILR 224
+E KH +IVR+Y+ + L + FE D +L + + G + IV+ F Q+L+
Sbjct: 54 -KELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYF--DSCNGDIDPEIVKSFMFQLLK 110
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRS 281
GL+ ++H DLKP+N+L+ K E+K+ DFG A V Y + + +YR
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRP 167
Query: 282 PEVLLGYQ-YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILG 330
P+VL G + Y+T+IDMWS GCI AEL G PLFPG D L+R+ R+LG
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 105/366 (28%), Positives = 162/366 (44%), Gaps = 93/366 (25%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN--SFVAVKIIKN---QPAYYQQALVEVSIL----- 159
RY + LG G +G V +AE + VA+K I N + ++AL E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 160 ----TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
T L YD + IV + L + EL++++L+++I+ + L+ +
Sbjct: 61 HKNITCL---YDMD----IVFPGNF----NELYLYEELMEADLHQIIRSG--QPLTDAHF 107
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-------TEDR 268
Q F QIL GL + A ++H DLKP N LL + E+KI DFG A
Sbjct: 108 QSFIYQILCGLKYIHSANVLHRDLKPGN-LLVNA--DCELKICDFGLARGFSENPGENAG 164
Query: 269 TVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+ Y+ +R+YR+PE++L +Q YT AID+WS GCI+AEL P+F G D L ++++
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
Query: 328 ILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
+LG P + L + K I S+ NI KKP
Sbjct: 225 VLGT-PDEETLSRIG-SPKAQNYIRSLPNIP-------------------------KKP- 256
Query: 388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQA 447
+ +P L+ +D L+ L+ FDP KR S +A
Sbjct: 257 -------------FESIFPNANPLA--------------LDLLEKLLAFDPTKRISVEEA 289
Query: 448 SRHPFV 453
HP++
Sbjct: 290 LEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 80/243 (32%), Positives = 126/243 (51%), Gaps = 26/243 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA---LVEVSILTTLNKKY 166
RY +++++G G++G V D VA+K I + + A L E+ +L L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 167 DREDKHHIV----RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
E KH ++ R + + + + FEL++S+L+++IK N L+ Q F Q+
Sbjct: 61 IVEIKHIMLPPSRREF------KDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQL 112
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR--TVY--SYIQS 276
LR L + A + H DLKP+NIL K +KI DFG A D ++ Y+ +
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 277 RYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
R+YR+PE+ + +YT AID+WS GCI AE+ G PLFPG + L + +LG P
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
Query: 335 DYV 337
+ +
Sbjct: 230 ETI 232
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 81/241 (33%), Positives = 129/241 (53%), Gaps = 28/241 (11%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-----YQQALVEVSILT 160
E +Y+ +G G +G V ++E N VA+K I N A+ ++ L E+ +L
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN--AFDNRIDAKRTLREIKLLR 59
Query: 161 TLNKKYDREDKHHIVRIYEYF--VCQRH---LCICFELLDSNLYELIKINHFRGLSLSIV 215
L D +++ I + + + I +EL+D++L+++I+ + + LS
Sbjct: 60 HL-------DHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHC 110
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT---VYS 272
Q F Q+LRGL + A ++H DLKP N+LL + ++KI DFG A T +
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTE 167
Query: 273 YIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
Y+ +R+YR+PE+LL +YTTAID+WS GCI AEL PLFPG L+ + +LG+
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227
Query: 332 Q 332
Sbjct: 228 P 228
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 6e-33
Identities = 104/372 (27%), Positives = 167/372 (44%), Gaps = 75/372 (20%)
Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
++ TQR I+ LLG GTFG+V + WD + + AVKI++N P Y + A +E+ + +
Sbjct: 124 IDVSTQRFKILS-LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKV 182
Query: 163 NKKYDREDKHHIVRIYEYFVCQR-HLCICFELLDSNLYELI----KINHFRGLSLSIVQL 217
++ D D+ +++I YF + H+CI L + I +H R L+ I Q
Sbjct: 183 -RQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH-RHLAQIIFQT 240
Query: 218 FSKQILRGLSL---LKDAGIIHCDLKPENILLCTS-------------VKPAEIKIIDFG 261
G++L + ++H DLKPENIL+ TS P ++I D G
Sbjct: 241 -------GVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293
Query: 262 SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
C E + + + +R+YRSPEV+LG + + DMWS GCI+ EL+ G L+ +
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEAR 381
L M + LG P ++ + + R Y + ++ R
Sbjct: 354 LHLMEKTLGRLPSEWAGRCGTEEA---------------------RLLYNSAGQL----R 388
Query: 382 ELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKR 441
P KHL I P R+ + +D+ L D + GL+ +D KR
Sbjct: 389 PCTDP---------KHLARIARARPVREVIR-DDL---------LCDLIYGLLHYDRQKR 429
Query: 442 WSPFQASRHPFV 453
+ Q + HP+V
Sbjct: 430 LNARQMTTHPYV 441
|
Length = 467 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 78/233 (33%), Positives = 127/233 (54%), Gaps = 20/233 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ--QALVEVSILTTLNKKYDR 168
Y D LG G++ V K VA+K I+ + A+ E S+L L
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL------ 60
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
KH +IV +++ ++ L + FE LD++L + + + GLS+ V+LF Q+LRGL+
Sbjct: 61 --KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMD-DCGGGLSMHNVRLFLFQLLRGLA 117
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEV 284
++H DLKP+N+L+ E+K+ DFG A + +T + + + +YR P+V
Sbjct: 118 YCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174
Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE-FDLLRRMIRILGAQPPD 335
LLG +Y+T++DMW GCI E+ G PLFPG+++ D L ++ R+LG +
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 8e-33
Identities = 77/233 (33%), Positives = 123/233 (52%), Gaps = 18/233 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKY 166
++ V ++G G +G V KC E VA+K K+ + L E+ +L TL ++
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE- 60
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+IV + E F + L + FE ++ N+ EL++ G+ V+ + Q+++ +
Sbjct: 61 ------NIVELKEAFRRRGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAI 113
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT----EDRTVYSYIQSRYYRSP 282
I+H D+KPEN+L+ + +K+ DFG A + Y+ +R+YRSP
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHN---DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
E+LLG Y A+DMWS GCI+ EL G PLFPG SE D L + ++LG P +
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 78/229 (34%), Positives = 123/229 (53%), Gaps = 19/229 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
+G GT+G V K + VA+K I+ A+ E+S+L LN +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP-------N 60
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
IV++ + + L + FE L +L + + + G+ L +++ + Q+L+GL+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLGYQ- 289
++H DLKP+N+L+ T IK+ DFG A V +Y + + +YR+PE+LLG +
Sbjct: 121 VLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
Y+TA+D+WS GCI AE+ LFPG SE D L R+ R LG PD V+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT--PDEVV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 69/262 (26%), Positives = 111/262 (42%), Gaps = 57/262 (21%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
+ ++G G+F V + E N A+KI+ + + +E +LT LN
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--- 59
Query: 167 DREDKHH--IVRIYE--------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
H I+++Y YFV + ELL I + L +
Sbjct: 60 -----GHPGIIKLYYTFQDEENLYFVLE--YAPNGELLQ-------YIRKYGSLDEKCTR 105
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC------------ 264
++ +IL L L GIIH DLKPENILL K IKI DFG+A
Sbjct: 106 FYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNK 162
Query: 265 ---TEDRTVYSYIQSRY--------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
T + + R+ Y SPE+L + D+W+ GCI+ ++ G P F
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
Query: 314 PGASEFDLLRRMIRILGAQPPD 335
G++E+ ++++++ + PP+
Sbjct: 223 RGSNEYLTFQKILKLEYSFPPN 244
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-32
Identities = 86/252 (34%), Positives = 137/252 (54%), Gaps = 28/252 (11%)
Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
+N + Y + +++G+G+FG V + + + VA+K + P Y + L+ + L +
Sbjct: 60 INRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI 119
Query: 163 NKKYDREDKHHIVRIYEYFVCQRH------LCICFELLDSNLYELIKI----NHFRGLSL 212
N + ++ Y Y C + L + E + +++ +K NH L L
Sbjct: 120 NIIFLKD--------YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH--ALPL 169
Query: 213 SIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRT 269
+V+L+S Q+ R L+ + I H DLKP+N+L+ +K+ DFGSA R+
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFGSAKNLLAGQRS 227
Query: 270 VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
V SYI SR+YR+PE++LG YTT ID+WS GCI+AE+ LG P+F G S D L R+I++
Sbjct: 228 V-SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286
Query: 329 LGAQPPDYVLKE 340
LG P + LKE
Sbjct: 287 LGT-PTEDQLKE 297
|
Length = 440 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 76/221 (34%), Positives = 115/221 (52%), Gaps = 22/221 (9%)
Query: 120 GTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKYDREDKH-HIV 175
GT+G V + D + VA+K +K + + +L E++IL L H +IV
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ--------HPNIV 67
Query: 176 RIYEYFV--CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
+ E V + + E ++ +L L++ + S V+ Q+L G++ L D
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW 126
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ-SRYYRSPEVLLGY-Q 289
I+H DLK N+LL +KI DFG A Y+ + + +YR+PE+LLG +
Sbjct: 127 ILHRDLKTSNLLLNNR---GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
Y+TAIDMWS GCI AEL PLFPG SE D L ++ ++LG
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG 224
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 72/235 (30%), Positives = 112/235 (47%), Gaps = 27/235 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
Y + DL+G G FG V K + E FVA+K I K + + + E+ +L L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
+IV+ L I E ++ +L ++IK F S+V ++ Q+L+G
Sbjct: 59 -----PNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQG 111
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSP 282
L+ L + G+IH D+K NIL K +K+ DFG A + S + + Y+ +P
Sbjct: 112 LAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQ-PP 334
EV+ +TA D+WS GC V EL G P + +DL + + RI+ PP
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPPY-----YDLNPMAALFRIVQDDHPP 218
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 106/370 (28%), Positives = 154/370 (41%), Gaps = 89/370 (24%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDRED 170
+G GT+G V + D VA+K ++ P +L E+++L L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPI---SSLREITLLLNL-------- 63
Query: 171 KHH--IVRIYEYFVCQR--HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
H IV + E V + + + E + +L L+ N S S V+ Q+LRGL
Sbjct: 64 -RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-NMPTPFSESQVKCLMLQLLRGL 121
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPE 283
L + IIH DLK N+LL +KI DFG A T + + +YR+PE
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPE 178
Query: 284 VLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
+LLG YTTAIDMW+ GCI+AEL PL PG SE + L +I++LG P +
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT-PNE------- 230
Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
+I G + L PL+GK +
Sbjct: 231 -------------SIWPG---------FSDL------------PLVGKFTLPKQ------ 250
Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
PY NL + S+ L L++F L+ +DP KR + +A + +P C
Sbjct: 251 ---PY-NNLKHK-FPWLSEAGLRLLNF---LLMYDPKKRATAEEALESSYFKEKPLPC-- 300
Query: 463 QPPPETPRVP 472
P P P
Sbjct: 301 -EPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 75/222 (33%), Positives = 120/222 (54%), Gaps = 18/222 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKH- 172
+G GT+G V K D N +A+K I+ A+ E+S+L +E +H
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLL--------KEMQHG 61
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
+IVR+ + ++ L + FE LD +L + + + + +++ + QILRG++
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLG-Y 288
++H DLKP+N+L+ +K+ DFG A RT + + +YR+PE+LLG
Sbjct: 122 RVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
Y+T +D+WS GCI AE+ PLFPG SE D L ++ RILG
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG 221
|
Length = 294 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 105/380 (27%), Positives = 167/380 (43%), Gaps = 87/380 (22%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNK 164
+RY +G G G V +D VA+K + ++P + ++A E+ ++ +N
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 165 KYDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIK--INHFRGLSLSIVQ 216
K +I+ + F Q+ + + EL+D+NL ++I+ ++H R +S + Q
Sbjct: 75 K-------NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER-MSYLLYQ 126
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACT--EDRTVY 271
+ L G+ L AGIIH DLKP NI++ CT +KI+DFG A T +
Sbjct: 127 M-----LCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 175
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
Y+ +RYYR+PEV+LG Y +D+WS GCI+ E+ G LFPG D ++I LG
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235
Query: 332 QPPDYVLKEAKNTSKFFKCIG-SVHN-IENGEVSIGGRSAYQALTEIEYEARELKKPLIG 389
+ F + +V N +EN R Y +
Sbjct: 236 PSDE-----------FMSRLQPTVRNYVEN-------RPKYAGYS--------------- 262
Query: 390 KEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASR 449
EE+ + + + + K SQ R D L ++ DP KR S A +
Sbjct: 263 --------FEELFPDVLFPPDSESHNKLKASQAR----DLLSKMLVIDPEKRISVDDALQ 310
Query: 450 HPFVT--GEPFTCPYQPPPE 467
HP++ +P PPP
Sbjct: 311 HPYINVWYDPSEV-EAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 78/233 (33%), Positives = 118/233 (50%), Gaps = 31/233 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
+G GT+G+V K D VA+K + ++ AL E+S+L L++ +
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES------IY 62
Query: 174 IVRIYEYFVCQRH---------LCICFELLDSNLYELIKINH---FRGLSLSIVQLFSKQ 221
IVR+ + H L + FE LDS+L + + N R L ++ F Q
Sbjct: 63 IVRL----LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRY 278
+L+G++ G++H DLKP+N+L+ +KI D G V SY I + +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQK--GLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
YR+PEVLLG Y+T +D+WS GCI AE+ PLFPG SE L + ++LG
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 81/240 (33%), Positives = 119/240 (49%), Gaps = 39/240 (16%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LG G+ G V D++ + VAVK I+ P + AL E+ I+ L D +IV
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-------DHDNIV 65
Query: 176 RIYEYFVCQRH--------------LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
++YE + I E ++++L +++ LS +LF Q
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFMYQ 122
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------I 274
+LRGL + A ++H DLKP N+ + T + +KI DFG A D YS+ +
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINT--EDLVLKIGDFGLARIVDPH-YSHKGYLSEGL 179
Query: 275 QSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
+++YRSP +LL YT AIDMW+ GCI AE+ G PLF GA E L +M IL + P
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE---LEQMQLILESVP 236
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 79/257 (30%), Positives = 130/257 (50%), Gaps = 31/257 (12%)
Query: 106 ETQRRYIVKDLL--GHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILT 160
E RY +DL G G +G V D + VA+K + + ++A E+ +L
Sbjct: 12 EVPDRY--RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL- 68
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGLSLSI 214
K+ + + +++ + + F L + + ++L +L+K LS
Sbjct: 69 ----KHMKHE--NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDR 119
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
+Q Q+L+GL + AGIIH DLKP N+ + + E+KI+DFG A D + Y+
Sbjct: 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQTDSEMTGYV 176
Query: 275 QSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
+R+YR+PEV+L + YT +D+WS GCI+AE+ G PLF G D L ++++ G
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 334 PDYVLK----EAKNTSK 346
++V K +AKN K
Sbjct: 237 KEFVQKLQSEDAKNYVK 253
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 74/251 (29%), Positives = 116/251 (46%), Gaps = 39/251 (15%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--IIKNQP-AYYQQALVEVSILTTLN 163
R Y + LG GTFG+V K + VA+K ++ N+ + AL E+ IL L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 164 KK---------YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
+R DK R Y V +D +L L++ + L+ S
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMV--------TPYMDHDLSGLLENPSVK-LTESQ 116
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------- 263
++ + Q+L G++ L + I+H D+K NIL+ +KI DFG A
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGPPPNPK 173
Query: 264 --CTEDRTVY-SYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319
Y + + +R+YR PE+LLG +YTTA+D+W GC+ AE+F P+ G S+
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
Query: 320 DLLRRMIRILG 330
D L + ++ G
Sbjct: 234 DQLHLIFKLCG 244
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 81/227 (35%), Positives = 127/227 (55%), Gaps = 19/227 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
Y+ D LG GT+ V K + VA+K I+ ++ A+ EVS+L L
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL------ 60
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
KH +IV +++ +R L + FE LDS+L + + N +S+ V++F Q+LRGLS
Sbjct: 61 --KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLD-NCGNLMSMHNVKIFMFQLLRGLS 117
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEV 284
I+H DLKP+N+L+ + E+K+ DFG A + +Y + + +YR P+V
Sbjct: 118 YCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174
Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
LLG +Y+T IDMW GCI+ E+ G P+FPG++ + L + R+LG
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 109/379 (28%), Positives = 172/379 (45%), Gaps = 86/379 (22%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
+RY +G G G V +D + VAVK + +NQ + ++A E+ +L +N
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNH 79
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELI--KINHFRGLSLSIVQ 216
K +I+ + F Q+ L + EL+D+NL ++I +++H R +
Sbjct: 80 K-------NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER------MS 126
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG---SACTEDRTV 270
Q+L G+ L AGIIH DLKP NI++ CT +KI+DFG +ACT + +
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTACT-NFMM 179
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
Y+ +RYYR+PEV+LG Y +D+WS GCI+ EL G +F G D ++I LG
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
+++ + + +EN R Y ++
Sbjct: 240 TPSAEFMNRLQPTVRNY---------VEN-------RPQYPGIS---------------- 267
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
EE+ ++ + S D K SQ R D L ++ DP KR S +A RH
Sbjct: 268 -------FEELFPDWIFPSE-SERDKLKTSQAR----DLLSKMLVIDPDKRISVDEALRH 315
Query: 451 PFVT--GEPFTCPYQPPPE 467
P++T +P PPP+
Sbjct: 316 PYITVWYDPAEAE-APPPQ 333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
LG G+ G V K A+K I + +Q L E+ L R + +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL--------RSCESPY 60
Query: 174 IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLL-KD 231
+V+ Y F + + I E +D +L +L+K + ++ ++QIL+GL L
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK 118
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTV--YSYIQSRYYRSPEVLLGY 288
IIH D+KP N+L+ + E+KI DFG S E+ +++ + Y SPE + G
Sbjct: 119 RHIIHRDIKPSNLLINSK---GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 289 QYTTAIDMWSFGCIVAELFLG-LPLFP--GASEFDLLR 323
Y+ A D+WS G + E LG P P S F+L++
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 80/236 (33%), Positives = 120/236 (50%), Gaps = 31/236 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHH 173
+G G +G V K D FVA+K ++ N+ + EV++L K+ + D +
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALL----KRLEAFDHPN 63
Query: 174 IVRIYEYFVC-------QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
IVR+ + VC + + + FE +D +L + GL ++ +Q LRGL
Sbjct: 64 IVRLMD--VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYY 279
L I+H DLKPENIL+ + ++K+ DFG A +YS + + +Y
Sbjct: 122 DFLHANCIVHRDLKPENILVTSG---GQVKLADFGLA-----RIYSCQMALTPVVVTLWY 173
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
R+PEVLL Y T +DMWS GCI AE+F PLF G SE D L ++ ++G P D
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 33/240 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTL 162
+Y + +G G+FG+V +K I K + + AL EV IL L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER----EDALNEVKILKKL 56
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS---IVQL 217
N H +I++ YE F + LCI E D +L + IK G I+
Sbjct: 57 N--------HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYI 274
F Q+ L L I+H D+KP+NI L ++ +K+ DFG + TV + +
Sbjct: 109 FV-QLCLALKYLHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSSTVDLAKTVV 164
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
+ YY SPE+ Y D+WS GC++ EL F G + +L ++++ G PP
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPP 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 77/263 (29%), Positives = 129/263 (49%), Gaps = 36/263 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVE-- 155
E RY +G G +G V +D + VAVK +I + Y + L++
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71
Query: 156 -----VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL 210
+ +L E+ + + Y V L+ ++L ++K + L
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEV-----YLVTN--------LMGADLNNIVK---CQKL 115
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
S VQ Q+LRGL + AGIIH DLKP N+ + + E++I+DFG A D +
Sbjct: 116 SDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEM 172
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
Y+ +R+YR+PE++L + Y +D+WS GCI+AEL G LFPG D L+R++ ++
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVV 232
Query: 330 GAQPPDYVLK-EAKNTSKFFKCI 351
G P+ + K +++ K+ + +
Sbjct: 233 GTPSPEVLKKISSEHARKYIQSL 255
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 65/237 (27%), Positives = 110/237 (46%), Gaps = 25/237 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH--I 174
LG G+FG+V + A+K++K + + + + TL ++ +H I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKK-----KIIKRKEVEHTLTERNILSRINHPFI 55
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
V+++ F + L + E EL ++ S + ++ +I+ L L G
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGG--ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG 113
Query: 234 IIHCDLKPENILLCTSVKPAE--IKIIDFGSA---CTEDRTVYSYIQSRYYRSPEVLLGY 288
II+ DLKPENILL A+ IK+ DFG A +E ++ + Y +PEVLLG
Sbjct: 114 IIYRDLKPENILLD-----ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKEAKN 343
Y A+D WS G ++ E+ G P F ++ +IL P+++ EA++
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE---KILKDPLRFPEFLSPEARD 222
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 81/247 (32%), Positives = 128/247 (51%), Gaps = 35/247 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKH- 172
+G GT+G V K + + VA+K I+ + A+ E+S+L +E +H
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLL--------KELQHP 59
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYE-LIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
+IV + + + + L + FE L +L + L + + + +V+ + QIL+G+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT------VYSY-IQSRYYRSPEV 284
++H DLKP+N+L+ IK+ DFG A R VY++ + + +YR+PEV
Sbjct: 120 RRVLHRDLKPQNLLIDNK---GVIKLADFGLA----RAFGIPVRVYTHEVVTLWYRAPEV 172
Query: 285 LLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV------ 337
LLG Y+T +D+WS G I AE+ PLF G SE D L R+ RILG P + V
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGVTS 231
Query: 338 LKEAKNT 344
L + KNT
Sbjct: 232 LPDYKNT 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 78/227 (34%), Positives = 126/227 (55%), Gaps = 19/227 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
YI D LG GT+ V K ++ VA+K I+ ++ A+ EVS+L L
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------ 61
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
KH +IV +++ ++ L + FE LD +L + + + +++ V+LF Q+LRGL+
Sbjct: 62 --KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-DCGNSINMHNVKLFLFQLLRGLN 118
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEV 284
++H DLKP+N+L+ + E+K+ DFG A + +T + + + +YR P++
Sbjct: 119 YCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
LLG Y+T IDMW GCI E+ G PLFPG++ + L + RILG
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-27
Identities = 110/380 (28%), Positives = 174/380 (45%), Gaps = 84/380 (22%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
+RY +G G G V +DA + VA+K + +NQ + ++A E+ ++ +N
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
K +I+ + F Q+ L I EL+D+NL ++I+ ++H R +
Sbjct: 83 K-------NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MS 129
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VY 271
Q+L G+ L AGIIH DLKP NI++ CT +KI+DFG A T + +
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 183
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
Y+ +RYYR+PEV+LG Y +D+WS GCI+ E+ G LFPG D ++I LG
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
P++ +K+ + T + + +EN R Y Y +L ++
Sbjct: 244 PCPEF-MKKLQPTVRTY--------VEN-------RPKYAG-----YSFEKLFPDVLFPA 282
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
H L K SQ R D L ++ D +KR S +A +HP
Sbjct: 283 DSEHNKL-------------------KASQAR----DLLSKMLVIDASKRISVDEALQHP 319
Query: 452 FVT--GEPFTCPYQPPPETP 469
++ +P PPP+ P
Sbjct: 320 YINVWYDPSEAE-APPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 77/259 (29%), Positives = 127/259 (49%), Gaps = 35/259 (13%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK--------IIKNQPAYYQQALVEVS 157
E RY +G G +G V +D + VAVK II + Y + L+
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL--- 70
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHL------CICFELLDSNLYELIKINHFRGL 210
+ KH +++ + + F R L + L+ ++L ++K + L
Sbjct: 71 ----------KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKL 117
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
+ VQ QILRGL + A IIH DLKP N+ + + E+KI+DFG A D +
Sbjct: 118 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEM 174
Query: 271 YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
Y+ +R+YR+PE++L + Y +D+WS GCI+AEL G LFPG D L+ ++R++
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234
Query: 330 GAQPPDYVLKEAKNTSKFF 348
G + + K + +++ +
Sbjct: 235 GTPGAELLKKISSESARNY 253
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 2e-27
Identities = 109/378 (28%), Positives = 171/378 (45%), Gaps = 84/378 (22%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
+RY +G G G V +DA ++ VA+K + +NQ + ++A E+ ++ +N
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 165 KYDREDKHHIVRIYEYFVCQRHL------CICFELLDSNLYELIK--INHFRGLSLSIVQ 216
K +I+ + F Q+ L + EL+D+NL ++I+ ++H R +
Sbjct: 76 K-------NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER------MS 122
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRT--VY 271
Q+L G+ L AGIIH DLKP NI++ CT +KI+DFG A T + +
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT------LKILDFGLARTAGTSFMMT 176
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
Y+ +RYYR+PEV+LG Y +D+WS GCI+ E+ LFPG D ++I LG
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
P+++ K + +EN R Y LT + L +
Sbjct: 237 PCPEFMKKLQPTVRNY---------VEN-------RPKYAGLT----FPKLFPDSLFPAD 276
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
H+K K SQ R D L ++ DPAKR S +A +HP
Sbjct: 277 SEHNK--------------------LKASQAR----DLLSKMLVIDPAKRISVDEALQHP 312
Query: 452 FVT--GEPFTCPYQPPPE 467
++ +P PPP+
Sbjct: 313 YINVWYDPAEVE-APPPQ 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 75/245 (30%), Positives = 118/245 (48%), Gaps = 33/245 (13%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYD 167
+ + +G GT+GQV K D + VA+K ++ + + A+ E+ IL LN +
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR-- 66
Query: 168 REDKHHIVRIYEYFVCQ----------RHLCICFELLDSNLYELI--KINHFRGLSLSIV 215
+IV + E + + FE +D +L L+ + HF S +
Sbjct: 67 -----NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF---SEDHI 118
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYS 272
+ F KQ+L GL+ +H D+K NILL +IK+ DFG A +E+ Y+
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK---GQIKLADFGLARLYNSEESRPYT 175
Query: 273 -YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
+ + +YR PE+LLG + Y AID+WS GCI+ ELF P+F E L + R+ G
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235
Query: 331 AQPPD 335
+ P
Sbjct: 236 SPCPA 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-27
Identities = 79/232 (34%), Positives = 125/232 (53%), Gaps = 19/232 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
YI + LG GT+ V K + VA+K I+ ++ A+ EVS+L L
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL------ 61
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
KH +IV +++ + L + FE LD +L + + + +S+ V++F QILRGL+
Sbjct: 62 --KHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMD-DCGNIMSMHNVKIFLYQILRGLA 118
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEV 284
++H DLKP+N+L+ + E+K+ DFG A + +Y + + +YR P+V
Sbjct: 119 YCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 285 LLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
LLG +Y+T IDMW GCI E+ G PLFPG++ D L + R+LG +
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 20/248 (8%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
E RY +G G +G V D VA+K + + ++A E+++L +
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS--IVQLFSK 220
+ +++ + + F + Y + G LS VQ
Sbjct: 72 QHE-------NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVY 124
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
Q+L GL + AGIIH DLKP N+ + + E+KI+DFG A D + Y+ +R+YR
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLARHADAEMTGYVVTRWYR 181
Query: 281 SPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
+PEV+L + Y +D+WS GCI+AE+ G LF G D L +++++ G P++V K
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241
Query: 340 ----EAKN 343
AK+
Sbjct: 242 LEDKAAKS 249
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 97/372 (26%), Positives = 144/372 (38%), Gaps = 102/372 (27%)
Query: 118 GHGTFGQVAKCWDAEM--NSFVAVKIIKNQPAYY----QQALVEVSILTTLNKKYDREDK 171
G GT+G+V K A+K K Y Q A E+++L RE K
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALL--------RELK 60
Query: 172 H-HIVRIYEYFVCQRHLCI--CFELLDSNLYELIKINHFRGLSLSIVQLFSK----QILR 224
H ++V + E F+ + F+ + +L+++IK H + +SI K QIL
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK-FHRQAKRVSIPPSMVKSLLWQILN 119
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQSRY---- 278
G+ L ++H DLKP NIL+ P +KI D G A R + ++
Sbjct: 120 GVHYLHSNWVLHRDLKPANILV-MGEGPERGVVKIGDLGLA----RLFNAPLKPLADLDP 174
Query: 279 ------YRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLL 322
YR+PE+LLG + YT AID+W+ GCI AEL P+F G D L
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234
Query: 323 RRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARE 382
R+ +LG P E
Sbjct: 235 ERIFEVLG--TPT----------------------------------------------E 246
Query: 383 LKKPLIGKEYFHHKHLEEIVTNYPYRKNLS--MEDISKESQIRLALVDFLKGLVEFDPAK 440
P I K + +++ T +L+ ME K L L+ L+E+DP K
Sbjct: 247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL---LRKLLEYDPTK 303
Query: 441 RWSPFQASRHPF 452
R + +A HP+
Sbjct: 304 RITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 67/237 (28%), Positives = 107/237 (45%), Gaps = 30/237 (12%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDK 171
+ +G GTFG+V + + +AVK I+ N P ++ E+ +L L
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHP------ 59
Query: 172 HHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
++V+ Y V + + I E L EL++ H R L ++++++ Q+L GL+ L
Sbjct: 60 -NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRSPE 283
GI+H D+KP NI L IK+ DFG A T V S + Y +PE
Sbjct: 117 SHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173
Query: 284 VLLGYQYT---TAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQPPDY 336
V+ G + A D+WS GC+V E+ G + +EF + M + P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFHVGAGHKPPI 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 120 GTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
G +G+V A+K+I KNQ Q L E IL+ Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ---VDQVLTERDILSQAQSPY------ 54
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
+V++Y F +++L + E L +L L++ + L + +++ +I+ L L
Sbjct: 55 -VVKLYYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHS 111
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSR---------YYR 280
GIIH DLKP+NIL+ +K+ DFG R + + Y
Sbjct: 112 NGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
+PEV+LG ++ +D WS GCI+ E +G+P F G +
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 71/232 (30%), Positives = 120/232 (51%), Gaps = 22/232 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNS-FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
+G G +G+V K D + FVA+K ++ Q L + + L + + + ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL-RHLETFEHPNVV 67
Query: 176 RIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
R+++ R L + FE +D +L + G+ ++ Q+LRGL L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY-------IQSRYYRSPE 283
++H DLKP+NIL+ +S +IK+ DFG A +YS+ + + +YR+PE
Sbjct: 128 SHRVVHRDLKPQNILVTSS---GQIKLADFGLA-----RIYSFQMALTSVVVTLWYRAPE 179
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
VLL Y T +D+WS GCI AE+F PLF G+S+ D L +++ ++G +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 57/156 (36%), Positives = 89/156 (57%), Gaps = 10/156 (6%)
Query: 183 CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPE 242
+ + EL+ S+L+++I + LS V++F QILRGL L AGI+H D+KP
Sbjct: 75 PFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPG 132
Query: 243 NILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMW 297
N+L+ ++ +KI DFG A E+ + + + ++YYR+PE+L+G + YT+A+D+W
Sbjct: 133 NLLVNSNCV---LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIW 189
Query: 298 SFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
S GCI AEL LF S L + +LG
Sbjct: 190 SVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 44/234 (18%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
LG G FG+V K + VAVK +K + Q L E I+ L
Sbjct: 4 GKKLGEGAFGEVYKGT-LKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL---- 58
Query: 167 DREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
H +IV++ VC + L I E + +L + ++ N + LSLS + F+ QI
Sbjct: 59 ----DHPNIVKLLG--VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-- 280
RG+ L+ IH DL N L+ + +KI DFG + R +Y YY+
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLS----RDLYDD---DYYKVK 162
Query: 281 ---------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
+PE L ++T+ D+WSFG ++ E+F LG +PG S ++L
Sbjct: 163 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY 216
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 81/266 (30%), Positives = 132/266 (49%), Gaps = 35/266 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ--QALVEVSILTTLNKKYDREDKH-H 173
LG G++ V K VA+K+I+ Q A+ E S+L L KH +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL--------KHAN 64
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
IV +++ + L + FE + ++L + + H GL V+LF Q+LRGLS +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMD-KHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY---IQSRYYRSPEVLLG-YQ 289
I+H DLKP+N+L+ + E+K+ DFG A + ++Y + + +YR P+VLLG +
Sbjct: 124 ILHRDLKPQNLLISDT---GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEF-DLLRRMIRILGA---------------QP 333
Y+T +DMW GCI E+ G+ FPG + D L R+ +LG +P
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIEN 359
+ L KN + + + V++ E+
Sbjct: 241 ERFTLYSPKNLRQAWNKLSYVNHAED 266
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 21/233 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
+ V LG G++G V K N F A+K + +Q + A+ E+ IL ++N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNH- 58
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG--LSLSIVQLFSKQI 222
+I+ E F+ LCI E +L + I + + + Q+
Sbjct: 59 ------PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRS 281
LRGL L + I+H DLK NILL +KI D G S + + I + +Y +
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKKNMAKTQIGTPHYMA 169
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
PEV G Y+ D+WS GC++ E+ P F S DL ++ R G PP
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--GKYPP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 78/233 (33%), Positives = 123/233 (52%), Gaps = 20/233 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDR 168
Y+ + LG G++ V K VA+K+I K + A+ E S+L L
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL------ 60
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
KH +IV +++ + L FE + ++L + + I H GL V+LF Q+LRGL+
Sbjct: 61 --KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYM-IQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEV 284
+ I+H DLKP+N+L+ E+K+ DFG A + +T S + + +YR P+V
Sbjct: 118 YIHGQHILHRDLKPQNLLISYL---GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174
Query: 285 LLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE-FDLLRRMIRILGAQPPD 335
LLG Y++A+D+W GCI E+ G P FPG S+ F+ L ++ +LG D
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 70/246 (28%), Positives = 118/246 (47%), Gaps = 37/246 (15%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALV----EVSILTTLNKKYDRE 169
LLG G+FG V + + + F AVK + + Q+A+ E+++L+ L
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL------- 59
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQILR 224
+H +IV+ + +L I EL+ + L + + +++L+++QIL
Sbjct: 60 -QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-----KYGSFPEPVIRLYTRQILL 113
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
GL L D +H D+K NIL+ T+ +K+ DFG A E S+ S Y+ +P
Sbjct: 114 GLEYLHDRNTVHRDIKGANILVDTN---GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
Query: 283 EVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI--LGAQP--PDYV 337
EV+ Y A D+WS GC V E+ G P + S+ + + + +I P PD++
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPIPDHL 227
Query: 338 LKEAKN 343
EAK+
Sbjct: 228 SDEAKD 233
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 45/234 (19%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKY 166
LG G FG+V K + VAVK +K + Q L E I+ L
Sbjct: 4 GKKLGEGAFGEVYKGK-LKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL---- 58
Query: 167 DREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
H ++V++ VC + L I E ++ +L ++ N LSLS + F+ QI
Sbjct: 59 ----DHPNVVKLLG--VCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQI 111
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-- 280
RG+ L+ IH DL N L+ + +KI DFG + R +Y YYR
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLS----RDLYDD---DYYRKR 161
Query: 281 ---------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
+PE L ++T+ D+WSFG ++ E+F LG +PG S ++L
Sbjct: 162 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY 215
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 35/239 (14%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA------YYQQALVEVSILTTLNKKYDRE 169
LLG G FG+V C+D + +AVK + P E+ +L L
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL------- 61
Query: 170 DKHHIVRIYEYFVCQR---HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
+H RI +Y+ C R L I E + ++ + +K + L+ ++ + +++QIL G
Sbjct: 62 -QHE--RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEG 116
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYY 279
+ L I+H D+K NIL ++ +K+ DFG++ C+ + S + Y+
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
SPEV+ G Y D+WS GC V E+ P P A EF+ + + +I QP + L
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKP--PWA-EFEAMAAIFKI-ATQPTNPQL 228
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 34/243 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDRE 169
LG G FG+V N A+K +K Q + E IL N +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPF--- 54
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL-LDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLS 227
IV++Y F ++++ + E L L+ ++ F + + ++
Sbjct: 55 ----IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLF---DEYTARFYIACVVLAFE 107
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPEV 284
L + GII+ DLKPEN+LL ++ +K++DFG A + +T +++ + Y +PE+
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKT-WTFCGTPEYVAPEI 163
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA----QPPDYVLKE 340
+L Y ++D WS G ++ EL G P F G + D + IL + P+Y+ K
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPF-GEDDEDPMEIYNDILKGNGKLEFPNYIDKA 222
Query: 341 AKN 343
AK+
Sbjct: 223 AKD 225
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 31/256 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+ + +++G GT+G+V K + VA+KI+ ++ E +IL +KY
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNIL----RKY--S 60
Query: 170 DKHHIVRIYEYFVCQRHLC------ICFELLDS-NLYELIKINHFRGLSLS--IVQLFSK 220
+ +I Y F+ + + EL ++ +L+K +G L + +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSR 277
+ LRGL+ L + +IH D+K +NILL + AE+K++DFG + D T+ ++I +
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKN---AEVKLVDFGVSAQLDSTLGRRNTFIGTP 177
Query: 278 YYRSPEVL-----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
Y+ +PEV+ Y D+WS G EL G P + +R + +I
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CDMHPMRALFKIPRNP 234
Query: 333 PPDYVLKEAKNTSKFF 348
PP LK +N SK F
Sbjct: 235 PP--TLKSPENWSKKF 248
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 30/238 (12%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKHH 173
+G GTFG+V K + VA+K + + + AL E+ IL L + +
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE-------N 72
Query: 174 IVRIYE--------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+V + E Y + + FE + +L L+ N +LS ++ K +L G
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS-NKNVKFTLSEIKKVMKMLLNG 131
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYS-YIQSRY 278
L + I+H D+K NIL+ K +K+ DFG A Y+ + + +
Sbjct: 132 LYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
YR PE+LLG Y IDMW GCI+AE++ P+ G +E L + ++ G+ P+
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK--IIKNQPAYYQQALV-EVSILTTLNKKYDREDKH- 172
+G G G+V K D VA+K ++ Q ++ ++ E+ I+ ++ KH
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQN---KELIINEILIM--------KDCKHP 75
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
+IV Y+ ++ L + E +D L ++I +F ++ + +++L+GL L
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-----SACTEDRTVYSYIQSRYYRSPEVLL 286
+IH D+K +NILL K +K+ DFG + R S + + Y+ +PEV+
Sbjct: 135 QNVIHRDIKSDNILLS---KDGSVKLADFGFAAQLTKEKSKRN--SVVGTPYWMAPEVIK 189
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
Y +D+WS G + E+ G P P LR + I P LK + S
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEP--PYL-REPPLRALFLITTKGIPP--LKNPEKWSP 244
Query: 347 FFK 349
FK
Sbjct: 245 EFK 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 21/242 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
+ + + LG G++G V K E VA+K++ + Q+ + E+SIL + Y
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPY---- 59
Query: 171 KHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
IV+ Y + L I E ++ +++KI + + L+ + Q L+GL L
Sbjct: 60 ---IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYL 115
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVY--SYIQSRYYRSPEVLL 286
IH D+K NILL + K+ DFG S D + I + ++ +PEV+
Sbjct: 116 HSNKKIHRDIKAGNILLNEE---GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
Y D+WS G E+ G P + S+ +R + I PP L + + S
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMIPNKPPPT--LSDPEKWSP 227
Query: 347 FF 348
F
Sbjct: 228 EF 229
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 3e-21
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 117 LGHGTFGQVAKC-WDAEMNSF---VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRED 170
LG G FG+V K + VAVK +K + ++ L E SI+ L+
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS------- 59
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
H +IVR+ L I E + +L + ++ H L+L + + QI +G+
Sbjct: 60 -HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEY 117
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-------- 280
L+ +H DL N L+ + +KI DFG + R +Y YYR
Sbjct: 118 LESKNFVHRDLAARNCLVT---ENLVVKISDFGLS----RDIYE---DDYYRKRGGGKLP 167
Query: 281 ----SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
+PE L ++T+ D+WSFG ++ E+F LG +PG S ++L
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL 216
|
Length = 258 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-21
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 27/235 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G G V K +A K+I + PA Q + E+ +L N Y I
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY-------I 61
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
V Y F + IC E +D + + + + +I+ S +LRGL+ L++
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPENILGKISIAVLRGLTYLREKHK 120
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
I+H D+KP NIL+ + EIK+ DFG S D S++ +R Y SPE L G YT
Sbjct: 121 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTV 177
Query: 293 AIDMWSFGCIVAELFLGL------------PLFPGASEFDLLRRMIRILGAQPPD 335
D+WS G + E+ +G +F + R + PPD
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G G V+K +AVK I+ A +Q L E+ IL N Y I
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY-------I 61
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
V Y F + IC E +D + I + I+ + +L+GL+ L +
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
IIH D+KP NIL+ + +IK+ DFG S + +++ + Y +PE + G Y+
Sbjct: 122 IIHRDVKPSNILVNSR---GQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 293 AIDMWSFGCIVAELFLGLPLFPGASE-------FDLLRRMIRILGAQPP 334
D+WS G + EL G FP E F+LL+ I+ PP
Sbjct: 179 KSDIWSLGLSLIELATG--RFPYPPENDPPDGIFELLQ---YIVNEPPP 222
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-20
Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIV 175
LG G FG+V K + E A K+I + + +VE+ IL + D +IV
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIV 65
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
++ + F + +L I E + + + R L+ +++ KQ L L+ L + II
Sbjct: 66 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLL-----G 287
H DLK NIL +IK+ DFG + RT+ S+I + Y+ +PEV++
Sbjct: 126 HRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
Y D+WS G + E+ + P E + +R +++I ++PP
Sbjct: 183 RPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 9e-20
Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 24/228 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V K + E + A K+I K++ + +VE+ IL T N +I
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL-EDYMVEIEILATCNH-------PYI 71
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
V++ F L I E + I + RGL+ +Q+ +Q+L L L I
Sbjct: 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLL----- 286
IH DLK N+LL +IK+ DFG + +T+ S+I + Y+ +PEV++
Sbjct: 132 IHRDLKAGNVLLTLD---GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
Y D+WS G + E+ + P E + +R +++I ++PP
Sbjct: 189 DTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKSEPP 233
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 62/240 (25%), Positives = 102/240 (42%), Gaps = 45/240 (18%)
Query: 115 DLLGHGTFGQVAKC-WDAEMNSF--VAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRE 169
LG G FG+V K + VAVK +K + L E ++ L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG------ 54
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKIN-----HFRGLSLSIVQL--FSK 220
H ++VR+ + L + E ++ +L + ++ + +LS+ L F+
Sbjct: 55 --HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
QI +G+ L +H DL N L+ + +KI DFG + R VY YYR
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLS----RDVYDD---DYYR 162
Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
+PE L +T+ D+WSFG ++ E+F LG +PG S ++L + +
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 22/227 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LG G FG+V K E F A KII+ + +VE+ IL+ IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN-------IV 65
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
+YE + + L I E D + I + RGL+ ++ +Q+L L+ L +I
Sbjct: 66 GLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVI 125
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFG-SA--CTEDRTVYSYIQSRYYRSPEVLL-----G 287
H DLK NILL ++K+ DFG SA + + ++I + Y+ +PEV+
Sbjct: 126 HRDLKAGNILLTLD---GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
Y D+WS G + EL P P E + +R +++IL ++PP
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEP--PH-HELNPMRVLLKILKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 79/288 (27%), Positives = 125/288 (43%), Gaps = 37/288 (12%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
+LG G+FG+V + AVK +K +VE +L +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL------AWEN 55
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ +Y F + HL E L+ ++ + F L ++ +I+ GL L
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF---DLYRATFYAAEIVCGLQFL 112
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
GII+ DLK +N++L + IKI DFG C E D ++ + Y +PE+L
Sbjct: 113 HSKGIIYRDLKLDNVML---DRDGHIKIADFG-MCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT- 344
G +YT ++D WSFG ++ E+ +G F G E D L IR+ P ++ KE+K+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVDTPHYPRWITKESKDIL 227
Query: 345 SKFF-----KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
K F + +G V NI G ++ + E REL P
Sbjct: 228 EKLFERDPTRRLGVVGNIR-------GHPFFKTINWTALEKRELDPPF 268
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 68/245 (27%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD-- 167
++I L+G G+FG V +A +AVK ++ + S+L L ++
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+E +H +IV+ + HL I E + + +N++ ++V+ F +QIL+GL
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAAL-LNNYGAFEETLVRNFVRQILKGL 119
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--------SACTEDRTVYSYIQ-SR 277
+ L + GIIH D+K NIL+ IKI DFG S T+ +Q S
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
++ +PEV+ YT D+WS GC+V E+ G FP ++ + ++ + P +
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI 236
Query: 338 LKEAK 342
EA
Sbjct: 237 SSEAI 241
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 7e-19
Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 24/238 (10%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
+LG G+FG+V N F A+K +K +VE +L+ +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL------AWEH 55
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ +Y F + +L E L+ ++ + + F L ++ +I+ GL L
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKF---DLPRATFYAAEIICGLQFL 112
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
GI++ DLK +NILL T IKI DFG C E D ++ + Y +PE+L
Sbjct: 113 HSKGIVYRDLKLDNILLDTD---GHIKIADFG-MCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
LG +Y T++D WSFG ++ E+ +G F G E +L + IR+ P ++ +EAK+
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS-IRMDNPCYPRWLTREAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 111 YIVKDLLGHGTFGQVAKCW---DAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
+ + + +G G+FG V K D + + + + K ++A+ E +L L+ Y
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY- 60
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
I+R YE F+ + L I E ++ +L++L+K+ R L V F QIL GL
Sbjct: 61 ------IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVY--SYIQSRYYRSPE 283
+ L I+H D+K N+ L +KI D G A D T + + + + YY SPE
Sbjct: 115 AHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE 171
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
+ Y D+W+ G ++ E G F ++ L+ ++IR G PP
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--GVFPP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 70/236 (29%), Positives = 102/236 (43%), Gaps = 33/236 (13%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYD 167
Y V + +G G+FG V K + K I QQ + EV+IL
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNIL-------- 53
Query: 168 REDKH-HIVRIYEYFV--CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
RE KH +IVR Y+ + + L I E + +L +LI+ + I + F +IL
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQ--KCKKERKYIEEEFIWRIL 111
Query: 224 RGLSL-------LKDAG--IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVY-- 271
L L D G ++H DLKP NI L + +K+ DFG A + +
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN---NVKLGDFGLAKILGHDSSFAK 168
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+Y+ + YY SPE L Y D+WS GC++ EL P F + L I+
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 31/249 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-----KNQPAYYQQALVEVSILTTLNK 164
+ + + +G G+FG+V K D N VA+K+I +++ QQ E+ L+
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFLSQCRS 58
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
Y I + Y F+ L I E + +L+K ++ + +++L
Sbjct: 59 PY-------ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFI---LREVL 108
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYR 280
GL L + G IH D+K NILL ++K+ DFG + T+ +++ + ++
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILLSEE---GDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
+PEV+ Y D+WS G EL G P P S+ +R + I PP E
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLIPKNNPP---SLE 219
Query: 341 AKNTSKFFK 349
SK FK
Sbjct: 220 GNKFSKPFK 228
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 72/247 (29%), Positives = 112/247 (45%), Gaps = 31/247 (12%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
+G GT GQV K + +AVK + + + IL L+ D +I
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK-----RILMDLDVVLKSHDCPYI 76
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDA- 232
V+ Y YF+ + IC EL+ + L +L+K I + I+ + I++ L LK+
Sbjct: 77 VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP--IPEDILGKMTVAIVKALHYLKEKH 134
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRSPEVL-- 285
G+IH D+KP NILL S +K+ DFG + R V S ++R Y +PE +
Sbjct: 135 GVIHRDVKPSNILLDAS---GNVKLCDFGIS---GRLVDSKAKTRSAGCAAYMAPERIDP 188
Query: 286 --LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDYVLKEAK 342
+Y D+WS G + EL G + +EF++L +IL +PP L +
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL---TKILQEEPP--SLPPNE 243
Query: 343 NTSKFFK 349
S F
Sbjct: 244 GFSPDFC 250
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALVEVSILTTLNKKYDRE 169
+ DL G G G V+K + +A K+ I + + +Q L E+ I+ Y
Sbjct: 9 TISDL-GAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY--- 64
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
IV Y F+ + ++C+C E +D + I + + I+ + ++ GL+ L
Sbjct: 65 ----IVSFYGAFLNENNICMCMEFMDCGSLDRI-YKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 230 KDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLG 287
+ I+H D+KP NIL+ + +IK+ DFG S + +++ + Y SPE + G
Sbjct: 120 YNVHRIMHRDIKPSNILVNSR---GQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG 176
Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
+YT D+WS G + EL LG
Sbjct: 177 GKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G G V KC A+K I P +Q L E+ I NK +I
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEI----NKSCKSP---YI 61
Query: 175 VRIYEYFV--CQRHLCICFEL-----LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
V+ Y F+ + I E LDS +Y+ +K R + ++ ++ +L+GLS
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGR-IGEKVLGKIAESVLKGLS 119
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLL 286
L IIH D+KP NILL ++K+ DFG S + ++ + +Y +PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFP 314
G Y+ D+WS G + E+ FP
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 70/237 (29%), Positives = 115/237 (48%), Gaps = 29/237 (12%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSIL---TTLNKKYDREDKH 172
LLG G FG+V C+DA+ +AVK ++ P + + EV+ L L K E
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHE--- 64
Query: 173 HIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
RI +Y+ C +R L I E + + ++ + L+ ++ + +++QIL G+S
Sbjct: 65 ---RIVQYYGCLRDPMERTLSIFMEHMPGGSIK-DQLKSYGALTENVTRKYTRQILEGVS 120
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRS 281
L I+H D+K NIL + +K+ DFG++ C + S + Y+ S
Sbjct: 121 YLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
PEV+ G Y D+WS GC V E+ P + +EF+ + + +I QP + VL
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKI-ATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 67/255 (26%), Positives = 110/255 (43%), Gaps = 32/255 (12%)
Query: 111 YIVKDLLGHGTFGQV--AKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKY 166
Y + +++G G V A C VA+K I + + EV ++ N
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEK--VAIKRIDLEKCQTSVDELRKEVQAMSQCN--- 57
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIK-INHFRGLSLSIVQLFSKQIL 223
H ++V+ Y FV L + L +L +++K GL +I+ K++L
Sbjct: 58 -----HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED------RTVYSYIQS 276
+GL L G IH D+K NILL +KI DFG SA D + +++ +
Sbjct: 113 KGLEYLHSNGQIHRDIKAGNILLGED---GSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 277 RYYRSPEVL-LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
+ +PEV+ + Y D+WSFG EL G + S++ ++ ++ L PP
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTLQNDPPS 226
Query: 336 Y-VLKEAKNTSKFFK 349
+ K SK F+
Sbjct: 227 LETGADYKKYSKSFR 241
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY----QQALVEVSILTTLNKK------Y 166
+G G +GQV + VA+K +K + + L E ILTT + Y
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+D ++ EY V F L +NL ++ +H R + ++ +
Sbjct: 69 AFQDDEYLYLAMEY-VPGGD----FRTLLNNL-GVLSEDHAR--------FYMAEMFEAV 114
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
L + G IH DLKPEN L+ S IK+ DFG + S + S Y +PEVL
Sbjct: 115 DALHELGYIHRDLKPENFLIDAS---GHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLR 171
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
G Y +D WS GC++ E G P F G++
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 21/202 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKI-----IKNQPAYYQQALVEVSILTTLNKKYDREDK 171
LG G FG+V C A K +K + Q AL E IL ++ ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGE-QMALNEKKILEKVSSRF----- 54
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
IV + F + LC+ L++ Y + + G + ++ QI+ GL L
Sbjct: 55 --IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHL 111
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVLLG 287
I++ DLKPEN+LL ++I D G A + + + Y +PEVL G
Sbjct: 112 HQRRIVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 288 YQYTTAIDMWSFGCIVAELFLG 309
Y ++D ++ GC + E+ G
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAG 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 71/255 (27%), Positives = 121/255 (47%), Gaps = 37/255 (14%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSIL---TTLNKKYDREDKH 172
LLG G FG+V C+D + +A K ++ P + + EVS L L K E
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS-KEVSALECEIQLLKNLQHE--- 64
Query: 173 HIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
RI +Y+ C ++ L I E + + ++ + L+ S+ + +++QIL G+S
Sbjct: 65 ---RIVQYYGCLRDRAEKTLTIFMEYMPGGSVK-DQLKAYGALTESVTRKYTRQILEGMS 120
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRS 281
L I+H D+K NIL ++ +K+ DFG++ C + S + Y+ S
Sbjct: 121 YLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP-----PDY 336
PEV+ G Y D+WS GC V E+ P + +E++ + + +I QP P +
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKI-ATQPTNPQLPSH 233
Query: 337 VLKEAKNTSKFFKCI 351
+ + A++ F CI
Sbjct: 234 ISEHARD---FLGCI 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 27/238 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK--KYDREDKHH 173
LLG G FG+V C+DA+ +AVK + P Q+ EV+ L + K R D
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS-QETSKEVNALECEIQLLKNLRHD--- 64
Query: 174 IVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
RI +Y+ C ++ L I E + + ++ + L+ ++ + +++QIL+G+S
Sbjct: 65 --RIVQYYGCLRDPEEKKLSIFVEYMPGGSIK-DQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA------CTEDRTVYSYIQSRYYRSP 282
L I+H D+K NIL ++ +K+ DFG++ C + S + Y+ SP
Sbjct: 122 LHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
EV+ G Y D+WS C V E+ P + +E++ + + +I QP +L +
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKI-ATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
YI +LG G FG+ E +S V K + + + AL E+ IL+ L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL---- 56
Query: 167 DREDKHH--IVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS--IVQLFSKQ 221
H I+ Y +F+ L I E + LY+ KI +G +V + Q
Sbjct: 57 -----QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYD--KIVRQKGQLFEEEMVLWYLFQ 109
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRY 278
I+ +S + AGI+H D+K NI L K IK+ DFG + +E + + + Y
Sbjct: 110 IVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
Y SPE+ G +Y D+W+ GC++ EL
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
LG G F + D + + +AVK + Q + E+ ++ LN
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP--- 63
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
HI+R+ H + E + + ++ + +++ +++Q+LRGLS
Sbjct: 64 ----HIIRMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYGAFKEAVIINYTEQLLRGLSY 118
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRY-----YRS 281
L + IIH D+K N+L+ ++ + ++I DFG+A T Q + + +
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
PEVL G QY + D+WS GC++ E+ P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDK 171
+LG G+FG+V N F A+K +K + +VE +L +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEH------ 55
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ ++ F + HL E L+ ++ + F + + ++ +I+ GL L
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRF---DEARARFYAAEIICGLQFL 112
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---DRTVYSYIQSRYYRSPEVLL 286
GII+ DLK +N+LL K IKI DFG + ++ + Y +PE+L
Sbjct: 113 HKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
G +Y ++D WSFG ++ E+ +G F G E D L I P ++ KEAK+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILNDRPHFPRWISKEAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 37/293 (12%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G+FG+V + AVK++K Q + + E +L K
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------- 54
Query: 172 H-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
H + +++ F + L E ++ +L + I + ++ +I+ GL L
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFL 112
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
+ GII+ DLK +N+LL + IKI DFG C E T ++ + Y +PE+L
Sbjct: 113 HERGIIYRDLKLDNVLLDSE---GHIKIADFG-MCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKEAKN 343
Y A+D W+ G ++ E+ G F G E +L + IL + P ++ KEAK+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ---SILEDEVRYPRWLSKEAKS 225
Query: 344 TSKFF------KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
K F K +G + GE I G ++ + + E +E+K P K
Sbjct: 226 ILKSFLTKNPEKRLGCL---PTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 71/256 (27%), Positives = 120/256 (46%), Gaps = 37/256 (14%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH- 173
+++G+GT+GQV K + A+K++ ++ +E+++L KKY HH
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML----KKY----SHHR 73
Query: 174 -IVRIYEYFVCQR------HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
I Y F+ + L + E + ++ +L+K L + ++ILRG
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSP 282
L+ L +IH D+K +N+LL + AE+K++DFG + DRTV ++I + Y+ +P
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
Query: 283 EVLL-------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
EV+ Y Y + D+WS G E+ G P + +R + I PP
Sbjct: 191 EVIACDENPDATYDYRS--DIWSLGITAIEMAEGAPPL---CDMHPMRALFLIPRNPPPK 245
Query: 336 YVLKEAKNTSKFFKCI 351
LK K + KF I
Sbjct: 246 --LKSKKWSKKFIDFI 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDK 171
+++LGHG G V K + +AVK+I +Q + E+ IL + Y
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY----- 60
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
I+ Y F + + IC E +D ++ +R + ++ + +++GL+ L
Sbjct: 61 --IIGFYGAFFVENRISICTEFMDGG-----SLDVYRKIPEHVLGRIAVAVVKGLTYLWS 113
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
I+H D+KP N+L+ T ++K+ DFG S + +Y+ + Y +PE + G QY
Sbjct: 114 LKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQY 170
Query: 291 TTAIDMWSFGCIVAELFLGLPLFP 314
D+WS G EL LG +P
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 64/244 (26%), Positives = 103/244 (42%), Gaps = 30/244 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ----QALVEVSILTTLNKKY 166
+ LG G+FG+V + A+KI+ L E IL ++ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILR 224
+V +Y F +L + E + L K F + + ++ Q++
Sbjct: 63 -------LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF---PEPVARFYAAQVVL 112
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRYYRSPE 283
L L I++ DLKPEN+LL IKI DFG A + RT Y+ + Y +PE
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFAKRVKGRT-YTLCGTPEYLAPE 168
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI--RILGA--QPPDYVLK 339
++L Y A+D W+ G ++ E+ G P F FD I +IL + P +
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPPF-----FDDNPIQIYEKILEGKVRFPSFFSP 223
Query: 340 EAKN 343
+AK+
Sbjct: 224 DAKD 227
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 115 DLLGHGTFGQVAKC-WDAEMNSF--VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
LG G+FG V + W VAVK +K L E +I+ +L
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL------- 53
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL--LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
D +++R+Y V L + EL L S L + ++ + +S + ++ QI G+
Sbjct: 54 DHENLIRLYG-VVLTHPLMMVTELAPLGS-LLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQSRY----YRS 281
L+ IH DL NILL + K +KI DFG A ++ Y + + +
Sbjct: 112 YLESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF 307
PE L ++ A D+W FG + E+F
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMF 194
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 25/235 (10%)
Query: 110 RYIVKDLLGHGTFGQ---VAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
+Y+ +G G+FG+ V D + + I K P +++ EV++L+ +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM---- 56
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFS--KQI 222
KH +IV+ E F +L I + + +LY+ KIN RG+ Q+ QI
Sbjct: 57 ----KHPNIVQYQESFEENGNLYIVMDYCEGGDLYK--KINAQRGVLFPEDQILDWFVQI 110
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYY 279
L + D I+H D+K +NI L K IK+ DFG A + TV + I + YY
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
SPE+ Y D+W+ GC++ E+ F + +L+ ++IR G+ PP
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYPP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 28/214 (13%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH- 173
+L+G+GT+GQV K + A+K++ ++ E+++L KKY HH
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINML----KKY----SHHR 63
Query: 174 -IVRIYEYFVCQR------HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
I Y F+ + L + E + ++ +LIK L + ++ILRG
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSP 282
LS L +IH D+K +N+LL + AE+K++DFG + DRTV ++I + Y+ +P
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 283 EVLLGYQ-----YTTAIDMWSFGCIVAELFLGLP 311
EV+ + Y D+WS G E+ G P
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G G V K +A K+I + +PA Q + E+ +L N Y I
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 65
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
V Y F + IC E +D + + + + + I+ S +LRGL+ L++
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQV-LKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
I+H D+KP NIL+ + EIK+ DFG S D S++ +R Y SPE L G Y+
Sbjct: 125 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 293 AIDMWSFGCIVAELFLG-LPLFP 314
D+WS G + EL +G P+ P
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 13/148 (8%)
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+ ++ ++Y F + +L + E L+ + LIK GL + + +++ G+
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVED 112
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVL 285
L GIIH D+KPEN+L+ + +K+ DFG + R ++ + Y +PE +
Sbjct: 113 LHQRGIIHRDIKPENLLIDQT---GHLKLTDFGLS----RNGLENKKFVGTPDYLAPETI 165
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
LG D WS GC++ E G P F
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 46/247 (18%)
Query: 117 LGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
+G GT+G V AK D + + A+K I+ A E+++L RE KH +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACREIALL--------RELKHPN 59
Query: 174 IVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQL-------FSKQILR 224
++ + + F+ R + + F+ + +L+ +IK + + VQL QIL
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 225 GLSLLKDAGIIHCDLKPENIL-LCTSVKPAEIKIIDFGSA----------CTEDRTVYSY 273
G+ L ++H DLKP NIL + + +KI D G A D V ++
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 274 IQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLR 323
+YR+PE+LLG + YT AID+W+ GCI AEL P+F E D L
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 235
Query: 324 RMIRILG 330
R+ ++G
Sbjct: 236 RIFNVMG 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 19/217 (8%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALV--EVSILTTLNKKYDREDK 171
+G GTFG+V D + A+K+ I Q+ V E +L ++ +
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF----- 62
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILRGLSLLK 230
I+R++ QR L + E + EL G S S ++ +I+ L L
Sbjct: 63 --IIRLFWTEHDQRFLYMLMEYVPGG--ELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYYRSPEVLLGYQ 289
I++ DLKPENILL K IK+ DFG A DRT ++ + Y +PEV+
Sbjct: 119 SKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRT-WTLCGTPEYLAPEVIQSKG 174
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
+ A+D W+ G ++ E+ +G P F + F + +++
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 38/248 (15%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKH-HI 174
+G GT+G V K D VA+K+IK +P ++ E+S+L +E +H +I
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISML--------KECRHPNI 62
Query: 175 VRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
V + ++ + L I E ++Y++ + LS + ++ L+GL+ L
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH 118
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVL-- 285
+ G IH D+K NILL ++K+ DFG + T+ S+I + Y+ +PEV
Sbjct: 119 ETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 286 -LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRR--MIRILGAQPPDYVLKE 340
Y D+W+ G EL P P FDL +R +I PP LK+
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQP--P---MFDLHPMRALFLISKSNFPPPK--LKD 228
Query: 341 AKNTSKFF 348
+ S F
Sbjct: 229 KEKWSPVF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 35/215 (16%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN------QPAYYQQALVEVSILTTLN 163
RYI++ LG G+FG V D + + +K++K P QA E +L+ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL- 59
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLSLS---IV 215
D IV+ + F+ + CI E LD L EL G +LS +
Sbjct: 60 ------DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKH----TGKTLSENQVC 109
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVY 271
+ F Q+L G+ + I+H DLK +NI L ++ +KI DFG + + D
Sbjct: 110 EWFI-QLLLGVHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLAT- 163
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
++ + YY SPE L Y + D+WS GCI+ E+
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 49/228 (21%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDR 168
+++ +L+G GT+G+V + +AVK ++ + + ++ L + +
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 169 -EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSL------------SIV 215
+D H+ I +Y + + Y I + + G S+ +V
Sbjct: 62 LKDLDHL-NIVQYLGFET----------TEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILL-----CTSVKPAEIKIIDFG-SACTEDRT 269
+ F++Q+L GL+ L GI+H DLK +N+L+ C KI DFG S ++D
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGIC--------KISDFGISKKSDD-- 160
Query: 270 VYSYIQ------SRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLG 309
+Y Q S ++ +PEV+ Y Y+ +D+WS GC+V E+F G
Sbjct: 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 61/247 (24%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALV--EVSILTTL 162
+ V ++G G FG+V D + A+K+++ + Q A V E IL
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN---QIAHVRAERDILADA 58
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS----NLYELIKINHFRGLSLSIVQLF 218
+ + IV++Y F + HL + E + NL LI+ + F + +
Sbjct: 59 DSPW-------IVKLYYSFQDEEHLYLVMEYMPGGDLMNL--LIRKDVFPE---ETARFY 106
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------------- 263
+++ L + G IH D+KP+NIL+ IK+ DFG
Sbjct: 107 IAELVLALDSVHKLGFIHRDIKPDNILIDAD---GHIKLADFGLCKKMNKAKDREYYLND 163
Query: 264 -----CTEDRTVYSYIQSRY------------YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
++ V + Y +PEVL G Y D WS G I+ E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 307 FLGLPLF 313
G P F
Sbjct: 224 LYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 73/247 (29%), Positives = 115/247 (46%), Gaps = 46/247 (18%)
Query: 117 LGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
+G GT+G V AK D + A+K I+ A E+++L RE KH +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-GISMSACREIALL--------RELKHPN 59
Query: 174 IVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRG-------LSLSIVQLFSKQILR 224
++ + + F+ R + + F+ + +L+ +IK + L S+V+ QIL
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 225 GLSLLKDAGIIHCDLKPENIL-LCTSVKPAEIKIIDFGSA----------CTEDRTVYSY 273
G+ L ++H DLKP NIL + + +KI D G A D V ++
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 274 IQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLR 323
+YR+PE+LLG + YT AID+W+ GCI AEL P+F E D L
Sbjct: 180 ----WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235
Query: 324 RMIRILG 330
R+ ++G
Sbjct: 236 RIFSVMG 242
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 23/215 (10%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDR 168
+ + LG G+FG+V + A+K +K + Q E SIL L+ +
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF-- 79
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG---LSLSIVQLFSKQILRG 225
IV + F + + E + EL H R + + + +++
Sbjct: 80 -----IVNMMCSFQDENRVYFLLEFVVGG--ELF--THLRKAGRFPNDVAKFYHAELVLA 130
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEV 284
L II+ DLKPEN+LL +K+ DFG A DRT ++ + Y +PEV
Sbjct: 131 FEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT-FTLCGTPEYLAPEV 186
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319
+ + A+D W+ G ++ E G P F + F
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF 221
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
LG G FG+V + A+K +K + + E I T N E
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN----SERHP 62
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
+V ++ F + H+C E +L I + F S ++ ++ GL L +
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVFYAACVVLGLQYLHE 119
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE-----DRTVYSYIQSRYYRSPEVLL 286
I++ DLK +N+LL T +KI DFG C E DRT ++ + + +PEVL
Sbjct: 120 NKIVYRDLKLDNLLLDTE---GFVKIADFG-LCKEGMGFGDRTS-TFCGTPEFLAPEVLT 174
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASE---FD 320
YT A+D W G ++ E+ +G FPG E FD
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 30/232 (12%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDRE 169
+L+G G +G V + VA+KII + + Q+ EV++L+ L +
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQS---- 59
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+I + Y ++ L I E + ++ L+K +S++ +++L L
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVI---IREVLVALKY 116
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSPE 283
+ G+IH D+K NIL+ +K+ DFG A + R+ +++ + Y+ +PE
Sbjct: 117 IHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRS--TFVGTPYWMAPE 171
Query: 284 VLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
V+ G Y T D+WS G + E+ G P + S+ D R M+ I ++PP
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPP 220
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 17/234 (7%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LLG GTFG+V + + A+KI+K + + EV+ T ++ +H +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKD---EVAHTLTESRVLQNT-RHPFL 57
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
+Y Q H +CF + +N EL ++ R S + + +I+ L L +
Sbjct: 58 TALKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
++ DLK EN++L K IKI DFG C E T+ ++ + Y +PEVL Y
Sbjct: 117 VYRDLKLENLML---DKDGHIKITDFG-LCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 291 TTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
A+D W G ++ E+ G LP + + + L +I + + P + EAK+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFELILMEEIRFPRTLSPEAKS 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 28/233 (12%)
Query: 117 LGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRED 170
LG G FG V K W E VA+K+++ + P ++ L E ++ ++ D
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-------D 67
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
H+VR+ + + I + L + ++ + S ++ + QI +G+S L+
Sbjct: 68 HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLN-WCVQIAKGMSYLE 126
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYRSPEVL 285
+ ++H DL N+L+ T P +KI DFG A D Y + + E +
Sbjct: 127 EKRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 286 LGYQYTTAIDMWSFGCIVAEL--FLGLPL--FPGASEFDLLRRMIRILGAQPP 334
L YT D+WS+G V EL F P P DLL + R+ QPP
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL--PQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 41/236 (17%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII-KN---QPAYYQQALVEVSILTTLNKKYDREDK 171
LLG G G+V A+K++ K + ++ L E IL TL+ +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF----- 62
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
+ +Y F + +LC+ + L+ L++ + LS + + ++ ++L L L
Sbjct: 63 --LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 231 DAGIIHCDLKPENILL----------------CTSVKPAEIKIIDFGS------------ 262
GI++ DLKPENILL P K + GS
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 263 -ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
+ S++ + Y +PEV+ G + +A+D W+ G ++ E+ G F G++
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 17/212 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G G V K +A K+I + +PA Q + E+ +L N Y I
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-------I 65
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-G 233
V Y F + IC E +D + + + + I+ S +++GL+ L++
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
I+H D+KP NIL+ + EIK+ DFG S D S++ +R Y SPE L G Y+
Sbjct: 125 IMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 181
Query: 293 AIDMWSFGCIVAELFLG-LPL-FPGASEFDLL 322
D+WS G + E+ +G P+ P A E +L+
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 67/264 (25%), Positives = 111/264 (42%), Gaps = 30/264 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKH 172
LG G FG+V A K + + + + AL+E IL +N +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF------ 54
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
IV + F + HLC+ L++ Y + + RGL + V +S QI G+ L
Sbjct: 55 -IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLH 112
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVLLGY 288
I++ D+KPEN+LL ++ D G A + +T+ + Y +PE+L
Sbjct: 113 SMDIVYRDMKPENVLLDDQ---GNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEF----DLLRRMIRILGAQPPDYVLKEAKNT 344
Y+ +D ++ GC + E+ G F E +L RR + D V E +N
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------DEVKFEHQNF 222
Query: 345 SKFFKCIGSVHNIENGEVSIGGRS 368
++ K I + + E +G R
Sbjct: 223 TEESKDICRLFLAKKPEDRLGSRE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY + +G G+FG++ + +K I ++ + L K
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM---- 56
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIK-INHFRGLSLSIVQLFS--KQILRG 225
KH +IV + F L I E D +L+K IN RG+ S Q+ S QI G
Sbjct: 57 -KHPNIVTFFASFQENGRLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQISLG 113
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSP 282
L + D I+H D+K +NI L + A K+ DFG A + ++ Y+ + + YY SP
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVA--KLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 283 EVLLGYQYTTAIDMWSFGCIVAEL 306
E+ Y D+WS GC++ EL
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 22/239 (9%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKH 172
+ +G G+FG+V K D VA+KII + A + E+++L+ + Y
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY------ 63
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
+ + Y ++ L I E L + +L++ F ++ + K+IL+GL L
Sbjct: 64 -VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHS 119
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGY 288
IH D+K N+LL + ++K+ DFG A T +++ + ++ +PEV+
Sbjct: 120 EKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347
Y + D+WS G EL G P P S+ +R + I PP + +K +F
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP--PN-SDMHPMRVLFLIPKNNPPTLTGEFSKPFKEF 232
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLN 163
Q Y + +G GT+G V K + AVKIIK +P + QQ + V
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV------- 60
Query: 164 KKYDREDKHH-IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQ 221
+E KH IV + ++ + L IC E L I H G LS + ++
Sbjct: 61 ----KECKHCNIVAYFGSYLSREKLWICMEYCGGG--SLQDIYHVTGPLSELQIAYVCRE 114
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRY 278
L+GL+ L G +H D+K NILL + ++K+ DFG A T+ S+I + Y
Sbjct: 115 TLQGLAYLHSKGKMHRDIKGANILLTDN---GDVKLADFGVAAKITATIAKRKSFIGTPY 171
Query: 279 YRSPEVLLGYQ---YTTAIDMWSFGCIVAELF-LGLPLF 313
+ +PEV + Y D+W+ G EL L P+F
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 25/200 (12%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
+GHG+FG V D N VA+K + K +Q + EV L L
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP------- 75
Query: 173 HIVRIYEYFVC--QRHLC-ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ + EY C + H + E + +++++ H + L + L+GL+ L
Sbjct: 76 NTI---EYKGCYLREHTAWLVMEYCLGSASDILEV-HKKPLQEVEIAAICHGALQGLAYL 131
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY- 288
IH D+K NILL +P +K+ DFGSA S++ + Y+ +PEV+L
Sbjct: 132 HSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVS-PANSFVGTPYWMAPEVILAMD 187
Query: 289 --QYTTAIDMWSFGCIVAEL 306
QY +D+WS G EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 47/240 (19%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVK-------IIKNQPAYYQQALVEVSILTTLNKKYDR 168
L+ +G +G V E A+K I++NQ QQ VE ILT +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ---IQQVFVERDILTFAENPF-- 62
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
+V ++ F +RHLC+ E ++ + L+K + L + + +++ + + L
Sbjct: 63 -----VVSMFCSFETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALE 115
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTE-------------- 266
L + GI+H DLKP+N LL TS+ IK+ DFG S T
Sbjct: 116 YLHNYGIVHRDLKPDN-LLITSM--GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
D+ V + Y +PEV+L Y +D W+ G I+ E +G F G + +L ++I
Sbjct: 173 DKQVCGTPE---YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 68/243 (27%), Positives = 109/243 (44%), Gaps = 41/243 (16%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK---IIKNQPAYYQQALV--EVSILTTLNKKYDREDK 171
+G G+ G V D VAVK + K Q ++ L+ EV I+ D
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ----RRELLFNEVVIM---------RDY 73
Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
H IV +Y ++ L + E L+ I + H R ++ + +L+ LS L
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIATVCLAVLKALSFL 131
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTED---RTVYSYIQSRYYRSPEV 284
G+IH D+K ++ILL + +K+ DFG + +++ R S + + Y+ +PEV
Sbjct: 132 HAQGVIHRDIKSDSILLTSD---GRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEV 186
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLKEAK 342
+ Y T +D+WS G +V E+ G P + F+ L+ M RI PP LK
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPY-----FNEPPLQAMKRIRDNLPPK--LKNLH 239
Query: 343 NTS 345
S
Sbjct: 240 KVS 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 38/212 (17%)
Query: 117 LGHGTFGQVAKC-WDAEMNS---FVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYD 167
LG G FG+V C +D ++ VAVK + + +++ E+ IL TL+ +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDHEN- 67
Query: 168 REDKHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
IV+ Y+ VC+ R L + E L S H ++L + LFS QI
Sbjct: 68 ------IVK-YKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS----- 276
+G+ L IH DL NIL+ +KI DFG ED+ Y Y++
Sbjct: 120 KGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYY-YVKEPGESP 175
Query: 277 -RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+Y +PE L ++++A D+WSFG + ELF
Sbjct: 176 IFWY-APECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
+GHG+FG V D N VA+K + K +Q + EV L + E K
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
+R + ++ + C+ S+L E+ H + L + + L+GL+ L
Sbjct: 93 CYLREHTAWLVMEY-CLGSA---SDLLEV----HKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY---Q 289
+IH D+K NILL +P ++K+ DFGSA S++ + Y+ +PEV+L Q
Sbjct: 145 NMIHRDIKAGNILL---TEPGQVKLADFGSASIAS-PANSFVGTPYWMAPEVILAMDEGQ 200
Query: 290 YTTAIDMWSFGCIVAEL 306
Y +D+WS G EL
Sbjct: 201 YDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 111 YIVKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIK-NQPAYYQQA----------LVEVSI 158
Y V + LG G FG V K + +A+K I + PA+ + + EV+I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 159 LTTLNKKYDREDKHH--IVRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSL 212
+ +E H IVR Y+ F+ L I +L++ + +K R
Sbjct: 62 I--------KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 213 SIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY- 271
I +F + +L L K+ I+H DL P NI+L K + I DFG A +
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQPESKL 170
Query: 272 -SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
S + + Y PE++ Y D+W+FGCI+ ++ P F
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 21/198 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
+GHG+FG V ++ N VAVK + K +Q + EV L L KH
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL--------KH 80
Query: 173 HIVRIYEYFVCQRHLC-ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
Y+ + H + E + +L+++ H + L + + L+GL+ L
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY--- 288
+IH D+K NILL +P ++K+ DFGSA ++ S++ + Y+ +PEV+L
Sbjct: 140 HNMIHRDIKAGNILL---TEPGQVKLADFGSA-SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 289 QYTTAIDMWSFGCIVAEL 306
QY +D+WS G EL
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 117 LGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHH 173
LG G FG+V W+ + VA+KI+K+ QQ EV L L K H
Sbjct: 14 LGSGYFGEV---WEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHK-------H 63
Query: 174 IVRIYEYFVCQRH--LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
++ ++ VC + I EL++ +L ++ + L ++ + + Q+ G++ L+
Sbjct: 64 LISLFA--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 231 DAGIIHCDLKPENIL-----LCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY---YRSP 282
+ IH DL NIL +C K+ DFG A VY + + +P
Sbjct: 122 EQNSIHRDLAARNILVGEDLVC--------KVADFGLARLIKEDVYLSSDKKIPYKWTAP 173
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFL--GLPLFPGASEFDLLRRMIR 327
E ++T D+WSFG ++ E+F +P +PG + ++ ++
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP-YPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNK 164
+ ++ +G G F V K VA+K ++ Q L E+ +L L+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD- 60
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGL-----SLSIVQL 217
H ++++ F+ L I EL D+ +L +IK HF+ +I +
Sbjct: 61 -------HPNVIKYLASFIENNELNIVLELADAGDLSRMIK--HFKKQKRLIPERTIWKY 111
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCT--SVKPAEIKIIDFGSACTEDRTVYSYIQ 275
F Q+ L + I+H D+KP N+ + VK ++ + F S+ T +S +
Sbjct: 112 FV-QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVG 168
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
+ YY SPE + Y D+WS GC++ E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 58/235 (24%), Positives = 105/235 (44%), Gaps = 22/235 (9%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169
V D LG G +G V K +A+K I+ + + + Q ++E+ IL Y
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY--- 60
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELI--KINHFRGLSLSIVQLFSKQILRGLS 227
IV Y F + + +C E +D+ + + G+ +++ + +++GL
Sbjct: 61 ----IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 228 LLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVL 285
LK+ IIH D+KP N+L+ + ++K+ DFG S + I + Y +PE +
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGN---GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERI 173
Query: 286 LG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
YT D+WS G + E+ LG +P + ++ ++ I+ PP
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-12
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 15/204 (7%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LLG GTFG+V + + A+KI+K + + + T + + +H +
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAH----TLTESRVLKNTRHPFL 57
Query: 176 RIYEY-FVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
+Y F + LC E ++ EL ++ R S + + +I+ L L
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQY 290
I++ DLK EN++L K IKI DFG T+ T+ ++ + Y +PEVL Y
Sbjct: 116 IVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 291 TTAIDMWSFGCIVAELFLG-LPLF 313
A+D W G ++ E+ G LP +
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
T R+Y V LG G FG+V C A K ++ + ++ AL E IL +
Sbjct: 1 TFRQYRV---LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV 57
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFR-GLSLSIVQLFSKQ 221
N ++ +V + + + LC+ +++ + N G ++ +
Sbjct: 58 NSQF-------VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE 110
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSYIQSRYY 279
IL GL L ++ DLKPENILL I+I D G A E ++ + + Y
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEGESIRGRVGTVGY 167
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
+PEVL +YT + D W GC++ E+ G F G E
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G+FG+V + A+KI+K Q + +VE +L K
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP------ 60
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ +++ F L E ++ +Y + ++ F+ ++ +I GL L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE---PHAVFYAAEIAIGLFFL 117
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
GII+ DLK +N++L IKI DFG C E +T ++ + Y +PE++
Sbjct: 118 HSKGIIYRDLKLDNVMLDAE---GHIKIADFG-MCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
Y ++D W+FG ++ E+ G P F G E +L
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
T R+Y V LG G FG+V C A K ++ + ++ AL E IL +
Sbjct: 1 TFRQYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV 57
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF--RGLSLSIVQLFSK 220
N ++ +V + + + LC+ L++ + I H G ++
Sbjct: 58 NSRF-------VVSLAYAYETKDALCLVLTLMNGGDLKF-HIYHMGEAGFEEGRAVFYAA 109
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRY 278
+I GL L I++ DLKPENILL I+I D G A E +T+ + +
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQTIKGRVGTVG 166
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
Y +PEV+ +YT + D W+ GC++ E+ G F
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 25/239 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHH-- 173
+G G+ G V + VAVK + + ++ L EV I+ D HH
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIM---------RDYHHEN 80
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
+V +Y ++ L + E L+ I + H R ++ + +LR LS L + G
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIATVCLSVLRALSYLHNQG 138
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQY 290
+IH D+K ++ILL + IK+ DFG + V S + + Y+ +PEV+ Y
Sbjct: 139 VIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
T +D+WS G +V E+ G P P +E L+ M RI PP +K++ S +
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEP--PYFNE-PPLQAMRRIRDNLPPR--VKDSHKVSSVLR 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 31/240 (12%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKH 172
+G G+FG+V + + A+K I+ + L E ++L +N +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPF------ 54
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
IV + F L + ++ + L + F LS + ++ ++L L L
Sbjct: 55 -IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRF---DLSRARFYTAELLCALENLH 110
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFG----SACTEDRTVYSYIQSRYYRSPEVLL 286
+I+ DLKPENILL I + DFG + +D+T ++ + Y +PE+LL
Sbjct: 111 KFNVIYRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKT-NTFCGTPEYLAPELLL 166
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP---PDYVLKEAKN 343
G+ YT A+D W+ G ++ E+ GLP F + ++ R++++ +P PD ++AK+
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----EPLRFPDGFDRDAKD 222
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 53/224 (23%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVE-VSILTTLNKKYDREDKHHI 174
+LG GT+G V D +A+K I + + Y Q L E +++ + L + +I
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR-------NI 67
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS---------------IVQLFS 219
V+ +L E N + I + G SLS + ++
Sbjct: 68 VQ---------YLGSDSE----NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------CTEDRTVY 271
KQIL GL L D I+H D+K +N+L+ T +KI DFG++ CTE
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPCTE----- 167
Query: 272 SYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLF 313
++ + Y +PEV+ Y D+WS GC + E+ G P F
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 41/121 (33%), Positives = 55/121 (45%), Gaps = 8/121 (6%)
Query: 199 YELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258
Y L + F S V+ + +I+ L L GIIH D+KP+NILL + + I
Sbjct: 89 YHLSQKVKF---SEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHIT 142
Query: 259 DFGSAC--TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
DF A T D S + Y +PEVL Y+ A+D WS G E G + G
Sbjct: 143 DFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202
Query: 317 S 317
S
Sbjct: 203 S 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 59/201 (29%), Positives = 86/201 (42%), Gaps = 23/201 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---YQQALVEVSILTTLNKKYDREDKH 172
++G G FG V C V +K I + A E +L L+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP------- 59
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSL----SIVQLFSKQILRGLS 227
+I+ YE F+ + L I E L E I+ R SL +I+ F QIL L
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK---RCNSLLDEDTILHFFV-QILLALH 115
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVL 285
+ I+H DLK +NILL +KI DFG + + Y+ + + Y SPE+
Sbjct: 116 HVHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 286 LGYQYTTAIDMWSFGCIVAEL 306
G Y D+W+ GC++ EL
Sbjct: 174 EGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII------KNQPAYYQQALVEVSILTTLNKKYDRE 169
+G G FG V K + +AVK I K Q ++ L+++ ++ +
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ----KRLLMDLDVV----MR--SS 60
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGL 226
D +IV+ Y + IC EL+D +L + K + S+ I+ + ++ L
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 227 SLLK-DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS-----RYYR 280
+ LK + IIH D+KP NILL + IK+ DFG + + V S ++ R Y
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGIS---GQLVDSIAKTRDAGCRPYM 174
Query: 281 SPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMI 326
+PE + Y D+WS G + E+ G +P S FD L +++
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 19/197 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
+GHG+FG V D + VA+K + K +Q + EV L L + +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
+R + ++ + C+ S+L E+ H + L + + L+GL+ L
Sbjct: 83 CYLREHTAWLVMEY-CLGSA---SDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY---Q 289
+IH D+K NILL +P +K+ DFGSA ++ + Y+ +PEV+L Q
Sbjct: 135 NMIHRDVKAGNILL---SEPGLVKLGDFGSASIMA-PANXFVGTPYWMAPEVILAMDEGQ 190
Query: 290 YTTAIDMWSFGCIVAEL 306
Y +D+WS G EL
Sbjct: 191 YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LLG GTFG+V + + A+KI++ + + + T + + +H +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH----TVTESRVLQNTRHPFL 57
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
+Y Q H +CF + +N EL ++ R + + + +I+ L L +
Sbjct: 58 TALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
++ D+K EN++L K IKI DFG ++ T+ ++ + Y +PEVL Y
Sbjct: 117 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 292 TAIDMWSFGCIVAELFLG-LPLF 313
A+D W G ++ E+ G LP +
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 22/235 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLN 163
+ + + + +G G+FG+V K D VA+KII + A + E+++L+ +
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
Y I R Y ++ L I E L + +L+K L + + ++I
Sbjct: 61 SPY-------ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREI 110
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYY 279
L+GL L IH D+K N+LL + ++K+ DFG A T +++ + ++
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
+PEV+ Y D+WS G EL G P S+ +R + I PP
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN---SDLHPMRVLFLIPKNSPP 219
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYD 167
++LG G +G V C +AVK ++ + Y++ EV +L +L
Sbjct: 6 EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL----- 59
Query: 168 REDKHHIVRIYEYF-VCQRH--LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
KH V I +Y C + I E + I +N F L + ++KQIL
Sbjct: 60 ---KH--VNIVQYLGTCLDDNTISIFMEFVPGGSISSI-LNRFGPLPEPVFCKYTKQILD 113
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---------CTEDRTVYSYIQ 275
G++ L + ++H D+K N++L + IK+IDFG A T + S
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
+ Y+ +PEV+ Y D+WS GC V E+ G P
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G+FG+V + A+KI+K Q + +VE +L K
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP----- 61
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL----------FSKQ 221
F+ Q H CF+ +D LY +++ + L I Q+ ++ +
Sbjct: 62 ---------FLTQLH--SCFQTMD-RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAE 109
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR----TVYSYIQSR 277
I GL L GII+ DLK +N++L + IKI DFG C E+ T ++ +
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFG-MCKENMWDGVTTKTFCGTP 165
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
Y +PE++ Y ++D W+FG ++ E+ G F G E +L + ++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 50/235 (21%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWDAEMN---SFVAVKIIKN--QPAYYQQALVEVS 157
QR IV K LG G FG+V +C+ E VAVK +K + E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKIN--HFRGLS--- 211
+LT +IV+ Y + FE ++ +L + ++ + L
Sbjct: 61 LLTNF-------QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113
Query: 212 -----LSIVQLF--SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
L++ QL + QI G+ L +H DL N L+ + +KI DFG +
Sbjct: 114 SPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV---VKIGDFGMS- 169
Query: 265 TEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
R VY+ + YYR PE ++ ++TT D+WSFG ++ E+F
Sbjct: 170 ---RDVYT---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 43/293 (14%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G+FG+V + A+KI+K Q + +VE +L +K
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----- 61
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL----------FSKQ 221
F+ Q H CF+ +D LY +++ + L I Q+ ++ +
Sbjct: 62 ---------FLTQLH--SCFQTVD-RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 109
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR----TVYSYIQSR 277
I GL L GII+ DLK +N++L + IKI DFG C E T ++ +
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSE---GHIKIADFG-MCKEHMVDGVTTRTFCGTP 165
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
Y +PE++ Y ++D W++G ++ E+ G P F G E +L + ++ P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-HNVSYPKSL 224
Query: 338 LKEAKNTSKFFKCIGSVHNI---ENGEVSIGGRSAYQALTEIEYEARELKKPL 387
KEA + K + GE I + ++ + + E RE++ P
Sbjct: 225 SKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPF 277
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 59/239 (24%), Positives = 107/239 (44%), Gaps = 34/239 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKH-HI 174
+G G+ G V + VAVK++ + ++ L EV I+ R+ +H ++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM--------RDYQHQNV 80
Query: 175 VRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
V +Y+ ++ L + E L +++ ++N + + + +L+ L L
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQ------IATVCESVLQALCYLH 134
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLG 287
G+IH D+K ++ILL +K+ DFG + V S + + Y+ +PEV+
Sbjct: 135 SQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 191
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
Y T +D+WS G +V E+ G P + S ++R L PP + KN K
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPP----PKLKNAHK 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LLG GTFG+V + + A+KI+K + + EV+ T N+ + +H +
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD---EVAHTLTENRVL-QNSRHPFL 57
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLL-KDAG 233
+Y Q H +CF + +N EL ++ R S + + +I+ L L +
Sbjct: 58 TALKYSF-QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQ 289
+++ DLK EN++L K IKI DFG C E T+ ++ + Y +PEVL
Sbjct: 117 VVYRDLKLENLML---DKDGHIKITDFG-LCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 290 YTTAIDMWSFGCIVAELFLG-LPLF 313
Y A+D W G ++ E+ G LP +
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V W N + VAVK +K Q L E +++ TL ++D+ +
Sbjct: 14 LGAGQFGEV---WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL--QHDK-----L 63
Query: 175 VRIYEYFVCQRHLCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
VR+Y + + I E + +L + +K + + L + FS QI G++ ++
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
IH DL+ N+L+ S+ KI DFG A ED + +++ + +PE +
Sbjct: 124 YIHRDLRAANVLVSESLM---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
+T D+WSFG ++ E+ G +PG S D++ + R
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 37/245 (15%)
Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKYDRE 169
+LG G+FG+V K + A+K++K + +E IL +N +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF--- 59
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI------VQLFSKQIL 223
IV+++ F + L + + L + F LS + V+ + ++
Sbjct: 60 ----IVKLHYAFQTEGKLYLILDFLRGG-------DLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
L L GII+ DLKPENILL IK+ DFG + ++ YS+ + Y
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAYSFCGTVEYM 165
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ--PPDYVL 338
+PEV+ +T + D WSFG ++ E+ G F G D M IL A+ P ++
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAKLGMPQFLS 222
Query: 339 KEAKN 343
EA++
Sbjct: 223 PEAQS 227
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV----EVSILTTLNK-- 164
+ VK L+G G FG+V + A+K++K Q+ + E IL+ N
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 165 ----KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
+Y +DK ++ + EY +L L+ + + Q +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEY------------QPGGDLLSLLN-RYEDQFDEDMAQFYLA 109
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSY--IQS 276
+++ + + G +H D+KPEN+L+ + IK+ DFGSA T ++ V S + +
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGT 166
Query: 277 RYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLG 309
Y +PEVL Y D WS G I E+ G
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG 205
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
+G GT+G V K + A+K+IK +P A+V+ I+ + K+ +IV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHS-----NIVA 70
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRG-LSLSIVQLFSKQILRGLSLLKDAGII 235
+ ++ + L IC E L I H G LS S + S++ L+GL L G +
Sbjct: 71 YFGSYLRRDKLWICMEFCGGG--SLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVLLGYQ--- 289
H D+K NILL + +K+ DFG + T+ S+I + Y+ +PEV +
Sbjct: 129 HRDIKGANILLTDN---GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 290 YTTAIDMWSFGCIVAELF-LGLPLF 313
Y D+W+ G EL L P+F
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMF 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-11
Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 12/115 (10%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-----------SACTEDRT 269
Q+L L+ + GI+H DLKP+NI++ + K++DFG T RT
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR 324
+ + Y +PE L G T D++++G I E G + GAS ++L +
Sbjct: 147 -TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 72/299 (24%), Positives = 123/299 (41%), Gaps = 55/299 (18%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G+FG+V + A+K++K Q + E IL L K+
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA-LAAKHP---- 56
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYEL---------IKINHFRGLSLSIVQLFSKQI 222
F+ L CF+ D + + +I R + ++ ++
Sbjct: 57 ---------FLTA--LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEV 105
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRY 278
L L G+I+ DLK +NILL K+ DFG C E T ++ +
Sbjct: 106 TLALMFLHRHGVIYRDLKLDNILLDAE---GHCKLADFG-MCKEGILNGVTTTTFCGTPD 161
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDY 336
Y +PE+L +Y ++D W+ G ++ E+ G P F +E DL ++ +L P +
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL---YPVW 218
Query: 337 VLKEA---------KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKP 386
+ KEA KN +K C+ S + GE +I ++ + + E R++K P
Sbjct: 219 LSKEAVSILKAFMTKNPNKRLGCVAS----QGGEDAIKQHPFFKEIDWVLLEQRKIKPP 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKHHI 174
+G G+FG+V K D VA+KII + A + E+++L+ + Y +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY-------V 64
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
+ Y ++ L I E L + + L + + ++IL+GL L
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGG--SALDLLEPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YIQSRYYRSPEVLLGYQYT 291
IH D+K N+LL + E+K+ DFG A T ++ + ++ +PEV+ Y
Sbjct: 123 IHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 292 TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
+ D+WS G EL G P SE ++ + I PP
Sbjct: 180 SKADIWSLGITAIELAKGE---PPHSELHPMKVLFLIPKNNPP 219
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 21/200 (10%)
Query: 113 VKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
+ +G G FG V + VAVK +K+ Q L E S++TTL
Sbjct: 10 LGATIGKGEFGDV---MLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHP------ 60
Query: 172 HHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
++V++ + L I E + +L + ++ ++L+ F+ + G+ L+
Sbjct: 61 -NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119
Query: 231 DAGIIHCDLKPENILLCTSVKPAE---IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287
+ +H DL N+L+ +E K+ DFG A + S + +PE L
Sbjct: 120 EKNFVHRDLAARNVLV------SEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALRE 173
Query: 288 YQYTTAIDMWSFGCIVAELF 307
+++T D+WSFG ++ E++
Sbjct: 174 KKFSTKSDVWSFGILLWEIY 193
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 28/223 (12%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
T R Y V LG G FG+V C A K ++ + ++ AL E IL +
Sbjct: 1 TFRHYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 57
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-----NLYELIKINHFRGLSLSIVQL 217
N ++ +V + + + LC+ L++ ++Y + G
Sbjct: 58 NSRF-------VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN----PGFDEERAVF 106
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSYIQ 275
++ +I GL L I++ DLKPENILL I+I D G A E T+ +
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLDDY---GHIRISDLGLAVEIPEGETIRGRVG 163
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
+ Y +PEV+ +YT + D W GC++ E+ G F E
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 71/257 (27%), Positives = 111/257 (43%), Gaps = 60/257 (23%)
Query: 117 LGHGTFGQVAKCWDAEMN-----SFVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRE 169
LG G FG+V K + + VAVK++K + + L E ++L +N
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP---- 63
Query: 170 DKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKI------------------NH 206
H++++Y L + E L S L E K+
Sbjct: 64 ---HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
R L++ + F+ QI RG+ L + ++H DL N+L+ K +KI DFG +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLS--- 174
Query: 267 DRTVY---SYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
R VY SY++ R + E L + YTT D+WSFG ++ E+ LG +PG
Sbjct: 175 -RDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233
Query: 317 SE---FDLLR---RMIR 327
+ F+LL+ RM R
Sbjct: 234 APERLFNLLKTGYRMER 250
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALVEVSILTTLNKKYD 167
+Y V ++G G+FG+ + A+K I+ + + + E +L +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM----- 55
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRG 225
KH +IV E F HL I E D +L + IK+ + + + Q+ G
Sbjct: 56 ---KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------CTEDRTVYSYIQ 275
+ + + ++H D+K +NI L + K +K+ DFGSA CT Y+
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGK---VKLGDFGSARLLTSPGAYACT-------YVG 162
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
+ YY PE+ Y D+WS GCI+ EL
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 117 LGHGTFGQVAK-CWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LG+G FG+V W+ N+ VAVK +K + L E I+ L R DK +V
Sbjct: 14 LGNGQFGEVWMGTWNG--NTKVAVKTLKPGTMSPESFLEEAQIMKKL-----RHDK--LV 64
Query: 176 RIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
++Y V + + I E + +L + +K R L L + + Q+ G++ ++
Sbjct: 65 QLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQY 290
IH DL+ NIL+ + KI DFG A ED + +++ + +PE L ++
Sbjct: 124 IHRDLRSANILVGDGLV---CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 291 TTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
T D+WSFG ++ EL G +PG + ++L ++ R
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 61/245 (24%), Positives = 102/245 (41%), Gaps = 30/245 (12%)
Query: 117 LGHGTFGQVAKC--WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
L G+ G+V C E V VK + + E+ IL T++ + I
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHR-------AI 148
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
+ + + + +C+ +L+ + + L L +++L L+ L GI
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGI 206
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQ 289
IH D+K ENI L +P + DFG+AC D Y + + SPE+L
Sbjct: 207 IHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLF----PGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
Y D+WS G ++ E+ + + LF +S LR +IR + P ++ + N
Sbjct: 264 YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS--QLRSIIRCMQVHPLEFPQNGSTNL 321
Query: 345 SKFFK 349
K FK
Sbjct: 322 CKHFK 326
|
Length = 392 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 117 LGHGTFGQV--AKCWDAE-----MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
LG G+FG+V A + + + F KIIK + E IL +N +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV--DHVFSERKILNYINHPF--- 92
Query: 170 DKHHIVRIYEYFVCQRHLCICFE-LLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
V +Y F + +L + E ++ + ++ N + + ++ QI+
Sbjct: 93 ----CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEY 146
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288
L+ I++ DLKPEN+LL K IK+ DFG A D Y+ + Y +PE+LL
Sbjct: 147 LQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNV 203
Query: 289 QYTTAIDMWSFGCIVAELFLGLPLF 313
+ A D W+ G + E+ +G P F
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 39/231 (16%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFV----AVKIIKNQPAYYQQALVEVSILTTLN 163
++R K+ LG G FG+V C M F+ ++ + NQP LV V +L
Sbjct: 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPV-----LVAVKMLREDA 58
Query: 164 KKYDRED------------KHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRG- 209
K R D +I+R+ + LC+ E +++ +L + + + +
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA 118
Query: 210 --------LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
+S S + + QI G+ L +H DL N C K IKI DFG
Sbjct: 119 AEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN---CLVGKNYTIKIADFG 175
Query: 262 SACTEDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+ Y IQ R + S E +L ++TTA D+W+FG + E+
Sbjct: 176 MSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKK 165
+++Y + +G G G V D VA+K + + QP ++ L+ IL
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVM---- 70
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
RE+KH +IV + ++ L + E L L + + + ++ L+
Sbjct: 71 --RENKHPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQSRYYRS 281
L L +IH D+K +NILL +K+ DFG E + + + Y+ +
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
PEV+ Y +D+WS G + E+ G P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 57/191 (29%), Positives = 85/191 (44%), Gaps = 42/191 (21%)
Query: 159 LTTLNKKYDREDKHHIVRIY----EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
L TL+ + + K H++ Y E F HL + HF S
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFT---HLY--------------QREHFT---ESE 106
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-----SACTEDRT 269
V+++ +I+ L L GII+ D+K ENILL + + DFG A E+R
Sbjct: 107 VRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 270 VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFP--GA--SEFDLLR 323
YS+ + Y +PEV+ G + A+D WS G + EL G F G S+ ++ R
Sbjct: 164 -YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR 222
Query: 324 RMIRILGAQPP 334
RIL ++PP
Sbjct: 223 ---RILKSKPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 67/233 (28%), Positives = 98/233 (42%), Gaps = 50/233 (21%)
Query: 108 QRRYIV-KDLLGHGTFGQV--AKCWDAEMNS---FVAVKIIKNQPAYYQQALV-EVSILT 160
+RR IV K LG G FG+V A+C + VAVK +K +Q E +LT
Sbjct: 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 62
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL--------------DSNLYELIKINH 206
L + HIVR Y R L + FE + D+ + +
Sbjct: 63 VLQHQ-------HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
L+L + + QI G+ L +H DL N L+ + +KI DFG +
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV---VKIGDFGMS--- 169
Query: 267 DRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
R +YS + YYR PE +L ++TT D+WSFG ++ E+F
Sbjct: 170 -RDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 67/266 (25%), Positives = 114/266 (42%), Gaps = 37/266 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
+G G FG V + VAVK IK Q L E +++T L+ K ++VR
Sbjct: 14 IGEGEFGAVLQ--GEYTGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHK-------NLVR 63
Query: 177 IYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSL-SIVQL--FSKQILRGLSLLKDA 232
+ + L I EL+ NL ++ RG +L S++QL FS + G+ L+
Sbjct: 64 LLG-VILHNGLYIVMELMSKGNLVNFLRT---RGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
++H DL NIL+ + K+ DFG A V + + +PE L ++++
Sbjct: 120 KLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSS 176
Query: 293 AIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCI 351
D+WS+G ++ E+F G +P S ++ + + +PP+ C
Sbjct: 177 KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPE-------------GCP 223
Query: 352 GSVHNIENG--EVSIGGRSAYQALTE 375
V+ + E R ++ L E
Sbjct: 224 ADVYVLMTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
+LG G+FG+V E AVK++K + Q VE T K+ ++H
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLK-KDVILQDDDVEC---TMTEKRILSLARNHP- 56
Query: 176 RIYEYFVCQRHLCICFELLDSNLYEL---------IKINHFRGLSLSIVQLFSKQILRGL 226
F+ Q L CF+ D + + I R + + ++ +I L
Sbjct: 57 -----FLTQ--LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL 109
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSP 282
L D GII+ DLK +N+LL K+ DFG C E +T ++ + Y +P
Sbjct: 110 MFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFG-MCKEGIFNGKTTSTFCGTPDYIAP 165
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
E+L Y ++D W+ G ++ E+ G F +E DL
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTL 162
T R Y V LG G FG+V C A K ++ + ++ AL E IL +
Sbjct: 1 TFRHYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV 57
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFR-GLSLSIVQLFSKQ 221
N ++ +V + + + LC+ +++ + N G ++ +
Sbjct: 58 NSRF-------VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE 110
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT--EDRTVYSYIQSRYY 279
+ GL L+ I++ DLKPENILL I+I D G A E TV + + Y
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDR---GHIRISDLGLAVQIPEGETVRGRVGTVGY 167
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLG 309
+PEV+ +YT + D W GC++ E+ G
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 39/210 (18%)
Query: 117 LGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDK 171
LG G FG V K S VAVKI+KN PA + L E +++ L+ Y
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPY----- 57
Query: 172 HHIVRIYEYFVCQRHLCICFE---LLDSNLYELIKINHF----RGLSLSIVQLFSKQILR 224
IVR+ + IC +L L EL +N F + ++ + Q+
Sbjct: 58 --IVRM---------IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM 106
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS-----R 277
G+ L++ +H DL N+LL T KI DFG A D Y +
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQ---HYAKISDFGLSKALGADENYYKAKTHGKWPVK 163
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+Y +PE + Y++++ D+WSFG ++ E F
Sbjct: 164 WY-APECMNYYKFSSKSDVWSFGVLMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 20/238 (8%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
++G G FG+V C A+ A+K + + +Q AL E +L+ ++ D
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DC 56
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
IV + F L +L++ Y L + F S + ++ ++ +I+ GL +
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEAEMRFYAAEIILGLEHM 113
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYYRSPEVLL-G 287
+ +++ DLKP NILL ++I D G AC + ++ + + Y +PEVL G
Sbjct: 114 HNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD--LLRRMIRILGAQPPDYVLKEAKN 343
Y ++ D +S GC++ +L G F D + RM + + PD E ++
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKN--QPAYYQQALVEVS 157
E QR I +G G FG V + + ++ VAVK KN P+ ++ L E
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIA--VAVKTCKNCTSPSVREKFLQEAY 59
Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFELLD-SNLYELIKINHFRGLSLSIV 215
I+ D HIV++ V + + I EL L +++N + L L+ +
Sbjct: 60 IMRQF-------DHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYS-LDLASL 109
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYI 274
L+S Q+ L+ L+ +H D+ N+L+ + P +K+ DFG S ED + Y
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSS---PDCVKLGDFGLSRYLEDESYYKAS 166
Query: 275 QSRY---YRSPEVLLGYQYTTAIDMWSFG-CIVAELFLGLPLFPGASEFDLLRRM 325
+ + + +PE + ++T+A D+W FG C+ L LG+ F G D++ R+
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 20/238 (8%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----ALVEVSILTTLNKKYDREDK 171
++G G FG+V C A+ A+K + + +Q AL E +L+ ++ D
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DC 56
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
IV + F LC +L++ Y L + F S ++ ++ +I+ GL +
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVF---SEKEMRFYATEIILGLEHM 113
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTVYSYIQSRYYRSPEVLL-G 287
+ +++ DLKP NILL + ++I D G AC + ++ + + Y +PEVL G
Sbjct: 114 HNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLKEAKN 343
Y ++ D +S GC++ +L G F D + RM + + PD E K+
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS 228
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 108 QRRYIVKDLLGHGTFGQVAKC-WDAEMNS---FVAVKIIKNQPAYYQQALV-EVSILTTL 162
+R LG G FG V C +D ++ VAVK +++ A + + E+ IL +L
Sbjct: 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL 62
Query: 163 NKKYDREDKHHIVRIYE---YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
IV+ Y+ Y +R+L + E L H L + L++
Sbjct: 63 QHDN-------IVK-YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSR 277
QI +G+ L +H DL NIL+ + +KI DFG +D+ Y +
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPG 171
Query: 278 ----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
++ +PE L +++ A D+WSFG ++ ELF
Sbjct: 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V W A N VAVK +K + L E +++ TL ++D+ K H
Sbjct: 14 LGAGQFGEV---WMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL--QHDKLVKLHA 68
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
V V + + I E + +L + +K + L + FS QI G++ ++
Sbjct: 69 V------VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
IH DL+ NIL+ S+ KI DFG A ED + +++ + +PE +
Sbjct: 123 YIHRDLRAANILVSASLV---CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
+T D+WSFG ++ E+ G +PG S +++R + R
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 21/237 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDREDKHHIV 175
+G G+ G V VAVK + + ++ L EV I+ + Y E+ +V
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIM----RDYQHEN---VV 80
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGII 235
+Y ++ L + E L+ I + H R ++ + +L+ LS+L G+I
Sbjct: 81 EMYNSYLVGDELWVVMEFLEGGALTDI-VTHTR-MNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 236 HCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTT 292
H D+K ++ILL +K+ DFG + V S + + Y+ +PE++ Y
Sbjct: 139 HRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 293 AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
+D+WS G +V E+ G P P +E L+ M I PP LK S K
Sbjct: 196 EVDIWSLGIMVIEMVDGEP--PYFNE-PPLKAMKMIRDNLPPK--LKNLHKVSPSLK 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKKYDREDKH 172
LG G FG+V+ C A K + + Y+ A+VE IL ++ ++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF------ 54
Query: 173 HIVRIYEYFVCQRHLCICFELLDS-----NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
IV + F + LC+ +++ ++Y + + N G ++ QI+ GL
Sbjct: 55 -IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN--PGFPEPRACFYTAQIISGLE 111
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT----EDRTVYSYIQSRYYRSPE 283
L II+ DLKPEN+LL ++I D G A + +T Y + + +PE
Sbjct: 112 HLHQRRIIYRDLKPENVLLDND---GNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPE 167
Query: 284 VLLGYQYTTAIDMWSFGCIVAEL 306
+L G +Y ++D ++ G + E+
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 37/126 (29%), Positives = 64/126 (50%), Gaps = 7/126 (5%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSR 277
+I L L GII+ DLKPENILL +K+ DFG + E +++ +
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
Y +PE+L+ + A+D WS G ++ ++ G P F + + ++++ PP Y+
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP-YL 223
Query: 338 LKEAKN 343
EA++
Sbjct: 224 TPEARD 229
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
LG G +G V K + +AVK I+ +Q +L L+ D + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLDISMRSVDCPYTVT 64
Query: 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSL--SIVQLFSKQILRGLSLLKDA-G 233
Y + + IC E++D++L + K + +GL++ I+ + I++ L L
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG--------SACTEDRTVYSYIQSRYYRSPEVL 285
+IH D+KP N+L+ + ++K+ DFG A T D + Y +PE +
Sbjct: 125 VIHRDVKPSNVLIN---RNGQVKLCDFGISGYLVDSVAKTID------AGCKPYMAPERI 175
Query: 286 LG----YQYTTAIDMWSFGCIVAELFLG 309
Y D+WS G + EL G
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 46/146 (31%), Positives = 68/146 (46%), Gaps = 18/146 (12%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
L+L + +S Q+ +G+ L IH DL NILL + +KI DFG A R
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLA----RD 228
Query: 270 VYS---YIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-E 318
+Y Y++ R +PE + YT D+WSFG ++ E+F LG +PG +
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288
Query: 319 FDLLRRMIRILGAQPPDYVLKEAKNT 344
+ RR+ + PDY E T
Sbjct: 289 EEFCRRLKEGTRMRAPDYTTPEMYQT 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 43/236 (18%)
Query: 116 LLGHGTFGQVAK------CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
LG G FG+V + VAVK ++ ++ L E +++ N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHP-- 59
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELI---KINHFRGLSLSIVQLFSK--Q 221
+IV++ + I EL++ +L + ++ F L++ +L
Sbjct: 60 -----NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
+ +G L+ IH DL N L+ +KI DFG A R +Y S YY
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA----RDIYK---SDYY 167
Query: 280 R------------SPEVLLGYQYTTAIDMWSFGCIVAE-LFLGLPLFPGASEFDLL 322
R +PE LL ++TT D+WSFG ++ E L LG +P + ++L
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 108 QRRYIVK-DLLGHGTFGQVA-KCWDA---EMNSFVAVKIIK--NQPAYYQQALVEVSILT 160
+RY+ K +LG G FG+V+ C+D VAVK +K E++IL
Sbjct: 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK 61
Query: 161 TLNKKYDREDKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
TL +IV+ Y C + L + E + L L L+L+ +
Sbjct: 62 TL-------YHENIVK---YKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQL 109
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSY 273
LF++QI G++ L IH DL N+LL +KI DFG A E Y
Sbjct: 110 LLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRV 166
Query: 274 IQSR----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+ ++ + E L +++ A D+WSFG + EL
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-09
Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 8/103 (7%)
Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--- 264
R L L+ V ++Q+L + + GIIH D+K EN+L+ P +I + DFG+AC
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG---PEDICLGDFGAACFAR 311
Query: 265 -TEDRTVYSYIQSRY-YRSPEVLLGYQYTTAIDMWSFGCIVAE 305
+ + I +PEVL G YT ++D+WS G ++ E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 45/218 (20%)
Query: 117 LGHGTFGQV-----AKCWDAEMNSFVAVKIIKNQPAYYQ--QALVEVSILTTLNKKYDRE 169
LG G+FG V E + VA+K + + + + L E S++ K+++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM----KEFN-- 67
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIK-----INHFRGLSLSIVQLF---SK 220
HH+VR+ + + EL+ +L ++ + GL +Q F +
Sbjct: 68 -CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
+I G++ L +H DL N C + +KI DFG R +Y ++ YYR
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARN---CMVAEDLTVKIGDFGMT----RDIY---ETDYYR 176
Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
+PE L +TT D+WSFG ++ E+
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 50/233 (21%)
Query: 108 QRRYIVKDLLGHGTFGQV--AKCWDAEMNS---FVAVKIIKNQPAYYQQALV-EVSILTT 161
+R ++K LG G FG+V A+C++ VAVK +K+ ++ E +LT
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELL---DSNLY-------ELIKIN----HF 207
L + HIV+ Y L + FE + D N + +I ++
Sbjct: 64 LQHE-------HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 208 RG-LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
+G L LS + + QI G+ L +H DL N L+ ++ +KI DFG +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFGMS--- 170
Query: 267 DRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
R VYS + YYR PE ++ ++TT D+WSFG I+ E+F
Sbjct: 171 -RDVYS---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 35/208 (16%)
Query: 117 LGHGTFGQVAKCWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDK 171
LGHG FG V K + VAVK +K + A ++ L E S++ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPC----- 57
Query: 172 HHIVRIYEYFVCQ-RHLCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGL 226
IVR+ VC+ L + EL L + + R + +S ++ + Q+ G+
Sbjct: 58 --IVRLIG--VCKGEPLMLVMELA-----PLGPLLKYLKKRREIPVSDLKELAHQVAMGM 108
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS-----RYY 279
+ L+ +H DL N+LL V + KI DFG A Y + ++Y
Sbjct: 109 AYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+PE + ++++ D+WS+G + E F
Sbjct: 166 -APECINYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 111 YIVKDLLGHGTFGQV--AKC-WDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
+ ++ +G G F +V A C D + + V+I + A +Q V E+ +L LN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP- 62
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHF----RGLSLSIVQLFSKQ 221
++++ + F+ L I EL D+ +L ++IK +F R + V + Q
Sbjct: 63 ------NVIKYLDSFIEDNELNIVLELADAGDLSQMIK--YFKKQKRLIPERTVWKYFVQ 114
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRY 278
+ + + ++H D+KP N+ + + +K+ D G ++ +S + + Y
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
Y SPE + Y D+WS GC++ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 58/240 (24%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSF--------------VAVKIIKNQPAYYQQA- 152
+++ +K+ LG G FG+V C + F VAVK+++ +
Sbjct: 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND 63
Query: 153 -LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL---DSNLY--------E 200
L E+ I++ L +I+R+ V LC+ E + D N +
Sbjct: 64 FLKEIKIMSRLKNP-------NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 201 LIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260
N+ +S++ + + QI G+ L +H DL N L+ IKI DF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT---IKIADF 173
Query: 261 GSACTEDRTVYSYIQSRYYRS-------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
G + R +YS YYR +LLG ++TTA D+W+FG + E+F
Sbjct: 174 GMS----RNLYS---GDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V W N + VA+K +K + L E I+ L R DK +
Sbjct: 14 LGQGCFGEV---WMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDK--L 63
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
V +Y V + + I E + +L + +K + L L + + QI G++ ++
Sbjct: 64 VPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
IH DL+ NIL+ ++ KI DFG A + Y+ Q + +PE L +
Sbjct: 123 YIHRDLRAANILVGDNLV---CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
+T D+WSFG ++ EL G +PG ++L ++ R
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V W N + VA+K +K + L E ++ L R +K +
Sbjct: 14 LGQGCFGEV---WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEK--L 63
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
V++Y V + + I E + +L + +K + L L + + QI G++ ++
Sbjct: 64 VQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLGYQ 289
+H DL+ NIL+ ++ K+ DFG A + Y+ Q + +PE L +
Sbjct: 123 YVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 290 YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
+T D+WSFG ++ EL G +PG ++L ++ R
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 28/238 (11%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
+ + +G GT+G+V K + + S AVKI+ ++ E +IL L+ D
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS------DHP 75
Query: 173 HIVRIYEYF-----VCQRHLCICFELLDS-NLYELIKINHFRGLSLS--IVQLFSKQILR 224
++V+ Y + L + EL + ++ +L+K RG + I+ + L
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS 281
GL L IH D+K NILL T +K++DFG + T + + + ++ +
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 282 PEVL-----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
PEV+ L Y D+WS G EL G P ++ +R + +I PP
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNPPP 247
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVY 271
+ ++ +I L L II+ DLKPENILL + + + DFG C E +T
Sbjct: 99 RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFG-LCKEGIEHSKTTS 154
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
++ + Y +PEVL Y +D W G ++ E+ GLP F
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
+ ++ +G G F +V + VA+K ++ + E+ +L LN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP- 62
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHF----RGLSLSIVQLFSKQ 221
++++ Y F+ L I EL D+ +L +IK HF R + V + Q
Sbjct: 63 ------NVIKYYASFIEDNELNIVLELADAGDLSRMIK--HFKKQKRLIPEKTVWKYFVQ 114
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
+ L + ++H D+KP N+ + + VK ++ + F S+ T +S + + YY
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYY 172
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAEL 306
SPE + Y D+WS GC++ E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 39/108 (36%), Positives = 54/108 (50%), Gaps = 17/108 (15%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YI 274
+S Q+ RG+ L IH DL NILL + +KI DFG A R +Y Y+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLA----RDIYKDPDYV 231
Query: 275 QSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
+ R +PE + YTT D+WSFG ++ E+F LG +PG
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 31/238 (13%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V W N VAVK +K + L E I+ L R DK +
Sbjct: 14 LGAGQFGEV---WMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-----RHDK--L 63
Query: 175 VRIYEYFVCQRH--LCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
V++Y VC + I E + +L + +K + L L + + QI G++ L+
Sbjct: 64 VQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYSYIQSRY---YRSPEVLLG 287
IH DL NIL+ KI DFG A ED + +++ + +PE
Sbjct: 122 RNYIHRDLAARNILV--GENLV-CKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 288 YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR------RMIRILGAQPPDYVL 338
++T D+WSFG ++ E+ G +PG + ++L RM R Y L
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA----LVEVSILTTLNKKYDREDK 171
++G G+FG+V SF AVK+++ + ++ + E ++L + K
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-------KNLK 54
Query: 172 H-HIVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSLL 229
H +V ++ F L + ++ EL + R + ++ ++ + L
Sbjct: 55 HPFLVGLHYSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYL 112
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEVL 285
II+ DLKPENILL + + + DFG C E + T ++ + Y +PEVL
Sbjct: 113 HSLNIIYRDLKPENILLDSQ---GHVVLTDFG-LCKEGVEPEETTSTFCGTPEYLAPEVL 168
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLF 313
Y +D W G ++ E+ GLP F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
++G G+FG+V F AVK+++ + ++ E I++ N +V
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLV 59
Query: 176 RIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
++ F L + ++ EL + R + ++ +I L L I
Sbjct: 60 GLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
++ DLKPENILL + I + DFG C E+ T ++ + Y +PEVL Y
Sbjct: 118 VYRDLKPENILLDSQ---GHIVLTDFG-LCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 291 TTAIDMWSFGCIVAELFLGLPLF 313
+D W G ++ E+ GLP F
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 43/127 (33%), Positives = 59/127 (46%), Gaps = 29/127 (22%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
F+ Q+ RG+ L IH DL N+L+ + +KI DFG A R ++
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLA----RDIHH---ID 186
Query: 278 YYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG-ASE--FDL 321
YYR +PE L YT D+WSFG ++ E+F LG +PG E F L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 322 LR---RM 325
L+ RM
Sbjct: 247 LKEGYRM 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 44/134 (32%), Positives = 64/134 (47%), Gaps = 18/134 (13%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YI 274
+S Q+ RG+ L IH DL NILL + +KI DFG A R +Y Y+
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSEN---NVVKICDFGLA----RDIYKDPDYV 230
Query: 275 QSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS-EFDLLRRMI 326
+ R +PE + YTT D+WSFG ++ E+F LG +PG + + RR+
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
Query: 327 RILGAQPPDYVLKE 340
+ P+Y E
Sbjct: 291 EGTRMRAPEYATPE 304
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 64/246 (26%), Positives = 104/246 (42%), Gaps = 53/246 (21%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
LG G FG+V K + + VA+K +K +P Q+ E +++ L
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP---- 68
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKIN----------HFRGLSLSIVQL- 217
+IV + ++ C+ FE L +L+E + N + S+
Sbjct: 69 ---NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 218 ---FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
+ QI G+ L +H DL N L+ + +KI DFG + R +YS
Sbjct: 126 FLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL---TVKISDFGLS----RDIYS-- 176
Query: 275 QSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDL 321
+ YYR PE +L ++TT D+WSFG ++ E+F GL + G S ++
Sbjct: 177 -ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 322 LRRMIR 327
+ MIR
Sbjct: 236 I-EMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
+ +G GT+G+V K + + S AVKI+ ++ E +IL +L + ++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL------PNHPNV 81
Query: 175 VRIYEYFVCQRH-----LCICFELLDS-NLYELIKINHFRGLSL--SIVQLFSKQILRGL 226
V+ Y F L + EL + ++ EL+K G L +++ L GL
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPE 283
L + IIH D+K NILL T +K++DFG + T + + + ++ +PE
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 284 VL-----LGYQYTTAIDMWSFGCIVAELFLGLP 311
V+ Y Y D+WS G EL G P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 24/165 (14%)
Query: 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247
C+ S+LY + R L + + KQIL GL L IIH D+K ENI +
Sbjct: 133 CMVLPHYSSDLYTYLT-KRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI- 190
Query: 248 TSVKPAEIKIIDFGSA-----CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCI 302
V ++ I D G+A + +++ +PEVL +Y + D+WS G +
Sbjct: 191 NDVD--QVCIGDLGAAQFPVVAPAFLGLAGTVET---NAPEVLARDKYNSKADIWSAGIV 245
Query: 303 VAELFLGLP--LF---------PGASEFDLLRRMIRILGAQPPDY 336
+ E+ L P +F S L ++I L P ++
Sbjct: 246 LFEM-LAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289
|
Length = 357 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 117 LGHGTFGQVAKCWDAEMN--SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V W+ N + VAVK +K + L E I+ L H
Sbjct: 14 LGAGQFGEV---WEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL---------RHP 61
Query: 175 VRIYEYFVCQRH--LCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
I Y VC + I EL+ +L E ++ R L L + + Q+ G++ L+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 232 AGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVY-SYIQSRY---YRSPEVLL 286
IH DL N+L V I K+ DFG A +Y + +++ + +PE L
Sbjct: 122 QNYIHRDLAARNVL----VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAAL 177
Query: 287 GYQYTTAIDMWSFGCIVAEL 306
+++ D+WSFG ++ E+
Sbjct: 178 YNRFSIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 16/130 (12%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTV 270
VQ++S +I+ L L GII+ D+K ENILL ++ + + DFG + E
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFHEDEVERA 163
Query: 271 YSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFP----GASEFDLLRR 324
YS+ + Y +P+++ G + A+D WS G ++ EL G F S+ ++ R
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR- 222
Query: 325 MIRILGAQPP 334
RIL ++PP
Sbjct: 223 --RILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 9/127 (7%)
Query: 195 DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254
DS + L+ + GL+ + F+ Q+ RG+ L +H DL N+LL
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG---KI 275
Query: 255 IKIIDFGSA--CTEDRTVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-L 308
+KI DFG A D S + + +PE + YTT D+WS+G ++ E+F L
Sbjct: 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335
Query: 309 GLPLFPG 315
G +PG
Sbjct: 336 GGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 16/213 (7%)
Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLN 163
+ +++Y + +G G G V D VA+K I Q ++ ++ E+ ++ L
Sbjct: 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
+IV + F+ L + E L L + + + + ++ L
Sbjct: 75 NP-------NIVNFLDSFLVGDELFVVMEYLAGG--SLTDVVTETCMDEAQIAAVCRECL 125
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYR 280
+ L L +IH D+K +N+LL +K+ DFG E + + + Y+
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
+PEV+ Y +D+WS G + E+ G P +
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 33/233 (14%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
+G G G V K A+K+I ++ +Q E+ IL +N ++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHP-------NV 134
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
V+ ++ F + + E +D E I + L+ ++QIL G++ L I
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRSPEVLL----- 286
+H D+KP N LL S K +KI DFG + +T+ S + + Y SPE +
Sbjct: 190 VHRDIKPSN-LLINSAK--NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH 246
Query: 287 ----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
GY A D+WS G + E +LG F + D M I +QPP+
Sbjct: 247 GAYDGY----AGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE 295
|
Length = 353 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 35/144 (24%), Positives = 66/144 (45%), Gaps = 17/144 (11%)
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
I+++ F + C+ ++LY + R +++ + + +LR + L +
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR 202
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY--------RSPEVL 285
IIH D+K ENI + P ++ + DFG+AC ++YY +PE+L
Sbjct: 203 IIHRDIKAENIFIN---HPGDVCLGDFGAACFP----VDINANKYYGWAGTIATNAPELL 255
Query: 286 LGYQYTTAIDMWSFGCIVAELFLG 309
Y A+D+WS G ++ E+
Sbjct: 256 ARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 8e-08
Identities = 71/248 (28%), Positives = 109/248 (43%), Gaps = 46/248 (18%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYD 167
Y V +G+G FG+V F K I + Q ++EV+++
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM-------- 66
Query: 168 REDKH-HIVRIYEYFV--CQRHLCICFELLDS-----NLYELIKINHFRGLSLSIVQLFS 219
RE KH +IVR + F+ + L I E D+ N+ + K+ F + + +
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDIT 124
Query: 220 KQILRGLSL---LKDAG----IIHCDLKPENILLCTSVK-----PAEI---------KII 258
+Q+L L+ LKD ++H DLKP+NI L T ++ A+ KI
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 259 DFGSA--CTEDRTVYSYIQSRYYRSPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFP 314
DFG + + +S + + YY SPE+LL Y DMW+ GCI+ EL G F
Sbjct: 185 DFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
Query: 315 GASEFDLL 322
A+ F L
Sbjct: 245 KANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQ-QALVEVSILTTLNKKYDREDKH 172
+LLG G FG+V K + VAVK K P + + L E IL K+YD +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARIL----KQYDHPN-- 53
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLK 230
IV++ ++ + I EL+ + + + L QL F+ G++ L+
Sbjct: 54 -IVKLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE 110
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY----YRSPEVLL 286
IH DL N L+ + +KI DFG + ED +YS + + +PE L
Sbjct: 111 SKNCIHRDLAARNCLVGEN---NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 287 GYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
+Y++ D+WS+G ++ E F LG+ +PG +
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 20/215 (9%)
Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALVEVSILTTL 162
+ +++Y + +G G G V D VA+K ++ QP ++ L+ IL
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVM- 70
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
RE+K+ +IV + ++ L + E L L + + + ++
Sbjct: 71 -----RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRE 123
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRY 278
L+ L L +IH D+K +NILL +K+ DFG E + + + Y
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
+ +PEV+ Y +D+WS G + E+ G P +
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 46/235 (19%)
Query: 117 LGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
LGHG FG+V + + VAVK + + ++ L+E I++ N +
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ---- 69
Query: 170 DKHHIVRIYEYFVCQRHL--CICFELLDS-NLYELIKINHFR-----GLSLSIVQLFSKQ 221
+IVR+ V L I EL+ +L ++ N R L++ + ++
Sbjct: 70 ---NIVRLIG--VSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYR 280
+ +G L++ IH D+ N LL T P + KI DFG A R +Y ++ YYR
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLL-TCKGPGRVAKIADFGMA----RDIY---RASYYR 176
Query: 281 S------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
PE L +T+ D+WSFG ++ E+F LG +PG + +++
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 47/226 (20%)
Query: 112 IVKDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQAL-VEVSILTTLNKK 165
++K LG G FG+V A+C++ + VAVK +K+ ++ E +LT L +
Sbjct: 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKI-----------NHFRGLSLS 213
HIV+ Y V L + FE + +L + ++ N L+ S
Sbjct: 68 -------HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY 273
+ ++QI G+ L +H DL N L+ ++ +KI DFG + R VYS
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL---VKIGDFGMS----RDVYS- 172
Query: 274 IQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
+ YYR PE ++ ++TT D+WS G ++ E+F
Sbjct: 173 --TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
++G G++ +V + A+K++K + + ++ + T +++ H +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDE---DIDWVQTEKHVFEQASNHPFL 58
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
V ++ F + L E ++ + + R L + +S +I L+ L + GI
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
I+ DLK +N+LL + IK+ D+G C E T ++ + Y +PE+L G Y
Sbjct: 118 IYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
++D W+ G ++ E + G S FD++
Sbjct: 174 GFSVDWWALGVLMFE------MMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 51/215 (23%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKI--IKNQPAYYQQALVEVSILTTL 162
+ +++Y + +G G G V D VA++ ++ QP ++ L+ IL
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVM- 71
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
RE+K+ +IV + ++ L + E L L + + + ++
Sbjct: 72 -----RENKNPNIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRE 124
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYS-YIQSRY 278
L+ L L +IH D+K +NILL +K+ DFG + T +++ S + + Y
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
+ +PEV+ Y +D+WS G + E+ G P +
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 32/215 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
Y V ++G G FG+V A+K++ ++ A++ + E I+ N
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 101
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
+ +V+++ F ++L + E + +L+ + + + ++ +++
Sbjct: 102 SPW-------VVQLFCAFQDDKYLYMVMEYMPGG--DLVNLMSNYDVPEKWAKFYTAEVV 152
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYY 279
L + G+IH D+KP+N+LL K +K+ DFG+ D T + + + Y
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY 209
Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
SPEVL GY Y D WS G + E+ +G
Sbjct: 210 ISPEVLKSQGGDGY-YGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 67/236 (28%)
Query: 117 LGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE-- 169
+G G FG+V + E + VAVK++K + + + + RE
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS------------ADMQADFQREAA 60
Query: 170 -----DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG-------------- 209
D +IV++ + +C+ FE + +L E ++ R
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 210 ------LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
LS + +KQ+ G++ L + +H DL N C + +KI DFG +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN---CLVGENMVVKIADFGLS 177
Query: 264 CTEDRTVYSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
R +YS + YY++ PE + +YTT D+W++G ++ E+F
Sbjct: 178 ----RNIYS---ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 59/242 (24%), Positives = 113/242 (46%), Gaps = 28/242 (11%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
+K LG G +G+V + + + VAVK +K ++ L E +++ +E K
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM--------KEIK 60
Query: 172 H-HIVRIYEYFVCQRH--LCICFELL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
H ++V++ VC R I E + NL + ++ + + ++ ++ + QI +
Sbjct: 61 HPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPE 283
L+ IH DL N L+ + +K+ DFG S T ++ +++ + +PE
Sbjct: 119 YLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 284 VLLGYQYTTAIDMWSFGCIVAEL-FLGLPLFPG---ASEFDLLR---RMIRILGAQPPDY 336
L +++ D+W+FG ++ E+ G+ +PG + ++LL RM R G P Y
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY 235
Query: 337 VL 338
L
Sbjct: 236 EL 237
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 39/221 (17%)
Query: 117 LGHGTFGQVAKCW-------DAEMNSFVAVKIIKNQP-AYYQQALV-EVSILTTLNKKYD 167
LG G FG+V + DA M VAVK++K + ++AL+ E+ I++ L +
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMK--VAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 168 RED-----KHH--IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
+ I+ I EY C +LL+ ++ L+L + FS
Sbjct: 101 IVNLLGACTIGGPILVITEY-------CCYGDLLN-----FLRRKRESFLTLEDLLSFSY 148
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY 278
Q+ +G++ L IH DL N+LL +KI DFG A D +R
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHG---KIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
+ +PE + YT D+WS+G ++ E+F LG +PG
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 115 DLLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRED 170
+ +G G FG V + + VAVK ++ P ++ L E IL K+YD +
Sbjct: 1 EKIGKGNFGDV---YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL----KQYDHPN 53
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLS--LSIVQL--FSKQILRGL 226
IV++ V ++ + I EL+ + R L++ +L S G+
Sbjct: 54 ---IVKLIGVCVQKQPIYIVMELVPGGSL----LTFLRKKKNRLTVKKLLQMSLDAAAGM 106
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYRS 281
L+ IH DL N C + +KI DFG + E+ +Y+ + +
Sbjct: 107 EYLESKNCIHRDLAARN---CLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
PE L +YT+ D+WS+G ++ E F LG +PG S
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVY 271
+ ++ +I L L I++ DLKPENILL + + + DFG C E T
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---GHVVLTDFG-LCKEGIAQSDTTT 154
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
++ + Y +PEV+ Y +D W G ++ E+ GLP F
Sbjct: 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 57/237 (24%), Positives = 86/237 (36%), Gaps = 59/237 (24%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVA--VKIIKNQPAYYQQALVEVSIL-----TTLNK 164
+ LG G FG+V C E + K LV V +L +
Sbjct: 8 NFVEKLGEGQFGEVHLC---EADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 165 KYDREDK-------HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF---------- 207
+ +E K +I R+ LC+ E + E +N F
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYM-----ENGDLNQFLQKHVAETSG 119
Query: 208 -----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262
+ LS S + + QI G+ L+ +H DL N L+ + IKI DFG
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT---IKIADFGM 176
Query: 263 ACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
R +YS S YYR + E +L ++TT D+W+FG + E+
Sbjct: 177 ----SRNLYS---SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 60/289 (20%), Positives = 114/289 (39%), Gaps = 51/289 (17%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD---REDKH 172
++G G FG+V + A+KI++ + ++E + + + D D
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILVEADGA 61
Query: 173 HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230
+V+++ F +R+L + E L + L+K + LS Q + + + + +
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH 118
Query: 231 DAGIIHCDLKPENILL-------------CTSVK---------------PAEIKIIDFGS 262
G IH D+KP+N+LL CT +K P++ + S
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 263 ACTED-------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
+ + YS + + Y +PEV + Y D WS G I+ E+ +G P F
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 316 ASEFDLLRRMI--RILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEV 362
+ + R+++ + PP+ + E C S + I + V
Sbjct: 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGV 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSR 277
+++ L L I++ DLKPENILL + I + DFG + T+++T ++ +
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDAT---GHIALCDFGLSKANLTDNKTTNTFCGTT 160
Query: 278 YYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLF 313
Y +PEVLL + YT +D WS G +V E+ G F
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 36/121 (29%), Positives = 58/121 (47%), Gaps = 17/121 (14%)
Query: 195 DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254
D +L++L+K LS + V+ +Q++ L+ L IIH D+K EN+ L K
Sbjct: 93 DGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV-LYDRAKD-R 148
Query: 255 IKIIDFG------SACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308
I + D+G + D T+ Y+ SPE + G+ Y + D W+ G + EL
Sbjct: 149 IYLCDYGLCKIIGTPSCYDGTL------DYF-SPEKIKGHNYDVSFDWWAVGVLTYELLT 201
Query: 309 G 309
G
Sbjct: 202 G 202
|
Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 46/212 (21%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HI 174
++G G++ +V + + A+K++K + + + ++ + T +++ + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---DIDWVQTEKHVFEQASSNPFL 58
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
V ++ F L + E ++ + + R L + ++ +I L+ L + GI
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAEICIALNFLHERGI 117
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVYSYIQSRYYRSPEVLLGYQY 290
I+ DLK +N+LL IK+ D+G C E T ++ + Y +PE+L G +Y
Sbjct: 118 IYRDLKLDNVLLDAD---GHIKLTDYG-MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 291 TTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
++D W+ G ++ E + G S FD++
Sbjct: 174 GFSVDWWALGVLMFE------MMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 43/128 (33%), Positives = 61/128 (47%), Gaps = 13/128 (10%)
Query: 209 GLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
L+L L FS Q+ +G+S L IH DL NILL T + KI DFG A +
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL-THGRIT--KICDFGLA-RD 263
Query: 267 DRTVYSYIQSRYYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
R +Y+ R +PE + YT D+WS+G ++ E+F LG +PG
Sbjct: 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
Query: 320 DLLRRMIR 327
+MI+
Sbjct: 324 SKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 61/229 (26%), Positives = 109/229 (47%), Gaps = 26/229 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG+V W N VA+K +K + L E +++ L ++ R +
Sbjct: 14 LGAGQFGEV---WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL--QHPR-----L 63
Query: 175 VRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKD 231
VR+Y V Q + I E +++ +L + +K G+ L+I +L + QI G++ ++
Sbjct: 64 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER 120
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY----RSPEVLLG 287
IH DL+ NIL+ ++ KI DFG A + Y+ + + +PE +
Sbjct: 121 KNYIHRDLRAANILVSETL---CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 288 YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPD 335
+T D+WSFG ++ E+ G +PG + ++++ + R PD
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 55/263 (20%), Positives = 97/263 (36%), Gaps = 61/263 (23%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
LG G FG+V + + A+K ++ + + + V + + D E +VR
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNE---WVVR 65
Query: 177 IYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
+Y F + +L + + + LI++ F + + + ++ + + G
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE---DLARFYIAELTCAVESVHKMGF 122
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVY------------------- 271
IH D+KP+NIL+ + IK+ DFG T D Y
Sbjct: 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 272 ---------------------------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVA 304
S + + Y +PEVLL YT D WS G I+
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 305 ELFLGLPLFPGASEFDLLRRMIR 327
E+ +G P F + + ++I
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 14/111 (12%)
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED----RTVY 271
+ +S +I L+ L + GII+ DLK +N+LL IK+ D+G C E T
Sbjct: 99 RFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYG-MCKEGIRPGDTTS 154
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
++ + Y +PE+L G Y ++D W+ G ++ E + G S FD++
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE------MMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 50/204 (24%), Positives = 92/204 (45%), Gaps = 33/204 (16%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
+G G FG V + E VA+K I+ + + E ++ L+ +V+
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHP-------KLVQ 63
Query: 177 IYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSL------- 228
+Y + +C+ FE ++ L + ++ RG FS++ L G+ L
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQ--RGK-------FSQETLLGMCLDVCEGMA 114
Query: 229 -LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPE 283
L+ + +IH DL N L+ + +K+ DFG + D S +++ + SPE
Sbjct: 115 YLESSNVIHRDLAARNCLVGEN---QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171
Query: 284 VLLGYQYTTAIDMWSFGCIVAELF 307
V +Y++ D+WSFG ++ E+F
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVF 195
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 21/198 (10%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LG G FG V W + + VA+K+IK + + E ++ L H
Sbjct: 12 LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMKL---------SHEK 60
Query: 176 RIYEYFVC--QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
+ Y VC QR + I E + + H + S + K + G++ L+
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
IH DL N C +K+ DFG S D S + S++ + PEVLL +
Sbjct: 121 FIHRDLAARN---CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 290 YTTAIDMWSFGCIVAELF 307
+++ D+W+FG ++ E++
Sbjct: 178 FSSKSDVWAFGVLMWEVY 195
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 108 QRRYI--VKDLLGHGTFGQVAKC-WDAEMNS---FVAVKIIKNQPAYYQQALV--EVSIL 159
++R++ ++DL G G FG+V C +D E ++ VAVK +K + A + E+ IL
Sbjct: 2 EKRFLKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 60
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQ----RHLCICFELLDS-NLYELIKINHFRGLSLSI 214
R H + Y+ +C + + E L S +L E + N + ++L
Sbjct: 61 --------RNLYHENIVKYKG-ICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-INLKQ 110
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYS 272
++ QI +G+ L +H DL N+L+ + ++KI DFG A D+ Y+
Sbjct: 111 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKAIETDKEYYT 167
Query: 273 YIQSR----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307
++ +PE L+ ++ A D+WSFG + EL
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 35/118 (29%), Positives = 54/118 (45%), Gaps = 11/118 (9%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQS 276
F Q+ +G+ L +H DL N +L S +K+ DFG A D+ YS
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT---VKVADFGLARDIYDKEYYSVHNH 159
Query: 277 RYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327
+ P E L ++TT D+WSFG ++ EL G P +P FD+ +++
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 63/247 (25%), Positives = 106/247 (42%), Gaps = 52/247 (21%)
Query: 116 LLGHGTFGQV---AKCWDAEMNSFVAVKIIKNQPAYYQQA---------------LVEVS 157
+LG G +G+V K + A+K+++ + A Q+A + +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQ-KAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 158 ILTTLNKKYDREDKHHIVRIY----EYFVCQRHLCICFELLDSNLYELIKINHFRGLSLS 213
L TL+ + E K H++ Y E F ++LY+ ++F S
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMF--------------THLYQR---DNF---SED 105
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRT 269
V+ +S +I+ L L GI++ D+K ENILL + + + DFG + E
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLSEEKER 162
Query: 270 VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-R 327
YS+ + Y +PE++ G + A+D WS G ++ EL G F E + + R
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222
Query: 328 ILGAQPP 334
IL PP
Sbjct: 223 ILKCDPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 34/208 (16%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
LLG G FG V K W E +S VA+K I+++ +Q E+ T D
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEI---TDHMLAMGSLDH 68
Query: 172 HHIVRIYEYFVCQRHLCIC----FELLDSNLYELIKINHFR----GLSLSIVQLFSKQIL 223
+IVR+ L IC +L+ ++H R L + + QI
Sbjct: 69 AYIVRL---------LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYIQSRY- 278
+G+ L++ ++H +L NILL + + ++I DFG A + + YS ++
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
+ + E +L +YT D+WS+G V E+
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 28/75 (37%), Positives = 39/75 (52%), Gaps = 8/75 (10%)
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY 273
I+Q +QIL L L GI+H D+KP+NI+ S KIID G+A + R +Y
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--SEGSGSFKIIDLGAA-ADLRVGINY 312
Query: 274 IQSRY-----YRSPE 283
I + Y +PE
Sbjct: 313 IPKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 114 KDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA----LVEVSILTTLNKKY 166
+ ++G G FG+V + VA+K +K P Y ++ L E SI+ +
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK--PGYTEKQRQDFLSEASIMGQFSH-- 65
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRG 225
H+I+R+ + I E +++ L + ++ + S +V + + I G
Sbjct: 66 -----HNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML-RGIAAG 119
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-----YY 279
+ L D +H DL NIL+ +++ E K+ DFG S ED +Y S +
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNL---ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAEL 306
+PE + ++T+A D+WSFG ++ E+
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEV 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 70/253 (27%), Positives = 112/253 (44%), Gaps = 48/253 (18%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAK-CW--DAE-MNSFVAVKIIK--NQPAYYQQALVEVSIL 159
ET+ + + +LG G FG V K W D E + VA+K+++ P ++ L E ++
Sbjct: 6 ETELKKVK--VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICF--------ELLDSN-LYELIKINHFRGL 210
+ Y VC R L IC +L+ L + ++ N R
Sbjct: 64 AGVGSPY---------------VC-RLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIG 107
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR 268
S ++ + QI +G+S L++ ++H DL N+L+ + P +KI DFG A D
Sbjct: 108 SQDLLN-WCVQIAKGMSYLEEVRLVHRDLAARNVLVKS---PNHVKITDFGLARLLDIDE 163
Query: 269 TVYSYIQSRY---YRSPEVLLGYQYTTAIDMWSFGCIVAEL--FLGLPL--FPGASEFDL 321
T Y + + + E +L ++T D+WS+G V EL F P P DL
Sbjct: 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 223
Query: 322 LRRMIRILGAQPP 334
L + R+ QPP
Sbjct: 224 LEKGERL--PQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 69/254 (27%)
Query: 117 LGHGTFGQVAKCW----DAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRED 170
LG FG++ K + VA+K +K N P + + E S++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-------- 64
Query: 171 KHH--IVRIYEYFVCQRHLCICFELLDS-NLYELI---------------------KINH 206
HH IV + ++ +C+ FE L+ +L+E + ++H
Sbjct: 65 -HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266
L ++I QI G+ L +H DL NIL+ + +KI D G +
Sbjct: 124 GDFLHIAI------QIAAGMEYLSSHFFVHKDLAARNILIGEQL---HVKISDLGLS--- 171
Query: 267 DRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLF 313
R +YS + YYR PE ++ ++++ D+WSFG ++ E+F GL +
Sbjct: 172 -REIYS---ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
Query: 314 PGASEFDLLRRMIR 327
G S +++ M+R
Sbjct: 228 YGFSNQEVI-EMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 49/221 (22%)
Query: 116 LLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYDR 168
LG G FG+V + + V VK ++ Q+ E+ + L+ K
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN-- 69
Query: 169 EDKHHIVRIYEYFVCQR---HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQIL- 223
+VR+ +C+ H + E D +L + ++ + L L +KQ +
Sbjct: 70 -----VVRLLG--LCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 224 ------RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
G+ L +A +H DL N L+ + E+K+ S + + VY+ S
Sbjct: 122 LCTQIALGMDHLSNARFVHRDLAARNCLVSSQR---EVKV----SLLSLSKDVYN---SE 171
Query: 278 YYR-----------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
YY+ +PE + ++T D+WSFG ++ E+F
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 53/245 (21%), Positives = 89/245 (36%), Gaps = 60/245 (24%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY--QQALV--EVSILTTLNKKYDREDK 171
++G G FG+V + A+K ++ Q A V E IL + +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW----- 62
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+V++Y F + +L + E L + L+K + F + + + + + + +
Sbjct: 63 --VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF---TEEETRFYIAETILAIDSI 117
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---------------------------- 261
G IH D+KP+N+LL IK+ DFG
Sbjct: 118 HKLGYIHRDIKPDNLLLDAK---GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 262 SACTEDRT-------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308
+ YS + + Y +PEV L Y D WS G I+ E+ +
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 309 GLPLF 313
G P F
Sbjct: 235 GYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 32/215 (14%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLN 163
Y V ++G G FG+V A+K++ ++ A++ + E I+ N
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFAN 101
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
+ +V+++ F R+L + E + +L+ + + + ++ +++
Sbjct: 102 SPW-------VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVV 152
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYY 279
L + G IH D+KP+N+LL K +K+ DFG+ ++ + + + Y
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG 309
SPEVL GY Y D WS G + E+ +G
Sbjct: 210 ISPEVLKSQGGDGY-YGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 42/137 (30%), Positives = 63/137 (45%), Gaps = 24/137 (17%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
FS Q+ +G+ L IH D+ N+LL T + A KI DFG A R + + S
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVA--KICDFGLA----RDIMN--DSN 267
Query: 278 Y-----------YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRM 325
Y + +PE + YT D+WS+G ++ E+F LG +PG +M
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327
Query: 326 IRILGAQ--PPDYVLKE 340
++ G Q PD+ E
Sbjct: 328 VK-RGYQMSRPDFAPPE 343
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 11/106 (10%)
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYS- 272
+ ++ +++ L + G IH D+KP+N+LL S +K+ DFG+ D V
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMDANGMVRCD 201
Query: 273 -YIQSRYYRSPEVLLGY----QYTTAIDMWSFGCIVAELFLGLPLF 313
+ + Y SPEVL Y D WS G + E+ +G F
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 67/246 (27%), Positives = 105/246 (42%), Gaps = 52/246 (21%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDRE 169
+LG G FG V K W E VA+K ++ P ++ L E ++ +++ +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH--- 70
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL------------ 217
VC R L IC L S + + ++ F G L V+
Sbjct: 71 ------------VC-RLLGIC---LTSTVQLITQLMPF-GCLLDYVREHKDNIGSQYLLN 113
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
+ QI +G++ L++ ++H DL N+L+ T P +KI DFG A D Y
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 276 SRY---YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG--ASEF-DLLRRMIRI 328
+ + + E +L YT D+WS+G V EL G + G ASE +L + R+
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 230
Query: 329 LGAQPP 334
QPP
Sbjct: 231 --PQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 45/198 (22%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LG G FG V W +++ VA+K+I+ + E ++ L+ ++V
Sbjct: 12 LGSGQFGVVHLGKWRGKID--VAIKMIREGAMSEDDFIEEAKVMMKLSHP-------NLV 62
Query: 176 RIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
++Y QR + I E + + L ++ + + ++ + + + L+ G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-CSDVCEAMEYLESNGF 121
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY---YRSPEVLLGYQ 289
IH DL N C + +K+ DFG A +D+ S +++ + PEV +
Sbjct: 122 IHRDLAARN---CLVGEDNVVKVSDFGLARYVLDDQYTSSQ-GTKFPVKWAPPEVFDYSR 177
Query: 290 YTTAIDMWSFGCIVAELF 307
+++ D+WSFG ++ E+F
Sbjct: 178 FSSKSDVWSFGVLMWEVF 195
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 11/102 (10%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
Q+ RG+ L IH DL N+L+ + +KI DFG A + Y Y ++ R
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLARDVNNIDY-YKKTTNGR 200
Query: 281 ------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
+PE L YT D+WSFG ++ E+F LG +PG
Sbjct: 201 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 41/124 (33%), Positives = 56/124 (45%), Gaps = 26/124 (20%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
Q+ RG+ L+ IH DL N+L+ + +KI DFG A R V+ YY+
Sbjct: 142 QVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLA----RGVH---DIDYYK 191
Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LG---LPLFPGASEFDLLRR 324
+PE L YT D+WSFG ++ E+F LG P P F LLR
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251
Query: 325 MIRI 328
R+
Sbjct: 252 GHRM 255
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 11/104 (10%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-- 275
FS Q+ G+ L +H DL N+L+C +KI DFG A R +YI
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEG---KLVKICDFGLARDIMRDS-NYISKG 299
Query: 276 SRY----YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFP 314
S + + +PE + YTT D+WSFG ++ E+F LG +P
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 37/120 (30%), Positives = 52/120 (43%), Gaps = 7/120 (5%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSR 277
QI L L + I+H DLK +N+ L + IK+ D G A + + I +
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTP 166
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQPPDY 336
YY SPE+ Y D+W+ GC V E+ F L+ R+I L P DY
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 35/205 (17%)
Query: 117 LGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
LG G FG V K W A++ VA+K I + + E ++ L+ +
Sbjct: 12 LGSGQFGVVHLGK-WRAQIK--VAIKAINEGAMSEEDFIEEAKVMMKLSHP-------KL 61
Query: 175 VRIYEYFVCQRHLCICFELLDSNL---YELIKINHF-RGLSLSIVQLFSKQILRGLSLLK 230
V++Y Q+ L I E +++ Y + + + LS+ Q + G+ L+
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGMEYLE 117
Query: 231 DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY--SYIQSR------YYRSP 282
IH DL N L+ ++ +K+ DFG R V Y S + P
Sbjct: 118 RNSFIHRDLAARNCLVSST---GVVKVSDFGMT----RYVLDDEYTSSSGAKFPVKWSPP 170
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELF 307
EV +Y++ D+WSFG ++ E+F
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVF 195
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHI 174
+G G FG+V N+ VAVK + P + L E IL K+Y + I
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARIL----KQYSHPN---I 55
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
VR+ ++ + I EL+ + L + + + G+ L+
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-----YRSPEVLLGYQ 289
IH DL N C + +KI DFG + E+ VY+ + +PE L +
Sbjct: 116 IHRDLAARN---CLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 290 YTTAIDMWSFGCIVAELF-LGLPLFPGAS 317
Y++ D+WSFG ++ E F LG + S
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLS 201
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 35/117 (29%), Positives = 58/117 (49%), Gaps = 8/117 (6%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY--- 271
V L QI+ L + ++H DLK NI L + IK+ DFG + +V
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQYSDSVSLDV 227
Query: 272 --SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
S+ + YY +PE+ +Y+ DMWS G I+ EL F G S+ +++++++
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-05
Identities = 27/80 (33%), Positives = 46/80 (57%), Gaps = 8/80 (10%)
Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CT--E 266
+++++ +Q+L GL L GI+H D+KPEN+L+ ++KIIDFG+A CT
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGIN 364
Query: 267 DRTVYSYIQSRYYRSPEVLL 286
+Y + RY E+++
Sbjct: 365 FNPLYGMLDPRYSPPEELVM 384
|
Length = 507 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 55/244 (22%)
Query: 108 QRRYIVKDLLGHGTFGQVAKC----------WDAEMNS------FVAVKIIKNQPAYYQQ 151
+ + K+ LG G FG+V C N VAVKI++ P +
Sbjct: 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR--PDANKN 61
Query: 152 A----LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINH 206
A L EV IL+ L +I+R+ V + LC+ E +++ +L + + +H
Sbjct: 62 ARNDFLKEVKILSRLKDP-------NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHH 114
Query: 207 F---------------RGLSLSIVQLFS--KQILRGLSLLKDAGIIHCDLKPENILLCTS 249
++S L QI G+ L +H DL N L+ +
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN 174
Query: 250 VKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVA 304
+ IKI DFG + Y IQ R + + E +L ++TTA D+W+FG +
Sbjct: 175 L---TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231
Query: 305 ELFL 308
E+ +
Sbjct: 232 EILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 62/290 (21%), Positives = 111/290 (38%), Gaps = 63/290 (21%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA----------LVEVSILTTLNKK 165
++G G FG+V + A+KI++ ++ LVE L +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
Y +DK ++ I E+ + + L+K + L+ Q + + +
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTL-----------LMKKD---TLTEEETQFYIAETVLA 113
Query: 226 LSLLKDAGIIHCDLKPENILL-------------CTSVK---------------PAEIKI 257
+ + G IH D+KP+N+LL CT +K P++
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 258 IDFGS---ACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310
+ S A T R +S + + Y +PEV + Y D WS G I+ E+ +G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 311 PLFPGASEFDLLRRMI--RILGAQPPDYVLKE-AKNTSKFFKCIGSVHNI 357
P F + + ++++ + PP+ + E AK+ F C H I
Sbjct: 234 PPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWE-HRI 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 42/131 (32%), Positives = 60/131 (45%), Gaps = 22/131 (16%)
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS---YI 274
F I G+ L IH DL N +L ++ + + DFG + + +Y+ Y
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVADFGLS----KKIYNGDYYR 169
Query: 275 QSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGA--SE-FDLLRR 324
Q R + P E L YTT D+WSFG + E+ G +PG SE +D LR+
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229
Query: 325 MIRILGAQPPD 335
R+ QPPD
Sbjct: 230 GNRL--KQPPD 238
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 8/109 (7%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-----SACTEDRTVYSYIQ 275
Q+L + + +IH D+K NILLC++ +K+ DFG +A D ++
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSN---GLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR 324
+ YY +PE+ Y+ DM+S G ++ EL F G + +++ +
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 40/127 (31%), Positives = 57/127 (44%), Gaps = 25/127 (19%)
Query: 212 LSIVQLFS--KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
LS L S Q+ RG+ L IH DL N+L+ + +KI DFG A R
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLA----RD 189
Query: 270 VYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
++ YY+ +PE L YT D+WSFG ++ E+F LG +PG
Sbjct: 190 IH---HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 317 SEFDLLR 323
+L +
Sbjct: 247 PVEELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 7e-05
Identities = 29/98 (29%), Positives = 43/98 (43%), Gaps = 3/98 (3%)
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
V+ ++ +++ L L GI+ DL P NILL I++ F + +
Sbjct: 87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDSCDGEA 143
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL 312
Y +PEV + T A D WS G I+ EL G L
Sbjct: 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 23/108 (21%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
Q+ RG+ L IH DL N+L+ + +KI DFG A R V++ YY+
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLA----RDVHNI---DYYK 191
Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
+PE L YT D+WSFG ++ E+F LG +PG
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 12/118 (10%)
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-EDRTV---YSYIQ 275
KQ+L + + D +IH D+K ENI L K I + DFG+A E Y ++
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK---IVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP----GASEFDLLRRMIRIL 329
+ SPE+L G Y D+WS G I+ ++ L P G L ++I L
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDM-LSHDFCPIGDGGGKPGKQLLKIIDSL 387
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 57/253 (22%), Positives = 96/253 (37%), Gaps = 73/253 (28%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVK-------IIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+G G FG+V + N+ A+K +++NQ A+ + E IL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILA-------EA 58
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLS 227
D +V++Y F + +L + + + LI++ F + + + ++ +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE---DLARFYIAELTCAIE 115
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR------------------- 268
+ G IH D+KP+NIL+ + IK+ DFG CT R
Sbjct: 116 SVHKMGFIHRDIKPDNILI---DRDGHIKLTDFG-LCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 269 ----------------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFG 300
+S + + Y +PEVLL YT D WS G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231
Query: 301 CIVAELFLGLPLF 313
I+ E+ +G P F
Sbjct: 232 VILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 44.4 bits (106), Expect = 1e-04
Identities = 15/60 (25%), Positives = 23/60 (38%), Gaps = 6/60 (10%)
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
L + + DIS E D ++ L+ DP KR + +A +HPF
Sbjct: 201 QLLELFKKIGKPKPPFPPPEWDISPE------AKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 28/234 (11%)
Query: 116 LLGHGTFGQVAK-CWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169
+LG G FG V K W E + VA+KI+ P + + E I+ ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM------- 66
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
D H+VR+ + + + L + + H + ++ + QI +G+ L
Sbjct: 67 DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRY---YRSPEV 284
++ ++H DL N+L+ + P +KI DFG A D Y+ + + + E
Sbjct: 126 EERRLVHRDLAARNVLVKS---PNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 285 LLGYQYTTAIDMWSFGCIVAEL--FLGLPL--FPGASEFDLLRRMIRILGAQPP 334
+ ++T D+WS+G + EL F G P P DLL + R+ QPP
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL--PQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 35/208 (16%)
Query: 117 LGHGTFGQVAK-CWDAEMNSF-VAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH 172
LG G FG V K + VA+K++K N+ + + + E I+ L+ Y
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY------ 56
Query: 173 HIVRIYEYFVCQ-RHLCICFELLDSNLYELIKINHFRG-----LSLSIVQLFSKQILRGL 226
IVR+ VC+ L + E+ +N F +++S V Q+ G+
Sbjct: 57 -IVRMIG--VCEAEALMLVMEMASGG-----PLNKFLSGKKDEITVSNVVELMHQVSMGM 108
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG--SACTEDRTVYSYIQS-----RYY 279
L+ +H DL N+LL V KI DFG A D + Y + ++Y
Sbjct: 109 KYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF 307
+PE + ++++ D+WS+G + E F
Sbjct: 166 -APECINFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 56/268 (20%), Positives = 97/268 (36%), Gaps = 71/268 (26%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE-----D 170
++G G FG+V + A+K + + + L V K +R+ D
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHV--------KAERDVLAESD 59
Query: 171 KHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+V +Y F ++L + E L + LIK + F S + + + + + +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF---SEDVTRFYMAECVLAIEA 116
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG------------------------SAC 264
+ G IH D+KP+NIL+ + IK+ DFG +
Sbjct: 117 VHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 265 TEDRTV--------------------------YSYIQSRYYRSPEVLLGYQYTTAIDMWS 298
+V YS + + Y +PE+ L Y D WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 299 FGCIVAELFLGLPLFPGASEFDLLRRMI 326
G I+ E +G P F + + R++I
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKII 261
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 51/232 (21%)
Query: 105 AETQRRYIVKDLLGHGTFGQV--AKCWDAEMNSF--VAVKIIKNQPAYYQQA--LVEVSI 158
A ++ R + DLL GTFG++ D + V VK +K+ + Q L E +
Sbjct: 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 159 LTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-----------SNLY------EL 201
L L+ + +I+ I L +C E + NL L
Sbjct: 62 LYGLSHQ-------NILPI---------LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRL 105
Query: 202 IKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
+ N+ + LS + + QI G+S L G+IH D+ N ++ ++ +KI D
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ---VKITD-- 160
Query: 262 SACTED--RTVYSYIQSRYYR-----SPEVLLGYQYTTAIDMWSFGCIVAEL 306
+A + D Y + R + E L+ +Y++A D+WSFG ++ EL
Sbjct: 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQ---ALV--EVSILTTLN 163
++G G FG+VA A+KI+ + + A +++ LV + +TTL+
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
Y +D++++ + +Y+V L + + D L + + + +++
Sbjct: 68 --YAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-------------LPEDMARFYIAEMV 112
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQ--SRYY 279
+ + +H D+KP+N+LL + I++ DFGS +D TV S + + Y
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 280 RSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLG 309
SPE+L + Y D WS G + E+ G
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 57/260 (21%), Positives = 98/260 (37%), Gaps = 65/260 (25%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
LG G FG+V + ++ A+K ++ + + + V + + D E +V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE---WVVK 65
Query: 177 IYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI 234
+Y F + +L + + + LI++ F + + + ++ + + G
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVF---PEVLARFYIAELTLAIESVHKMGF 122
Query: 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACT----------------------------- 265
IH D+KP+NIL+ IK+ DFG CT
Sbjct: 123 IHRDIKPDNILIDLD---GHIKLTDFG-LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 266 --------------EDRT--------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIV 303
E R +S + + Y +PEVLL YT D WS G I+
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 304 AELFLGLPLF--PGASEFDL 321
E+ +G P F P +E L
Sbjct: 239 FEMLVGQPPFLAPTPTETQL 258
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 22/139 (15%)
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
L L + F I G+ L + IH DL N +L + + + DFG + +
Sbjct: 110 LPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVADFGLS----KK 162
Query: 270 VYS---YIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASE- 318
+YS Y Q R + P E L YT+ D+W+FG + E+ G +PG
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222
Query: 319 --FDLLRRMIRILGAQPPD 335
+D LR R+ QP D
Sbjct: 223 EIYDYLRHGNRL--KQPED 239
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 27/123 (21%), Positives = 44/123 (35%), Gaps = 18/123 (14%)
Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL---DSNLYELIKINHFRGLSLSI 214
+L + D+ V I + R ++L +S+ + + + G +L
Sbjct: 25 VLKINPSREKGADREREVAILQLL--ARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE 82
Query: 215 VQLFSK--------QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACT 265
V K ++L L L + H DL P NIL V +I IID+ A
Sbjct: 83 VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL----VDDGKILGIIDWEYAGY 138
Query: 266 EDR 268
Sbjct: 139 GPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 31/87 (35%), Positives = 43/87 (49%), Gaps = 14/87 (16%)
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQ--SRYYRSPEVLLG 287
G +H D+KP+N+LL K I++ DFGS C D TV S + + Y SPE+L
Sbjct: 122 GYVHRDIKPDNVLL---DKNGHIRLADFGS-CLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 288 YQ-----YTTAIDMWSFGCIVAELFLG 309
+ Y D WS G + E+ G
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 42/220 (19%)
Query: 114 KDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDRE 169
+D++G G FGQV A+ + A+K +K + ++ E+ +L L
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------ 65
Query: 170 DKHHIVRIYEYFVCQR----HLCICF----ELLD----SNLYEL---IKINHFRGLSLSI 214
HH I C+ +L I + LLD S + E I + +LS
Sbjct: 66 --HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
QL F+ + RG+ L IH DL NIL+ + KI DFG + R
Sbjct: 124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLS----RGQEV 176
Query: 273 YIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAEL 306
Y++ R P E L YTT D+WS+G ++ E+
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 32/205 (15%)
Query: 117 LGHGTFGQVAK-CWDAEMNS----FVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
+G G FG+V + ++ VA+K +K + Q+ L E SI+ +
Sbjct: 12 IGGGEFGEVCRGRL--KLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM-------GQF 62
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFS--KQILRGL 226
D +I+R+ R + I E +++ +L + ++ N + ++ QL + I G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGM 119
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED-RTVYSY----IQSRYYR 280
L + +H DL NIL+ +++ K+ DFG S ED Y+ I R+
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRRLEDSEATYTTKGGKIPIRW-T 175
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAE 305
+PE + ++T+A D+WSFG ++ E
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKII-------KNQPAYYQQALVEVSILTTLNKK--- 165
++G G FG+VA + A+KI+ + + A +++ E +L + +
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDNQWIT 64
Query: 166 ---YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
Y +D++++ + +Y+V L + + D L + + + ++
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-------------LPEDMARFYLAEM 111
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ--SRY 278
+ + + +H D+KP+NIL+ + I++ DFGS ED TV S + +
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168
Query: 279 YRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLG 309
Y SPE+L + Y D WS G + E+ G
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 24/120 (20%)
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
QI G+ L ++H DL N+L+ + +KI D G R VY+ + YY+
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGLF----REVYA---ADYYK 181
Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
SPE ++ +++ D+WS+G ++ E+F GL + G S D++ MIR
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI-EMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 53/222 (23%)
Query: 117 LGHGTFGQVAK-----CWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDRE 169
LG G+FG V + E + VA+K + + ++ L E S++ N
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC----- 68
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGL-------------SLSIVQ 216
HH+VR+ + + EL+ + ++ R L SL +
Sbjct: 69 --HHVVRLLGVVSQGQPTLVIMELMTRGDLK----SYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
+ +I G++ L +H DL N C + +KI DFG R +Y ++
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARN---CMVAEDFTVKIGDFGMT----RDIY---ET 172
Query: 277 RYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
YYR SPE L +TT D+WSFG ++ E+
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 212 LSIVQLFS--KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDR 268
+++QL + I G+ L D G +H DL NIL+ +++ K+ DFG S ED
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDD 159
Query: 269 TVYSY------IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
+Y I R+ +PE + ++T+A D+WS+G ++ E+
Sbjct: 160 PEAAYTTRGGKIPIRW-TAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 64/259 (24%), Positives = 106/259 (40%), Gaps = 54/259 (20%)
Query: 115 DLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDR 168
D++G G FGQV K M++ A+K +K + ++ E+ +L L
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDA--AIKRMKEYASKDDHRDFAGELEVLCKLG----- 53
Query: 169 EDKHHIVRIYEYFVCQR--HLCICFELLD-SNLYELIKIN------------HFRGLSLS 213
HH I C+ +L + E NL + ++ + + +LS
Sbjct: 54 ---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110
Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
QL F+ + RG+ L IH DL NIL+ + KI DFG + ++
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLSRGQE---- 163
Query: 272 SYIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
Y++ R P E L YTT D+WS+G ++ E+ LG + G + +L +
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 325 MIRILGAQPPDYVLKEAKN 343
+ P Y L++ N
Sbjct: 224 L-------PQGYRLEKPLN 235
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 64/260 (24%), Positives = 111/260 (42%), Gaps = 54/260 (20%)
Query: 114 KDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYD 167
+D++G G FGQV + +MN+ A+K++K + ++ E+ +L L
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNA--AIKMLKEFASENDHRDFAGELEVLCKLG---- 60
Query: 168 REDKHHIVRIYEYFVCQR--HLCICFELLD-SNLYELIKIN------------HFRGLSL 212
HH I C+ +L I E NL + ++ + H +L
Sbjct: 61 ----HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
+ QL F+ + G+ L + IH DL N+L+ ++ KI DFG + E+
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS---KIADFGLSRGEE--- 170
Query: 271 YSYIQSRYYRSP------EVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
Y++ R P E L YTT D+WSFG ++ E+ LG + G + +L
Sbjct: 171 -VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229
Query: 324 RMIRILGAQPPDYVLKEAKN 343
++ P Y +++ +N
Sbjct: 230 KL-------PQGYRMEKPRN 242
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 17/136 (12%)
Query: 206 HFRGLSLSIVQL-FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
++ V + ++ GL L A IH DL N L +KI D+G A
Sbjct: 92 MVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD---LSVKIGDYGLAL 148
Query: 265 TEDRTVYSYIQSRY-----YRSPEV-------LLGYQYTTAIDMWSFGCIVAELF-LGLP 311
+ Y + + + +PE+ LL T ++WS G + ELF
Sbjct: 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQ 208
Query: 312 LFPGASEFDLLRRMIR 327
+P S+ +L++++R
Sbjct: 209 PYPDLSDEQVLKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 113 VKDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
+++++G G FG+V + + FVA+K +K+ Q+ L E SI+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF----- 62
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFS--KQILR 224
D +I+ + R + I E +++ L ++ N + +++QL + I
Sbjct: 63 --DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIAA 117
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSR----- 277
G+ L + +H DL NIL+ +++ K+ DFG + +D + +Y S
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 278 -YYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
+ +PE + ++T+A D+WS+G ++ E+
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 40/204 (19%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 113 VKDLLGHGTFGQVAKCW---DAEMNSFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYD 167
++ +LG G FG++ + ++ VA+ ++ + Q+ L E L
Sbjct: 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF----- 63
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
D +IVR+ + I E + + + H L + + G+
Sbjct: 64 --DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQSR---YYRSP 282
L + G +H L +L+ + + KI F ED+ +Y+ + + + +P
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV---CKISGFRRL-QEDKSEAIYTTMSGKSPVLWAAP 177
Query: 283 EVLLGYQYTTAIDMWSFGCIVAEL 306
E + + +++A D+WSFG ++ E+
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 21/196 (10%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176
+G G FG V D N VAVK IKN A Q L E S++T L ++V+
Sbjct: 14 IGKGEFGDVM-LGDYRGNK-VAVKCIKND-ATAQAFLAEASVMTQLRHS-------NLVQ 63
Query: 177 IYEYFVCQR-HLCICFELLDSNLYELIKINHFRGLSL---SIVQLFSKQILRGLSLLKDA 232
+ V ++ L I E + L+ RG S+ + FS + + L+
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKG--SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 233 GIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYT 291
+H DL N+L V + K+ DFG T + + +PE L +++
Sbjct: 122 NFVHRDLAARNVL----VSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 292 TAIDMWSFGCIVAELF 307
T D+WSFG ++ E++
Sbjct: 178 TKSDVWSFGILLWEIY 193
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 46/209 (22%), Positives = 74/209 (35%), Gaps = 34/209 (16%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII--KNQP-AYYQQALVEVSILTTLNKKYDREDKHH 173
+AK N+ VAVK I + + E+ L +
Sbjct: 10 FEDLMIVHLAKHKPT--NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP-------N 60
Query: 174 IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKD 231
I+ F+ L + L+ + +L+K HF GL + K +L L +
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLK-THFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT------EDRTVYSYIQSR----YYRS 281
G IH +K +ILL K + + + + R V+ + +S + S
Sbjct: 120 KGFIHRSVKASHILLSGDGK---VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 282 PEVLLGYQ----YTTAIDMWSFGCIVAEL 306
PEVL Q Y D++S G EL
Sbjct: 177 PEVL--QQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.002
Identities = 19/58 (32%), Positives = 27/58 (46%), Gaps = 7/58 (12%)
Query: 395 HKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
K L +I TN P + + K S DFLK ++ +P KR + Q +HPF
Sbjct: 203 MKALFKIATNGPPG----LRNPEKWSDE---FKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 63/251 (25%), Positives = 103/251 (41%), Gaps = 48/251 (19%)
Query: 116 LLGHGTFGQVAKCW-DAEMNSF--VAVKIIK---NQPAYYQQALVEVSILTTLNKKYDRE 169
+LG G FG V + +E SF VAVK++K + ++ L E + + K++D
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACM----KEFDHP 61
Query: 170 DKHHIVRIYEYFVCQRHLCICFELL------DSNLYEL---IKINHFRGLSLSIVQLFSK 220
+ ++ + + L I +L D + + L I F L L + F
Sbjct: 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRFMI 120
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
I G+ L IH DL N +L ++ + + DFG + + +YS YYR
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVADFGLS----KKIYS---GDYYR 170
Query: 281 ------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMI- 326
+ E L YTT D+W+FG + E+ G + G ++ +I
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230
Query: 327 --RILGAQPPD 335
R+ QPPD
Sbjct: 231 GNRL--KQPPD 239
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 17/70 (24%), Positives = 29/70 (41%), Gaps = 5/70 (7%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLS---MEDISKESQIRLALVDFLKGLVEFDPAKRWS 443
L GK F +++ + R+ L D K S D +K + DP+KR +
Sbjct: 193 LTGKPPFSGENILDQ--LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPT 250
Query: 444 PFQASRHPFV 453
+ +HP+
Sbjct: 251 AEEILQHPWF 260
|
Length = 260 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 820 | |||
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.74 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.2 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.93 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.72 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.7 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.47 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.18 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.16 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.13 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.06 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.81 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.65 | |
| PLN02236 | 344 | choline kinase | 96.64 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.55 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.54 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.68 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.57 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.56 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.55 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.46 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.23 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.94 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.28 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.94 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.66 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.4 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 92.18 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.32 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 91.13 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-63 Score=558.39 Aligned_cols=397 Identities=46% Similarity=0.756 Sum_probs=332.3
Q ss_pred ccchhhHhhhhhHHHHhhhcCCCcccccccCCCccccCCCccccCCCccCCCCcceEeeceeeeccccCCceEEEEEecc
Q 003438 40 VRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGH 119 (820)
Q Consensus 40 ~~~~~~~~Lt~~i~~~y~~~~p~~~~~~~~~~~r~~t~p~~~~~n~g~d~~~~d~~~~l~~~l~~~~~~~rY~i~~~LG~ 119 (820)
.+...+...+....++|.+|+..+.+....++++..+.+.......++++.+++|.+.+++++. .+|+|++.||+
T Consensus 122 ~~~~~~~~~~~s~~e~~ei~~~~~~~~~~~~~~~~~t~~~~~~~~~~~~~~~~dY~~v~~d~i~-----~rY~V~e~LGk 196 (586)
T KOG0667|consen 122 SQASPLYKHSLSLIETYEIINYPEVYFVGLNAKKVLTFPSEGINTKNFDDEDGDYQLVVNDHIA-----YRYEVLEVLGK 196 (586)
T ss_pred hhhhhhhccccchhhhhhccChHHhhhhccccccccCCCcccccCCCCCCCCCceeEEecceeE-----EEEEEEEEecc
Confidence 3444566677778999999999999999999999999999998888899999999999999998 59999999999
Q ss_pred CCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccCCChH
Q 003438 120 GTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLY 199 (820)
Q Consensus 120 G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~ 199 (820)
|+||+|.+|++..|++.||||+++++.....+...|+.||..|++ .+..+..|||+++|+|...+|+|||+|+++.+|+
T Consensus 197 GtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~-~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLY 275 (586)
T KOG0667|consen 197 GSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNK-HDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLY 275 (586)
T ss_pred cccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhc-cCCCCCeeEEEeeeccccccceeeeehhhhhhHH
Confidence 999999999999999999999999999999999999999999985 5667788999999999999999999999999999
Q ss_pred HHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccccccccccc
Q 003438 200 ELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279 (820)
Q Consensus 200 d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y 279 (820)
++++.+.+.+++...++.|+.|||.||.+||+.+|||+|||||||||..- ....|||+|||++|...+...+++++++|
T Consensus 276 ellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~q~vytYiQSRfY 354 (586)
T KOG0667|consen 276 ELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFESQRVYTYIQSRFY 354 (586)
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccCCcceeeeecccc
Confidence 99999999999999999999999999999999999999999999999754 45699999999999999999999999999
Q ss_pred cCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCC
Q 003438 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIEN 359 (820)
Q Consensus 280 ~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~ 359 (820)
+|||+|++.+|+.++||||||||++||++|.++|+|.++.|++..|++++| .||.++++.+++..+||++....+....
T Consensus 355 RAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG-~Pp~~mL~~~~~~~kff~~~~~~~~~~~ 433 (586)
T KOG0667|consen 355 RAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG-LPPPKMLDTAKKAHKFFTSLKGFPRLCV 433 (586)
T ss_pred ccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC-CCCHHHHHhccccceehhccCCceeeee
Confidence 999999999999999999999999999999999999999999999999999 9999999999999999998421111000
Q ss_pred CccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcC
Q 003438 360 GEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPA 439 (820)
Q Consensus 360 ~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~ 439 (820)
+.+..+..+......++....++.. .| .....-+..........|+|||++||++||.
T Consensus 434 -----------------~~~~~~~~k~~~~~~~~~~~~~~~~---~P--~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 434 -----------------ETSAPRGTKSPEVRKYYRKARLERR---GP--PGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred -----------------eecccccccchhhhhhhhhhccccc---CC--CCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0000000011111111111101000 11 0111111112223567899999999999999
Q ss_pred CCCCHHHHHcCCccCCCCCCCCCCCCC
Q 003438 440 KRWSPFQASRHPFVTGEPFTCPYQPPP 466 (820)
Q Consensus 440 kRpTa~EaL~HPff~~~~~~~~~~~~~ 466 (820)
+|+|+.|+|+||||++..+.+....+.
T Consensus 492 ~R~tp~qal~Hpfl~~~~~~~~~~~~~ 518 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGTSLERRNQSPL 518 (586)
T ss_pred hcCCHHHHhcCcccccccccccCCCCc
Confidence 999999999999999887765554443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=457.50 Aligned_cols=284 Identities=36% Similarity=0.554 Sum_probs=240.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHH--HHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ--ALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~--~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~- 185 (820)
+||.++++||.|+||.||+|+.+++++.||||.++++-...++ -++|++.|++|+ .|||||+|++++.+.+
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln------~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN------PHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC------CCCcchhhHHHhhccCc
Confidence 7999999999999999999999999999999999976443443 367999999994 3999999999999988
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++|+|||||+.+|+++++.+ .+.|++..++.|++||++||+|+|++|+.||||||||||+. ....|||+|||+|+.
T Consensus 84 ~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 84 ILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLARE 159 (538)
T ss_pred eEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccc
Confidence 99999999999999999988 57899999999999999999999999999999999999995 467899999999987
Q ss_pred cCC--ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDR--TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~--~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
... ..+.++-|+||+|||+++.. -|+.+.||||+|||++|+.+-+++|+|.++.|++.+|++++| .|.+..+.+..
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG-tP~~~~~~eg~ 238 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG-TPDKDSWPEGY 238 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC-CCccccchhHH
Confidence 653 34568999999999999765 789999999999999999999999999999999999999999 66544433321
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+. .... .....++....+..++.+ +
T Consensus 239 ~L----------------------------a~~m----------nf~~P~~~~~~l~~L~p~-----------------~ 263 (538)
T KOG0661|consen 239 NL----------------------------ASAM----------NFRFPQVKPSPLKDLLPN-----------------A 263 (538)
T ss_pred HH----------------------------HHHh----------ccCCCcCCCCChHHhCcc-----------------c
Confidence 11 0000 011122334455555544 5
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
+.++.+||.+||.|||.+||||.|+|+||||+....
T Consensus 264 s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 264 SSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred CHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 588999999999999999999999999999987654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=433.90 Aligned_cols=281 Identities=32% Similarity=0.592 Sum_probs=237.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+.+.++|+|+||+||+|+++.||+.||||++... +...+-+++||++|++| .|+|+|.++++|..+.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-------kH~NLVnLiEVFrrkr 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-------KHENLVNLIEVFRRKR 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-------ccchHHHHHHHHHhcc
Confidence 5799999999999999999999999999999999853 34556789999999999 5889999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.++||||||+.++++.+.... .+++.+.++.+++|++.|+.|||+++||||||||+||||+ ..+.+||||||+|+.
T Consensus 75 klhLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 75 KLHLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFART 150 (396)
T ss_pred eeEEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHh
Confidence 999999999999988888765 5799999999999999999999999999999999999996 789999999999986
Q ss_pred cC---CccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 ED---RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~---~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.. +..+.++.|+||+|||++.+ .+|+..+||||+||++.||++|.++|++.++.|++..|++.+|..+|..+.--
T Consensus 151 L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF- 229 (396)
T KOG0593|consen 151 LSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF- 229 (396)
T ss_pred hcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh-
Confidence 54 33456789999999999998 58999999999999999999999999999999999999999998777654221
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
....||..+. ++. ...++.+-..|| .
T Consensus 230 -~~N~~F~Gv~-lP~--------------------------------------~~~~epLe~k~p--------------~ 255 (396)
T KOG0593|consen 230 -SSNPFFHGVR-LPE--------------------------------------PEHPEPLERKYP--------------K 255 (396)
T ss_pred -ccCCceeeee-cCC--------------------------------------CCCccchhhhcc--------------c
Confidence 1122222211 000 001111112222 3
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
++..++||+++||+.||.+|++.+|+|.||||.+
T Consensus 256 ~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 256 ISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred chHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 5568899999999999999999999999999954
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=422.52 Aligned_cols=286 Identities=33% Similarity=0.562 Sum_probs=242.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|..+++||+|+||+||+|++.++|+.||||.|+..+ .....+++||+.|+++ .|+||+.++|+|...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-------~h~nIi~LiD~F~~~~ 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-------KHPNIIELIDVFPHKS 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-------cCcchhhhhhhccCCC
Confidence 68999999999999999999999999999999998542 3356789999999999 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+.||+||++.+|..+++... ..++..+++.++.++++||+|||++.|+||||||.|+|++ .++.+||+|||+|+.
T Consensus 75 ~l~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 75 NLSLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARF 150 (318)
T ss_pred ceEEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhc
Confidence 999999999999999998765 5699999999999999999999999999999999999996 789999999999986
Q ss_pred cCCcc---ccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
..... ...+-|++|+|||++.|. .|+..+||||+|||+.||+.|.|.|+|.++.|++..|.+.+| .|.+..|++.
T Consensus 151 f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG-TP~~~~WP~~ 229 (318)
T KOG0659|consen 151 FGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG-TPTPDQWPEM 229 (318)
T ss_pred cCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC-CCCcccCccc
Confidence 65433 233679999999999987 799999999999999999999999999999999999999999 6666655554
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....|.+-. .++...+..++. .
T Consensus 230 ~~lpdY~~~~----------------------------------------~~P~~~~~~lf~-----------------a 252 (318)
T KOG0659|consen 230 TSLPDYVKIQ----------------------------------------QFPKPPLNNLFP-----------------A 252 (318)
T ss_pred cccccHHHHh----------------------------------------cCCCCccccccc-----------------c
Confidence 4433332211 111112222111 2
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQ 463 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~ 463 (820)
.+.+++|||.+||.+||.+|+||.|+|+|+||+..|.+++..
T Consensus 253 as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~ 294 (318)
T KOG0659|consen 253 ASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPS 294 (318)
T ss_pred ccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChh
Confidence 446779999999999999999999999999999987765543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=439.35 Aligned_cols=261 Identities=30% Similarity=0.499 Sum_probs=219.7
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
..+.|.+.+.||+|+||.|-+|..+.|++.||||++.+.. .......+|++||++| +|||||+++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-------~HP~IV~~~ 242 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-------SHPNIVRIK 242 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-------CCCCEEEEe
Confidence 4578999999999999999999999999999999998532 1233457999999999 799999999
Q ss_pred EEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
++|...+..||||||++ |+|.+.+-.+. .+.+...+.+++||+.||.|||++||+||||||+|||+..+.++..+||
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999997 68999887764 5889999999999999999999999999999999999987778899999
Q ss_pred eeccccccc--CCccccccccccccCcccccccc--c-cccchhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Q 003438 258 IDFGSACTE--DRTVYSYIQSRYYRSPEVLLGYQ--Y-TTAIDMWSFGCIVAELFLGLPLFPGASEFD-LLRRMIRILGA 331 (820)
Q Consensus 258 ~DFGlA~~~--~~~~~~~~gt~~Y~APEvl~~~~--y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d-~l~~I~~~lG~ 331 (820)
+|||+|+.. ...+.+.|||+.|.|||++.... + ..++||||||||||-+++|.+||....... +.++|.+ |
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~--G- 397 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK--G- 397 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc--C-
Confidence 999999877 45567889999999999998764 3 348899999999999999999997654322 2222222 0
Q ss_pred CCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 332 ~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
.|.+
T Consensus 398 -------------------------------------~y~f--------------------------------------- 401 (475)
T KOG0615|consen 398 -------------------------------------RYAF--------------------------------------- 401 (475)
T ss_pred -------------------------------------cccc---------------------------------------
Confidence 0000
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.-..+..++++++|||.+||+.||++|+|++|||+||||+..+.
T Consensus 402 ---~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 402 ---GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ---cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 00123447789999999999999999999999999999997663
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=443.36 Aligned_cols=292 Identities=30% Similarity=0.529 Sum_probs=242.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.+.|+.+++||+|+||.||+|++..+|+.||+|.++.+ +.......+||.||++| +||||++|.++....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-------~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-------DHPNIIKLEEIVTSK 188 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-------CCCcccceeeEEEec
Confidence 47899999999999999999999999999999999843 45667788999999999 799999999999887
Q ss_pred --ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 185 --RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 185 --~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..+|||||||+.+|..++.... -.|++.+|+.+++||+.||+|||.+||+|||||..||||+ ..+.+||+|||+
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid---n~G~LKiaDFGL 264 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID---NNGVLKIADFGL 264 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc---CCCCEEeccccc
Confidence 6899999999999999887653 3599999999999999999999999999999999999995 789999999999
Q ss_pred ccccCC----ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 263 ACTEDR----TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 263 A~~~~~----~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|+.... ..+..+-|++|+|||++++. .|+.++|+||+||||.||++|++.|++.++.+++..|.+.+| .|.+..
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG-SP~e~~ 343 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG-SPTEDY 343 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC-CCChhc
Confidence 984322 24456789999999999997 799999999999999999999999999999999999999999 665554
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
|+. .+.. ++.. |+ ..... ...+.+.+..
T Consensus 344 W~~-~kLP-~~~~-------------------~k-------------p~~~y-----~r~l~E~~~~------------- 371 (560)
T KOG0600|consen 344 WPV-SKLP-HATI-------------------FK-------------PQQPY-----KRRLRETFKD------------- 371 (560)
T ss_pred ccc-ccCC-cccc-------------------cC-------------CCCcc-----cchHHHHhcc-------------
Confidence 441 1110 0000 00 00000 1223344333
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCCCCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPE 467 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~~~ 467 (820)
++..+++||..||.+||.+|.||.++|+|+||+..+++|...-.|.
T Consensus 372 ----~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 372 ----FPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPK 417 (560)
T ss_pred ----CCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCC
Confidence 4478899999999999999999999999999999998876554444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=445.65 Aligned_cols=261 Identities=28% Similarity=0.457 Sum_probs=229.5
Q ss_pred eeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCC
Q 003438 97 AVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKH 172 (820)
Q Consensus 97 ~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~Hp 172 (820)
.+++++.+... .+|+..+.||+|+|++||++++..+|+.||+|++.+ +....++..+||+|.+.| .||
T Consensus 7 ~ip~~i~D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-------~Hp 78 (592)
T KOG0575|consen 7 EIPEVIEDPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-------KHP 78 (592)
T ss_pred CCCCeeecCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-------CCC
Confidence 34556666555 899999999999999999999999999999999986 556778899999999999 689
Q ss_pred ceeEEeEEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 173 nIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
|||+++++|++.+++|||.|+|. ++|.+++++ .+.++|.+++.+++||+.||.|||+++|||||||..||||+ +
T Consensus 79 nIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~---~ 153 (592)
T KOG0575|consen 79 NIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN---E 153 (592)
T ss_pred cEEeeeeEeecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec---C
Confidence 99999999999999999999998 678888774 35799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeecccccccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003438 252 PAEIKIIDFGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~ 328 (820)
+..|||+|||+|.... +...+.||||.|+|||++....++..+||||+|||||.||+|+|||...+-.+.+.+|...
T Consensus 154 ~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~ 233 (592)
T KOG0575|consen 154 NMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN 233 (592)
T ss_pred cCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence 7899999999997654 6678899999999999999999999999999999999999999999887777766666431
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
-- .++
T Consensus 234 ~Y---------------------------------------------------------------------------~~P 238 (592)
T KOG0575|consen 234 EY---------------------------------------------------------------------------SMP 238 (592)
T ss_pred Cc---------------------------------------------------------------------------ccc
Confidence 10 011
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..++.++.|||.+||+.||.+|||+++||.|+||+..
T Consensus 239 -----------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 239 -----------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred -----------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 1245778999999999999999999999999999654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-50 Score=419.37 Aligned_cols=301 Identities=29% Similarity=0.469 Sum_probs=246.8
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
...+.|+.+.+|++|+||.||+|+|+.|++.||+|.++.+ ....-..++||.+|.++ .|||||.+.++..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-------~H~NIV~vkEVVv 145 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-------RHPNIVEVKEVVV 145 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-------CCCCeeeeEEEEe
Confidence 3457899999999999999999999999999999999854 23445678999999998 6899999999987
Q ss_pred ec--ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 183 CQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 183 ~~--~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
-. +.+|||||||+.+|..++..-. +++...+++.++.|+++||+|||.+.|+|||||++|+|++ ..|.+||+||
T Consensus 146 G~~~d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDF 221 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADF 221 (419)
T ss_pred ccccceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEeccc
Confidence 54 5799999999999999887654 6799999999999999999999999999999999999996 7899999999
Q ss_pred ccccccCCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 261 GSACTEDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 261 GlA~~~~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
|+|+..+.. .+..+-|.+|+|||++++. .|++++|+||+|||+.||++++++|++.++.+++.+|.+.+| .|.+.
T Consensus 222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG-tPte~ 300 (419)
T KOG0663|consen 222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG-TPSEA 300 (419)
T ss_pred chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC-CCccc
Confidence 999987766 4556789999999999987 699999999999999999999999999999999999999999 88777
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
+|+...... . ...+.+ .-.+...|+. .|+..
T Consensus 301 iwpg~~~lp----------~----------~k~~~f------------------~~~pyn~lr~---kF~~~-------- 331 (419)
T KOG0663|consen 301 IWPGYSELP----------A----------VKKMTF------------------SEHPYNNLRK---KFGAL-------- 331 (419)
T ss_pred cCCCccccc----------h----------hhcccc------------------CCCCchhhhh---hcccc--------
Confidence 665422110 0 000000 0001111221 22210
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCCCCCCCCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRV 471 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~~~~p~~ 471 (820)
..++...|||.++|.+||++|+||+|+|+|.||.+.|.+++....|..|..
T Consensus 332 ----~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k 382 (419)
T KOG0663|consen 332 ----SLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAK 382 (419)
T ss_pred ----ccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccc
Confidence 145778999999999999999999999999999999988766555555443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=423.66 Aligned_cols=280 Identities=34% Similarity=0.608 Sum_probs=238.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
..+|..++.||+|+||.|+.|.++.+++.||||++.+ .....++..+|+++|+.+ .|+||+.+++++...
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-------~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-------RHENIIGLLDIFRPP 93 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-------cCCCcceEEeecccc
Confidence 3788889999999999999999999999999999973 456778899999999999 589999999999862
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+|+|+|+|+.+|..+++... .+++..++.+++||+.||+|+|+.+|+||||||.|+|++ .++.+||+|
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n---~~c~lKI~D 168 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN---ADCDLKICD 168 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec---cCCCEEecc
Confidence 4799999999999999998764 499999999999999999999999999999999999996 778899999
Q ss_pred cccccccC-----CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 260 FGSACTED-----RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 260 FGlA~~~~-----~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
||+|+... ...+.++.|++|+|||++... .|+.++||||+||||.||++|+++|+|.+..+++..|++.+| .|
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG-tP 247 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG-TP 247 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC-CC
Confidence 99998773 445778999999999998754 899999999999999999999999999999999999999999 66
Q ss_pred chHHHHhhh--ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 334 PDYVLKEAK--NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 334 p~~~l~~~~--~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
+++.+.... +.+.|.+... ..+..++..++++
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp---------------------------------------~~p~~~f~~~fp~------- 281 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLP---------------------------------------QIPKQPFSSIFPN------- 281 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCC---------------------------------------CCCCCCHHHHcCC-------
Confidence 666555432 1222222221 1112233344332
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.++.++|||++||++||.+|+|++|||+||||..-
T Consensus 282 ----------a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 282 ----------ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred ----------CCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 55889999999999999999999999999999873
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=424.43 Aligned_cols=324 Identities=36% Similarity=0.667 Sum_probs=270.9
Q ss_pred cCCCCcceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcC
Q 003438 88 DNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167 (820)
Q Consensus 88 d~~~~d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~ 167 (820)
|+..++++..++|.+. .||+++++||+|+||.|.+|++..++..|||||++.-..+.+..+.|+++|++++.. +
T Consensus 73 dD~dGH~v~~~gD~l~-----~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~-D 146 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILT-----NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINES-D 146 (415)
T ss_pred CCCCceEEEEeccccc-----cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhc-C
Confidence 7788899999999886 899999999999999999999999999999999999888889999999999999653 3
Q ss_pred CCCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccc
Q 003438 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247 (820)
Q Consensus 168 ~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~ 247 (820)
..+.--+|++.++|...++.|||+|.++-+++++++.+...+++...++.|.+||+++++|||+.+++|.||||||||+.
T Consensus 147 P~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfv 226 (415)
T KOG0671|consen 147 PNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFV 226 (415)
T ss_pred CCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEe
Confidence 33344588999999999999999999999999999999989999999999999999999999999999999999999995
Q ss_pred cc-----------------cCCCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCC
Q 003438 248 TS-----------------VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310 (820)
Q Consensus 248 ~~-----------------~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~ 310 (820)
.+ .+...|||+|||.|....+...+.+.|+.|+|||++++..++.++||||+||||+||++|.
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 32 1245689999999999888888889999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCc
Q 003438 311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390 (820)
Q Consensus 311 ~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~ 390 (820)
.+|...++.+.+..|.+++| ++|..|+.+.. ..+||... .+++++....+...|.+. .
T Consensus 307 ~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~-~~Kyf~~~----rldw~e~~~~~~~k~v~~-----------~----- 364 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILG-PIPSRMIKKTR-KEKYFRRG----RLDWPEVSSKGKSKYVFE-----------P----- 364 (415)
T ss_pred eecccCCcHHHHHHHHHhhC-CCcHHHhhhhh-hHhhhhcc----cccCccccccccchhhhc-----------C-----
Confidence 99999999999999999999 77777777654 45666654 223333333332211111 0
Q ss_pred cccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 391 ~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.+.|..++.. .......|+|||++||.+||.+|+|+.|||.||||+...
T Consensus 365 ----ckpl~~~~~~--------------~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 365 ----CKPLKKYMLQ--------------DDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred ----CccHHHHhcc--------------CcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 1222222211 112345799999999999999999999999999998743
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=413.53 Aligned_cols=253 Identities=30% Similarity=0.492 Sum_probs=217.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe--CChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik--~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~- 185 (820)
.+.+.++.||+|..|+||+|+++.|++.+|+|+|. .++...+++.+|++|++++ +||+||++|+.|..++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-------~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-------QSPYIVGFYGAFYSNGE 151 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-------CCCCeeeEeEEEEeCCc
Confidence 56778899999999999999999999999999995 4567788999999999998 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.++|+||||+ |+|.++++.. +.++|..+.+|+++|++||.|||+ ++||||||||+||||+ ..++|||||||.+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN---skGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN---SKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec---cCCCEEecccccc
Confidence 5999999998 5788877765 569999999999999999999995 9999999999999996 7899999999999
Q ss_pred cccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCCchHH
Q 003438 264 CTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-----SEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 264 ~~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~-----s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
...... ..+++||..|||||.+.+..|+.++||||||++++||++|+.||... ...+++..|+. .+||.
T Consensus 227 ~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~-- 301 (364)
T KOG0581|consen 227 GILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPR-- 301 (364)
T ss_pred HHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCC--
Confidence 765444 47889999999999999999999999999999999999999999764 22333333222 11110
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+. +
T Consensus 302 -------------------------------------------------------------------------lP-~--- 304 (364)
T KOG0581|consen 302 -------------------------------------------------------------------------LP-E--- 304 (364)
T ss_pred -------------------------------------------------------------------------CC-c---
Confidence 00 0
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++++|++||..||+.||.+|+|++|+|+|||+++..
T Consensus 305 --~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 305 --GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred --ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 12678999999999999999999999999999999754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=408.39 Aligned_cols=301 Identities=34% Similarity=0.555 Sum_probs=240.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--- 185 (820)
-.|+-.+++|.|+||.||+|+..++++.||||.+-.+.. ..-+|+++|+.+ +|||||+++-+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l-------~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKL-------DHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhc-------CCcCeeeEEEEEEecCCCc
Confidence 478899999999999999999999999999999876543 233699999977 7999999999887532
Q ss_pred --eeEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 186 --HLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 186 --~l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
++.+|||||..+|.++++.. ....++...++.+++||++||.|||+.|||||||||.|||++ .+.+.+||||||
T Consensus 94 ~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFG 171 (364)
T KOG0658|consen 94 EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFG 171 (364)
T ss_pred hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCC
Confidence 56799999999999999853 234689999999999999999999999999999999999997 577999999999
Q ss_pred ccccc--CCccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 262 SACTE--DRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 262 lA~~~--~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
.|+.. ++....++.|++|+|||++.+. .|+.++||||.||++.||+.|++.|+|++..+++..|++++| .|+++-+
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG-~Pt~e~I 250 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG-TPTREDI 250 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC-CCCHHHH
Confidence 99754 4555778999999999999987 799999999999999999999999999999999999999999 6766554
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
...+-...- .+.|. +....+.+++
T Consensus 251 ~~mn~~y~~-----------------------------------~~~p~-----ik~~~~~~~~---------------- 274 (364)
T KOG0658|consen 251 KSMNPNYTE-----------------------------------FKFPQ-----IKAHPWHKVF---------------- 274 (364)
T ss_pred hhcCccccc-----------------------------------ccCcc-----cccccceeec----------------
Confidence 433211000 00000 0111111110
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCCCCCCCCCCCCcccccccc
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVD 480 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~~~~p~~~~~~~~~~~ 480 (820)
....++++.||+.++|+++|.+|.||.|+|.||||.+...+ ....+.....|...+++..
T Consensus 275 ~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~--~~~l~~g~~lp~lf~f~~~ 334 (364)
T KOG0658|consen 275 FKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP--NTKLPNGRPLPPLFNFKRA 334 (364)
T ss_pred ccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc--CccCcCCCcCCCccCchHH
Confidence 11245788999999999999999999999999999986543 3333333355555666544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=414.73 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=226.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
..+|++.+.||+|+|++|++|+++.+++.||||++.+. +...+.+.+|-.+|.+|. +||.|++|+-.|++
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~------~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS------GHPGIVKLYFTFQD 145 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh------CCCCeEEEEEEeec
Confidence 47899999999999999999999999999999999753 233455678999999996 69999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+..+|+|+||+. |+|+++|++. +.|++..++.++.||+.||+|||++||||||||||||||+ +++++||+|||.
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd---~dmhikITDFGs 220 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD---KDGHIKITDFGS 220 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc---CCCcEEEeeccc
Confidence 999999999997 7999999875 5799999999999999999999999999999999999995 889999999999
Q ss_pred ccccCC----------------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003438 263 ACTEDR----------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 263 A~~~~~----------------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~ 326 (820)
|..... ....++||-.|.+||+|.....++.+|||+||||||+|+.|.+||.+.++.-..++|+
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 953321 1145799999999999999999999999999999999999999999999999888887
Q ss_pred HHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCC
Q 003438 327 RILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP 406 (820)
Q Consensus 327 ~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P 406 (820)
.+--..|
T Consensus 301 ~l~y~fp------------------------------------------------------------------------- 307 (604)
T KOG0592|consen 301 ALDYEFP------------------------------------------------------------------------- 307 (604)
T ss_pred HhcccCC-------------------------------------------------------------------------
Confidence 7432111
Q ss_pred CCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCCC
Q 003438 407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQ 463 (820)
Q Consensus 407 ~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~ 463 (820)
. .+++.++|||+++|+.||.+|+|++||.+||||.+..|..-+.
T Consensus 308 --~-----------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~ 351 (604)
T KOG0592|consen 308 --E-----------GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQ 351 (604)
T ss_pred --C-----------CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhh
Confidence 1 1336789999999999999999999999999999988765433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=402.92 Aligned_cols=269 Identities=26% Similarity=0.465 Sum_probs=228.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+|+.++.+.+++.+|+|++++.. ...+....|..||.++ .||.||+++-.|++
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-------~hPFiv~l~ysFQt 96 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-------KHPFIVKLIYSFQT 96 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-------CCCcEeeeEEeccc
Confidence 489999999999999999999999999999999998643 3456778899999997 79999999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+++|||+||+.| .|.-.|.+. +.++|..++.++.+|+.||.|||++|||||||||+||||+ ..|.|+|+|||+
T Consensus 97 ~~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL 171 (357)
T KOG0598|consen 97 EEKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGL 171 (357)
T ss_pred CCeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEecccc
Confidence 9999999999974 888887765 3699999999999999999999999999999999999995 889999999999
Q ss_pred ccc---cCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~---~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
++. .+....+.|||+.|||||++.+..|+.++|.|||||++|||++|.+||.+.+.....++|.+.-...+|
T Consensus 172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p----- 246 (357)
T KOG0598|consen 172 CKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP----- 246 (357)
T ss_pred chhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-----
Confidence 963 334556689999999999999999999999999999999999999999998877777776552110000
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
T Consensus 247 -------------------------------------------------------------------------------- 246 (357)
T KOG0598|consen 247 -------------------------------------------------------------------------------- 246 (357)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred HHhHHHHHHHHHhccccCcCCCC----CHHHHHcCCccCCCCCCCCCCCCCCCCCCCc
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRW----SPFQASRHPFVTGEPFTCPYQPPPETPRVPV 473 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRp----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~~ 473 (820)
.-++.+++|||+++|..||++|+ .++++-+||||.+..+.........+|..|.
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~ 304 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPN 304 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecC
Confidence 01346789999999999999996 7899999999999876544333333344443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=402.71 Aligned_cols=285 Identities=36% Similarity=0.611 Sum_probs=233.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---hHHHHHHHHHHHHHHhhhcCCCCCCc-eeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKYDREDKHH-IVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~---~~~~~~~Ei~iL~~L~~~~~~~~Hpn-IVkl~d~f~~~ 184 (820)
..|+.+++||+|+||+||+|+++.+|+.||+|+++.+.. .....++|+.+|++|+ |+| ||++++++...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-------~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-------HANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-------CCcceEEEEeeeeec
Confidence 567788899999999999999999999999999985433 5567899999999995 556 99999999987
Q ss_pred c------eeEEEEeccCCChHHHHHhhhc--CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEE
Q 003438 185 R------HLCICFELLDSNLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 185 ~------~l~LVmEy~~gsL~d~l~~~~~--~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
. .+++||||++.+|..++..... ..++...++.+++||+.||+|||+++|+||||||+||||+ +.+.+|
T Consensus 84 ~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lK 160 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLK 160 (323)
T ss_pred ccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEe
Confidence 7 8999999999999999988654 3688899999999999999999999999999999999996 689999
Q ss_pred EeecccccccC---CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 257 IIDFGSACTED---RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 257 L~DFGlA~~~~---~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
|+|||+|+... ......+.|.+|+|||++.+. .|+...||||+|||++||++++++|++.++.+++.+|.+.+| .
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lG-t 239 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLG-T 239 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcC-C
Confidence 99999997543 223455889999999999998 799999999999999999999999999999999999999999 7
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
|.+..|+....... |.. + -..+-..+.+..++
T Consensus 240 P~e~~Wp~v~~~~~-----------------------~k~-------------~--f~~~~~~~~l~~~~---------- 271 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPD-----------------------YKA-------------P--FPKWPGPKDLSSIL---------- 271 (323)
T ss_pred CCccCCCCcccccc-----------------------ccc-------------c--CcCCCCccchHHhc----------
Confidence 76655443222111 100 0 00000011121211
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
...+....||+.+||++||.+|+||+.+|.||||.+.+..
T Consensus 272 -------~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 272 -------PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred -------cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 1123578999999999999999999999999999987653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=401.54 Aligned_cols=319 Identities=34% Similarity=0.596 Sum_probs=270.4
Q ss_pred CcceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhc-CCCC
Q 003438 92 SDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY-DRED 170 (820)
Q Consensus 92 ~d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~-~~~~ 170 (820)
++..+.+++++.+ .||.++++||.|-|++||+|+|..+.++||+|+.+....+.+..+.||++|++++..= ...+
T Consensus 65 GYHpV~IGD~F~~----gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~ 140 (590)
T KOG1290|consen 65 GYHPVRIGDVFNG----GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPG 140 (590)
T ss_pred CCceeeccccccC----ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 3557888888853 8999999999999999999999999999999999998889999999999999997531 1345
Q ss_pred CCceeEEeEEEeec----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcc
Q 003438 171 KHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENIL 245 (820)
Q Consensus 171 HpnIVkl~d~f~~~----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNIL 245 (820)
..+||+|+|.|... .|+|+|+|+++.+|+.+|+...+++++...++.|++|||.||.|||+ .||||.||||+|||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 56899999999875 49999999999999999999999999999999999999999999995 69999999999999
Q ss_pred cccc----------------------------------------------------------------------------
Q 003438 246 LCTS---------------------------------------------------------------------------- 249 (820)
Q Consensus 246 l~~~---------------------------------------------------------------------------- 249 (820)
+...
T Consensus 221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~ 300 (590)
T KOG1290|consen 221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ 300 (590)
T ss_pred eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence 8310
Q ss_pred -------------------------------------c------------------------------------------
Q 003438 250 -------------------------------------V------------------------------------------ 250 (820)
Q Consensus 250 -------------------------------------~------------------------------------------ 250 (820)
.
T Consensus 301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v 380 (590)
T KOG1290|consen 301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV 380 (590)
T ss_pred cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence 0
Q ss_pred --------CCCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC------C
Q 003438 251 --------KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG------A 316 (820)
Q Consensus 251 --------~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~------~ 316 (820)
.+.+|||+|||.||......+..++|+.|+||||+.+..|++.+||||++|++|||+||..+|.- .
T Consensus 381 ~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~ 460 (590)
T KOG1290|consen 381 NPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYS 460 (590)
T ss_pred CCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCC
Confidence 00147999999999998888889999999999999999999999999999999999999999953 3
Q ss_pred CHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccc
Q 003438 317 SEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK 396 (820)
Q Consensus 317 s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~ 396 (820)
.+++.+..|++.+| ..|..+....+..+.||+..+.+.++..-+. +
T Consensus 461 rDEDHiA~i~ELLG-~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~----------W----------------------- 506 (590)
T KOG1290|consen 461 RDEDHIALIMELLG-KIPRKIALGGKYSRDFFNRRGELRHIRRLKP----------W----------------------- 506 (590)
T ss_pred ccHHHHHHHHHHHh-hccHHHHhcCcchHhhhccccceecccccCC----------C-----------------------
Confidence 47889999999999 6677778888999999999998877654111 0
Q ss_pred hhHHHH-hcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 397 HLEEIV-TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 397 ~L~~il-~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
.|.+++ ..|-+. .+...+|.|||.-||+++|+||+||.++|+|||+...+.+
T Consensus 507 pL~~VL~eKY~~s-----------~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 507 PLYEVLIEKYEWS-----------EEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHHHHHhCCC-----------HHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 122222 222211 1244689999999999999999999999999999976653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=411.88 Aligned_cols=340 Identities=34% Similarity=0.561 Sum_probs=284.7
Q ss_pred ccCCCccCCCCcceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHH
Q 003438 82 VLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT 161 (820)
Q Consensus 82 ~~n~g~d~~~~d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~ 161 (820)
-+.++||+..++|.+.++++|. .+|.+....|+|-|++|.+|.+...+..||||||.+.+...+.-+.|++||++
T Consensus 410 ~L~DNWdDaEGYYrv~igE~LD-----~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkK 484 (752)
T KOG0670|consen 410 GLQDNWDDAEGYYRVRIGELLD-----SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKK 484 (752)
T ss_pred ccccCcccccceEEEehhhhhc-----ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHH
Confidence 4578899999999999999997 89999999999999999999999999999999999999989999999999999
Q ss_pred HhhhcCCCCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCC
Q 003438 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLK 240 (820)
Q Consensus 162 L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLK 240 (820)
|+.. +.++..|+++|+..|...+|+|||||.+.-+|.++++... .-+|....++.++.||+.||..|-.+||+|+|||
T Consensus 485 L~~A-D~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIK 563 (752)
T KOG0670|consen 485 LNDA-DPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIK 563 (752)
T ss_pred hhcc-CchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccC
Confidence 9764 6677789999999999999999999999999999998753 3358899999999999999999999999999999
Q ss_pred CCCcccccccCCCeEEEeecccccccC-CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 241 PENILLCTSVKPAEIKIIDFGSACTED-RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 241 PeNILl~~~~~~~~iKL~DFGlA~~~~-~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
|+||||+ .....+||||||.|.... .....+.-+.+|+|||++++.+|+...|+||+||+||||.||+.+|+|.++.
T Consensus 564 PDNiLVN--E~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 564 PDNILVN--ESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred ccceEec--cCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 9999997 467789999999997665 4466778899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhH
Q 003438 320 DLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLE 399 (820)
Q Consensus 320 d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~ 399 (820)
+++..++.+-| ..|..|+.........|+...++...+.+.++......... ..+ +.+.|.
T Consensus 642 ~MLrl~me~KG-k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~----------~vk--------Ptkdl~ 702 (752)
T KOG0670|consen 642 QMLRLFMELKG-KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMV----------NVK--------PTKDLG 702 (752)
T ss_pred HHHHHHHHhcC-CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEec----------ccC--------cchhHH
Confidence 99999999999 78888888888777778776665554444333222110000 000 012333
Q ss_pred HHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 400 EIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 400 ~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
..+...+ +++.+ +...-.+|.|||.+||..||++|+|+.|||+||||++
T Consensus 703 s~l~~~q---~~~de----q~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 703 SELIAVQ---RLPDE----QPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHhccC---CCCch----hHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 3333221 22222 2345578999999999999999999999999999985
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=416.56 Aligned_cols=304 Identities=31% Similarity=0.562 Sum_probs=234.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-ce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-RH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-~~ 186 (820)
.++|+++++||+|+||+||+|++..+++.||||+++...........|+++++.+++. ...+|.+|++++++|... .+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQA-DPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhc-CcccCcceeeeEEEEEcCCce
Confidence 4799999999999999999999999999999999986555556677899999998653 334577899999998865 58
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCccccccc-------------CC
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSV-------------KP 252 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~-------------~~ 252 (820)
+|||||+++++|.+++... ..+++..++.|+.||+.||+|||+ .|||||||||+|||++... +.
T Consensus 207 ~~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 9999999999999988764 469999999999999999999997 5999999999999996432 12
Q ss_pred CeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 253 AEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
..+||+|||.++.........++|+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.+.+|..
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 36999999998766555566789999999999999999999999999999999999999999999999999999999944
Q ss_pred CchHHHHhh--hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 333 PPDYVLKEA--KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 333 Pp~~~l~~~--~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
| ..+.... .....+++....+. ..+..+.+..+....+.
T Consensus 365 p-~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~--- 405 (467)
T PTZ00284 365 P-SEWAGRCGTEEARLLYNSAGQLR-----------------------------------PCTDPKHLARIARARPV--- 405 (467)
T ss_pred C-HHHHhhccchhHHHHhhhccccc-----------------------------------ccCCHHHHHhhhcccch---
Confidence 4 4433221 11112222211000 00011111111111000
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCC
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTC 460 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~ 460 (820)
. +...++.++|||++||++||++|+|++|||+||||.+....|
T Consensus 406 ---~----~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 448 (467)
T PTZ00284 406 ---R----EVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC 448 (467)
T ss_pred ---h----hhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence 0 001246789999999999999999999999999999855434
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=397.52 Aligned_cols=258 Identities=28% Similarity=0.417 Sum_probs=222.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
..+|.+.++||+|+|++||+|+++.++..||||.+.+. ....+....||.||++| .|||||++++++..+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-------~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-------KHPNIVRLLDCIEDD 81 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-------CCcceeeEEEEEecC
Confidence 37899999999999999999999999999999999754 45566788999999999 589999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC---CeEEEeec
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP---AEIKIIDF 260 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~---~~iKL~DF 260 (820)
+.+|||||||. |+|.++++... .++|..++.++.||+.||++||+++||||||||+||||+..... ..+||+||
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 99999999998 79999998764 69999999999999999999999999999999999999865233 67999999
Q ss_pred ccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 261 GSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 261 GlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
|+|+..... ..+.||++.|||||++....|+.|+|+||+|+|+|+|++|++||...+..+++..+.+.....
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~------ 233 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV------ 233 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc------
Confidence 999876543 467899999999999999999999999999999999999999999888877766443311100
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
.. .
T Consensus 234 ----------------------------------------------------------------~~-------------~ 236 (429)
T KOG0595|consen 234 ----------------------------------------------------------------PV-------------L 236 (429)
T ss_pred ----------------------------------------------------------------Cc-------------h
Confidence 00 0
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+...+..+.+|+..+|..||.+|.+..+-+.|+++...+
T Consensus 237 ~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 237 PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 011234456999999999999999999999999999876
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=385.15 Aligned_cols=278 Identities=32% Similarity=0.540 Sum_probs=222.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++...+.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-------KHANIVTLHDIIHTERC 77 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-------CCCCEeeEEEEEcCCCe
Confidence 6899999999999999999999999999999999743 22344677899999998 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
.++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 78 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 78 LTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN---EKGELKLADFGLARAK 153 (288)
T ss_pred EEEEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEECcCcceeec
Confidence 99999999999998886543 3589999999999999999999999999999999999995 6688999999998654
Q ss_pred CC---ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 267 DR---TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 267 ~~---~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .|+...++...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG-TPTEETWPGIT 232 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChHHhhccc
Confidence 32 2234567899999999876 4689999999999999999999999999999999999999888 44444333221
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
....+....- +. +....+.. .....
T Consensus 233 ~~~~~~~~~~---------------------------------~~-----~~~~~~~~-----------------~~~~~ 257 (288)
T cd07871 233 SNEEFRSYLF---------------------------------PQ-----YRAQPLIN-----------------HAPRL 257 (288)
T ss_pred cchhhhcccc---------------------------------Cc-----cCCCchHH-----------------hCCCC
Confidence 1111110000 00 00000000 01124
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+.+++|||++||++||.+|+|++|||+||||
T Consensus 258 ~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 258 DTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 5678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=402.20 Aligned_cols=263 Identities=26% Similarity=0.488 Sum_probs=221.3
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..++|++++.||+|+||.||+|+.+.||+.+|+|++++.. ...+.++.|-.+|... +.+.||+|+-.|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-------ds~~vVKLyYsFQ 211 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-------DSPWVVKLYYSFQ 211 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-------CCCcEEEEEEEec
Confidence 3489999999999999999999999999999999999753 3344566677777774 7899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+.+++||||||+. |++..+|... ..|++..++.++.+++.||..||+.|+|||||||+|+||+ ..|+|||+|||
T Consensus 212 D~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD---~~GHiKLSDFG 286 (550)
T KOG0605|consen 212 DKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID---AKGHIKLSDFG 286 (550)
T ss_pred CCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---CCCCEeecccc
Confidence 9999999999997 5888888765 4699999999999999999999999999999999999995 88999999999
Q ss_pred cccccCC-------------------------c-------------------------cccccccccccCcccccccccc
Q 003438 262 SACTEDR-------------------------T-------------------------VYSYIQSRYYRSPEVLLGYQYT 291 (820)
Q Consensus 262 lA~~~~~-------------------------~-------------------------~~~~~gt~~Y~APEvl~~~~yt 291 (820)
++..... . ....+|||.|+||||+.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 9821000 0 1235899999999999999999
Q ss_pred ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchh
Q 003438 292 TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQ 371 (820)
Q Consensus 292 ~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~ 371 (820)
..+|.|||||||||||.|.+||.+.+..+...+|+.... .-
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-------------~l-------------------------- 407 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-------------TL-------------------------- 407 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-------------hc--------------------------
Confidence 999999999999999999999999999888888876221 00
Q ss_pred hhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCC---HHHHH
Q 003438 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQAS 448 (820)
Q Consensus 372 ~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT---a~EaL 448 (820)
.+| .+...+++++|||.+||. ||++|+- ++||.
T Consensus 408 --------------------------------~fP-----------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 408 --------------------------------KFP-----------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred --------------------------------cCC-----------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 001 011244788999999999 9999995 89999
Q ss_pred cCCccCCCCCCCCCCC
Q 003438 449 RHPFVTGEPFTCPYQP 464 (820)
Q Consensus 449 ~HPff~~~~~~~~~~~ 464 (820)
+||||++..+..-+..
T Consensus 444 ~HPfF~~v~W~~l~~~ 459 (550)
T KOG0605|consen 444 KHPFFKGVDWDHLREM 459 (550)
T ss_pred cCCccccCCcchhhcC
Confidence 9999999887655443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=409.16 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=222.1
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+..-|++.+.||.|+.|.|-+|++..||+.+|||+|.+. ......+.+||.||+.| .||||+++|++++
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-------~HpnVl~LydVwe 82 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-------EHPNVLRLYDVWE 82 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-------cCCCeeeeeeeec
Confidence 347899999999999999999999999999999999754 33455688999999999 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.+.++|+|.||+. |.|++++..+ +++++.++.++++||+.|+.|||..+||||||||+|+||+ ..+.|||+|||
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADFG 157 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADFG 157 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeeccc
Confidence 9999999999997 6899998875 4799999999999999999999999999999999999996 55669999999
Q ss_pred cccc--cCCccccccccccccCcccccccccc-ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 262 SACT--EDRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 262 lA~~--~~~~~~~~~gt~~Y~APEvl~~~~yt-~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+|.. .+.-..+.||++.|.|||++.+.+|+ .++||||+|||||.||+|+.||.+++...++.++.+..-
T Consensus 158 MAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-------- 229 (786)
T KOG0588|consen 158 MASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-------- 229 (786)
T ss_pred eeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc--------
Confidence 9964 34556788999999999999999997 699999999999999999999998777766666544111
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
.+ +
T Consensus 230 ------------------------~M-------------------------------------------P---------- 232 (786)
T KOG0588|consen 230 ------------------------EM-------------------------------------------P---------- 232 (786)
T ss_pred ------------------------cC-------------------------------------------C----------
Confidence 00 0
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..++.+++|||++||++||++|+|.+||++|||+.+..-
T Consensus 233 -s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 233 -SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 125578999999999999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=400.28 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=216.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----h--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----P--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.++|++.+.||+|+||+|++|++..+++.||||++.+. . ...+.+.+|+.+++.+. .||||+++++++
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~------~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR------SHPNIIRLLEVF 89 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc------cCCCEeEEEEEE
Confidence 37999999999999999999999999999999988753 1 23456668999999994 389999999999
Q ss_pred eecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC-CeEEEee
Q 003438 182 VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIID 259 (820)
Q Consensus 182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~-~~iKL~D 259 (820)
....++|||||||.| +|++.+.. .+++.|.+++.+++||+.||+|||++||+||||||+|||++ .. +.+||+|
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~D 164 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSD 164 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEec
Confidence 999999999999985 99999988 35799999999999999999999999999999999999996 44 8999999
Q ss_pred ccccccc---CCccccccccccccCcccccccc-cc-ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 260 FGSACTE---DRTVYSYIQSRYYRSPEVLLGYQ-YT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 260 FGlA~~~---~~~~~~~~gt~~Y~APEvl~~~~-yt-~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
||++... .....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+...|.+..-
T Consensus 165 FG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~---- 240 (370)
T KOG0583|consen 165 FGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF---- 240 (370)
T ss_pred cccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc----
Confidence 9999865 45667889999999999999987 87 799999999999999999999988665555554332100
Q ss_pred hHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChh
Q 003438 335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME 414 (820)
Q Consensus 335 ~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e 414 (820)
.+| .
T Consensus 241 ---------------------------------------------------------------------~~p--~----- 244 (370)
T KOG0583|consen 241 ---------------------------------------------------------------------KIP--S----- 244 (370)
T ss_pred ---------------------------------------------------------------------cCC--C-----
Confidence 000 0
Q ss_pred hhhhhHHh-HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 415 DISKESQI-RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 415 ~~~~~~~~-s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.+ +.++++||++||..||.+|+|+.|+++||||+..
T Consensus 245 ------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 245 ------YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred ------CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 12 5778999999999999999999999999999984
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=380.28 Aligned_cols=279 Identities=31% Similarity=0.538 Sum_probs=221.1
Q ss_pred CceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~- 183 (820)
++|++++.||+|+||+||+|++.. +++.||||+++.. ........+|+.+++.+... .||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----EHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhccc----CCCCcceEEEEEecc
Confidence 479999999999999999999854 5788999998743 22334567788888887543 79999999999863
Q ss_pred ----cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 184 ----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 184 ----~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
...+++||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~D 153 (290)
T cd07862 77 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD 153 (290)
T ss_pred cCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEcc
Confidence 3568999999999999998876555699999999999999999999999999999999999995 668899999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++...... .....+++.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+....+...+..+
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 9999654322 23456899999999999889999999999999999999999999999999999999888774433332
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
..........+. ......++++..
T Consensus 234 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~-------------- 257 (290)
T cd07862 234 PRDVALPRQAFH------------------------------------------SKSAQPIEKFVT-------------- 257 (290)
T ss_pred hhhhcccchhcc------------------------------------------CCCCCCHHHHcc--------------
Confidence 221100000000 000111222221
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.++..+.+||.+||++||++|||+.|+|+||||
T Consensus 258 ---~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 258 ---DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ---CCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 244678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=375.17 Aligned_cols=255 Identities=24% Similarity=0.455 Sum_probs=226.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++++.||.|+||+|.+++.+.++..+|+|+++++. ...+...+|..+|+.+ .||.++++++.|.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-------~~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-------SHPFLVKLYGTFKDN 116 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-------cCceeEEEEEeeccC
Confidence 78999999999999999999999999999999998653 3445677899999998 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||++ |.|..++++. +++++..++.++.||+.||+|||+++|++||||||||||+ ..|.+||+|||+|
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD---~~G~iKitDFGFA 191 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD---QNGHIKITDFGFA 191 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec---cCCcEEEEeccce
Confidence 99999999998 5899988875 4699999999999999999999999999999999999995 8899999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
+.......+.|||+.|+|||++...+|+.++|.|||||++|||+.|.+||...+.....++|++.--.
T Consensus 192 K~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~------------ 259 (355)
T KOG0616|consen 192 KRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK------------ 259 (355)
T ss_pred EEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc------------
Confidence 99988899999999999999999999999999999999999999999999998887777777652110
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+| ...+
T Consensus 260 -------------------------------------------------------------fP-------------~~fs 265 (355)
T KOG0616|consen 260 -------------------------------------------------------------FP-------------SYFS 265 (355)
T ss_pred -------------------------------------------------------------CC-------------cccC
Confidence 01 1245
Q ss_pred HHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCP 461 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~ 461 (820)
.+++|||+++|+.|-.+|. -.++|.+||||++..+..-
T Consensus 266 ~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 266 SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence 7789999999999999994 5679999999998766433
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=382.45 Aligned_cols=285 Identities=30% Similarity=0.502 Sum_probs=219.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|+++++||+|+||+||+|++..+++.||||+++... .....+.+|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-------KHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-------CCCCcCeEEEEEecCC
Confidence 478999999999999999999999999999999997532 2234567899999988 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..|+||||+.++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||++..
T Consensus 77 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 77 TLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARA 152 (303)
T ss_pred eEEEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECCCCccee
Confidence 999999999999998887643 4689999999999999999999999999999999999995 678899999999864
Q ss_pred cCC---ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCchHHHHh
Q 003438 266 EDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS-EFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 266 ~~~---~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s-~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ..+.+..+...++ .+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (303)
T cd07869 153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG-TPNEDTWPG 231 (303)
T ss_pred ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhC-CCChhhccc
Confidence 332 22345678999999998764 68899999999999999999999998754 3456666666666 333322221
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
......+ + . ..+ ..+....+.+.....
T Consensus 232 ~~~~~~~-~---------~--------~~~--------------------~~~~~~~~~~~~~~~--------------- 258 (303)
T cd07869 232 VHSLPHF-K---------P--------ERF--------------------TLYSPKNLRQAWNKL--------------- 258 (303)
T ss_pred hhhcccc-c---------c--------ccc--------------------cccCCccHHHHhhcc---------------
Confidence 1100000 0 0 000 000111111111110
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+..+.|||++||++||++|+|++|||+||||++.+
T Consensus 259 ~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 259 SYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred CCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 1335788999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=377.36 Aligned_cols=280 Identities=33% Similarity=0.581 Sum_probs=222.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.+.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+.+++.+ .|+||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-------KQENIVELKEAFRRRG 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-------CCccccchhhhEecCC
Confidence 4799999999999999999999999999999999753 23345677899999988 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+||||||+.+++.+.+.... ..+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 74 KLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARN 149 (287)
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCccc
Confidence 999999999988777665443 4699999999999999999999999999999999999995 667899999999975
Q ss_pred cCCc----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... .....+++.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+.+..+..+++.+....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 4321 223568999999999999899999999999999999999999999988888888888888855544332111
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+ ..+ ... ..+. ......+. ......
T Consensus 230 ~~-~~~-~~~--------------------------------~~~~----~~~~~~~~----------------~~~~~~ 255 (287)
T cd07848 230 SN-PRF-HGL--------------------------------RFPA----VNHPQSLE----------------RRYLGI 255 (287)
T ss_pred cc-chh-ccc--------------------------------ccCc----ccCcccHH----------------Hhhhcc
Confidence 00 000 000 0000 00000000 001112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.+..++|||++||++||++|||++|+|+||||
T Consensus 256 ~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 256 LSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 55789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=405.91 Aligned_cols=266 Identities=23% Similarity=0.426 Sum_probs=226.4
Q ss_pred ceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCC
Q 003438 94 LILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKH 172 (820)
Q Consensus 94 ~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~Hp 172 (820)
+...+..++...+...+|...++||+|+.|.||.|+...+++.||||.+.... ...+-+++|+.+|+.+ .|+
T Consensus 258 ~~~~l~~v~~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-------~H~ 330 (550)
T KOG0578|consen 258 ILAKLKRVVSQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-------HHP 330 (550)
T ss_pred HHHHhheeccCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-------cch
Confidence 33444555556667789999999999999999999999999999999998543 3456678999999998 689
Q ss_pred ceeEEeEEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 173 HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 173 nIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
|||.+++.|..++.+|+|||||+ |+|.|++.... ++|.+|..|++++|+||+|||.+||+|||||.+|||++ .
T Consensus 331 NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~ 404 (550)
T KOG0578|consen 331 NIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---M 404 (550)
T ss_pred HHHHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---c
Confidence 99999999999999999999998 58888887765 99999999999999999999999999999999999996 6
Q ss_pred CCeEEEeecccccccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003438 252 PAEIKIIDFGSACTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~ 328 (820)
++.+||+|||+|..... ...+.+||++|||||++....|++|+||||||++++||+-|.+||-.++....+..|...
T Consensus 405 ~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n 484 (550)
T KOG0578|consen 405 DGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 484 (550)
T ss_pred CCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc
Confidence 78899999999976543 345779999999999999999999999999999999999999999876665555544331
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
| .|
T Consensus 485 -g-~P--------------------------------------------------------------------------- 487 (550)
T KOG0578|consen 485 -G-TP--------------------------------------------------------------------------- 487 (550)
T ss_pred -C-CC---------------------------------------------------------------------------
Confidence 1 00
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
++.....++..|+|||.+||+.|+++|+||.|+|+||||+.
T Consensus 488 ------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 488 ------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred ------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 00111236789999999999999999999999999999954
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=373.26 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=223.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+.|++.+.||+|.|+.|+++.+..+|+.+|+|++... ....+++.+|+.|-+.| .|||||++++.+....
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-------qHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-------QHPNIVRLHDSIQEES 83 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-------CCCcEeehhhhhcccc
Confidence 7899999999999999999999999999999999732 34678889999999998 6899999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..|||||+|.| +|..-|-... -++|..+-.+++||+++|.|||.++|||||+||+|+|+...+...-+||+|||+|.
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred eeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999986 6665444433 37899999999999999999999999999999999999887778889999999997
Q ss_pred ccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....+|||.|||||++...+|+..+|||+.|||||-|+.|++||.+.+..++.++|++.--..++
T Consensus 162 ~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~-------- 233 (355)
T KOG0033|consen 162 EVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS-------- 233 (355)
T ss_pred EeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC--------
Confidence 6653 234568999999999999999999999999999999999999999998888888888763221110
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+ .+..+
T Consensus 234 ------------------------------------------------~--------------------------~w~~i 239 (355)
T KOG0033|consen 234 ------------------------------------------------P--------------------------EWDTV 239 (355)
T ss_pred ------------------------------------------------c--------------------------ccCcC
Confidence 0 11235
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++++++||++||..||.+|+|+.|+|+|||+.+..
T Consensus 240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred CHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 67899999999999999999999999999999753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=372.05 Aligned_cols=278 Identities=33% Similarity=0.553 Sum_probs=219.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
+|++++.||+|+||+||+|+++.+++.||||+++.. ........+|+.+++.+.+. +|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF----DHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhc----CCCCeeeeeeeeccccC
Confidence 589999999999999999999999999999999743 22234566788888888654 799999999998752
Q ss_pred ---ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 ---RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ---~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+++|||++.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~dfg 153 (288)
T cd07863 77 DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADFG 153 (288)
T ss_pred CCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccC
Confidence 468999999999999988776555699999999999999999999999999999999999995 66889999999
Q ss_pred cccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 262 SACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 262 lA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
++...... .....++..|+|||++.+..++.++|||||||++|+|++|++||.+....+.+.++....+......+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 99754322 2345678999999999988999999999999999999999999999888888888888777332221111
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
........+. + .....+.++..
T Consensus 234 ~~~~~~~~~~------------------------------------~------~~~~~~~~~~~---------------- 255 (288)
T cd07863 234 DVTLPRGAFS------------------------------------P------RGPRPVQSVVP---------------- 255 (288)
T ss_pred cccccccccC------------------------------------C------CCCCchHHhCc----------------
Confidence 0000000000 0 00011111111
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.++..+.|||.+||++||++|||+.|+|.||||
T Consensus 256 -~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 256 -EIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred -CcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 244678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=398.14 Aligned_cols=251 Identities=31% Similarity=0.503 Sum_probs=220.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|.+.+.||+|.||+|||++.+.+.+.||||.+.+. +...+.+.+|++|++.| .|||||.++++|+...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-------kHpniv~m~esfEt~~ 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-------KHPNIVEMLESFETSA 74 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-------CCcchhhHHHhhcccc
Confidence 5788999999999999999999999999999999753 45567788999999999 5899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++|+|.|||.|+|..++.... .++|+.++.|+.+++.||.|||+++|+|||+||.|||+. +.+.+||||||+|+.
T Consensus 75 ~~~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 75 HLWVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARA 149 (808)
T ss_pred eEEEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhh
Confidence 999999999999999998764 699999999999999999999999999999999999995 889999999999976
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....||+.|||||++.+.+|+..+|+||||||+|||++|+|||...+...++..|.. .|+.+
T Consensus 150 m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~----d~v~~------ 219 (808)
T KOG0597|consen 150 MSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK----DPVKP------ 219 (808)
T ss_pred cccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc----CCCCC------
Confidence 5543 2345799999999999999999999999999999999999999987665555554433 11100
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
...+
T Consensus 220 ----------------------------------------------------------------------------p~~~ 223 (808)
T KOG0597|consen 220 ----------------------------------------------------------------------------PSTA 223 (808)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0125
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+..|+.||+.+|..||.+|+|=.++|.|||+++.-
T Consensus 224 S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 224 SSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred cHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 67899999999999999999999999999999753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=379.04 Aligned_cols=280 Identities=31% Similarity=0.547 Sum_probs=220.6
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
+|++.++||+|+||.||+|++..+++.||||+++.. ......+.+|+.+|+.+ .||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~ 73 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-------RHPDIVEIKHIMLPPSR 73 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-------CCCCEeeecceEeccCC
Confidence 699999999999999999999999999999998742 23345678899999998 689999999988653
Q ss_pred ---ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 ---RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ---~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+|+|||||+++|.+++.... .+++..++.++.||++||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 74 ~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kL~Dfg 148 (338)
T cd07859 74 REFKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN---ADCKLKICDFG 148 (338)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEccCc
Confidence 2589999999999999887543 599999999999999999999999999999999999995 67889999999
Q ss_pred cccccCCc------cccccccccccCcccccc--ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 262 SACTEDRT------VYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 262 lA~~~~~~------~~~~~gt~~Y~APEvl~~--~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
++...... ....++|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+..+....+ .|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~-~~ 227 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG-TP 227 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC-CC
Confidence 98643211 123578999999999876 5789999999999999999999999999988888888888888 44
Q ss_pred chHHHHhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 334 PDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 334 p~~~l~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
+.......... ..++.... ... ...+.+.+
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~------------------------------~~~---------~~~~~~~~--------- 259 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMR------------------------------KKQ---------PVPFSQKF--------- 259 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhc------------------------------ccC---------CCchHHhc---------
Confidence 44333322110 00000000 000 00000100
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...++.+.+||.+||+.||++|||++|+|+||||++...
T Consensus 260 --------~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 260 --------PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred --------CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 113467899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=382.49 Aligned_cols=288 Identities=30% Similarity=0.546 Sum_probs=223.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.+.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++...+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~ 93 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-------NHKNIISLLNVFTPQK 93 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-------CCCCEeeeeeeeccCC
Confidence 8999999999999999999999999999999999743 34456677899999888 6899999999987543
Q ss_pred ------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 ------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~---~~~~~kl~D 166 (359)
T cd07876 94 SLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 166 (359)
T ss_pred CccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEec
Confidence 5799999999998887643 388999999999999999999999999999999999996 678999999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++ .|+..+
T Consensus 167 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 245 (359)
T cd07876 167 FGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG-TPSAEF 245 (359)
T ss_pred CCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCcHHH
Confidence 9999654322 2345789999999999999999999999999999999999999999988888888888888 444433
Q ss_pred HHhhhc-cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 338 LKEAKN-TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 338 l~~~~~-~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
...... ...+..... .+....+.++...+.... ..
T Consensus 246 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~~-----~~ 281 (359)
T cd07876 246 MNRLQPTVRNYVENRP---------------------------------------QYPGISFEELFPDWIFPS-----ES 281 (359)
T ss_pred HHHHHHHHHHHHhhCC---------------------------------------CCCCcchhhhcccccccc-----cc
Confidence 332211 111111110 001111122211111100 00
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
......+..+++||.+||.+||++|||+.|+|+||||+.
T Consensus 282 ~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 282 ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred ccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 011124567899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=378.63 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=214.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+|+.+ .||||+++++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-------SHPFIIRLFWTEHDQ 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-------CCCcHhhhHhhhccC
Confidence 47899999999999999999999999999999997532 2345677899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~---~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEEecCcc
Confidence 99999999997 5898888754 3689999999999999999999999999999999999995 6788999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
..........+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....-
T Consensus 149 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------------- 215 (291)
T cd05612 149 KKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL------------- 215 (291)
T ss_pred hhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------------
Confidence 8766555566899999999999998999999999999999999999999987766555444332000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.+| ...+
T Consensus 216 ------------------------------------------------------------~~~-------------~~~~ 222 (291)
T cd05612 216 ------------------------------------------------------------EFP-------------RHLD 222 (291)
T ss_pred ------------------------------------------------------------CCC-------------ccCC
Confidence 000 0123
Q ss_pred HHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
..+++||++||+.||.+|++ ++|+++||||+...+
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 56899999999999999995 999999999987554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=378.19 Aligned_cols=265 Identities=24% Similarity=0.382 Sum_probs=219.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.+.|++.+.||.|..++||+|+...+++.||||++..+ ....+.+.+|++.|..+ +||||++++..|..+.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-------~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-------DHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-------CCCCcceEEEEEEecc
Confidence 48999999999999999999999999999999999854 34467888999999998 7999999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||.||. |+++++++..-..+++|..|..|++++++||.|||.+|.||||||+.||||+ .+|.|||+|||...
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~---~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID---SDGTVKLADFGVSA 174 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc---CCCcEEEcCceeee
Confidence 9999999997 7999999988878899999999999999999999999999999999999995 88999999999873
Q ss_pred ccC---Cc----cccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 265 TED---RT----VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 265 ~~~---~~----~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
... .. ..+.++|++|||||++... .|+.|+||||||+++.||.+|..||.......++. ++..+ .||.
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn-~pp~ 251 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQN-DPPT 251 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcC-CCCC
Confidence 221 11 1456899999999997654 79999999999999999999999997544433222 12222 2221
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
-. .+..+
T Consensus 252 ~~-------------------------------------------------------------------------t~~~~ 258 (516)
T KOG0582|consen 252 LL-------------------------------------------------------------------------TSGLD 258 (516)
T ss_pred cc-------------------------------------------------------------------------cccCC
Confidence 10 00011
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.......+..|+++|..||+.||++||||+++|+|+||+....
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 1122335568999999999999999999999999999998654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=394.83 Aligned_cols=282 Identities=33% Similarity=0.594 Sum_probs=220.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--- 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--- 184 (820)
.++|+++++||+|+||+||+|++..+++.||||++..... ...+|+.+|+.+ .|+|||+++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-------~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNL-------NHINIIFLKDYYYTECFK 134 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhc-------CCCCCcceeeeEeecccc
Confidence 4789999999999999999999999999999999875432 234699999988 689999999987542
Q ss_pred -----ceeEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 185 -----RHLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
..+++||||+.++|.+++... ....+++..++.++.||+.||+|||+++||||||||+||||+ .....+||
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL 212 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKL 212 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceee
Confidence 257899999999998877642 234699999999999999999999999999999999999996 23457999
Q ss_pred eecccccccC--CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 258 IDFGSACTED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 258 ~DFGlA~~~~--~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
+|||+|+... ......++|+.|+|||++.+. .|+.++|||||||+||||++|.+||.+.+..+.+.++.+.++ .|+
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~p~ 291 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG-TPT 291 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCC
Confidence 9999997543 233456789999999998765 699999999999999999999999999999999999999888 444
Q ss_pred hHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChh
Q 003438 335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME 414 (820)
Q Consensus 335 ~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e 414 (820)
...+..... .+.... .+ ......+... +|
T Consensus 292 ~~~~~~~~~---~~~~~~--------------------------------~~-----~~~~~~l~~~---~p-------- 320 (440)
T PTZ00036 292 EDQLKEMNP---NYADIK--------------------------------FP-----DVKPKDLKKV---FP-------- 320 (440)
T ss_pred HHHHHHhch---hhhccc--------------------------------CC-----ccCchhHHHH---hc--------
Confidence 333221100 000000 00 0001111111 11
Q ss_pred hhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 415 ~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...++++++||.+||++||.+|+|+.|+|+||||.+...
T Consensus 321 -----~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 321 -----KGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred -----cCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 113467899999999999999999999999999987543
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=389.49 Aligned_cols=282 Identities=20% Similarity=0.366 Sum_probs=217.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..+|+++++||+|+||.||+|++..+++.||||+... ..+.+|+++|++| .|||||+++++|..+...
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAI-------NHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhC-------CCCCCCCEeEEEEECCee
Confidence 4689999999999999999999999999999997653 3467899999998 689999999999999999
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
|+|||++.++|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++ ..+.+||+|||+++...
T Consensus 159 ~lv~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCcccccc
Confidence 999999999999888664 3589999999999999999999999999999999999995 66889999999996432
Q ss_pred ----CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhCCCCchH
Q 003438 268 ----RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-------SEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 268 ----~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~-------s~~d~l~~I~~~lG~~Pp~~ 336 (820)
......+||+.|+|||++.+..++.++|||||||++|||++|..||... .....+..+.+..|..|.++
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 1223457899999999999989999999999999999999999776432 23456777777777433322
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
...........+... .......+ .....+
T Consensus 314 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~------~~~~~~------------------ 342 (391)
T PHA03212 314 PIDAQANLDEIYIGL---------------------------AKKSSRKP------GSRPLW------------------ 342 (391)
T ss_pred CcchhHHHHHHHHHH---------------------------HhccCCCC------CCCCCH------------------
Confidence 111100000000000 00000000 000000
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
......+.++.+||.+||++||++||||+|+|+||||++.+
T Consensus 343 ~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 343 TNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 01112456789999999999999999999999999998754
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=381.10 Aligned_cols=252 Identities=24% Similarity=0.429 Sum_probs=214.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|+++ .||||+++++++..+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-------SHPFIVNMMCSFQDE 90 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-------CCCCCCcEEEEEEcC
Confidence 78999999999999999999999999999999998532 2345678899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD---NKGHVKVTDFGFA 165 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC---CCCCEEEeeccCc
Confidence 99999999997 5888888754 3589999999999999999999999999999999999995 6788999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
..........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+..-
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------------- 232 (329)
T PTZ00263 166 KKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL------------- 232 (329)
T ss_pred eEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc-------------
Confidence 8776666667899999999999999999999999999999999999999987765544443322000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.+| ..++
T Consensus 233 ------------------------------------------------------------~~p-------------~~~~ 239 (329)
T PTZ00263 233 ------------------------------------------------------------KFP-------------NWFD 239 (329)
T ss_pred ------------------------------------------------------------CCC-------------CCCC
Confidence 000 0023
Q ss_pred HHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
..+.+||++||+.||++|++ ++++|+||||.+..+
T Consensus 240 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 56789999999999999997 799999999988543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=371.00 Aligned_cols=282 Identities=30% Similarity=0.523 Sum_probs=223.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||+|+++.+++.||||+++... .....+.+|+.+++++ .|+||+++++++..++.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-------KHANIVTLHDIVHTDKS 78 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-------CCCCcceEEEEEeeCCe
Confidence 78999999999999999999999999999999997432 2334567899999888 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
.|+||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||++...
T Consensus 79 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 79 LTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAK 154 (309)
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECccccceec
Confidence 99999999999988876543 3589999999999999999999999999999999999996 6678999999998653
Q ss_pred CCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .|+...+....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLG-TPTEETWPGIS 233 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHHhhhc
Confidence 322 2234678899999998764 689999999999999999999999999998899999999888 44433333221
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
....+.+ .. .+. +....+ . .....+
T Consensus 234 ~~~~~~~-~~--------------------------------~~~-----~~~~~~---~--------------~~~~~~ 258 (309)
T cd07872 234 SNDEFKN-YN--------------------------------FPK-----YKPQPL---I--------------NHAPRL 258 (309)
T ss_pred chhhhhh-hh--------------------------------cCc-----cCCCch---h--------------hhccCC
Confidence 1110000 00 000 000000 0 011124
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+.+++|||.+||.+||++|+|++|+|+||||+...
T Consensus 259 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 259 DTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 56789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=379.84 Aligned_cols=289 Identities=30% Similarity=0.541 Sum_probs=224.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+ .|+||+++++++...
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIIGLLNVFTPQK 96 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-------CCCCccccceeecccc
Confidence 7999999999999999999999999999999999753 33456677899999888 689999999988654
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+|+||||+.++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~D 169 (364)
T cd07875 97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 169 (364)
T ss_pred cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC---CCCcEEEEe
Confidence 35799999999999887753 388999999999999999999999999999999999996 678899999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.++++.+
T Consensus 170 fG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 170 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9999765433 23457899999999999999999999999999999999999999999999999999998885444433
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
.........+...... +....++++....... .+..
T Consensus 250 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~-----~~~~ 285 (364)
T cd07875 250 KKLQPTVRTYVENRPK---------------------------------------YAGYSFEKLFPDVLFP-----ADSE 285 (364)
T ss_pred HhhhHHHHHHHhhCCC---------------------------------------cCCCChHhhCcccccc-----cccc
Confidence 2221111111111110 0000111111110000 0000
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.....+..++|||.+||++||.+|||++|+|+||||..
T Consensus 286 ~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 286 HNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred ccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 11123467899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=385.84 Aligned_cols=260 Identities=31% Similarity=0.480 Sum_probs=224.5
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
....|++.+.||.|.||+||+|+++.+++.+|+|++++... ..+.+.+|++||++|. .|||||.++++|+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~------~hpniv~l~~~~e 106 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS------GHPNIVQLKDAFE 106 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc------CCCCEEEEEEEEE
Confidence 34799999999999999999999999999999999986432 4468899999999994 3999999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC-CCeEEEeec
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKIIDF 260 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~iKL~DF 260 (820)
....++||||+|. |.|++.+... .++|..+..+++||+.+++|||+.|||||||||+|||+..... .+.+|++||
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999998 6899988776 2999999999999999999999999999999999999986543 458999999
Q ss_pred ccccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 261 GSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 261 GlA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
|++..... .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+.......|.+.--
T Consensus 184 Gla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-------- 255 (382)
T KOG0032|consen 184 GLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-------- 255 (382)
T ss_pred CCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--------
Confidence 99976654 56778999999999999999999999999999999999999999999887776665443100
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
.....+
T Consensus 256 ------------------------------------------------~f~~~~-------------------------- 261 (382)
T KOG0032|consen 256 ------------------------------------------------DFTSEP-------------------------- 261 (382)
T ss_pred ------------------------------------------------CCCCCC--------------------------
Confidence 000011
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+..++..+.|||++||..||.+|+|+.++|+|||+++..
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 122567899999999999999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=396.98 Aligned_cols=256 Identities=25% Similarity=0.458 Sum_probs=223.4
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..++|+++++||+|.||+|+++..+.+++.+|||+++++ ....+..+.|..|+...+ .||.++.++.+|+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~------~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN------RHPFLVNLFSCFQ 439 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc------cCCeEeecccccc
Confidence 347999999999999999999999999999999999975 456778888999998885 5999999999999
Q ss_pred ecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 183 CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 183 ~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.++++|+||||+.|+. ++.....+.+++..++.++..|+.||+|||++|||+||||.+||||+ ..|.+||+|||+
T Consensus 440 T~~~l~fvmey~~Ggd--m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD---~eGh~kiADFGl 514 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGD--LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD---TEGHVKIADFGL 514 (694)
T ss_pred cCCeEEEEEEecCCCc--EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc---ccCcEEeccccc
Confidence 9999999999998643 33333335699999999999999999999999999999999999995 889999999999
Q ss_pred ccc---cCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~---~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
++. .+....+.|||+.|+|||++.+..|+.++|.|+|||+||||+.|..||++++++++...|+..--
T Consensus 515 cKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~--------- 585 (694)
T KOG0694|consen 515 CKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV--------- 585 (694)
T ss_pred ccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 974 34566788999999999999999999999999999999999999999999999988877754100
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.||
T Consensus 586 ----------------------------------------------------------------~yP------------- 588 (694)
T KOG0694|consen 586 ----------------------------------------------------------------RYP------------- 588 (694)
T ss_pred ----------------------------------------------------------------CCC-------------
Confidence 011
Q ss_pred HHhHHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT 459 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~ 459 (820)
..++.+++++|++||..||++|+- +++|.+||||+...+.
T Consensus 589 ~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 589 RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 124577899999999999999995 5899999999997753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=341.74 Aligned_cols=280 Identities=33% Similarity=0.558 Sum_probs=234.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.+|...++||+|+||+||+++++++++.||+|.++.+ +......++||.+|++|+ |.|||+++++...+.
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-------hknivrl~dvlhsdk 74 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-------HKNIVRLHDVLHSDK 74 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-------hcceeehhhhhccCc
Confidence 3567778999999999999999999999999999854 345567899999999994 679999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+.+|+|||+.+|..++...+ +.++.+.++.++.|+++||.|||+++++||||||.|+||+ .++++||+|||+++.
T Consensus 75 kltlvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin---~ngelkladfglara 150 (292)
T KOG0662|consen 75 KLTLVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN---RNGELKLADFGLARA 150 (292)
T ss_pred eeEEeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec---cCCcEEecccchhhh
Confidence 999999999999999888765 5699999999999999999999999999999999999995 789999999999986
Q ss_pred cCCcccc---ccccccccCccccccc-cccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 266 EDRTVYS---YIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 266 ~~~~~~~---~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.+-.... .+-|.+|++|.++.+. -|++..|+||.|||+.|+.. |+++|++.+..+++.+|.+.+| .|.+..|+.
T Consensus 151 fgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg-~p~ed~wps 229 (292)
T KOG0662|consen 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEDQWPS 229 (292)
T ss_pred cCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC-CCccccCCc
Confidence 6554433 3669999999999987 58999999999999999996 9999999999999999999999 666554443
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
..+... |.. ...|-..+++..++++
T Consensus 230 ~t~lpd-----------------------yk~----------------yp~ypattswsqivp~---------------- 254 (292)
T KOG0662|consen 230 MTKLPD-----------------------YKP----------------YPIYPATTSWSQIVPK---------------- 254 (292)
T ss_pred cccCCC-----------------------Ccc----------------cCCccccchHHHHhhh----------------
Confidence 222211 110 0011122345555544
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.+..-+||++++|..+|.+|++|+++|+||||.+.
T Consensus 255 -lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 255 -LNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -hcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 33556899999999999999999999999999863
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.80 Aligned_cols=295 Identities=29% Similarity=0.524 Sum_probs=237.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
..|++++.||+|+||.||+|..+.++. .+|||.++.+. .....+.+|+.++++| .|+||+.|..+|
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-------~h~nvi~Lv~Vf 96 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-------KHPNVISLVKVF 96 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-------cCCcchhHHHHH
Confidence 689999999999999999997655533 78999998542 3446788999999999 689999999999
Q ss_pred ee-cceeEEEEeccCCChHHHHHhhh---cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc-cCCCeEE
Q 003438 182 VC-QRHLCICFELLDSNLYELIKINH---FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIK 256 (820)
Q Consensus 182 ~~-~~~l~LVmEy~~gsL~d~l~~~~---~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~iK 256 (820)
.. +..+++++||.+.+|+++|+.+. .+.++...++.|+.||+.|+.|||++=|+||||||.||||..+ .+.+.||
T Consensus 97 l~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 97 LSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred hccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 88 77899999999999999998654 2458999999999999999999999999999999999999643 3459999
Q ss_pred EeecccccccCCcc------ccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCC---------HHH
Q 003438 257 IIDFGSACTEDRTV------YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS---------EFD 320 (820)
Q Consensus 257 L~DFGlA~~~~~~~------~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s---------~~d 320 (820)
|+|||+++...... ...+-|.+|+|||++++. .|+.++|||++|||+.||++-.++|.+.. ..+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999998665443 234679999999999987 69999999999999999999999998753 367
Q ss_pred HHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHH
Q 003438 321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEE 400 (820)
Q Consensus 321 ~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~ 400 (820)
++.+|++++| .|.+..|+..++..+|-..+... ...++....|..
T Consensus 257 Ql~rIf~vLG-~Pt~~~Wp~lkk~Pe~q~~ls~f----------------------------------~~~~~~n~sL~~ 301 (438)
T KOG0666|consen 257 QLDRIFEVLG-TPTDKDWPDLKKMPEYQTLLSDF----------------------------------RRHYYDNVSLHK 301 (438)
T ss_pred HHHHHHHHcC-CCccccchhhhhCcchHHHHHHh----------------------------------HHhhcCcchHHH
Confidence 8999999999 88887777766654443222100 011233333443
Q ss_pred HHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 401 IVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 401 il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
.....- .-++...|||.+||.+||.+|+|++|||+|+||++.+.+
T Consensus 302 ~~~~~k--------------~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 302 YYHKHK--------------VKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHHHhc--------------CCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 332211 123458899999999999999999999999999998653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=377.42 Aligned_cols=246 Identities=25% Similarity=0.427 Sum_probs=204.4
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||+||+|+++.+++.||||++++. ......+.+|+.+|+.+ .||||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-------RHPFLTALKYSFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-------CCCCCCCEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999853 23345667888998888 689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEeeCCCCcccccC
Confidence 99997 5788877654 4689999999999999999999999999999999999995 6788999999998643
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---------------- 212 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---------------- 212 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 2223446799999999999999999999999999999999999999987665443333211000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ..++..+
T Consensus 213 ---------------------------------------------------------~~p-------------~~~~~~~ 222 (323)
T cd05571 213 ---------------------------------------------------------RFP-------------RTLSPEA 222 (323)
T ss_pred ---------------------------------------------------------CCC-------------CCCCHHH
Confidence 000 0134678
Q ss_pred HHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
.+||++||+.||++|+ ++.|+|+||||.+..+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999999999 8999999999988644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=378.23 Aligned_cols=278 Identities=31% Similarity=0.603 Sum_probs=222.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
++|++++.||+|+||+||+|.+..+++.||||+++... ...+.+.+|+.+|+.+ .|+||++++++|...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-------KHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-------CCCchhhhhhhhcccc
Confidence 78999999999999999999999999999999997532 2345567899999988 689999999988643
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
...|+|||+++++|.++++. ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~~~~~~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~D 161 (343)
T cd07878 88 SIENFNEVYLVTNLMGADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILD 161 (343)
T ss_pred cccccCcEEEEeecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcC
Confidence 35799999999999887764 3599999999999999999999999999999999999996 678899999
Q ss_pred cccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 260 FGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 260 FGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
||++..........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+..+++ ..
T Consensus 162 fg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 240 (343)
T cd07878 162 FGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE-VL 240 (343)
T ss_pred CccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH-HH
Confidence 9999877666666789999999999987 478999999999999999999999999988888888888888743333 22
Q ss_pred Hhhhc--cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 339 KEAKN--TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 339 ~~~~~--~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
..... ...+.... ..+....+..++.
T Consensus 241 ~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~------------- 268 (343)
T cd07878 241 KKISSEHARKYIQSL---------------------------------------PHMPQQDLKKIFR------------- 268 (343)
T ss_pred HhcchhhHHHHhhcc---------------------------------------ccccchhHHHhcc-------------
Confidence 21100 00000000 0000111111111
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..++.++|||.+||++||++|||+.|+|+||||.+.
T Consensus 269 ----~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 269 ----GANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 134568999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=381.45 Aligned_cols=283 Identities=30% Similarity=0.454 Sum_probs=223.2
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR- 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~- 185 (820)
+|+++++||+|+||+||++++..+++.||||++... ....+.+.+|+.+|+.+ .|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~ 73 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-------KHDNVLSALDILQPPHI 73 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-------CCCCcCCHhheecCCCc
Confidence 477899999999999999999999999999998743 23456778899999988 6899999999998876
Q ss_pred ----eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 186 ----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 186 ----~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
++|+||||+.++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 74 ~~~~~~~lv~e~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg 148 (372)
T cd07853 74 DPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN---SNCVLKICDFG 148 (372)
T ss_pred cccceEEEEeeccccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC---CCCCEEecccc
Confidence 89999999999998887654 3699999999999999999999999999999999999996 67899999999
Q ss_pred cccccCCc----cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 262 SACTEDRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 262 lA~~~~~~----~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
++...... .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.+.+|..+.+.
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 99654321 2234678899999999875 589999999999999999999999999999999999999998444433
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
+.........++.... .. ...+..+..
T Consensus 229 ~~~~~~~~~~~~~~~~-------------------------------~~---------~~~~~~~~~------------- 255 (372)
T cd07853 229 MRSACEGARAHILRGP-------------------------------HK---------PPSLPVLYT------------- 255 (372)
T ss_pred HHHhhHHHHHHHHhCC-------------------------------CC---------CCchHHhcc-------------
Confidence 3222111111100000 00 000001000
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.....++++.+||.+||++||++|||++|+|+||||++..+
T Consensus 256 -~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 256 -LSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL 296 (372)
T ss_pred -cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence 01123567899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=369.42 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=209.0
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.|++.++||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|+.+ .|+||+++++++...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~iv~~~~~~~~~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-------NSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-------CCCcEEEEEEEEccCC
Confidence 3788999999999999999999999999999987532 2233567899999988 6889999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+. ++|.+.+.......+++..++.++.||+.||+|||+++|+||||||+|||++ +++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~---~~~~~kl~Dfg~~~ 150 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD---DRGHIRISDLGLAV 150 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeCCCcE
Confidence 9999999997 5787777654444689999999999999999999999999999999999995 66789999999997
Q ss_pred ccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+...+. ..
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~~--------- 220 (285)
T cd05631 151 QIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK-ED--------- 220 (285)
T ss_pred EcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh-cc---------
Confidence 5432 23345789999999999999999999999999999999999999986554322222211110 00
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
. ..+ ....
T Consensus 221 -------------------------------------------~----------------~~~-------------~~~~ 228 (285)
T cd05631 221 -------------------------------------------Q----------------EEY-------------SEKF 228 (285)
T ss_pred -------------------------------------------c----------------ccC-------------CccC
Confidence 0 000 0113
Q ss_pred HHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
+..+.+||++||..||++|+| ++|+++||||.+..+
T Consensus 229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 467899999999999999997 999999999998664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=378.69 Aligned_cols=290 Identities=29% Similarity=0.518 Sum_probs=224.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.+ .|+||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~ 89 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIISLLNVFTPQK 89 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-------CCCchhceeeeeeccc
Confidence 7999999999999999999999999999999999753 33456677899999888 689999999998754
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
...|+||||++++|.+.+.. .+++..++.++.||++||+|||++||+||||||+|||++ .++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~---~~~~~kl~D 162 (355)
T cd07874 90 SLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 162 (355)
T ss_pred cccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC---CCCCEEEee
Confidence 35799999999998887753 388999999999999999999999999999999999995 678899999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++...++.+
T Consensus 163 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred CcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999765433 23457899999999999989999999999999999999999999999988888888888885555443
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
.........+.+...... ...+......... ..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~-----~~~~~ 278 (355)
T cd07874 243 KKLQPTVRNYVENRPKYA---------------------------------------GLTFPKLFPDSLF-----PADSE 278 (355)
T ss_pred HhhcHHHHHHHhcCCccc---------------------------------------cccchhhcccccc-----ccccc
Confidence 322211122221111000 0000000000000 00001
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.....+..+++||.+||++||++|||+.|+|+||||...
T Consensus 279 ~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 279 HNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 111234678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=374.68 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=211.8
Q ss_pred eeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------------hhHHHHHHHHHHHHHHhhhc
Q 003438 102 LVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------------AYYQQALVEVSILTTLNKKY 166 (820)
Q Consensus 102 l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------------~~~~~~~~Ei~iL~~L~~~~ 166 (820)
.......++|++++.||+|.||.|-+|++..+++.||||++.+.+ ...++..+||.||++|
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl---- 165 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL---- 165 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc----
Confidence 334445589999999999999999999999999999999997421 1235788999999999
Q ss_pred CCCCCCceeEEeEEEeec--ceeEEEEeccCC-ChHHHHHhhhcCC-CCHHHHHHHHHHHHHHhhhcccCCeeeccCCCC
Q 003438 167 DREDKHHIVRIYEYFVCQ--RHLCICFELLDS-NLYELIKINHFRG-LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPE 242 (820)
Q Consensus 167 ~~~~HpnIVkl~d~f~~~--~~l~LVmEy~~g-sL~d~l~~~~~~~-l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPe 242 (820)
.|+|||+|+++..+. +.+|||+|||.. .+.. ....+. +++.+++++++.++.||+|||.+|||||||||.
T Consensus 166 ---~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPs 239 (576)
T KOG0585|consen 166 ---HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPS 239 (576)
T ss_pred ---CCcCeeEEEEeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 789999999998864 689999999983 3322 222234 899999999999999999999999999999999
Q ss_pred CcccccccCCCeEEEeecccccccC--------CccccccccccccCccccccc---c-ccccchhHhHHHHHHHHHhCC
Q 003438 243 NILLCTSVKPAEIKIIDFGSACTED--------RTVYSYIQSRYYRSPEVLLGY---Q-YTTAIDMWSFGCIVAELFLGL 310 (820)
Q Consensus 243 NILl~~~~~~~~iKL~DFGlA~~~~--------~~~~~~~gt~~Y~APEvl~~~---~-yt~ksDIWSLG~ILyeLltG~ 310 (820)
|+||+ .++++||+|||.+.... ......+||+.|+|||.+.+. . .+.+.|||||||+||.|+.|+
T Consensus 240 NLLl~---~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 240 NLLLS---SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred heEEc---CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99996 67999999999986431 123346899999999999873 2 347999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCc
Q 003438 311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390 (820)
Q Consensus 311 ~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~ 390 (820)
.||-+....++..+|+..--
T Consensus 317 ~PF~~~~~~~l~~KIvn~pL------------------------------------------------------------ 336 (576)
T KOG0585|consen 317 LPFFDDFELELFDKIVNDPL------------------------------------------------------------ 336 (576)
T ss_pred CCcccchHHHHHHHHhcCcc------------------------------------------------------------
Confidence 99998888887777765111
Q ss_pred cccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 391 ~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.+| ....+.+.++|||.+||++||++|+|..++..|||....
T Consensus 337 -------------~fP-----------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 337 -------------EFP-----------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -------------cCC-----------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 001 001245778999999999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.55 Aligned_cols=210 Identities=29% Similarity=0.425 Sum_probs=185.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE-EEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE-YFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d-~f~~ 183 (820)
...|+|+++||+|.||+||++++..+++.||.|.++- +....+....|+.+|++| +|||||++++ .|..
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-------~HpNIVqYy~~~f~~ 90 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-------NHPNIVQYYAHSFIE 90 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-------CCchHHHHHHHhhhc
Confidence 3689999999999999999999999999999999973 445667888999999999 6899999998 5555
Q ss_pred cce-eEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhccc--CC--eeeccCCCCCcccccccCCCeE
Q 003438 184 QRH-LCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKD--AG--IIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 184 ~~~-l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs--~g--IVHrDLKPeNILl~~~~~~~~i 255 (820)
+.. ++||||+|+ |+|..+++..+ .+.++|..+++++.|++.||..||. .. |+||||||.||+|+ ..+.+
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvv 167 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVV 167 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCce
Confidence 555 999999998 79999887543 4569999999999999999999998 55 99999999999996 78899
Q ss_pred EEeecccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 003438 256 KIIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 256 KL~DFGlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~ 327 (820)
||+|||+++..... ...++|||+||+||++.+.+|+.|+|||||||++|||+.-++||.+++-.++..+|.+
T Consensus 168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q 242 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ 242 (375)
T ss_pred eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc
Confidence 99999999876544 3467999999999999999999999999999999999999999999876666666544
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=368.49 Aligned_cols=284 Identities=27% Similarity=0.476 Sum_probs=208.6
Q ss_pred EEEeccCCceeEEEeecc--CCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--cceeEE
Q 003438 114 KDLLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCI 189 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~--~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~~~l~L 189 (820)
.++||+|+||+||+|+++ .+++.||||+++.... ...+.+|+.+|+++ .||||+++++++.. +..+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLREL-------KHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhc-------CCCCCcceeeeEecCCCcEEEE
Confidence 357999999999999865 4678999999975432 34567899999998 68999999999864 457899
Q ss_pred EEeccCCChHHHHHhhh-------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc-cCCCeEEEeecc
Q 003438 190 CFELLDSNLYELIKINH-------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFG 261 (820)
Q Consensus 190 VmEy~~gsL~d~l~~~~-------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~iKL~DFG 261 (820)
||||+.++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+... +..+.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 78 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99999999998876432 1248999999999999999999999999999999999999532 356789999999
Q ss_pred cccccCCc------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q 003438 262 SACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLRRM 325 (820)
Q Consensus 262 lA~~~~~~------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~---------~d~l~~I 325 (820)
+++..... ....++|+.|+|||++.+. .++.++|||||||++|+|++|++||..... .+.+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 99654322 2345789999999999875 589999999999999999999999975442 3567777
Q ss_pred HHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcC
Q 003438 326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405 (820)
Q Consensus 326 ~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~ 405 (820)
...+| .|....+.............. .+. ...+....+...+...
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~------------------------~~~----------~~~~~~~~~~~~~~~~ 282 (317)
T cd07868 238 FNVMG-FPADKDWEDIKKMPEHSTLMK------------------------DFR----------RNTYTNCSLIKYMEKH 282 (317)
T ss_pred HHhcC-CCChHHhHHHhhccchhhhhh------------------------hhh----------ccccCcccccchHHhc
Confidence 77777 444443333222111000000 000 0000000000000000
Q ss_pred CCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 406 P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
....+..++|||++||++||++|+|++|||+||||
T Consensus 283 -------------~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 283 -------------KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred -------------CCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00123568999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=376.88 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=212.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC-eEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg-~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++|+++++||+|+||.||+|++..++ ..||||++... ....+.+.+|+.+++.+ .||||+++++++..
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~Iv~~~~~~~~ 102 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-------NHPFCVNLYGSFKD 102 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-------CCCCCcceEEEEEe
Confidence 78999999999999999999876554 78999999743 23345677899999988 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+||||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~ikL~DFG~ 177 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGF 177 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEecCCC
Confidence 999999999996 6898888764 3599999999999999999999999999999999999995 678999999999
Q ss_pred ccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 263 A~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
+..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+.+...
T Consensus 178 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~------------ 245 (340)
T PTZ00426 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII------------ 245 (340)
T ss_pred CeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC------------
Confidence 98766555667899999999999998899999999999999999999999987765544444322100
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.+| ...
T Consensus 246 -------------------------------------------------------------~~p-------------~~~ 251 (340)
T PTZ00426 246 -------------------------------------------------------------YFP-------------KFL 251 (340)
T ss_pred -------------------------------------------------------------CCC-------------CCC
Confidence 000 012
Q ss_pred HHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
+..+.+||++||+.||++|+ |++|+++||||.+..+
T Consensus 252 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 252 DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 35678999999999999996 8999999999998654
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=369.53 Aligned_cols=252 Identities=23% Similarity=0.435 Sum_probs=208.3
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
|+++++||+|+||.||+|++..+++.||||++++.. ...+.+.+|+.++..++.. .||||+++++++...+.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l----~hp~i~~~~~~~~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE----RHPFLVNLFACFQTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc----CCCChhceeeEEEcCCE
Confidence 788999999999999999999999999999998532 2345567777777666433 79999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+.+ +|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~---~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD---TEGFVKIADFGLCKE 150 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCcEEeCcccCCcc
Confidence 9999999985 77766643 3599999999999999999999999999999999999996 678999999999864
Q ss_pred c---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 E---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
. .......++++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------ 218 (324)
T cd05589 151 GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------ 218 (324)
T ss_pred CCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 3 2223456789999999999998999999999999999999999999988776555444322100
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.+| ..+
T Consensus 219 -------------------------------------------------------------~~p-------------~~~ 224 (324)
T cd05589 219 -------------------------------------------------------------RYP-------------RFL 224 (324)
T ss_pred -------------------------------------------------------------CCC-------------CCC
Confidence 000 013
Q ss_pred HHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
+..+.+||++||+.||.+|| +++++++||||++..+
T Consensus 225 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 225 SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 46688999999999999999 7999999999988543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=358.35 Aligned_cols=254 Identities=29% Similarity=0.479 Sum_probs=216.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
.+|.-.+.||.|..++|-+|.++.+++.+|+|+|... ....+....|+.||+++. +||+|+++.|
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~------GHP~II~l~D 90 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM------GHPYIIDLQD 90 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc------CCCcEEEeee
Confidence 5788889999999999999999999999999999631 233456678999999995 8999999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
+|+.+..+++|+|+|. |.|+|++...- .++|...++|++||++|+.|||.++||||||||+|||++ ++..|||+
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld---dn~~i~is 165 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD---DNMNIKIS 165 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec---cccceEEe
Confidence 9999999999999997 89999998764 599999999999999999999999999999999999995 77889999
Q ss_pred eccccccc--CCccccccccccccCccccccc------cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003438 259 DFGSACTE--DRTVYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330 (820)
Q Consensus 259 DFGlA~~~--~~~~~~~~gt~~Y~APEvl~~~------~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG 330 (820)
|||+++.. ++.....|||+.|+|||.+... .|+..+|+|++|||||.|+.|.+||......-++..|++ |
T Consensus 166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--G 243 (411)
T KOG0599|consen 166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--G 243 (411)
T ss_pred ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--c
Confidence 99999865 4556778999999999999643 588899999999999999999999976655555555444 1
Q ss_pred CCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 331 ~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
.|++ ...
T Consensus 244 --------------------------------------kyqF---------------------~sp-------------- 250 (411)
T KOG0599|consen 244 --------------------------------------KYQF---------------------RSP-------------- 250 (411)
T ss_pred --------------------------------------cccc---------------------CCc--------------
Confidence 1111 111
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
++.+++...+|||.+||+.||.+|+|++|+|+||||.+
T Consensus 251 -------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 -------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred -------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 22335677899999999999999999999999999954
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=371.46 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=203.4
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||+||+|++..+++.||||++++. ......+.+|+.+|+.+ .||||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-------RHPFLTSLKYSFQTKDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCcceEEEEEcCCEEEEE
Confidence 3689999999999999999999999999853 23345677888888887 689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC--
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED-- 267 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~-- 267 (820)
|||+. ++|.+.+... +.+++.+++.++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||++....
T Consensus 74 ~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~---~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD---KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC---CCCcEEEecCcCCccCCCc
Confidence 99997 5787777554 3589999999999999999999999999999999999995 67889999999986432
Q ss_pred -CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 268 -~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~---------------- 212 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDI---------------- 212 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCc----------------
Confidence 222345789999999999988999999999999999999999999987665443332211000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ..++..+
T Consensus 213 ---------------------------------------------------------~~p-------------~~~~~~~ 222 (328)
T cd05593 213 ---------------------------------------------------------KFP-------------RTLSADA 222 (328)
T ss_pred ---------------------------------------------------------cCC-------------CCCCHHH
Confidence 000 0134678
Q ss_pred HHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
.+||++||+.||++|+ |++|+|+||||.+..+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999997 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=372.23 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=216.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||.||+|++..+++.||||+++... .....+.+|+++++.+ .|+||+++++++...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~iv~~~~~~~~~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-------KSEWLVKLLYAFQDD 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-------CCCCCccEEEEEEcC
Confidence 47999999999999999999999999999999998532 2345677889888888 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEEEeCcCC
Confidence 99999999997 5898888654 3589999999999999999999999999999999999995 6788999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
..........++|+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..... .
T Consensus 149 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~----------- 216 (333)
T cd05600 149 KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-T----------- 216 (333)
T ss_pred cccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-c-----------
Confidence 8766555667899999999999999999999999999999999999999988776655544432111 0
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.. .+. +.. ....++
T Consensus 217 -------~~--------------------------------~~~-----~~~----------------------~~~~~s 230 (333)
T cd05600 217 -------LQ--------------------------------RPV-----YDD----------------------PRFNLS 230 (333)
T ss_pred -------cc--------------------------------CCC-----CCc----------------------cccccC
Confidence 00 000 000 001245
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.++.+||.+||..+|++|+|++|+++||||++..+
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 67899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=372.29 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=206.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-- 185 (820)
.+|...+.||+|+||+||++.+.++++..|||.+.... ...+.+.+|+.+|.+| .|||||++++......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-------~~p~IV~~~G~~~~~~~~ 89 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-------NHPNIVQYYGSSSSREND 89 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-------CCCCEEeeCCccccccCe
Confidence 56888899999999999999999999999999998542 1256688999999999 5899999999755544
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC-CCeEEEeecccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKIIDFGSA 263 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~iKL~DFGlA 263 (820)
.++|+|||+. |+|.++++.... .+++..++.+++||++||+|||++|||||||||+|||++ . ++.+||+|||++
T Consensus 90 ~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 90 EYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLA 165 (313)
T ss_pred eeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCccc
Confidence 6999999997 699999988764 799999999999999999999999999999999999996 4 689999999999
Q ss_pred cccC------CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 264 CTED------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 264 ~~~~------~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
.... .......||+.|||||++... ....++|||||||++.||+||++||... .+....+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---- 239 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED---- 239 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC----
Confidence 7554 223457899999999999963 3345999999999999999999999653 11111111111000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
..+.+|
T Consensus 240 ----------------------------------------------------------------~~P~ip---------- 245 (313)
T KOG0198|consen 240 ----------------------------------------------------------------SLPEIP---------- 245 (313)
T ss_pred ----------------------------------------------------------------CCCCCC----------
Confidence 000011
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++++++|||.+||.+||++||||+++|+|||+++..
T Consensus 246 ---~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 246 ---DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ---cccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 12457889999999999999999999999999998754
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=376.03 Aligned_cols=206 Identities=23% Similarity=0.456 Sum_probs=178.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||++++.. .....+.+|+.++.++ +|+||+++++.+.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-------~~~~iv~~~~~~~~~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-------DSLWVVKMFYSFQDK 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-------CCCCcceEEEEEecC
Confidence 47899999999999999999999999999999998532 2334567788888887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
..+|||||||. ++|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla 148 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLC 148 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCc
Confidence 99999999997 5888888754 4699999999999999999999999999999999999995 5688999999998
Q ss_pred cccCCc--------------------------------------cccccccccccCccccccccccccchhHhHHHHHHH
Q 003438 264 CTEDRT--------------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAE 305 (820)
Q Consensus 264 ~~~~~~--------------------------------------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILye 305 (820)
...... ....+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 643211 123578999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHH
Q 003438 306 LFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 306 LltG~~PF~~~s~~d~l~~I~ 326 (820)
|++|++||.+.+..+...++.
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~ 249 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVM 249 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHH
Confidence 999999998877666555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=373.21 Aligned_cols=255 Identities=24% Similarity=0.449 Sum_probs=209.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||+++.. ......+.+|+.+|+.+ +|+||++++++|...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~h~~iv~~~~~~~~~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-------DNPWVVKLYYSFQDE 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCcceEEEEEcC
Confidence 4799999999999999999999999999999999853 23345567899999888 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++||||||+. ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD---AKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEeecccc
Confidence 99999999997 5888888654 3599999999999999999999999999999999999995 6788999999998
Q ss_pred cccCCc-----------------------------------------cccccccccccCccccccccccccchhHhHHHH
Q 003438 264 CTEDRT-----------------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCI 302 (820)
Q Consensus 264 ~~~~~~-----------------------------------------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~I 302 (820)
...... ....+||+.|+|||++.+..++.++|||||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 532110 112468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHh
Q 003438 303 VAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARE 382 (820)
Q Consensus 303 LyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~ 382 (820)
+|||++|.+||...+..+.+..+..... .
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~-~-------------------------------------------------- 257 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWKE-T-------------------------------------------------- 257 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCCC-c--------------------------------------------------
Confidence 9999999999987776554444322100 0
Q ss_pred hcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCC---HHHHHcCCccCCCCC
Q 003438 383 LKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQASRHPFVTGEPF 458 (820)
Q Consensus 383 ~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT---a~EaL~HPff~~~~~ 458 (820)
+ .+| ....+++.+.+||++||. ||.+|++ ++|+|+||||++..+
T Consensus 258 ----------~----------~~~-----------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 258 ----------L----------QFP-----------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred ----------c----------CCC-----------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0 000 000134678999999997 9999998 999999999998654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=359.57 Aligned_cols=281 Identities=32% Similarity=0.538 Sum_probs=221.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||.||+|++..+++.||+|.++.. ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-------KHANIVTLHDIIHTEKS 78 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-------CCCCcceEEEEEecCCe
Confidence 7899999999999999999999999999999998743 22334567899999988 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
.|+||||+.++|.+++.... ..+++..++.++.||++||.|||+++|+|+||||+|||++ .++.+||+|||++...
T Consensus 79 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 79 LTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN---ERGELKLADFGLARAK 154 (301)
T ss_pred EEEEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC---CCCcEEECcCcchhcc
Confidence 99999999999998887543 4589999999999999999999999999999999999996 6678999999998643
Q ss_pred CCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+.+.++ .+....+....
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-TPTEETWPGIL 233 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC-CCChhhchhhh
Confidence 321 2234568899999998764 588899999999999999999999999888888888888877 33333222111
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.... +.... .+ .+....+.. .....
T Consensus 234 ~~~~-~~~~~--------------------------------~~-----~~~~~~~~~-----------------~~~~~ 258 (301)
T cd07873 234 SNEE-FKSYN--------------------------------YP-----KYRADCLHN-----------------HAPRL 258 (301)
T ss_pred cccc-ccccc--------------------------------cC-----ccccccHHh-----------------hcCCC
Confidence 0000 00000 00 000000000 11124
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+..+.|||.+||++||.+|||++|+|+||||+..
T Consensus 259 ~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 259 DSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 5678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=374.96 Aligned_cols=205 Identities=24% Similarity=0.455 Sum_probs=176.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||++.+.. ...+.+.+|+++++.+ +|+||++++++|...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~iv~~~~~~~~~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-------DSPWVVSLYYSFQDA 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-------CCCCcceEEEEEEcC
Confidence 47899999999999999999999999999999997532 2345667788888887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++||||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeecccc
Confidence 99999999996 6898888654 4689999999999999999999999999999999999995 6788999999998
Q ss_pred cccCCc--------------------------------------------------cccccccccccCcccccccccccc
Q 003438 264 CTEDRT--------------------------------------------------VYSYIQSRYYRSPEVLLGYQYTTA 293 (820)
Q Consensus 264 ~~~~~~--------------------------------------------------~~~~~gt~~Y~APEvl~~~~yt~k 293 (820)
+..... ....+||+.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 521100 012468999999999999899999
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 294 IDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 294 sDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
+|||||||++|||++|.+||.+.+..+.+..+
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 260 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKI 260 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 99999999999999999999877765554444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=365.61 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=222.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
+.|+++++||.|.-|+||+|+.+.++..+|+|++.+.. ....++..|-+||+.+ +||.++.||..|+.+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-------DHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-------DHPFLPTLYASFETD 149 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-------CCCccchhhheeecc
Confidence 78999999999999999999999999999999998653 3345667789999998 899999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..|+|||||. |+|..+++++..+.+++..++.++.+++.||+|||-.|||.||||||||||. ++|.|.|+||.++
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS 226 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLS 226 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeecccc
Confidence 99999999997 5899998888888899999999999999999999999999999999999995 8899999999987
Q ss_pred ccc-----------------------------------C-C-----------------------ccccccccccccCccc
Q 003438 264 CTE-----------------------------------D-R-----------------------TVYSYIQSRYYRSPEV 284 (820)
Q Consensus 264 ~~~-----------------------------------~-~-----------------------~~~~~~gt~~Y~APEv 284 (820)
... . . .....+||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 210 0 0 0112467888999999
Q ss_pred cccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCcccc
Q 003438 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSI 364 (820)
Q Consensus 285 l~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~ 364 (820)
+.+...+.++|.|+|||++|||+.|..||.+.+..+.+..|+. .++.
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~----~~l~----------------------------- 353 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG----QPLK----------------------------- 353 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc----CCCc-----------------------------
Confidence 9999999999999999999999999999999998888777654 1110
Q ss_pred CCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCC-
Q 003438 365 GGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS- 443 (820)
Q Consensus 365 ~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT- 443 (820)
+| ....++..++|||+++|++||++|+.
T Consensus 354 ----------------------------------------Fp-----------~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 354 ----------------------------------------FP-----------EEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred ----------------------------------------CC-----------CCCcchhHHHHHHHHHhccChhhhhcc
Confidence 01 01124578899999999999999999
Q ss_pred ---HHHHHcCCccCCCCCC
Q 003438 444 ---PFQASRHPFVTGEPFT 459 (820)
Q Consensus 444 ---a~EaL~HPff~~~~~~ 459 (820)
|.||-+||||++..+.
T Consensus 383 ~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 383 KRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred ccchHHhhcCccccCCChh
Confidence 9999999999998875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=367.46 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=203.4
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
+.||+|+||.||++++..+++.||+|+++.. ......+.+|+.+++.+ .||||++++++|...+.+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~i~~~~~~~~~~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-------RHPFLTALKYAFQTHDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-------CCCCCcceeeEEecCCEEEEE
Confidence 4699999999999999999999999999853 23344567788888888 689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC--
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED-- 267 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~-- 267 (820)
|||+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 74 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc---CCCCEEecccHHhccccCC
Confidence 99997 5787777654 3589999999999999999999999999999999999995 66889999999986432
Q ss_pred -CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 268 -~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
.......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~---------------- 212 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------------- 212 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 222345789999999999998999999999999999999999999987665444333221000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ..+++.+
T Consensus 213 ---------------------------------------------------------~~p-------------~~~~~~~ 222 (323)
T cd05595 213 ---------------------------------------------------------RFP-------------RTLSPEA 222 (323)
T ss_pred ---------------------------------------------------------CCC-------------CCCCHHH
Confidence 000 0134678
Q ss_pred HHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
.+||++||+.||++|+ ++.++|+||||.+..+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999999998 9999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=365.26 Aligned_cols=244 Identities=27% Similarity=0.505 Sum_probs=202.9
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||+|+||+||+|++..+++.||||+++.. ......+.+|+.+|+++ +||||+++++++...+.+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-------NCPFIVPLKFSFQSPEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCcEeceeeEEecCCeEEEEEc
Confidence 79999999999999999999999999743 23445677899998888 68999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC---C
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---R 268 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~---~ 268 (820)
|+. ++|.+++... +.+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||++.... .
T Consensus 74 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD---YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC---CCCcEEEEECcccccCccCCC
Confidence 997 5888888654 3599999999999999999999999999999999999995 67889999999986432 2
Q ss_pred ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhh
Q 003438 269 TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348 (820)
Q Consensus 269 ~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f 348 (820)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... +.
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~----~~-------------- 210 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE----PL-------------- 210 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC----CC--------------
Confidence 233457899999999999999999999999999999999999999876654443332210 00
Q ss_pred hhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHH
Q 003438 349 KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVD 428 (820)
Q Consensus 349 ~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~D 428 (820)
.+| ..+++.+.+
T Consensus 211 -------------------------------------------------------~~~-------------~~~~~~~~~ 222 (312)
T cd05585 211 -------------------------------------------------------RFP-------------DGFDRDAKD 222 (312)
T ss_pred -------------------------------------------------------CCC-------------CcCCHHHHH
Confidence 000 013467899
Q ss_pred HHHhccccCcCCCC---CHHHHHcCCccCCCCC
Q 003438 429 FLKGLVEFDPAKRW---SPFQASRHPFVTGEPF 458 (820)
Q Consensus 429 LI~kmL~~DP~kRp---Ta~EaL~HPff~~~~~ 458 (820)
||.+||..||++|+ ++.|+|+||||.+..+
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 99999999999997 5899999999998643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=373.05 Aligned_cols=203 Identities=24% Similarity=0.433 Sum_probs=175.0
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.|+++++||+|+||+||+|++..+++.||||++++.. .....+.+|+.+|+.+ .|+||+++++++.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-------~h~~iv~l~~~~~~~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-------DNEWVVKLYYSFQDKD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-------CCCCeeeeEEEEecCC
Confidence 5899999999999999999999999999999997532 3345677899999888 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
++||||||+. ++|.+++... ..+++..++.++.||+.||+|||++|||||||||+||||+ ..+.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~---~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID---LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC---CCCCEEEeeCcCCc
Confidence 9999999997 5888888754 3589999999999999999999999999999999999995 67899999999874
Q ss_pred ccCC--------------------------------------------------ccccccccccccCccccccccccccc
Q 003438 265 TEDR--------------------------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAI 294 (820)
Q Consensus 265 ~~~~--------------------------------------------------~~~~~~gt~~Y~APEvl~~~~yt~ks 294 (820)
.... .....+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 2110 01234789999999999998999999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003438 295 DMWSFGCIVAELFLGLPLFPGASEFDLLRR 324 (820)
Q Consensus 295 DIWSLG~ILyeLltG~~PF~~~s~~d~l~~ 324 (820)
||||||||+|||++|.+||...+..+....
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~ 259 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLK 259 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHH
Confidence 999999999999999999987665544433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=363.81 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=208.7
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+|++++.||+|+||.||+|++..+++.||||++++. ....+.+..|+.++..+. .|++|+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~ 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG------KPPFLTQLHSCFQTMD 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC------CCCceeeeEEEEEcCC
Confidence 488999999999999999999999999999999853 234456677888887774 3567999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~ 149 (324)
T cd05587 75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcce
Confidence 9999999997 5888887654 3589999999999999999999999999999999999996 66889999999986
Q ss_pred cc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------- 218 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------- 218 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 42 2233445789999999999999999999999999999999999999988776555544432100
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+| ..
T Consensus 219 --------------------------------------------------------------~~~-------------~~ 223 (324)
T cd05587 219 --------------------------------------------------------------SYP-------------KS 223 (324)
T ss_pred --------------------------------------------------------------CCC-------------CC
Confidence 000 01
Q ss_pred hHHHHHHHHHhccccCcCCCCCH-----HHHHcCCccCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPF 458 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa-----~EaL~HPff~~~~~ 458 (820)
.+..+++||++||..||.+|+++ +++++||||....+
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 224 LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 34678899999999999999986 89999999987543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=368.94 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=201.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
+.||+|+||+||+|++..+++.||||++++.. .......+|+++++.+ .|+||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-------~hp~i~~~~~~~~~~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-------RHPFLTALKYSFQTHDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCCceEEEEEcCCEEEEE
Confidence 36999999999999999999999999998532 2344566788888777 689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecccccccC-
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED- 267 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~- 267 (820)
|||+. ++|.+++... +.+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||++....
T Consensus 74 ~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~---~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC---CCCCEEEecCCCCeecCC
Confidence 99998 5777776544 358999999999999999999997 7999999999999995 67889999999986422
Q ss_pred --CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccc
Q 003438 268 --RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345 (820)
Q Consensus 268 --~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~ 345 (820)
......++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....-
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~--------------- 213 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------------- 213 (325)
T ss_pred CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 223345789999999999998999999999999999999999999987665443333211000
Q ss_pred hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHH
Q 003438 346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA 425 (820)
Q Consensus 346 ~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~ 425 (820)
.+| ..+++.
T Consensus 214 ----------------------------------------------------------~~p-------------~~~~~~ 222 (325)
T cd05594 214 ----------------------------------------------------------RFP-------------RTLSPE 222 (325)
T ss_pred ----------------------------------------------------------CCC-------------CCCCHH
Confidence 000 013467
Q ss_pred HHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 426 LVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 426 l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
+.+||++||+.||++|+ ++.|+|+||||.+..+
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 88999999999999997 9999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.98 Aligned_cols=255 Identities=25% Similarity=0.467 Sum_probs=212.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||+++... .....+.+|+.++..+ .|+||+++++++.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-------DSPWIVKLYYSFQDE 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-------CCCCccchhhheecC
Confidence 47999999999999999999999999999999998532 3345677888888888 589999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~---~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEeecCCCC
Confidence 99999999997 5898888765 4699999999999999999999999999999999999995 6788999999998
Q ss_pred cccCCc--------------------------------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCC
Q 003438 264 CTEDRT--------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 264 ~~~~~~--------------------------------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 654322 234568999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCcc
Q 003438 312 LFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391 (820)
Q Consensus 312 PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~ 391 (820)
||...+..+...++..... ..
T Consensus 229 Pf~~~~~~~~~~~i~~~~~-------------------~~---------------------------------------- 249 (350)
T cd05573 229 PFYSDTLQETYNKIINWKE-------------------SL---------------------------------------- 249 (350)
T ss_pred CCCCCCHHHHHHHHhccCC-------------------cc----------------------------------------
Confidence 9987775554444332110 00
Q ss_pred ccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCC-HHHHHcCCccCCCCC
Q 003438 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS-PFQASRHPFVTGEPF 458 (820)
Q Consensus 392 ~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT-a~EaL~HPff~~~~~ 458 (820)
.+|. ...+++.+.+||.+||. ||.+|++ ++|+|+||||++..+
T Consensus 250 ------------~~p~-----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 250 ------------RFPP-----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred ------------cCCC-----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 0000 00134678999999998 9999999 999999999998655
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=376.04 Aligned_cols=204 Identities=25% Similarity=0.447 Sum_probs=175.5
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+|+++++||+|+||+||+|++..+++.||||++.+.. .....+.+|+.+|+++ .|+||++++++|..++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-------~h~~iv~~~~~~~~~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-------DNEWVVRLYYSFQDKD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-------CCCcCCeEEEEEEeCC
Confidence 6899999999999999999999999999999997532 3345677899999888 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|||||||. ++|.+++... +.+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~---~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEeECCCCc
Confidence 9999999997 5888888654 3589999999999999999999999999999999999995 67899999999974
Q ss_pred ccCC--------------------------------------------------ccccccccccccCccccccccccccc
Q 003438 265 TEDR--------------------------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAI 294 (820)
Q Consensus 265 ~~~~--------------------------------------------------~~~~~~gt~~Y~APEvl~~~~yt~ks 294 (820)
.... .....+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 2100 01124689999999999999999999
Q ss_pred hhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 295 DMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 295 DIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
|||||||+||||++|++||.+.+..+....+
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 260 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999887665544433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=351.77 Aligned_cols=277 Identities=31% Similarity=0.512 Sum_probs=217.2
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++++.||+|++|.||+|++..+++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++..++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 73 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-------QHPNIVCLQDVLMQESR 73 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-------CCCCEeeeEEEEeeCCe
Confidence 488999999999999999999999999999998743 22345677899999998 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhc-CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDSNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~-~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+.++|.+++..... ..+++..++.++.||++||+|||+++|+|+||||+||+++ .++.+||+|||++..
T Consensus 74 ~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~ 150 (285)
T cd07861 74 LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARA 150 (285)
T ss_pred EEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceee
Confidence 999999999999888865432 4589999999999999999999999999999999999995 678899999999864
Q ss_pred cCCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+.+.++ .+.+..+...
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 229 (285)
T cd07861 151 FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG-TPTEDVWPGV 229 (285)
T ss_pred cCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhcc
Confidence 4322 1223568889999998764 578999999999999999999999999888887777777776 3333222211
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+.... + .+....+... ...
T Consensus 230 ~~~~~~~~~~----------------------------------~-----~~~~~~~~~~-----------------~~~ 253 (285)
T cd07861 230 TSLPDYKNTF----------------------------------P-----KWKKGSLRSA-----------------VKN 253 (285)
T ss_pred hhhHHHHhhc----------------------------------c-----ccCcchhHHh-----------------cCC
Confidence 1110000000 0 0000001111 112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+++++++||++||+.||++|||+.|||+||||
T Consensus 254 ~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 254 LDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 45788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=370.60 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=226.5
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
+..-|.+.+.||+|.|++|-+|++..||+.||||+|.+. ......+..|+..|+.+ .|||||+||++...
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-------QHpNiVRLYEViDT 88 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-------QHPNIVRLYEVIDT 88 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-------cCcCeeeeeehhcc
Confidence 346788999999999999999999999999999999864 34456788899999999 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
...+|||+|+-+ |+|+|+|.++. .++.|+.++++++||+.|+.|||+..+|||||||+||.+- .+-+.|||+|||+
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGF 165 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGF 165 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccc
Confidence 999999999997 59999999886 5699999999999999999999999999999999999886 4678999999999
Q ss_pred cc--ccCCccccccccccccCcccccccccc-ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 AC--TEDRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~--~~~~~~~~~~gt~~Y~APEvl~~~~yt-~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+. ..++...+.||+..|-|||++++..|+ +++||||||||||-|++|++||...++.+.+..|+.+.- ..
T Consensus 166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-tv------ 238 (864)
T KOG4717|consen 166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-TV------ 238 (864)
T ss_pred cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-cC------
Confidence 84 456777889999999999999999998 689999999999999999999999998888887765322 00
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.
T Consensus 239 -------------------------------------------------------------------------------P 239 (864)
T KOG4717|consen 239 -------------------------------------------------------------------------------P 239 (864)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...+.+++|||..||+.||++|.|.+||..|+|++...
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 13567899999999999999999999999999998743
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=372.37 Aligned_cols=204 Identities=24% Similarity=0.430 Sum_probs=175.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.+|+++++||+|+||+||+|++..+++.||||++.+.. .....+.+|+++|+++ .|+||+++++.|..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~h~~iv~~~~~~~~~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-------DNEWVVKLYYSFQDK 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-------CCCCcceEEEEEEcC
Confidence 36999999999999999999999999999999997532 2345577899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||+|
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC---CCCCEEEEeCCCC
Confidence 99999999997 6899988764 3589999999999999999999999999999999999995 6788999999997
Q ss_pred cccCC----------------------------------------------ccccccccccccCccccccccccccchhH
Q 003438 264 CTEDR----------------------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMW 297 (820)
Q Consensus 264 ~~~~~----------------------------------------------~~~~~~gt~~Y~APEvl~~~~yt~ksDIW 297 (820)
..... .....+||+.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 42100 01124789999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003438 298 SFGCIVAELFLGLPLFPGASEFDLLRR 324 (820)
Q Consensus 298 SLG~ILyeLltG~~PF~~~s~~d~l~~ 324 (820)
|||||+|||++|+.||.+.+..+....
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~ 255 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLK 255 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHH
Confidence 999999999999999988766554433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=367.18 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=204.5
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||+||+|+++.+++.||||++++. ....+.+..|+.++..+. .|+||+++++++...+.+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~h~~iv~~~~~~~~~~~~~iv 74 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR------NHPFLTQLYCCFQTPDRLFFV 74 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc------CCCchhceeeEEEcCCEEEEE
Confidence 3699999999999999999999999999853 233455667888877663 589999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 75 ~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~---~~~~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 75 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGIFN 149 (320)
T ss_pred EcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeeCCCCeecCcC
Confidence 99998 5888777654 3699999999999999999999999999999999999995 6688999999998643
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------------- 213 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------------- 213 (320)
T ss_pred CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 2223345789999999999998999999999999999999999999988776555444322000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ...+..+
T Consensus 214 ---------------------------------------------------------~~~-------------~~~~~~~ 223 (320)
T cd05590 214 ---------------------------------------------------------VYP-------------TWLSQDA 223 (320)
T ss_pred ---------------------------------------------------------CCC-------------CCCCHHH
Confidence 000 0133678
Q ss_pred HHHHHhccccCcCCCCCH------HHHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRWSP------FQASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRpTa------~EaL~HPff~~~~~ 458 (820)
.+||++||+.||++|+++ +++++||||+...+
T Consensus 224 ~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 224 VDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred HHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999999999998 99999999987554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=375.14 Aligned_cols=282 Identities=25% Similarity=0.427 Sum_probs=214.9
Q ss_pred CceEEEEEeccCCceeEEEeecc--CCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~--~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.+|+++++||+|+||.||+|... .+++.||||++.... ...+|+++|+.| .|+||+++++++.....
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l-------~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTI-------SHRAIINLIHAYRWKST 160 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhc-------CCCCccceeeeEeeCCE
Confidence 68999999999999999999653 456889999987542 345799999998 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+|+|||++.++|.+++... ..+++.+++.++.||+.||.|||++|||||||||+|||++ ..+.+||+|||+++..
T Consensus 161 ~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~---~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 161 VCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLGDFGAACKL 235 (392)
T ss_pred EEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEccCcccccc
Confidence 9999999999999988433 4699999999999999999999999999999999999995 6788999999999654
Q ss_pred CCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCchHHH
Q 003438 267 DRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS---EFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 267 ~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s---~~d~l~~I~~~lG~~Pp~~~l 338 (820)
... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.. ....+..+.+.++..+.+...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 332 224578999999999999899999999999999999999999997653 345666677666633322110
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
.........+.. +.. ...+ . + .+.+++ .
T Consensus 316 ~~~~~~~~~~~~---------------------------~~~--~~~~----~-~---~~~~~~---------------~ 343 (392)
T PHA03207 316 NGSTNLCKHFKQ---------------------------YAI--VLRP----P-Y---TIPPVI---------------R 343 (392)
T ss_pred ccchhHHHHHHh---------------------------hcc--cccC----C-c---cccchh---------------h
Confidence 000000000000 000 0000 0 0 000111 0
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
....+.++.+||++||.+||++|||+.|+|+||||++.+.
T Consensus 344 ~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 344 KYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 1123467889999999999999999999999999998664
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=365.11 Aligned_cols=196 Identities=23% Similarity=0.409 Sum_probs=167.7
Q ss_pred ceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
+|+++++||+|+||+||+|++. .+++.||+|++++. ....+.+.+|+.+|+.++ +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR------QSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc------CCCCcccEEEEE
Confidence 4889999999999999998763 57899999999743 223455678899998884 489999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
...+.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Df 149 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDF 149 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeC
Confidence 99999999999997 5888888654 3599999999999999999999999999999999999996 5678999999
Q ss_pred ccccccCC----ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 261 GSACTEDR----TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 261 GlA~~~~~----~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
|+++.... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 99864321 22345789999999999875 4789999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.61 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=204.8
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||+||+|++..+++.||||++++. ....+.+..|++++..+. .||||++++++|...+.+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~------~hp~i~~~~~~~~~~~~~~lv 74 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA------KHPFLTALHCCFQTKDRLFFV 74 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc------CCCCccceeeEEEcCCeEEEE
Confidence 3699999999999999999999999999853 233445667888877663 689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC--
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED-- 267 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~-- 267 (820)
|||+. ++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 75 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~---~~~~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 75 MEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD---AEGHCKLADFGMCKEGILN 149 (321)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEeecccceecccC
Confidence 99997 5888777654 3589999999999999999999999999999999999995 67889999999986432
Q ss_pred -CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 268 -~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+....-
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------------- 213 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------------- 213 (321)
T ss_pred CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 223345789999999999998999999999999999999999999988776665554432000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ...+.++
T Consensus 214 ---------------------------------------------------------~~p-------------~~~~~~~ 223 (321)
T cd05591 214 ---------------------------------------------------------LYP-------------VWLSKEA 223 (321)
T ss_pred ---------------------------------------------------------CCC-------------CCCCHHH
Confidence 000 0123568
Q ss_pred HHHHHhccccCcCCCC-------CHHHHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRW-------SPFQASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRp-------Ta~EaL~HPff~~~~~ 458 (820)
.+||++||+.||++|+ +++++++||||....+
T Consensus 224 ~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 8999999999999999 9999999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=356.99 Aligned_cols=288 Identities=31% Similarity=0.479 Sum_probs=224.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.++||+|+||.||+|++..+++.||+|+++... .......+|+.+++++ .|+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~ 78 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-------RHPNIVELKEVVVGK 78 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-------CCCCCcceEEEEecC
Confidence 378999999999999999999999999999999997432 2233456799999988 689999999999765
Q ss_pred --ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 185 --RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 185 --~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+.+++||||+.++|.+++.... ..+++.+++.++.||+.||+|||+.||+||||||+||+++ ..+.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~ 154 (309)
T cd07845 79 HLDSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGL 154 (309)
T ss_pred CCCeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccce
Confidence 5689999999999988887643 4689999999999999999999999999999999999995 667899999999
Q ss_pred ccccCCc---cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 263 ACTEDRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 263 A~~~~~~---~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+...... ......+..|+|||++.+ ..++.++|||||||++|||++|++||...+..+.+..+...++ .++..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (309)
T cd07845 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLG-TPNESIW 233 (309)
T ss_pred eeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCChhhc
Confidence 9654322 222345778999999876 4688999999999999999999999999999999999988887 4433332
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
+...... .. ..+.+ .... ...+...
T Consensus 234 ~~~~~~~----------~~----------~~~~~----------------~~~~--~~~~~~~----------------- 258 (309)
T cd07845 234 PGFSDLP----------LV----------GKFTL----------------PKQP--YNNLKHK----------------- 258 (309)
T ss_pred hhhhccc----------cc----------ccccc----------------cCCC--CCchHHh-----------------
Confidence 2211100 00 00000 0000 0000000
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~ 462 (820)
....++.+.|||++||++||++|||++|+|+||||++.+++++.
T Consensus 259 ~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~ 302 (309)
T cd07845 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEP 302 (309)
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCC
Confidence 01135678999999999999999999999999999998877653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=367.85 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=209.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+++.+ .|+||+++++++...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-------~~~~i~~~~~~~~~~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-------NSPWIPQLQYAFQDK 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCCcceeeEEecC
Confidence 46999999999999999999999999999999998542 2345567788888776 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~---~~~~~kL~Dfg~a 149 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID---RTGHIKLADFGSA 149 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC---CCCCEEeccCCCC
Confidence 99999999996 68988887653 4699999999999999999999999999999999999995 6789999999999
Q ss_pred cccCCc----cccccccccccCccccc------cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLL------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~------~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
...... .....+|+.|+|||++. ...++.++|||||||++|||++|+.||...+....+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~--- 226 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR--- 226 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC---
Confidence 654322 12346899999999987 44678999999999999999999999987766554444332100
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
. ..+|
T Consensus 227 -----------------~---------------------------------------------------~~~~------- 231 (330)
T cd05601 227 -----------------F---------------------------------------------------LKFP------- 231 (330)
T ss_pred -----------------c---------------------------------------------------cCCC-------
Confidence 0 0000
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
....++..+.+||++||. ||++|+|++++++||||+...+
T Consensus 232 ----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 232 ----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred ----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 001134678999999998 9999999999999999997554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=372.44 Aligned_cols=255 Identities=22% Similarity=0.377 Sum_probs=210.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||++++.. .....+.+|+.+++.+ +|+||+++++++...
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-------~h~~iv~~~~~~~~~ 115 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-------NSEWIVQLHYAFQDD 115 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-------CCCCcceEEEEEecC
Confidence 78999999999999999999999999999999997432 2334466788888887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++... .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~---~~~~~kL~DfG~~ 189 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc---CCCCEEEEeccce
Confidence 99999999997 5888887653 489999999999999999999999999999999999995 6789999999999
Q ss_pred cccCCc----cccccccccccCccccccc----cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLLGY----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~~~----~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
...... ....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+....+..+..... ..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~~-- 266 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-SL-- 266 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-cC--
Confidence 654322 2345789999999998754 478999999999999999999999988776555444432100 00
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
.+|
T Consensus 267 --------------------------------------------------------------------~~~--------- 269 (370)
T cd05596 267 --------------------------------------------------------------------TFP--------- 269 (370)
T ss_pred --------------------------------------------------------------------CCC---------
Confidence 000
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCC--CCCHHHHHcCCccCCCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAK--RWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~k--RpTa~EaL~HPff~~~~~ 458 (820)
....++..+.+||++||..+|++ |+|++|+|+||||++..+
T Consensus 270 --~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 270 --DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred --CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 00114567899999999999998 999999999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.33 Aligned_cols=205 Identities=24% Similarity=0.416 Sum_probs=176.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||.||+|++..+++.||+|++++. ......+.+|+.+++.+ +||||+++++++..+
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-------~hp~iv~~~~~~~~~ 115 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-------NSPWVVQLFCAFQDD 115 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence 7899999999999999999999999999999999742 22334566788888887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+|||||. ++|.+++... .+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~---~~~~~kL~DFG~a 189 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD---KHGHLKLADFGTC 189 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEEecccc
Confidence 99999999997 6899888654 489999999999999999999999999999999999995 6789999999999
Q ss_pred cccCCc----cccccccccccCcccccccc----ccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~~~~----yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~ 326 (820)
...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+..+.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 754322 23457999999999997643 7889999999999999999999998877655554443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=362.14 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=208.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+|+++++||+|+||+||+|++..+++.||||++++.. ...+....|..++..+. .|++|+++++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~ 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG------KPPFLTQLHSCFQTMD 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc------CCCeEeeEEEEEecCC
Confidence 4889999999999999999999999999999998532 22344566777776653 5789999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+||||||+. ++|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kL~DfG~~~ 149 (323)
T cd05616 75 RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC---CCCcEEEccCCCce
Confidence 9999999997 5888877654 3589999999999999999999999999999999999995 67889999999986
Q ss_pred ccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 218 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----------- 218 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 432 223345789999999999999999999999999999999999999988776655554432100
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+| ..
T Consensus 219 --------------------------------------------------------------~~p-------------~~ 223 (323)
T cd05616 219 --------------------------------------------------------------AYP-------------KS 223 (323)
T ss_pred --------------------------------------------------------------CCC-------------Cc
Confidence 000 01
Q ss_pred hHHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
.+..+.+||.+||+.||++|++ ..++++||||+...+
T Consensus 224 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 224 MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 3467889999999999999998 489999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=359.76 Aligned_cols=200 Identities=31% Similarity=0.485 Sum_probs=176.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||.||++++..++..||+|+++.. ....+.+.+|+++|+++ +|+||+++++++..++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 77 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE 77 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-------CCCCCCeEEEEEEECCE
Confidence 7999999999999999999999999999999999753 34456788999999998 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~ 152 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSG 152 (331)
T ss_pred EEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCcccc
Confidence 999999998 5888888754 3589999999999999999999985 699999999999996 66789999999986
Q ss_pred ccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 265 TEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 265 ~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
.... ......+++.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 153 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred cccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5432 2334578999999999999899999999999999999999999998766544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=355.47 Aligned_cols=284 Identities=27% Similarity=0.469 Sum_probs=206.2
Q ss_pred EEEeccCCceeEEEeeccC--CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--cceeEE
Q 003438 114 KDLLGHGTFGQVAKCWDAE--MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCI 189 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~--tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~~~l~L 189 (820)
..+||+|+||+||+|+++. +++.||+|.++.... ...+.+|+++|+++ .|+||+++++++.. +..+|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLREL-------KHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhC-------CCCCeeeEEEEEeccCCCeEEE
Confidence 3589999999999998653 668899999975432 34567899999998 68999999999864 467899
Q ss_pred EEeccCCChHHHHHhhh-------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc-cCCCeEEEeecc
Q 003438 190 CFELLDSNLYELIKINH-------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFG 261 (820)
Q Consensus 190 VmEy~~gsL~d~l~~~~-------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~iKL~DFG 261 (820)
||||++++|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+|||+..+ ...+.+||+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 78 LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99999999998876432 1248899999999999999999999999999999999999532 356789999999
Q ss_pred cccccCCc------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q 003438 262 SACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLLRRM 325 (820)
Q Consensus 262 lA~~~~~~------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~---------~d~l~~I 325 (820)
+++..... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||....+ .+.+..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 99754322 2234678999999999774 589999999999999999999999975432 3455666
Q ss_pred HHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcC
Q 003438 326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405 (820)
Q Consensus 326 ~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~ 405 (820)
...++ .+....++..+....+....... ....+....+...+...
T Consensus 238 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~ 282 (317)
T cd07867 238 FSVMG-FPADKDWEDIRKMPEYPTLQKDF----------------------------------RRTTYANSSLIKYMEKH 282 (317)
T ss_pred HHhcC-CCChhhhhhhhhcccchhhhhhh----------------------------------cccccCCchhhhhhhcc
Confidence 66666 33333333222211111100000 00000001111111100
Q ss_pred CCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 406 P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
....+..+++||.+||+.||++|||++|||+||||
T Consensus 283 -------------~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 283 -------------KVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred -------------cCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 01134568999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.79 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=222.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|++.+.||+|-||.||+|+.++++-.||+|++.+.. ....++.+|++|-..| .||||+++|++|.+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-------~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-------RHPNILRLYGYFHD 93 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-------CCccHHhhhhheec
Confidence 378999999999999999999999999999999998643 3345677788888777 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
...+||++||.. |.|+..+.....+.+++.....+++|++.||.|||.++||||||||+|+|++ ..+.+||+|||.
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGw 170 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGW 170 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCc
Confidence 999999999997 7999999977777899999999999999999999999999999999999996 778899999999
Q ss_pred cccc-CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 263 ACTE-DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 263 A~~~-~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
+... .....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||...+..+..++|.+.--.
T Consensus 171 sV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~---------- 240 (281)
T KOG0580|consen 171 SVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK---------- 240 (281)
T ss_pred eeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc----------
Confidence 8655 45567789999999999999999999999999999999999999999988877777777653210
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
+| ..
T Consensus 241 ---------------------------------------------------------------~p-------------~~ 244 (281)
T KOG0580|consen 241 ---------------------------------------------------------------FP-------------ST 244 (281)
T ss_pred ---------------------------------------------------------------CC-------------cc
Confidence 00 12
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
++..+.|||.+||..+|.+|++..|+++|||+...
T Consensus 245 is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 245 ISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred cChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 45678999999999999999999999999999753
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=366.27 Aligned_cols=205 Identities=25% Similarity=0.480 Sum_probs=176.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++++.||+|+||+||+|+++.+++.||||+++.. ......+.+|+.++..+ +|+||+++++.+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~iv~~~~~~~~~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-------DGAWVVKMFYSFQDK 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence 3689999999999999999999999999999999743 23345667788888887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++|||||||. ++|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~---~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD---AKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC---CCCCEEEeeccCC
Confidence 99999999997 5888888654 3589999999999999999999999999999999999995 6789999999998
Q ss_pred cccCCc--------------------------------------cccccccccccCccccccccccccchhHhHHHHHHH
Q 003438 264 CTEDRT--------------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAE 305 (820)
Q Consensus 264 ~~~~~~--------------------------------------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILye 305 (820)
...... ....+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 533210 123478999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH
Q 003438 306 LFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 306 LltG~~PF~~~s~~d~l~~I 325 (820)
|++|++||...+..+....+
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i 248 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKV 248 (360)
T ss_pred cccCCCCCCCCCHHHHHHHH
Confidence 99999999877765554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.07 Aligned_cols=252 Identities=33% Similarity=0.501 Sum_probs=208.9
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHH---HHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ---QALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~---~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
|+++++||+|+||+||++++..+++.||+|++........ ...+|+.+++++ .|+||+++++++......
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~ 73 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-------RHPNIVQILDVFQDDNYL 73 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-------TBTTBCHEEEEEEESSEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-------cccccccccccccccccc
Confidence 8899999999999999999999999999999997643333 234589999999 589999999999999999
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc-
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT- 265 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~- 265 (820)
++|||++.+ +|.+++... ..+++..++.++.||++||.+||+++|+|+||||+||+++ .++.++|+|||.+..
T Consensus 74 ~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~---~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 74 YIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD---ENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES---TTSEEEESSGTTTEES
T ss_pred ccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccc
Confidence 999999997 899998833 4689999999999999999999999999999999999995 778999999999964
Q ss_pred --cCCccccccccccccCccccc-cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 --EDRTVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 --~~~~~~~~~gt~~Y~APEvl~-~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.........++..|+|||++. +..++.++|||||||++|+|++|..||......+....+.+......+.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------- 221 (260)
T PF00069_consen 149 SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS------- 221 (260)
T ss_dssp TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc-------
Confidence 233445567899999999998 7789999999999999999999999998775444444444332200000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
. .......
T Consensus 222 -------------------------------------------------------------~-----------~~~~~~~ 229 (260)
T PF00069_consen 222 -------------------------------------------------------------S-----------SQQSREK 229 (260)
T ss_dssp -------------------------------------------------------------H-----------TTSHTTS
T ss_pred -------------------------------------------------------------c-----------ccccchh
Confidence 0 0000012
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
...+.+||++||..||++|||+.|+++||||
T Consensus 230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 230 SEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 3678999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=353.67 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=209.9
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.|++.++||+|+||+||++.+..+++.||||++.... .....+.+|+.+++.+ +|+||+++++++..++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-------NSRFVVSLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-------CCCCEeeeeeeecCCC
Confidence 4889999999999999999999999999999997532 2234467799999988 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+. ++|.+.+.......+++..++.++.||+.||.|||+.+|+||||||+||+++ +.+.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~Dfg~~~ 150 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLGLAV 150 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC---CCCCEEEeeCCCce
Confidence 9999999997 5787777654445699999999999999999999999999999999999995 66889999999986
Q ss_pred ccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....+++..|+|||++.+..++.++|||||||++|||++|..||.+.........+...+...++
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 222 (285)
T cd05605 151 EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE-------- 222 (285)
T ss_pred ecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc--------
Confidence 5432 223357899999999999889999999999999999999999999876544333332221110000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.+ ....
T Consensus 223 -------------------------------------------------------------~~-------------~~~~ 228 (285)
T cd05605 223 -------------------------------------------------------------EY-------------SEKF 228 (285)
T ss_pred -------------------------------------------------------------cc-------------Cccc
Confidence 00 0113
Q ss_pred HHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFT 459 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~ 459 (820)
+..+.+||.+||..||++|+ +++++++||||....+.
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 229 SEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 46789999999999999999 99999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=359.40 Aligned_cols=246 Identities=29% Similarity=0.488 Sum_probs=200.2
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||+||+|++..+++.||||+++... ...+....|..++..+. .|+||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~hp~i~~~~~~~~~~~~~~lv 74 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW------EHPFLTHLFCTFQTKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhcc------CCCCccceeeEEEcCCEEEEE
Confidence 36999999999999999999999999998532 23344555666665442 699999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC--
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED-- 267 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~-- 267 (820)
|||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 75 ~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 75 MEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNG 149 (316)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC---CCCCEEEccCcCCeECCCC
Confidence 99997 5888777654 3699999999999999999999999999999999999995 66889999999986432
Q ss_pred -CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 268 -RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 268 -~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 213 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP---------------- 213 (316)
T ss_pred CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 223345789999999999998999999999999999999999999988776554443321000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ..++..+
T Consensus 214 ---------------------------------------------------------~~~-------------~~~~~~~ 223 (316)
T cd05592 214 ---------------------------------------------------------HFP-------------RWISKEA 223 (316)
T ss_pred ---------------------------------------------------------CCC-------------CCCCHHH
Confidence 000 0123567
Q ss_pred HHHHHhccccCcCCCCCH-HHHHcCCccCCCC
Q 003438 427 VDFLKGLVEFDPAKRWSP-FQASRHPFVTGEP 457 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRpTa-~EaL~HPff~~~~ 457 (820)
.+||++||+.||++|+++ .++++||||....
T Consensus 224 ~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 224 KDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 899999999999999986 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=350.54 Aligned_cols=276 Identities=32% Similarity=0.538 Sum_probs=215.1
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.++||+|+||.||+|++..+++.||+|+++... .....+.+|+++++.+ +|+||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~i~~~~~~~~~~~~ 73 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-------KHKNIVRLYDVLHSDKK 73 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-------CCCCeeeHHHHhccCCc
Confidence 5899999999999999999999999999999997432 2234567899999998 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+|+|+||++++|.+++.... ..+++..++.++.||++||.|||+++|+||||||+||+++ ..+.+||+|||++...
T Consensus 74 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~ 149 (284)
T cd07839 74 LTLVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAF 149 (284)
T ss_pred eEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhcc
Confidence 99999999999998876543 4599999999999999999999999999999999999996 5688999999998654
Q ss_pred CCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPL-FPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~P-F~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... .....++..|+|||++.+. .++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++ .++...+...
T Consensus 150 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (284)
T cd07839 150 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEESWPGV 228 (284)
T ss_pred CCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC-CCChHHhHHh
Confidence 322 2234568899999998775 478999999999999999998766 566677777888877777 3333322211
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+ .... .+.....+.+.. ..
T Consensus 229 ~~~~~~-~~~~--------------------------------------~~~~~~~~~~~~-----------------~~ 252 (284)
T cd07839 229 SKLPDY-KPYP--------------------------------------MYPATTSLVNVV-----------------PK 252 (284)
T ss_pred hhcccc-cccC--------------------------------------CCCCcchhhhhc-----------------cc
Confidence 110000 0000 000000011111 12
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.++.+.+||++||..||.+|||++|+|+||||
T Consensus 253 ~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 253 LNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 45788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=360.20 Aligned_cols=247 Identities=29% Similarity=0.484 Sum_probs=201.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||.||+|+++.+++.||||+++... ...+....|..++..+. +|+||+++++++..++++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~~~~lv 74 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW------ENPFLTHLYCTFQTKEHLFFV 74 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc------CCCCccCeeEEEEeCCEEEEE
Confidence 46999999999999999999999999998532 23345566777766542 689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 75 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKENVFG 149 (316)
T ss_pred ECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEeCccCCCeecccC
Confidence 99997 5888877654 3589999999999999999999999999999999999995 6678999999998642
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~---------------- 213 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP---------------- 213 (316)
T ss_pred CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence 2233456789999999999999999999999999999999999999987765544433321000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ...+..+
T Consensus 214 ---------------------------------------------------------~~~-------------~~~~~~~ 223 (316)
T cd05620 214 ---------------------------------------------------------HYP-------------RWITKES 223 (316)
T ss_pred ---------------------------------------------------------CCC-------------CCCCHHH
Confidence 000 0123568
Q ss_pred HHHHHhccccCcCCCCCH-HHHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRWSP-FQASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRpTa-~EaL~HPff~~~~~ 458 (820)
.+||++||+.||++|+|+ +++++||||+...+
T Consensus 224 ~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 224 KDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred HHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 899999999999999998 58899999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.90 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=219.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
+.+|++.+.||+|+||.|-+|.+...++.||||.|+++ +.+.-.+.+||+||..| +||||+.+|++|+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-------NHPhII~IyEVFEN 124 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-------NHPHIIQIYEVFEN 124 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-------CCCceeehhhhhcC
Confidence 47999999999999999999999999999999999864 45556688999999999 79999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
++.++|||||.. |.|+|++.... .|+|.+++.|++||..|+.|||++++||||||.+|||++ .++.+||+|||+
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD---~N~NiKIADFGL 199 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD---QNNNIKIADFGL 199 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec---CCCCeeeeccch
Confidence 999999999997 79999998764 699999999999999999999999999999999999995 788999999999
Q ss_pred cccc--CCccccccccccccCcccccccccc-ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTE--DRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~--~~~~~~~~gt~~Y~APEvl~~~~yt-~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+... .....++||++.|.+||++.+.+|. +.+|.|||||+||.|+.|..||.+.+...++.+|.+..-
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY--------- 270 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY--------- 270 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc---------
Confidence 9543 3445688999999999999999986 789999999999999999999999988777776644111
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
+..
T Consensus 271 -----------------------------------------------------rEP------------------------ 273 (668)
T KOG0611|consen 271 -----------------------------------------------------REP------------------------ 273 (668)
T ss_pred -----------------------------------------------------cCC------------------------
Confidence 000
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
..+..+.-||+.||..||++|.|++++..|-|+.=
T Consensus 274 -~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 274 -ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred -CCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 01235678999999999999999999999999864
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=365.78 Aligned_cols=191 Identities=26% Similarity=0.393 Sum_probs=167.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
.+|++++.||+|+||.||+|++..+++.||+|+.... ....|+.+|+++ .|+||+++++++......|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-------NHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-------CCCCCcChhheEEeCCeeE
Confidence 5799999999999999999999999999999986543 234688899888 6899999999999999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
+|||++.++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+|||++ ..+.+||+|||++.....
T Consensus 134 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN---DVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEecCcccccccc
Confidence 999999999999887643 4699999999999999999999999999999999999995 677899999999964322
Q ss_pred --ccccccccccccCccccccccccccchhHhHHHHHHHHHhC-CCCCCC
Q 003438 269 --TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPG 315 (820)
Q Consensus 269 --~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~PF~~ 315 (820)
......+|+.|+|||++.+..++.++|||||||++|||+++ .++|..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 23345789999999999999999999999999999999985 455543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=359.07 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=203.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||+||+|++..+++.||||++++. ........+|+.+++.+. .|+||+++++++...+.+|+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~------~h~~i~~~~~~~~~~~~~~lv 74 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------KHPFLTQLHSCFQTKDRLFFV 74 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc------CCCCccceeeEEEcCCEEEEE
Confidence 3699999999999999999999999999853 233455677888887763 589999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+.+... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 75 MEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILG 149 (318)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC---CCCcEEecccCCCeecCcC
Confidence 99997 5787777654 3699999999999999999999999999999999999995 6788999999998542
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
.......++++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---------------- 213 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---------------- 213 (318)
T ss_pred CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 2223345789999999999999999999999999999999999999987765544333221000
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ..++..+
T Consensus 214 ---------------------------------------------------------~~~-------------~~~~~~~ 223 (318)
T cd05570 214 ---------------------------------------------------------RYP-------------RWLSKEA 223 (318)
T ss_pred ---------------------------------------------------------CCC-------------CcCCHHH
Confidence 000 0133678
Q ss_pred HHHHHhccccCcCCCCCH-----HHHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRpTa-----~EaL~HPff~~~~~ 458 (820)
.+||++||+.||++|||+ .++++||||+...+
T Consensus 224 ~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 224 KSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999999999 99999999988543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=358.96 Aligned_cols=290 Identities=30% Similarity=0.540 Sum_probs=223.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++++.||+|+||+||+|++..+++.||||++.+. ......+.+|+.+++.+ .|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~ 87 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-------NHKNIIGLLNVFTPQ 87 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-------CCCCCcceeeeeccC
Confidence 38999999999999999999999999999999998642 33445677899999988 689999999998754
Q ss_pred ------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
...|+||||+.++|.+.+... +++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~---~~~~~kL~ 160 (353)
T cd07850 88 KSLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKIL 160 (353)
T ss_pred CCccccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEc
Confidence 357999999999998887542 89999999999999999999999999999999999995 66789999
Q ss_pred ecccccccCCcc--ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 259 DFGSACTEDRTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 259 DFGlA~~~~~~~--~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+.+..+.+.++ .|+..
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 239 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG-TPSDE 239 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC-CCCHH
Confidence 999997654332 234678899999999999999999999999999999999999999988888999988888 44444
Q ss_pred HHHhhhcc-chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 337 VLKEAKNT-SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 337 ~l~~~~~~-~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
+....... ..+..... .+....+.+++....+....
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~~~~---- 276 (353)
T cd07850 240 FMSRLQPTVRNYVENRP---------------------------------------KYAGYSFEELFPDVLFPPDS---- 276 (353)
T ss_pred HHHHhhhhhhHHhhcCC---------------------------------------CCCCcchhhhCcccccCccc----
Confidence 43332211 11111000 00001111111110000000
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.......+..+++||.+||++||++|||+.|+|+||||+.
T Consensus 277 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 277 ESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred ccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0001224567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.17 Aligned_cols=278 Identities=33% Similarity=0.573 Sum_probs=220.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.+ .|+||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~ 73 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-------QHPYVVKLLDVFPHGSG 73 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-------CCCCCcceeeEEecCCe
Confidence 589999999999999999999999999999999753 23456788899999988 58999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+++||||++++|.+++.... ..+++.+++.++.||+++|+|||+.+|+|+||||+||+++ ..+.++|+|||++...
T Consensus 74 ~~~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 74 FVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLF 149 (286)
T ss_pred eEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccc
Confidence 99999999779999887654 5699999999999999999999999999999999999996 5788999999998754
Q ss_pred CCc----cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 267 DRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 267 ~~~----~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... .....++..|+|||++.+. .++.++|||||||++|+|++|.++|.+..+.+.+..+...++ .+....+...
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (286)
T cd07832 150 SEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG-TPNEETWPGL 228 (286)
T ss_pred cCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcC-CCChHHHhhc
Confidence 432 2345678899999998765 568999999999999999999999999888888888888777 3333322221
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+-. .. . + .-....+.++. ..
T Consensus 229 ~~~~~~~~-~~-----------~---------------------~-----~~~~~~~~~~~-----------------~~ 253 (286)
T cd07832 229 TSLPDYNK-IT-----------F---------------------P-----ESKPIPLEEIF-----------------PD 253 (286)
T ss_pred cCcchhhc-cc-----------C---------------------C-----CCCcchHHHhC-----------------CC
Confidence 11100000 00 0 0 00000111111 12
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~ 454 (820)
.+..+++||++||..||++|||++|+|+||||.
T Consensus 254 ~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 254 ASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 347889999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=358.32 Aligned_cols=246 Identities=23% Similarity=0.442 Sum_probs=198.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHH-HHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSI-LTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~i-L~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
++||+|+||+||+|++..+++.||||++.... .....+..|..+ ++.+ .||||+++++++...+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-------~hp~iv~~~~~~~~~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-------KHPFLVGLHYSFQTADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-------CCCCCCCeeEEEEeCCEEEE
Confidence 36999999999999999999999999997532 122334444443 3444 79999999999999999999
Q ss_pred EEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc--
Q 003438 190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE-- 266 (820)
Q Consensus 190 VmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~-- 266 (820)
||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 74 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~---~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC---CCCcEEEeccCCCccccc
Confidence 999997 5888877654 3689999999999999999999999999999999999995 6788999999998643
Q ss_pred -CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccc
Q 003438 267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345 (820)
Q Consensus 267 -~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~ 345 (820)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+....-
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------- 213 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--------------- 213 (323)
T ss_pred CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2223345789999999999999999999999999999999999999987765554443322000
Q ss_pred hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHH
Q 003438 346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA 425 (820)
Q Consensus 346 ~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~ 425 (820)
... ...+..
T Consensus 214 ------------------------------------------------------------~~~-----------~~~~~~ 222 (323)
T cd05575 214 ------------------------------------------------------------RLK-----------PNISVS 222 (323)
T ss_pred ------------------------------------------------------------CCC-----------CCCCHH
Confidence 000 012367
Q ss_pred HHHHHHhccccCcCCCCCH----HHHHcCCccCCCCC
Q 003438 426 LVDFLKGLVEFDPAKRWSP----FQASRHPFVTGEPF 458 (820)
Q Consensus 426 l~DLI~kmL~~DP~kRpTa----~EaL~HPff~~~~~ 458 (820)
+.+||++||+.||++|+++ .|+++||||....+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 8999999999999999998 69999999987554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.66 Aligned_cols=281 Identities=31% Similarity=0.547 Sum_probs=220.6
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh------hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
+|++.++||+|+||.||+|.+..+++.||||+++.... ....+..|+++++.+ .|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~ 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-------KHPNIIGLLDVFGH 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-------CCCCChhhhheeec
Confidence 58899999999999999999999999999999985422 234566788888888 68999999999999
Q ss_pred cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 184 ~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.+.+++||||+.++|.+++.... ..+++..++.++.||++||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~ 149 (298)
T cd07841 74 KSNINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLA 149 (298)
T ss_pred CCEEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceee
Confidence 99999999999889999887643 3699999999999999999999999999999999999996 5788999999999
Q ss_pred cccCCc---cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 264 CTEDRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 264 ~~~~~~---~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.++|.+.+..+.+.++.+.++ .+....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (298)
T cd07841 150 RSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG-TPTEENWP 228 (298)
T ss_pred eeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcC-CCchhhhh
Confidence 754332 223356788999999865 3678999999999999999999999998888888888777766 33333222
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.......+.... ......+..+.
T Consensus 229 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~----------------- 251 (298)
T cd07841 229 GVTSLPDYVEFK----------------------------------------PFPPTPLKQIF----------------- 251 (298)
T ss_pred hccccccccccc----------------------------------------ccCCcchhhhc-----------------
Confidence 111110000000 00000111111
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
...+..+++||.+||.+||++|||++|+|+||||++.+..
T Consensus 252 ~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 252 PAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred ccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 1235778999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.87 Aligned_cols=277 Identities=31% Similarity=0.575 Sum_probs=219.7
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.|++++.||.|+||.||+|++..+++.||||+++.+. .....+.+|+++++++ +|+||+++++++...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~ 73 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-------NHPNIVKLLDVIHTENK 73 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-------CCCCCcchhhhcccCCc
Confidence 4889999999999999999999999999999987432 2335678899999998 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
.++||||+.++|.+++.......+++..++.++.||+.||+|||+.+|+|+||||+||+++ .++.+||+|||++...
T Consensus 74 ~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~---~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 74 LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF 150 (284)
T ss_pred EEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEeeccchhhc
Confidence 9999999998998888766556689999999999999999999999999999999999996 6678999999998654
Q ss_pred CCc---cccccccccccCcccccccc-ccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~~-yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
... .....++..|+|||++.+.. ++.++|||||||++|+|+||+.||...++.+.+.++.+..+ .++..++....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (284)
T cd07860 151 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVWPGVT 229 (284)
T ss_pred ccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC-CCChhhhhhhh
Confidence 322 22335678899999987654 68899999999999999999999999888888888888777 44443332211
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
....+-... + .+....+..+.. ..
T Consensus 230 ~~~~~~~~~----------------------------------~-----~~~~~~~~~~~~-----------------~~ 253 (284)
T cd07860 230 SLPDYKPSF----------------------------------P-----KWARQDFSKVVP-----------------PL 253 (284)
T ss_pred HHHHHHhhc----------------------------------c-----cccccCHHHHcc-----------------cC
Confidence 110000000 0 000111111111 13
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+..+++||.+||+.||++|||++|+|+||||
T Consensus 254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 4678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.46 Aligned_cols=190 Identities=24% Similarity=0.415 Sum_probs=165.8
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||.||+|++..+++.||||++++. ......+.+|+.+++.+. +||||++++++|...+.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~------~hp~Iv~~~~~~~~~~~~~lv 74 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS------NHPFLVGLHSCFQTESRLFFV 74 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc------CCCCCCceEEEEEcCCEEEEE
Confidence 3689999999999999999999999999853 233455677888888774 589999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++...
T Consensus 75 ~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 75 IEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGMCKEGIRP 149 (329)
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEECcCccccccccC
Confidence 99997 5887777654 4699999999999999999999999999999999999995 6688999999998642
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2233456789999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=357.34 Aligned_cols=247 Identities=29% Similarity=0.501 Sum_probs=202.1
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
+.||+|+||+||+|++..+++.||||+++... ........|..++..+. .||||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~hp~iv~~~~~~~~~~~~~lv 74 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EHPFLTHLYCTFQTKENLFFV 74 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc------CCCcCcceEEEEEeCCEEEEE
Confidence 36999999999999999999999999998542 23345566777776542 699999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 75 ~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 75 MEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLG 149 (316)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCC
Confidence 99997 5888888654 3589999999999999999999999999999999999996 6678999999998642
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
........||..|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+... . +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~--~------------- 213 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-N--P------------- 213 (316)
T ss_pred CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C--C-------------
Confidence 22234457899999999999989999999999999999999999999877655444333210 0 0
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
.+| ...+..+
T Consensus 214 ---------------------------------------------------------~~~-------------~~~~~~~ 223 (316)
T cd05619 214 ---------------------------------------------------------CYP-------------RWLTREA 223 (316)
T ss_pred ---------------------------------------------------------CCC-------------ccCCHHH
Confidence 000 0123567
Q ss_pred HHHHHhccccCcCCCCCHH-HHHcCCccCCCCC
Q 003438 427 VDFLKGLVEFDPAKRWSPF-QASRHPFVTGEPF 458 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRpTa~-EaL~HPff~~~~~ 458 (820)
.+||.+||+.||++|+++. ++++||||++..+
T Consensus 224 ~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 224 KDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred HHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 8999999999999999996 9999999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=362.63 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=199.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.+|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+++|+.+ .|+||+++++++...+.
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-------NHPNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-------CCCCcceeeeEeccCCe
Confidence 6788999999999999999999999999999999743 34456788999999988 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+++||||+.+ +|.+. ..+.+..++.++.||+.||+|||+++||||||||+|||++ .++.+||+|||++..
T Consensus 147 ~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRI 217 (353)
T ss_pred EEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccccccee
Confidence 9999999985 55331 2367788899999999999999999999999999999996 668899999999975
Q ss_pred cCCc---cccccccccccCccccccc-----cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
.... .....||..|+|||++... ..+.++|||||||++|||++|+.||......+....+.......+
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 293 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP---- 293 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC----
Confidence 4332 2345789999999998532 345689999999999999999999974322211111111000000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+ .
T Consensus 294 ------------------------------------------------~------------------------------~ 295 (353)
T PLN00034 294 ------------------------------------------------P------------------------------E 295 (353)
T ss_pred ------------------------------------------------C------------------------------C
Confidence 0 0
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.....+.++++||.+||..||++|||++|+|+||||.+...
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 00113467899999999999999999999999999998643
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.51 Aligned_cols=280 Identities=32% Similarity=0.536 Sum_probs=217.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+. +|+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS------ESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc------CCCCccceeeeEeecC
Confidence 46999999999999999999999999999999987432 23356778999999984 4799999999998776
Q ss_pred e-----eEEEEeccCCChHHHHHhhhc---CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 186 H-----LCICFELLDSNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 186 ~-----l~LVmEy~~gsL~d~l~~~~~---~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
. .|+||||+.++|.+++..... ..+++..++.++.||++||.|||+++|+||||||+||+++ ...+.+||
T Consensus 75 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl 152 (295)
T cd07837 75 KNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKI 152 (295)
T ss_pred CCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEE
Confidence 5 899999999999988865432 3589999999999999999999999999999999999996 23688999
Q ss_pred eecccccccCCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 258 IDFGSACTEDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 258 ~DFGlA~~~~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
+|||++...... .....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.++.+.+..+.+.++ .+
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~ 231 (295)
T cd07837 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TP 231 (295)
T ss_pred eecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CC
Confidence 999998644322 1223567889999998754 678999999999999999999999999888888888877666 34
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
+...+........+... ..+....+...
T Consensus 232 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~------------ 259 (295)
T cd07837 232 TEQVWPGVSKLRDWHEF----------------------------------------PQWKPQDLSRA------------ 259 (295)
T ss_pred ChhhCcchhhccchhhc----------------------------------------CcccchhHHHh------------
Confidence 33322211111000000 00000001111
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~ 454 (820)
....+..+.+||.+||.+||.+|||++|+|.||||+
T Consensus 260 -----~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 260 -----VPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred -----ccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 112457789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.52 Aligned_cols=206 Identities=23% Similarity=0.365 Sum_probs=174.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++++.||+|+||+||++++..+++.||||++.+. ....+.+.+|+.+++.+ +|+||++++++|...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-------DRRWITNLHYAFQDE 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-------CCCCCCceEEEEecC
Confidence 4799999999999999999999999999999999742 22344567788888776 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~ 149 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD---KNGHIRLADFGSC 149 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC---CCCCEEEEECCce
Confidence 99999999996 68988886543 4589999999999999999999999999999999999995 6788999999998
Q ss_pred cccCCc----cccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
...... ....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 654321 122468999999999973 35788999999999999999999999876655544443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=357.45 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=201.8
Q ss_pred EEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 115 DLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++||+|+||.||+|++. .+++.||||++++.. .....+.+|+.+|+.+ .||||++++++|..++.
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-------KHPFIVDLIYAFQTGGK 74 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-------CCCchhceeeEEecCCe
Confidence 68999999999999863 578899999998532 2334567899999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+. ++|.+.+... +.+.+..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 75 LYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEeeCcCCee
Confidence 999999998 4888887654 3588999999999999999999999999999999999995 678999999999864
Q ss_pred cC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 ED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.. .......+++.|+|||++.+..++.++|||||||++|||++|+.||...+....+..+.....
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~------------ 217 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL------------ 217 (323)
T ss_pred cccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 22 222345789999999999998899999999999999999999999987665544433322000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.+| ...
T Consensus 218 -------------------------------------------------------------~~~-------------~~~ 223 (323)
T cd05584 218 -------------------------------------------------------------NLP-------------PYL 223 (323)
T ss_pred -------------------------------------------------------------CCC-------------CCC
Confidence 000 013
Q ss_pred HHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
++.+.+||++||+.||++|+ +++++++||||....+
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 46788999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=371.58 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=212.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
..|+.+++||+|.||.||+|.+..+++.||||++..+ +...+.+..|+.+|.++ .++||.++|+.|..+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-------~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-------DSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-------CcchHHhhhhheeeccc
Confidence 6788889999999999999999999999999999854 35567788899999999 57899999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++|+||||. |++.++++... .+.|..+..++++++.||.|||.++.+|||||+.|||+. ..+.+||+|||.+..
T Consensus 86 LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeee
Confidence 999999998 58888887654 358999999999999999999999999999999999996 558999999999965
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... ..+++||++||||||+.+..|+.|+||||||++++||++|.+|+.......++..|-
T Consensus 161 l~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---------------- 224 (467)
T KOG0201|consen 161 LTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---------------- 224 (467)
T ss_pred eechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc----------------
Confidence 5432 367899999999999998899999999999999999999999997654311111110
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
++.|. . .+..+
T Consensus 225 ------------------------------------------------------------k~~PP--~-------L~~~~ 235 (467)
T KOG0201|consen 225 ------------------------------------------------------------KSAPP--R-------LDGDF 235 (467)
T ss_pred ------------------------------------------------------------CCCCC--c-------ccccc
Confidence 00110 0 11136
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
++.|++||..||+.||+.||||.++|+|+|++.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 788999999999999999999999999999997
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=355.38 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=207.5
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+|++.+.||+|+||+||+|+++.+++.||||++++.. ...+.+..|+.++..+. +|++|+++++++...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~i~~~~~~~~~~~ 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD------KPPFLTQLHSCFQTVD 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc------CCCchhheeeEEecCC
Confidence 4788999999999999999999999999999998532 23345667888877763 4678999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+. ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~---~~~~ikL~Dfg~~~ 149 (323)
T cd05615 75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD---SEGHIKIADFGMCK 149 (323)
T ss_pred EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEecccccc
Confidence 9999999997 5888877654 3599999999999999999999999999999999999995 66889999999986
Q ss_pred ccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+....+..+.+...
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----------- 218 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----------- 218 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 432 122345689999999999998999999999999999999999999988776555544432100
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+| ..
T Consensus 219 --------------------------------------------------------------~~p-------------~~ 223 (323)
T cd05615 219 --------------------------------------------------------------SYP-------------KS 223 (323)
T ss_pred --------------------------------------------------------------CCC-------------cc
Confidence 000 01
Q ss_pred hHHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
.+..+.+||.+||..||.+|++ .+++++||||....+
T Consensus 224 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 224 LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 2356789999999999999997 589999999998653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=348.94 Aligned_cols=191 Identities=27% Similarity=0.450 Sum_probs=163.9
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||+|+||+||+++++.+++.||||++.... ...+.+..|+++++.+ +|+||+++++++..+..+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~i~~~~~~~~~~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSRFIVSLAYAFQTKTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-------CCCcEeeeeEEEcCCCeEEEEEe
Confidence 799999999999999999999999997532 2234567799999888 68999999999999999999999
Q ss_pred ccC-CChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc
Q 003438 193 LLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269 (820)
Q Consensus 193 y~~-gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~ 269 (820)
|+. ++|.+.+... ....+++..++.++.||+.||.|||+++|+||||||+||+++ ..+.+||+|||++......
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCC
Confidence 997 5777766432 224589999999999999999999999999999999999995 5678999999998654322
Q ss_pred ---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 270 ---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 270 ---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.....+++.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 151 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 233578999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.42 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=216.4
Q ss_pred CceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 109 RRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 109 ~rY~i~-~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
++|.|. ++||-|-.|.|..|.++.|++.+|+|++... .++.+|+++.-... .|+|||.++|+|+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s------~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS------GHPHIVSIIDVYENSYQG 130 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc------CCCceEEeehhhhhhccC
Confidence 677766 5799999999999999999999999998743 45667887765553 79999999999875
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
...+.||||.|+ |.|+..+..+..+.++|.++..|++||..|+.|||+.+|.||||||+|+|++....+..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 357899999998 5899999988777899999999999999999999999999999999999999888889999999999
Q ss_pred ccccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 263 ACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 263 A~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
|+... ....+.+-|++|.|||++...+|+..+|+||+|||||-|++|.+||....-. ..+.-|..+
T Consensus 211 AK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~------------aispgMk~r 278 (400)
T KOG0604|consen 211 AKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------------AISPGMKRR 278 (400)
T ss_pred ccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc------------cCChhHHhH
Confidence 98665 4566778999999999999999999999999999999999999999754321 111111111
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.+ ...|. |+. +++.
T Consensus 279 I~------------------------~gqy~---------------------FP~---------------------pEWs 292 (400)
T KOG0604|consen 279 IR------------------------TGQYE---------------------FPE---------------------PEWS 292 (400)
T ss_pred hh------------------------ccCcc---------------------CCC---------------------hhHh
Confidence 00 00111 111 1345
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.+++.++|+|++||..||.+|+|++|+++|||+.+...
T Consensus 293 ~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 293 CVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 57889999999999999999999999999999998653
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=344.34 Aligned_cols=280 Identities=30% Similarity=0.524 Sum_probs=214.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++.++||+|++|.||+|+++.+++.||||.+.... .....+.+|+++++.+ .|+||+++++++..++.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-------KHANIVTLHDIIHTKKT 77 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-------CCcceeeEEEEEecCCe
Confidence 78999999999999999999999999999999987432 2234567899999998 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
.|+||||+.++|.+++.... ..+++..++.++.||++||.|||+++|+||||||+||+++ ..+.+||+|||++...
T Consensus 78 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 78 LTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAK 153 (291)
T ss_pred EEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---CCCCEEECcccccccc
Confidence 99999999999998887653 3689999999999999999999999999999999999995 6678999999998654
Q ss_pred CCc---cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCchHHHHhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGAS-EFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s-~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+.+.++. +....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT-PTEETWPGV 232 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC-CChhhhhhh
Confidence 321 122346788999999876 468899999999999999999999997765 55667777777763 333322221
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+..... ..+....+...+... .
T Consensus 233 ~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~---------------~ 259 (291)
T cd07844 233 SSNPEFKPYSF--------------------------------------PFYPPRPLINHAPRL---------------D 259 (291)
T ss_pred hhccccccccc--------------------------------------cccCChhHHHhCcCC---------------C
Confidence 11111000000 000001111111000 0
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
....+.+||.+||.+||++|||+.|+|+||||
T Consensus 260 ~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 260 RIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 12567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.47 Aligned_cols=205 Identities=23% Similarity=0.418 Sum_probs=175.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||+|+++.+++.||+|++.+.. .....+.+|+.+++.+ .||||+++++++...
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-------~hp~iv~~~~~~~~~ 115 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-------NSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEcC
Confidence 79999999999999999999999999999999997422 2334466788888877 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+. ++|.+++... .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCce
Confidence 99999999997 5888887653 489999999999999999999999999999999999996 6788999999999
Q ss_pred cccCCc----cccccccccccCcccccccc----ccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~~~~----yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~ 326 (820)
...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+.......+.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 260 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 754322 23457899999999997643 7899999999999999999999998877655544443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=342.21 Aligned_cols=280 Identities=29% Similarity=0.472 Sum_probs=214.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++++.||+|+||.||+|.+..+++.||||+++... .....+.+|+.+++.+ .|+||+++++++...+.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-------KHANIVLLHDIIHTKET 77 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-------CCCCEeEEEEEEecCCe
Confidence 78999999999999999999999999999999997542 2233567899999988 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
.|+||||+.++|.+.+.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++ ..+.+||+|||++...
T Consensus 78 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 78 LTFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAK 153 (291)
T ss_pred EEEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEecccccccc
Confidence 99999999999988776543 4588899999999999999999999999999999999995 6678999999998643
Q ss_pred CC---ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCchHHHHhh
Q 003438 267 DR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS-EFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 267 ~~---~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s-~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.. ......++..|+|||++.+. .++.++|||||||++|+|++|..||.... ..+.+..+...++ .|+..+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLG-VPTEDTWPGV 232 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcC-CCChhhhhhh
Confidence 22 22334568899999998764 58889999999999999999999997654 3456666666666 4443333322
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+...... . .....+..+.... .
T Consensus 233 ~~~~~~~~~~~~-------------------------------------~-~~~~~~~~~~~~~---------------~ 259 (291)
T cd07870 233 SKLPNYKPEWFL-------------------------------------P-CKPQQLRVVWKRL---------------S 259 (291)
T ss_pred hhcccccchhcc-------------------------------------c-cCCcchhhhcccc---------------C
Confidence 222111111000 0 0000011111100 1
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.+..+.+||.+||+.||++|||++|+|.||||
T Consensus 260 ~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 260 RPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred CChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 24678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=357.18 Aligned_cols=257 Identities=24% Similarity=0.415 Sum_probs=219.4
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
..+-|.++++||+|+||.||+|.++++|+.||||.+..+ .+.++++.||.||+++ ..++||++|+.|.....
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC-------~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQC-------KSKYVVKYYGSYFKHSD 102 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHc-------CCchhhhhhhhhccCCc
Confidence 346778899999999999999999999999999999865 4578899999999999 56799999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|||||||+ |+..|+++.++ +.|+|.++..+++..++||+|||...-||||||..|||++ .++..||+|||.|.+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN---T~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN---TDGIAKLADFGVAGQ 178 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc---ccchhhhhhccccch
Confidence 999999998 78999888765 6799999999999999999999999999999999999996 678999999999977
Q ss_pred cCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
..+.+ .+.+||+.|||||++..-.|+.++||||||++..||..|++||........ |.-+-..+|
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PP--------- 246 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPP--------- 246 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCC---------
Confidence 66543 567999999999999999999999999999999999999999975432111 110000001
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
..+.+...+
T Consensus 247 -----------------------------------------------------------------------PTF~KPE~W 255 (502)
T KOG0574|consen 247 -----------------------------------------------------------------------PTFKKPEEW 255 (502)
T ss_pred -----------------------------------------------------------------------CCCCChHhh
Confidence 111223347
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
+.+|.|||++||...|++|.||.++++|||+++.+.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 889999999999999999999999999999998653
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=342.72 Aligned_cols=283 Identities=30% Similarity=0.511 Sum_probs=221.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.++||+|.+|+||+++++.+++.||||+++... ...+.+.+|+++++.+ .|+||+++++++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~ 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-------QHGNIVRLQDVVHSEK 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-------cCCCEeeEEEEEecCC
Confidence 57999999999999999999999999999999986432 2345677899999998 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..|+||||++++|.+.+.......+++..++.++.||+.||+|||+++|+|+||||+||+++ .....+||+|||++..
T Consensus 75 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 75 RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARA 152 (294)
T ss_pred eEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccc
Confidence 99999999999998888765544578899999999999999999999999999999999996 2456799999999965
Q ss_pred cCCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|++||......+.+.++....+ .|.+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (294)
T PLN00009 153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG-TPNEETWPGV 231 (294)
T ss_pred cCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhcccc
Confidence 4322 2234567889999998764 578999999999999999999999998888888888877777 4444333221
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+.... .-+....+... ...
T Consensus 232 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~-----------------~~~ 255 (294)
T PLN00009 232 TSLPDYKSAF---------------------------------------PKWPPKDLATV-----------------VPT 255 (294)
T ss_pred ccchhhhhhc---------------------------------------ccCCCCCHHHh-----------------CcC
Confidence 1111100000 00000011111 112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++.+.+||.+||..||++||+++++|+||||.+.+
T Consensus 256 ~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred CChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 456789999999999999999999999999998743
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.66 Aligned_cols=197 Identities=27% Similarity=0.427 Sum_probs=171.2
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.|++.++||+|+||+||++.+..+++.||||.+.... .....+.+|+.+++.+ +|++|+++++.+...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~i~~~~~~~~~~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-------NSRFVVSLAYAYETKD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-------CCCCeeeeeEEEecCC
Confidence 4788899999999999999999999999999987532 2234567799999888 6889999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+. ++|.+++.......+++..++.++.||+.||.|||+++|+||||||+||+++ ..+.++|+|||++.
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~ 150 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeecccee
Confidence 9999999997 5888887655445699999999999999999999999999999999999995 66789999999986
Q ss_pred ccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
.... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 151 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred ecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 5432 223357899999999999989999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=373.60 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=221.0
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC-ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~-~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..+.|+|+..||.|+||.||+|.++.++-..|.|+|.. .....+.++.||+||..+ +||+||+|++.|..++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-------dHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-------DHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-------CChHHHHHHHHHhccC
Confidence 34788899999999999999999999999999999974 456678899999999998 7999999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.++|+.|||+|.-.|.+...-.+.|++.+|..+++|+|.||.|||+++|||||||..|||++ -+|.|+|+|||.+..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAK 179 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeeccccccc
Confidence 99999999998776666555557899999999999999999999999999999999999997 678999999999854
Q ss_pred cC---CccccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 266 ED---RTVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 266 ~~---~~~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
.. .....++||++|||||++. ..+|++++||||||++|.||..+.||-...+...++-+|.+ ..||.
T Consensus 180 n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPT-- 254 (1187)
T KOG0579|consen 180 NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPT-- 254 (1187)
T ss_pred chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCc--
Confidence 33 3345789999999999975 45899999999999999999999999977666555544433 12221
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+.
T Consensus 255 ------------------------------------------------------------------------------Ll 256 (1187)
T KOG0579|consen 255 ------------------------------------------------------------------------------LL 256 (1187)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 11
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
....|+..|.|||++||..||..||++.|+|+||||+..+.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 22347788999999999999999999999999999997654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.29 Aligned_cols=279 Identities=33% Similarity=0.565 Sum_probs=214.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.++||+|+||.||+|+++.+++.||+|++.... ...+.+.+|+.+++.+ .|+||+++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~ 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-------KHPNLVNLIEVFRRKR 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-------CCCCEeeeeeEEeeCC
Confidence 47999999999999999999999999999999987432 2335577899999988 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+++||||+++++++.+.... ..+++..++.++.||+.+|.|||+.+|+|+||||+||+++ .++.+||+|||++..
T Consensus 74 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~ 149 (286)
T cd07847 74 KLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARI 149 (286)
T ss_pred EEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECcccccee
Confidence 999999999986666554332 3589999999999999999999999999999999999996 567899999999975
Q ss_pred cCCcc---ccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+....+...+... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~- 227 (286)
T cd07847 150 LTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQ-QI- 227 (286)
T ss_pred cCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHh-hh-
Confidence 43322 23467888999999876 46889999999999999999999999988887877777776663322110 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+++... .+.. .....++..+ ..
T Consensus 228 ~~~~~~~~~~~--------------------------------~~~~----~~~~~~~~~~-----------------~~ 254 (286)
T cd07847 228 FSTNQFFKGLS--------------------------------IPEP----ETREPLESKF-----------------PN 254 (286)
T ss_pred ccccccccccc--------------------------------CCCc----ccccCHHHHh-----------------cc
Confidence 00000000000 0000 0000111111 12
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.+..+.+||.+||..||++|||+.|+|.||||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 255 ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 45788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=345.69 Aligned_cols=288 Identities=29% Similarity=0.515 Sum_probs=214.5
Q ss_pred ceEEEEEeccCCceeEEEeeccC--CCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAE--MNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~--tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
+|++.++||+|+||.||+|++.. +++.||||++... ....+...+|+.+++.+ .|+||+++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-------KHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-------CCCCccceEEEEeC
Confidence 58999999999999999999988 8999999999863 23345677899999988 68999999999998
Q ss_pred c--ceeEEEEeccCCChHHHHHhhhc---CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc-ccCCCeEEE
Q 003438 184 Q--RHLCICFELLDSNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT-SVKPAEIKI 257 (820)
Q Consensus 184 ~--~~l~LVmEy~~gsL~d~l~~~~~---~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~-~~~~~~iKL 257 (820)
. ..+|+||||++++|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++. ++..+.+||
T Consensus 74 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl 153 (316)
T cd07842 74 HADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153 (316)
T ss_pred CCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence 8 88999999999999888764432 25899999999999999999999999999999999999963 122789999
Q ss_pred eecccccccCCc------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCH---------HHH
Q 003438 258 IDFGSACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDL 321 (820)
Q Consensus 258 ~DFGlA~~~~~~------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~---------~d~ 321 (820)
+|||++...... ....+++..|+|||++.+. .++.++|||||||++|+|++|++||.+... .+.
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 233 (316)
T cd07842 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233 (316)
T ss_pred CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence 999998754322 1234678889999998764 688999999999999999999999976543 234
Q ss_pred HHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHH
Q 003438 322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEI 401 (820)
Q Consensus 322 l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~i 401 (820)
+..+++.++ .++............+.+... .. ....+....+...
T Consensus 234 ~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~-----------------------------~~-----~~~~~~~~~~~~~ 278 (316)
T cd07842 234 LERIFEVLG-TPTEKDWPDIKKMPEYDTLMK-----------------------------DF-----KTKTYPSNSLAKW 278 (316)
T ss_pred HHHHHHHhC-CCchhHHHHHhhcccchhhhh-----------------------------hc-----cCCCCCCccHHHH
Confidence 556666666 333222222111111100000 00 0000010111111
Q ss_pred HhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 402 VTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 402 l~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+. .....+..+.+||.+||.+||++|||+.|+++||||
T Consensus 279 ~~--------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 279 ME--------------KHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HH--------------hccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 10 001345789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=356.19 Aligned_cols=246 Identities=26% Similarity=0.431 Sum_probs=202.8
Q ss_pred EEeccCCceeEEEeec---cCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 115 DLLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d---~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
+.||+|+||.||++++ ..+++.||||++++.. .......+|+++|+++ .|+||+++++++...+.+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~~ 74 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-------NHPFIVKLHYAFQTEGKLY 74 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-------CCCCcccEEEEEEcCCEEE
Confidence 5799999999999876 4678999999998532 2334566788888888 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
|||||+. ++|.+.+... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~~ 149 (318)
T cd05582 75 LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESI 149 (318)
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC---CCCcEEEeeccCCcccC
Confidence 9999997 6888887654 3589999999999999999999999999999999999995 66789999999986543
Q ss_pred Cc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003438 268 RT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344 (820)
Q Consensus 268 ~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~ 344 (820)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+.+..+.+...
T Consensus 150 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~-------------- 215 (318)
T cd05582 150 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL-------------- 215 (318)
T ss_pred CCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 22 3345789999999999988899999999999999999999999987766554444322100
Q ss_pred chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHH
Q 003438 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424 (820)
Q Consensus 345 ~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~ 424 (820)
.+| ..++.
T Consensus 216 -----------------------------------------------------------~~p-------------~~~~~ 223 (318)
T cd05582 216 -----------------------------------------------------------GMP-------------QFLSP 223 (318)
T ss_pred -----------------------------------------------------------CCC-------------CCCCH
Confidence 000 01346
Q ss_pred HHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 425 ALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 425 ~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
.+.+||++||+.||++|+| ++++++||||....+
T Consensus 224 ~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred HHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 6889999999999999999 788999999987543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=352.25 Aligned_cols=199 Identities=30% Similarity=0.469 Sum_probs=175.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++.++||+|+||.||++.+..+++.||+|+++.. ......+.+|+++|+.+ +|+||++++++|..+++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 77 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE 77 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-------CCCcccceeEEEEECCE
Confidence 7999999999999999999999999999999998753 34456788999999998 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+||||||+. ++|.+++... +.+++..++.++.||+.||.|||+. +|+|+||||+|||++ .++.+||+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~ 152 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 152 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcch
Confidence 999999997 5899888754 3589999999999999999999974 799999999999995 56789999999986
Q ss_pred ccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 265 TEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 265 ~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
..... .....++..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred hhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 54322 23457899999999999889999999999999999999999999766543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.90 Aligned_cols=275 Identities=34% Similarity=0.584 Sum_probs=214.8
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--ce
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--RH 186 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--~~ 186 (820)
|+++++||+|+||.||+|.+..+++.||||+++.. ........+|+.+++++. +|+||+++++++.+. +.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~~~~~~~~~~ 74 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS------PHPNILRLIEVLFDRKTGR 74 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC------CCCCccceEEEEecCCCCc
Confidence 67899999999999999999999999999998753 222233456888887773 589999999999988 89
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+++||||+.++|.+.+.... ..+++..++.++.||+.||+|||+++|+||||||+||+++ . +.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 75 LALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGI 149 (282)
T ss_pred EEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEeccccccc
Confidence 99999999999998887643 4689999999999999999999999999999999999996 3 89999999999754
Q ss_pred CCc--cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 DRT--VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 ~~~--~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... .....++..|+|||++.. ..++.++|||||||++|||++|.+||.+.+..+.+..+...++ .++..+......
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (282)
T cd07831 150 YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG-TPDAEVLKKFRK 228 (282)
T ss_pred ccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcC-CCCHHHHHhhcc
Confidence 322 233467889999998754 4578899999999999999999999999998888888888887 444333221100
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.. . ..+.+ +. .....+..+. ...+
T Consensus 229 ~~-----~----------------~~~~~-------------~~-----~~~~~~~~~~-----------------~~~~ 252 (282)
T cd07831 229 SR-----H----------------MNYNF-------------PS-----KKGTGLRKLL-----------------PNAS 252 (282)
T ss_pred cc-----c----------------ccccC-------------cc-----cccccHHHHc-----------------cccc
Confidence 00 0 00000 00 0000111111 1245
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+++||.+||.+||++|||++|+|+||||
T Consensus 253 ~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 253 AEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=369.81 Aligned_cols=190 Identities=26% Similarity=0.421 Sum_probs=167.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
...|.+.++||+|+||.||+|++..+++.||||.... ....+|+++|++| .|+|||++++++...+..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L-------~HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRL-------SHPAVLALLDVRVVGGLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHC-------CCCCCCcEEEEEEECCEE
Confidence 3589999999999999999999999999999996532 3456899999998 689999999999999999
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
|||||++.++|.+++.... ..+++.+++.|+.||+.||.|||++|||||||||+||||+ ..+.+||+|||+++...
T Consensus 236 ~lv~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 236 CLVLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceecc
Confidence 9999999999999887543 4699999999999999999999999999999999999995 56789999999996543
Q ss_pred Cc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCC
Q 003438 268 RT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 268 ~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
.. .....||+.|+|||++.+..++.++||||||||||||++|..++
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 21 12346899999999999999999999999999999999986544
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.47 Aligned_cols=189 Identities=23% Similarity=0.422 Sum_probs=164.2
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
+.||+|+||+||+|++..+++.||+|++++. ....+.+.+|+.++.++. +||||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~------~hp~iv~~~~~~~~~~~~~lv 74 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS------NHPFLVGLHSCFQTESRLFFV 74 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC------CCCcCCceeeEEEeCCEEEEE
Confidence 3699999999999999999999999999853 233455677888877663 689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+.+... +.+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 75 ~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~---~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCCEEEeeCCccccccCC
Confidence 99998 5787776544 4699999999999999999999999999999999999995 6788999999998643
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 222344578999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.69 Aligned_cols=277 Identities=30% Similarity=0.551 Sum_probs=218.7
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
+|++.++||.|++|.||+|++..+++.||||+++... .....+.+|+.+++++ .|+||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-------KHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-------cCCCEeeeeeeEeeCCcE
Confidence 5899999999999999999999999999999997542 2345677899999998 589999999999999999
Q ss_pred EEEEeccCCChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDSNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+|||||+.++|.+++.... ...+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++...
T Consensus 74 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~---~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 74 MLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150 (284)
T ss_pred EEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC---CCCcEEEeecchhhhh
Confidence 9999999999998886543 23589999999999999999999999999999999999995 6678999999998644
Q ss_pred CCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
... .....++..|++||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.++.+... .|....++...
T Consensus 151 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 229 (284)
T cd07836 151 GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTESTWPGIS 229 (284)
T ss_pred cCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChhhHHHHh
Confidence 322 1234568889999998764 578899999999999999999999999888888888887766 44433333222
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
....+.... .......+..+. ...
T Consensus 230 ~~~~~~~~~---------------------------------------~~~~~~~~~~~~-----------------~~~ 253 (284)
T cd07836 230 QLPEYKPTF---------------------------------------PRYPPQDLQQLF-----------------PHA 253 (284)
T ss_pred cCchhcccc---------------------------------------cCCChHHHHHHh-----------------hhc
Confidence 111100000 000000111111 123
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+..+++||.+||+.||.+|||++|+|+||||
T Consensus 254 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 254 DPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 5678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=357.19 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=197.4
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||+|+||+||+|++..+++.||||++.+.. ........|..++..+.. .+||||+++++++.....+|||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~----~~~p~i~~~~~~~~~~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL----DESPFIVGLKFSFQTDSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhcc----CCCCcCcceEEEEecCCeEEEEEc
Confidence 799999999999999999999999997532 122334456666655532 269999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC---C
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---R 268 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~---~ 268 (820)
|+. ++|.+.+... ..+++..++.++.||++||+|||+++|+||||||+|||++ .++.+||+|||++.... .
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCC
Confidence 997 5888877654 4699999999999999999999999999999999999996 66789999999986432 2
Q ss_pred ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchh
Q 003438 269 TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKF 347 (820)
Q Consensus 269 ~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~ 347 (820)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------------- 214 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV----------------- 214 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 23346789999999999765 589999999999999999999999987665444333221000
Q ss_pred hhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHH
Q 003438 348 FKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALV 427 (820)
Q Consensus 348 f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~ 427 (820)
. +| ...+++.+.
T Consensus 215 --------------------------------------------~------------~~------------~~~~~~~~~ 226 (330)
T cd05586 215 --------------------------------------------R------------FP------------KNVLSDEGR 226 (330)
T ss_pred --------------------------------------------C------------CC------------CccCCHHHH
Confidence 0 00 001346678
Q ss_pred HHHHhccccCcCCCC----CHHHHHcCCccCCCC
Q 003438 428 DFLKGLVEFDPAKRW----SPFQASRHPFVTGEP 457 (820)
Q Consensus 428 DLI~kmL~~DP~kRp----Ta~EaL~HPff~~~~ 457 (820)
+||++||..||++|+ +++|+++||||....
T Consensus 227 ~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=350.44 Aligned_cols=196 Identities=24% Similarity=0.454 Sum_probs=163.4
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHH-HHHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVS-ILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~-iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
++||+|+||+||+|++..+++.||||++.+.. .....+..|+. +++.+ .|+||+++++++...+..||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-------~h~~iv~~~~~~~~~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-------KHPFLVGLHYSFQTAEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-------CCCCccceeeEEEcCCEEEE
Confidence 36999999999999999999999999997532 12233444443 34444 69999999999999999999
Q ss_pred EEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc--
Q 003438 190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE-- 266 (820)
Q Consensus 190 VmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~-- 266 (820)
||||+.+ +|.+.+... ..+++..++.++.||++||.|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 74 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD---SQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEccCCCCccCCC
Confidence 9999984 777766543 4589999999999999999999999999999999999995 6788999999998642
Q ss_pred -CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 003438 267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322 (820)
Q Consensus 267 -~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l 322 (820)
.......++|+.|+|||++.+..++.++|||||||++|||++|.+||...+.....
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 12233457899999999999889999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=353.40 Aligned_cols=246 Identities=22% Similarity=0.412 Sum_probs=197.9
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHH-HHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSI-LTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~i-L~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
++||+|+||+||+|++..+++.||||++.+.. .....+..|..+ ++.+ .||||+++++++...+.+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-------~hp~iv~~~~~~~~~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-------KHPFLVGLHYSFQTTEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-------CCCCCccEEEEEecCCEEEE
Confidence 36999999999999999999999999997532 222344445443 3334 79999999999999999999
Q ss_pred EEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc--
Q 003438 190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE-- 266 (820)
Q Consensus 190 VmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~-- 266 (820)
||||+. ++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 74 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~---~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD---SQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEEeecCCcccCCC
Confidence 999997 4787776543 4699999999999999999999999999999999999995 6788999999998642
Q ss_pred -CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccc
Q 003438 267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345 (820)
Q Consensus 267 -~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~ 345 (820)
.......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+....+....-
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--------------- 213 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--------------- 213 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------------
Confidence 2223445789999999999999999999999999999999999999987765544433322000
Q ss_pred hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHH
Q 003438 346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA 425 (820)
Q Consensus 346 ~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~ 425 (820)
... ...+..
T Consensus 214 ------------------------------------------------------------~~~-----------~~~~~~ 222 (325)
T cd05604 214 ------------------------------------------------------------VLR-----------PGASLT 222 (325)
T ss_pred ------------------------------------------------------------cCC-----------CCCCHH
Confidence 000 012356
Q ss_pred HHHHHHhccccCcCCCCCH----HHHHcCCccCCCCC
Q 003438 426 LVDFLKGLVEFDPAKRWSP----FQASRHPFVTGEPF 458 (820)
Q Consensus 426 l~DLI~kmL~~DP~kRpTa----~EaL~HPff~~~~~ 458 (820)
+.+||++||+.||++|+++ .++++||||....+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 7899999999999999987 59999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.35 Aligned_cols=206 Identities=22% Similarity=0.349 Sum_probs=173.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+++++.+++.||+|++.+.. .....+.+|+.++..+ .|++|+++++++...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-------DNQWITTLHYAFQDE 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-------CCCCEeeEEEEEecC
Confidence 47999999999999999999999999999999997422 2233456677777666 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~---~~~~~kL~DfG~a 149 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSC 149 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC---CCCCEEEeecchh
Confidence 99999999996 68999887643 4589999999999999999999999999999999999995 6788999999998
Q ss_pred cccCCc----cccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
...... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||...+..+.+..+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i 220 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 643221 123478999999999863 46889999999999999999999999877665554444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.11 Aligned_cols=280 Identities=32% Similarity=0.576 Sum_probs=218.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC--ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
.++|++.++||+|+||.||+|++..+++.||||+++. .......+.+|+.+++++ .|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-------KHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-------CCCCcCchhheeeccc
Confidence 3789999999999999999999999999999999864 233456677899999998 589999999987654
Q ss_pred ----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 ----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
.+.|+|+||+.++|.+++... .+++..++.++.||++||+|||+++|+||||||+|||++ ..+.+||+||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~---~~~~~kl~df 150 (336)
T cd07849 77 FESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TNCDLKICDF 150 (336)
T ss_pred ccccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEECcc
Confidence 358999999999988877643 599999999999999999999999999999999999995 6788999999
Q ss_pred ccccccCCc------cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 261 GSACTEDRT------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 261 GlA~~~~~~------~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
|++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+...++..+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 998643221 123467889999998765 4689999999999999999999999998888888888888887433
Q ss_pred chHHHHhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 334 PDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 334 p~~~l~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
++.+ ...... ..++... + .-....+..+.
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~----------------------------------~-----~~~~~~~~~~~--------- 261 (336)
T cd07849 231 QEDL-NCIISLRARNYIKSL----------------------------------P-----FKPKVPWNKLF--------- 261 (336)
T ss_pred HHHH-HHhhchhhhhHHhhc----------------------------------C-----cCCcccHHHHh---------
Confidence 3322 211100 0000000 0 00000011111
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...+..+.+||.+||+.||++|||+.|+|+||||+.-.
T Consensus 262 --------~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 262 --------PNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred --------cccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 12356789999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.07 Aligned_cols=283 Identities=32% Similarity=0.558 Sum_probs=219.7
Q ss_pred CCceEE-EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhH---------------HHHHHHHHHHHHHhhhcCCCCC
Q 003438 108 QRRYIV-KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---------------QQALVEVSILTTLNKKYDREDK 171 (820)
Q Consensus 108 ~~rY~i-~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~---------------~~~~~Ei~iL~~L~~~~~~~~H 171 (820)
.++|.+ .+.||.|+||+||+|++..+++.||||+++...... ..+.+|+++++.+ .|
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h 79 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-------KH 79 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-------CC
Confidence 467765 477999999999999999999999999987532211 2467899999988 68
Q ss_pred CceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 172 pnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
+||+++++++...+..|+||||+.++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+||+++ .
T Consensus 80 ~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~ 154 (335)
T PTZ00024 80 ENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---S 154 (335)
T ss_pred cceeeeeEEEecCCcEEEEEeccccCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---C
Confidence 9999999999999999999999999999988654 3589999999999999999999999999999999999995 6
Q ss_pred CCeEEEeecccccccC-----------------CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCC
Q 003438 252 PAEIKIIDFGSACTED-----------------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~-----------------~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
.+.+||+|||++.... .......++..|+|||++.+. .++.++|||||||++|+|++|.+||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 234 (335)
T PTZ00024 155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234 (335)
T ss_pred CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 6789999999986433 111223457789999999765 4789999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCcccc
Q 003438 314 PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393 (820)
Q Consensus 314 ~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f 393 (820)
.+.+..+.+..+.+.++ .|+...+........+.. + ...
T Consensus 235 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~--------------------~--------------------~~~ 273 (335)
T PTZ00024 235 PGENEIDQLGRIFELLG-TPNEDNWPQAKKLPLYTE--------------------F--------------------TPR 273 (335)
T ss_pred CCCCHHHHHHHHHHHhC-CCchhhCcchhhcccccc--------------------c--------------------CcC
Confidence 99998888888888877 333322211111000000 0 000
Q ss_pred ccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCC
Q 003438 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTC 460 (820)
Q Consensus 394 ~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~ 460 (820)
....+..+. ...+..+.+||.+||+.||++|||++|+|.||||+..+...
T Consensus 274 ~~~~~~~~~-----------------~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 274 KPKDLKTIF-----------------PNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred CcccHHHhC-----------------cCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 001111111 11346789999999999999999999999999999876543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.91 Aligned_cols=190 Identities=23% Similarity=0.409 Sum_probs=165.9
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
++||+|+||+||+|++..+++.||||++++.. ...+.+.+|+.++.++. .|+||+++++++...+.+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~------~~~~i~~~~~~~~~~~~~~lv 74 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS------SNPFLVGLHSCFQTTSRLFLV 74 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc------CCCCEeeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999998542 33455678888888774 589999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--- 266 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--- 266 (820)
|||+. ++|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||++...
T Consensus 75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGP 149 (327)
T ss_pred EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCC
Confidence 99997 5887777654 3699999999999999999999999999999999999995 6688999999998642
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 2233456789999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=341.14 Aligned_cols=191 Identities=28% Similarity=0.427 Sum_probs=164.6
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||+|+||+||+++++.+++.||+|++.... ........|+++++++ +|+||+++++++..+.++|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-------NSPFIVNLAYAFESKTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-------CCCcEEEEEEEEecCCeEEEEEe
Confidence 799999999999999999999999997432 1233455689999888 68999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc--
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-- 269 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-- 269 (820)
|+. ++|.+.+.......+++..+..++.||+.||+|||++||+||||||+||+++ ..+.+||+|||++......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~ 150 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKT 150 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCce
Confidence 997 5888877665545689999999999999999999999999999999999996 6678999999998654332
Q ss_pred cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.....++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 233468899999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.50 Aligned_cols=246 Identities=23% Similarity=0.417 Sum_probs=198.0
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHH-HHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSI-LTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~~~~~~~Ei~i-L~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
+.||+|+||+||+|++..+++.||+|++.+... ....+..|..+ ++.+ .|+||+++++++...+.+|+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-------~h~~Iv~~~~~~~~~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-------KHPFLVGLHFSFQTADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-------CCCCCCceeEEEEcCCeEEE
Confidence 369999999999999999999999999985321 12233334333 3334 79999999999999999999
Q ss_pred EEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc--
Q 003438 190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE-- 266 (820)
Q Consensus 190 VmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~-- 266 (820)
||||+.+ +|.+++... ..+.+..++.++.||++||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 74 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~---~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC---CCCCEEEccCCCCccccc
Confidence 9999985 788877654 3588999999999999999999999999999999999995 6678999999998643
Q ss_pred -CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccc
Q 003438 267 -DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345 (820)
Q Consensus 267 -~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~ 345 (820)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..+.+..+.....
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~--------------- 213 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------------- 213 (325)
T ss_pred CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc---------------
Confidence 2223445789999999999999999999999999999999999999987776555444322000
Q ss_pred hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHH
Q 003438 346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA 425 (820)
Q Consensus 346 ~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~ 425 (820)
. ....++..
T Consensus 214 ------------------------------------------------------------~-----------~~~~~~~~ 222 (325)
T cd05602 214 ------------------------------------------------------------Q-----------LKPNITNS 222 (325)
T ss_pred ------------------------------------------------------------C-----------CCCCCCHH
Confidence 0 00013467
Q ss_pred HHHHHHhccccCcCCCCCHH----HHHcCCccCCCCC
Q 003438 426 LVDFLKGLVEFDPAKRWSPF----QASRHPFVTGEPF 458 (820)
Q Consensus 426 l~DLI~kmL~~DP~kRpTa~----EaL~HPff~~~~~ 458 (820)
+.+||++||+.||.+|+++. ++++|+||....+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 89999999999999999876 8999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.34 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=210.0
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.|++.++||+|+||+||++.+..+++.||+|++.... .....+.+|+++|+.+ .|+||+++++++..++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~~~~i~~~~~~~~~~~ 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-------NSQFVVNLAYAYETKD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-------CCcCceeEEEEEecCC
Confidence 4778899999999999999999999999999997542 2234567899999988 6889999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..|+||||+.+ +|.+.+.......+++..+..++.||+.||.|||+++|+||||||+||+++ ..+.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~ 150 (285)
T cd05632 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcce
Confidence 99999999984 787777654444699999999999999999999999999999999999995 56789999999986
Q ss_pred ccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||...........+.+.......
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~-------- 222 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-------- 222 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc--------
Confidence 5432 223457899999999999889999999999999999999999999876654443333221110000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.+ ....
T Consensus 223 -------------------------------------------------------------~~-------------~~~~ 228 (285)
T cd05632 223 -------------------------------------------------------------VY-------------SAKF 228 (285)
T ss_pred -------------------------------------------------------------cc-------------CccC
Confidence 00 0013
Q ss_pred HHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT 459 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~ 459 (820)
+..+.+||.+||+.||++|+| +.++++|+||+..++.
T Consensus 229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred CHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 456789999999999999999 8999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.12 Aligned_cols=276 Identities=33% Similarity=0.581 Sum_probs=217.8
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
|+++++||.|++|.||+|.++.+++.||||++.... ...+.+.+|+++++.+ .|+||+++++++...+..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-------~~~~iv~~~~~~~~~~~~ 73 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-------NHPNIVRLLDVVHSENKL 73 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-------CCCCccCHhheeccCCeE
Confidence 678899999999999999999999999999997532 2335677899999988 689999999999999999
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
|+||||+.++|.+++.......+++..++.++.||++||+|||+++++|+||+|+||+++ .++.++|+|||++....
T Consensus 74 ~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 74 YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFG 150 (283)
T ss_pred EEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccC
Confidence 999999998999988765434689999999999999999999999999999999999996 57889999999986543
Q ss_pred Ccc---ccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 268 RTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 268 ~~~---~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... ....++..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+.+..+ .|....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (283)
T cd07835 151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG-TPDEDVWPGVTS 229 (283)
T ss_pred CCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChHHhhhhhh
Confidence 221 223557889999988764 578999999999999999999999998888888888877766 444433322211
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
...+..... .+....+.... ...+
T Consensus 230 ~~~~~~~~~---------------------------------------~~~~~~~~~~~-----------------~~~~ 253 (283)
T cd07835 230 LPDYKPTFP---------------------------------------KWARQDLSKVV-----------------PNLD 253 (283)
T ss_pred chhhhhhcc---------------------------------------cccccchhhhc-----------------CCCC
Confidence 111100000 00000111111 1244
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+.+||.+||+.||++|||++|+|+||||
T Consensus 254 ~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 254 EDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.45 Aligned_cols=280 Identities=29% Similarity=0.472 Sum_probs=213.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||.||+|++..+++.||||++... ........+|+++++++ .||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTKA 84 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-------CCCCccceEEEEeccc
Confidence 7899999999999999999999999999999998643 22234556799999988 6899999999987653
Q ss_pred --------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 186 --------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 186 --------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
..++||||+.++|.+++.... ..+++.+++.++.||++||+|||+++|+|+||||+||+++ ..+.+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl 160 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKL 160 (310)
T ss_pred ccccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC---CCCcEEE
Confidence 459999999999988876543 3589999999999999999999999999999999999995 6788999
Q ss_pred eecccccccCCc-------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003438 258 IDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329 (820)
Q Consensus 258 ~DFGlA~~~~~~-------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~l 329 (820)
+|||++...... .....++..|+|||++.+. .++.++|||||||++|||++|++||.+.+....+..+.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999998643221 1234567889999998765 47889999999999999999999999988888888888877
Q ss_pred CCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCC
Q 003438 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409 (820)
Q Consensus 330 G~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~ 409 (820)
+..+++ +.+..... ..++... .+. ... ..+...+.
T Consensus 241 ~~~~~~-~~~~~~~~-~~~~~~~--------------------------------~~~---~~~--~~~~~~l~------ 275 (310)
T cd07865 241 GSITPE-VWPGVDKL-ELFKKME--------------------------------LPQ---GQK--RKVKERLK------ 275 (310)
T ss_pred CCCChh-hcccccch-hhhhhcc--------------------------------CCC---ccc--hhhHHhcc------
Confidence 744443 22211100 0000000 000 000 00000000
Q ss_pred CCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 410 ~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
....+..+.|||.+||..||++|||++|+|+||||
T Consensus 276 ---------~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 276 ---------PYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ---------cccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00123567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.78 Aligned_cols=280 Identities=33% Similarity=0.532 Sum_probs=219.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
++|++.+.||.|+||.||+|.+..+++.||||.++... .....+.+|+.+++++ .|+||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~~~~~ 77 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-------QHPNIVTVKEVVVGSN 77 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-------CCCCEEEEEEEEEecC
Confidence 67999999999999999999999999999999997432 2234567899999988 689999999999887
Q ss_pred -ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 -RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 -~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..||||||+.++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+|||++ ..+.+||+|||++
T Consensus 78 ~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~~l~d~g~~ 153 (293)
T cd07843 78 LDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN---NRGILKICDFGLA 153 (293)
T ss_pred CCcEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCcEEEeecCce
Confidence 8999999999999998887654 3589999999999999999999999999999999999996 6688999999998
Q ss_pred cccCCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 264 CTEDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 264 ~~~~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
...... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||......+.+.++...++ .|....+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG-TPTEKIWP 232 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCchHHHH
Confidence 654332 2234568889999998765 468999999999999999999999999988888888888887 44444333
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.......... ..+.......+...++.
T Consensus 233 ~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~------------ 259 (293)
T cd07843 233 GFSELPGAKK-----------------------------------------KTFTKYPYNQLRKKFPA------------ 259 (293)
T ss_pred Hhhccchhcc-----------------------------------------cccccccchhhhccccc------------
Confidence 2211100000 00000000011111110
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+++.+.+||++||+.||++|||++|+|+||||
T Consensus 260 ~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 260 LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0035678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.27 Aligned_cols=252 Identities=25% Similarity=0.479 Sum_probs=212.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||++.+..+++.||||+++... ...+.+.+|+++|+++ +|+||+++++++...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-------RHPFLVNLYGSFQDD 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-------CCCCccceeeEEEcC
Confidence 47999999999999999999999999999999997532 3445677899999888 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+. ++|.+++... ..+++..++.++.||++||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~dfg~~ 148 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD---SDGYIKITDFGFA 148 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEeeCCCc
Confidence 99999999995 7899888765 4699999999999999999999999999999999999995 5678999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
...........+++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.. + .++
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~-~~~--------- 216 (290)
T cd05580 149 KRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--G-KVR--------- 216 (290)
T ss_pred cccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C-Ccc---------
Confidence 7765555556789999999999888899999999999999999999999977664333333221 0 000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+| ...+
T Consensus 217 -------------------------------------------------------------~~-------------~~~~ 222 (290)
T cd05580 217 -------------------------------------------------------------FP-------------SFFS 222 (290)
T ss_pred -------------------------------------------------------------CC-------------ccCC
Confidence 00 0123
Q ss_pred HHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
..+.+||++||..||.+|+ +++|+++||||....+
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 6788999999999999999 9999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.03 Aligned_cols=258 Identities=26% Similarity=0.473 Sum_probs=212.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||+||+|.+..+++.||||.+.... ...+.+..|+++++.+ .|+||+++++.+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-------DHPFLPTLYASFQTE 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-------CCCCchhheeeeecC
Confidence 47999999999999999999999999999999998543 2445677899998888 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
...|+||||+. ++|.+++.......+++..++.++.||++||+|||+.||+|+||||+||+++ .++.++|+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~ 150 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLS 150 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchh
Confidence 99999999997 5899988765545699999999999999999999999999999999999996 5678999999998
Q ss_pred cccCCc--------------------------------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCC
Q 003438 264 CTEDRT--------------------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 264 ~~~~~~--------------------------------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
...... .....++..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence 533211 112367888999999998889999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCcc
Q 003438 312 LFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391 (820)
Q Consensus 312 PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~ 391 (820)
||.+.+....+..+.....
T Consensus 231 pf~~~~~~~~~~~~~~~~~------------------------------------------------------------- 249 (316)
T cd05574 231 PFKGSNRDETFSNILKKEV------------------------------------------------------------- 249 (316)
T ss_pred CCCCCchHHHHHHHhcCCc-------------------------------------------------------------
Confidence 9987665444333221000
Q ss_pred ccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCC----HHHHHcCCccCCCCCCC
Q 003438 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS----PFQASRHPFVTGEPFTC 460 (820)
Q Consensus 392 ~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT----a~EaL~HPff~~~~~~~ 460 (820)
.++ .....+..+.+||++||..||++||| ++|+|+||||++..+..
T Consensus 250 ------------~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~ 299 (316)
T cd05574 250 ------------TFP-----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL 299 (316)
T ss_pred ------------cCC-----------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence 000 00013467899999999999999999 99999999999876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.06 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=223.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|.++++||+|+||.+++++++...+.||+|.|... ....+.+..|+.+++++ .|||||.+++.|..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-------~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-------LHPNIVEYKDSFEEDG 76 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-------cCCCeeeeccchhcCC
Confidence 6899999999999999999999999999999999843 33445778899999998 6899999999999998
Q ss_pred e-eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 186 H-LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 186 ~-l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
. +||||+||+ |+|.+.|+..+..-++|+.+..++.||+.||.|||++.|+|||||+.|||++ ++..|||.|||+|
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGla 153 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLA 153 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhh
Confidence 8 999999998 5899999888767799999999999999999999999999999999999997 6678899999999
Q ss_pred cccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
+..... ..+.+||+.|+.||++.+.+|+.|+|||||||++|||++-+++|.+.+...++.+|.+....+.
T Consensus 154 K~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------- 226 (426)
T KOG0589|consen 154 KILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------- 226 (426)
T ss_pred hhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence 876544 4568999999999999999999999999999999999999999999988888888776442000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
..
T Consensus 227 ------------------------------------------------------------------------------p~ 228 (426)
T KOG0589|consen 227 ------------------------------------------------------------------------------PS 228 (426)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 01
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.++.+++.||+.||..+|+.||+|.++|.+|.+..
T Consensus 229 ~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 229 MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 24578899999999999999999999999988874
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.23 Aligned_cols=206 Identities=22% Similarity=0.345 Sum_probs=173.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+++++.+++.||||++++.. .....+.+|+.++..+ .|+||+++++++...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~l~~~~~~~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-------DCQWITTLHYAFQDE 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence 47999999999999999999999999999999997532 2233456677777766 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..||||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfG~a 149 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD---MNGHIRLADFGSC 149 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc---CCCCEEEEeccce
Confidence 99999999997 68988887643 4689999999999999999999999999999999999995 6678999999998
Q ss_pred cccCCcc----ccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 264 CTEDRTV----YSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 264 ~~~~~~~----~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH
Confidence 6543221 23468999999999876 46788999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=371.82 Aligned_cols=286 Identities=22% Similarity=0.277 Sum_probs=204.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC-CeEEE------------------EEEEeCChhhHHHHHHHHHHHHHHhhhcCC
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM-NSFVA------------------VKIIKNQPAYYQQALVEVSILTTLNKKYDR 168 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t-g~~VA------------------IKiik~~~~~~~~~~~Ei~iL~~L~~~~~~ 168 (820)
.++|+++++||+|+||+||+|..+.. ++.++ +|.++........+.+|+.+|+.+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l------ 220 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL------ 220 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC------
Confidence 37899999999999999999865432 12222 222223334455678899999998
Q ss_pred CCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhhhc---CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcc
Q 003438 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL 245 (820)
Q Consensus 169 ~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~---~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL 245 (820)
+|+|||++++++...+..|+|+|++.++|.+++..... ....+..++.|+.||+.||+|||++|||||||||+|||
T Consensus 221 -~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL 299 (501)
T PHA03210 221 -NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299 (501)
T ss_pred -CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 68999999999999999999999999999888764321 22446778899999999999999999999999999999
Q ss_pred cccccCCCeEEEeecccccccCCc----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCC-CCC--CCH
Q 003438 246 LCTSVKPAEIKIIDFGSACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL-FPG--ASE 318 (820)
Q Consensus 246 l~~~~~~~~iKL~DFGlA~~~~~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~P-F~~--~s~ 318 (820)
++ ..+.+||+|||++...... ....+||..|+|||++.+..++.++|||||||+||||++|..+ |.. ...
T Consensus 300 l~---~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 300 LN---CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred EC---CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 95 6788999999999754322 2235789999999999999999999999999999999998754 432 234
Q ss_pred HHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchh
Q 003438 319 FDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL 398 (820)
Q Consensus 319 ~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L 398 (820)
...+.+++..++ .+.+.+.....+ +++.+. ...+ . .....+
T Consensus 377 ~~~~~~~~~~~~-~~~~~~p~~~~~---~~~~i~----------------------~~~~----------~---~~~~~~ 417 (501)
T PHA03210 377 GKQLLKIIDSLS-VCDEEFPDPPCK---LFDYID----------------------SAEI----------D---HAGHSV 417 (501)
T ss_pred HHHHHHHHHhcc-cChhhcCCcHHH---HHHHhh----------------------hhhc----------c---cCccch
Confidence 445555555444 121111110000 000000 0000 0 000111
Q ss_pred HHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 399 ~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++.. ..++..+.+||.+||.+||++|||+.|+|+||||....
T Consensus 418 ~~~~~~---------------~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 418 PPLIRN---------------LGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred hhHHHh---------------cCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 122211 12446789999999999999999999999999998754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=365.39 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=209.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCC-CeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t-g~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
..|.+.++||+|+||.||+|.+..+ ++.||+|.+... ......+.+|+.+|+.+ +|||||+++++|...++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-------~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-------DHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCEeEEEEEEEECCE
Confidence 5699999999999999999998877 788999987644 33345667799999888 78999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 187 LCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+||||||+. ++|.+++... ....+++.++..++.||+.||.|||+++||||||||+|||++ ..+.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCc
Confidence 999999997 6898877643 234589999999999999999999999999999999999996 6788999999999
Q ss_pred cccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 264 CTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 264 ~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+..... +
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~--~----- 289 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY--D----- 289 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--C-----
Confidence 754332 2345689999999999998999999999999999999999999987766554444322000 0
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
+ +|
T Consensus 290 -----------------------------------------------~------------------~~------------ 292 (478)
T PTZ00267 290 -----------------------------------------------P------------------FP------------ 292 (478)
T ss_pred -----------------------------------------------C------------------CC------------
Confidence 0 00
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
..++..+.+||.+||..||++|||++|+|.|+|++.
T Consensus 293 -~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 293 -CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 013457899999999999999999999999999975
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.32 Aligned_cols=198 Identities=18% Similarity=0.260 Sum_probs=166.6
Q ss_pred EEEEeccC--CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 113 VKDLLGHG--TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 113 i~~~LG~G--~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
++++||+| +|++||+++++.+++.||||+++.. ....+.+.+|+++++.+ +||||++++++|..++..
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~hpniv~~~~~~~~~~~~ 74 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-------NHPNIVPYRATFIADNEL 74 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEEECCEE
Confidence 56789999 7899999999999999999999753 23445667799999888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.++|+||+.+...
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 75 WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSM 151 (327)
T ss_pred EEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcc
Confidence 99999997 5888888765545699999999999999999999999999999999999996 5678999999865322
Q ss_pred CC----------ccccccccccccCcccccc--ccccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 267 DR----------TVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 267 ~~----------~~~~~~gt~~Y~APEvl~~--~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 11 1112345677999999976 368999999999999999999999998655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=348.82 Aligned_cols=281 Identities=31% Similarity=0.610 Sum_probs=224.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+ .|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~ 86 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-------DHENVIGLLDVFTPA 86 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-------cCCCHHHHHHHhhcc
Confidence 47899999999999999999999999999999998742 23445677899999888 689999999988766
Q ss_pred ce------eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 RH------LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ~~------l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
+. .|+|+||++++|.+++.. ..+++..++.++.||++||+|||+.||+|+||||+||+++ ..+.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~ 160 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKIL 160 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEc
Confidence 54 899999999999998875 3599999999999999999999999999999999999996 56889999
Q ss_pred ecccccccCCccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||++...........++..|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+.+..+ .+++.+
T Consensus 161 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 239 (343)
T cd07851 161 DFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG-TPDEEL 239 (343)
T ss_pred cccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCHHH
Confidence 999998766555566788899999998764 678999999999999999999999999888888888888877 444444
Q ss_pred HHhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 338 LKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 338 l~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
+...... ..+..... ....+.+.++.
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~------------- 267 (343)
T cd07851 240 LQKISSESARNYIQSLP---------------------------------------QMPKKDFKEVF------------- 267 (343)
T ss_pred HhhccchhHHHHHHhcc---------------------------------------ccCCCCHHHHh-------------
Confidence 3322110 00000000 00000111111
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...+..+.|||++||..||++|||+.|||+||||.+...
T Consensus 268 ----~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 268 ----SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred ----ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 113578999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.30 Aligned_cols=279 Identities=28% Similarity=0.569 Sum_probs=219.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.+|.+.+.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+ .|+||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~~~~~~~ 87 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-------QHENVIGLLDVFTSAV 87 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-------CCCCccchhheecccc
Confidence 7899999999999999999999999999999998753 23345677899999888 6899999999987653
Q ss_pred ------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 ------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.+|+|+||+..+|..++. ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~d 160 (342)
T cd07879 88 SGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILD 160 (342)
T ss_pred cCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEee
Confidence 569999999887766542 3589999999999999999999999999999999999996 678999999
Q ss_pred cccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 260 FGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 260 FGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
||++...........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+....+...+. +.
T Consensus 161 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (342)
T cd07879 161 FGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE-FV 239 (342)
T ss_pred CCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH-HH
Confidence 9999766555555677889999999876 468899999999999999999999999988888888888877733333 32
Q ss_pred Hhhhccc--hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 339 KEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 339 ~~~~~~~--~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
+...... .+.... ..+....+..+..
T Consensus 240 ~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~------------- 267 (342)
T cd07879 240 QKLEDKAAKSYIKSL---------------------------------------PKYPRKDFSTLFP------------- 267 (342)
T ss_pred HHhcccchHHHHhhc---------------------------------------CCcccchHHHHhc-------------
Confidence 2211100 000000 0000111111111
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..+..+++||++||+.||++|||++|+|.||||.....
T Consensus 268 ----~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 268 ----KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 13467899999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.88 Aligned_cols=201 Identities=28% Similarity=0.487 Sum_probs=172.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--- 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--- 184 (820)
.++|++.+.||+|+||.||+|++..+++.||||++.........+..|+.+++++. +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS------HHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc------CCCCeeeEeeEEeecCCC
Confidence 47899999999999999999999999999999999876555567788999998874 589999999998753
Q ss_pred ---ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 ---RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 ---~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
..+|+||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+|+||||+||+++ .++.+||+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEccC
Confidence 46899999997 5898888765545689999999999999999999999999999999999996 6678999999
Q ss_pred ccccccCC---ccccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 261 GSACTEDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 261 GlA~~~~~---~~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
|++..... ......++..|+|||++. +..++.++|||||||++|||++|..||....
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 99865432 223457888999999986 3368889999999999999999999996543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.93 Aligned_cols=254 Identities=27% Similarity=0.432 Sum_probs=205.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc--
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-- 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-- 185 (820)
.++|++.+.||+|+||.||+|.++.+++.||+|++.......+.+.+|+.+++++. .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS------NHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc------CCCChheEEEEEEecCCC
Confidence 48999999999999999999999989999999999876666677889999999884 5899999999997644
Q ss_pred ----eeEEEEeccCC-ChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 186 ----HLCICFELLDS-NLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 186 ----~l~LVmEy~~g-sL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
.+|+||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+++|+|+||+|+||+++ .++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~ 155 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLV 155 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEEC
Confidence 58999999985 8888876543 35689999999999999999999999999999999999996 56889999
Q ss_pred ecccccccCCc---cccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003438 259 DFGSACTEDRT---VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330 (820)
Q Consensus 259 DFGlA~~~~~~---~~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG 330 (820)
|||++...... .....++..|+|||++.. ..++.++|||||||+||+|++|++||........+..+.+.
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 233 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN-- 233 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc--
Confidence 99998654322 233567889999999854 24778999999999999999999999754433322222110
Q ss_pred CCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 331 ~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
.++
T Consensus 234 -~~~---------------------------------------------------------------------------- 236 (275)
T cd06608 234 -PPP---------------------------------------------------------------------------- 236 (275)
T ss_pred -CCC----------------------------------------------------------------------------
Confidence 000
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.+.....++..+.+||++||..||++|||++|+++|||+
T Consensus 237 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 ----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000011244678999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.13 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=206.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.+.|+++++||+|+||.||++++..+++.||+|++... ....+.+.+|+.+++.+ .|+||+++++++..++.
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-------NHPYIVKLLGAFYWDGK 83 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCcEeeeEEEEEeCCe
Confidence 37899999999999999999999999999999999754 34456778899999888 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+.+ +|..++.... ..+++..++.++.||+.+|.|||+++|+||||||+||+++ .++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~ 159 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAK 159 (292)
T ss_pred EEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCcccee
Confidence 9999999986 5655554433 4689999999999999999999999999999999999995 567899999999864
Q ss_pred cCCc---cccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
.... .....++..|+|||++. ...++.++|||||||++|+|++|.+||...+....+.++.. . .++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~-~~~~-- 234 (292)
T cd06644 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--S-EPPT-- 234 (292)
T ss_pred ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--C-CCcc--
Confidence 3222 23446788999999985 33578899999999999999999999976554332222211 0 0000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
..
T Consensus 235 ------------------------------------------------------------------------------~~ 236 (292)
T cd06644 235 ------------------------------------------------------------------------------LS 236 (292)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
....++..+.+||++||..||++|||++|+|+||||.....
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00113456889999999999999999999999999986543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=332.38 Aligned_cols=277 Identities=33% Similarity=0.558 Sum_probs=216.5
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce-
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH- 186 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~- 186 (820)
|++.+.||+|+||.||+|+++.+++.||||+++.. ......+.+|+.+++++... .|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESF----EHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhcc----CCCCcceEEEEEeeccCC
Confidence 67899999999999999999888999999999743 22234566788888888543 69999999999998876
Q ss_pred ----eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 187 ----LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 187 ----l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+++|||++.++|.+++.......+++..++.++.||++||.|||+.+|+|+||||+||+++ .++.+||+|||+
T Consensus 77 ~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~ 153 (287)
T cd07838 77 RELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGL 153 (287)
T ss_pred CCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCc
Confidence 9999999999999888765444689999999999999999999999999999999999996 568899999999
Q ss_pred ccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 263 ACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 263 A~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
+...... .....++..|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.++.+..+......+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 154 ARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred ceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 8654322 22345788899999999989999999999999999999999999998888888887776552111110000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.... ...+ .......+.++ ..
T Consensus 234 ~~~~----------------------~~~~--------------------~~~~~~~~~~~-----------------~~ 254 (287)
T cd07838 234 VSLP----------------------RSSF--------------------PSYTPRSFKSF-----------------VP 254 (287)
T ss_pred cccc----------------------hhhc--------------------ccccccchhhh-----------------hh
Confidence 0000 0000 00000000111 11
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+..+.+||++||..||++|||++|+|+||||
T Consensus 255 ~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 255 EICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 245788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.23 Aligned_cols=280 Identities=33% Similarity=0.602 Sum_probs=219.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.++||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+++++.+ .|+||+++++++..++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~ 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-------RHENIVNLKEAFRRKG 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-------CCCCeeehhheEEECC
Confidence 4799999999999999999999999999999998743 23446788899999998 5899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..++||||+.+++.+.+.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ +.+.+||+|||++..
T Consensus 74 ~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~ 149 (288)
T cd07833 74 RLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARA 149 (288)
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccc
Confidence 999999999987776655443 4589999999999999999999999999999999999996 578899999999865
Q ss_pred cCCc----cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 266 EDRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 266 ~~~~----~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.... .....++..|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+..+...++..++......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred cCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 4432 2345678889999999888 8899999999999999999999999988888888888887774444322111
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
. ... .+.... + +... ....+++ .+ ..
T Consensus 230 ~-~~~-~~~~~~-----------------~---------------~~~~----~~~~~~~---~~-------------~~ 255 (288)
T cd07833 230 S-SNP-RFAGVA-----------------F---------------PEPS----QPESLER---RY-------------PG 255 (288)
T ss_pred c-cCc-cccccc-----------------c---------------CCCC----CcHHHHH---hc-------------CC
Confidence 0 000 000000 0 0000 0000000 00 11
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.++..+++||++||..||++|||++++++||||
T Consensus 256 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 256 KVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 135789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=345.05 Aligned_cols=280 Identities=29% Similarity=0.556 Sum_probs=220.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.+.||+|+||.||++.+..+++.||||+++.. ....+.+.+|+.+++++ .|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-------~h~~iv~~~~~~~~~ 88 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-------KHENVIGLLDVFTPA 88 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-------CCCcccceeeeeeec
Confidence 38999999999999999999999999999999999753 22345677899999988 689999999988643
Q ss_pred ------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
...|+|+++++++|.+++... .+++..++.++.||++||+|||+++|+||||||+||+++ .++.+||+
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEe
Confidence 357999999988998877643 489999999999999999999999999999999999996 66789999
Q ss_pred ecccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||++...........++..|+|||++.+ ..++.++|||||||++|+|++|++||........+..+.+..+ .++..+
T Consensus 163 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 241 (345)
T cd07877 163 DFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-TPGAEL 241 (345)
T ss_pred cccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHH
Confidence 99999876655556678899999999876 4688999999999999999999999998888888888888777 444333
Q ss_pred HHhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 338 LKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 338 l~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
....... ..++.... . .....+.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~-------------------------------~--------~~~~~~~~~~------------- 269 (345)
T cd07877 242 LKKISSESARNYIQSLT-------------------------------Q--------MPKMNFANVF------------- 269 (345)
T ss_pred HhhcccHhHHHHHHHhc-------------------------------c--------cCCcchhhhc-------------
Confidence 3321100 00000000 0 0000000000
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...+..+++||.+||+.||.+|+|+.++|+||||++..
T Consensus 270 ----~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 270 ----IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred ----CCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 01346789999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=353.33 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=202.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe---CChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik---~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+.|+++++||.|+.+.||++.... ...||+|.+. .+.....-+.+||..|.+|+ +|.+||+|+||-..++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk------g~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLK------GHDKIIQLYDYEVTDG 433 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc------CCceEEEEeeeeccCc
Confidence 789999999999999999997654 4456666654 34566778899999999996 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+|||||+-+.+|..+|++.. ..++.-.++.+.+|||.|+.++|.+||||.||||.|+|+ -.|.+||+|||+|..
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANA 508 (677)
T ss_pred eEEEEeecccccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcc
Confidence 999999999999999998765 334445899999999999999999999999999999999 579999999999965
Q ss_pred cCCcc-----ccccccccccCccccccc-----------cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003438 266 EDRTV-----YSYIQSRYYRSPEVLLGY-----------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329 (820)
Q Consensus 266 ~~~~~-----~~~~gt~~Y~APEvl~~~-----------~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~l 329 (820)
..... ...+||+.||+||.+... +.+.++||||||||||+|+.|++||.. ....+.++..+.
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--IINQIAKLHAIT 586 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--HHHHHHHHHhhc
Confidence 54332 346899999999998643 256789999999999999999999942 122333333222
Q ss_pred CCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCC
Q 003438 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409 (820)
Q Consensus 330 G~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~ 409 (820)
. |.. +--|+. .|
T Consensus 587 ~--P~~------------------------------------------------------~Iefp~---------~~--- 598 (677)
T KOG0596|consen 587 D--PNH------------------------------------------------------EIEFPD---------IP--- 598 (677)
T ss_pred C--CCc------------------------------------------------------cccccC---------CC---
Confidence 1 000 000000 00
Q ss_pred CCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 410 ~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
-..+++|+++.||.+||++|||+.|+|+|||++..+.
T Consensus 599 ------------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 599 ------------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred ------------CchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 0123899999999999999999999999999987554
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=326.75 Aligned_cols=249 Identities=28% Similarity=0.381 Sum_probs=208.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.|++.+.||+|++|.||+|.+..+++.|++|.+... ......+.+|+++++.+ .|+||+++++++...+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 73 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-------DSSYIIRYYESFLDKGK 73 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-------CCCCeehheeeeccCCE
Confidence 478999999999999999999999999999998743 34566788899998888 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.|+||||+. ++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+||+++ ..+.+||+|||++..
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~ 150 (256)
T cd08529 74 LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKL 150 (256)
T ss_pred EEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEccccccee
Confidence 999999996 5899988876456799999999999999999999999999999999999996 568899999999865
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.+... +
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--------- 219 (256)
T cd08529 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF--P--------- 219 (256)
T ss_pred ccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C---------
Confidence 4332 2234678899999999998999999999999999999999999987665444333221000 0
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.. ....
T Consensus 220 -------------------------------------------------------------~~-------------~~~~ 225 (256)
T cd08529 220 -------------------------------------------------------------PV-------------SQMY 225 (256)
T ss_pred -------------------------------------------------------------CC-------------cccc
Confidence 00 0013
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+..+.+||++||+.||++||++.|+++|||+
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 3678999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.05 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=204.1
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-cc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-QR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-~~ 185 (820)
.|++++.||+|++|.||+++++.+++.||||++... ....+.+.+|+++++++ .|+||+++++.+.. +.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-------KHPNIVAYRESWEGEDG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-------CCCCeeeeeeeecCCCC
Confidence 489999999999999999999999999999999753 23445677888888888 68999999998874 44
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+. ++|.+.+.......+++.+++.++.||+.||++||++||+|+||||+||+++ ..+.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~ 150 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIAR 150 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceE
Confidence 6899999997 5888888765555689999999999999999999999999999999999995 67889999999986
Q ss_pred ccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... ......+++.|+|||++.+..++.++|||||||++++|++|+.||...+.......+....- ++
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--~~------- 221 (257)
T cd08223 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--PP------- 221 (257)
T ss_pred EecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--CC-------
Confidence 4422 22334678899999999998999999999999999999999999976654443332221000 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
. ...
T Consensus 222 ---------------------------------------------------------------~-------------~~~ 225 (257)
T cd08223 222 ---------------------------------------------------------------M-------------PKD 225 (257)
T ss_pred ---------------------------------------------------------------C-------------ccc
Confidence 0 001
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.++.+.+||.+||..||++|||+.++|+||||
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 226 YSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 34678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=344.84 Aligned_cols=282 Identities=33% Similarity=0.578 Sum_probs=220.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.+.||+|+||+||+|++..+++.||||.++.. ......+.+|+.+++.+ +|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~ni~~~~~~~~~~ 76 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-------DHENVIAIKDIMPPP 76 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-------CCCCccchHHheecc
Confidence 37899999999999999999999999999999998742 23345667899999888 689999999988754
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+||||||+.++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||+++ ..+.+||+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~D 151 (337)
T cd07858 77 HREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICD 151 (337)
T ss_pred cccccCcEEEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECc
Confidence 358999999999999888754 4699999999999999999999999999999999999995 567899999
Q ss_pred cccccccCCc---cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 260 FGSACTEDRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 260 FGlA~~~~~~---~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
||++...... .....++..|+|||++.. ..++.++|||||||++|+|++|++||.+.+....+..+.+..+..+++
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 152 FGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9999754332 234567889999999875 468899999999999999999999999888888888888888744433
Q ss_pred HHHHhhh--ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 336 YVLKEAK--NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 336 ~~l~~~~--~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
.+ .... ...++.+ ..+.......
T Consensus 232 ~~-~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~ 256 (337)
T cd07858 232 DL-GFIRNEKARRYIR------------------------------------------------------SLPYTPRQSF 256 (337)
T ss_pred Hh-hhcCchhhhHHHH------------------------------------------------------hcCcccccCH
Confidence 22 1100 0000000 0000000000
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
. .....++..+++||++||+.||++|||++|+|+||||.....
T Consensus 257 ~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 257 A--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred H--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0 011125578899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=365.75 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=207.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.++||+|+||+||+|++..+++.||||++... ......+.+|+.+|..+ .|+||+++++.+...
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-------~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-------DFFSIVKCHEDFAKK 103 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-------CCCcEEEeecceecc
Confidence 37999999999999999999999999999999999753 34445677888888777 689999999887644
Q ss_pred c--------eeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC
Q 003438 185 R--------HLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 185 ~--------~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~ 253 (820)
+ .+++||||+. |+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCC
Confidence 2 4789999997 68999886532 34589999999999999999999999999999999999996 678
Q ss_pred eEEEeecccccccCC-----ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003438 254 EIKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~-----~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~ 328 (820)
.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 899999999864322 223457899999999999999999999999999999999999999877655544433210
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
.- . + .|
T Consensus 261 ~~--~----------------------------------------------------~------------------~~-- 266 (496)
T PTZ00283 261 RY--D----------------------------------------------------P------------------LP-- 266 (496)
T ss_pred CC--C----------------------------------------------------C------------------CC--
Confidence 00 0 0 00
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
..+++.+.+||.+||..||++|||+.++|+|||++.
T Consensus 267 -----------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 267 -----------PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred -----------CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 013467899999999999999999999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.52 Aligned_cols=198 Identities=28% Similarity=0.490 Sum_probs=170.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+.|++.++||+|++|.||+|.+..+++.||||++.... ...+.+.+|+++++++ +|+||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~ 74 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-------QHERIVQYYGCLR 74 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-------CCCCeeeeEEEEc
Confidence 46899999999999999999999999999999987431 1234677788888888 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.++.+++||||+. ++|.+.+... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.++|+|||
T Consensus 75 ~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg 149 (263)
T cd06625 75 DDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFG 149 (263)
T ss_pred cCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecc
Confidence 9999999999997 5888887754 3589999999999999999999999999999999999995 56789999999
Q ss_pred cccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 262 SACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 262 lA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
++....... ....++..|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 986432211 234577889999999998999999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=335.37 Aligned_cols=201 Identities=26% Similarity=0.487 Sum_probs=173.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
.+.|++.+.||.|+||.||+|++..+++.||+|++.........+..|+.+++++. +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS------HHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc------CCCcEEEEeeehhccccc
Confidence 47899999999999999999999999999999999876655667788999988884 58999999999863
Q ss_pred --cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 184 --QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 184 --~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
...+|+||||+. ++|.+++.......+++..++.++.||+.||.|||+.+|+|+||||+||+++ ..+.++|+||
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~df 165 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDF 165 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeC
Confidence 467899999997 4888888765555689999999999999999999999999999999999996 5678999999
Q ss_pred ccccccCC---ccccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 261 GSACTEDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 261 GlA~~~~~---~~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
|++..... ......++..|+|||++. ...++.++|||||||++|||++|..||....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 99865432 223456888999999986 3468889999999999999999999996544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=340.00 Aligned_cols=289 Identities=27% Similarity=0.449 Sum_probs=228.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
..|+-+.+||+|.||.||+|+.+.+++.||+|++-- +..+....++|+++|+.| .|+|++.++++|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-------kHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTKA 89 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-------cchhHHHHHHHHhhcc
Confidence 678888899999999999999999999999998643 345667789999999999 478999888877643
Q ss_pred -------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 185 -------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 185 -------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
..+|+||++|+.+|..++.... ..++..+|++++.+++.||.|+|+..|+|||+|++|+||+ .++.+||
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilkl 165 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKL 165 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEe
Confidence 3599999999999999887653 4699999999999999999999999999999999999996 7799999
Q ss_pred eecccccccCCc-------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003438 258 IDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329 (820)
Q Consensus 258 ~DFGlA~~~~~~-------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~l 329 (820)
+|||+++..... ....+-|.+|++||.+++. .|+++.|||..||||.||+++.+.|.+.++..++..|...+
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc 245 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC 245 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence 999999543221 2234569999999999987 79999999999999999999999999999999999999999
Q ss_pred CCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCC
Q 003438 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409 (820)
Q Consensus 330 G~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~ 409 (820)
| ....++|+...+...| ..+. .++.++..+. .+++.++.|
T Consensus 246 G-s~tkevWP~~d~lpL~-~sie--------------------------------~ePl~~~~~r--kv~n~~kp~---- 285 (376)
T KOG0669|consen 246 G-SITKEVWPNVDNLPLY-QSIE--------------------------------LEPLPKGQKR--KVKNRLKPY---- 285 (376)
T ss_pred c-cCCcccCCCcccchHH-Hhcc--------------------------------CCCCCcchhh--hhhhhcccc----
Confidence 9 4444444433322111 1110 0011111111 122222211
Q ss_pred CCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 410 ~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
--++++.|||.+||.+||.+|+++.|+|+|.||..++.+
T Consensus 286 -----------~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 286 -----------VKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred -----------cCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 123578999999999999999999999999999988754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.77 Aligned_cols=204 Identities=31% Similarity=0.427 Sum_probs=174.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeE-EEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSF-VAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~-VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
....+.+.||.|+||+||++... ++. ||||++.... ...+.+.+|+.+|.+| .|||||++++++...
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-------~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-------RHPNIVQFYGACTSP 111 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEcCC
Confidence 44556667999999999999665 445 9999998532 2256899999999998 689999999999988
Q ss_pred c-eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC-eeeccCCCCCcccccccCCC-eEEEeec
Q 003438 185 R-HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG-IIHCDLKPENILLCTSVKPA-EIKIIDF 260 (820)
Q Consensus 185 ~-~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g-IVHrDLKPeNILl~~~~~~~-~iKL~DF 260 (820)
. .++|||||+. |+|.+++.......++...+..|+.||++||.|||+++ ||||||||+||||+ ... .+||+||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DF 188 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADF 188 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCC
Confidence 7 7999999997 68999887754567999999999999999999999999 99999999999996 554 9999999
Q ss_pred ccccccC---CccccccccccccCccccc--cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003438 261 GSACTED---RTVYSYIQSRYYRSPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR 324 (820)
Q Consensus 261 GlA~~~~---~~~~~~~gt~~Y~APEvl~--~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~ 324 (820)
|+++... .......||..|||||++. ...|+.|+||||||++||||+||+.||.+.........
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~ 257 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA 257 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9997655 3344468999999999999 55999999999999999999999999998776444333
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=344.03 Aligned_cols=280 Identities=31% Similarity=0.504 Sum_probs=211.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
..+|++.+.||.|+||.||+|++..+++.||||++.... ...+.+.+|+++++.+ .|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-------~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-------DHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-------CCCcchhhHhhhccccc
Confidence 489999999999999999999999999999999987543 3446678899999988 689999999876654
Q ss_pred ------------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 185 ------------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 185 ------------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
...|+||||+.++|.+++... .+++..++.++.||++||.|||+.||+||||||+||+++ ..+
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~ 151 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TED 151 (342)
T ss_pred ccccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCC
Confidence 358999999999888877543 489999999999999999999999999999999999996 345
Q ss_pred CeEEEeecccccccCCc------cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 253 AEIKIIDFGSACTEDRT------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~------~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
..+||+|||.+...... .....++..|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 67999999998654321 112356888999998765 46888999999999999999999999988877776666
Q ss_pred HHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcC
Q 003438 326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405 (820)
Q Consensus 326 ~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~ 405 (820)
........++..... ..... ..... .. ......+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~-------~~~~~-------------------------~~~~~--~~-----~~~~~~~~~~~~-- 270 (342)
T cd07854 232 LESVPVVREEDRNEL-------LNVIP-------------------------SFVRN--DG-----GEPRRPLRDLLP-- 270 (342)
T ss_pred HHhcCCCChHHhhhh-------hhhhh-------------------------hhhhh--cc-----cccCCCHHHHcc--
Confidence 654331111111000 00000 00000 00 000011111111
Q ss_pred CCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 406 P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
..+.++++||++||..||++|||+.|+|+||||+.
T Consensus 271 ---------------~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 271 ---------------GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ---------------CCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 24467899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=346.14 Aligned_cols=281 Identities=31% Similarity=0.547 Sum_probs=221.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-- 183 (820)
++|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+|+.+ .|+||++++++|..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-------KHDNIIAIRDILRPPG 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-------CCCCccCHHHhccccC
Confidence 78999999999999999999999999999999987532 3445677899999988 68999999998864
Q ss_pred --cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 184 --QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 184 --~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg 152 (334)
T cd07855 78 ADFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFG 152 (334)
T ss_pred CCCceEEEEEehhhhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEecccc
Confidence 3478999999999998887654 3599999999999999999999999999999999999996 67889999999
Q ss_pred cccccCCc-------cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 262 SACTEDRT-------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 262 lA~~~~~~-------~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+....| .|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g-~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG-SP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC-CC
Confidence 98643221 123467889999999866 4689999999999999999999999999888888888888888 44
Q ss_pred chHHHHhhhc--cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 334 PDYVLKEAKN--TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 334 p~~~l~~~~~--~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
+..++..... ...+++... ......+.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~--------- 263 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLP---------------------------------------RKQPVPWSKIF--------- 263 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcc---------------------------------------cCCCCCHHHHc---------
Confidence 4443332110 000010000 00000111111
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...+..+.+||++||+.||++|||++++|+||||.+.+.
T Consensus 264 --------~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 264 --------PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred --------ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 123578999999999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.83 Aligned_cols=282 Identities=28% Similarity=0.561 Sum_probs=220.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++++.||+|+||.||++.+..+++.||||++... ....+.+.+|+.+|+.+ .|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~ 86 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-------KHENVIGLLDVFTPD 86 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-------CCCCccceeeeecCC
Confidence 47899999999999999999999999999999998642 23345677899999998 689999999998765
Q ss_pred c------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 R------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ~------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
. .+|+||||++++|.+++.. ..+++..++.++.||++||+|||+.||+||||||+||+++ ..+.+||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~ 160 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKIL 160 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEe
Confidence 4 4699999998888888764 3589999999999999999999999999999999999996 56789999
Q ss_pred ecccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||++...........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....+..+.+..+ .++..+
T Consensus 161 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 239 (343)
T cd07880 161 DFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG-TPSKEF 239 (343)
T ss_pred ecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHH
Confidence 99999776655555677899999999876 3688999999999999999999999998888777777777666 333333
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
........ ...+.... + .+....+..+.
T Consensus 240 ~~~~~~~~-----------------------------~~~~~~~~---~-----~~~~~~~~~~~--------------- 267 (343)
T cd07880 240 VQKLQSED-----------------------------AKNYVKKL---P-----RFRKKDFRSLL--------------- 267 (343)
T ss_pred HHhhcchh-----------------------------HHHHHHhc---c-----ccCcchHHHhc---------------
Confidence 22211000 00000000 0 00000111111
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...+..+.+||.+||..||++|||+.++|+||||+...
T Consensus 268 --~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 268 --PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred --cCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 12456789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.40 Aligned_cols=319 Identities=25% Similarity=0.386 Sum_probs=242.6
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+-++|..+++||+|+||+|.+|+.+.+++.+|||+++++ .......+.|-++|+.. .||.+..|.-.|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-------~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-------RHPFLTSLKYSFQ 238 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-------cCcHHHHhhhhhc
Confidence 347899999999999999999999999999999999864 23344456678888877 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.++++|+||||.. |.|+-.+... +.+++...+.+-..|+.||.|||+++||.||||.+|+|++ +++.|||+|||
T Consensus 239 t~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD---kDGHIKitDFG 313 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD---KDGHIKITDFG 313 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec---cCCceEeeecc
Confidence 9999999999997 4676555543 4699999999999999999999999999999999999995 88999999999
Q ss_pred cccc---cCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 262 SACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 262 lA~~---~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+++. .+....+.|||+.|+|||++....|+.++|.|.+||+||||++|+.||...+...+...|+.
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~----------- 382 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM----------- 382 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-----------
Confidence 9964 35667789999999999999999999999999999999999999999987776555444422
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
+++..
T Consensus 383 ---------------------------------------------------------------------------ed~kF 387 (516)
T KOG0690|consen 383 ---------------------------------------------------------------------------EDLKF 387 (516)
T ss_pred ---------------------------------------------------------------------------hhccC
Confidence 11111
Q ss_pred hHHhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCCCCCCCCCCCCCCCCccccccccCCCCCCCCc---c
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWF---A 490 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~ 490 (820)
...++++++.||..+|..||++|+ .|.|+.+|+||....+...+...-++|..|...+..-.. .-..-| .
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTr--yFD~EFT~q~ 465 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTR--YFDEEFTSQP 465 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchh--hhhhhhhcce
Confidence 223567889999999999999998 589999999999987654444333333333222211100 000001 0
Q ss_pred CCCCCCccCccccccCCCCCCccccCCCCCccccc
Q 003438 491 AGLSPNISGRSKFSMHNSPHFQVVPYGYGNSYGSV 525 (820)
Q Consensus 491 ~~l~~~~~~~~~~~~~n~~~~~~~~~~~g~s~~~~ 525 (820)
-.+.|.--............+..++|.|-.|-||.
T Consensus 466 v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~~~s~ 500 (516)
T KOG0690|consen 466 VTLTPPDRYGSTVDEDEERRPHFPQFSYSASMGSI 500 (516)
T ss_pred eEecCCCCCCcccchhhhhccCCcceeeecchhhh
Confidence 11222222222333455556667788888777765
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=342.93 Aligned_cols=280 Identities=34% Similarity=0.558 Sum_probs=223.6
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR- 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~- 185 (820)
+|++.++||.|+||.||+|++..+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-------RHENIIGLLDILRPPSP 73 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-------CCcchhhhhhhhcccCc
Confidence 689999999999999999999999999999998753 33456788899999988 5899999999998775
Q ss_pred ----eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 186 ----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 186 ----~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.+|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+|||++ .++.++|+|||
T Consensus 74 ~~~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg 148 (330)
T cd07834 74 EDFNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFG 148 (330)
T ss_pred ccccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccC
Confidence 899999999998988886543 699999999999999999999999999999999999996 56899999999
Q ss_pred cccccCCc------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 262 SACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 262 lA~~~~~~------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
++...... .....++..|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+..++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 99654332 2344678899999999888 8899999999999999999999999999999999999888874333
Q ss_pred hHHHHhhh--ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 335 DYVLKEAK--NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 335 ~~~l~~~~--~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
+. +.... ....+..... . .....+..+.
T Consensus 229 ~~-~~~~~~~~~~~~~~~~~---------------------------------~------~~~~~~~~~~---------- 258 (330)
T cd07834 229 ED-LKFITSEKARNYLKSLP---------------------------------K------KPKKPLSKLF---------- 258 (330)
T ss_pred hH-hhhccccchhhHHhhcc---------------------------------c------CCcchhHHhc----------
Confidence 32 22100 0000000000 0 0001111111
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...+..+.+||++||++||++|||++++|+||||++...
T Consensus 259 -------~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 259 -------PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred -------ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 114578899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=339.42 Aligned_cols=257 Identities=21% Similarity=0.396 Sum_probs=208.9
Q ss_pred cccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 105 AETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 105 ~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+...+|+++++||+|+||.||++++..+++.||||.+.... ...+.+.+|+.+++.+ .|+||+++++.+..
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-------~h~~v~~~~~~~~~ 88 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDSYLV 88 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-------CCCCEeeEEEEEEe
Confidence 344589999999999999999999999999999999997542 3346677899999887 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..+.|+||||+. ++|.+++... .+++.++..++.||+.||.|||+.||+|+||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~ 162 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGF 162 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECcccc
Confidence 999999999997 5888887543 489999999999999999999999999999999999995 567899999999
Q ss_pred ccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+...... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........+..+.. .+ .++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~-~~~----- 235 (296)
T cd06654 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NG-TPE----- 235 (296)
T ss_pred chhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CC-CCC-----
Confidence 8643322 2234678899999999988899999999999999999999999976554332221110 00 000
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
+...
T Consensus 236 ----------------------------------------------------------------------------~~~~ 239 (296)
T cd06654 236 ----------------------------------------------------------------------------LQNP 239 (296)
T ss_pred ----------------------------------------------------------------------------CCCc
Confidence 0000
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++..+.+||.+||..||++|||++|+|+||||....
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 11335688999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.68 Aligned_cols=201 Identities=28% Similarity=0.443 Sum_probs=167.2
Q ss_pred CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+.+|+.+. .||||++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~niv~~~~~ 79 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG------NHLNVVNLLGA 79 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc------cCcceeeEEeE
Confidence 47999999999999999999974 345678999999753 234467888999999984 58999999998
Q ss_pred Eeec-ceeEEEEeccC-CChHHHHHhhh----------------------------------------------------
Q 003438 181 FVCQ-RHLCICFELLD-SNLYELIKINH---------------------------------------------------- 206 (820)
Q Consensus 181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~---------------------------------------------------- 206 (820)
+... ..+++||||+. |+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8764 46899999997 68988886532
Q ss_pred --------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCcc-----ccc
Q 003438 207 --------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSY 273 (820)
Q Consensus 207 --------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~-----~~~ 273 (820)
...+++..+..++.||++||+|||+++|+||||||+|||++ .++.+||+|||+++...... ...
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcchhcccCC
Confidence 12478889999999999999999999999999999999996 56789999999997542211 122
Q ss_pred cccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 274 ~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 44678999999999899999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.19 Aligned_cols=255 Identities=29% Similarity=0.499 Sum_probs=207.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|+++++||.|+||+||++.+..+++.||+|+++.. ....+.+.+|+++++++ +|+||+++++++..+..
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-------KHPNIVGLYEAYFYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-------CCCceeEEEEEEecCCe
Confidence 37899999999999999999999889999999999754 34456788899999988 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~---~~~~~~l~d~g~~~~ 152 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT---LDGDVKLADFGVSAK 152 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC---CCCCEEEccCccchh
Confidence 9999999985 7777776543 4699999999999999999999999999999999999995 678899999998864
Q ss_pred cCC---ccccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 266 EDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 266 ~~~---~~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
... ......++..|+|||++. ...++.++|||||||++|+|++|++||...+....+..+.. + .++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~-~~~~-- 227 (280)
T cd06611 153 NKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--S-EPPT-- 227 (280)
T ss_pred hcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--C-CCCC--
Confidence 332 223456888999999985 33578899999999999999999999976654433322211 0 0000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+.
T Consensus 228 ------------------------------------------------------------------------------~~ 229 (280)
T cd06611 228 ------------------------------------------------------------------------------LD 229 (280)
T ss_pred ------------------------------------------------------------------------------cC
Confidence 00
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....++..+.+||.+||+.||.+|||++++|+||||.+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 001134678899999999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=333.59 Aligned_cols=254 Identities=29% Similarity=0.467 Sum_probs=206.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
+.|++++.||+|+||.||++.+..++..+|+|.+... ....+.+.+|+++++.+ +|+||+++++++..++..
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-------CCCCeeeEEEEEeeCCEE
Confidence 5578999999999999999999999999999999754 34556778899999988 689999999999999999
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+.+ +|.+++... ...+++..++.++.||++||.|||+.||+||||||+|||++ ..+.+||+|||++...
T Consensus 78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEccccccccc
Confidence 999999985 666655443 24689999999999999999999999999999999999995 6678999999998644
Q ss_pred CCc---cccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 267 DRT---VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
... .....++..|+|||++. +..++.++|||||||++|+|++|.+||...+..+.+..+..... +.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~--- 227 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---PT--- 227 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC---CC---
Confidence 322 23346788999999984 34678899999999999999999999987665444333322100 00
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
+..
T Consensus 228 -----------------------------------------------------------------------------~~~ 230 (282)
T cd06643 228 -----------------------------------------------------------------------------LAQ 230 (282)
T ss_pred -----------------------------------------------------------------------------CCC
Confidence 000
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
...++..+.+||++||..||.+|||++++|+||||+..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 01134678999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=330.91 Aligned_cols=276 Identities=36% Similarity=0.639 Sum_probs=218.7
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
|++.+.||+|++|.||+|++..+++.||+|+++... .....+.+|+++|+.+ .|+||+++++++...+..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~ 73 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-------NHPNIIKLLDVFRHKGDL 73 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-------cCCCcchHHHhhccCCCE
Confidence 677899999999999999999999999999987542 2356778899999988 589999999999999999
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
++||||+.++|.+++.... ..+++..++.++.||++||.|||+.+|+|+||||+||+++ .++.+||+|||.+....
T Consensus 74 ~~v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~ 149 (283)
T cd05118 74 YLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFG 149 (283)
T ss_pred EEEEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecC
Confidence 9999999999998887654 4699999999999999999999999999999999999996 56889999999986544
Q ss_pred Ccc---ccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 268 RTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 268 ~~~---~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... ....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+.+..+.+.++...+ ..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (283)
T cd05118 150 SPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP-EVWPKFTS 228 (283)
T ss_pred CCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCch-Hhcccchh
Confidence 322 234577889999999877 7899999999999999999999999999988888888887773322 22221111
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
...+.. ..++.......+. .....+
T Consensus 229 ~~~~~~-----------------------------------------------------~~~~~~~~~~~~~--~~~~~~ 253 (283)
T cd05118 229 LARNYK-----------------------------------------------------FSFPKKAGMPLPK--LFPNAS 253 (283)
T ss_pred hhhhhh-----------------------------------------------------hhhccccccCHHH--hhhhhC
Confidence 000000 0000000000000 112356
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+++||.+||..||.+||++.|+|+||||
T Consensus 254 ~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 254 PQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.40 Aligned_cols=277 Identities=32% Similarity=0.577 Sum_probs=216.6
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--c
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--R 185 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--~ 185 (820)
|++.++||.|+||.||+|++..+++.||+|+++.. ......+.+|+++++.+ .|+||+++++++... +
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~ 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-------RHPNIVRLKEIVTSKGKG 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-------cCCCeeeheeeEecCCCC
Confidence 67899999999999999999999999999999864 33445678899999998 589999999999988 8
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..++||||+.++|.+++.... ..+++..++.++.||++||+|||+.+++|+||||+||+++ +++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~ 149 (287)
T cd07840 74 SIYMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARP 149 (287)
T ss_pred cEEEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceee
Confidence 999999999999988887653 4699999999999999999999999999999999999996 678899999999965
Q ss_pred cCCc----cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 266 EDRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 266 ~~~~----~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+.+..+.+..+...+.. +..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 228 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN-WPG 228 (287)
T ss_pred ccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh-ccc
Confidence 5433 2234567889999987754 688999999999999999999999998888888888887776332222 111
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.... .++.... + .. -....+.+.+..
T Consensus 229 ~~~~-~~~~~~~---------------------------------~---~~-~~~~~~~~~~~~---------------- 254 (287)
T cd07840 229 VSKL-PWFENLK---------------------------------P---KK-PYKRRLREFFKH---------------- 254 (287)
T ss_pred cccc-hhhhhcc---------------------------------c---cc-cchhHHHHHhcc----------------
Confidence 1100 0000000 0 00 000011111111
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+..+++||++||.+||++|||++++|+||||
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 255 LIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 025788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=326.28 Aligned_cols=198 Identities=28% Similarity=0.466 Sum_probs=174.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.++||+|+||.||++++..+++.||+|.++.... .+.+.+|+++++.+ .|+||+++++++.....+|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~~ 74 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-------DSPYIVKYYGSYFKNTDLW 74 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-------CCCcEeeeeeeeecCCcEE
Confidence 689999999999999999999998899999999986544 67888999999988 6899999999999999999
Q ss_pred EEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+|+||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++ .++.+||+|||++....
T Consensus 75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLT 150 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcc
Confidence 99999984 8888876543 4689999999999999999999999999999999999996 56789999999987544
Q ss_pred Cc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 268 RT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 268 ~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
.. .....++..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 151 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 32 2234578889999999988999999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.83 Aligned_cols=279 Identities=30% Similarity=0.496 Sum_probs=214.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.++||+|+||.||+|+++.+++.||||++.... .......+|+++++.+ +|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~ 79 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-------KHPNVVPLIDMAVER 79 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-------CCCCccchhhheecc
Confidence 389999999999999999999999999999999986432 2234567899999988 689999999987643
Q ss_pred --------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEE
Q 003438 185 --------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 185 --------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
..+++||||+.++|.+.+.... ..+++..++.++.||++||.|||++||+|+||||+||+++ .++.+|
T Consensus 80 ~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~---~~~~~~ 155 (311)
T cd07866 80 PDKSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID---NQGILK 155 (311)
T ss_pred cccccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEE
Confidence 3579999999998888776543 4699999999999999999999999999999999999995 678899
Q ss_pred EeecccccccCCcc--------------ccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHH
Q 003438 257 IIDFGSACTEDRTV--------------YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321 (820)
Q Consensus 257 L~DFGlA~~~~~~~--------------~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~ 321 (820)
|+|||++....... ....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999986432211 123557889999998764 588999999999999999999999999998888
Q ss_pred HHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHH
Q 003438 322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEI 401 (820)
Q Consensus 322 l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~i 401 (820)
...+....+..++. .+............. ..... ...+.+.
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-------------------------------------~~~~~-~~~~~~~ 276 (311)
T cd07866 236 LHLIFKLCGTPTEE-TWPGWRSLPGCEGVH-------------------------------------SFTNY-PRTLEER 276 (311)
T ss_pred HHHHHHHhCCCChh-hchhhhhcccccccc-------------------------------------cCCCC-CccHHHH
Confidence 88888877733332 222211110000000 00000 0001111
Q ss_pred HhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 402 VTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 402 l~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
. ....+.+.+||.+||..||++|||+.|+|.||||
T Consensus 277 ~-----------------~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 277 F-----------------GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred c-----------------ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 1133678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.87 Aligned_cols=202 Identities=28% Similarity=0.448 Sum_probs=175.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|++.++||.|+||.||+|.+..+++.+|+|++... ....+.+.+|+++++.+ +|+||+++++++...+.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-------RHPNIVAYFGSYLRRDK 74 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-------CCCChhceEEEEEeCCE
Confidence 37899999999999999999999999999999999854 23456788899999988 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ +.+.+||+|||++..
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~ 150 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchh
Confidence 9999999985 7777776542 4699999999999999999999999999999999999996 667899999999865
Q ss_pred cCCc---cccccccccccCccccccc---cccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
.... .....++..|+|||++.+. .++.++|||||||++|+|++|++||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4432 2344678889999999877 88999999999999999999999997665443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.01 Aligned_cols=270 Identities=28% Similarity=0.421 Sum_probs=212.0
Q ss_pred ceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 110 RYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 110 rY~i~-~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
-|++. +.||+|+|+.|--|....++..||||+|.+.+ ....++.+|++++.+.. +|+||++|+++|+++..+
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq------gh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ------GHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc------CCccHHHHHHHhcccceE
Confidence 34443 57999999999999999999999999998765 34567889999999885 799999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|||||-|. |.|+..|.++. .++|.++.++++.|+.||.|||.+||.||||||+|||....+.-.-||||||.++...
T Consensus 152 YLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999997 58888877664 5999999999999999999999999999999999999976666667899999987421
Q ss_pred C----------CccccccccccccCccccc---c--ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003438 267 D----------RTVYSYIQSRYYRSPEVLL---G--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331 (820)
Q Consensus 267 ~----------~~~~~~~gt~~Y~APEvl~---~--~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~ 331 (820)
. ....+.+|+..|||||+.. + ..|+.++|.||||||||-|+.|.+||.+....+ +|
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d--------CG- 300 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD--------CG- 300 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc--------CC-
Confidence 1 1234568888899999874 2 268999999999999999999999998754211 11
Q ss_pred CCchHHHHhhhc----cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCC
Q 003438 332 QPPDYVLKEAKN----TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPY 407 (820)
Q Consensus 332 ~Pp~~~l~~~~~----~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~ 407 (820)
|.+.+. ..+.|..+. .++--|+++
T Consensus 301 ------WdrGe~Cr~CQ~~LFesIQ-----------------------------------EGkYeFPdk----------- 328 (463)
T KOG0607|consen 301 ------WDRGEVCRVCQNKLFESIQ-----------------------------------EGKYEFPDK----------- 328 (463)
T ss_pred ------ccCCCccHHHHHHHHHHHh-----------------------------------ccCCcCChh-----------
Confidence 000000 001111111 011112222
Q ss_pred CCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 408 RKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 408 ~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.+..++.+++|||..+|..|+.+|.+|.++|+|||+.....
T Consensus 329 ----------dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 329 ----------DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred ----------hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 34457889999999999999999999999999999987654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.33 Aligned_cols=275 Identities=35% Similarity=0.584 Sum_probs=220.5
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
|++.++||+|.||.||+|++..+++.||+|+++.. ....+.+..|+.+++.+ .|+||+++++++...+..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~~ 73 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-------KHPNIVKLLDVIHTERKL 73 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-------CCCCHHHHHhhhhcCCce
Confidence 67788999999999999999999999999999864 33456677899999888 589999999999999999
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
++||||+.++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||+|+||+++ +++.+||+|||.+....
T Consensus 74 ~~v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~ 149 (282)
T cd07829 74 YLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFG 149 (282)
T ss_pred EEEecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccC
Confidence 9999999999999988763 3599999999999999999999999999999999999996 57889999999986543
Q ss_pred Ccc---ccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 268 RTV---YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 268 ~~~---~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... .....+..|+|||.+.+. .++.++|||||||++|||++|.+||...+..+.+.++.+.++ .+.+..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (282)
T cd07829 150 IPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG-TPTEESWPGVTK 228 (282)
T ss_pred CCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhC-CCcHHHHHhhcc
Confidence 322 233457789999999876 789999999999999999999999999988888888888887 444443333222
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.. +++..- ..+....+.+.++ ..+
T Consensus 229 ~~-~~~~~~--------------------------------------~~~~~~~~~~~~~-----------------~~~ 252 (282)
T cd07829 229 LP-DYKPTF--------------------------------------PKFPPKDLEKVLP-----------------RLD 252 (282)
T ss_pred cc-cccccc--------------------------------------cccCccchHHhcc-----------------ccc
Confidence 11 000000 0000111111111 124
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+.+||++||..||++|||++|++.||||
T Consensus 253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.68 Aligned_cols=203 Identities=27% Similarity=0.414 Sum_probs=170.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--- 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--- 184 (820)
.++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++++. +|+||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~------~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP------NHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc------CCCCeEEEEEEEEecccc
Confidence 37899999999999999999999999999999999865545566778999988874 589999999998754
Q ss_pred --ceeEEEEeccC-CChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 --RHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 --~~l~LVmEy~~-gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+..|+||||+. ++|.++++.. ....+++..++.++.||+.||+|||+++|+|+||||+||+++ ..+.+||+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEee
Confidence 36899999997 5888887642 234589999999999999999999999999999999999995 567899999
Q ss_pred cccccccCCc---cccccccccccCccccccc-----cccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 260 FGlA~~~~~~---~~~~~gt~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
||++...... .....++..|+|||++... .++.++|||||||++|||++|++||......
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 9998654321 2234678889999998643 3688999999999999999999999765543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.41 Aligned_cols=203 Identities=22% Similarity=0.408 Sum_probs=174.6
Q ss_pred eeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 102 LVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 102 l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
+...+...+|+++++||+|+||.||++++..+++.||||.+.... ...+.+.+|+.+++.+ +|+||++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~ 84 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDS 84 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-------CCCCEeeEEEE
Confidence 333445589999999999999999999999999999999997532 3345677899988887 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+...++.|+||||+. ++|.+++... .+++..+..++.||+.+|.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~D 158 (297)
T cd06656 85 YLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTD 158 (297)
T ss_pred EecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECc
Confidence 999999999999997 5788877543 489999999999999999999999999999999999995 668899999
Q ss_pred cccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 260 FGlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
||++...... .....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 159 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998643322 223467889999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.75 Aligned_cols=250 Identities=27% Similarity=0.374 Sum_probs=207.1
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+++|+.+ .|+||+++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~ 73 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-------SHPNIIEYYENFLEDKA 73 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-------CCCchhheeeeEecCCE
Confidence 589999999999999999999999999999998753 23456778899999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.++||||+. ++|.+++.......+++..++.++.||+.+|+|||+++|+|+||||+||+++ .....+||+|||.+..
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~ 151 (256)
T cd08220 74 LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKI 151 (256)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCcee
Confidence 999999997 5899998776545689999999999999999999999999999999999996 3456789999999975
Q ss_pred cCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 266 EDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 266 ~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..... .
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~--~---------- 219 (256)
T cd08220 152 LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF--A---------- 219 (256)
T ss_pred cCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC--C----------
Confidence 5432 2235678899999999988899999999999999999999999976654433322211000 0
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+ . ....+
T Consensus 220 ------------------------------------------~------------------~-------------~~~~~ 226 (256)
T cd08220 220 ------------------------------------------P------------------I-------------SDRYS 226 (256)
T ss_pred ------------------------------------------C------------------C-------------CCCcC
Confidence 0 0 00134
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+.+||.+||..||++|||+.|+|+||||
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.24 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=201.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++++.||+|+||.||++++..+++.||||+++... ....++..|+.++.+. .+|+||+++++++..++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~------~~~~~iv~~~~~~~~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS------VDCPYTVTFYGALFREGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH------cCCCCeeeeeEEEecCCc
Confidence 46899999999999999999999999999999997542 2334555566654333 279999999999999999
Q ss_pred eEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 187 LCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+|+||||++++|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+||+++ ..+.+||+|||++
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~---~~~~~kl~dfg~~ 151 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN---RNGQVKLCDFGIS 151 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecccc
Confidence 9999999999998887653 224589999999999999999999997 999999999999995 6788999999998
Q ss_pred cccCCcc--ccccccccccCcccccc----ccccccchhHhHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCchH
Q 003438 264 CTEDRTV--YSYIQSRYYRSPEVLLG----YQYTTAIDMWSFGCIVAELFLGLPLFPGAS-EFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 264 ~~~~~~~--~~~~gt~~Y~APEvl~~----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s-~~d~l~~I~~~lG~~Pp~~ 336 (820)
....... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..+.+..+.. + ..+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~-~~~-- 226 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--E-PSP-- 226 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--c-CCC--
Confidence 7543322 22467888999999865 457889999999999999999999995321 1121111111 0 000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
.+|
T Consensus 227 -------------------------------------------------------------------~~~---------- 229 (283)
T cd06617 227 -------------------------------------------------------------------QLP---------- 229 (283)
T ss_pred -------------------------------------------------------------------CCC----------
Confidence 000
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++..+.+||.+||..||++|||++|+++||||....
T Consensus 230 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 --AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred --ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 001346789999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.61 Aligned_cols=192 Identities=28% Similarity=0.495 Sum_probs=167.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||.||+|++..+++.||||++... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 73 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-------DSPYIIGFYGAFFVENR 73 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEEECCE
Confidence 3688999999999999999999999999999999754 33445678899999888 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
.++||||+.+..++.. ..+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||++...
T Consensus 74 ~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 74 ISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQL 145 (279)
T ss_pred EEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceec
Confidence 9999999986444332 2478999999999999999999999999999999999996 6788999999999654
Q ss_pred CC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 267 DR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 267 ~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.. ......++..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 146 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 146 VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 33 23345789999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=334.88 Aligned_cols=198 Identities=31% Similarity=0.491 Sum_probs=173.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++.++||+|+||.||++.+..+++.||+|+++.. .....++.+|+++++++ .|+||++++++|..+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-------NSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEeeCCE
Confidence 3689999999999999999999999999999998753 34456688899999998 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+|+||||+. ++|.+++... +.+++..++.++.||++||.|||+ .+|+|+||||+|||++ .++.+||+|||++.
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~ 148 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 148 (308)
T ss_pred EEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCcc
Confidence 999999997 5888888754 468999999999999999999997 6999999999999996 56789999999986
Q ss_pred ccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 265 TEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 265 ~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
.... .....+++..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 149 QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred cccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 5432 22345788999999999888899999999999999999999999976553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.35 Aligned_cols=279 Identities=32% Similarity=0.565 Sum_probs=211.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||.||+|.+..+++.||||++.... ...+.+.+|+++++.+ .|+||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~ 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-------RHENLVNLIEVFRRKK 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-------CCcchhhHHHhcccCC
Confidence 47999999999999999999999899999999986432 2345677899999888 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..|+||||+.+.+.+.+.... ..+++.+++.++.||+.||+|||+.+|+|+||+|+||+++ +++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~---~~~~~~l~dfg~~~~ 149 (286)
T cd07846 74 RLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFART 149 (286)
T ss_pred eEEEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCcEEEEeeeeeee
Confidence 999999999976555443332 3589999999999999999999999999999999999995 678899999999865
Q ss_pred cCCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... .....++..|+|||++.+. .++.++|||||||++|||++|++||......+.+..+....+...+... .
T Consensus 150 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 226 (286)
T cd07846 150 LAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQ-E-- 226 (286)
T ss_pred ccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhH-H--
Confidence 3221 2234678899999998764 5788999999999999999999999988877777777776662221110 0
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+...... .....+.. -....+.. ....
T Consensus 227 -----~~~~~~~~--------------------------~~~~~~~~----~~~~~~~~-----------------~~~~ 254 (286)
T cd07846 227 -----IFQKNPLF--------------------------AGMRLPEV----KEIEPLEK-----------------RFPK 254 (286)
T ss_pred -----HhccchHh--------------------------hccccccc----cCcchHHH-----------------hCCC
Confidence 00000000 00000000 00000000 1112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
++..+.+||++||..||++|||+.++|+||||
T Consensus 255 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 255 LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 45789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=357.71 Aligned_cols=261 Identities=24% Similarity=0.397 Sum_probs=222.1
Q ss_pred eeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe----CChhhHHHHHHHHHHHHHHhhhcCCCCCCceeE
Q 003438 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDKHHIVR 176 (820)
Q Consensus 101 ~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik----~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk 176 (820)
++...++...|.-++.||.|+||.||-|++..+.+.||||.+. ......+.++.|+.+|++| .|||+|.
T Consensus 18 LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-------~HPntie 90 (948)
T KOG0577|consen 18 LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-------RHPNTIE 90 (948)
T ss_pred HHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-------cCCCccc
Confidence 3334445577888889999999999999999999999999986 2344567789999999999 6899999
Q ss_pred EeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEE
Q 003438 177 IYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 177 l~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
+.++|..+...|||||||-|+-.|++...+ +++.+.+|..|+.+.+.||+|||+.+.||||||..|||++ +.+.||
T Consensus 91 YkgCyLre~TaWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VK 166 (948)
T KOG0577|consen 91 YKGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVK 166 (948)
T ss_pred ccceeeccchHHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeee
Confidence 999999999999999999998888877665 6799999999999999999999999999999999999996 789999
Q ss_pred EeecccccccCCccccccccccccCcccccc---ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 257 L~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~---~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
|+|||.|.... ....++|||+|||||||+. +.|+-++||||||++..||...+||+-..+....+..|.+.-.
T Consensus 167 LaDFGSAsi~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes--- 242 (948)
T KOG0577|consen 167 LADFGSASIMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--- 242 (948)
T ss_pred eccccchhhcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC---
Confidence 99999996543 3567899999999999974 4799999999999999999999999877666555555543110
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
|. +
T Consensus 243 Pt---------------------------------------------------------------------------L-- 245 (948)
T KOG0577|consen 243 PT---------------------------------------------------------------------------L-- 245 (948)
T ss_pred CC---------------------------------------------------------------------------C--
Confidence 00 0
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....+++.|+.||..||+.-|.+|||.+++|.|+|+...+
T Consensus 246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 1124788999999999999999999999999999998754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.30 Aligned_cols=278 Identities=35% Similarity=0.590 Sum_probs=215.9
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
|++.+.||+|+||+||+|++..+++.||||.+..... ......+|+..++++. +|+||+++++++..++..|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~------~h~~i~~~~~~~~~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN------EHPNIVKLKEVFRENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhcc------CCCCchhHHHHhhcCCcEE
Confidence 6788999999999999999998999999999875422 2223456777777772 3899999999999999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
+||||+.++|.+.+.......+++..++.++.||+.+|.|||+++|+|+||||+||+++ ..+.++|+|||.+.....
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccC
Confidence 99999999999988776545689999999999999999999999999999999999996 678999999999975543
Q ss_pred c--cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccc
Q 003438 269 T--VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345 (820)
Q Consensus 269 ~--~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~ 345 (820)
. .....++..|+|||++.. ..++.++|||||||++++|++|++||......+.+..+...++... ...+.......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPT-KQDWPEGYKLA 230 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCC-hhhhhhHhhhh
Confidence 2 234567889999998854 4688999999999999999999999999998888888888887333 32222111100
Q ss_pred hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHH
Q 003438 346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLA 425 (820)
Q Consensus 346 ~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~ 425 (820)
..+. +.+ .......+.+.+ ...+..
T Consensus 231 ~~~~--------------------~~~------------------~~~~~~~~~~~~-----------------~~~~~~ 255 (283)
T cd07830 231 SKLG--------------------FRF------------------PQFAPTSLHQLI-----------------PNASPE 255 (283)
T ss_pred cccc--------------------ccc------------------cccccccHHHHc-----------------ccCCHH
Confidence 0000 000 000000011111 012467
Q ss_pred HHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 426 LVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 426 l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+++||++||..||++|||++|++.||||
T Consensus 256 ~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 256 AIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 8999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.60 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=169.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe-----
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV----- 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~----- 182 (820)
.++|++++.||+|+||+||+|++..+++.||||+++........+.+|+.+++.+. +|+||+++++++.
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS------DHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh------cCCCeeeeeeeeeecccC
Confidence 48999999999999999999999999999999998765444566778999998884 5899999999884
Q ss_pred ecceeEEEEeccC-CChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQRHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+.+++||||++ ++|.+++... ....+++..++.++.||++||.|||+++|+||||||+||+++ ..+.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEcc
Confidence 3457899999997 5888877532 224588999999999999999999999999999999999996 567799999
Q ss_pred cccccccCC---ccccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 260 FGSACTEDR---TVYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 260 FGlA~~~~~---~~~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
||++..... ......++..|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 999865432 2233468899999999853 3578899999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.29 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=207.2
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.++||+|+||.||++++..+++.||||.+... ....+.+.+|+.+++.+ .|+||+++++++...++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-------KHPNIVQYQESFEENGN 73 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-------CCCCeeeeEeeecCCCe
Confidence 689999999999999999999999999999998742 33455788899999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.|+||||+. ++|.+.+.......+++.+++.++.||+.||.|||+++++|+||+|+|||++ .++.++|+|||++..
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~ 150 (256)
T cd08218 74 LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARV 150 (256)
T ss_pred EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceee
Confidence 999999997 5898888765444689999999999999999999999999999999999995 567899999999865
Q ss_pred cCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
..... ....++..|+|||++.+..++.++|||||||++++|++|+.||......+....+.. + ..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~-~~~-------- 219 (256)
T cd08218 151 LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--G-SYP-------- 219 (256)
T ss_pred cCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--C-CCC--------
Confidence 43322 234578889999999988899999999999999999999999976655444333321 1 000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+ . ....
T Consensus 220 -------------------------------------------~------------------~-------------~~~~ 225 (256)
T cd08218 220 -------------------------------------------P------------------V-------------SSHY 225 (256)
T ss_pred -------------------------------------------C------------------C-------------cccC
Confidence 0 0 0013
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+..+.+||.+||+.||++||++.|+|+||||
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 226 SYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 4678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=351.74 Aligned_cols=252 Identities=29% Similarity=0.406 Sum_probs=218.0
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
++||.|.||+||-++++.+|+.||||+|.+. .....+..+|+.||+.+ .||.||.+--.|+..+.+++||
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-------~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-------HHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-------CCCCeeEEEEeecCCceEEEEe
Confidence 6899999999999999999999999999753 23346788999999999 7999999999999999999999
Q ss_pred eccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCcc-
Q 003438 192 ELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV- 270 (820)
Q Consensus 192 Ey~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~- 270 (820)
|-+.|+.++.|.....++|++...+.++.||+.||.|||-++|||+||||+|||+...+.-.++||||||+|+.+++..
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9999999999998888899999999999999999999999999999999999999877777899999999999887654
Q ss_pred -ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhh
Q 003438 271 -YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349 (820)
Q Consensus 271 -~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~ 349 (820)
...+||+.|+|||+++++.|+..-|+||+|||+|--+.|..||..+.+ +-.+|....-..|
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyP---------------- 784 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYP---------------- 784 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccC----------------
Confidence 456999999999999999999999999999999999999999965432 2222211110011
Q ss_pred hcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHH
Q 003438 350 CIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDF 429 (820)
Q Consensus 350 ~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DL 429 (820)
.. .+.+++..++||
T Consensus 785 ---------------------------------------------p~---------------------PW~eis~~Aidl 798 (888)
T KOG4236|consen 785 ---------------------------------------------PN---------------------PWSEISPEAIDL 798 (888)
T ss_pred ---------------------------------------------CC---------------------chhhcCHHHHHH
Confidence 11 122356789999
Q ss_pred HHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 430 LKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 430 I~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
|.++|+..=.+|.|.++.|.|||+++.+
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhhcch
Confidence 9999999999999999999999999864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=335.78 Aligned_cols=281 Identities=33% Similarity=0.610 Sum_probs=222.4
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
..++|++++.||.|+||.||+|++..+++.||||++.+. ....+.+.+|+++++.+ .||||++++++|..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~ 80 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-------RHENIISLSDIFIS 80 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-------CCCCeeeEeeeEec
Confidence 347899999999999999999999999999999988642 23345677899999988 68999999999876
Q ss_pred -cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 -QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 -~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
....|+||||++++|.++++.. .+++..++.++.||++||+|||+++|+||||||.||+++ ..+.+||+|||.
T Consensus 81 ~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~---~~~~~~l~dfg~ 154 (328)
T cd07856 81 PLEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN---ENCDLKICDFGL 154 (328)
T ss_pred CCCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC---CCCCEEeCcccc
Confidence 4678999999998988877643 488999999999999999999999999999999999995 678899999999
Q ss_pred ccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 263 ACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 263 A~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
+...........++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.+.++ .+++.+....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (328)
T cd07856 155 ARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG-TPPDDVINTI 233 (328)
T ss_pred ccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHHHhc
Confidence 9766555555677889999999876 5789999999999999999999999998888777888888888 4554443321
Q ss_pred hcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 342 KNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 342 ~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
... .+++.... . .. .....+.+
T Consensus 234 ~~~~~~~~~~~~~-------------------------------~-----~~---~~~~~~~~----------------- 257 (328)
T cd07856 234 CSENTLRFVQSLP-------------------------------K-----RE---PVPFSEKF----------------- 257 (328)
T ss_pred cchhhHHHHhhcc-------------------------------c-----cC---CCcHHHHc-----------------
Confidence 100 00000000 0 00 00000111
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++.+.+||++||+.||++|||++++|.||||....
T Consensus 258 ~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 258 KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 12347789999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.90 Aligned_cols=201 Identities=26% Similarity=0.421 Sum_probs=173.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++.+.||.|+||+||+|.+..+++.||+|++... ....+.+.+|+++|+.+ .|+||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-------NHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-------CCCCEEEEEEEEeeCCE
Confidence 4799999999999999999998889999999999743 23556788899998888 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhc-CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~-~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.++|||++. ++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||||+||+++ +++.+||+|||++.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~ 150 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSA 150 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHH
Confidence 999999997 588888876533 4689999999999999999999999999999999999996 56789999999985
Q ss_pred ccCCc-------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 265 TEDRT-------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 265 ~~~~~-------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
..... .....++..|+|||++... .++.++|||||||++|+|++|+.||...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~ 213 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh
Confidence 43321 1234678899999999877 7899999999999999999999999765543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.19 Aligned_cols=249 Identities=28% Similarity=0.455 Sum_probs=208.9
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++++.||.|+||.||.+++..+++.|++|.+... ......+.+|+++++++ +|+||+++++++...+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~~ 73 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-------QHPNIIAYYNHFMDDNT 73 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-------CCCCeeEEEeEEecCCe
Confidence 689999999999999999999999999999998743 34456788899999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+++||||+. ++|.+++.......+++..++.++.|++.+|.|||+.+|+|+||||+||+++ ..+.+||+|||++..
T Consensus 74 ~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~ 150 (256)
T cd08221 74 LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKI 150 (256)
T ss_pred EEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEE
Confidence 999999997 5899988776445689999999999999999999999999999999999996 567899999999865
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....++..|+|||++.+..++.++|||||||++|+|++|..||......+....+.. + .++
T Consensus 151 ~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~-~~~-------- 219 (256)
T cd08221 151 LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--G-NYT-------- 219 (256)
T ss_pred cccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--C-CCC--------
Confidence 4332 2345688999999999988899999999999999999999999987665444443321 1 000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+ .....
T Consensus 220 -------------------------------------------~-------------------------------~~~~~ 225 (256)
T cd08221 220 -------------------------------------------P-------------------------------VVSVY 225 (256)
T ss_pred -------------------------------------------C-------------------------------Ccccc
Confidence 0 00013
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
+..+.+||.+||..||++|||++|+|+|||+
T Consensus 226 ~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 226 SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 4668899999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=352.68 Aligned_cols=210 Identities=29% Similarity=0.380 Sum_probs=185.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
+.+++++.||+|.||.||+++... ...||+|.++......+.+.+|+++|++| .|+|||++++++..++.+|
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-------~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKL-------RHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhC-------cccCeEEEEEEEecCCceE
Confidence 556677899999999999997653 34699999998777778899999999999 6889999999999988999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||||||. |+|+++|+......+...+...++.|||+|++||+++++|||||.+.||||+ ++..+||+|||+|+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccC
Confidence 9999997 8999999986667799999999999999999999999999999999999995 77899999999999654
Q ss_pred Cccccc-c---ccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q 003438 268 RTVYSY-I---QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRIL 329 (820)
Q Consensus 268 ~~~~~~-~---gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~~l 329 (820)
+..... . -...|.|||.+....|+.|+|||||||+||||+| |+.||++.+..++++.+.+..
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy 421 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY 421 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC
Confidence 443322 1 2456999999999999999999999999999998 999999999999988876643
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=330.38 Aligned_cols=278 Identities=30% Similarity=0.527 Sum_probs=215.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.++||+|+||+||+|.++.+++.||||+++.. ......+.+|+++++.+ .|+||+++++++....
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-------~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-------NHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-------CCCCeeeeeheecCcc
Confidence 7899999999999999999999999999999999743 22334567799999888 6899999999987655
Q ss_pred ----------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeE
Q 003438 186 ----------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 186 ----------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~i 255 (820)
.+||||||+++++.+++... ...+++..++.++.||+.||+|||+.+|+|+||||+||+++ ..+.+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~---~~~~~ 155 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQI 155 (302)
T ss_pred hhhhccccCCcEEEEEcccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCcE
Confidence 89999999999888887654 34689999999999999999999999999999999999995 67889
Q ss_pred EEeecccccccCCcc----ccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003438 256 KIIDFGSACTEDRTV----YSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330 (820)
Q Consensus 256 KL~DFGlA~~~~~~~----~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG 330 (820)
||+|||.+....... .....+..|+|||++.+. .++.++|||||||++|+|++|++||...+..+.+..+.+..+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999986543221 123457789999988654 578999999999999999999999998888888888888777
Q ss_pred CCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 331 ~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
..++..+ +.......+ .... .+.... ..+....
T Consensus 236 ~~~~~~~-~~~~~~~~~-~~~~------------------------------------~~~~~~-~~~~~~~-------- 268 (302)
T cd07864 236 SPCPAVW-PDVIKLPYF-NTMK------------------------------------PKKQYR-RRLREEF-------- 268 (302)
T ss_pred CCChhhc-ccccccccc-cccc------------------------------------cccccc-cchhhhc--------
Confidence 4443321 111100000 0000 000000 0000000
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..++..+.+||.+||..||.+|||++++|+||||
T Consensus 269 ---------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 269 ---------SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ---------CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1134678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=329.43 Aligned_cols=198 Identities=27% Similarity=0.464 Sum_probs=170.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|++.++||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.+ +|+||+++++++...+.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-------~h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-------KHSNIVAYFGSYLRRDK 80 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-------CCCCeeeEEEEEEeCCE
Confidence 368999999999999999999999999999999998543 3345577899888888 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||++ ++|.+++... +.+++.+++.++.||+.||.|||++||+|+||||+||+++ ..+.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~ 155 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQ 155 (267)
T ss_pred EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeE
Confidence 999999998 5888887654 3699999999999999999999999999999999999995 667899999999864
Q ss_pred cCCc---cccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.... .....++..|+|||++. ...++.++|||||||++|+|++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 156 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 4322 23347889999999985 4468899999999999999999999986544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=337.82 Aligned_cols=282 Identities=32% Similarity=0.591 Sum_probs=218.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++++. +|+||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~------~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG------DHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc------CCCCccceeeeeccC
Confidence 47999999999999999999999999999999988532 233455678999999883 489999999998754
Q ss_pred --ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 185 --RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 185 --~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..+|+||||+.++|.+++... .+++..++.++.||+.||+|||++||+|+||||+||+++ .++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~ 153 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGL 153 (337)
T ss_pred CCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccc
Confidence 368999999999998888654 588999999999999999999999999999999999995 678999999999
Q ss_pred ccccCC--------ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 263 ACTEDR--------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 263 A~~~~~--------~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
+..... ......++..|+|||++.+. .++.++|||||||++|+|++|++||.+....+.+.++....+ .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~-~~ 232 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG-PP 232 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CC
Confidence 864322 22235678899999988654 678999999999999999999999999988888888888777 33
Q ss_pred chHHHHhhhc-cc-hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 334 PDYVLKEAKN-TS-KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 334 p~~~l~~~~~-~~-~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
+...+..... .. ..++... ......+..++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~--------- 264 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLP---------------------------------------SRPRKPLDELL--------- 264 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcc---------------------------------------cccccchhhhc---------
Confidence 3322221110 00 0000000 00000011111
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...+..+.+||.+||+.||++|||+.++|+||||++...
T Consensus 265 --------~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 265 --------PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred --------cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 114578999999999999999999999999999988543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=335.87 Aligned_cols=278 Identities=33% Similarity=0.576 Sum_probs=217.1
Q ss_pred ceEEEEEeccCCceeEEEeeccCC--CeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEM--NSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~t--g~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
+|++.+.||+|+||.||++++..+ ++.||||++... ....+.+.+|+.+++++. +|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR------GHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc------CCCChheeeeeeeec
Confidence 588999999999999999999888 899999998742 223456778999998884 589999999875432
Q ss_pred ----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 ----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
..+|+++|+++++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+||
T Consensus 75 ~~~~~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Df 149 (332)
T cd07857 75 PGNFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDF 149 (332)
T ss_pred cccCCcEEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcC
Confidence 468999999999999888654 3689999999999999999999999999999999999995 5678999999
Q ss_pred ccccccCCc-------cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 261 GSACTEDRT-------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 261 GlA~~~~~~-------~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
|++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...+..+.+..++..++ .
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~ 228 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-T 228 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-C
Confidence 998643321 223468899999998876 4789999999999999999999999999998999999999998 4
Q ss_pred CchHHHHhhhccc--hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 333 PPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 333 Pp~~~l~~~~~~~--~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
++...+....... .+..... . .....+..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~-------------------------------~--------~~~~~~~~~~-------- 261 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLP-------------------------------N--------IPKKPFESIF-------- 261 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhcc-------------------------------c--------cCCcchHhhC--------
Confidence 4444333211100 0000000 0 0000011110
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
...+..+.+||.+||++||++|||+.|+|+||||++
T Consensus 262 ---------~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 262 ---------PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred ---------CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 113467899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.58 Aligned_cols=254 Identities=24% Similarity=0.421 Sum_probs=208.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
..+|++.++||.|+||+||++.+..+++.||||.+... ....+.+.+|+.+++.+ .|+||+++++++...+.
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-------KNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-------CCCceeeeeeeEecCce
Confidence 37899999999999999999999999999999998753 23456678899999888 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+.+ +|.+++... .+++.++..++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++..
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~ 164 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchh
Confidence 9999999975 777776543 489999999999999999999999999999999999995 578899999999864
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.+..+... . .++
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~-~~~-------- 234 (296)
T cd06655 165 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G-TPE-------- 234 (296)
T ss_pred cccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-Ccc--------
Confidence 4322 22346788999999999888999999999999999999999999876654433322110 0 000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+......
T Consensus 235 -------------------------------------------------------------------------~~~~~~~ 241 (296)
T cd06655 235 -------------------------------------------------------------------------LQNPEKL 241 (296)
T ss_pred -------------------------------------------------------------------------cCCcccC
Confidence 0000113
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+..+.+||++||..||++|||+.++++||||+...
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 46788999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.34 Aligned_cols=197 Identities=31% Similarity=0.515 Sum_probs=169.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
+|.+.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ .|+||+++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~ 73 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-------QHENIVQYLG 73 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-------CCCCeeeEEE
Confidence 5778899999999999999999899999999886431 1234577889999888 6899999999
Q ss_pred EEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 180 YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
++...+..++||||+.+ +|.+++... +.+++..++.++.||+.||+|||+++|+||||||+||+++ ..+.+||+
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~---~~~~~~l~ 148 (267)
T cd06628 74 SSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD---NKGGIKIS 148 (267)
T ss_pred EEEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc---CCCCEEec
Confidence 99999999999999974 888888654 4589999999999999999999999999999999999995 67889999
Q ss_pred ecccccccCCc---------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 259 DFGSACTEDRT---------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 259 DFGlA~~~~~~---------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 99998654311 1123578889999999988899999999999999999999999976544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.53 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=207.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++.+.||.|+||.||+|++..+++.||||++... ......+.+|+++++.+ .|+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-------RSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-------CCCCeeeeeEEEEECCe
Confidence 4788999999999999999999999999999999754 23445677899999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+|+||+. ++|.+++... .+++..++.++.||+.||.|||+++|+|+||+|+||+++ ..+.++|+|||++..
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~ 147 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQ 147 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccccccee
Confidence 999999997 5888887754 589999999999999999999999999999999999996 578899999999966
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....++..|+|||++.+..++.++|||||||++|+|++|.+||...+.......+.... ++
T Consensus 148 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~-------- 216 (274)
T cd06609 148 LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PP-------- 216 (274)
T ss_pred ecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC---CC--------
Confidence 5432 234567888999999998889999999999999999999999997654332222211100 00
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
. + ....+
T Consensus 217 --------------------------------------------~-----------------------~------~~~~~ 223 (274)
T cd06609 217 --------------------------------------------S-----------------------L------EGNKF 223 (274)
T ss_pred --------------------------------------------C-----------------------C------ccccc
Confidence 0 0 00003
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+..+.+||.+||..||++|||++++|+||||++..
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 35688999999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.40 Aligned_cols=197 Identities=25% Similarity=0.456 Sum_probs=169.3
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+|+..++||+|+||.||++.+..+++.||+|+++... ...+.+.+|+++++++ .|+||+++++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~ 73 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-------NHPHIIRMLGATC 73 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-------CCCceehhhceec
Confidence 4778899999999999999999999999999997432 2356788899999998 6899999999999
Q ss_pred ecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+.+++||||+.+ +|.+++... +.+++..++.++.||+.||.|||++|++|+||||+||+++ .....+||+|||
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg 149 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFG 149 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEcccc
Confidence 99999999999984 888887654 3689999999999999999999999999999999999995 233469999999
Q ss_pred cccccCCc-------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 262 lA~~~~~~-------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.+...... .....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 98654322 123457888999999988889999999999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=373.30 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=205.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
.+|+++++||+|+||+||+|++..+++.||+|++... ......+..|+.+|+.| .|||||+++++|...
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-------~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-------KHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-------CCCCcCeEEEEEEecC
Confidence 7999999999999999999999999999999999743 34456788899999999 689999999998654
Q ss_pred -ceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccC-------CeeeccCCCCCcccccc----
Q 003438 185 -RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDA-------GIIHCDLKPENILLCTS---- 249 (820)
Q Consensus 185 -~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~-------gIVHrDLKPeNILl~~~---- 249 (820)
..+||||||+. ++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 57999999998 58998887532 24699999999999999999999984 49999999999999632
Q ss_pred ----------cCCCeEEEeecccccccCCc--cccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 250 ----------VKPAEIKIIDFGSACTEDRT--VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 250 ----------~~~~~iKL~DFGlA~~~~~~--~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
+....+||+|||++...... ....++|+.|+|||++.+. .++.++||||||||||+|++|..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 12345899999999754322 2345789999999999653 588999999999999999999999976
Q ss_pred CCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCcccccc
Q 003438 316 ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHH 395 (820)
Q Consensus 316 ~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~ 395 (820)
......+...+.. .|.
T Consensus 246 ~~~~~qli~~lk~---~p~------------------------------------------------------------- 261 (1021)
T PTZ00266 246 ANNFSQLISELKR---GPD------------------------------------------------------------- 261 (1021)
T ss_pred CCcHHHHHHHHhc---CCC-------------------------------------------------------------
Confidence 5443322221110 000
Q ss_pred chhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 396 KHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 396 ~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.|. ...+..+.+||.+||.+||.+|||+.|+|.||||+..
T Consensus 262 ---------lpi------------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 262 ---------LPI------------KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred ---------CCc------------CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 000 0123578999999999999999999999999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.02 Aligned_cols=197 Identities=28% Similarity=0.467 Sum_probs=169.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++++ .|+||+++++++..++.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-------~h~~ii~~~~~~~~~~~ 80 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-------KHCNIVAYFGSYLSREK 80 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-------CCCCeeeeeEEEEeCCE
Confidence 478999999999999999999999999999999997542 3345677899998888 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+++||||+. ++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||+++ ..+.+||+|||++..
T Consensus 81 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~ 155 (267)
T cd06646 81 LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAK 155 (267)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC---CCCCEEECcCcccee
Confidence 999999998 5888877654 3689999999999999999999999999999999999995 667899999999865
Q ss_pred cCCc---cccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
.... .....++..|+|||.+. ...++.++|||||||++|||++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 4322 23346788999999985 335788999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.15 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=205.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++++.||+|+||.||+|++..+++.||+|.++.. ......+.+|+.+++++ .|+||+++++++...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-------VSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-------CCCcHHhhhhheecCCe
Confidence 4688999999999999999999999999999998753 34456788899999988 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 187 LCICFELLDS-NLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+|+||||+.+ +|..++.... ...+++..++.++.||+.||.|||+ .+|+|+||||+||+++ ..+.+||+|||++
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~ 150 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVS 150 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCc
Confidence 9999999985 7777776531 2358999999999999999999996 6999999999999996 5788999999998
Q ss_pred cccCC-ccccccccccccCccccccc------cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 264 CTEDR-TVYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 264 ~~~~~-~~~~~~gt~~Y~APEvl~~~------~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
..... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+.......++.
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 229 (286)
T cd06622 151 GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT- 229 (286)
T ss_pred ccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCC-
Confidence 65432 22344678889999998654 35889999999999999999999997554333222222211100000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
.
T Consensus 230 --------------------------------------------------------------------~----------- 230 (286)
T cd06622 230 --------------------------------------------------------------------L----------- 230 (286)
T ss_pred --------------------------------------------------------------------C-----------
Confidence 0
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++.++.+||.+||..||++|||++++++||||....
T Consensus 231 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 --PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred --CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 001346788999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=330.37 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=206.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++++.||+|+||.||++.+..+++.||||.++... ...+.+.+|+.+++.+ .|+||+++++.+..+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-------ENPFVVSMFCSFETK 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-------CCCCeeeeEEEEecC
Confidence 36899999999999999999999999999999997542 2344667888888877 689999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++|+||||+.+ +|.+++... +.+++..++.++.||+.||.|||+++|+||||||+||+++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCc
Confidence 999999999985 888888654 3589999999999999999999999999999999999995 6788999999988
Q ss_pred cccCCc------------------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 264 CTEDRT------------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 264 ~~~~~~------------------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
...... .....++..|+|||.+.+..++.++|||||||++|||++|..||.+....+.+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 531100 01235677899999999888999999999999999999999999876655444433
Q ss_pred HHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcC
Q 003438 326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405 (820)
Q Consensus 326 ~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~ 405 (820)
..... . +
T Consensus 229 ~~~~~-~------------------------------------------------------------------------~ 235 (305)
T cd05609 229 ISDDI-E------------------------------------------------------------------------W 235 (305)
T ss_pred Hhccc-C------------------------------------------------------------------------C
Confidence 22100 0 0
Q ss_pred CCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCC---HHHHHcCCccCCCCC
Q 003438 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQASRHPFVTGEPF 458 (820)
Q Consensus 406 P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT---a~EaL~HPff~~~~~ 458 (820)
|. .....+..+.+||++||..||++||| +.|+|+||||...+.
T Consensus 236 ~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 236 PE----------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred CC----------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 00 00013467899999999999999998 899999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=323.10 Aligned_cols=196 Identities=26% Similarity=0.454 Sum_probs=167.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+|++.+.||+|+||+||+|.+ .+++.||||+++... .....+.+|+++|+.+ +|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~ 72 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-------KHVNIVQYLGTCL 72 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-------CCCCEeeEeeEee
Confidence 478889999999999999976 478899999987431 2234577899998888 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.+|+|+||||+||+++ ..+.+||+|||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg 147 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFG 147 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC---CCCeEEeccch
Confidence 9999999999997 5888888654 3589999999999999999999999999999999999995 67889999999
Q ss_pred cccccC---------CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 262 SACTED---------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 262 lA~~~~---------~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
++.... .......++..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 213 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh
Confidence 986431 112234678899999999988899999999999999999999999976543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=329.00 Aligned_cols=287 Identities=32% Similarity=0.585 Sum_probs=231.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.||.-++.++.|.- .|..|.|.-.++.||||.+... ....++..+|+.++..+ .|+||++++.+|.-..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-------~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-------NHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-------cccceeeeeeccCccc
Confidence 78999999999998 8888999999999999998643 33456778899999999 6889999999998653
Q ss_pred ------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 ------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..|+|||+|..+|.+++.. .++-+.++.|++|++.|++|||+.||+||||||+||++. .++.+||.|
T Consensus 89 ~l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~d 161 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILD 161 (369)
T ss_pred cHHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeecc
Confidence 6899999999999998873 378889999999999999999999999999999999995 778999999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||+|+..+.. ...++.|+.|+|||++.+..|...+||||+|||+.||++|+.+|++.+..++..++.+.+|.+-+.++
T Consensus 162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 9999876554 46678999999999999999999999999999999999999999999999999999999994444444
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
.+.....+.|+.. +..|+.. ++.++++..-+... .+
T Consensus 242 ~qL~~~~r~yv~~----------------~~~y~~~-----------------------~f~~~fpD~~f~~~-----~e 277 (369)
T KOG0665|consen 242 KQLQPTVRNYVEN----------------RPQYQAI-----------------------SFSELFPDSLFPVV-----LE 277 (369)
T ss_pred HHhhHHHHHHhhc----------------ChHhhcc-----------------------chhhhCCccccccc-----cc
Confidence 4433333333331 1122221 22222222211111 11
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~ 454 (820)
.+......+.||+.+||..||++|.++++||+||||+
T Consensus 278 ~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 278 GSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred CCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1223446789999999999999999999999999998
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.98 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=207.2
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..+.|.....||+|+||.||++.+..+++.||||++.... ...+.+.+|+.+++.+ .|+||+++++.+...+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-------HHENVVDMYNSYLVGD 92 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-------CCCcHHHHHHheecCC
Confidence 3366677788999999999999999999999999987533 3445678899988888 6899999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..|+||||+.+ +|.+++.. +.+++.+++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~ 166 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCA 166 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchh
Confidence 99999999985 67776643 3489999999999999999999999999999999999995 56789999999986
Q ss_pred ccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
..... .....++..|+|||++.+..++.++|||||||++|||++|+.||...+....+..+..... +.
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~------ 237 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP---PR------ 237 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---Cc------
Confidence 43222 2335688899999999888899999999999999999999999987655443333221110 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
+.....
T Consensus 238 --------------------------------------------------------------------------~~~~~~ 243 (292)
T cd06658 238 --------------------------------------------------------------------------VKDSHK 243 (292)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000001
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.+..+.+||.+||..||++|||++|+|+||||...+.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 3456889999999999999999999999999997553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.56 Aligned_cols=192 Identities=27% Similarity=0.452 Sum_probs=159.5
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
+||+|+||.||++.+..+++.||||++.+.. .......+|..+++.+.. ..|+||+.+++++...+..|+||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----GDCPFIVCMTYAFHTPDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh----CCCCcEeEEEEEEecCCeEEEEE
Confidence 4899999999999999999999999997532 112234455555555533 27899999999999999999999
Q ss_pred eccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC-c
Q 003438 192 ELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-T 269 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~-~ 269 (820)
||+. ++|.+++... +.+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++..... .
T Consensus 77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~---~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC---CCCCEEEccCCcceeccccC
Confidence 9998 5787777654 3599999999999999999999999999999999999995 667899999999865432 2
Q ss_pred cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 270 VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
.....++..|+|||++.. ..++.++|||||||++|+|++|..||...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 233468999999999864 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.93 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=208.7
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..++|++.++||+|+||+||++++..+++.||||++... ....+.+.+|+++++.+ .|+||+++++++.
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-------~h~niv~~~~~~~ 85 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-------RHPNTIEYKGCYL 85 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEE
Confidence 447899999999999999999999999999999998632 23345678899999988 6899999999999
Q ss_pred ecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 183 CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 183 ~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..+..|+||||+.++|.+++.... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++ +++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~ 161 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGS 161 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCc
Confidence 999999999999999988876543 4589999999999999999999999999999999999995 668899999999
Q ss_pred ccccCCccccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~~~~~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+...... ....++..|+|||++. ...++.++|||||||++|||++|.+||...+....+..+.. . .++.
T Consensus 162 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~-~~~~---- 233 (307)
T cd06607 162 ASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--N-DSPT---- 233 (307)
T ss_pred ceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--C-CCCC----
Confidence 8654332 3456788999999985 34688999999999999999999999976654433222111 0 0000
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
+ ..
T Consensus 234 -----------------------------------------------------------------------~------~~ 236 (307)
T cd06607 234 -----------------------------------------------------------------------L------SS 236 (307)
T ss_pred -----------------------------------------------------------------------C------Cc
Confidence 0 00
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++..+.+||.+||..||++|||+.+++.||||....
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 01346789999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=317.25 Aligned_cols=286 Identities=22% Similarity=0.446 Sum_probs=218.9
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
.+++|++++++|+|-|+.||.+.+..+++.++||+++. ...+.+.+|++||+.|. +|+||++++++..+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~------gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLR------GGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhcc------CCCCeeehhhhhcCccc
Confidence 45899999999999999999999999999999999984 33578899999999995 799999999999875
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
....|||||++..-+..+- ..++...++.++.||++||.|||++||+|||+||.|++|+ .+...++|+|+|+|.
T Consensus 108 ktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAE 181 (338)
T ss_pred cCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHh
Confidence 4678999999864332222 2478889999999999999999999999999999999997 466789999999996
Q ss_pred ccCC--ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~-~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.... .-.-.+.++.|.-||++... .|+..-|+|||||+|..|+..+ +.|.|.++.+++.+|.+++| .+++...
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG---t~el~~Y 258 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG---TDELYAY 258 (338)
T ss_pred hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC---hHHHHHH
Confidence 5433 33445678999999999775 6899999999999999999865 45588899999999999999 2332222
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
. .+.. +.-.-+++... ..+..+.|...+.. +. .-
T Consensus 259 l-------~KY~-------------------i~Ldp~~~~i~--------~~~~rk~w~~Fi~~---------~n---~h 292 (338)
T KOG0668|consen 259 L-------NKYQ-------------------IDLDPQFEDIL--------GRHSRKPWSRFINS---------EN---QH 292 (338)
T ss_pred H-------HHHc-------------------cCCChhHhhHh--------hccccccHHHhCCc---------cc---cc
Confidence 1 1111 00000000000 00111122222211 10 11
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
-.+++++|||.++|.+|-.+|+||+|++.||||..
T Consensus 293 l~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 293 LVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred cCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 14578999999999999999999999999999975
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.31 Aligned_cols=197 Identities=29% Similarity=0.470 Sum_probs=172.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++.+.||.|+||.||+|.++.+++.||+|++... ....+.+.+|+++++++ .|+||+++++++...+.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~ 73 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-------NSPYIVGFYGAFYNNGD 73 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-------CCCchhhhheeeecCCE
Confidence 3678889999999999999999999999999998764 34456778899999888 58999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+++|+||+. ++|.+++.... ..+++..++.++.||+.+|+|||+ .+++|+||||+||+++ ..+.+||+|||.+.
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~ 149 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSG 149 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccch
Confidence 999999998 68988887653 568999999999999999999999 9999999999999996 57789999999986
Q ss_pred ccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 265 TEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 265 ~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 150 QLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 44322 12256788899999999889999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.04 Aligned_cols=200 Identities=30% Similarity=0.454 Sum_probs=171.6
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--c
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--Q 184 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~ 184 (820)
+|++++.||.|+||.||+|.+..+++.||+|+++.. ....+.+..|+++++.+ .|+||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-------KHPNIVRYYDRIIDRSN 73 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-------CCCccceeeeeeecCCC
Confidence 588999999999999999999999999999998743 34456678899999988 68999999998764 3
Q ss_pred ceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcc-----cCCeeeccCCCCCcccccccCCCeEE
Q 003438 185 RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLK-----DAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLH-----s~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
..+|+||||+. ++|.+++.... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ ..+.+|
T Consensus 74 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~k 150 (265)
T cd08217 74 QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVK 150 (265)
T ss_pred CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEE
Confidence 56899999997 58888886542 346899999999999999999999 89999999999999996 568999
Q ss_pred EeecccccccCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 257 IIDFGSACTEDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 257 L~DFGlA~~~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 216 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH
Confidence 99999987554322 2456789999999999888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.53 Aligned_cols=197 Identities=27% Similarity=0.432 Sum_probs=173.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+|++.++||.|+||.||+|++..+++.||+|++.+.. ...+.+.+|+++++++ +||||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-------NHPFLVNLWYSFQDEE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-------CCCChHHHHHhhcCCC
Confidence 5899999999999999999999999999999997532 3456788899999888 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..|+||||+. ++|.+.+... ..+++..++.++.||++||.|||+++|+|+||||+||+++ +++.++|+|||.+.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeeccccc
Confidence 9999999997 4888888665 4699999999999999999999999999999999999996 67889999999986
Q ss_pred ccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 265 TEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 265 ~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 54332 2345678889999999988899999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.49 Aligned_cols=207 Identities=26% Similarity=0.403 Sum_probs=170.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccC----------------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCC
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE----------------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~----------------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~ 169 (820)
.++|++.++||+|+||.||+|++.. ++..||||+++.. ......+.+|+++|.++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------- 76 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL------- 76 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-------
Confidence 4799999999999999999997532 3457999999853 33456788999999988
Q ss_pred CCCceeEEeEEEeecceeEEEEeccC-CChHHHHHhhhc-----------------CCCCHHHHHHHHHHHHHHhhhccc
Q 003438 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF-----------------RGLSLSIVQLFSKQILRGLSLLKD 231 (820)
Q Consensus 170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----------------~~l~e~~i~~I~~QIl~aL~yLHs 231 (820)
.|+||+++++++...+..||||||+. ++|.+++..... ..+++..+..++.||+.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 68999999999999999999999997 589888865321 236778899999999999999999
Q ss_pred CCeeeccCCCCCcccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHH
Q 003438 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAEL 306 (820)
Q Consensus 232 ~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeL 306 (820)
+||+||||||+|||++ ..+.+||+|||++....... ....++..|+|||++....++.++|||||||++|||
T Consensus 157 ~~ivH~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 157 LNFVHRDLATRNCLVG---ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred CCccccCcchhheEEc---CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 9999999999999996 66889999999986543221 122346789999999988999999999999999999
Q ss_pred Hh--CCCCCCCCCHHHHHHH
Q 003438 307 FL--GLPLFPGASEFDLLRR 324 (820)
Q Consensus 307 lt--G~~PF~~~s~~d~l~~ 324 (820)
++ +..||...+..+.+..
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~ 253 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIEN 253 (304)
T ss_pred HHccCCCCCCcCCHHHHHHH
Confidence 86 5678876665554443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.71 Aligned_cols=202 Identities=27% Similarity=0.434 Sum_probs=175.7
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
+|++.++||+|+||.||++++..+++.||+|.++.. ....+.+.+|+.+++.+ .|+||+++++.+..++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-------KHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-------CCCCcceEEEEEEECCEE
Confidence 588999999999999999999999999999998643 34456778899998888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++ +++.++|+|||.+...
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLL 150 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC---CCCcEEEcccCcceee
Confidence 99999997 5898888765555689999999999999999999999999999999999995 6788999999998644
Q ss_pred CCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHH
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~ 321 (820)
... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+....
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 151 TSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred cccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 322 2335688899999999988899999999999999999999999976654433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.47 Aligned_cols=203 Identities=21% Similarity=0.360 Sum_probs=176.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
..|++.++||+|+||.||+|.+..+++.||+|+++.+......+.+|+++++.+ .|+||+++++++..++.++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-------CCCChhheEEEEcCCCCcE
Confidence 579999999999999999999999999999999987666667788999999998 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..++.++.||++||+|||+++|+||||||+||+++ +.+.+||+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~ 155 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT 155 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccc
Confidence 9999997 6899988765545689999999999999999999999999999999999995 67889999999986544
Q ss_pred Cccc----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 268 RTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 268 ~~~~----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
.... ....+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 214 (263)
T cd05052 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 214 (263)
T ss_pred cceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 3221 1123557999999998899999999999999999998 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=360.70 Aligned_cols=199 Identities=25% Similarity=0.343 Sum_probs=172.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe-CChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE-Eeec--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY-FVCQ-- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik-~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~-f~~~-- 184 (820)
.+++|.+.|.+|+|+.||+|++...+..||+|++- .++...+.+.+||++|++|. +|+|||.++|. ....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~------gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS------GHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc------CCCceeeEeccccccccC
Confidence 68899999999999999999999888889999875 46677888999999999996 79999999993 3221
Q ss_pred ----ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEE
Q 003438 185 ----RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 185 ----~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL 257 (820)
-+++|.||||. |.|.|++..+....|+|.+|++|++|+++|+++||... |||||||-|||||. .++.+||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KL 187 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKL 187 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEe
Confidence 36889999999 69999999776667999999999999999999999987 99999999999996 6789999
Q ss_pred eecccccccCCcc------------ccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 258 IDFGSACTEDRTV------------YSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 258 ~DFGlA~~~~~~~------------~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
||||.|+..-... .....|+.|||||++. +.+.+.|+|||+|||+||-||....||...
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 9999996432221 1124589999999984 668999999999999999999999999653
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.80 Aligned_cols=199 Identities=31% Similarity=0.527 Sum_probs=175.6
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
.|++.+.||+|++|.||++.+..+++.|++|++..... ..+.+.+|+++++.+ .|+||+++++++......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-------KHPNIVKYYGSYLKKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-------CCCCEeEEEEEEecCCeEE
Confidence 47889999999999999999998999999999986543 567788899999988 5899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+|+||+. ++|.+++.... ..+++..+..++.||+.+|.+||+++++|+||+|+||+++ ..+.++|+|||.+....
T Consensus 74 l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLS 149 (253)
T ss_pred EEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccc
Confidence 9999998 68888877653 4689999999999999999999999999999999999996 57889999999997655
Q ss_pred Ccc--ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 268 RTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 268 ~~~--~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..
T Consensus 150 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 203 (253)
T cd05122 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM 203 (253)
T ss_pred ccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 432 4557788999999998888999999999999999999999999765443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.02 Aligned_cols=191 Identities=29% Similarity=0.436 Sum_probs=164.7
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||+|+||+||+|.+..+++.||||++.... .....+.+|+++|+.+ .|+||+++++++...+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-------SSRFIVSLAYAFETKDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-------CCCCEeeeeeEEecCCeEEEEEe
Confidence 689999999999999999999999997432 2234556799999888 58999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC--c
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--T 269 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~--~ 269 (820)
|+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||.+..... .
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~ 150 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLGLAVELKGGKK 150 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC---CCCCEEEccCcchhhhccCCc
Confidence 998 5888888765545699999999999999999999999999999999999995 667899999999865432 2
Q ss_pred cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 233466788999999988889999999999999999999999996544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.24 Aligned_cols=198 Identities=27% Similarity=0.450 Sum_probs=169.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
++|++.++||.|++|.||+|.+..+++.||+|++.... .....+.+|+++++.+ +|+||++++++|...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-------KSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-------CCCCeeeeeeEEEccCC
Confidence 46899999999999999999999999999999998542 3556788899999888 689999999998654
Q ss_pred ceeEEEEeccC-CChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 RHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+.+|+||||++ ++|.+++... ....+++..+..++.||+.||.|||+.+++|+||+|+||+++ ..+.++|+|||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg 150 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFG 150 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeecc
Confidence 47899999997 5888776542 234589999999999999999999999999999999999996 56789999999
Q ss_pred cccccCCcc-ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 262 SACTEDRTV-YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 262 lA~~~~~~~-~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++....... ....++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 986443222 2345688899999999889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.09 Aligned_cols=252 Identities=24% Similarity=0.428 Sum_probs=206.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
..|+++++||.|+||.||+|.+..+++.||||+++.. ......+.+|+++++.+ .|+||+++++++.....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEECCE
Confidence 5788899999999999999999999999999999854 34456778899998888 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.||||||+.+ +|.+++... .+++..+..++.|++.||+|||+.+++|+||+|+||+++ ..+.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~ 150 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQ 150 (277)
T ss_pred EEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEccccccee
Confidence 9999999974 888887643 589999999999999999999999999999999999996 667899999999854
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....++..|+|||++.+..++.++|||||||++|||++|.+||...........+.. + .++
T Consensus 151 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~-~~~-------- 219 (277)
T cd06640 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--N-NPP-------- 219 (277)
T ss_pred ccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--C-CCC--------
Confidence 4322 2234578889999999988899999999999999999999999976543322211100 0 000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
. .....
T Consensus 220 ------------------------------------------------------~--------------------~~~~~ 225 (277)
T cd06640 220 ------------------------------------------------------T--------------------LTGEF 225 (277)
T ss_pred ------------------------------------------------------C--------------------Cchhh
Confidence 0 00113
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
+..+.+||.+||..||++|||++++|+|+||.....
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 466889999999999999999999999999987664
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.03 Aligned_cols=202 Identities=27% Similarity=0.401 Sum_probs=173.0
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.+.||+|+||.||++.++.++..||+|.+... ....+.+.+|+++++.+ .|+||+++++.+.....
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-------~h~~i~~~~~~~~~~~~ 73 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-------KHPNIVTFFASFQENGR 73 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-------CCCChhhhhheeccCCe
Confidence 588999999999999999999999999999999753 23345677899999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.|+|+||+. ++|.+++.......+++..++.++.||++||.|||+.+|+|+||||+||+++ .....+||+|||.+..
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 74 LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQ 151 (257)
T ss_pred EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchh
Confidence 999999997 5898888765544589999999999999999999999999999999999996 2334679999999865
Q ss_pred cCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
..... ....+++.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred ccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 43322 23457888999999988889999999999999999999999997655433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=326.20 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=202.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+..++||+|+||.||++++..+++.||||++... ......+.+|+.++.++. +|+||+++++++..++.
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~------~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS------DCPYIVKFYGALFREGD 77 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc------CCCCEeeeeeEEecCCc
Confidence 4667778999999999999999999999999998753 234456778988888873 48999999999999999
Q ss_pred eEEEEeccCCChHHHHH---hhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 187 LCICFELLDSNLYELIK---INHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~---~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.++||||+..++.++.. ......+++..+..++.|++.||+|||+ .+|+||||||+||+++ ..+.+||+|||+
T Consensus 78 ~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~ 154 (288)
T cd06616 78 CWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGI 154 (288)
T ss_pred EEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecch
Confidence 99999999877665443 2223569999999999999999999997 5999999999999996 567899999999
Q ss_pred ccccCCc--cccccccccccCccccccc---cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 263 ACTEDRT--VYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 263 A~~~~~~--~~~~~gt~~Y~APEvl~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
+...... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||.... .....+.+.....++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~- 231 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL- 231 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-
Confidence 8643322 2334678899999999876 68999999999999999999999996543 12222222111000000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+ ..
T Consensus 232 --------------------------------------------------------------------~------~~--- 234 (288)
T cd06616 232 --------------------------------------------------------------------S------NS--- 234 (288)
T ss_pred --------------------------------------------------------------------C------Cc---
Confidence 0 00
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....++..+.+||++||..||++|||++|+++||||...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 001144678999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.74 Aligned_cols=193 Identities=24% Similarity=0.380 Sum_probs=161.8
Q ss_pred CceEEEEEe--ccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLL--GHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~L--G~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++.+.+ |+|+||.||+++++.+++.+|+|++....... .|+.+...+. +|+||++++++|...+.
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~------~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMK------DNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhh------cCCCEEEEEEEEecCCe
Confidence 456666665 99999999999999999999999997542111 1333332221 58999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC-eEEEeeccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~-~iKL~DFGlA~ 264 (820)
+|+||||+. ++|.+++.... .+++.+++.++.||++||.|||+.+|+||||||+||+++ ..+ .++|+|||++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCK 158 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccce
Confidence 999999997 69999887653 699999999999999999999999999999999999996 344 89999999986
Q ss_pred ccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 265 TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 265 ~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
..... ....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 159 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 159 IIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 55433 23467889999999998899999999999999999999999997543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.99 Aligned_cols=319 Identities=23% Similarity=0.367 Sum_probs=251.4
Q ss_pred CccccceeccchhhHhhhhhHHHHhhhcCCCcccccccCC-------Ccccc---CCCccccCC--CccCCCCcceEeec
Q 003438 32 DAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNP-------KRYLT---SPSVGVLND--GYDNVNSDLILAVN 99 (820)
Q Consensus 32 ~~~~l~~~~~~~~~~~Lt~~i~~~y~~~~p~~~~~~~~~~-------~r~~t---~p~~~~~n~--g~d~~~~d~~~~l~ 99 (820)
+++||+......+.+.|+++--++|++-.+.-.. ++... .+.-. .|....... ...+.. ..
T Consensus 271 gisEl~K~p~~GWyKlLsqeEGEyyNvp~~~~~~-e~~~~lr~k~~~~~~~~~~s~p~~~~~~~~~~~~~~~------~~ 343 (683)
T KOG0696|consen 271 GISELQKAPVDGWYKLLSQEEGEYYNVPVPDEDS-EDNEELRQKFERARIGPGSSKPEKKTMPTDSKFHNSS------KR 343 (683)
T ss_pred cHHHHhhcchhhHHHHhhhhcCceeccCCCCchh-hHHHHHHHHHhhcccCCCcCCCCCCCCCCcccCCCCC------cc
Confidence 7899999999999999999999999876654321 11111 11111 111111111 111111 11
Q ss_pred eeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCcee
Q 003438 100 LVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIV 175 (820)
Q Consensus 100 ~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIV 175 (820)
+.+ ...+|.++.+||+|+||.|.++..+.+.+.+|||+++++ ..+.+-.+.|.++|.... .-|.++
T Consensus 344 d~i----~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~------kppFL~ 413 (683)
T KOG0696|consen 344 DRI----KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG------KPPFLV 413 (683)
T ss_pred cce----eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCC------CCchHH
Confidence 111 126889999999999999999999999999999999874 344555667777776654 347899
Q ss_pred EEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCe
Q 003438 176 RIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 176 kl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
+++.+|+.-+.+|+||||+.| +|--.|++ .+.+.|..+..++.+|+.||-|||++|||.||||.+|||++ .++.
T Consensus 414 qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd---~eGH 488 (683)
T KOG0696|consen 414 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---SEGH 488 (683)
T ss_pred HHHHHhhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec---cCCc
Confidence 999999999999999999985 66655544 35699999999999999999999999999999999999995 8899
Q ss_pred EEEeecccccc---cCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003438 255 IKIIDFGSACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331 (820)
Q Consensus 255 iKL~DFGlA~~---~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~ 331 (820)
|||+|||+++. ......+.|||+.|+|||++.-++|+..+|.||+||+||||+.|++||.+.++.++.+.|++..-
T Consensus 489 iKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv- 567 (683)
T KOG0696|consen 489 IKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV- 567 (683)
T ss_pred eEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC-
Confidence 99999999964 34556778999999999999999999999999999999999999999999999999888876322
Q ss_pred CCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 332 ~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
.||
T Consensus 568 ------------------------------------------------------------------------syP----- 570 (683)
T KOG0696|consen 568 ------------------------------------------------------------------------SYP----- 570 (683)
T ss_pred ------------------------------------------------------------------------cCc-----
Confidence 011
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCH-----HHHHcCCccCCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPF 458 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa-----~EaL~HPff~~~~~ 458 (820)
..++.++.++++.+|...|.+|+.+ .++-+||||+...+
T Consensus 571 --------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 571 --------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred --------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 1245678899999999999999865 68999999998655
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=316.80 Aligned_cols=197 Identities=29% Similarity=0.490 Sum_probs=168.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..|++.++||+|+||.||++++..+++.||||++... ....+.+.+|+.+++++ .|+||+++++++.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~ 74 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-------LHERIVQYYGCLR 74 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-------CCCCeeeEEeEec
Confidence 5799999999999999999999999999999998632 22345677899999988 6899999999987
Q ss_pred ec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+. ..+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ ..+.+||+|
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~D 149 (265)
T cd06652 75 DPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGD 149 (265)
T ss_pred cCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECc
Confidence 64 46889999997 5888887654 3589999999999999999999999999999999999995 668899999
Q ss_pred cccccccCC------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 260 FGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 260 FGlA~~~~~------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
||++..... ......++..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 999864321 1233467889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.77 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=206.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..|...++||+|++|.||++.+..+++.||||+++... ...+.+.+|+.+++.+ +|+||+++++++...++.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-------~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-------CCCChheEEEEEEcCCeE
Confidence 45666789999999999999999999999999987533 3345677899998888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+|+||+. ++|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+||+++ .++.++|+|||.+...
T Consensus 92 ~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQV 165 (285)
T ss_pred EEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhh
Confidence 99999997 588888766 3589999999999999999999999999999999999995 6788999999987543
Q ss_pred CCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+....+..+... .++.
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~-------- 234 (285)
T cd06648 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPK-------- 234 (285)
T ss_pred ccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCC--------
Confidence 322 22346888999999999888999999999999999999999999765544433332211 0000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
. ......+
T Consensus 235 --------------------------------------------~----------------------------~~~~~~~ 242 (285)
T cd06648 235 --------------------------------------------L----------------------------KNLHKVS 242 (285)
T ss_pred --------------------------------------------C----------------------------cccccCC
Confidence 0 0000133
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+.+||++||..||++|||+.|+|+||||++.+
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 5789999999999999999999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.86 Aligned_cols=196 Identities=28% Similarity=0.530 Sum_probs=167.3
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
+|.+.+.||+|+||.||+|.+..+++.||||.++... ...+.+.+|+.+++.+ +|+||++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~ 74 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-------DHLNIVQYL 74 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-------CCCCcceEE
Confidence 5889999999999999999999999999999986321 1223566788888888 689999999
Q ss_pred EEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
+++...+.+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+||+++ .++.++|
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~---~~~~~~l 149 (272)
T cd06629 75 GFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD---ADGICKI 149 (272)
T ss_pred EEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc---CCCeEEE
Confidence 99999999999999997 5888888765 4689999999999999999999999999999999999995 6789999
Q ss_pred eecccccccCCc-----cccccccccccCcccccccc--ccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 258 IDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 258 ~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~--yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
+|||++...... .....++..|+|||++.... ++.++|||||||++|+|++|..||....
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 999998654321 22345788899999987654 8899999999999999999999996544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.92 Aligned_cols=205 Identities=20% Similarity=0.307 Sum_probs=170.9
Q ss_pred CceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+|++.++||+|+||.||+|+.+ ..+..||+|+++.. ......+.+|+.+++++ .||||+++++++..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~ 77 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-------DHSNIVRLEGVITR 77 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-------CCCCcCeEEEEEec
Confidence 68999999999999999999764 45678999999864 23345678899988887 68999999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
++..||||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~---~~~~~~l~dfg~ 153 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRR 153 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc---CCCcEEECCCcc
Confidence 9999999999985 7777776543 4689999999999999999999999999999999999995 567899999998
Q ss_pred ccccCCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 263 ACTEDRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 263 A~~~~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
+....... ....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~ 220 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA 220 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 75432211 11234567999999999999999999999999999775 9999987766554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=320.33 Aligned_cols=207 Identities=26% Similarity=0.407 Sum_probs=173.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.+.||+|+||.||+|.+.. +...||+|.++.. ......+.+|+.+++.+ +|+||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~ 77 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-------NHQNIVRLIGV 77 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEE
Confidence 3789999999999999999999877 7789999998743 23345678899999888 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhc-----CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCe
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
+...+..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++++||||||+|||++.+.....
T Consensus 78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence 999999999999996 689998876532 24899999999999999999999999999999999999975444557
Q ss_pred EEEeecccccccCCccc-----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 255 IKIIDFGSACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 255 iKL~DFGlA~~~~~~~~-----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
+||+|||++........ ....+..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999975532211 1223467999999998899999999999999999997 9999987665443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.63 Aligned_cols=256 Identities=22% Similarity=0.398 Sum_probs=207.1
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
...++|++.+.||+|+||+||++.+..+++.||+|.+... ....+.+.+|+.+++.+ .|+||+++++++...
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~hp~i~~~~~~~~~~ 88 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-------KHPNIVNYLDSYLVG 88 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-------CCCCeeehhheeeeC
Confidence 3458999999999999999999999889999999998743 33345678899888887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..|+|+||+. ++|.+++... .+++..+..++.||+.||.|||++|++|+||||+||+++ ..+.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~ 162 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFC 162 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcce
Confidence 99999999997 5888887653 488999999999999999999999999999999999996 5678999999987
Q ss_pred cccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
...... .....+++.|+|||.+....++.++|||||||++|+|++|+.||...+..+.+..+.. +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~~~------- 233 (293)
T cd06647 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTP------- 233 (293)
T ss_pred ecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CCCC-------
Confidence 543221 2234678889999999888899999999999999999999999976544322111100 0000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.+ + ...
T Consensus 234 ---------------------------------------------------~~------------~-----------~~~ 239 (293)
T cd06647 234 ---------------------------------------------------EL------------Q-----------NPE 239 (293)
T ss_pred ---------------------------------------------------CC------------C-----------Ccc
Confidence 00 0 001
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+..+.+||++||..||++|||+.|++.|+||+...
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 1345688999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.63 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=207.3
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.+.||.|+||.||++.+..+++.||+|++... ....+.+.+|+++++.+ .|+|++++++.+...+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~~~~~~~~~~~~~~ 73 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-------NHPNIIKYYESFEEKGK 73 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-------CCCChhheEEEEecCCE
Confidence 588999999999999999999999999999999854 24556788899999988 58999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 187 LCICFELLDS-NLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.++|+|++++ +|.+.+.... ...+++..+..++.||+.||.|||++|++|+||+|+||+++ ..+.++|+|||++
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~ 150 (258)
T cd08215 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGIS 150 (258)
T ss_pred EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccce
Confidence 9999999985 8988887653 35699999999999999999999999999999999999996 5688999999998
Q ss_pred cccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
...... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||...+..+....+.+... +
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---~------ 221 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY---P------ 221 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC---C------
Confidence 654332 2334678889999999988899999999999999999999999976654333332211000 0
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
..| .
T Consensus 222 ---------------------------------------------------------------~~~-------------~ 225 (258)
T cd08215 222 ---------------------------------------------------------------PIP-------------S 225 (258)
T ss_pred ---------------------------------------------------------------CCC-------------C
Confidence 000 0
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+..+.++|++||..||++|||+.|+|+||||
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 133678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.00 Aligned_cols=254 Identities=24% Similarity=0.438 Sum_probs=205.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.-|....+||+|+||.||++.+..+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++...+..
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-------QHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-------CCCchhhhhhheeeCCeE
Confidence 4455566899999999999999999999999998743 23345677898888887 689999999999999999
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||++...
T Consensus 94 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQI 167 (297)
T ss_pred EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhc
Confidence 999999985 77776644 3489999999999999999999999999999999999995 6788999999998643
Q ss_pred CCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... .....++..|+|||++.+..++.++|||||||++|||++|+.||......+.+..+.. .++..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~----~~~~~------- 236 (297)
T cd06659 168 SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD----SPPPK------- 236 (297)
T ss_pred ccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----cCCCC-------
Confidence 322 2345688999999999988999999999999999999999999976665444333211 00000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+ ......+
T Consensus 237 -------------------------------------------------~-----------------------~~~~~~~ 244 (297)
T cd06659 237 -------------------------------------------------L-----------------------KNAHKIS 244 (297)
T ss_pred -------------------------------------------------c-----------------------cccCCCC
Confidence 0 0000133
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..+.+||++||+.||++|||++|+++||||.+...
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 56889999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.03 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=176.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|+++++||+|+||.||+|.+. +++.||+|.++......+.+.+|+.+++.+ .|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-------QHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-------CCCCeeeEEEEEcCCCCc
Confidence 378999999999999999999864 456799999886655567888999999998 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||||+. ++|.+++.......+++..++.++.||+.||+|||+++++||||||+||+++ ..+.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVI 153 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceec
Confidence 99999996 6999998776556689999999999999999999999999999999999996 6788999999999755
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
.... ....++..|+|||++....++.++|||||||++|+|++ |..||......+....
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence 4322 12234567999999988889999999999999999998 9999987665544433
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.52 Aligned_cols=197 Identities=28% Similarity=0.491 Sum_probs=167.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+.+++.+ .|+||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~ 74 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-------QHERIVQYYGCLR 74 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-------CCCCeeeEEEEEE
Confidence 3688999999999999999999999999999998642 12345677899999988 6899999999987
Q ss_pred ec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.. ..+++||||+. ++|.+.+.... .+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|
T Consensus 75 ~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---~~~~~~l~d 149 (266)
T cd06651 75 DRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGD 149 (266)
T ss_pred cCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEcc
Confidence 63 57899999997 58888886543 589999999999999999999999999999999999995 567899999
Q ss_pred cccccccCC------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 260 FGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 260 FGlA~~~~~------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
||++..... ......++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 999864322 1122457888999999998889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.81 Aligned_cols=196 Identities=31% Similarity=0.487 Sum_probs=170.2
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
+|+..+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+++++.+ .|+||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~ 73 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-------QHPNIVQYLGTERE 73 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-------CCCCchheeeeEec
Confidence 5778899999999999999999899999999987432 3456788899999888 68999999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
...+++||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.+|+|+||||+||+++ ..+.+||+|||.
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~ 148 (258)
T cd06632 74 EDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGM 148 (258)
T ss_pred CCeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCcc
Confidence 9999999999974 888888654 3589999999999999999999999999999999999996 568899999999
Q ss_pred ccccCCc--cccccccccccCcccccccc-ccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 263 ACTEDRT--VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 263 A~~~~~~--~~~~~gt~~Y~APEvl~~~~-yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
+...... .....++..|+|||.+.... ++.++|||||||++|+|++|+.||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 149 AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 8654322 23456788999999998766 8999999999999999999999997554
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.25 Aligned_cols=196 Identities=25% Similarity=0.471 Sum_probs=162.4
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
+.||+|+||.||+|.+..+++.||||++++... .......|..++... ..|+||+++++++..++.+|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~------~~~~~i~~~~~~~~~~~~~~lv 75 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ------GESPYVAKLYYSFQSKDYLYLV 75 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhc------CCCCCeeeeeeeEEcCCeEEEE
Confidence 579999999999999999999999999975432 112233344333322 2689999999999999999999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~ 269 (820)
|||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||+|+||+++ ..+.+||+|||++.....
T Consensus 76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~- 149 (260)
T cd05611 76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLE- 149 (260)
T ss_pred EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceeccc-
Confidence 99997 5888888654 3589999999999999999999999999999999999996 567899999999865433
Q ss_pred cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 003438 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l 322 (820)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 202 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 23346788899999999888999999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.42 Aligned_cols=206 Identities=28% Similarity=0.388 Sum_probs=173.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC-----eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN-----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg-----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.+.||+|+||.||+|.+...+ +.||+|+++.. ......+.+|+.++..+ .|+||+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~i~~~~~~~ 77 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-------QHPNIVCLLGVC 77 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-------CCcccceEEEEE
Confidence 68999999999999999999876554 78999999743 33455678899999888 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhc--------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl 246 (820)
...+..|+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+++|+|+||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 99999999999997 689998876421 458899999999999999999999999999999999999
Q ss_pred ccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 247 CTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 247 ~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+ +++.+||+|||++...... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus 158 ~---~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 158 G---EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred c---CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 6 5678999999998643221 123355788999999998899999999999999999998 999998766554
Q ss_pred HHHH
Q 003438 321 LLRR 324 (820)
Q Consensus 321 ~l~~ 324 (820)
....
T Consensus 235 ~~~~ 238 (283)
T cd05048 235 VIEM 238 (283)
T ss_pred HHHH
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=316.14 Aligned_cols=189 Identities=26% Similarity=0.454 Sum_probs=166.2
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||.|+||.||+|++..+++.||||++.... ...+.+.+|+++++.+ +|+||+++++.+..+..+|+|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-------NHPFIVKLYRTFKDKKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-------CCCCEeeeeeeEEcCCccEEEEe
Confidence 689999999999999999999999997532 3446678899998888 68999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc--
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-- 269 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-- 269 (820)
|+. ++|.+++... ..+++..++.++.||+.||+|||+++++|+||||+||+++ .++.+||+|||++......
T Consensus 74 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccc
Confidence 997 6899888764 3589999999999999999999999999999999999996 5678999999999765432
Q ss_pred cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.....++..|++||.+.+..++.++|||||||++|+|++|..||....
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 234567889999999988889999999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.27 Aligned_cols=275 Identities=25% Similarity=0.359 Sum_probs=223.2
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.+.+.|+.-++||+|+||.|+-|+.+.||+.+|+|.+.++. ......++|-.||.+++ .+.||.+--.|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-------s~FiVslaYAf 254 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-------SPFIVSLAYAF 254 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-------cCcEEEEeeee
Confidence 34578899999999999999999999999999999987542 33456788999999994 56999999999
Q ss_pred eecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
+.++.+|+||..|.| +|.-.|.......+++..++.++.+|+.||++||+.+||.|||||+|||++ +.|.|+|.|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD---d~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD---DHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec---cCCCeEeecc
Confidence 999999999999985 666555554445799999999999999999999999999999999999995 8899999999
Q ss_pred ccccccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 261 GSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 261 GlA~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
|+|+... +.....+||..|||||++.+..|+...|.|+|||+||||+.|+.||....+....+.+-+..-
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-------- 403 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-------- 403 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--------
Confidence 9997653 445566999999999999999999999999999999999999999975443332222221110
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
. +..+.
T Consensus 404 -----------------------------------------------------------------~---------~~~ey 409 (591)
T KOG0986|consen 404 -----------------------------------------------------------------E---------DPEEY 409 (591)
T ss_pred -----------------------------------------------------------------c---------chhhc
Confidence 0 11112
Q ss_pred hHHhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCCCCCCCCCCCCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPFTCPYQPPPETPRVP 472 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~~~~~~~~~~~p~~~ 472 (820)
...+++++++|++.+|..||++|+ .++++-+||||+...+...+.-+-++|.+|
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCC
Confidence 234678999999999999999998 567999999999988765544444444443
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.66 Aligned_cols=195 Identities=31% Similarity=0.498 Sum_probs=170.5
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~---~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.+.||+|+||.||++.+..+++.||||+++.... ..+.+.+|+.+++.+ .|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~ 73 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-------KHPNLVKYYGVEVHREK 73 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-------CCCChhheeeeEecCCE
Confidence 68999999999999999999998999999999986533 567788999999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+|+||+|+||+++ ..+.+||+|||++..
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~ 148 (264)
T cd06626 74 VYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVK 148 (264)
T ss_pred EEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccc
Confidence 999999997 5888887654 3488999999999999999999999999999999999996 578899999999865
Q ss_pred cCCcc-------ccccccccccCcccccccc---ccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 266 EDRTV-------YSYIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 266 ~~~~~-------~~~~gt~~Y~APEvl~~~~---yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
..... ....++..|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 43221 1245678899999998765 889999999999999999999999654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=314.24 Aligned_cols=196 Identities=30% Similarity=0.469 Sum_probs=173.9
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
+|++.+.||+|++|.||+|++..+++.||||++.... ...+.+.+|+.++..+ .|+||+++++++...+.+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-------ESPYVVKCYGAFYKEGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEccCCeE
Confidence 6889999999999999999999999999999998653 3567788899999988 589999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++||||+. ++|.+++... ..+++..++.++.||++||+|||+ .+++|+||+|+||+++ .++.++|+|||.+..
T Consensus 75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~---~~~~~~l~df~~~~~ 149 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKV 149 (264)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC---CCCCEEEccCcccee
Confidence 99999998 6899888765 469999999999999999999999 9999999999999996 678899999999865
Q ss_pred cCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
..... ....++..|+|||.+....++.++|||||||++|+|++|..||....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 150 LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred cccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 43322 23467888999999998889999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.60 Aligned_cols=201 Identities=32% Similarity=0.532 Sum_probs=173.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||++++..+++.||||++... ....+.+.+|+++++++. +|+||+++++++...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~------~~~~i~~~~~~~~~~ 74 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN------GHPGIIKLYYTFQDE 74 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc------cCCCchhHHHHhcCC
Confidence 4799999999999999999999999999999999752 233456778888888883 389999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..++|||++. ++|.+++.... .+++..++.++.||+.||.|||+++++|+||||+||+++ .++.++|+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~ 149 (280)
T cd05581 75 ENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTA 149 (280)
T ss_pred ceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccc
Confidence 99999999994 79999887653 699999999999999999999999999999999999995 6688999999998
Q ss_pred cccCCcc-----------------------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 264 CTEDRTV-----------------------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 264 ~~~~~~~-----------------------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
....... ....++..|+|||++....++.++|||||||++++|++|..||.......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 6433221 22356788999999988889999999999999999999999998766433
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=321.53 Aligned_cols=192 Identities=26% Similarity=0.430 Sum_probs=159.6
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
.||+|+||.||+|++..+++.||||++.+.. ........|..+++.++. .+|++|+++++++...+.+|+||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST----GDCPFIVCMSYAFHTPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh----CCCCcEeeeeeeeecCCEEEEEE
Confidence 4899999999999999999999999987532 112234455555555543 27999999999999999999999
Q ss_pred eccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC-c
Q 003438 192 ELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-T 269 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~-~ 269 (820)
||+. ++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++..... .
T Consensus 77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCccC
Confidence 9997 4777776543 4699999999999999999999999999999999999996 567899999999864432 2
Q ss_pred cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 270 VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
.....++..|+|||++.+. .++.++||||+||++|+|++|+.||...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2345789999999999754 6899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.24 Aligned_cols=199 Identities=20% Similarity=0.255 Sum_probs=163.2
Q ss_pred EEeccC--CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHG--TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G--~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
..||+| +|++||+|++..+++.||||++... ....+.+.+|+.+++.+ +|+||++++++|..++.+|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-------~h~niv~~~~~~~~~~~~~~ 76 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-------RHPNIMTSWTVFTTGSWLWV 76 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCcceEeeeEecCCceEE
Confidence 456666 9999999999999999999998743 23346677888888777 68999999999999999999
Q ss_pred EEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 190 VmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+||+||+.+.....
T Consensus 77 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 77 ISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred EEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhc
Confidence 999998 5888888776545699999999999999999999999999999999999996 567899999986532111
Q ss_pred ---c-------cccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 003438 269 ---T-------VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323 (820)
Q Consensus 269 ---~-------~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~ 323 (820)
. .....++..|+|||++.+. .++.++|||||||++|+|++|.+||........+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 0 0111235669999999764 57899999999999999999999998766544433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.42 Aligned_cols=205 Identities=23% Similarity=0.355 Sum_probs=173.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.+.||+|+||.||+++.+. +..||+|.++........+.+|+.+|+++ +|+||+++++++...+..|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKL-------SHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHC-------CCCCceeEEEEEccCCCEE
Confidence 679999999999999999997654 56799999886655556788899999998 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+|||.+....
T Consensus 76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVL 151 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccC
Confidence 9999997 68888886543 3589999999999999999999999999999999999995 66789999999986543
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i 214 (256)
T cd05114 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214 (256)
T ss_pred CCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 211 11234567999999998899999999999999999999 89999877655554443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=341.79 Aligned_cols=248 Identities=28% Similarity=0.454 Sum_probs=204.7
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEecc
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL 194 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~ 194 (820)
+||+|+||+||.|+|..++..+|||.|... ....+-...||.+.++|+ |.|||++++.+..++++-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-------HkNIVrYLGs~senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-------HKNIVRYLGSVSENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh-------hHhHHHHhhccCCCCeEEEEeecC
Confidence 699999999999999999999999999854 455667788999999995 569999999999999999999999
Q ss_pred C-CChHHHHHhhhcCCC--CHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc---CC
Q 003438 195 D-SNLYELIKINHFRGL--SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE---DR 268 (820)
Q Consensus 195 ~-gsL~d~l~~~~~~~l--~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~---~~ 268 (820)
. |+|.++++.. .+++ .|..+-.+.+||++||.|||++.|||||||-+||||+ .-.|.+||.|||.++.. +.
T Consensus 655 PGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 655 PGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred CCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc
Confidence 7 5777777654 5677 8899999999999999999999999999999999996 46799999999998653 34
Q ss_pred ccccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccch
Q 003438 269 TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346 (820)
Q Consensus 269 ~~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~ 346 (820)
...++.||..|||||++..+ .|+.++|||||||++.||.||+|||..... |...|.+-.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--------------pqAAMFkVG----- 792 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--------------PQAAMFKVG----- 792 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC--------------hhHhhhhhc-----
Confidence 45677899999999999866 699999999999999999999999964321 111111100
Q ss_pred hhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHH
Q 003438 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLAL 426 (820)
Q Consensus 347 ~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l 426 (820)
+|+.. +.+| ..++.++
T Consensus 793 myKvH---------------------------------------------------P~iP-------------eelsaea 808 (1226)
T KOG4279|consen 793 MYKVH---------------------------------------------------PPIP-------------EELSAEA 808 (1226)
T ss_pred ceecC---------------------------------------------------CCCc-------------HHHHHHH
Confidence 00000 0011 2356789
Q ss_pred HHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 427 VDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 427 ~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+.||.+|+.+||.+||+|.++|+.||++..
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999999876
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.98 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=212.4
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+..+.|++.+.||+|+||.||++.+..+++.||+|+++......+.+.+|+++++.+ .|+||+++++++....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~ 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-------KHPNIVDYYDSYLVGD 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-------CCCCeeEEEEEEEECC
Confidence 345789999999999999999999998899999999986554566788899999888 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..|+|+||+. ++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~ 164 (286)
T cd06614 89 ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAA 164 (286)
T ss_pred EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhh
Confidence 9999999998 69999888753 3699999999999999999999999999999999999996 56789999999885
Q ss_pred ccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
..... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+... + ++.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~------ 235 (286)
T cd06614 165 QLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-G--IPP------ 235 (286)
T ss_pred hhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C--CCC------
Confidence 43322 12335678899999999888999999999999999999999999765544333222110 0 000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
......
T Consensus 236 --------------------------------------------------------------------------~~~~~~ 241 (286)
T cd06614 236 --------------------------------------------------------------------------LKNPEK 241 (286)
T ss_pred --------------------------------------------------------------------------Ccchhh
Confidence 000011
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++..+.+||++||..||.+|||+.|+|+|+||++.-
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 346788999999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.15 Aligned_cols=197 Identities=28% Similarity=0.460 Sum_probs=171.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||++++..+++.||+|++... ....+.+.+|+++++.+ +|+||+++++++.....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-------RSPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-------CCCCcceEeeeEecCCE
Confidence 6899999999999999999999999999999998753 34456788999999988 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+|+||||+.+ +|.+++... +.+++..++.++.||+.+|.|||+ .+|+||||||+||+++ ..+.++|+|||++.
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~ 152 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSG 152 (284)
T ss_pred EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCccc
Confidence 9999999985 777776653 468999999999999999999996 6999999999999995 66789999999986
Q ss_pred ccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 265 TEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 265 ~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.... ......++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 153 ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred chhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 4322 2234578899999999988889999999999999999999999997544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.31 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=167.5
Q ss_pred CceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.++||+|+||.||+|++.. +.+.||||+++.. ....+.+.+|+.+|+.+. .|+|||++++++
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~------~h~nIv~~~~~~ 111 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG------QHKNIVNLLGAC 111 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc------cCCceeeEeeEe
Confidence 689999999999999999998543 3457999999753 334556788999999883 489999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh------------------------------------------------------
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH------------------------------------------------------ 206 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~------------------------------------------------------ 206 (820)
...+.+|+|||||. |+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999997 68998886432
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccc-
Q 003438 207 --------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY- 271 (820)
Q Consensus 207 --------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~- 271 (820)
...+++..++.++.||+.||.|||++||+||||||+|||++ +...+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcce
Confidence 12478889999999999999999999999999999999996 567899999999865432211
Q ss_pred ----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 272 ----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 272 ----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
...++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 1234567999999998899999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.73 Aligned_cols=206 Identities=26% Similarity=0.367 Sum_probs=173.3
Q ss_pred CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|.+.+.||+|+||.||+|++. .+++.||||+++... ...+.+.+|+++|+.+ .|+||+++++++
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~ 77 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-------QHENIVKFYGVC 77 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-------CCCCchheeeEE
Confidence 67999999999999999999764 346789999998542 2456788999999998 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~ 248 (820)
......|+||||+. ++|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+||+++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~- 156 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG- 156 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc-
Confidence 99999999999997 58988887542 23478999999999999999999999999999999999996
Q ss_pred ccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 249 SVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 249 ~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
.++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||...+..+.+
T Consensus 157 --~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 157 --YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred --CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 6689999999998643221 122344678999999999999999999999999999998 99999776655544
Q ss_pred HH
Q 003438 323 RR 324 (820)
Q Consensus 323 ~~ 324 (820)
..
T Consensus 235 ~~ 236 (280)
T cd05049 235 EC 236 (280)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.29 Aligned_cols=198 Identities=25% Similarity=0.473 Sum_probs=170.4
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.|++++.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+.+. .|+||+++++++..+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~----~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQS----QPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccC----CCCCeeeEeeeeeeCCEE
Confidence 478889999999999999999999999999998753 34456788899999999543 699999999999999999
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+.+ +|.+++... .+++..++.++.||+.+|.|||+.||+|+||+|+||+++ ..+.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeec
Confidence 999999975 788877543 589999999999999999999999999999999999996 5788999999998654
Q ss_pred CCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
... .....++..|+|||.+.+. .++.++|||||||++|+|++|..||....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2334678899999998754 57899999999999999999999997544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.32 Aligned_cols=193 Identities=28% Similarity=0.443 Sum_probs=163.6
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
....||+|+||.||++++..++..||+|.+... ....+.+.+|+.+++.+ .|+||+++++++...+..++||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-------KHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-------CCCCeeeeeeeeccCCEEEEEE
Confidence 345899999999999999999999999998754 34456788899999988 6899999999999999999999
Q ss_pred eccC-CChHHHHHhhhcCCC--CHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 192 ELLD-SNLYELIKINHFRGL--SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~~~~l--~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
||+. ++|.+++.... ..+ ++..+..++.||+.||+|||+++|+||||||+||+++ ...+.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheeccc
Confidence 9997 58888887542 335 8889999999999999999999999999999999996 2356899999999864322
Q ss_pred ---ccccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 269 ---TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 269 ---~~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
......++..|+|||++... .++.++|||||||++|+|++|++||..
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 12234578899999998765 378999999999999999999999964
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.96 Aligned_cols=205 Identities=24% Similarity=0.333 Sum_probs=167.9
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||.||+|.++ ..+..||+|+++... .....+.+|+.+++.+ +|+||++++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~ 77 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-------TCHHVVRLLGV 77 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEE
Confidence 379999999999999999998654 235589999987543 2334567788888888 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhh--------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINH--------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~--------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
+...+..|+||||+. ++|.+++.... ...++...++.++.||+.||.|||+++|+||||||+|||++ .
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~ 154 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---H 154 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---C
Confidence 999999999999997 69999987532 12356778899999999999999999999999999999996 5
Q ss_pred CCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 252 PAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
++.+||+|||+++...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 6889999999986443211 12234667999999998899999999999999999998 78899776654433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.83 Aligned_cols=202 Identities=25% Similarity=0.369 Sum_probs=170.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.++||+|+||+||+|++..+. .||||+++......+.+.+|+++++.+ +|+||+++++++. .+..|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l-------~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhC-------CCCCcceEEEEEC-CCCcE
Confidence 78999999999999999999886654 599999986554556788899999998 6899999999875 45689
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..++.++.||+.||+|||+.+|+||||||+||+++ .++.+||+|||.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeecc
Confidence 9999997 5899998765444589999999999999999999999999999999999996 56789999999996543
Q ss_pred Cccc----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 268 RTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 268 ~~~~----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
.... ...++..|+|||++.+..++.++|||||||++|+|++ |..||......+.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~ 213 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence 3221 2234667999999988899999999999999999999 89999776554433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.90 Aligned_cols=206 Identities=25% Similarity=0.405 Sum_probs=174.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.++||+|+||.||+|.+.. ++.||||.++......+.+.+|+.+++++ .|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKL-------RHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHC-------CCCCccceeEEEecCCCe
Confidence 3789999999999999999998654 56799999987655567788999999998 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+. ++|.+++.......+++..+..++.||+.||.|||+++|+||||||+||+++ ..+.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVI 153 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEc
Confidence 99999995 7999998765445689999999999999999999999999999999999996 6678999999998654
Q ss_pred CCccc-ccc---ccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 267 DRTVY-SYI---QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 267 ~~~~~-~~~---gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
..... ... .+..|+|||++.+..++.++|||||||++|||++ |+.||.+......+..
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 216 (261)
T cd05068 154 KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ 216 (261)
T ss_pred cCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 42211 112 2357999999998899999999999999999999 9999987665444433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.85 Aligned_cols=196 Identities=32% Similarity=0.509 Sum_probs=173.8
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
+|++.+.||+|++|.||+|.+..+++.|++|++.... ...+.+.+|+.+++++ +|+||+++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-------QHPNIVRYYGSERDEEK 73 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-------CCCCEeeEEEEEecCCC
Confidence 4788999999999999999999999999999998654 4567788899999998 689999999999988
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
..+++|+|++. ++|.+++.... .+++..++.++.|++.+|.|||+.+++|+||+|+||+++ ..+.+||+|||.+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~ 148 (260)
T cd06606 74 NTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCA 148 (260)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccE
Confidence 89999999995 68888887654 699999999999999999999999999999999999996 5688999999998
Q ss_pred cccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 264 CTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 264 ~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
...... .....++..|+|||.+....++.++|||||||++|+|++|..||....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 755433 234567888999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=321.56 Aligned_cols=197 Identities=19% Similarity=0.239 Sum_probs=167.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----cce
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC----QRH 186 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~----~~~ 186 (820)
..|++|+++.||+|.. +++.||||+++... ...+.+.+|+.+|+++ .||||+++++++.+ ...
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-------DSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-------CCCCEEEEeeeEEecccCCCc
Confidence 4689999999999976 68899999997532 2246677999999998 68999999999877 347
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+++||||+. |+|.+++... +.+++.....++.|++.||.|||+ .+++||||||+|||++ +++.+||+|||++.
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~ 171 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEK 171 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHh
Confidence 899999998 5899888764 368999999999999999999998 5999999999999996 67889999999997
Q ss_pred ccCCccccccccccccCcccccc--ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 265 TEDRTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 265 ~~~~~~~~~~gt~~Y~APEvl~~--~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
..........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i 234 (283)
T PHA02988 172 ILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234 (283)
T ss_pred hhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 65555455678899999999976 58999999999999999999999999877655544433
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.93 Aligned_cols=196 Identities=28% Similarity=0.465 Sum_probs=169.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+.|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++..+..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYITRYYGSYLKGTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-------CCCccHhhhcccccCCc
Confidence 5677788999999999999999999999999998743 33445678899998888 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.|+||||+. ++|.+++.. ..+++..++.++.||++||.|||+++|+|+||+|+||+++ .++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~ 150 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEcccccccc
Confidence 999999998 478777754 3589999999999999999999999999999999999996 567899999999865
Q ss_pred cCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
..... ....++..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred ccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 43321 23457888999999998899999999999999999999999996543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=345.13 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=209.7
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
...+.|++...||.|+|+.|-.|.+..+++..++|++.+.. .+..+|+.++.... +|+||+++++++.+..
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~------~h~niv~~~~v~~~~~ 389 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR------DHPNIVKSHDVYEDGK 389 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc------CCCcceeecceecCCc
Confidence 34589999999999999999999999999999999998662 23446777777764 6999999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+.|+|||++.| .|.+-+.... ....++..|++||+.|+.|||++|||||||||+|||+. ...+.|+|+|||.++
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhh
Confidence 99999999986 4555554433 33377888999999999999999999999999999995 467899999999999
Q ss_pred ccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003438 265 TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344 (820)
Q Consensus 265 ~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~ 344 (820)
.......+.+-|..|.|||++....|+.++||||||++||+|++|+.||...... ..|...++ .++.
T Consensus 465 ~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~-~~~~--------- 531 (612)
T KOG0603|consen 465 ELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ-MPKF--------- 531 (612)
T ss_pred hCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc-CCcc---------
Confidence 8877766778899999999999999999999999999999999999999765544 12222222 1100
Q ss_pred chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHH
Q 003438 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424 (820)
Q Consensus 345 ~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~ 424 (820)
...+++
T Consensus 532 --------------------------------------------------------------------------s~~vS~ 537 (612)
T KOG0603|consen 532 --------------------------------------------------------------------------SECVSD 537 (612)
T ss_pred --------------------------------------------------------------------------ccccCH
Confidence 012567
Q ss_pred HHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 425 ~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.++|||++||++||.+|+|+.|++.||||.+.+.
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 8999999999999999999999999999955544
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.26 Aligned_cols=197 Identities=32% Similarity=0.527 Sum_probs=173.3
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.+.||+|++|.||++++..+++.||||.+.... ...+.+.+|+++++++ .|+||+++++++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-------KHPNIVKYIGSIETSDS 73 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-------CCCCccEEEEEEEeCCE
Confidence 5889999999999999999999999999999998654 4566788899999988 58999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.++|||++.+ +|.+++... ..+++..++.++.|++.+|.|||++||+|+||||+||+++ ..+.+||+|||.+..
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~ 148 (254)
T cd06627 74 LYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATK 148 (254)
T ss_pred EEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEecccccee
Confidence 9999999985 888888765 4699999999999999999999999999999999999996 468899999999975
Q ss_pred cCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 266 EDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 266 ~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
..... ....++..|+|||.+.+..++.++|||+||+++|+|++|..||.....
T Consensus 149 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~ 204 (254)
T cd06627 149 LNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204 (254)
T ss_pred cCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence 54332 234678889999999888889999999999999999999999975543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.00 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=203.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+-|+++++||.|+||.||++.+..+++.||||++... ......+.+|+.+++++ .|+||+++++++..+..
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~ 76 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYVTKYYGSYLKDTK 76 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-------CCCCEeEEEEEEEeCCe
Confidence 4578889999999999999999999999999998743 23445677899988888 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.|+||||+.+ +|.+++... .+++..+..++.||+.+|.|||+++|+|+||||+||+++ ..+.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~ 150 (277)
T cd06641 77 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ 150 (277)
T ss_pred EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeeccccee
Confidence 9999999985 787777543 489999999999999999999999999999999999995 567899999999865
Q ss_pred cCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...........+.. + .++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-~~~-------- 219 (277)
T cd06641 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--N-NPP-------- 219 (277)
T ss_pred cccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--C-CCC--------
Confidence 4332 1234678889999999888889999999999999999999999975443322222110 0 000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
. + ....
T Consensus 220 --------------------------------------------~-----------------------~-------~~~~ 225 (277)
T cd06641 220 --------------------------------------------T-----------------------L-------EGNY 225 (277)
T ss_pred --------------------------------------------C-----------------------C-------Cccc
Confidence 0 0 0012
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+..+.+||.+||..||.+||++.++|+||||.+.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 3568899999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.99 Aligned_cols=200 Identities=25% Similarity=0.369 Sum_probs=175.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.+.||.|+||.||+|... ++.||||+++......+++.+|+.+++.+ .|+||+++++++...+..|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTL-------RHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhc-------CCcceeeeEEEEcCCCCeE
Confidence 68999999999999999999764 78899999987655567888999999998 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEcccccccccc
Confidence 9999998 5999998776545699999999999999999999999999999999999995 67889999999997665
Q ss_pred CccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 268 RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 268 ~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
........+..|+|||.+....++.++|||||||++|+|++ |..||......+
T Consensus 154 ~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~ 207 (256)
T cd05039 154 QGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207 (256)
T ss_pred cccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 44333445667999999988889999999999999999997 999997655443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=334.34 Aligned_cols=200 Identities=27% Similarity=0.387 Sum_probs=167.9
Q ss_pred CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.++||+|+||+||+|++ ..++..||||+++.. ....+.+.+|+.+|+.+. .||||+++++++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~------~HpnIv~l~~~~ 108 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG------NHINIVNLLGAC 108 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc------CCcceeeeeeee
Confidence 6899999999999999999963 456778999999743 234456788999999984 489999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh------------------------------------------------------
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH------------------------------------------------------ 206 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~------------------------------------------------------ 206 (820)
...+..++|||||. |+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999997 68988886432
Q ss_pred -------------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 207 -------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 207 -------------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
...+++..++.++.||+.||+|||+++|+||||||+|||++ ....+||+|||++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceecc
Confidence 12478889999999999999999999999999999999996 56789999999996543
Q ss_pred Cccc-----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 268 RTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 268 ~~~~-----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
.... ...++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2211 1233567999999999999999999999999999998 899997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.07 Aligned_cols=204 Identities=22% Similarity=0.332 Sum_probs=171.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.+.||+|+||+||++.... +..||||.++......+.+.+|+.+++++ +||||+++++++...+.++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-------SHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-------CCCCeeeEEEEEccCCCcE
Confidence 689999999999999999997654 44699999986554456788899999888 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+|+||||+||+++ .++.+||+|||.+....
T Consensus 76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~ 151 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVL 151 (256)
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecC
Confidence 9999997 58888887643 3689999999999999999999999999999999999995 56789999999986443
Q ss_pred Ccc-c---cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 268 RTV-Y---SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 268 ~~~-~---~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
... . ...++..|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 152 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05113 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213 (256)
T ss_pred CCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 221 1 1234567999999988889999999999999999998 9999976665444333
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=314.92 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=211.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++.+++..||.|+.|+|++++.+.++...|||.+.+. ....++++..+.++.... ++|.||+++++|..+..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~------dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH------DCPYIVQCFGYFITNTD 165 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc------CCCeeeeeeeEEeeCch
Confidence 4566778899999999999999999999999999864 344566777777765552 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++|.||.|...+..+++.-. ++++|..+-++...+++||.||.+ ++||||||||+|||++ +.+.|||||||++..
T Consensus 166 V~IcMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---e~GniKlCDFGIsGr 241 (391)
T KOG0983|consen 166 VFICMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGNIKLCDFGISGR 241 (391)
T ss_pred HHHHHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---cCCCEEeecccccce
Confidence 99999999877776666553 679999999999999999999985 6999999999999995 889999999999954
Q ss_pred cC--CccccccccccccCccccccc---cccccchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCchHHHH
Q 003438 266 ED--RTVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 266 ~~--~~~~~~~gt~~Y~APEvl~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~~-s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
.- .......|.+.|||||.+.-. .|+.++||||||++++||.||+.||++. .+++.+.+|... .||.
T Consensus 242 lvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~---ePP~---- 314 (391)
T KOG0983|consen 242 LVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE---EPPL---- 314 (391)
T ss_pred eecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc---CCCC----
Confidence 32 333455788999999999643 7999999999999999999999999874 567777766551 2210
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
+ ...
T Consensus 315 -----------------------------------------------------------------------L-----~~~ 318 (391)
T KOG0983|consen 315 -----------------------------------------------------------------------L-----PGH 318 (391)
T ss_pred -----------------------------------------------------------------------C-----Ccc
Confidence 0 011
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..+++.|++|+..||..|+.+||.-.++|+|||+..-
T Consensus 319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 1256889999999999999999999999999999863
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.73 Aligned_cols=205 Identities=24% Similarity=0.389 Sum_probs=173.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|+++++||+|+||.||+|... +++.||+|++.........+.+|+.+++.+ .|+||+++++++. .+..
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-------QHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-------CCcCeeeEEEEEc-cCCc
Confidence 378999999999999999999864 567899999987665567888999999998 6899999999874 5679
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+. ++|.+++.......+++.++..++.||+.||+|||+.+|+||||||+||+++ .++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceeec
Confidence 99999997 6899988765555689999999999999999999999999999999999996 6678999999998654
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
.... ....++..|+|||++....++.++|||||||++|||++ |++||.+.+..+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 4211 12234567999999988889999999999999999999 9999987765554443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.60 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=206.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
+.|...++||+|+||+||+|++..+++.||||++... ....+.+.+|+++++.+ .|+||+++++++...
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~ 93 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-------KHPNTIEYKGCYLKE 93 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-------CCCCCccEEEEEEeC
Confidence 5577788999999999999999999999999998742 23345677899998888 689999999999999
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
...|+||||+.++|.+++.... ..+++.+++.++.||+.+|.|||++||+|+||||+||+++ .++.+||+|||++.
T Consensus 94 ~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~ 169 (313)
T cd06633 94 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSAS 169 (313)
T ss_pred CEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCc
Confidence 9999999999999988876543 4689999999999999999999999999999999999995 56789999999986
Q ss_pred ccCCccccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~~~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... .....++..|+|||++. ...++.++|||||||++|+|++|.+||...+....+..+... .++..
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~----- 240 (313)
T cd06633 170 KSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---DSPTL----- 240 (313)
T ss_pred ccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---CCCCC-----
Confidence 4332 23457888999999984 346889999999999999999999999776554443332210 00000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
....
T Consensus 241 ----------------------------------------------------------------------------~~~~ 244 (313)
T cd06633 241 ----------------------------------------------------------------------------QSNE 244 (313)
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0001
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++..+.+||.+||+.||++|||+.++|+||||...+
T Consensus 245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 235688999999999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.25 Aligned_cols=206 Identities=24% Similarity=0.344 Sum_probs=171.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe--EEEEEEEeC--ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS--FVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~--~VAIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||+|++..++. .+++|.++. .....+.+.+|++++.++. .||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~~~~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG------HHPNIINLLGACENR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc------CCCchhheEEEEccC
Confidence 579999999999999999998877664 478888874 2344567888999998884 489999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 185 RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
+.+|+||||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~-- 153 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG-- 153 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC--
Confidence 99999999997 68999886532 12488999999999999999999999999999999999996
Q ss_pred cCCCeEEEeecccccccCCccccc--cccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 250 VKPAEIKIIDFGSACTEDRTVYSY--IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~~~~~~~~--~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
.++.+||+|||++.......... ..+..|+|||++....++.++|||||||++|||++ |..||......+...
T Consensus 154 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 154 -ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred -CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 56789999999986443222222 22456999999998899999999999999999997 999998766554433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.04 Aligned_cols=198 Identities=23% Similarity=0.389 Sum_probs=171.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||+|++..+++.||||+++. +......+.+|+++++.+ .|+||+++++++...
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-------NHPNVIKYLDSFIED 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-------CCcceeeeeeeEEEC
Confidence 589999999999999999999999999999998863 233445678899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++|+|+||||+||+++ ..+.++|+|||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g 151 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccc
Confidence 99999999998 58888776432 23489999999999999999999999999999999999996 56789999999
Q ss_pred cccccCCcc---ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 262 SACTEDRTV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 262 lA~~~~~~~---~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++....... ....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 986544322 2346788999999999888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.65 Aligned_cols=193 Identities=26% Similarity=0.409 Sum_probs=163.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
+.||+|+||.||+|+++.+++.||+|++... ......+.+|+++++.+ +|+||+++++++......+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-------SHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEcCCCCeEEEEe
Confidence 3699999999999999999999999998743 34456788899999988 68999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccc
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~ 271 (820)
|+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++........
T Consensus 74 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 74 LVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred eccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccc
Confidence 997 58888876543 3589999999999999999999999999999999999995 567899999999865432211
Q ss_pred cc-----cccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 272 SY-----IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 272 ~~-----~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
.. ..+..|+|||.+.+..++.++|||||||++|||++ |.+||.....
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 11 12356999999988889999999999999999997 8899965544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.80 Aligned_cols=189 Identities=22% Similarity=0.268 Sum_probs=158.0
Q ss_pred CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccC-C
Q 003438 121 TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-S 196 (820)
Q Consensus 121 ~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~-g 196 (820)
+++.||.+++..+++.||||+++.. ....+.+.+|+++++.+ .|+||+++++++...+..++||||+. +
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-------~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-------QHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-------CCcchhhhhheeecCCeEEEEEeccCCC
Confidence 4455666666778999999999754 34556788999999988 68999999999999999999999998 5
Q ss_pred ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC--------
Q 003438 197 NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-------- 268 (820)
Q Consensus 197 sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~-------- 268 (820)
+|.+++.......+++..++.+++||++||+|||+++|+||||||+||+++ .++.+||+||+.+.....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccccccccc
Confidence 788888765545689999999999999999999999999999999999996 568899999998853321
Q ss_pred --ccccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 269 --TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 269 --~~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
......++..|+|||++... .++.++|||||||++|||++|+.||......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~ 216 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11233567789999999763 5889999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=320.03 Aligned_cols=197 Identities=27% Similarity=0.418 Sum_probs=166.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+.|++.++||+|+||+||+|.+..+++.||||+++... .....+..|+.++.++. +|+||+++++++.....
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~------~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH------DCPYIVKCYGYFITDSD 88 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhcc------CCCchHhhheeeecCCe
Confidence 78999999999999999999999899999999998542 23345566777665552 58999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+.+.|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||+|+||+++ .++.+||+|||++..
T Consensus 89 ~~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~---~~~~~kL~dfg~~~~ 164 (296)
T cd06618 89 VFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD---ASGNVKLCDFGISGR 164 (296)
T ss_pred EEEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc---CCCCEEECccccchh
Confidence 99999999988887776543 468999999999999999999997 6999999999999995 678899999999865
Q ss_pred cCCc--cccccccccccCcccccccc----ccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 266 EDRT--VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 266 ~~~~--~~~~~gt~~Y~APEvl~~~~----yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.... .....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 165 LVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred ccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 4322 22235678899999987553 88999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.26 Aligned_cols=206 Identities=25% Similarity=0.360 Sum_probs=169.4
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||+||+|.+. .+++.||||+++... .....+.+|+.+++.+ +|+||++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~iv~~~~~ 77 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-------NCHHVVRLLGV 77 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEE
Confidence 378999999999999999998754 345789999986432 3345677899998887 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhc--------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHF--------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
+......++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+++|+||||+||+++ .
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~ 154 (277)
T cd05062 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---E 154 (277)
T ss_pred EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---C
Confidence 999999999999997 589888865321 2357788999999999999999999999999999999996 5
Q ss_pred CCeEEEeecccccccCCccc-----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 252 PAEIKIIDFGSACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~~~~-----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
++.+||+|||++........ ...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~ 232 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 78899999999864432211 1234677999999998899999999999999999999 789997766544433
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.26 Aligned_cols=207 Identities=26% Similarity=0.373 Sum_probs=173.6
Q ss_pred CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
+.+|.+.+.||+|+||+||++.+ ..++..||+|.++.. ....+.+.+|+++++++ .|+||+++++++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~ 76 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-------QHEHIVKFYGVC 76 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEE
Confidence 47899999999999999999975 345677999999754 34456788999999998 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh-----------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH-----------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~-----------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
...+.+++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~-- 154 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-- 154 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc--
Confidence 99999999999997 68988887542 12489999999999999999999999999999999999995
Q ss_pred cCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 250 VKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
+.+.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||......+.+.
T Consensus 155 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 155 -ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred -cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 67889999999997543221 12234668999999998899999999999999999998 999997766555444
Q ss_pred H
Q 003438 324 R 324 (820)
Q Consensus 324 ~ 324 (820)
.
T Consensus 234 ~ 234 (288)
T cd05093 234 C 234 (288)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=321.68 Aligned_cols=253 Identities=23% Similarity=0.415 Sum_probs=204.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..|+...+||+|+||.||++....+++.||||++... ......+.+|+.+++.+ +|+||+++++++...+..
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHENVVEMYNSYLVGDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-------CCcchhheeeEEEeCCEE
Confidence 3444456899999999999999999999999998643 23445678899999888 689999999999999999
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+.+ +|.+++.. ..+++..++.++.||+.+|+|||+.||+|+||||+||+++ .++.++|+|||++...
T Consensus 93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 93 WVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQV 166 (292)
T ss_pred EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceec
Confidence 999999985 67776543 2489999999999999999999999999999999999996 5678999999988644
Q ss_pred CCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+....+.+..+..... +.
T Consensus 167 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~---~~-------- 235 (292)
T cd06657 167 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PK-------- 235 (292)
T ss_pred ccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---cc--------
Confidence 322 2234678899999999888899999999999999999999999987655444333221100 00
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+ ......+
T Consensus 236 -------------------------------------------------~-----------------------~~~~~~~ 243 (292)
T cd06657 236 -------------------------------------------------L-----------------------KNLHKVS 243 (292)
T ss_pred -------------------------------------------------c-----------------------CCcccCC
Confidence 0 0000123
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+.+||.+||..||.+|||+.|+|+||||....
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 5678999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.55 Aligned_cols=204 Identities=27% Similarity=0.381 Sum_probs=171.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|+++++||+|+||.||+|.+. .+..||+|+++......+.+.+|+.+++++ +|+||+++++++. ....+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-------~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-------RHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-------CCCceEEEEeEEC-CCCcE
Confidence 68999999999999999999765 556799999986555556788999999998 6899999999875 45689
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..++.++.||+.||+|||+++|+||||||+||+++ +++.+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeecc
Confidence 9999997 5899988765545689999999999999999999999999999999999996 56789999999996543
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
... ....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 221 11234567999999988889999999999999999999 8999987665544443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.97 Aligned_cols=254 Identities=24% Similarity=0.409 Sum_probs=207.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
...|++.+.||+|+||.||++++..+++.||||++... ......+.+|+++++.+ .|+||+++++++..
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~ 96 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-------KHPNSIEYKGCYLR 96 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEee
Confidence 36688999999999999999999999999999998743 23345677899999888 68999999999999
Q ss_pred cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 184 ~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+...+|||||+.++|.+++.... ..+++..+..++.||+.||.|||+++|+||||+|+||+++ .++.+||+|||++
T Consensus 97 ~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~---~~~~~kl~dfg~~ 172 (317)
T cd06635 97 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSA 172 (317)
T ss_pred CCeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC---CCCCEEEecCCCc
Confidence 99999999999999888876543 4689999999999999999999999999999999999995 5688999999998
Q ss_pred cccCCccccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
..... .....++..|+|||++. ...++.++|||||||++|+|++|++||........+..+..... ++
T Consensus 173 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~------ 243 (317)
T cd06635 173 SIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PT------ 243 (317)
T ss_pred cccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC--CC------
Confidence 65433 23456788999999984 34688999999999999999999999976554443333222100 00
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
. ...
T Consensus 244 ----------------------------------------------------------------------~------~~~ 247 (317)
T cd06635 244 ----------------------------------------------------------------------L------QSN 247 (317)
T ss_pred ----------------------------------------------------------------------C------CCc
Confidence 0 000
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++..+.+||.+||+.||.+|||+.|+++|+|+....
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1345689999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.76 Aligned_cols=196 Identities=24% Similarity=0.365 Sum_probs=169.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-- 185 (820)
+||+|.++||+|+|+-||+++...+++.||+|++.... ...+..++|++..+++ +||||++++++...+.
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-------~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-------NSPNVLRLVDHQLREEKD 93 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-------CCcchHHHHHHHHHhhcc
Confidence 89999999999999999999999999999999998543 6778899999999999 6899999998776543
Q ss_pred ---eeEEEEeccC-CChHHHHHhhhcC--CCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEE
Q 003438 186 ---HLCICFELLD-SNLYELIKINHFR--GLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 186 ---~l~LVmEy~~-gsL~d~l~~~~~~--~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL 257 (820)
..||+++|.. |+|.+.+.....+ .++|.++..|+.+|++||++||+.. +.||||||.|||+. +.+.++|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl 170 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVL 170 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEE
Confidence 5999999986 7899988765433 4999999999999999999999998 99999999999996 5788999
Q ss_pred eecccccccCCcc------------ccccccccccCcccccc---ccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 258 IDFGSACTEDRTV------------YSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 258 ~DFGlA~~~~~~~------------~~~~gt~~Y~APEvl~~---~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
.|||.++...-.. .....|..|+|||++.- ...+.++|||||||+||+|+.|..||.
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 9999996543221 12245888999999864 367899999999999999999999994
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=313.45 Aligned_cols=206 Identities=25% Similarity=0.411 Sum_probs=177.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.+|+++++||.|+||.||+|++.. ++.||+|+++.... ....+.+|+.+++.+ .|+||+++++++...+..
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-------RHKHLISLFAVCSVGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-------CCcchhheeeeEecCCCe
Confidence 679999999999999999999877 88999999986543 456788899999888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||.+...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhc
Confidence 99999997 5999999876556689999999999999999999999999999999999996 6678999999999654
Q ss_pred CCccc---cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 267 DRTVY---SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 267 ~~~~~---~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
..... ...++..|+|||++....++.++|||||||++|+|++ |+.||...+..+.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 33221 2234567999999988899999999999999999998 89999876655544443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.64 Aligned_cols=201 Identities=30% Similarity=0.431 Sum_probs=172.9
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+|++.++||+|+||.||++++..+++.||||++... ......+.+|+++++.+ .|+||+++++++.....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~ 73 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-------NHPNIISYKEAFLDGNK 73 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-------CCCCchhhhhhhccCCE
Confidence 588999999999999999999999999999999753 23445667888888888 58999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 187 LCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.|+||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.|++|+||+|+||+++ ..+.+||+|||++
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~ 150 (256)
T cd08530 74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGIS 150 (256)
T ss_pred EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccch
Confidence 999999997 58888876532 24589999999999999999999999999999999999996 4678999999998
Q ss_pred cccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 264 CTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 264 ~~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~ 208 (256)
T cd08530 151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD 208 (256)
T ss_pred hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 654433 223467889999999998899999999999999999999999997765443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=310.96 Aligned_cols=244 Identities=28% Similarity=0.527 Sum_probs=200.3
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||.|+||.||++++..+++.||||++.... ...+.+.+|+++++.+ .|+||+++++.+......|+|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-------QSPYVVKLYYSFQGKKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-------CCcchhHHHHheecCcEEEEEEe
Confidence 689999999999999999999999997543 3455677888888888 58999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc--
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-- 269 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-- 269 (820)
|+. ++|.+++.... .+++..++.++.||++||+|||+++|+|+||+|+||+++ .++.+||+|||++......
T Consensus 74 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCcc
Confidence 997 58888887643 689999999999999999999999999999999999996 6678999999998643221
Q ss_pred ---------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 270 ---------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 270 ---------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.....++..|+|||.+....++.++|||||||++|+|++|..||......+....+.. +..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~------- 219 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE------- 219 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC-------
Confidence 2234677889999999888899999999999999999999999987665444333221 0000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
+ | . ..
T Consensus 220 ----------------------------------------------------~------------~--~---------~~ 224 (265)
T cd05579 220 ----------------------------------------------------W------------P--E---------DV 224 (265)
T ss_pred ----------------------------------------------------C------------C--c---------cc
Confidence 0 0 0 00
Q ss_pred HhHHHHHHHHHhccccCcCCCCCH---HHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSP---FQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa---~EaL~HPff~~~ 456 (820)
..+..+.+||++||+.||++|||+ .|+|+||||++.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 024678999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.80 Aligned_cols=205 Identities=24% Similarity=0.392 Sum_probs=170.3
Q ss_pred CceEEEEEeccCCceeEEEeec----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..|++.++||+|+||+||+|.. ..+++.||+|.++.. ......+.+|+.+++.+ .|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~ 77 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-------HHPNIVCLLGVVT 77 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-------CCCCeeeEEEEEe
Confidence 6789999999999999999974 345678999999743 23345678899999988 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhh---------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINH---------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~---------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl 246 (820)
..+..|+||||+. ++|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 9999999999997 58988875332 1247889999999999999999999999999999999999
Q ss_pred ccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 247 CTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 247 ~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+ ....+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |.+||.+....+
T Consensus 158 ~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 158 G---EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred c---CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 6 5678999999999654221 122344667999999988889999999999999999998 999997766544
Q ss_pred HHH
Q 003438 321 LLR 323 (820)
Q Consensus 321 ~l~ 323 (820)
...
T Consensus 235 ~~~ 237 (283)
T cd05090 235 VIE 237 (283)
T ss_pred HHH
Confidence 333
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.49 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=169.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe-eccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-~~~~l 187 (820)
++|++.+.||+|+||.||++.. .++.||+|.++... ..+.+.+|+.+++++ .|+||+++++++. .....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-hHHHHHHHHHHHHhC-------CCCCeeeEEEEEEcCCCce
Confidence 6899999999999999999965 47789999997653 345678899999988 6899999999765 45678
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++ +++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA 152 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCccceec
Confidence 99999997 5999998776545589999999999999999999999999999999999995 6788999999998765
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
.........+..|+|||++.+..++.++|||||||++|+|++ |+.||......+.
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~ 208 (256)
T cd05082 153 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208 (256)
T ss_pred cccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 444334455678999999998889999999999999999997 9999976554333
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.71 Aligned_cols=207 Identities=26% Similarity=0.374 Sum_probs=176.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.++||+|+||.||+|.+. ..+.||||++.......+.+.+|+.+++++ .|+||+++++++......
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-------RHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-------CCCCEeeeeeeeecCCce
Confidence 379999999999999999999875 457799999987666667888999999998 689999999999998999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||||+. ++|.+++.......+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.+||+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLI 153 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceec
Confidence 99999997 5899988776545689999999999999999999999999999999999996 6689999999998654
Q ss_pred CCccc----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 267 DRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 267 ~~~~~----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
..... ....+..|+|||.+.+..++.++|||||||++|+|++ |+.||.+......+..+
T Consensus 154 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05034 154 EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217 (261)
T ss_pred cchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 42211 1223567999999998889999999999999999998 99999876655544443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.25 Aligned_cols=203 Identities=26% Similarity=0.367 Sum_probs=171.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.++||+|+||.||+|.+..+. .||+|++.......+.+.+|+++++.+ .|+||+++++++. .+..+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKL-------RHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhC-------CCCCeeeEEEEEc-CCCcE
Confidence 68999999999999999999876554 599999886555556788899999988 6899999999875 45789
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..+..++.||+.||.|||+.+|+|+||||+||+++ +++.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~---~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCeEEECCCccceEcc
Confidence 9999998 5899998765545589999999999999999999999999999999999995 67889999999996543
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE 214 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 221 12234667999999988889999999999999999999 999998766544433
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.25 Aligned_cols=200 Identities=27% Similarity=0.403 Sum_probs=170.9
Q ss_pred EEeccCCceeEEEeeccCC---CeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
++||+|+||.||+|.+... +..||||+++.... ..+.+.+|+++++.+ .|+||+++++++.....+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-------GHPNVVRLLGVCTEEEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-------CCCChheeeeeecCCCceEE
Confidence 4699999999999998866 88999999986533 357788899999988 58999999999999999999
Q ss_pred EEeccC-CChHHHHHhhh-------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 190 CFELLD-SNLYELIKINH-------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 190 VmEy~~-gsL~d~l~~~~-------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
||||+. ++|.+++.... ...+++..++.++.||+.||+|||+++|+|+||||+||+++ .++.+||+|||
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg 150 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFG 150 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccc
Confidence 999995 79999887652 24699999999999999999999999999999999999996 56899999999
Q ss_pred cccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 262 SACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 262 lA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
.+...... .....++..|+|||.+....++.++|||||||++|+|++ |..||......+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 219 (262)
T cd00192 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY 219 (262)
T ss_pred cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99755432 233456788999999988889999999999999999999 6999987755444333
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.00 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=170.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
.+|++.+.||+|+||.||+++++ ++..+|||++.........+.+|+++++.+ .|+||+++++++...+..|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-------SHPNLVQLYGVCTKQRPIF 75 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-------CCCCEEEEEEEEcCCCceE
Confidence 57889999999999999999875 466799999986544456778899999988 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++ .++.+||+|||++....
T Consensus 76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVL 151 (256)
T ss_pred EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceecc
Confidence 9999997 58998887644 3589999999999999999999999999999999999996 67889999999986543
Q ss_pred Ccc-ccc---cccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 268 RTV-YSY---IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 268 ~~~-~~~---~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
... ... ..+..|+|||++.+..++.++|||||||++|+|++ |+.||...+..+..
T Consensus 152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 152 DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred cccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 221 111 22346999999998899999999999999999999 89999766554443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=311.85 Aligned_cols=206 Identities=23% Similarity=0.356 Sum_probs=171.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t-----g~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.+.||+|+||.||++.+... +..||||++.... .....+.+|+.+|+.+ +|+||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~ 77 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-------NCHHVVRLLGV 77 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-------CCCceeEEEEE
Confidence 37899999999999999999987643 4889999987542 3345677889988887 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhh--------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINH--------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~--------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
+......++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|||++ .
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~ 154 (277)
T cd05032 78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---E 154 (277)
T ss_pred EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---C
Confidence 999999999999997 68998886532 12368889999999999999999999999999999999996 6
Q ss_pred CCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 252 PAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
++.+||+|||+++..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+...
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 232 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence 788999999998643322 122345778999999988889999999999999999998 999998766544433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.94 Aligned_cols=205 Identities=27% Similarity=0.427 Sum_probs=170.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t-----g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.+.||+|+||.||++..... ...||+|+++.. ......+.+|+.+++++. .|+||+++++++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~i~~~~~~~ 85 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLLGVC 85 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc------CCCCeeeEEEEE
Confidence 7899999999999999999987643 378999999753 234456788999998883 489999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhh--------------hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKIN--------------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~--------------~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl 246 (820)
..++.+++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 99999999999997 6898888642 23458999999999999999999999999999999999999
Q ss_pred ccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 247 CTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 247 ~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+ .++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 166 ~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 T---EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred c---CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 5 67899999999997543221 11223567999999988899999999999999999997 999998765544
Q ss_pred HH
Q 003438 321 LL 322 (820)
Q Consensus 321 ~l 322 (820)
..
T Consensus 243 ~~ 244 (293)
T cd05053 243 LF 244 (293)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.54 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=214.2
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
....|.++++||+|.|++|.++++..++..||||+|.+. ....+...+|+++|+.| +|||||+++.+...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-------~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-------NHPNIVKLFSVIET 126 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-------CCcceeeeeeeeee
Confidence 347899999999999999999999999999999999864 34445678999999999 79999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
...+|+||||+. |.+++++..+. .+.+..++.++.|++.|++|||+++|||||||++||||+ .+..+||+|||+
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~---~~mnikIaDfgf 201 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD---ENMNIKIADFGF 201 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc---cccceeeecccc
Confidence 999999999996 68999998764 577899999999999999999999999999999999995 667799999999
Q ss_pred ccccC--CccccccccccccCcccccccccc-ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTED--RTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~~--~~~~~~~gt~~Y~APEvl~~~~yt-~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+.... ....+.||++.|.|||++.+..|+ +.+|+||||++||.|+.|..||.+.+-.++..+.+..
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g----------- 270 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG----------- 270 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-----------
Confidence 96543 445678999999999999999876 7999999999999999999999876543322221110
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.|+ +|
T Consensus 271 -----------------------------k~r---------------------------------Ip------------- 275 (596)
T KOG0586|consen 271 -----------------------------KYR---------------------------------IP------------- 275 (596)
T ss_pred -----------------------------eec---------------------------------cc-------------
Confidence 000 00
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.-++.++.+||++||..+|.+|.+++|+..|.|+....
T Consensus 276 ~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 276 FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 01345688999999999999999999999999997643
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.68 Aligned_cols=201 Identities=21% Similarity=0.330 Sum_probs=165.2
Q ss_pred eEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~---tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
|++.+.||+|+||.||+|.... +++.||||+++.+ ......+.+|+++++.+ +|+||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-------DHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEeeeccC
Confidence 5688999999999999998654 3478999999854 23456788899999888 689999999988765
Q ss_pred ce------eEEEEeccC-CChHHHHHhhh----cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC
Q 003438 185 RH------LCICFELLD-SNLYELIKINH----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 185 ~~------l~LVmEy~~-gsL~d~l~~~~----~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~ 253 (820)
.. .++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+||+++ +++
T Consensus 74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~---~~~ 150 (273)
T cd05035 74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR---EDM 150 (273)
T ss_pred CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC---CCC
Confidence 54 799999997 58888775432 23589999999999999999999999999999999999995 668
Q ss_pred eEEEeecccccccCCccc-----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 254 EIKIIDFGSACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~~~-----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
.+||+|||+++....... ....+..|+|||++.+..++.++|||||||++|||++ |.+||.+....+.
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 899999999865432211 1234567999999988889999999999999999999 8999977655443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.28 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=206.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+.|.+.+.||+|+||.||++++..+++.||||.+.. .....+.+.+|+++++.+ .|+||+++++++..
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 86 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-------RHPNTIQYRGCYLR 86 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-------CCCCcccEEEEEEc
Confidence 3678888999999999999999999999999999863 223445677899999988 68999999999999
Q ss_pred cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 184 ~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
....++||||+.++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+||+++ ..+.+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~ 162 (308)
T cd06634 87 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 162 (308)
T ss_pred CCeeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCcccc
Confidence 99999999999999888776543 4589999999999999999999999999999999999996 5688999999998
Q ss_pred cccCCccccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
...... ....++..|+|||++. ...++.++|||||||++|+|++|..||...+..+.+..+.+... +.
T Consensus 163 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~------ 233 (308)
T cd06634 163 SIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA------ 233 (308)
T ss_pred eeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--CC------
Confidence 654332 3456788999999985 34678899999999999999999999966543333322211000 00
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
+ ...
T Consensus 234 ----------------------------------------------------~------------------------~~~ 237 (308)
T cd06634 234 ----------------------------------------------------L------------------------QSG 237 (308)
T ss_pred ----------------------------------------------------c------------------------Ccc
Confidence 0 000
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++..+.+||++||..+|++|||++++++|||+....
T Consensus 238 ~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred cccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 1346688999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=320.45 Aligned_cols=200 Identities=24% Similarity=0.381 Sum_probs=167.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.+|++.+.||+|+||+||+|++..+++ .||||+++.. ....+.+.+|+.+++.+ .|+||+++++++.
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~g~~~ 79 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGICL 79 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEc
Confidence 689999999999999999998766555 4899998743 34456788899999888 6899999999987
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.. ..++|+||+. |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG 154 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFG 154 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEcccc
Confidence 64 5778999987 68999887653 3588999999999999999999999999999999999995 56789999999
Q ss_pred cccccCCccc-----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 262 SACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 262 lA~~~~~~~~-----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+++....... ....+..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9975432211 1223567999999999999999999999999999997 999997655433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=338.63 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=207.7
Q ss_pred EEEEEeccCCceeEEEeeccCCCeEEEEEEEe-----CChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 112 ~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik-----~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+...+||+|+|-+||+|.|..+|..||--.++ +.+...+++..|+.+|+.| .|+|||++|+++.+...
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-------~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-------KHPNIIRFYDSWVDTDN 115 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-------CCCceeeeeeheecCCC
Confidence 45578999999999999999999888865554 3455668899999999999 68999999999997654
Q ss_pred --eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC--CeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 187 --LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--GIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 187 --l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~--gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+.+|.|++. |+|..++++.+ .+....++.|++|||+||.|||++ -|||||||.+||+|+ ...|.|||+|+|
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLG 191 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLG 191 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchh
Confidence 889999997 89999998764 689999999999999999999987 499999999999997 567999999999
Q ss_pred cccccCCcc-ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCchHHHH
Q 003438 262 SACTEDRTV-YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF-DLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 262 lA~~~~~~~-~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~-d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+|....... ...+|||.|||||+.. ..|+..+||||||++|+||+|+..||...... .+++++.. | ..|..+.
T Consensus 192 LAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--G-iKP~sl~- 266 (632)
T KOG0584|consen 192 LATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--G-IKPAALS- 266 (632)
T ss_pred HHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--C-CCHHHhh-
Confidence 997665443 3469999999999997 68999999999999999999999999755443 33333332 2 2221110
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
+
T Consensus 267 ------------------------------------------------------------k------------------- 267 (632)
T KOG0584|consen 267 ------------------------------------------------------------K------------------- 267 (632)
T ss_pred ------------------------------------------------------------c-------------------
Confidence 0
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
-.++++++||.+||.. .++|+||.|+|+||||.....
T Consensus 268 -V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g 304 (632)
T KOG0584|consen 268 -VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG 304 (632)
T ss_pred -cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence 0136789999999999 999999999999999998754
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.66 Aligned_cols=201 Identities=28% Similarity=0.428 Sum_probs=166.4
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||.||+|++. .+++.||+|+++.. ....+.+.+|+.+++++. +|+||++++++
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~------~h~niv~~~~~ 79 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG------HHLNVVNLLGA 79 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc------cCcchhheeee
Confidence 379999999999999999999743 34578999999753 234456778999998884 58999999998
Q ss_pred Eeec-ceeEEEEeccC-CChHHHHHhhh----------------------------------------------------
Q 003438 181 FVCQ-RHLCICFELLD-SNLYELIKINH---------------------------------------------------- 206 (820)
Q Consensus 181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~---------------------------------------------------- 206 (820)
+... ..+++||||+. ++|.+++....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 8654 57899999997 58888876432
Q ss_pred -------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCcc-----cccc
Q 003438 207 -------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYI 274 (820)
Q Consensus 207 -------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~ 274 (820)
...+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++....... ....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcchhhccCCC
Confidence 12588999999999999999999999999999999999996 56789999999997543211 1234
Q ss_pred ccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 275 gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 4677999999999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.77 Aligned_cols=248 Identities=29% Similarity=0.436 Sum_probs=197.8
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
||.+.++||+|+||+||++++..++..+++|+++.. ......+..|+.+++.+ +||||+++++++..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 73 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-------DHPAIVKFHASFLE 73 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-------CCCcHHHHHHHHhc
Confidence 689999999999999999999888777777777631 22334566788888877 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 184 QRHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
....|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++ .+.+||+||
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~ 149 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDF 149 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeeccc
Confidence 999999999997 4787777542 234589999999999999999999999999999999999995 356999999
Q ss_pred ccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 261 GSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 261 GlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|++...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...........+.. + .++.
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~-~~~~-- 224 (260)
T cd08222 150 GVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--G-PTPS-- 224 (260)
T ss_pred CceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--C-CCCC--
Confidence 998644221 2234578889999999888899999999999999999999999976544333222211 0 0000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
T Consensus 225 -------------------------------------------------------------------------------- 224 (260)
T cd08222 225 -------------------------------------------------------------------------------- 224 (260)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
.....+.++.+||.+||..||++||++.|+|+||||
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 001134678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.23 Aligned_cols=203 Identities=25% Similarity=0.320 Sum_probs=168.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe--EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~--~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||+||+|+++.++. .+|+|.++.. ......+.+|++++.++. +|+||+++++++..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~------~h~~iv~~~~~~~~~ 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHR 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc------CCCCcceEEEEECCC
Confidence 689999999999999999999877765 4577777642 334556788999998884 589999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 185 RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
+.+|+||||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~-- 158 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-- 158 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec--
Confidence 99999999997 68999887542 12478999999999999999999999999999999999996
Q ss_pred cCCCeEEEeecccccccCCcccc--ccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 250 VKPAEIKIIDFGSACTEDRTVYS--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~~~~~~~--~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
.++.+||+|||++......... ...+..|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 159 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 159 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred -CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 6678999999998643222112 123567999999988889999999999999999998 999997655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=357.31 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=215.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+|+++||+|+||.|.+++.+.+++.||+|++++ +......|..|-.||..- +.+=|++++-.|++
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-------ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-------NSEWIVQLHYAFQD 146 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-------CcHHHHHHHHHhcC
Confidence 4799999999999999999999999999999999986 233445566677777655 34569999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+.++|+||||+. |+|..++.... .+++..++.++..|+.||.-||+.|+|||||||+||||+ ..|+|||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld---~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD---KSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec---ccCcEeeccchh
Confidence 999999999996 69999988764 699999999999999999999999999999999999995 889999999999
Q ss_pred ccccCCc----cccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 263 ACTEDRT----VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 263 A~~~~~~----~~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
|...... ....+|||-|++||++.. ..|+..+|.|||||++|||+.|..||..++-.+.+.+|+..-.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~--- 298 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE--- 298 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh---
Confidence 9655422 345689999999999963 3689999999999999999999999998887777777765311
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
.+ .||
T Consensus 299 ----------------~l----------------------------------------------------~FP------- 303 (1317)
T KOG0612|consen 299 ----------------SL----------------------------------------------------SFP------- 303 (1317)
T ss_pred ----------------hc----------------------------------------------------CCC-------
Confidence 00 011
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCCC---HHHHHcCCccCCCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRWS---PFQASRHPFVTGEPFT 459 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT---a~EaL~HPff~~~~~~ 459 (820)
.+..++++++|||+++|. +|+.|+. ++++-.||||.+..|.
T Consensus 304 ----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 304 ----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred ----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 111266889999999774 8999999 9999999999998874
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.61 Aligned_cols=196 Identities=24% Similarity=0.421 Sum_probs=166.8
Q ss_pred ceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.|++.+.||+|+||.||+|++. .+++.||+|+++... ...+.+.+|+++|+.+. +|+||+++++++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR------QSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc------cCCChhceeeEe
Confidence 4889999999999999999874 478999999997532 23456778999999884 489999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
..+..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~df 149 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDF 149 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeC
Confidence 99999999999998 5888888764 3589999999999999999999999999999999999996 5688999999
Q ss_pred ccccccCCc----cccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 261 GSACTEDRT----VYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 261 GlA~~~~~~----~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
|++...... .....++..|+|||.+... .++.++|||||||++|+|++|..||...
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 998654321 2234678899999998753 4778999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=307.94 Aligned_cols=203 Identities=23% Similarity=0.339 Sum_probs=170.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++|++.+.||+|+||+||+|++..+ ...||||+++.. ......+.+|+.+++.+ .|+||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 76 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-------DHPNIIRLEGVVTK 76 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-------CCCCcceEeEEEec
Confidence 6899999999999999999987644 468999998753 33445678899999888 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.+||+|||+
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~ 152 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGL 152 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccch
Confidence 999999999997 58888887643 3689999999999999999999999999999999999996 667899999999
Q ss_pred ccccCCcc---c--cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 263 ACTEDRTV---Y--SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 263 A~~~~~~~---~--~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
+....... . ....+..|+|||.+.+..++.++|||||||++|+|++ |..||......+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~ 218 (266)
T cd05033 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218 (266)
T ss_pred hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence 97653111 1 1233567999999998899999999999999999998 99999765544433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.05 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=169.0
Q ss_pred CceEEEEEeccCCceeEEEeeccC-------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
++|.+.+.||+|+||.||++++.. +...||+|+++.. ......+.+|+.+++.+. .|+||+++++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~ 91 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG------KHKNIINLLG 91 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc------CCCCEeeEEE
Confidence 789999999999999999997543 2357999999853 334556788999999884 4899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhhc--------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
++...+..|+||||+. ++|.+++..... ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999997 599999876431 2488899999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ .++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 172 ll~---~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EEc---CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 996 56789999999986543211 11223467999999998889999999999999999998 8899976554
Q ss_pred HH
Q 003438 319 FD 320 (820)
Q Consensus 319 ~d 320 (820)
.+
T Consensus 249 ~~ 250 (307)
T cd05098 249 EE 250 (307)
T ss_pred HH
Confidence 33
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=303.05 Aligned_cols=204 Identities=30% Similarity=0.447 Sum_probs=172.2
Q ss_pred eEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg----~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
+++.+.||.|+||.||++++...+ +.||+|+++.... ..+.+..|+.+++.+ +|+||+++++++...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-------DHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-------CCCchheEEEEEcCC
Confidence 357789999999999999988766 8999999986543 467788899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..++|||++. ++|.+++.......+++..++.++.||+.||+|||+.+++|+||||+||+++ ..+.++|+|||++
T Consensus 74 ~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~ 150 (258)
T smart00219 74 EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLS 150 (258)
T ss_pred CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCc
Confidence 99999999997 5898888765433389999999999999999999999999999999999995 6678999999999
Q ss_pred cccCCccc----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 264 CTEDRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 264 ~~~~~~~~----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
........ ...++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 216 (258)
T smart00219 151 RDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY 216 (258)
T ss_pred eecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 65443211 1225678999999988889999999999999999998 8899977555444433
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=311.88 Aligned_cols=204 Identities=28% Similarity=0.389 Sum_probs=171.7
Q ss_pred CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|.+.+.||+|+||.||+|++. .++..|++|.++... ...+.+.+|+++++.+ .|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~ 77 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-------QHEHIVKFYGVCG 77 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-------CCCCcceEEEEEc
Confidence 67999999999999999999743 355679999987543 3345678899999888 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~ 247 (820)
..+..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 9999999999997 68999887542 13488999999999999999999999999999999999996
Q ss_pred cccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 248 TSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 248 ~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.
T Consensus 158 ---~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ---ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred ---cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 66899999999996543221 22345778999999999899999999999999999998 9999977665444
Q ss_pred H
Q 003438 322 L 322 (820)
Q Consensus 322 l 322 (820)
+
T Consensus 235 ~ 235 (291)
T cd05094 235 I 235 (291)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.23 Aligned_cols=190 Identities=31% Similarity=0.521 Sum_probs=166.8
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
||.|+||.||++.+..+++.||+|+++... .....+..|+++++.+ .|+||+++++.+..++..|+|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-------NHPFIVKLHYAFQTEEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-------CCCcHHHHHHHeecCCeeEEEEe
Confidence 689999999999998889999999997542 2455778899999888 58999999999999999999999
Q ss_pred cc-CCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc--
Q 003438 193 LL-DSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-- 269 (820)
Q Consensus 193 y~-~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-- 269 (820)
++ +++|.+++.... .+++..+..++.||++||.|||+.+++|+||||+||+++ ..+.++|+|||++......
T Consensus 74 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCC
Confidence 99 579999887653 589999999999999999999999999999999999996 5678999999998654432
Q ss_pred -cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 270 -VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 270 -~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 198 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3445678889999999888889999999999999999999999976654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.12 Aligned_cols=198 Identities=28% Similarity=0.483 Sum_probs=169.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.+|++.++||+|+||.||++++..+++.||+|++... ......+.+|+++++++ .|+||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~i~~~~~~~~ 74 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-------RHDRIVQYYGCLR 74 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-------CCCCcceEEEEEE
Confidence 5799999999999999999999999999999998532 23445778899999998 6899999999987
Q ss_pred ec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.. ..+++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.++|+|
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~d 149 (264)
T cd06653 75 DPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGD 149 (264)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECc
Confidence 64 46899999997 5788887654 3489999999999999999999999999999999999995 567899999
Q ss_pred cccccccCC------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 260 FGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 260 FGlA~~~~~------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
||++..... ......++..|+|||++.+..++.++|||||||++|+|++|++||.....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence 999965422 12234678899999999988899999999999999999999999975543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.48 Aligned_cols=204 Identities=29% Similarity=0.404 Sum_probs=169.9
Q ss_pred EEEEEeccCCceeEEEeecc----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 112 IVKDLLGHGTFGQVAKCWDA----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 112 ~i~~~LG~G~fG~Vyka~d~----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++.+.||.|.||.||+|... ..+..|+||+++.. ....+.+.+|+++++++ +|+||+++++++...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-------RHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-------SBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-------cccccccccccccccc
Confidence 57789999999999999876 45678999999753 34467889999999998 5899999999999888
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..++||||+. ++|.+++.......+++..+..|+.||+.||.|||+++|+|+||+++|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSR 151 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc
Confidence 8999999998 6999999987445699999999999999999999999999999999999996 67899999999997
Q ss_pred ccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 265 TEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 265 ~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
..... .........|+|||++....++.++||||||+++|||++ |+.||...+..+....+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~ 218 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL 218 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 65221 122345678999999999899999999999999999999 78999877666555444
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=311.42 Aligned_cols=207 Identities=25% Similarity=0.390 Sum_probs=172.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCC----------------eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCC
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN----------------SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg----------------~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~ 169 (820)
..+|+++++||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l------- 76 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL------- 76 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-------
Confidence 378999999999999999998876543 56899998854 34456788899999998
Q ss_pred CCCceeEEeEEEeecceeEEEEeccC-CChHHHHHhhh---------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccC
Q 003438 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINH---------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL 239 (820)
Q Consensus 170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~---------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL 239 (820)
.|+||+++++++..++..++|||++. ++|.+++.... ...+++..++.++.||+.||+|||+++|+||||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl 156 (296)
T cd05051 77 SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL 156 (296)
T ss_pred CCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 68999999999999999999999997 58888886543 125899999999999999999999999999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh--CCCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPL 312 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt--G~~P 312 (820)
||+||+++ ..+.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ +..|
T Consensus 157 kp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 157 ATRNCLVG---KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred chhceeec---CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 99999996 5589999999998643221 122345678999999988889999999999999999998 6788
Q ss_pred CCCCCHHHHHHH
Q 003438 313 FPGASEFDLLRR 324 (820)
Q Consensus 313 F~~~s~~d~l~~ 324 (820)
|......+.+..
T Consensus 234 ~~~~~~~~~~~~ 245 (296)
T cd05051 234 YEHLTDQQVIEN 245 (296)
T ss_pred CCCcChHHHHHH
Confidence 876555444443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.29 Aligned_cols=199 Identities=23% Similarity=0.318 Sum_probs=163.3
Q ss_pred EEEEEeccCCceeEEEeeccCCCe--EEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 112 IVKDLLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 112 ~i~~~LG~G~fG~Vyka~d~~tg~--~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
.+.++||+|+||.||+|++..+++ .||||.++.. ....+.+.+|+++++.+ +|+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-------DHPNVMRLIGVCLQTVE 74 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEccCCc
Confidence 467899999999999999877765 6999998753 34456778899999888 689999999987532
Q ss_pred ----ceeEEEEeccC-CChHHHHHhhh----cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeE
Q 003438 185 ----RHLCICFELLD-SNLYELIKINH----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 185 ----~~l~LVmEy~~-gsL~d~l~~~~----~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~i 255 (820)
...++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~ 151 (272)
T cd05075 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNV 151 (272)
T ss_pred ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc---CCCCE
Confidence 25789999997 68888775322 23488999999999999999999999999999999999995 67889
Q ss_pred EEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 256 KIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 256 KL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
||+|||++....... .....++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999997543221 12234667999999999899999999999999999999 899998765543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.48 Aligned_cols=198 Identities=24% Similarity=0.368 Sum_probs=165.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|+++++||+|+||+||+|++..+++ .||||+++.. ....+.+.+|+.+++.+ .|+||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~ 79 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-------GSPYVCRLLGICL 79 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-------CCCCCceEEEEEc
Confidence 789999999999999999998766665 4899998743 33456677888888877 6899999999887
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
. ...+++|||+. |+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG 154 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFG 154 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCC
Confidence 5 45789999997 68998887643 4589999999999999999999999999999999999995 56789999999
Q ss_pred cccccCCccc-----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 262 SACTEDRTVY-----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 262 lA~~~~~~~~-----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
++........ ...++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9875432211 1233567999999998899999999999999999998 8999976544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=304.80 Aligned_cols=199 Identities=27% Similarity=0.418 Sum_probs=169.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.+.||+|+||.||++. .+++.||+|+++... ..+.+.+|+.+++.+ .|+||+++++++..+ ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~-------~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKL-------HHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhC-------CCCCcCeEEEEEcCC-CcE
Confidence 689999999999999999985 467889999997543 345678899999888 689999999998754 579
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++ .++.+||+|||++....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~~ 151 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGS 151 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceecc
Confidence 9999997 5999998776545689999999999999999999999999999999999995 56789999999987544
Q ss_pred CccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 268 RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 268 ~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
........+..|+|||.+.+..++.++|||||||++|+|++ |++||...+..+.
T Consensus 152 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 206 (254)
T cd05083 152 MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV 206 (254)
T ss_pred ccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 33333344667999999988899999999999999999997 9999977655443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.19 Aligned_cols=206 Identities=26% Similarity=0.416 Sum_probs=170.3
Q ss_pred CceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
++|++.++||+|+||.||+|++. .....||+|+++.. ......+.+|+++++.+. +|+||+++++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~ 85 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG------KHKNIINLLG 85 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc------CCCCeeeEEE
Confidence 78999999999999999999753 23567999998853 334556788999988883 4899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
++...+.+|+||||+. ++|.+++.... ...+++.++..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999999999999997 68999887632 13488999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ .++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 166 ll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVT---EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEc---CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 996 56789999999997543211 11223457999999998899999999999999999999 8999977655
Q ss_pred HHHHH
Q 003438 319 FDLLR 323 (820)
Q Consensus 319 ~d~l~ 323 (820)
.+...
T Consensus 243 ~~~~~ 247 (314)
T cd05099 243 EELFK 247 (314)
T ss_pred HHHHH
Confidence 44433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.98 Aligned_cols=198 Identities=25% Similarity=0.390 Sum_probs=171.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+.+|+++++++ .|+||+++++++...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-------~~~~i~~~~~~~~~~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-------DHPNVIKYLASFIEN 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-------CCCCeeeeeeeeecC
Confidence 6899999999999999999999999999999998632 23356788899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~ 151 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccc
Confidence 99999999998 58988886532 24589999999999999999999999999999999999996 56789999999
Q ss_pred cccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 262 SACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 262 lA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred eeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 98644322 22346788899999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.32 Aligned_cols=204 Identities=26% Similarity=0.386 Sum_probs=172.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.++||+|+||.||++.+. .+..||+|+++......+.+.+|+++++.+ .|+||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-------QHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-------CCCCcceEEEEEcC-CCe
Confidence 489999999999999999999754 456699999987665567788999999988 68999999999887 788
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||||+. ++|.+++.......+++..++.++.||+.||.|||+.+++|+||||+||+++ ..+.+||+|||.+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVI 152 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeec
Confidence 99999997 6999998775545688999999999999999999999999999999999995 6789999999998654
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
.... ....++..|+|||++....++.++|||||||++|+|++ |+.||...+..+...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 3221 11234567999999988889999999999999999998 999998766554443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.44 Aligned_cols=203 Identities=22% Similarity=0.389 Sum_probs=171.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
.+|++.+.||+|+||.||++.+. .++.+|+|+++........+.+|+++++++ .|+||+++++++......|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-------SHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-------CCCCeeeEEEEEccCCceE
Confidence 57999999999999999999875 366899999986655556788899999998 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..++++.++.++.||+.+|+|||+++|+|+||||+||+++ .++.+||+|||.+....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL 151 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecc
Confidence 9999997 47877776543 4589999999999999999999999999999999999995 56789999999986543
Q ss_pred Cccc----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 268 RTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 268 ~~~~----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
.... ....+..|+|||++.+..++.++|||||||++|||++ |..||......+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 212 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212 (256)
T ss_pred cCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 2211 1234567999999998889999999999999999998 999997665544433
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=340.08 Aligned_cols=260 Identities=25% Similarity=0.456 Sum_probs=220.6
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
+..+.|+|.+.||.|.+|.||+++.+.+++.+||||..-+....+++..|.+||+.+. +|||++.++++|...
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~------~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS------HHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc------CCCCcceEEEEEEEec
Confidence 3458999999999999999999999999999999999877666678888999998885 799999999999853
Q ss_pred ----ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 ----RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 ----~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+.+|||||||+ |+.-|+++......+.|+.+..|++.++.||.+||.+.++|||||-.|||++ .++.|||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEee
Confidence 68999999998 6888999887777899999999999999999999999999999999999997 779999999
Q ss_pred cccccccCCc---cccccccccccCccccccc-----cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003438 260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331 (820)
Q Consensus 260 FGlA~~~~~~---~~~~~gt~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~ 331 (820)
||.+.+.+.. ..+.+||++|||||++... .|+..+|+||||++..||.-|.+|+........+..|-+
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---- 242 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---- 242 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC----
Confidence 9999776543 4567999999999999643 478899999999999999999999976544322222111
Q ss_pred CCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 332 ~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
.||
T Consensus 243 NPP----------------------------------------------------------------------------- 245 (953)
T KOG0587|consen 243 NPP----------------------------------------------------------------------------- 245 (953)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 111
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
-.+....+++.+|.|||..||..|-++||+..++|+|||+++.+
T Consensus 246 --PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 246 --PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred --ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence 01122345788999999999999999999999999999999655
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=347.11 Aligned_cols=144 Identities=24% Similarity=0.409 Sum_probs=128.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||+++.. ......+..|+.+++.+ .|+||+++++++...
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~Iv~~~~~~~~~ 76 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-------KSPFIVHLYYSLQSA 76 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-------CCCCcCeEEEEEEEC
Confidence 7899999999999999999999999999999999753 23346677888888877 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++||||||+. ++|.+++... +.+++..++.|+.||+.||+|||.++||||||||+||||+ ..+.+||+|||++
T Consensus 77 ~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls 151 (669)
T cd05610 77 NNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151 (669)
T ss_pred CEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCC
Confidence 99999999996 6898888654 3589999999999999999999999999999999999995 5678999999987
Q ss_pred c
Q 003438 264 C 264 (820)
Q Consensus 264 ~ 264 (820)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=312.52 Aligned_cols=207 Identities=23% Similarity=0.328 Sum_probs=169.7
Q ss_pred CceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-----tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.+|++.++||+|+||.||+|.+.. .++.||||+++... ...+.+.+|+.++..+ .|+||+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-------~h~~iv~~~~~~ 77 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-------QHPNIVCLLGVV 77 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-------CCCCcCeEEEEE
Confidence 568889999999999999998653 35789999998542 3345677888888887 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl 246 (820)
......++++||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 78 ~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 99999999999997 57888875321 1347888999999999999999999999999999999999
Q ss_pred ccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 247 CTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 247 ~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+ +++.+||+|||+++...... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 158 ~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 158 F---DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred c---CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 6 56789999999986543221 12344678999999988889999999999999999998 888998766555
Q ss_pred HHHHH
Q 003438 321 LLRRM 325 (820)
Q Consensus 321 ~l~~I 325 (820)
.+..+
T Consensus 235 ~~~~i 239 (283)
T cd05091 235 VIEMI 239 (283)
T ss_pred HHHHH
Confidence 44443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.26 Aligned_cols=201 Identities=25% Similarity=0.382 Sum_probs=170.5
Q ss_pred CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.+.||+|+||.||++.+ ..++..||||+++.. ....+.+.+|+++++++. +|+||+++++++
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~~ 108 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG------NHENIVNLLGAC 108 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc------CCCCcceEEEEE
Confidence 7899999999999999999974 345668999998753 334456788999999883 489999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
...+..|+||||+. ++|.+++.......+++.+++.++.||+.||+|||+++|+|+||||+|||++ ....+||+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCC
Confidence 99999999999997 6899988765434489999999999999999999999999999999999995 6678999999
Q ss_pred ccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 261 GSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 261 GlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 9986543221 12234677999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=328.52 Aligned_cols=201 Identities=28% Similarity=0.393 Sum_probs=167.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||.||+|.+.. ++..||||+++.. ....+.+.+|+++|+++. .||||++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~------~HpnIv~l~~~ 109 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG------PHLNIVNLLGA 109 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC------CCCCeeeEEEE
Confidence 4789999999999999999997643 3457999999743 334567889999999983 38999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhh-----------------------------------------------------
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINH----------------------------------------------------- 206 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~----------------------------------------------------- 206 (820)
+...+.+|||||||. |+|.+++....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999997 68988876431
Q ss_pred -----------------------------------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcc
Q 003438 207 -----------------------------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL 245 (820)
Q Consensus 207 -----------------------------------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL 245 (820)
...+++..++.++.||++||+|||+++|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 124788889999999999999999999999999999999
Q ss_pred cccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 246 LCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 246 l~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
++ ..+.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 270 l~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 270 LA---QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred Ee---CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 96 5678999999998654221 122345678999999998899999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=307.34 Aligned_cols=198 Identities=24% Similarity=0.386 Sum_probs=171.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||++++..+++.||||.+... ......+.+|+.+++.+ .|+||+++++++..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~~~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-------NHPNVIKYYASFIED 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-------cCCchhhhhheeEeC
Confidence 5788999999999999999999999999999988642 23445678899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 RHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg 151 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLG 151 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcch
Confidence 99999999998 48888876422 24589999999999999999999999999999999999995 56789999999
Q ss_pred cccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 262 SACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 262 lA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++...... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98654322 22346788999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.12 Aligned_cols=205 Identities=29% Similarity=0.391 Sum_probs=171.1
Q ss_pred CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|++.++||+|+||.||+++. ..++..||+|.++.. ....+.+.+|+++++.+ .|+||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~ 77 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-------QHQHIVRFYGVCT 77 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-------CCCCCceEEEEEe
Confidence 6889999999999999999964 345678999998753 34456788899999988 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhc-------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHF-------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~-------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~ 248 (820)
..+..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~- 156 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG- 156 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc-
Confidence 9999999999997 689888875421 2488999999999999999999999999999999999996
Q ss_pred ccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 249 SVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 249 ~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
+++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |.+||......+.+
T Consensus 157 --~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 157 --QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred --CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 57889999999986432211 12234678999999999899999999999999999998 99999766554443
Q ss_pred H
Q 003438 323 R 323 (820)
Q Consensus 323 ~ 323 (820)
.
T Consensus 235 ~ 235 (280)
T cd05092 235 E 235 (280)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=350.20 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=171.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||.||+|++..+++.||||+++.. ....+++.+|+++++.+ .||||+++++++...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-------~HPNIVkl~~v~~d~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-------IHPGIVPVYSICSDG 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-------CCcCcCeEEEEEeeC
Confidence 6899999999999999999999999999999999743 23456788899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh---------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCe
Q 003438 185 RHLCICFELLD-SNLYELIKINH---------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~---------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
+..|+||||+. ++|.+++.... ...+++..+..++.||++||+|||++||+||||||+|||++ ..+.
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~ 151 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGE 151 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCC
Confidence 99999999997 58888876421 12356677899999999999999999999999999999995 6688
Q ss_pred EEEeecccccccCC---------------------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCC
Q 003438 255 IKIIDFGSACTEDR---------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 255 iKL~DFGlA~~~~~---------------------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 99999999964410 011246899999999999999999999999999999999999999
Q ss_pred CCCC
Q 003438 314 PGAS 317 (820)
Q Consensus 314 ~~~s 317 (820)
....
T Consensus 232 ~~~~ 235 (932)
T PRK13184 232 RRKK 235 (932)
T ss_pred CCcc
Confidence 7543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=313.72 Aligned_cols=317 Identities=29% Similarity=0.462 Sum_probs=235.0
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-----
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ----- 184 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~----- 184 (820)
-.+.||.|+||+||.+.|..+++.||+|++.+- -...+.+.+|+++|..+ .|.|++..+|+.+-.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-------kHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-------RHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-------ccccHHHHHHhcCCCCchHH
Confidence 336799999999999999999999999998753 34457788999999988 477999999887644
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.++|+|.|+|..+|..+|-.- +.++.+.++.+++||++||+|||+.+|+||||||.|+|++ .+..+||||||+|+
T Consensus 130 qEiYV~TELmQSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLAR 204 (449)
T KOG0664|consen 130 QELYVLTELMQSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHHhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEeccccccc
Confidence 368999999999998887654 4699999999999999999999999999999999999995 78899999999998
Q ss_pred ccCCc----cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 265 TEDRT----VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 265 ~~~~~----~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
..+.. +...+-|.+|+|||++.+. .|+.++||||+|||+.||+..+.+|...+..++++.|...+| .|..+.++
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG-TPs~EaMr 283 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG-TPSQEAMK 283 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC-CCcHHHHH
Confidence 65433 3345668899999999987 799999999999999999999999999999999999999999 56544433
Q ss_pred hh-hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 340 EA-KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 340 ~~-~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
.. ...+...- ....+.| .+..+. .+ ..
T Consensus 284 ~ACEGAk~H~L------------------------------R~~~k~P----------s~~vLY-------tl-----sS 311 (449)
T KOG0664|consen 284 YACEGAKNHVL------------------------------RAGLRAP----------DTQRLY-------KI-----AS 311 (449)
T ss_pred HHhhhhHHHhh------------------------------ccCCCCC----------Ccccee-------ee-----cC
Confidence 21 11000000 0000001 010000 00 01
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCCC---CCCCCCCCCccccccccCCCCCCCCccCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQ---PPPETPRVPVAQNFKVDHHPGAGHWFAAGLSP 495 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~l~~ 495 (820)
......+..+++.+||.+||.+|++.+++|.|+|+.+.+..-... ---.+++ -..+.+..+..|..+..|...++.
T Consensus 312 ~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~sCmC~~~~tt~~-~~~r~f~~~~~P~~~~pFd~~~e~ 390 (449)
T KOG0664|consen 312 PDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHSCMCSCCYTKPN-MPSRLFAQDLDPRHESPFDPKWEK 390 (449)
T ss_pred CcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeeeeeEeeeccCCC-cchhhhccccCcccCCCcChhHHH
Confidence 111235678999999999999999999999999999876521100 0011111 123445556666655555444443
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.95 Aligned_cols=207 Identities=25% Similarity=0.404 Sum_probs=169.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCC--------------eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCC
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN--------------SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDK 171 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg--------------~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~H 171 (820)
.++|++.++||+|+||.||+|++..++ ..||||+++.. ......+.+|+++|+++ .|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-------~h 76 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-------KN 76 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-------CC
Confidence 379999999999999999999875432 35999999753 33445688899999998 68
Q ss_pred CceeEEeEEEeecceeEEEEeccC-CChHHHHHhhhc----------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCC
Q 003438 172 HHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF----------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLK 240 (820)
Q Consensus 172 pnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~----------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLK 240 (820)
+||+++++++...+..|+||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++|+|+|||
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 77 PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred CCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 999999999999999999999997 588888764321 136888999999999999999999999999999
Q ss_pred CCCcccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh--CCCCC
Q 003438 241 PENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPLF 313 (820)
Q Consensus 241 PeNILl~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt--G~~PF 313 (820)
|+||+++ .++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ +..||
T Consensus 157 p~Nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 157 TRNCLVG---NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred hhhEEEc---CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9999996 56789999999986432211 11234668999999998899999999999999999998 67788
Q ss_pred CCCCHHHHHHH
Q 003438 314 PGASEFDLLRR 324 (820)
Q Consensus 314 ~~~s~~d~l~~ 324 (820)
...+..+.+..
T Consensus 234 ~~~~~~~~~~~ 244 (295)
T cd05097 234 SLLSDEQVIEN 244 (295)
T ss_pred cccChHHHHHH
Confidence 77665554443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.13 Aligned_cols=205 Identities=23% Similarity=0.410 Sum_probs=170.7
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++++.||+|+||.||+|.+. .+++.||||+++.. ......+.+|+.+++++ +|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-------~h~~iv~~~~~ 76 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-------DHPNIVKLLGV 76 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-------CCCchheEEEE
Confidence 378999999999999999999864 36789999998754 23446688899999988 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhh--------------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccC
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINH--------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL 239 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL 239 (820)
+...+..|+||||+. ++|.+++.... ...+++..++.++.||+.||+|||+++++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999999999999998 58998886432 124788899999999999999999999999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLF 313 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF 313 (820)
||+||+++ .++.+||+|||++...... ......+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 157 ~p~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 157 ATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred cHhheEec---CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999995 6788999999998643221 112234567999999998899999999999999999997 88888
Q ss_pred CCCCHHHHH
Q 003438 314 PGASEFDLL 322 (820)
Q Consensus 314 ~~~s~~d~l 322 (820)
.+....+.+
T Consensus 234 ~~~~~~~~~ 242 (288)
T cd05050 234 YGMAHEEVI 242 (288)
T ss_pred CCCCHHHHH
Confidence 766554433
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.56 Aligned_cols=201 Identities=26% Similarity=0.408 Sum_probs=167.2
Q ss_pred ceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~-----tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+|++.++||+|+||.||+|++.. ....||+|++.... ...+.+.+|+.+++.+ .||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-------NHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-------CCCCEeeEEEEEe
Confidence 47889999999999999998643 33679999987542 3456788899999988 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhh----------------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccC
Q 003438 183 CQRHLCICFELLD-SNLYELIKINH----------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL 239 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~----------------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL 239 (820)
.++..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+++|+||||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di 153 (290)
T cd05045 74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153 (290)
T ss_pred cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 9999999999998 68888876421 134788999999999999999999999999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLF 313 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF 313 (820)
||+|||++ +.+.+||+|||+++...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 154 kp~nill~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 154 AARNVLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhheEEEc---CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 99999995 56789999999986532211 12234667999999988889999999999999999998 99999
Q ss_pred CCCCHHH
Q 003438 314 PGASEFD 320 (820)
Q Consensus 314 ~~~s~~d 320 (820)
.+....+
T Consensus 231 ~~~~~~~ 237 (290)
T cd05045 231 PGIAPER 237 (290)
T ss_pred CCCCHHH
Confidence 7765443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.27 Aligned_cols=206 Identities=25% Similarity=0.393 Sum_probs=170.6
Q ss_pred CceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
++|++.+.||+|+||.||+|+.. .++..||||+++.. ....+.+.+|+.+++.+. .|+||+++++
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~i~~~~~ 88 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLLG 88 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc------cCCCchheeE
Confidence 78999999999999999999642 23457999998753 344567888999998884 5899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
++......|+||||+. ++|.+++.... ...+++..+..++.||++||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999997 58998887642 12478889999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ ..+.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 169 li~---~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LVT---ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEc---CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 995 66889999999997543211 12234567999999998889999999999999999998 8889977655
Q ss_pred HHHHH
Q 003438 319 FDLLR 323 (820)
Q Consensus 319 ~d~l~ 323 (820)
.+...
T Consensus 246 ~~~~~ 250 (304)
T cd05101 246 EELFK 250 (304)
T ss_pred HHHHH
Confidence 44433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=303.51 Aligned_cols=206 Identities=23% Similarity=0.328 Sum_probs=170.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~---~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+|+..+.||+|+||.||+|+++.+++ .||||+++.. ....+.+..|+++++.+ .|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 77 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-------SHHNIIRLEGVVTK 77 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-------CCCCeeEEEEEEcc
Confidence 678899999999999999998876554 7999998754 33456678899888888 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+..++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+|+|+||||+||+++ .++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~ 153 (268)
T cd05063 78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGL 153 (268)
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCcc
Confidence 999999999998 47878776543 4689999999999999999999999999999999999996 567899999999
Q ss_pred ccccCCcccc------ccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 263 ACTEDRTVYS------YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 263 A~~~~~~~~~------~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
+......... ...+..|+|||++....++.++|||||||++|||++ |..||...+..+....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i 223 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 8644322111 112346999999988889999999999999999997 99999776655444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.61 Aligned_cols=194 Identities=26% Similarity=0.373 Sum_probs=161.8
Q ss_pred EEeccCCceeEEEeeccCCC---eEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg---~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
++||+|+||.||+|+...++ ..||+|++..... ..+.+.+|+++++.+ .|+||+++++++. .+..++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~-~~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-------DHPCIVRLIGVCK-GEPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEc-CCceEE
Confidence 46999999999999765554 7899999986543 456788899999888 6899999999876 456899
Q ss_pred EEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 190 VmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
||||+. ++|.+++.... .+++..++.++.||+.+|+|||..+|+|+||||+|||++ .++.+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 73 VMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGA 147 (257)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeec
Confidence 999997 68999887653 689999999999999999999999999999999999996 678899999999875432
Q ss_pred ccccc------cccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 269 TVYSY------IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 269 ~~~~~------~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
..... .++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+.
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~ 207 (257)
T cd05060 148 GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207 (257)
T ss_pred CCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 22111 12357999999988899999999999999999998 9999976654433
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.70 Aligned_cols=193 Identities=24% Similarity=0.365 Sum_probs=167.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+...+.++||+|.||+||+|++..+ ||||+++.+ +...+.|.+|+.+|++-+ |.||+-+.+++....
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-------H~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-------HENILLFMGACMNPP 461 (678)
T ss_pred HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcc-------hhhheeeehhhcCCc
Confidence 5677889999999999999987653 999999853 567888999999999984 679999999999877
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
. .||..+|+| +|+.++...+ ..|.....+.|++||++|+.|||.++|||||||..||++. ++++|||+|||++.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~---~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH---EDLKVKIGDFGLAT 536 (678)
T ss_pred e-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc---cCCcEEEeccccee
Confidence 7 999999997 7888887665 4599999999999999999999999999999999999995 56999999999984
Q ss_pred cc-----CCccccccccccccCccccccc---cccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 265 TE-----DRTVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 265 ~~-----~~~~~~~~gt~~Y~APEvl~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
.. ........+...|||||+++.+ +|++.+|||||||++|||++|..||...
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~ 596 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ 596 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC
Confidence 32 2233445678889999999754 7999999999999999999999999843
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=302.16 Aligned_cols=196 Identities=27% Similarity=0.420 Sum_probs=161.9
Q ss_pred EeccCCceeEEEeec--cCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 116 LLGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d--~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
+||+|+||.||+|.. ..+++.||||+++.. ....+.+.+|+.+++.+ .|+||+++++++. .+..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-------DNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEc-CCCcEEE
Confidence 589999999999953 567889999998753 23456778899999888 6899999999875 4577999
Q ss_pred EeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc
Q 003438 191 FELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269 (820)
Q Consensus 191 mEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~ 269 (820)
|||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||.||+++ .++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 74 MELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCC
Confidence 99998 5788888654 3589999999999999999999999999999999999996 5678999999998654332
Q ss_pred cc------cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 270 VY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 270 ~~------~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
.. ...++..|+|||.+....++.++|||||||++|||++ |..||......+....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~ 210 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM 210 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 11 1223568999999988889999999999999999998 9999987665544333
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=360.00 Aligned_cols=255 Identities=30% Similarity=0.475 Sum_probs=208.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
-++.-...||.|.||.||-|.+..+|+..|+|-++-+. .....+.+|..+|..| .|||||+++++=.+.+
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-------nHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-------NHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-------cCccccccCceeecHH
Confidence 46777789999999999999999999999999998543 3345677899999998 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..+|.||||+ |+|.+++.... ..+|...+.+..|++.||+|||++|||||||||+||+|+ ..+.||+.|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld---~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD---FNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee---cCCcEEeeccccee
Confidence 9999999998 68888877643 478888899999999999999999999999999999995 67899999999997
Q ss_pred ccCCc-------cccccccccccCccccccc---cccccchhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Q 003438 265 TEDRT-------VYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASE-FDLLRRMIRILGAQP 333 (820)
Q Consensus 265 ~~~~~-------~~~~~gt~~Y~APEvl~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~~s~-~d~l~~I~~~lG~~P 333 (820)
..... ...+.||+.|||||++.+. ....++|||||||++.||+||+.||...+. ..++.++- .|..
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~--~gh~- 1459 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA--AGHK- 1459 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh--ccCC-
Confidence 55433 3456899999999999875 355799999999999999999999964332 22222111 1101
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
|. +|
T Consensus 1460 ----------------------------------------------------Pq-----------------~P------- 1463 (1509)
T KOG4645|consen 1460 ----------------------------------------------------PQ-----------------IP------- 1463 (1509)
T ss_pred ----------------------------------------------------CC-----------------Cc-------
Confidence 10 11
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTC 460 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~ 460 (820)
..++.+..|||..||+.||++|+|+.|+|+|-|-+.....+
T Consensus 1464 ------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~~ 1504 (1509)
T KOG4645|consen 1464 ------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDED 1504 (1509)
T ss_pred ------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccccc
Confidence 11567789999999999999999999999999998765443
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.49 Aligned_cols=206 Identities=26% Similarity=0.393 Sum_probs=170.0
Q ss_pred CceEEEEEeccCCceeEEEeeccC-------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
.+|++.+.||+|+||.||+|++.. ....||+|+++.. ....+.+.+|+++++++. .|+||+++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~ 85 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG------KHKNIINLLG 85 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc------CCCCeeeeeE
Confidence 689999999999999999997542 2347999998753 344567888999999884 4899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
++...+.+++||||+. ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999997 58999887532 12478888999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ .++.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 166 ll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVT---EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEc---CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 996 56789999999986543221 11233467999999999899999999999999999998 8999987665
Q ss_pred HHHHH
Q 003438 319 FDLLR 323 (820)
Q Consensus 319 ~d~l~ 323 (820)
.+...
T Consensus 243 ~~~~~ 247 (334)
T cd05100 243 EELFK 247 (334)
T ss_pred HHHHH
Confidence 44433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.45 Aligned_cols=205 Identities=23% Similarity=0.363 Sum_probs=170.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~---~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
..|++.+.||+|+||.||+|.++.+++ .||||+++.. ......+..|+.+++.+ .||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~~~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-------DHPNIIHLEGVVTK 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCcCcceEEEEECC
Confidence 578999999999999999999876654 6999998753 44456788899999888 68999999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+...++||||+.+ +|.+++.... +.+++.+++.++.|++.||.|||++|++|+||||+||+++ ....+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~---~~~~~kl~dfg~ 152 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGL 152 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc---CCCcEEECCCcc
Confidence 9999999999985 7887776543 4589999999999999999999999999999999999995 567899999999
Q ss_pred ccccCCccc-----ccc---ccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 263 ACTEDRTVY-----SYI---QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 263 A~~~~~~~~-----~~~---gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
+........ ... .+..|+|||.+.+..++.++|||||||++|||++ |..||...+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~ 223 (269)
T cd05065 153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINA 223 (269)
T ss_pred ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 864332111 111 1346999999998899999999999999999886 9999977665444333
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.94 Aligned_cols=204 Identities=26% Similarity=0.404 Sum_probs=168.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccC----------------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCC
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE----------------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDRE 169 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~----------------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~ 169 (820)
.++|++.++||+|+||+||++.+.. +...||+|+++.. ......+.+|+++|+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l------- 76 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL------- 76 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-------
Confidence 3689999999999999999985432 3457999999853 33456788999999998
Q ss_pred CCCceeEEeEEEeecceeEEEEeccC-CChHHHHHhhhc---------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccC
Q 003438 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF---------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL 239 (820)
Q Consensus 170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~---------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL 239 (820)
.|+||+++++++...+..|+||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++|+|+||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl 156 (296)
T cd05095 77 KDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156 (296)
T ss_pred CCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 68999999999999999999999997 689888875421 23678899999999999999999999999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh--CCCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPL 312 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt--G~~P 312 (820)
||+|||++ ..+.+||+|||++....... .....+..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 157 kp~Nili~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 157 ATRNCLVG---KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred ChheEEEc---CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 99999996 56789999999986542211 11233567999999888889999999999999999998 7788
Q ss_pred CCCCCHHHH
Q 003438 313 FPGASEFDL 321 (820)
Q Consensus 313 F~~~s~~d~ 321 (820)
|...+..+.
T Consensus 234 ~~~~~~~~~ 242 (296)
T cd05095 234 YSQLSDEQV 242 (296)
T ss_pred ccccChHHH
Confidence 876555443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.93 Aligned_cols=195 Identities=25% Similarity=0.402 Sum_probs=164.7
Q ss_pred ceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
+|++.+.||+|+||.||++++. .+++.||||++++.. ...+.+.+|+++++++. +|+||+++++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~------~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR------RCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc------CCcchhhhheee
Confidence 4889999999999999999753 467899999997432 23355678999999884 589999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
..+..+|+||||+. ++|.+.+... ..+++..++.++.||+++|.|||+.+++|+||||+||+++ .++.++|+||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df 149 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDF 149 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEEC
Confidence 99999999999997 5888887654 3589999999999999999999999999999999999996 5678999999
Q ss_pred ccccccCCc----cccccccccccCcccccccc--ccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 261 GSACTEDRT----VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 261 GlA~~~~~~----~~~~~gt~~Y~APEvl~~~~--yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
|++...... .....++..|+|||.+.+.. .+.++|||||||++|+|++|..||..
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 998653322 12245788999999987664 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.64 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=167.6
Q ss_pred EEeccCCceeEEEeeccC-CC--eEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAE-MN--SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~-tg--~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
++||+|++|.||+|.+.. .+ ..||||+++... ...+.+.+|+.+++++ .|+||+++++++.. ...++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~-~~~~~ 72 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-------DHENLIRLYGVVLT-HPLMM 72 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-------CCCCccceeEEEcC-CeEEE
Confidence 368999999999998755 33 369999998653 3556788899999988 68999999999988 89999
Q ss_pred EEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 190 VmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
||||+. ++|.+.+.......+++..++.++.||++||+|||+++|+|+||||+||+++ .++.+||+|||++.....
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccc
Confidence 999996 6899988775434689999999999999999999999999999999999996 568999999999865433
Q ss_pred cc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 269 TV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 269 ~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
.. ....++..|+|||.+....++.++|||||||++|+|++ |+.||...+..+.+..+
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 150 NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred cccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 11 12345678999999998899999999999999999998 99999776665544443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.76 Aligned_cols=196 Identities=25% Similarity=0.326 Sum_probs=163.4
Q ss_pred EeccCCceeEEEeeccCCCe--EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 116 LLGHGTFGQVAKCWDAEMNS--FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~--~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
.||+|+||.||+|++..++. .+|+|.++.. ....+.+.+|+++++++. .|+||+++++++...+..|+||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc------cCCCeeeEEEEEecCCCceEEE
Confidence 68999999999999887765 5788888742 344567888999999884 5899999999999999999999
Q ss_pred eccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEE
Q 003438 192 ELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
||+. ++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~---~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc---CCCeEE
Confidence 9997 68999887542 12478999999999999999999999999999999999996 678899
Q ss_pred EeecccccccCCcccc--ccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 257 IIDFGSACTEDRTVYS--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 257 L~DFGlA~~~~~~~~~--~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
|+|||++......... ...+..|+|||++....++.++|||||||++|||++ |..||.+.+..+
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~ 219 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 219 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH
Confidence 9999998543322111 223566999999988899999999999999999997 999997655443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=302.35 Aligned_cols=204 Identities=22% Similarity=0.329 Sum_probs=170.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+|++.+.||+|+||.||+|+++.++ ..||+|.++.. ....+.+.+|+.+++++ .||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 76 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-------DHPNIIHLEGVVTK 76 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEec
Confidence 68999999999999999999876444 47999998753 33456788899999888 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
++..|+||||+. ++|.+++.... ..+++.++..++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~ 152 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGL 152 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCc
Confidence 999999999997 58888887543 4589999999999999999999999999999999999995 567899999999
Q ss_pred ccccCCccc------cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 263 ACTEDRTVY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 263 A~~~~~~~~------~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
+........ ....+..|+|||.+.+..++.++|||||||++|||++ |..||......+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~ 220 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK 220 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH
Confidence 865432211 1122457999999998899999999999999999886 999997665544433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.93 Aligned_cols=201 Identities=27% Similarity=0.411 Sum_probs=165.5
Q ss_pred CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||+||+|++ ..+++.||||+++.. ......+.+|+.+|.++. +|+||++++++
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~niv~~~~~ 79 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA 79 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc------CCccHhhhcce
Confidence 37899999999999999999974 356789999999753 334556788999999984 47999999998
Q ss_pred Eeec-ceeEEEEeccC-CChHHHHHhhh----------------------------------------------------
Q 003438 181 FVCQ-RHLCICFELLD-SNLYELIKINH---------------------------------------------------- 206 (820)
Q Consensus 181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~---------------------------------------------------- 206 (820)
+... ..+++|||||. ++|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 8654 46899999998 68988876431
Q ss_pred -------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCcc---
Q 003438 207 -------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV--- 270 (820)
Q Consensus 207 -------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~--- 270 (820)
...+++..+..++.||++||+|||+++|+||||||+|||++ ..+.+||+|||++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcchh
Confidence 12367888899999999999999999999999999999995 56789999999986542211
Q ss_pred --ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 271 --YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 271 --~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
....++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 12234567999999998899999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=304.03 Aligned_cols=179 Identities=22% Similarity=0.298 Sum_probs=152.8
Q ss_pred CCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccC-CCh
Q 003438 120 GTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNL 198 (820)
Q Consensus 120 G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL 198 (820)
|.|+.||+|+++.+++.||+|+++.... ..+|...+... .|+||+++++++...+..|+||||+. ++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~-------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPH-------CVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhc-------CCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 8999999999999999999999986432 22333333222 58999999999999999999999998 589
Q ss_pred HHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCcccccccccc
Q 003438 199 YELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278 (820)
Q Consensus 199 ~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~ 278 (820)
.+++.... .+++..++.++.||++||.|||+++|+||||||+||+++ .++.++|+|||.+...........++..
T Consensus 73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~ 147 (237)
T cd05576 73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDSCDGEAVENM 147 (237)
T ss_pred HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhccccccccCCcCcc
Confidence 88886543 589999999999999999999999999999999999996 6678999999988665554445566778
Q ss_pred ccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 279 Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
|+|||.+....++.++||||+||++|||++|+.||.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 999999988889999999999999999999998774
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.13 Aligned_cols=194 Identities=28% Similarity=0.375 Sum_probs=162.8
Q ss_pred Cce-EEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRY-IVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY-~i~~~LG~G~fG~Vyka~----d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
+|| ++++.||+|+||+||++. ...+++.||+|+++... .....+.+|+++|+.+ +|+||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~ 75 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-------YHENIVKYKGCC 75 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEE
Confidence 445 999999999999998764 44578899999998542 3456778899999998 689999999988
Q ss_pred eec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 182 VCQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 182 ~~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
... ..+++||||+. ++|.+++... .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~ 149 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIG 149 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEe
Confidence 754 46899999998 5888887654 499999999999999999999999999999999999996 56789999
Q ss_pred ecccccccCCccc------cccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 259 DFGSACTEDRTVY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 259 DFGlA~~~~~~~~------~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
|||++........ ...++..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 9999875433211 12345679999999888899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=302.01 Aligned_cols=194 Identities=22% Similarity=0.225 Sum_probs=153.8
Q ss_pred EEeccCCceeEEEeeccC------------CCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAE------------MNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~------------tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
+.||+|+||.||+++... ....||+|++.... .....+.+|+.+++.+ .||||+++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-------~hp~iv~~~~~~ 73 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-------SHKHIVLLYGVC 73 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-------CCCCEeeEEEEE
Confidence 368999999999997432 23468999887543 3334566778888877 689999999999
Q ss_pred eecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc----CCCeEE
Q 003438 182 VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV----KPAEIK 256 (820)
Q Consensus 182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~----~~~~iK 256 (820)
..+...++||||+++ .|..++... ...+++..++.++.||++||+|||+++|+||||||+|||++.+. ....+|
T Consensus 74 ~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 74 VRDVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred ecCCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 999999999999985 555555433 34589999999999999999999999999999999999996321 112489
Q ss_pred EeecccccccCCccccccccccccCccccc-cccccccchhHhHHHHHHHHH-hCCCCCCCCC
Q 003438 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELF-LGLPLFPGAS 317 (820)
Q Consensus 257 L~DFGlA~~~~~~~~~~~gt~~Y~APEvl~-~~~yt~ksDIWSLG~ILyeLl-tG~~PF~~~s 317 (820)
|+|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..||....
T Consensus 153 l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 153 LSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred eCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999998654322 2346788899999987 457899999999999999998 5888886543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=301.13 Aligned_cols=204 Identities=26% Similarity=0.421 Sum_probs=169.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|.+.++||+|+||.||+|.+... ...||||.+... ....+.+.+|+.+++.+ .|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-------~h~~i~~~~~~~~ 77 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-------DHPHIVKLIGVIT 77 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-------CCCchhceeEEEc
Confidence 36799999999999999999986544 456999998754 34556788899999988 6899999999887
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
. ...|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.+++|+||||+|||++ ..+.+||+|||
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g 152 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFG 152 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCc
Confidence 5 56789999997 68999887643 3589999999999999999999999999999999999996 56789999999
Q ss_pred cccccCCccc----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 262 SACTEDRTVY----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 262 lA~~~~~~~~----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
++........ ...++..|+|||.+....++.++|||||||++|||++ |..||......+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9865433211 1223457999999988889999999999999999996 999998776554443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=297.17 Aligned_cols=193 Identities=28% Similarity=0.428 Sum_probs=163.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
++||+|+||.||+|.+.. ++.||+|+++... .....+.+|+++++.+ .|+||+++++++......++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-------DHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCeEEEEEEEecCCCeEEEEE
Confidence 369999999999999877 9999999988543 2456788899999888 68999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccc
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~ 271 (820)
|+. ++|.+++.... ..+++..+..++.|++.+|+|||+++|+||||||+|||++ .++.+||+|||++........
T Consensus 73 ~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 73 LVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc---CCCcEEEeeccccccccCCcc
Confidence 996 57888886543 3588999999999999999999999999999999999995 677899999999975442211
Q ss_pred -----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHH
Q 003438 272 -----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEF 319 (820)
Q Consensus 272 -----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~ 319 (820)
....+..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~ 202 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202 (251)
T ss_pred eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence 1122456999999988899999999999999999999 89999766543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.26 Aligned_cols=203 Identities=24% Similarity=0.332 Sum_probs=170.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccC----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.++|++.++||+|+||.||+|.+.. +++.||+|+++.. ....+.+.+|+.+++.+ .|+||+++++++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-------~h~ni~~~~~~~ 77 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-------SHQNILPILHVC 77 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEE
Confidence 3799999999999999999998776 3688999998753 34456678899998888 689999999987
Q ss_pred ee-cceeEEEEeccC-CChHHHHHhhhc------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC
Q 003438 182 VC-QRHLCICFELLD-SNLYELIKINHF------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 182 ~~-~~~l~LVmEy~~-gsL~d~l~~~~~------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~ 253 (820)
.. ....++++||+. ++|.+++..... ..+++..++.++.||+.||+|||+++|+|+||||+||+++ +.+
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~ 154 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EEL 154 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCC
Confidence 66 467899999997 688888866432 3589999999999999999999999999999999999996 568
Q ss_pred eEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 254 EIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
.+||+|||+++...... ....++..|+|||++.+..++.++|||||||++|||++ |++||...+..+
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 89999999996432211 12234667999999998899999999999999999998 999997665443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.43 Aligned_cols=199 Identities=25% Similarity=0.325 Sum_probs=163.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|++++.||+|+||+||+|++..+++ .|++|++... .....++..|+.++..+ .|+||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-------~h~~iv~~~~~~~ 79 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-------DHAYIVRLLGICP 79 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-------CCCCcceEEEEEC
Confidence 689999999999999999999877766 4777777543 22334566677677666 7899999999875
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
....++|+||+. ++|.+++.... ..+++..++.++.||+.||.|||+++++||||||+|||++ .++.+||+|||
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~---~~~~~kl~Dfg 154 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK---SDSIVQIADFG 154 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEEcCCc
Confidence 456788999987 79999887643 4589999999999999999999999999999999999995 67889999999
Q ss_pred cccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHH
Q 003438 262 SACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEF 319 (820)
Q Consensus 262 lA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~ 319 (820)
+++..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99643221 122345678999999998899999999999999999998 99999766543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=296.21 Aligned_cols=195 Identities=28% Similarity=0.427 Sum_probs=163.2
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
++||+|+||.||++... ++..||+|+++.. ......+.+|+++++.+ .|+||+++++++...+..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-------DHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-------CCCCcCeEEEEEecCCccEEEEE
Confidence 36899999999999854 6788999998754 23345678899999888 68999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccc
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~ 271 (820)
|+. ++|.+++.... ..+++..+..++.||+.+|.|||++|++||||||+||+++ .++.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceecccccc
Confidence 997 58888776543 4589999999999999999999999999999999999995 677899999999865433221
Q ss_pred ----cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 272 ----SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 272 ----~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
....+..|+|||++....++.++|||||||++|+|++ |..||........
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~ 203 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA 203 (250)
T ss_pred ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 1233566999999988889999999999999999998 9999987655443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.03 Aligned_cols=199 Identities=24% Similarity=0.377 Sum_probs=164.0
Q ss_pred EeccCCceeEEEeeccCCC------eEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 116 LLGHGTFGQVAKCWDAEMN------SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg------~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.||+|+||.||+|+++... +.||||.+.... .....+.+|+.+++.+ .|+||+++++++...+..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~ 74 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-------NHPNIVKLLGVCLLNEPQ 74 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-------CCCCeeeEeeeecCCCCe
Confidence 6899999999999876544 789999987543 4456788899999888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhc-----CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc--CCCeEEEee
Q 003438 188 CICFELLD-SNLYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIID 259 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~-----~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~iKL~D 259 (820)
++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++++|+||||+||+++.+. ....+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999997 689988875422 2378899999999999999999999999999999999997432 223799999
Q ss_pred cccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 260 FGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 260 FGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
||++...... ......+..|+|||++.+..++.++|||||||++|||++ |..||...+..+.
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~ 222 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH
Confidence 9998643221 112244678999999998899999999999999999998 9999986665443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=302.60 Aligned_cols=195 Identities=27% Similarity=0.405 Sum_probs=163.7
Q ss_pred CceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~----d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+|++++.||+|+||.||++. +..+++.||||+++.. ....+.+.+|+++++.+ .|+||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~ 76 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-------QHDNIVKYKGVCYS 76 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCCeeEEEEEEcc
Confidence 689999999999999999987 4567889999999754 34456788899999988 68999999998754
Q ss_pred c--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 184 Q--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 184 ~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
. ..+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~---~~~~~~l~df 152 (284)
T cd05081 77 AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE---SENRVKIGDF 152 (284)
T ss_pred CCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC---CCCeEEECCC
Confidence 3 46899999996 68999886543 3589999999999999999999999999999999999995 6678999999
Q ss_pred ccccccCCccc------cccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 261 GSACTEDRTVY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 261 GlA~~~~~~~~------~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
|++........ ....+..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 99975432211 1123446999999998899999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.18 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=170.0
Q ss_pred CceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-----tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++++.||+|+||.||+|+.+. +.+.||+|.+..... ..+.+.+|+++++++ .|+||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~ 77 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-------SHKNVVRLLGLC 77 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-------CCcceeeeEEEE
Confidence 789999999999999999998653 356799999875432 456788999999998 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhc-------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHF-------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~-------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~ 253 (820)
...+..|+||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++|+||||||+||+++ ..+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~ 154 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQR 154 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCC
Confidence 99999999999998 689998876541 1589999999999999999999999999999999999996 567
Q ss_pred eEEEeecccccccCCc----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 254 EIKIIDFGSACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
.++|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~ 226 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226 (275)
T ss_pred cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence 8999999998643221 122345677999999988888999999999999999998 888997654433
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=336.40 Aligned_cols=274 Identities=21% Similarity=0.256 Sum_probs=180.6
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCC----CeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE--
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEM----NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY-- 180 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~t----g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~-- 180 (820)
..++|++.++||+|+||.||+|++..+ +..||||+++.... .|+.+..++.+. .+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~------~e~~~~e~l~~~----~~~~~~~~~~~~~ 199 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA------VEIWMNERVRRA----CPNSCADFVYGFL 199 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch------hHHHHHHHHHhh----chhhHHHHHHhhh
Confidence 347999999999999999999999888 89999999874322 122222222221 11122222111
Q ss_pred ----EeecceeEEEEeccC-CChHHHHHhhhcC------------------CCCHHHHHHHHHHHHHHhhhcccCCeeec
Q 003438 181 ----FVCQRHLCICFELLD-SNLYELIKINHFR------------------GLSLSIVQLFSKQILRGLSLLKDAGIIHC 237 (820)
Q Consensus 181 ----f~~~~~l~LVmEy~~-gsL~d~l~~~~~~------------------~l~e~~i~~I~~QIl~aL~yLHs~gIVHr 237 (820)
......++|||||+. ++|.+++...... ...+..++.++.||+.||+|||+++||||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 234568999999998 5788887643210 12234577899999999999999999999
Q ss_pred cCCCCCcccccccCCCeEEEeecccccccCC----ccccccccccccCccccccc----------------------ccc
Q 003438 238 DLKPENILLCTSVKPAEIKIIDFGSACTEDR----TVYSYIQSRYYRSPEVLLGY----------------------QYT 291 (820)
Q Consensus 238 DLKPeNILl~~~~~~~~iKL~DFGlA~~~~~----~~~~~~gt~~Y~APEvl~~~----------------------~yt 291 (820)
||||+|||++ .+.+.+||+|||+|+.... .....++++.|+|||.+... .++
T Consensus 280 DLKP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 280 DVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred cCCHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9999999996 3457899999999964322 23456789999999976422 244
Q ss_pred ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchh
Q 003438 292 TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQ 371 (820)
Q Consensus 292 ~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~ 371 (820)
.++||||||||||||+++..++ .+....+..++...+.....+ ... ..
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~-~~~----------~~------------------- 405 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAW-RKL----------VE------------------- 405 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHH-HHh----------hc-------------------
Confidence 5679999999999999865543 333333444333333111000 000 00
Q ss_pred hhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCC
Q 003438 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451 (820)
Q Consensus 372 ~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HP 451 (820)
+. ....+.+. +.........+.|||++||++||++|||++|||+||
T Consensus 406 --------------~~------~~~~~~~~--------------~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 406 --------------PR------ASPDLRRG--------------FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP 451 (566)
T ss_pred --------------cc------cchhhhhh--------------hhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence 00 00000000 000011234577999999999999999999999999
Q ss_pred ccCCCCC
Q 003438 452 FVTGEPF 458 (820)
Q Consensus 452 ff~~~~~ 458 (820)
||++...
T Consensus 452 ff~~~~~ 458 (566)
T PLN03225 452 YFDREGL 458 (566)
T ss_pred CcCCCCc
Confidence 9988653
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=305.52 Aligned_cols=195 Identities=26% Similarity=0.352 Sum_probs=164.5
Q ss_pred CceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~----d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+-|+++++||+|+||.||+|+ ...+++.||+|.++.. ......+.+|+++++.+ .|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-------YHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-------CCCCeeeeeeEEe
Confidence 567999999999999999997 3567889999998743 33456788899999988 6899999999988
Q ss_pred ec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.. ...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECC
Confidence 75 57899999996 58888876543 3589999999999999999999999999999999999996 567899999
Q ss_pred cccccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 260 FGlA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
||++....... ....++..|+|||++.+..++.++|||||||++|||++++.|+.
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 99986543221 12345667999999998889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=299.13 Aligned_cols=195 Identities=24% Similarity=0.343 Sum_probs=160.0
Q ss_pred EeccCCceeEEEeecc--CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 116 LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~--~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
.||+|+||.||+|.+. .++..||||+++.. ....+.+.+|+.+++++ .|+||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-------DNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-------CCCCeEEEEEEEc-CCCeEEEE
Confidence 3899999999998754 45667999999754 23345688999999998 6899999999875 45789999
Q ss_pred eccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCcc
Q 003438 192 ELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~ 270 (820)
||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||++.......
T Consensus 74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADD 149 (257)
T ss_pred EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCc
Confidence 9997 58888876543 4689999999999999999999999999999999999995 66789999999986432221
Q ss_pred c------cccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 271 Y------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 271 ~------~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
. ...++..|+|||++....++.++|||||||++|+|++ |..||......+..
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 208 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 1 1122467999999988889999999999999999996 99999876654433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.39 Aligned_cols=202 Identities=24% Similarity=0.388 Sum_probs=169.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.+|++.+.||+|+||+||+|.++.+++ .||+|+++... .....+.+|+.+++.+ .|+||+++++++.
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~ 79 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-------DHPHVVRLLGICL 79 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEe
Confidence 789999999999999999998776654 68999887543 3456778899999988 6899999999988
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
. ...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+||+++ ..+.+||+|||
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kL~dfg 154 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK---TPQHVKITDFG 154 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc---CCCeEEECCCc
Confidence 7 78999999997 68998887653 3589999999999999999999999999999999999995 56789999999
Q ss_pred cccccCCcccc-----ccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 262 SACTEDRTVYS-----YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 262 lA~~~~~~~~~-----~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
.+......... ...+..|+|||.+....++.++|||||||++|||++ |+.||.+....+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 221 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 99654322111 122467999999988889999999999999999998 99999876654433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.28 Aligned_cols=184 Identities=28% Similarity=0.412 Sum_probs=162.8
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
-++-||.|+.|.||+++. .++.||||+++. ....+|+-|++| .|+||+.+.++|...-.+|||||
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~e------lkETdIKHLRkL-------kH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRE------LKETDIKHLRKL-------KHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhh------hhhhhHHHHHhc-------cCcceeeEeeeecCCceeEEeee
Confidence 356799999999999964 478899999863 223477778888 68999999999999999999999
Q ss_pred ccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc--
Q 003438 193 LLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT-- 269 (820)
Q Consensus 193 y~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-- 269 (820)
||. |-|+++|+..+ .++...+..|.++|+.|+.|||.+.|||||||.-||||+ .+..|||+|||.++...+.
T Consensus 193 fCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred ccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh
Confidence 997 89999998765 689999999999999999999999999999999999997 5567999999999765543
Q ss_pred cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
...++||..|||||+|++.+++.|+|||||||+|||||||..||..-
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 45679999999999999999999999999999999999999999653
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=302.09 Aligned_cols=194 Identities=20% Similarity=0.226 Sum_probs=154.1
Q ss_pred EeccCCceeEEEeeccC------------------------CCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCC
Q 003438 116 LLGHGTFGQVAKCWDAE------------------------MNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDRED 170 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~------------------------tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~ 170 (820)
+||+|+||.||++.... ....||+|++.... .....+.+|+.+++.+ .
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-------~ 74 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-------S 74 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-------C
Confidence 59999999999986421 12458999987543 2334566777777777 6
Q ss_pred CCceeEEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 171 KHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 171 HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
|+||+++++++......++||||+.+ +|..++... ...+++..+..++.||+.||+|||+++|+||||||+|||++..
T Consensus 75 h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 75 HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL 153 (274)
T ss_pred CCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence 89999999999999999999999985 666666543 3468999999999999999999999999999999999999632
Q ss_pred ----cCCCeEEEeecccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHH-hCCCCCCCCCH
Q 003438 250 ----VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELF-LGLPLFPGASE 318 (820)
Q Consensus 250 ----~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLl-tG~~PF~~~s~ 318 (820)
.....+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 12345899999998543322 23356788999999876 46899999999999999995 69999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.26 Aligned_cols=200 Identities=22% Similarity=0.277 Sum_probs=159.9
Q ss_pred EeccCCceeEEEeecc--CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 116 LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~--~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
.||+|+||+||+|... .....||+|.+... ......+.+|+.+++.+ +|+||+++++.+.....+|+||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-------~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-------NHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-------CCCCcceEEEEECCCCceEEEE
Confidence 5899999999999543 34567899987643 23345677899888887 6899999999999999999999
Q ss_pred eccC-CChHHHHHhhhc---CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 192 ELLD-SNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~~---~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||+. ++|.+++..... ...++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT---ADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec---CCCcEEEeccccccccc
Confidence 9997 589998876532 2356788899999999999999999999999999999996 67889999999986432
Q ss_pred Cc-----cccccccccccCcccccc-------ccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 268 RT-----VYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 268 ~~-----~~~~~gt~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
.. .....++..|+|||++.. ..++.++|||||||++|||++ |..||....+.+.+..+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 222 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 21 122244667999999753 357889999999999999999 78899876665544443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=320.40 Aligned_cols=202 Identities=28% Similarity=0.408 Sum_probs=168.2
Q ss_pred CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|.+.++||+|+||.||+|++ ..+++.||||+++.. ....+.+.+|+++|.++. .|+||+++++++
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~------~H~niv~~~~~~ 110 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG------PHLNIVNLLGAC 110 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC------CCCCeEEEEEEE
Confidence 6788999999999999999984 345678999999854 233456788999999883 389999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhc-----------------------------------------------------
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHF----------------------------------------------------- 207 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~----------------------------------------------------- 207 (820)
...+.++||||||. |+|.+++.....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999998 699998865321
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 208 -------------------------------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 208 -------------------------------------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
..+++..++.++.||+.||+|||+.+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 2367778899999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ +.+.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~---~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LIC---EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEe---CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 996 5678999999998643211 122356778999999998889999999999999999998 8899976543
Q ss_pred H
Q 003438 319 F 319 (820)
Q Consensus 319 ~ 319 (820)
.
T Consensus 348 ~ 348 (401)
T cd05107 348 N 348 (401)
T ss_pred h
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.82 Aligned_cols=193 Identities=25% Similarity=0.371 Sum_probs=157.3
Q ss_pred EEeccCCceeEEEeeccCCCe-------EEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 115 DLLGHGTFGQVAKCWDAEMNS-------FVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~-------~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+.||+|+||+||+|.+..+++ .||+|++.... ...+.+.+|+.+++.+ .|+||+++++++...+.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-------~h~~iv~~~~~~~~~~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-------SHKHLVLNYGVCVCGDE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-------CCCChhheeeEEEeCCC
Confidence 369999999999998765544 48899886543 3345677788888887 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC-----CCeEEEeec
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-----PAEIKIIDF 260 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-----~~~iKL~DF 260 (820)
.++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+.. ...++|+||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999997 57888876543 35899999999999999999999999999999999999974321 234899999
Q ss_pred ccccccCCccccccccccccCccccccc-cccccchhHhHHHHHHHHHhC-CCCCCCC
Q 003438 261 GSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLG-LPLFPGA 316 (820)
Q Consensus 261 GlA~~~~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG-~~PF~~~ 316 (820)
|.+..... .....++..|+|||++.+. .++.++|||||||++|+|++| .+||...
T Consensus 153 g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 153 GISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred ccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 99865432 2234678889999999874 589999999999999999998 4666443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=336.52 Aligned_cols=210 Identities=28% Similarity=0.413 Sum_probs=183.5
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
..+.++.+.||+|+||+||+|+.. .....||||.++... ...++|.+|+++|..| +|||||+|+++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-------~H~nIVrLlGV 557 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-------QHPNIVRLLGV 557 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-------cCCCeEEEEEE
Confidence 367778899999999999999743 345689999999643 3577899999999999 79999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhc------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccc
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHF------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~ 247 (820)
|..++.+|+|||||. |+|.++|+.... .+|+..+...|+.||+.|+.||-++.+|||||..+|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 999999999999998 899999986531 2288899999999999999999999999999999999996
Q ss_pred cccCCCeEEEeecccccccCCcccccc-----ccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 248 TSVKPAEIKIIDFGSACTEDRTVYSYI-----QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 248 ~~~~~~~iKL~DFGlA~~~~~~~~~~~-----gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
+...|||+|||+++..-....... -..+||+||.|+..+|++++||||+||+|||+++ |+.||.+.++.++
T Consensus 638 ---e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 638 ---ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred ---cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 778999999999986654443333 3677999999999999999999999999999998 9999999999998
Q ss_pred HHHHHH
Q 003438 322 LRRMIR 327 (820)
Q Consensus 322 l~~I~~ 327 (820)
++.|.+
T Consensus 715 Ie~i~~ 720 (774)
T KOG1026|consen 715 IECIRA 720 (774)
T ss_pred HHHHHc
Confidence 887754
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.98 Aligned_cols=192 Identities=22% Similarity=0.265 Sum_probs=159.3
Q ss_pred EEeccCCceeEEEeeccCCC----------eEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 115 DLLGHGTFGQVAKCWDAEMN----------SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg----------~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
+.||+|+||.||++.+..++ ..|++|+++........+.+|+.+|+.+ .|+||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-------SHKHLVKLYGVCVR- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-------CCcchhheeeEEec-
Confidence 36899999999999988776 4588898876544467788899998887 68999999999988
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc----CCCeEEEee
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV----KPAEIKIID 259 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~----~~~~iKL~D 259 (820)
...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+. ....+||+|
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 78899999998 57888777643 3689999999999999999999999999999999999996322 112799999
Q ss_pred cccccccCCccccccccccccCccccccc--cccccchhHhHHHHHHHHHh-CCCCCCCC
Q 003438 260 FGSACTEDRTVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFL-GLPLFPGA 316 (820)
Q Consensus 260 FGlA~~~~~~~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLlt-G~~PF~~~ 316 (820)
||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...
T Consensus 152 fg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 999976543 2234567789999999876 78999999999999999999 57777554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.64 Aligned_cols=201 Identities=22% Similarity=0.226 Sum_probs=157.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCChhhH--HH-------HHHHHHHHHHHhhhcCCCCCCcee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQPAYY--QQ-------ALVEVSILTTLNKKYDREDKHHIV 175 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~~~~~--~~-------~~~Ei~iL~~L~~~~~~~~HpnIV 175 (820)
.++|++.++||+|+||+||+|++..+ +..+|+|+........ +. ...++..+..+ ....|++|+
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~----~~~~h~~i~ 86 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI----HNIDHLGIP 86 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh----ccCCCCCCC
Confidence 37999999999999999999998777 6778888754322110 10 01122223333 234799999
Q ss_pred EEeEEEeecc----eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 176 RIYEYFVCQR----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 176 kl~d~f~~~~----~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
++++++.... ..++++|++..++.+++... ...++..++.++.||+.||+|||+++|+||||||+|||++ .
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~ 161 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---G 161 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence 9998766543 45789998888887776653 2367889999999999999999999999999999999995 5
Q ss_pred CCeEEEeecccccccCC----------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 252 PAEIKIIDFGSACTEDR----------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~----------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.+.+||+|||+|+.... ......+|+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 67899999999864321 1123468999999999999999999999999999999999999998763
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.09 Aligned_cols=202 Identities=27% Similarity=0.428 Sum_probs=167.2
Q ss_pred ceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC-----------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ-----------PAYYQQALVEVSILTTLNKKYDREDKHHIVRI 177 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~-tg~~VAIKiik~~-----------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl 177 (820)
.|++.+.||+|+||.||++++.. +++.||+|++... .....++..|+.++.+. .+|+||+++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~------~~h~~i~~~ 74 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ------LRHPNIVRY 74 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc------CCCCCeeeE
Confidence 37888999999999999999887 6889999998632 22334456677766553 268999999
Q ss_pred eEEEeecceeEEEEeccCC-ChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCC
Q 003438 178 YEYFVCQRHLCICFELLDS-NLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 178 ~d~f~~~~~l~LVmEy~~g-sL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~ 253 (820)
++++..++..|+||||+.+ +|.+++... ....+++..++.++.||+.+|.|||+ .+|+|+||||+||+++ ..+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~ 151 (269)
T cd08528 75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDD 151 (269)
T ss_pred EeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCC
Confidence 9999999999999999974 888877542 23458999999999999999999996 7899999999999995 678
Q ss_pred eEEEeecccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 254 EIKIIDFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
.+||+|||.+...... .....++..|+|||.+.+..++.++|||||||++|+|++|++||.......
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~ 220 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS 220 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence 8999999999654332 234567888999999998889999999999999999999999997654433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.09 Aligned_cols=195 Identities=23% Similarity=0.349 Sum_probs=157.4
Q ss_pred EEeccCCceeEEEeeccC---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe-ecceeE
Q 003438 115 DLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHLC 188 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-~~~~l~ 188 (820)
+.||+|+||+||+|.+.. ....||||.+... ....+.+.+|+.+++.+ .|+||+++++++. .++..+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~~~ 73 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-------SHPNVLSLLGICLPSEGSPL 73 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-------CCCCcceEEEEeecCCCCcE
Confidence 368999999999998643 3467999998642 34456777888888877 6899999999765 455689
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..+++..+..++.||++||.|||+.+|+||||||+|||++ ..+.+||+|||+++...
T Consensus 74 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIY 149 (262)
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCcccccccc
Confidence 9999997 68888886543 3467888899999999999999999999999999999996 56789999999986443
Q ss_pred Cc-------cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 268 RT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 268 ~~-------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
.. .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~ 210 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 21 112244667999999988899999999999999999999 577786655433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=315.79 Aligned_cols=196 Identities=27% Similarity=0.361 Sum_probs=170.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh-HHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-e
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-H 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~-~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-~ 186 (820)
+.|.-..+||+|+||.||+|.... ++.||||.+...... ..++.+|+.+|.++ .|+|||+|++||.+.+ +
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-------~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRL-------RHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcC-------CCcCcccEEEEEecCCce
Confidence 678888899999999999997654 488999988865443 56699999999999 6899999999999998 5
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC---eeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG---IIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g---IVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+||+|||. |+|.+.+.......++|....+|+.++++||+|||+.. |||||||+.||||+ ++...||+|||+
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD---~~~~aKlsDFGL 223 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD---EDFNAKLSDFGL 223 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC---CCCCEEccCccC
Confidence 999999997 79999887654327899999999999999999999754 99999999999995 788999999999
Q ss_pred ccccCC-ccc--cc-cccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 263 ACTEDR-TVY--SY-IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 263 A~~~~~-~~~--~~-~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
|+.... ... .. .||..|+|||.+.....+.|+|||||||+|.||++|+.+...
T Consensus 224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred cccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 976543 222 22 789999999999988999999999999999999999988764
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.42 Aligned_cols=196 Identities=20% Similarity=0.232 Sum_probs=159.4
Q ss_pred EeccCCceeEEEeecc--CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 116 LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~--~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
.||+|+||.||+|... .++..+|+|.++... .....+.+|+.+++++ .|+||+++++++......++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~~lv~ 74 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-------QHSNLLQCLGQCTEVTPYLLVM 74 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEcCCCCcEEEE
Confidence 6899999999999743 456789999987543 2334677899999888 6899999999999999999999
Q ss_pred eccC-CChHHHHHhhhc---CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 192 ELLD-SNLYELIKINHF---RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~~---~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||+. ++|.+++..... ..+++..++.++.||+.||+|||+++|+|+||||+||+++ ..+.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKY 151 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCcccccccc
Confidence 9998 689888865431 2356778889999999999999999999999999999996 56789999999986433
Q ss_pred Ccc-----ccccccccccCccccccc-------cccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 268 RTV-----YSYIQSRYYRSPEVLLGY-------QYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 268 ~~~-----~~~~gt~~Y~APEvl~~~-------~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
... ....++..|+|||++.+. .++.++|||||||++|||++ |..||......+.
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 221 123457789999998642 35789999999999999996 9999976655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=321.41 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=218.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.+++++..||-|+||.|-++........+|+|++++. ....+.+..|-.||..+ ..+.||++|..|.+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-------~s~fIvrLYrTfrd~ 492 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-------RSDFIVRLYRTFRDS 492 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-------CchHHHHHHHHhccc
Confidence 5677888999999999999977666667999999863 34456677899999888 457999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.++|+.||-|- |.|+.+++.+ +.+++..++.++..+++|++|||++|||.|||||+|+|++ ..+-+||.|||+|
T Consensus 493 kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd---~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 493 KYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD---NRGYLKLVDFGFA 567 (732)
T ss_pred hhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec---cCCceEEeehhhH
Confidence 99999999985 6899888765 4699999999999999999999999999999999999995 7899999999999
Q ss_pred cccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 264 CTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 264 ~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
+... ....++|||+.|.|||++++...+.++|.||||+++|||++|.+||.+.+.......|.+.+.
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid----------- 636 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID----------- 636 (732)
T ss_pred HHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----------
Confidence 8764 456788999999999999999999999999999999999999999999888777777766332
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+.....
T Consensus 637 -------------------------------------------------------------------------~i~~Pr~ 643 (732)
T KOG0614|consen 637 -------------------------------------------------------------------------KIEFPRR 643 (732)
T ss_pred -------------------------------------------------------------------------hhhcccc
Confidence 0000112
Q ss_pred hHHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPFT 459 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~~ 459 (820)
+...+.+||+++...+|.+|+- +.+|-.|.||.+..+.
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 4466889999999999999996 8999999999987654
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.99 Aligned_cols=196 Identities=30% Similarity=0.391 Sum_probs=167.1
Q ss_pred CceEEEEEeccCCceeEEEeecc----CCCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA----EMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~----~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+.|++.+.||+|+||.||+++.. .+++.||||+++.... ..+.+.+|+++++.+ .|+||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-------~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-------DHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-------CCCChheEEeeee
Confidence 67889999999999999999854 4578999999986544 467788999999888 6899999999988
Q ss_pred e--cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 C--QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~--~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
. ....++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~d 152 (284)
T cd05038 77 KPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISD 152 (284)
T ss_pred cCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcc
Confidence 7 558999999997 58988887653 3589999999999999999999999999999999999996 568899999
Q ss_pred cccccccCCccc------cccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 260 FGSACTEDRTVY------SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 260 FGlA~~~~~~~~------~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||.+........ ....+..|+|||.+.+..++.++|||||||++|||++|..||..
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 153 FGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred cccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 999976542211 12335569999999888999999999999999999999988854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=300.67 Aligned_cols=198 Identities=23% Similarity=0.360 Sum_probs=164.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.+|++.+.||+|+||.||++++..+++ .||+|++.... .....+.+|+.+++.+ .|+||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-------~h~niv~~~~~~~ 79 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-------DHPHLVRLLGVCL 79 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCcccEEEEEc
Confidence 688999999999999999999877775 57899887542 3334677888888888 6899999999887
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.. ..++|+||+. |+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||+++ ..+.+||+|||
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg 154 (303)
T cd05110 80 SP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFG 154 (303)
T ss_pred CC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEcccc
Confidence 54 5779999997 68988887543 3589999999999999999999999999999999999995 56789999999
Q ss_pred cccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 262 SACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 262 lA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 997543221 12234668999999998899999999999999999997 8999976543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=293.60 Aligned_cols=200 Identities=22% Similarity=0.337 Sum_probs=162.6
Q ss_pred eEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 111 YIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
|++.++||+|+||.||+|.+. .+++.||||+++.+ ....+++.+|+++++++ .|+||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-------DHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-------CCCCcceEEEEEccC
Confidence 567889999999999999854 35789999999753 34456778899999888 689999999988754
Q ss_pred c------eeEEEEeccC-CChHHHHHhhh----cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC
Q 003438 185 R------HLCICFELLD-SNLYELIKINH----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 185 ~------~l~LVmEy~~-gsL~d~l~~~~----~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~ 253 (820)
. ..++++||+. ++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+||+++ ...
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~ 150 (273)
T cd05074 74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENM 150 (273)
T ss_pred CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCC
Confidence 2 3478899987 68877765332 12478999999999999999999999999999999999995 567
Q ss_pred eEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 254 EIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
.+||+|||+++...... ....++..|++||.+....++.++|||||||++|+|++ |++||......+
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 89999999987543221 12234567999999998889999999999999999999 899997665443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=318.51 Aligned_cols=207 Identities=27% Similarity=0.413 Sum_probs=176.7
Q ss_pred ceEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg----~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
+-.+.++||+|+||.||+|..+..+ ..||||..+. ......++++|.++|+++ +|+|||++|++.
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-------~H~NVVr~yGVa 230 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-------NHPNVVRFYGVA 230 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEE
Confidence 4445689999999999999865542 2389999984 256677899999999998 799999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
..+..++||||+|. |+|.++|+... ..++..+...++.+.+.||+|||++++|||||-.+|+|++ ....+||+||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDF 306 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDF 306 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCcc
Confidence 99999999999998 59999998875 3599999999999999999999999999999999999996 5567899999
Q ss_pred ccccccCCcccc---ccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003438 261 GSACTEDRTVYS---YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 261 GlA~~~~~~~~~---~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~ 327 (820)
|+++........ ..-...|+|||.+....|+.++|||||||++||+++ |..||.+....+...+|..
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 999765422111 123577999999999999999999999999999998 8889999988877777643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=307.99 Aligned_cols=299 Identities=26% Similarity=0.413 Sum_probs=216.6
Q ss_pred cCCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~---tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
..+.|.++++||+|.|++||++.+.. ..++||+|.+.... ...++.+|+++|..+. ++.||+++.+++..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~g------G~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLG------GSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhc------cchhhhcchhhhcc
Confidence 34789999999999999999999887 78999999997543 3456889999999996 67899999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
++..++||||++. ...+++. .++..+++.+++.++.||.++|.+|||||||||.|+|++ ...+.-.|+|||+
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGL 179 (418)
T ss_pred CCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechh
Confidence 9999999999986 5555543 377899999999999999999999999999999999997 5677889999999
Q ss_pred ccc-----------c------CC------------------------------ccccccccccccCccccccc-cccccc
Q 003438 263 ACT-----------E------DR------------------------------TVYSYIQSRYYRSPEVLLGY-QYTTAI 294 (820)
Q Consensus 263 A~~-----------~------~~------------------------------~~~~~~gt~~Y~APEvl~~~-~yt~ks 294 (820)
|.. . .. ......||+.|+|||++... ..++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 830 0 00 00124689999999999876 578899
Q ss_pred hhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCchHHHHhhhccch--hhhhcCCccccCCCccccCCccchh
Q 003438 295 DMWSFGCIVAELFLGLPLF-PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK--FFKCIGSVHNIENGEVSIGGRSAYQ 371 (820)
Q Consensus 295 DIWSLG~ILyeLltG~~PF-~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~--~f~~~~~l~~~~~~~~~~~~~~~y~ 371 (820)
||||.|+|+..+++++.|| ...++.+.+.+|..++| +..+.+...-..+ ++.. ..+-
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG---~~~mrk~A~l~g~~~l~~k-----------------sn~~ 319 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFG---SAEMRKCAALPGRILLWQK-----------------SNIP 319 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhC---hHHHHHHhhcCCceeeecc-----------------cccc
Confidence 9999999999999998877 55677888999999888 2333332211111 1110 0000
Q ss_pred hhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCC
Q 003438 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451 (820)
Q Consensus 372 ~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HP 451 (820)
.........+... .+. +...... +...+ ......+..+.|||.+||+.||.+|+||+++|+||
T Consensus 320 ~~~e~~~~f~s~~-------------~~~-~~~~~q~-n~~~~--~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 320 TIPELRVNFETLH-------------IES-IYKSRQP-NTERE--IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred ccHHHHhchhccC-------------hhh-ccccccc-ceeec--cccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 0000000000000 000 0000000 00000 01112345889999999999999999999999999
Q ss_pred ccCCC
Q 003438 452 FVTGE 456 (820)
Q Consensus 452 ff~~~ 456 (820)
||...
T Consensus 383 FF~~~ 387 (418)
T KOG1167|consen 383 FFDEA 387 (418)
T ss_pred CCcch
Confidence 99954
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=311.93 Aligned_cols=200 Identities=25% Similarity=0.449 Sum_probs=169.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhH----HHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY----QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~----~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
+.-|..++.||-|+||.|.+++...|...||+|.+++.+... ..+..|-.||.+. +.+=||+||-.|++
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-------Dn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-------DNEWVVRLYYSFQD 700 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-------CCcceEEEEEEecc
Confidence 357889999999999999999999999999999998654322 2345577777666 56779999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
++.+|+||||+. |++-.+|.+. +-|.|..++.++.+|..|+++.|+.|+|||||||+||||+ .++.|||+|||+
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID---rdGHIKLTDFGL 775 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGL 775 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc---cCCceeeeeccc
Confidence 999999999997 5777776653 4599999999999999999999999999999999999995 889999999999
Q ss_pred ccc-----------cCC----------------------------------ccccccccccccCccccccccccccchhH
Q 003438 263 ACT-----------EDR----------------------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMW 297 (820)
Q Consensus 263 A~~-----------~~~----------------------------------~~~~~~gt~~Y~APEvl~~~~yt~ksDIW 297 (820)
|.- .+. .....+||+.|+|||+|....|+..+|.|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 820 000 01235789999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCHH
Q 003438 298 SFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 298 SLG~ILyeLltG~~PF~~~s~~ 319 (820)
|.|||||||+.|++||......
T Consensus 856 s~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCC
Confidence 9999999999999999766543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.89 Aligned_cols=200 Identities=20% Similarity=0.263 Sum_probs=159.2
Q ss_pred EeccCCceeEEEeeccCC--CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 116 LLGHGTFGQVAKCWDAEM--NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~t--g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
+||+|+||+||+++.... ...+++|.++.. ....+.+.+|+.+++.+ +||||+++++.+......|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-------~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-------QHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-------CCcchhheEEEecCCCccEEEE
Confidence 599999999999975333 345677777643 23456788888888877 6899999999999999999999
Q ss_pred eccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 192 ELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 192 Ey~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
||+. ++|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~---~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT---SDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc---CCccEEecccccccccCc
Confidence 9998 58998887643 23467788899999999999999999999999999999995 668899999999854221
Q ss_pred -----ccccccccccccCcccccc-------ccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 269 -----TVYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 269 -----~~~~~~gt~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
......++..|+|||++.. ..++.++|||||||++|||++ +..||...++.+.+..+
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 221 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 1123467888999999853 246789999999999999997 57788776665554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=332.80 Aligned_cols=210 Identities=25% Similarity=0.405 Sum_probs=180.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t-----g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
...-++.+.||+|+||.||+|.-... ...||||.+++. .....++++|..+|..+ +|||||+++++
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-------~HpNiv~liGv 763 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-------DHPNIVSLIGV 763 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-------CCcceeeEEEe
Confidence 46788999999999999999975432 235999999864 66778899999999999 79999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhh-----cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCe
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINH-----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~-----~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
+......+|++|||. |+|+.+|+..+ ...++..++..|+.||++|+.||+++++|||||..+|+||+ ....
T Consensus 764 ~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~ 840 (1025)
T KOG1095|consen 764 CLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRV 840 (1025)
T ss_pred ecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCc
Confidence 999999999999997 69999999863 23589999999999999999999999999999999999996 5689
Q ss_pred EEEeecccccccCCccccc-----cccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003438 255 IKIIDFGSACTEDRTVYSY-----IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 255 iKL~DFGlA~~~~~~~~~~-----~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~ 327 (820)
+||+|||+|+......... .-...|||||.+....|+.|+|||||||+|||+++ |..||+..++.+++..+.+
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ 919 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE 919 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh
Confidence 9999999998443332221 22467999999999999999999999999999998 9999999988887765544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=333.22 Aligned_cols=193 Identities=33% Similarity=0.505 Sum_probs=158.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
.+|+.++.||+|+||.||+|+++-+|+.||||+|... .....++.+|+.+|.+| +|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-------nHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-------NHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-------CCcceeeeehhhhccCC
Confidence 5678889999999999999999999999999999865 45567788999999999 789999998533210
Q ss_pred --------------------------------------------------------------------------------
Q 003438 185 -------------------------------------------------------------------------------- 184 (820)
Q Consensus 185 -------------------------------------------------------------------------------- 184 (820)
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence
Q ss_pred -------------------------------------ceeEEEEeccCCCh-HHHHHhhhcCCCCHHHHHHHHHHHHHHh
Q 003438 185 -------------------------------------RHLCICFELLDSNL-YELIKINHFRGLSLSIVQLFSKQILRGL 226 (820)
Q Consensus 185 -------------------------------------~~l~LVmEy~~gsL-~d~l~~~~~~~l~e~~i~~I~~QIl~aL 226 (820)
-.+||-||||+.++ .+++..+... -....++++++||++||
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHH
Confidence 13689999999754 4555554321 14788999999999999
Q ss_pred hhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC---------------------CccccccccccccCcccc
Q 003438 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED---------------------RTVYSYIQSRYYRSPEVL 285 (820)
Q Consensus 227 ~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~---------------------~~~~~~~gt~~Y~APEvl 285 (820)
.|+|++|||||||||.||+++ ..+.|||+|||+|+... ...+..+||-.|+|||++
T Consensus 711 aYIH~~giIHRDLKP~NIFLd---~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLD---SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCceeeccCCcceeEEc---CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999999999999999996 77899999999995410 023456899999999999
Q ss_pred ccc---cccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 286 LGY---QYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 286 ~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.+. .|+.|+||||||+||+||+. ||..
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T 817 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT 817 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCc
Confidence 765 49999999999999999984 4643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=305.82 Aligned_cols=261 Identities=27% Similarity=0.443 Sum_probs=206.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
.++|-++.+||+|+|+.||+|.|...+++||||+-... ..+.+.+.+|..|.+.| +||.||++||
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-------DHpRIVKlYD 534 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-------DHPRIVKLYD 534 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-------Ccceeeeeee
Confidence 37999999999999999999999999999999997532 34556678899998888 8999999999
Q ss_pred EEeec-ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC--CeeeccCCCCCcccccccCCCeEE
Q 003438 180 YFVCQ-RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--GIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 180 ~f~~~-~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~--gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
+|..+ +.+|-|+|||+|+-+|+..+.. +-++|.+++.|+.||+.||.||.+. -|||-||||.|||+.....-+.||
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 99855 6799999999986666554443 4599999999999999999999976 599999999999997767788999
Q ss_pred EeecccccccCCcc----------ccccccccccCccccccc----cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 003438 257 IIDFGSACTEDRTV----------YSYIQSRYYRSPEVLLGY----QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322 (820)
Q Consensus 257 L~DFGlA~~~~~~~----------~~~~gt~~Y~APEvl~~~----~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l 322 (820)
|+|||+++..+... ....||.||++||.+.-. ..+.|+||||+|||+|..+.|+.||......
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--- 690 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--- 690 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---
Confidence 99999997554322 234789999999998643 5788999999999999999999999643221
Q ss_pred HHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHH
Q 003438 323 RRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402 (820)
Q Consensus 323 ~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il 402 (820)
+.|++.-. +++. .+
T Consensus 691 QdILqeNT------IlkA------------------------------------------------tE------------ 704 (775)
T KOG1151|consen 691 QDILQENT------ILKA------------------------------------------------TE------------ 704 (775)
T ss_pred HHHHhhhc------hhcc------------------------------------------------ee------------
Confidence 11111000 0000 00
Q ss_pred hcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 403 ~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
-.||..+ .++.++.+||++||.+.-++|+...|+..||||.-.
T Consensus 705 VqFP~KP-----------vVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 705 VQFPPKP-----------VVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred ccCCCCC-----------ccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 0122221 245778999999999999999999999999999753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.06 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=205.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+..+-+..||.|+||+|++..++.+|+..|||.|+.. ....++++.|.+...+- .++||||++|+....++.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks------~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS------SNCPNIVKFYGALFSEGD 137 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh------cCCcHHHHHhhhhhcCCc
Confidence 3444556899999999999999999999999999853 34455666777665544 378999999999999999
Q ss_pred eEEEEeccCCChHHHHH---hhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 187 LCICFELLDSNLYELIK---INHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~---~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.||.||+|+-+|..+.+ ......++|..+-.|....+.||.||.+ ..||||||||+|||++ ..|.|||||||.
T Consensus 138 cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld---r~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD---RHGDVKLCDFGI 214 (361)
T ss_pred eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe---cCCCEeeecccc
Confidence 99999999976654443 2334569999999999999999999985 6899999999999995 789999999999
Q ss_pred ccccCCcc--ccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 263 ACTEDRTV--YSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 263 A~~~~~~~--~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+....... ....|.+.|||||.+... .|+.++||||||++|||+.||..|+.+.+. ++.++..+.-..||.-..
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF 292 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC
Confidence 97654433 334788899999999754 599999999999999999999999976543 444444433324432100
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
. . +
T Consensus 293 ~-------------------------------------------------------------------------~----~ 295 (361)
T KOG1006|consen 293 D-------------------------------------------------------------------------K----E 295 (361)
T ss_pred c-------------------------------------------------------------------------c----c
Confidence 0 0 0
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....+..++.||.-||..|-.+||.-.+++++||++.-
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 01245779999999999999999999999999999864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-33 Score=317.01 Aligned_cols=200 Identities=28% Similarity=0.411 Sum_probs=172.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
.-|...+.||+|+||.||+++++++|+.||||.+++. ....+...+|+++|++| .|+|||+++++-+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-------nh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-------NHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-------CchhhhhhcccCCcccc
Confidence 4566778999999999999999999999999999863 34467788999999999 589999999986654
Q ss_pred ----ceeEEEEeccC-CChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc-CCCeEEE
Q 003438 185 ----RHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKI 257 (820)
Q Consensus 185 ----~~l~LVmEy~~-gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~iKL 257 (820)
+...+|||||. |+|+.++..-. ..+|++.+++.++..+..||.|||++|||||||||+||++-... ..-..||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence 36789999997 68998887532 35699999999999999999999999999999999999986433 3344699
Q ss_pred eecccccccCC--ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 258 ~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
+|||.|+..++ .....+||+.|.+||++.. ..|+..+|.|||||++|+++||..||.-
T Consensus 166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99999987654 4567799999999999995 7899999999999999999999999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=274.97 Aligned_cols=184 Identities=40% Similarity=0.672 Sum_probs=161.8
Q ss_pred CceeEEEeeccCCCeEEEEEEEeCChhh--HHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccCC-C
Q 003438 121 TFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-N 197 (820)
Q Consensus 121 ~fG~Vyka~d~~tg~~VAIKiik~~~~~--~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-s 197 (820)
+||.||+|++..+++.||+|++...... .+.+.+|+++++++ .|+||+++++++......++|||++.+ +
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-------KHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-------CCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 5899999999988999999999854321 57788899999888 689999999999999999999999986 8
Q ss_pred hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC--ccccccc
Q 003438 198 LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQ 275 (820)
Q Consensus 198 L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~--~~~~~~g 275 (820)
|.+++.... .+++..+..++.+++.+|.+||+.+|+|+||+|.||+++ ..+.++|+|||.+..... ......+
T Consensus 74 L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~ 148 (244)
T smart00220 74 LFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGLLTTFVG 148 (244)
T ss_pred HHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccccccccC
Confidence 998887643 389999999999999999999999999999999999996 558899999999976554 3345567
Q ss_pred cccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 276 t~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
+..|++||.+.+..++.++|||+||+++++|++|..||...
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 88899999999888999999999999999999999999763
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=305.88 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=208.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCC-C--eEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM-N--SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t-g--~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++.++.++||+|.||.|+++.+... | ..||||+++.+. .....|++|+.+|.+| .|+|+|+||++..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-------~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-------QHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-------cCcceeEEeeeecc
Confidence 5667788999999999999976543 2 369999998643 3578899999999999 78999999999987
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..+.+|||++. |+|++.|.......|....+..++.||+.||.||..+++|||||...||||. ....|||+|||+
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGL 258 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGL 258 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccc
Confidence 67889999998 7999999885556688999999999999999999999999999999999996 577899999999
Q ss_pred ccccCCccccccc------cccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 263 ACTEDRTVYSYIQ------SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 263 A~~~~~~~~~~~g------t~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
.+........++- ...|+|||.|....++.++|||++||+||||++ |..||.+..-.+++++|-+ |
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--~----- 331 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--G----- 331 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--c-----
Confidence 9876554333322 345999999999999999999999999999998 8999999888777766532 1
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
|.
T Consensus 332 ------------------------------------------------------------------------------er 333 (1039)
T KOG0199|consen 332 ------------------------------------------------------------------------------ER 333 (1039)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+.....+++.+.++++.|+..+|++|||...|.+.-++.+.
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 01112256788999999999999999999988766666543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=301.59 Aligned_cols=200 Identities=30% Similarity=0.468 Sum_probs=169.9
Q ss_pred EEEEEeccCCceeEEEeeccC--CC--eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 112 IVKDLLGHGTFGQVAKCWDAE--MN--SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 112 ~i~~~LG~G~fG~Vyka~d~~--tg--~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++.++||+|.||.||++.... .| -.||||..|.+ ....+.++.|..+|+.+ +|||||++++++.+ .
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-------dHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-------DHPHIIKLIGVCVE-Q 463 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-------CCcchhheeeeeec-c
Confidence 344579999999999996422 23 35999999863 56688999999999999 89999999999875 4
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..|||||++. |.|..+++.+. ..++...+..+++||+.||+|||+.++|||||...|||+. ....|||+|||+++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhh
Confidence 7899999998 89999998875 4699999999999999999999999999999999999996 67789999999998
Q ss_pred ccCCccccc----cccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 265 TEDRTVYSY----IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 265 ~~~~~~~~~----~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
......... .-...|||||.+.-..++.++|||.|||+|||++. |..||.+-.+.|++.
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~ 603 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG 603 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE
Confidence 776543321 22556999999999999999999999999999996 999998766555443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=302.23 Aligned_cols=206 Identities=21% Similarity=0.347 Sum_probs=183.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
.+..+..+||-|.||.||.+.+++-.-.||||.++.+....++|+.|..+|+.+ .|||+|+|+++|..+-.+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-------kHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-------cCccHHHHhhhhccCCCeE
Confidence 345677899999999999999999999999999999988999999999999999 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||.|||. |+|+++|+..+...++.-.+..++.||..|+.||..+++|||||...|+||. ++..||++|||+++...
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhc
Confidence 9999996 8999999998877788888999999999999999999999999999999996 77889999999998664
Q ss_pred Ccccc-ccc---cccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 268 RTVYS-YIQ---SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 268 ~~~~~-~~g---t~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
....+ ..| ...|.|||-+.-+.++.|+|||+|||+|||+.| |..||++.+-..++..
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L 478 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL 478 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH
Confidence 44332 233 566999999999999999999999999999998 9999998775444433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=285.17 Aligned_cols=196 Identities=22% Similarity=0.415 Sum_probs=174.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|.++.+||+|+|++|.+++.+.|.+.+|+|++++ +.........|..+..+.. +||.+|-++.+|+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as------n~pflvglhscfqt 322 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS------NNPFLVGLHSCFQT 322 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc------CCCeEEehhhhhcc
Confidence 3789999999999999999999999999999999985 3455566677877777663 79999999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+..+++|.||+.| +|.=.++++ +.++|+.++.+...|+.||.|||++|||.||||.+|||++ ..+.|||+|+|+
T Consensus 323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld---aeghikltdygm 397 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD---AEGHIKLTDYGM 397 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc---cCCceeecccch
Confidence 9999999999985 554334333 4699999999999999999999999999999999999995 889999999999
Q ss_pred ccc---cCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 263 ACT---EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 263 A~~---~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
++. .+....+.|||+.|.|||++++..|...+|.|+|||+|+||+.|+.||.
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 964 3455678899999999999999999999999999999999999999994
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=302.66 Aligned_cols=204 Identities=21% Similarity=0.343 Sum_probs=148.5
Q ss_pred cCCceEEEEEeccCCceeEEEeecc----------------CCCeEEEEEEEeCChh-hHH--------------HHHHH
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDA----------------EMNSFVAVKIIKNQPA-YYQ--------------QALVE 155 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~----------------~tg~~VAIKiik~~~~-~~~--------------~~~~E 155 (820)
..++|++.++||+|+||+||+|.+. ..++.||||.++.... ..+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4589999999999999999998642 3456799999875321 112 22346
Q ss_pred HHHHHHHhhhcCCCCCCceeEEeEEEee--------cceeEEEEeccC-CChHHHHHhhh--------------------
Q 003438 156 VSILTTLNKKYDREDKHHIVRIYEYFVC--------QRHLCICFELLD-SNLYELIKINH-------------------- 206 (820)
Q Consensus 156 i~iL~~L~~~~~~~~HpnIVkl~d~f~~--------~~~l~LVmEy~~-gsL~d~l~~~~-------------------- 206 (820)
+.++.++.+. ...+.++++++++|.. ++..+|||||+. ++|.+++....
T Consensus 223 ~~~l~~l~~~--~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 223 AYMCAKIKRN--PIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHhhcc--cchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 6666666431 1123455777777653 357899999997 58888775321
Q ss_pred --cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCcc--c--ccccccccc
Q 003438 207 --FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV--Y--SYIQSRYYR 280 (820)
Q Consensus 207 --~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~--~--~~~gt~~Y~ 280 (820)
...+++..++.++.||+.+|.|||+++|+||||||+|||++ .++.+||+|||++....... . ....++.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 11246778999999999999999999999999999999996 56789999999996433211 1 123478999
Q ss_pred Ccccccccc--------------------cc--ccchhHhHHHHHHHHHhCCC-CCCC
Q 003438 281 SPEVLLGYQ--------------------YT--TAIDMWSFGCIVAELFLGLP-LFPG 315 (820)
Q Consensus 281 APEvl~~~~--------------------yt--~ksDIWSLG~ILyeLltG~~-PF~~ 315 (820)
|||++.... |. .+.||||+|||+|+|+++.. ||..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 999986432 12 24799999999999999875 6643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=298.44 Aligned_cols=210 Identities=25% Similarity=0.362 Sum_probs=177.7
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
...+..++++||+|-||.|.+|+- ....+||+|+++.. ......+.+||++|.+| .|||||+|+++|..+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-------khPNIveLvGVC~~D 607 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-------KHPNIVELLGVCVQD 607 (807)
T ss_pred chhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-------CCCCeeEEEeeeecC
Confidence 357889999999999999999964 34689999999864 33457899999999999 589999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+|+||++ |+|.+++..+....+.-....+|+.||+.|++||.+.++|||||.+.|+|++ .+.++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCcccc
Confidence 99999999998 8999999988543345556677999999999999999999999999999995 7899999999999
Q ss_pred cccCCcccc-----ccccccccCccccccccccccchhHhHHHHHHHHHh--CCCCCCCCCHHHHHHHHHH
Q 003438 264 CTEDRTVYS-----YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL--GLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 264 ~~~~~~~~~-----~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt--G~~PF~~~s~~d~l~~I~~ 327 (820)
+..-..... .+-...|||+|.+.-.+++.++|+|+||+++||+++ ...||...++++.++....
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~ 755 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE 755 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh
Confidence 854333222 244678999999999999999999999999999875 7889987777666555444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=312.51 Aligned_cols=191 Identities=27% Similarity=0.351 Sum_probs=157.5
Q ss_pred EEeccCCcee-EEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEec
Q 003438 115 DLLGHGTFGQ-VAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL 193 (820)
Q Consensus 115 ~~LG~G~fG~-Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy 193 (820)
+.+|.|+-|+ ||++. -.++.||||.+-. .....+.+||..|+.-. .|||||++++.-.++..+||+.|+
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~--e~~~~A~rEi~lL~eSD------~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLE--EFFDFAQREIQLLQESD------EHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhh--HhHHHHHHHHHHHHhcc------CCCceEEEEeeccCCceEEEEehH
Confidence 4689999886 68884 4578999998864 34456788999998874 799999999999999999999999
Q ss_pred cCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc--CCCeEEEeecccccccCCc
Q 003438 194 LDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTEDRT 269 (820)
Q Consensus 194 ~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~iKL~DFGlA~~~~~~ 269 (820)
|..+|.+++... ..........+.++.|+++||++||+.+||||||||.||||...+ ...+++|.|||+++.....
T Consensus 585 C~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 585 CACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999999874 111112145678999999999999999999999999999997542 3467899999999765432
Q ss_pred ------cccccccccccCccccccccccccchhHhHHHHHHHHHhC-CCCCCC
Q 003438 270 ------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPG 315 (820)
Q Consensus 270 ------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~PF~~ 315 (820)
.....||-.|+|||++....-+.++|||||||++|..++| ..||..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 3345789999999999998888899999999999999985 999954
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=302.74 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=213.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
...+|.++||.|.||.|++++.+..+ ..||||.+|.. +.....|+.|..||-++ +||||++|.++...
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-------dHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-------DHPNIIRLEGVVTK 701 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-------CCCcEEEEEEEEec
Confidence 56778899999999999999887665 47999999963 55667899999999998 89999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
...+.||.|||+ |.|..+|+.+. +.|+..++.-+++.|+.|++||-+.++|||||...||||+ .+-.+|++|||+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN---snLvCKVsDFGL 777 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN---SNLVCKVSDFGL 777 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---cceEEEeccccc
Confidence 999999999998 78988998887 5599999999999999999999999999999999999995 678899999999
Q ss_pred ccccCCccccc---cc---cccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 263 ACTEDRTVYSY---IQ---SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 263 A~~~~~~~~~~---~g---t~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
++...+..... .| ...|.|||.|...+++.++||||+|++|||.+. |..||...++.|++..|.+....+||-
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 98664443221 11 467999999999999999999999999999886 999999999999999998866633321
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
T Consensus 858 -------------------------------------------------------------------------------- 857 (996)
T KOG0196|consen 858 -------------------------------------------------------------------------------- 857 (996)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~H 450 (820)
+++..+..|+..|+++|-.+||+..||+.+
T Consensus 858 -----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 858 -----DCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred -----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 134678899999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=301.29 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=212.5
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
+.+++|+++.++|.|+||.|||++++.+++..|+|+++... ....-...|+-+++.. .|+|||.+++.+...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-------~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-------RHPNIVAYFGSYLRR 84 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-------CCcChHHHHhhhhhh
Confidence 56799999999999999999999999999999999999764 4455667788888887 689999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.++|+||||++ +|.+..... ..++|.++..+++..+++|+|||+.|-+|||||-.|||++ +.+.+||+|||.+
T Consensus 85 dklwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvs 159 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVS 159 (829)
T ss_pred cCcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCch
Confidence 999999999985 666655433 5799999999999999999999999999999999999996 7789999999999
Q ss_pred cccCCc---cccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 264 CTEDRT---VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 264 ~~~~~~---~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
...... ....+||++|||||+.. ...|...+|||++|++..|+-.-++|.........+..+.+ -+..||.
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk-S~~qpp~-- 236 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK-SGFQPPT-- 236 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc-cCCCCCc--
Confidence 766544 34579999999999874 44799999999999999999888777654443333333222 1111110
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
| +
T Consensus 237 ------------------------------------------------------------l------------------k 238 (829)
T KOG0576|consen 237 ------------------------------------------------------------L------------------K 238 (829)
T ss_pred ------------------------------------------------------------c------------------c
Confidence 1 1
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....+++.|.+|++.+|..+|++|||++.+|+|||+.+.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 112367889999999999999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=316.43 Aligned_cols=186 Identities=19% Similarity=0.243 Sum_probs=154.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
..|...++||+|+||.||+|++..+++.||||+++.... ....|+++++++ +|||||++++++...+..|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l-------~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL-------QHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC-------CCCCcceEEEEEEcCCCCE
Confidence 456677899999999999999989999999999875432 123467777777 6999999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc---cCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK---DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH---s~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+||||+. ++|.++++ .+++..+..|+.||++||+||| +.+|+||||||+||+++ .....++. |+.+.
T Consensus 760 lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~ 830 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPG 830 (968)
T ss_pred EEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-ecccc
Confidence 9999997 68988885 3889999999999999999999 67999999999999996 33444543 55543
Q ss_pred ccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 265 TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 265 ~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
.... .....++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 831 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 831 LLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred cccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 2211 123367899999999999999999999999999999999999994
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=288.05 Aligned_cols=197 Identities=27% Similarity=0.473 Sum_probs=176.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHH---------HHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ---------ALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~---------~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
..|..++.||+|+||.|++|.++++...|+||.|.+++...+. +-.||+||..|++. .|+||+++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~----sH~NIlKlLd 636 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH----SHENILKLLD 636 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc----Cccchhhhhh
Confidence 4699999999999999999999999999999999876543333 33599999999765 7999999999
Q ss_pred EEeecceeEEEEeccC-C-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 180 YFVCQRHLCICFELLD-S-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
+|++++++||+||--+ | +|+++|..+. .++|.+++.|++|++.|+++||+.||||||||-+||.++ .++.+||
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd---~~g~~kl 711 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD---SNGFVKL 711 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEe---cCCeEEE
Confidence 9999999999999886 4 8999998764 699999999999999999999999999999999999995 7899999
Q ss_pred eeccccccc-CCccccccccccccCcccccccccc-ccchhHhHHHHHHHHHhCCCCCC
Q 003438 258 IDFGSACTE-DRTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 258 ~DFGlA~~~-~~~~~~~~gt~~Y~APEvl~~~~yt-~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
+|||.|... .......+||..|.|||++.+.+|- ..-|||+||++||.++....||.
T Consensus 712 idfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998654 4455678999999999999999875 67999999999999999998885
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=276.45 Aligned_cols=191 Identities=26% Similarity=0.317 Sum_probs=159.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--- 185 (820)
...++.++||+|.||.||+|+. +++.||||++... ..+.+.+|-.|...... .|+||++++..-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m-----~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPGM-----KHENILQFIGAEKRGTADR 280 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHH--HHHHHHhHHHHHhccCc-----cchhHHHhhchhccCCccc
Confidence 4456788999999999999954 4689999999743 45778889888888754 5999999998766544
Q ss_pred -eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC---------CeeeccCCCCCcccccccCCCe
Q 003438 186 -HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA---------GIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 186 -~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~---------gIVHrDLKPeNILl~~~~~~~~ 254 (820)
.++||+||.. |+|.++|+.+. +++....+|+..|++||+|||+. .|+|||||..||||. .+..
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---~DlT 354 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---NDLT 354 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc---cCCc
Confidence 8999999997 89999999875 99999999999999999999953 599999999999996 7789
Q ss_pred EEEeecccccccCC-----ccccccccccccCccccccc-ccc-----ccchhHhHHHHHHHHHhCCCCCC
Q 003438 255 IKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGY-QYT-----TAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 255 iKL~DFGlA~~~~~-----~~~~~~gt~~Y~APEvl~~~-~yt-----~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
..|+|||+|..... .....+||.+|||||++.+. .+. .++||||+|.|||||++....+.
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 99999999964332 22336899999999999875 333 47999999999999999876553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=252.05 Aligned_cols=210 Identities=22% Similarity=0.390 Sum_probs=176.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
+....+..||+|++|.|-+.++..+|...|+|.++.. ....++.++|+.+..+. .++|.+|.+|+.+.....
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~------~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT------VDCPFTVHFYGALFREGD 119 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC------CCCCeEEEeehhhhcccc
Confidence 5666778899999999999999999999999999843 34445566677665544 479999999999999999
Q ss_pred eEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 187 LCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
++|.||.|..+|..+.++- ..+.++|..+-+|+..++.||.|||++ .|||||+||.|||++ ..+++||||||.+
T Consensus 120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn---~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN---YDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc---cCCcEEEcccccc
Confidence 9999999998887666542 235699999999999999999999965 899999999999995 7899999999999
Q ss_pred cccCCcccc--ccccccccCcccccc----ccccccchhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHH
Q 003438 264 CTEDRTVYS--YIQSRYYRSPEVLLG----YQYTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIR 327 (820)
Q Consensus 264 ~~~~~~~~~--~~gt~~Y~APEvl~~----~~yt~ksDIWSLG~ILyeLltG~~PF~~-~s~~d~l~~I~~ 327 (820)
-...+.... ..|...|||||.+.. ..|+.++||||||+++.||.+++.||.. .++++++.++++
T Consensus 197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 765544332 467778999999864 3799999999999999999999999964 578888888876
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=287.57 Aligned_cols=200 Identities=28% Similarity=0.435 Sum_probs=168.6
Q ss_pred CceEEEEEeccCCceeEEEeecc----C---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA----E---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~----~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
++.++.+.||+|.||.|+++.-. . ....||||.++.. ....+.+..|+++|+.+. .|+||+.+++
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g------~H~niv~llG 369 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG------KHPNIVNLLG 369 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc------CCcchhhhee
Confidence 44467779999999999998632 1 2567999999853 345678899999999996 5999999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhh------c--------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINH------F--------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~------~--------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
++..++.+++|+||+. |+|.++++..+ . ..++..++..++.||+.|++||+++.+|||||..+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999997 89999998765 0 1288999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCccccc----c--ccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRTVYSY----I--QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~~~~~----~--gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
|++ ++..+||+|||+|+......... . -...|||||.+....|+.++||||+|++||||++ |..||++-.
T Consensus 450 Li~---~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 450 LIT---KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred Eec---CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 996 66789999999998543322211 1 2345999999999999999999999999999998 899998743
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=265.32 Aligned_cols=191 Identities=25% Similarity=0.350 Sum_probs=159.4
Q ss_pred eccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 103 ~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
......++.++++.||+|.||.||+++. .|+.||||++...+ .+.+.+|.+|.+.+.- .|+||+.++..-.
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd--E~SWfrEtEIYqTvmL-----RHENILgFIaaD~ 275 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD--ERSWFRETEIYQTVML-----RHENILGFIAADN 275 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc--hhhhhhHHHHHHHHHh-----ccchhhhhhhccc
Confidence 3445568999999999999999999965 48899999998543 3567789999888753 6999999998755
Q ss_pred ecc----eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC--------CeeeccCCCCCcccccc
Q 003438 183 CQR----HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--------GIIHCDLKPENILLCTS 249 (820)
Q Consensus 183 ~~~----~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~--------gIVHrDLKPeNILl~~~ 249 (820)
.+. .+|||.+|.+ |+|+|+|.... ++.+...+++..++.||++||.. .|.|||||..||||.
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-- 350 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-- 350 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc--
Confidence 442 7999999998 89999998854 99999999999999999999942 599999999999996
Q ss_pred cCCCeEEEeeccccccc-------CCccccccccccccCccccccc----ccc--ccchhHhHHHHHHHHHh
Q 003438 250 VKPAEIKIIDFGSACTE-------DRTVYSYIQSRYYRSPEVLLGY----QYT--TAIDMWSFGCIVAELFL 308 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~-------~~~~~~~~gt~~Y~APEvl~~~----~yt--~ksDIWSLG~ILyeLlt 308 (820)
+++.+.|+|+|+|... +......+||..|||||++... .+. ..+||||||+|+||++.
T Consensus 351 -kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 351 -KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred -cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 7899999999999533 2334567999999999999654 122 46999999999999985
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=232.22 Aligned_cols=179 Identities=39% Similarity=0.598 Sum_probs=157.1
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEecc
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL 194 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~ 194 (820)
||+|.+|.||++.+..+++.+++|++..... ..+.+.+|+++++.+ .|++|+++++++......++|||++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-------~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-------NHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-------CCCCeeeEeeeeecCCeEEEEEecC
Confidence 6899999999999988899999999986543 356788999999998 4689999999999999999999999
Q ss_pred C-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC-CCeEEEeecccccccCCc---
Q 003438 195 D-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKIIDFGSACTEDRT--- 269 (820)
Q Consensus 195 ~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~iKL~DFGlA~~~~~~--- 269 (820)
. ++|.+++.... ..+++..++.++.+++++|++||+.+++|+||+|.||+++ . ...++|+||+.+......
T Consensus 74 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~~ 149 (215)
T cd00180 74 EGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKSL 149 (215)
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcch
Confidence 9 68988887652 3589999999999999999999999999999999999996 4 678999999999765543
Q ss_pred cccccccccccCccccccc-cccccchhHhHHHHHHHH
Q 003438 270 VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAEL 306 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeL 306 (820)
.....+...|++||.+... .++.+.|+|+||+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 3445678889999999887 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=278.27 Aligned_cols=199 Identities=24% Similarity=0.347 Sum_probs=168.6
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
..+..++||+|+||+||++.....++ +||||++.... ....++++|.-+|..| +|||+++|++++..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-------dHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-------DHPNLLRLLGVCML 769 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-------CCchHHHHhhhccc
Confidence 34556899999999999997654444 68999987543 3467888999999988 79999999999987
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.. +.||++|+. |.|+|+++.++ ..+-......|..||++||.|||++++|||||-.+||||. ....+||.|||+
T Consensus 770 s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgl 844 (1177)
T KOG1025|consen 770 ST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGL 844 (1177)
T ss_pred ch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecch
Confidence 76 889999998 79999999876 5688999999999999999999999999999999999996 778999999999
Q ss_pred ccccCCccccc---c--ccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 263 ACTEDRTVYSY---I--QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 263 A~~~~~~~~~~---~--gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
++........+ . -.+.|||=|.+....|+.++||||+||++|||+| |..|+.+....+
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 97654332222 2 2456999999999999999999999999999998 999998766544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=252.84 Aligned_cols=198 Identities=21% Similarity=0.332 Sum_probs=170.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE-Eeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY-FVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~-f~~~~~ 186 (820)
.+.|.|.+.||+|.||.+-+|+++.+++.+|+|.+.+......++.+|...--.|. .|.||+.-|++ |+..+.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls------~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS------PHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec------cchhhhHHHHHHhhcCce
Confidence 37899999999999999999999999999999999987777778888876655553 68899988865 667788
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+++++||+. |+|..-+.. .++-|...++++.|++.||.|||++++||||||.+||||-.. +..+|||||||..+.
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRK 172 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccc
Confidence 999999998 788876654 358899999999999999999999999999999999999754 445999999999988
Q ss_pred cCCccccccccccccCccccccc-----cccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 266 EDRTVYSYIQSRYYRSPEVLLGY-----QYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 266 ~~~~~~~~~gt~~Y~APEvl~~~-----~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.+.......-+..|.+||+.... ...+.+|||.||+|+|.++||++||..
T Consensus 173 ~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 173 VGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 88777666667789999987543 467889999999999999999999964
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-28 Score=295.38 Aligned_cols=142 Identities=18% Similarity=0.235 Sum_probs=115.2
Q ss_pred CceeEEeEEE-------eecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 172 HHIVRIYEYF-------VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 172 pnIVkl~d~f-------~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
+||++++++| ...+.++++||+++++|.+++.... ..+++.+++.|++||++||+|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4777777777 2335688899999999999997542 4599999999999999999999999999999999999
Q ss_pred cccc----------------ccCCCeEEEeecccccccCCc-------------------cccccccccccCcccccccc
Q 003438 245 LLCT----------------SVKPAEIKIIDFGSACTEDRT-------------------VYSYIQSRYYRSPEVLLGYQ 289 (820)
Q Consensus 245 Ll~~----------------~~~~~~iKL~DFGlA~~~~~~-------------------~~~~~gt~~Y~APEvl~~~~ 289 (820)
||+. .+....+||+|||+++..... ....++|++|||||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9952 123456788888887532110 01135788999999999999
Q ss_pred ccccchhHhHHHHHHHHHhCCCCCC
Q 003438 290 YTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 290 yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
|+.++|||||||+||||++|.+|+.
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchh
Confidence 9999999999999999999888764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=235.06 Aligned_cols=206 Identities=33% Similarity=0.513 Sum_probs=174.5
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
|.+.+.||.|++++||++.+..+++.||||.+..... ..+.+.+|++.++.+ .|+||+++++++......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-------KHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-------CCCChhhheeeeecCCceE
Confidence 5678999999999999999998899999999986532 466788899998888 5789999999999999999
Q ss_pred EEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+|+|++.+ +|.+++..... .+++..+..++.+++.+|.+||+++++|+||+|.||+++ ....++|+|||.+....
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIH 149 (225)
T ss_pred EEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEec
Confidence 99999986 89988876542 289999999999999999999999999999999999996 45899999999987654
Q ss_pred Ccc----ccccccccccCcccc-ccccccccchhHhHHHHHHHHHhCCCCCCC-CCHH-HHHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVL-LGYQYTTAIDMWSFGCIVAELFLGLPLFPG-ASEF-DLLRRMIR 327 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl-~~~~yt~ksDIWSLG~ILyeLltG~~PF~~-~s~~-d~l~~I~~ 327 (820)
... ....++..|++||.+ ....++.++|||+|||++++|++|+.||.. .+.. .+.+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 432 445678889999998 666788899999999999999999999977 3433 44444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=217.74 Aligned_cols=107 Identities=25% Similarity=0.318 Sum_probs=93.2
Q ss_pred CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccccccc
Q 003438 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275 (820)
Q Consensus 196 gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~g 275 (820)
|+|.+++.... ..+++.+++.|++||+.||+|||+++ ||+|||++ .++.+|+ ||++...... ...+
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---~~~~~~~--fG~~~~~~~~--~~~g 66 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---WDGLLKL--DGSVAFKTPE--QSRV 66 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---Cccceee--ccceEeeccc--cCCC
Confidence 67888887643 46999999999999999999999998 99999995 6678888 9998765432 2368
Q ss_pred cccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 276 t~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 89999999999999999999999999999999999999654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=230.56 Aligned_cols=208 Identities=21% Similarity=0.293 Sum_probs=164.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t-----g~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
+.|+++..++-+|+||.||++..++. .+.|.+|.++... .....++.|--+|..+ .|||++.+.++
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-------sH~nll~V~~V 355 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-------SHPNLLSVLGV 355 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-------cCCCccceeEE
Confidence 36788889999999999999965433 3456777777543 2333445555555444 69999999998
Q ss_pred Eeec-ceeEEEEeccC-CChHHHHHhhh------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 181 FVCQ-RHLCICFELLD-SNLYELIKINH------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
..++ ...++++.+++ |+|..++...+ .+.++..++..++.||+.|++|||+++|||.||..+|.+|+ +.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId---d~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID---DQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh---hh
Confidence 8765 46778888888 89999998433 23477788889999999999999999999999999999995 67
Q ss_pred CeEEEeecccccccCCccccccc-----cccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 253 AEIKIIDFGSACTEDRTVYSYIQ-----SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~~~~~~g-----t~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
-++||+|=.+++..-.......| ...||+||.+.+..|+.++|+||||++||||+| |+.|+...+++++...+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 89999999988765444333333 456999999999999999999999999999998 99999887777665444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=227.90 Aligned_cols=210 Identities=26% Similarity=0.279 Sum_probs=174.1
Q ss_pred ceEEEEEeccCCceeEEEeeccCCC-eEEEEEEEeCChh-hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE-eecce
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF-VCQRH 186 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg-~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f-~~~~~ 186 (820)
+|++.++||+|+||.||+|.+..++ +.+|+|+...... ....+..|+.+|..+.. .....++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~---~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK---KNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh---hcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987774 6899999875422 11267789999999964 11346899999999 57789
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc--CCCeEEEeeccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~iKL~DFGlA~ 264 (820)
.||||++++.+|.++.+....+.++..++..|+.|++.+|++||+.|+|||||||+|+++.... ....+.|+|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999999999988776667799999999999999999999999999999999999997442 12579999999997
Q ss_pred --cc----C-----C-c-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 003438 265 --TE----D-----R-T-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322 (820)
Q Consensus 265 --~~----~-----~-~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l 322 (820)
.. . . . .....||..|+++++..+.+.+.+.|+||++.++.+|+.|..||.+.......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 31 1 0 1 12345999999999999999999999999999999999999999776543333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-22 Score=208.61 Aligned_cols=195 Identities=36% Similarity=0.564 Sum_probs=163.4
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHHhhhcCCCCCC-ceeEEeEEEeecc
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQR 185 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~Hp-nIVkl~d~f~~~~ 185 (820)
|++.+.||.|+|+.||++.+. ..+|+|.+..... ....+.+|+.++..+. |+ +|+++++++....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-------~~~~i~~~~~~~~~~~ 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-------HPPNIVKLYDFFQDEG 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-------CCcceeeEEEEEecCC
Confidence 788999999999999999887 7899999985422 4667888999888884 44 8999999998778
Q ss_pred eeEEEEeccCC-ChHHHHHhhhc-CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC-eEEEeeccc
Q 003438 186 HLCICFELLDS-NLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGS 262 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~-~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~-~iKL~DFGl 262 (820)
..++|++++.+ .+.+++..... ..+.+..+..++.|++.+|.|+|+.+++||||||+||+++ ... .++++|||.
T Consensus 72 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~ 148 (384)
T COG0515 72 SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGL 148 (384)
T ss_pred EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCc
Confidence 88999999985 66655554321 1589999999999999999999999999999999999996 444 799999999
Q ss_pred ccccCC---------ccccccccccccCcccccc---ccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 263 ACTEDR---------TVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 263 A~~~~~---------~~~~~~gt~~Y~APEvl~~---~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
+..... .....+++..|+|||++.+ ..+....|+|++|++++++++|..||.....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 864332 2356688999999999988 5788999999999999999999999876553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-24 Score=254.80 Aligned_cols=261 Identities=25% Similarity=0.313 Sum_probs=190.3
Q ss_pred Cce-EEEEEeccCCceeEEEeeccCCCeEEEEEEEe----CChh---hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 109 RRY-IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPA---YYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 109 ~rY-~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik----~~~~---~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
+.| ....++|.|++|.|+.+......+.++.|.++ .... ....+..|+.+-..| .|+||+..++.
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-------~h~~~~e~l~~ 389 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-------SHPNIIETLDI 389 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-------cCCchhhhHHH
Confidence 334 45678999999988888777776666666554 2111 111133344443344 78999888887
Q ss_pred EeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 181 FVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 181 f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
+.+.....-+||||.++|+.++... ..+...++..+++||+.||+|||+.||.|||||++|++++ ..+.+||+||
T Consensus 390 ~~~~~~~~~~mE~~~~Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Df 464 (601)
T KOG0590|consen 390 VQEIDGILQSMEYCPYDLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDF 464 (601)
T ss_pred HhhcccchhhhhcccHHHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeec
Confidence 7777666666999999999888765 2488999999999999999999999999999999999996 6779999999
Q ss_pred ccccccC-------CccccccccccccCccccccccccc-cchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 261 GSACTED-------RTVYSYIQSRYYRSPEVLLGYQYTT-AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 261 GlA~~~~-------~~~~~~~gt~~Y~APEvl~~~~yt~-ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
|.+.... ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+.... ...+
T Consensus 465 g~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~--~~~~-- 540 (601)
T KOG0590|consen 465 GAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK--TNNY-- 540 (601)
T ss_pred CcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh--hhcc--
Confidence 9984221 1234468899999999999999986 79999999999999999999975443222110 0000
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
...++.. .....++
T Consensus 541 ------------~~~~~~~--------------------------------------------~~~~~~~---------- 554 (601)
T KOG0590|consen 541 ------------SDQRNIF--------------------------------------------EGPNRLL---------- 554 (601)
T ss_pred ------------ccccccc--------------------------------------------cChHHHH----------
Confidence 0000000 0011111
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..++...+.+|.+||++||.+|+|+++||+.+||+....
T Consensus 555 -------~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 555 -------SLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred -------HhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 124466789999999999999999999999999998653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=209.24 Aligned_cols=208 Identities=22% Similarity=0.298 Sum_probs=178.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
.+|+++++||.|+||.+|++.....|+.||||+-.++.. ..+...|.++.+.|+. ...|..+..++.++.+-.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~------g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQG------GVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhcc------CCCCchhhhhccccccce
Confidence 799999999999999999999999999999999875433 3456779999999963 467888888889999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC-
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED- 267 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~- 267 (820)
+|||+++.+|.+++.... +.++..++..++-|++.-|+|+|.+++|||||||+|+|+.......++.|+|||+|+..-
T Consensus 88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999999999999988765 569999999999999999999999999999999999999877677889999999995322
Q ss_pred ---------CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003438 268 ---------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR 324 (820)
Q Consensus 268 ---------~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~ 324 (820)
.......||..|.+=-...+..-+...|+=|+|.+|..+..|..||.+.......++
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 122345789999988887777888899999999999999999999988765444443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-22 Score=218.70 Aligned_cols=167 Identities=22% Similarity=0.276 Sum_probs=127.0
Q ss_pred CceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC------hhhHHHHHHHHHHHHHHhhhcCCCCCCcee-EEeEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIV-RIYEY 180 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIV-kl~d~ 180 (820)
.+|++.++||+|+||+||+|+++. +++.||||++... ....+.+.+|+++|++| .|+||+ +++++
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-------~h~~iv~~l~~~ 90 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-------RGIGVVPQLLAT 90 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-------cCCCCCcEEEEc
Confidence 789999999999999999998776 6888899987532 22355688999999999 577887 45542
Q ss_pred EeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccC-CCCCcccccccCCCeEEEee
Q 003438 181 FVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL-KPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 181 f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL-KPeNILl~~~~~~~~iKL~D 259 (820)
+..|||||||.|..+..+. . .. ...++.|++++|.|||++||+|||| ||+|||++ .++.+||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~~~~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiD 155 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLAR--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVID 155 (365)
T ss_pred ----CCcEEEEEccCCCCHHHhC--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEE
Confidence 4689999999864333221 1 11 2467899999999999999999999 99999995 557899999
Q ss_pred cccccccCCc-----------cccccccccccCcccccccc------ccccchhH
Q 003438 260 FGSACTEDRT-----------VYSYIQSRYYRSPEVLLGYQ------YTTAIDMW 297 (820)
Q Consensus 260 FGlA~~~~~~-----------~~~~~gt~~Y~APEvl~~~~------yt~ksDIW 297 (820)
||+|+..... .....+++.|+|||.+.... .+...|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999643222 13446778899999986432 33456766
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=205.03 Aligned_cols=211 Identities=22% Similarity=0.280 Sum_probs=179.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
-.|+|.++||+|.||+++.+.+.-+++.||||.-.... ..-++..|....+.|. ..+.|..++-+-.+..+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~------g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLG------GTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHc------CCCCCCceeeeccccchhh
Confidence 57999999999999999999999999999999876432 3456778999999996 5689999999888999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc--cCCCeEEEeeccccccc
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~--~~~~~iKL~DFGlA~~~ 266 (820)
||||+++.+|.|++.-.. +.|+..++..++.||+.-++|+|++.+|.|||||+|+||... .+...|.|+|||+|+..
T Consensus 101 LVidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999999999988764 569999999999999999999999999999999999999642 34567999999999643
Q ss_pred CC----------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHH
Q 003438 267 DR----------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS---EFDLLRRMIR 327 (820)
Q Consensus 267 ~~----------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s---~~d~l~~I~~ 327 (820)
.+ ......||..||+=...++.+-+.+.|+=|||-++...|-|..||.+.. ..+..++|-+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 22 2344578999999999999999999999999999999999999998753 4444444433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-22 Score=232.70 Aligned_cols=193 Identities=27% Similarity=0.386 Sum_probs=148.5
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ...+.+.++++-++..- ..+||++.+.-+...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l-----~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFAL-----MKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHh-----hcCCcccchHHHHHhhHHH
Confidence 56778899999999999998765 33 9999987543 22333333333333211 1689999998888888889
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc-
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE- 266 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~- 266 (820)
|||-+|+..+|+|.+..+.+ +.+.+.+.|+.||+.||.-||+.||+|+|||.|||||+ .-+-+.|+||..-+..
T Consensus 97 ylvRqyvkhnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 97 YLVRQYVKHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHHHHHHhhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCcc
Confidence 99999999999999876653 78888999999999999999999999999999999996 6677899999865321
Q ss_pred ---CCc--cccc----cccccccCccccccc----------c-ccccchhHhHHHHHHHHHh-CCCCCC
Q 003438 267 ---DRT--VYSY----IQSRYYRSPEVLLGY----------Q-YTTAIDMWSFGCIVAELFL-GLPLFP 314 (820)
Q Consensus 267 ---~~~--~~~~----~gt~~Y~APEvl~~~----------~-yt~ksDIWSLG~ILyeLlt-G~~PF~ 314 (820)
++. ...+ ..-.+|.|||.+... . .+++.||||+||+++||++ |++||.
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 111 1111 223459999988531 2 6789999999999999998 899994
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=200.90 Aligned_cols=205 Identities=21% Similarity=0.263 Sum_probs=134.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcC---CCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYD---REDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~---~~~HpnIVkl~d~f 181 (820)
..++..+.||.|+++.||.+.+..|++.+|+|+.... ....+++.+|.-....+..... ...|-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 4567788999999999999999999999999998632 2234445544433322111000 00011333344433
Q ss_pred eec------------c-----eeEEEEeccCCChHHHHHh---hhcC--CCCHHHHHHHHHHHHHHhhhcccCCeeeccC
Q 003438 182 VCQ------------R-----HLCICFELLDSNLYELIKI---NHFR--GLSLSIVQLFSKQILRGLSLLKDAGIIHCDL 239 (820)
Q Consensus 182 ~~~------------~-----~l~LVmEy~~gsL~d~l~~---~~~~--~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL 239 (820)
... . ..+++|+-+.++|.+++.. .... .+.......+..|+++.+++||..||||+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 321 1 3478899999998887653 2111 1223334556699999999999999999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCccccccccccccCcccccc--------ccccccchhHhHHHHHHHHHhCCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG--------YQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~--------~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
||+|++++ .+|.++|+||+.....+........+..|.+||+... ..++.+.|.|+||+++|.|+|+..
T Consensus 172 ~~~nfll~---~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLD---QDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE----TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEc---CCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999995 7899999999998777665554455677999998743 258899999999999999999999
Q ss_pred CCCCC
Q 003438 312 LFPGA 316 (820)
Q Consensus 312 PF~~~ 316 (820)
||...
T Consensus 249 Pf~~~ 253 (288)
T PF14531_consen 249 PFGLS 253 (288)
T ss_dssp STCCC
T ss_pred CCCCC
Confidence 99643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-21 Score=224.61 Aligned_cols=222 Identities=24% Similarity=0.378 Sum_probs=168.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..+|+.+++|..|+||.||.++++.+.+.+|+|+-+++ ...+. ||... +.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-lilRn------ilt~a-------~npfvv------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-LILRN------ILTFA-------GNPFVV------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc-hhhhc------ccccc-------CCccee------------
Confidence 37899999999999999999999999999999654322 11110 11111 333333
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
|+-..+++.- +.++... +.+++|||+.||||||+||+|.+|+ .-+.+||+|||+.....
T Consensus 136 --------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 --------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred --------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhh
Confidence 4444444432 2344332 7899999999999999999999997 77999999999984211
Q ss_pred C------------------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003438 268 R------------------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329 (820)
Q Consensus 268 ~------------------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~l 329 (820)
. .....+||+.|+|||++..+.|...+|.|++|+|+||.+.|+.||.++..++++..++...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 0 1234589999999999999999999999999999999999999999999988887776533
Q ss_pred CCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCC
Q 003438 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409 (820)
Q Consensus 330 G~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~ 409 (820)
. ..|+.
T Consensus 275 i-~wpE~------------------------------------------------------------------------- 280 (1205)
T KOG0606|consen 275 I-EWPEE------------------------------------------------------------------------- 280 (1205)
T ss_pred c-ccccc-------------------------------------------------------------------------
Confidence 3 11100
Q ss_pred CCChhhhhhhHHhHHHHHHHHHhccccCcCCCC---CHHHHHcCCccCCCCCC
Q 003438 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRW---SPFQASRHPFVTGEPFT 459 (820)
Q Consensus 410 ~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRp---Ta~EaL~HPff~~~~~~ 459 (820)
+....+++.|+|.++|+.+|..|. .+-++.+|+||+...+.
T Consensus 281 ---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 281 ---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ---------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 011346789999999999999996 56788899999998876
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-21 Score=220.24 Aligned_cols=240 Identities=23% Similarity=0.378 Sum_probs=190.2
Q ss_pred EeccCCceeEEEeec---cCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 116 LLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d---~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
.+|+|+||.|++++. ...+..+|+|+.++.. ........|-.++..++ .|+.+|+++-.|+.+..+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~------~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH------NTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc------CCCceeeeeeeeccccchhH
Confidence 379999999998753 4557789999987531 11113445667777663 48999999999999999999
Q ss_pred EEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 190 VmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
++++..| .|..-+... ..+.+...+.+...++-+|+++|+.+|+|||+|++||+++ ..|.+|+.|||+++..-.
T Consensus 75 ~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld---~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL---LEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec---ccCccccCCchhhhHhHh
Confidence 9999975 666555443 3588899999999999999999999999999999999995 789999999999975543
Q ss_pred ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhh
Q 003438 269 TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFF 348 (820)
Q Consensus 269 ~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f 348 (820)
.... |||..|||||++. ....++|.||||++++||++|..||.. +.+..|.+..-
T Consensus 150 ~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~------------------ 204 (612)
T KOG0603|consen 150 EKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL------------------ 204 (612)
T ss_pred hhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc------------------
Confidence 3323 9999999999998 578899999999999999999999976 44444433111
Q ss_pred hhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHH
Q 003438 349 KCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVD 428 (820)
Q Consensus 349 ~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~D 428 (820)
......+..+.+
T Consensus 205 --------------------------------------------------------------------~~p~~l~~~a~~ 216 (612)
T KOG0603|consen 205 --------------------------------------------------------------------EMPRELSAEARS 216 (612)
T ss_pred --------------------------------------------------------------------CCchhhhHHHHH
Confidence 001124567889
Q ss_pred HHHhccccCcCCCCCH-----HHHHcCCccCCCCCC
Q 003438 429 FLKGLVEFDPAKRWSP-----FQASRHPFVTGEPFT 459 (820)
Q Consensus 429 LI~kmL~~DP~kRpTa-----~EaL~HPff~~~~~~ 459 (820)
++..|+..+|..|.-+ .|+++|+||....+.
T Consensus 217 ~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 217 LFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 9999999999999865 799999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-20 Score=201.98 Aligned_cols=144 Identities=24% Similarity=0.349 Sum_probs=117.0
Q ss_pred CCCCceeEEeEEEeec---------------------------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHH
Q 003438 169 EDKHHIVRIYEYFVCQ---------------------------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221 (820)
Q Consensus 169 ~~HpnIVkl~d~f~~~---------------------------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~Q 221 (820)
..|||||++...|.+. ..+|+||..+..+|.+++..+. .+....+.++.|
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHH
Confidence 4799999999988752 3589999999999999998764 778888999999
Q ss_pred HHHHhhhcccCCeeeccCCCCCccccccc-CCCeEEEeecccccccCC---------ccccccccccccCcccccccc--
Q 003438 222 ILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSACTEDR---------TVYSYIQSRYYRSPEVLLGYQ-- 289 (820)
Q Consensus 222 Il~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~iKL~DFGlA~~~~~---------~~~~~~gt~~Y~APEvl~~~~-- 289 (820)
+++|+.|||++||.|||||.+||||..++ .-..++|+|||++--.+. .....-|.-.-||||+....+
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 99999999999999999999999996543 345689999999832211 112234567789999987542
Q ss_pred ---cc-ccchhHhHHHHHHHHHhCCCCCCC
Q 003438 290 ---YT-TAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 290 ---yt-~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.+ .|+|.|+.|.+.||++....||.+
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 22 489999999999999999999976
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-20 Score=193.54 Aligned_cols=168 Identities=10% Similarity=0.139 Sum_probs=126.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHH------HHHHHHHHHHHhhhcCCCCCCceeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQ------ALVEVSILTTLNKKYDREDKHHIVRI 177 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~------~~~Ei~iL~~L~~~~~~~~HpnIVkl 177 (820)
.++|+++++||.|+||.||++.+ ++..+|||++.... ..... +.+|+..+.+| .|++|..+
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-------~~~GI~~~ 100 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-------RSEGLASL 100 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-------HHCCCCcc
Confidence 38999999999999999999755 46679999997432 22222 56888889998 46788888
Q ss_pred eEEEeec--------ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc
Q 003438 178 YEYFVCQ--------RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248 (820)
Q Consensus 178 ~d~f~~~--------~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~ 248 (820)
.+++... ...+|||||++| +|.++.. +++ ..+.+|+.+|..||+.||+||||||.||+++
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~- 169 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS- 169 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe-
Confidence 8886643 358999999997 6766521 333 2456999999999999999999999999996
Q ss_pred ccCCCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHH
Q 003438 249 SVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF 307 (820)
Q Consensus 249 ~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLl 307 (820)
..+ ++|+|||........... ..+++...|+.++|||+||+++..+.
T Consensus 170 --~~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 --KNG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --CCC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 345 999999988544322111 11444556788999999999876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=185.45 Aligned_cols=139 Identities=19% Similarity=0.162 Sum_probs=103.6
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---h------------------------HHHHHHHHHHHHHHhhhc
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---Y------------------------YQQALVEVSILTTLNKKY 166 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~---~------------------------~~~~~~Ei~iL~~L~~~~ 166 (820)
.+.||+|+||+||+|.+. +|+.||||+++.... . .....+|+++|..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 899999999975311 0 112345999999996421
Q ss_pred CCCCCCceeEEeEEEeecceeEEEEeccCCC-hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhc-ccCCeeeccCCCCCc
Q 003438 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLL-KDAGIIHCDLKPENI 244 (820)
Q Consensus 167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yL-Hs~gIVHrDLKPeNI 244 (820)
..+|+++ ... ..+|||||++|+ +...+.. ...+++..+..++.||+.+|.+| |+.||+||||||+||
T Consensus 81 --v~~p~~~------~~~-~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NI 149 (190)
T cd05147 81 --IPCPEPI------LLK-SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNL 149 (190)
T ss_pred --CCCCcEE------Eec-CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 0123332 112 238999999974 3333222 24689999999999999999999 799999999999999
Q ss_pred ccccccCCCeEEEeecccccccCC
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
|++ ++.++|+|||+|.....
T Consensus 150 li~----~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 150 LYH----DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred EEE----CCcEEEEEccccccCCC
Confidence 995 36799999999975443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=176.65 Aligned_cols=138 Identities=21% Similarity=0.194 Sum_probs=104.9
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh---------------------------HHHHHHHHHHHHHHhhhc
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY---------------------------YQQALVEVSILTTLNKKY 166 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~---------------------------~~~~~~Ei~iL~~L~~~~ 166 (820)
.+.||+|+||+||+|++. +|+.||||+++..... .....+|.+.+.++.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-- 78 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE-- 78 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh--
Confidence 468999999999999987 8999999999854110 1123568888888853
Q ss_pred CCCCCCceeEEeEEEeecceeEEEEeccCCC-hHHH-HHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCC
Q 003438 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYEL-IKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPEN 243 (820)
Q Consensus 167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~d~-l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeN 243 (820)
++|.....+... ..||||||++|. +... +.. ..+++..+..++.|++.+|.+||. .||+||||||+|
T Consensus 79 -----~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N 148 (190)
T cd05145 79 -----AGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN 148 (190)
T ss_pred -----CCCCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence 454333322222 248999999874 3332 322 357889999999999999999999 999999999999
Q ss_pred cccccccCCCeEEEeecccccccCC
Q 003438 244 ILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 244 ILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
||++ ++.++|+|||++.....
T Consensus 149 Ill~----~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 149 ILYH----DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEEE----CCCEEEEEcccceecCC
Confidence 9995 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=175.33 Aligned_cols=140 Identities=19% Similarity=0.158 Sum_probs=109.5
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---e-eE
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---H-LC 188 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---~-l~ 188 (820)
.+.||+|+|+.||. +..+... +||++... ....+.+.+|+.+++.|.+ ....||||++++++++.+. . +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~--~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSR--RLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhc--cCCCCcccceeeEEEEeCCCCeEEEE
Confidence 36899999999995 6777666 69988753 2345678999999999965 2346899999999999873 4 34
Q ss_pred EEEeccC---CChHHHHHhhhcCCCCHHHHHHHHHHHHHHh-hhcccCCeeeccCCCCCccccccc-CCCeEEEeecccc
Q 003438 189 ICFELLD---SNLYELIKINHFRGLSLSIVQLFSKQILRGL-SLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSA 263 (820)
Q Consensus 189 LVmEy~~---gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL-~yLHs~gIVHrDLKPeNILl~~~~-~~~~iKL~DFGlA 263 (820)
+||||++ ++|.++++.. .+++. ..++.|++.++ +|||+++||||||||+|||++... ....++|+||+-+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8899955 5999999653 36665 35688888888 999999999999999999997433 3458999994443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=209.98 Aligned_cols=195 Identities=23% Similarity=0.378 Sum_probs=157.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..+|.|.+.||+|+||+||+|.... ++.||||+-+....+ ++..-.+++.+|+ ..-.+.|..+...+...+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk----~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLK----PQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhc----hhhhcchHHHHHHHccCCcc
Confidence 4799999999999999999998877 999999997754322 1112223344443 11235677777777778889
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc----ccCCCeEEEeeccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT----SVKPAEIKIIDFGS 262 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~----~~~~~~iKL~DFGl 262 (820)
+||+||.. |+|++++. ..+.+++..+..|+.|||..|+.||..+|||+||||+|+||.. +....-++|+|||.
T Consensus 770 ~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 99999998 89999998 3457999999999999999999999999999999999999953 23356799999999
Q ss_pred ccc-----cCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCC
Q 003438 263 ACT-----EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 263 A~~-----~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
+.. ........++|-.+-.+|+..|.+++..+|.|.|+.+++.||.|+.
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 842 2234556678888999999999999999999999999999999863
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.8e-18 Score=173.14 Aligned_cols=181 Identities=17% Similarity=0.132 Sum_probs=134.8
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHH-----HHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ-----QALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~-----~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
+...|+.|+||+|+.+.. .+..++.+.+.......+ .+.+|+++|++|. ++++|++++++ +..
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~------~~~~vP~ll~~----~~~ 73 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLD------GLPRTPRLLHW----DGR 73 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcC------CCCCCCEEEEE----cCE
Confidence 567899999999998754 677888888876554333 5788999999995 35788888886 457
Q ss_pred EEEEeccCCC-hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccC-CCCCcccccccCCCeEEEeecccccc
Q 003438 188 CICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL-KPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 188 ~LVmEy~~gs-L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL-KPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
|+||||+.|. |.+.+. .. ...++.|++.+|.+||++||||||| ||+|||++ .++.++|+|||+|..
T Consensus 74 ~lvmeyI~G~~L~~~~~--------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPP--------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVR 141 (218)
T ss_pred EEEEeeecCccHHhhhh--------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCcee
Confidence 9999999874 433221 11 2357889999999999999999999 79999995 567899999999974
Q ss_pred cCCccc----------------cccccccccCccccccc-ccc-ccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 266 EDRTVY----------------SYIQSRYYRSPEVLLGY-QYT-TAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 266 ~~~~~~----------------~~~gt~~Y~APEvl~~~-~yt-~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
...... ....++.|++|+...-. ..+ ...+.++.|+-+|.++|+..++.++.
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 433221 01235667777654432 334 45677789999999999998886554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.5e-17 Score=171.21 Aligned_cols=145 Identities=19% Similarity=0.145 Sum_probs=110.4
Q ss_pred CceEEEEEeccCCceeEEEee-ccCCCeEEEEEEEeCChh-------------------------hHHHHHHHHHHHHHH
Q 003438 109 RRYIVKDLLGHGTFGQVAKCW-DAEMNSFVAVKIIKNQPA-------------------------YYQQALVEVSILTTL 162 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~-d~~tg~~VAIKiik~~~~-------------------------~~~~~~~Ei~iL~~L 162 (820)
.-|++.+.||+|+||.||+|. +..+++.||||+++.... ....+.+|+++++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 677899999999974321 112356799999999
Q ss_pred hhhcCCCCCCceeEEeEEEeecceeEEEEeccCCC-hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC-eeeccCC
Q 003438 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG-IIHCDLK 240 (820)
Q Consensus 163 ~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g-IVHrDLK 240 (820)
.+. ...+.++++. ...+|||||++|. |....... ..+.+..+..++.||+.+|.+||+.| |+|||||
T Consensus 108 ~~~-----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dik 176 (237)
T smart00090 108 YEA-----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLS 176 (237)
T ss_pred Hhc-----CCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCC
Confidence 531 2334444442 2358999999984 44433221 24667778899999999999999999 9999999
Q ss_pred CCCcccccccCCCeEEEeecccccccCC
Q 003438 241 PENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 241 PeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
|+||+++ .+.++|+|||.+.....
T Consensus 177 p~NIli~----~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 177 EYNILVH----DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhhEEEE----CCCEEEEEChhhhccCC
Confidence 9999995 56899999999865443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.8e-18 Score=188.24 Aligned_cols=118 Identities=32% Similarity=0.514 Sum_probs=101.5
Q ss_pred ceeEEEEeccC-CChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 185 RHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.++||.|++|. .+|.+.|...+ ....+....+.++.|+..++.| ++.+|+|+||.||++. .+.++||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 46899999998 68999987443 3447788899999999999999 9999999999999996 456899999999
Q ss_pred ccccCC---------ccccccccccccCccccccccccccchhHhHHHHHHHHHh
Q 003438 263 ACTEDR---------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308 (820)
Q Consensus 263 A~~~~~---------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt 308 (820)
...... .....+||.+||+||.|.+..|+.++||||||+||+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 854322 2345689999999999999999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-16 Score=157.68 Aligned_cols=133 Identities=26% Similarity=0.290 Sum_probs=106.3
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+.||+|++|.||+|.. .+..|+||+..... .....+.+|+.++..+. |++|+....++....
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-------KAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-------HCCCCCCeEEEEeCC
Confidence 5799999999999976 66779999865321 11235678999999884 456666666666777
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..++||||++| +|.+++.... . .+..++.+|+.+|.+||+.+++|+|++|.|||++ .+.++|+|||.+.
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~ 142 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAE 142 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCccc
Confidence 88999999986 7877775432 2 7889999999999999999999999999999995 5679999999986
Q ss_pred cc
Q 003438 265 TE 266 (820)
Q Consensus 265 ~~ 266 (820)
..
T Consensus 143 ~~ 144 (211)
T PRK14879 143 FS 144 (211)
T ss_pred CC
Confidence 53
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-16 Score=163.97 Aligned_cols=198 Identities=19% Similarity=0.208 Sum_probs=149.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
....++-+|.+...|..|+++.. |..+++|+++.. ....+.+..|.-.|+.+ .||||+.+++.+...-
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-------shpnilpvlgacnspp 260 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-------SHPNILPVLGACNSPP 260 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-------cCCchhhhhhhccCCC
Confidence 34556678899999999999765 445777887643 22334566677666666 7999999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
++.++..||. |+|+.++.....--++..++.+++..|++|++|||+.. |.---|....|+|+.+ -..++-.+|--+
T Consensus 261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarismad~kf 339 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMADTKF 339 (448)
T ss_pred CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheeccccee
Confidence 9999999998 89999998765445778899999999999999999864 3344677888888632 234455555444
Q ss_pred ccccCCccccccccccccCcccccccccc---ccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYT---TAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 263 A~~~~~~~~~~~gt~~Y~APEvl~~~~yt---~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
+.+.. ...-.+.|++||.+...+-+ .++|+|||.+++|||.|...||...+..+
T Consensus 340 sfqe~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 340 SFQEV----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred eeecc----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 43322 22346889999999877544 58999999999999999999998766544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.1e-15 Score=151.20 Aligned_cols=128 Identities=21% Similarity=0.225 Sum_probs=98.0
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.||+|+||.||++. .++..|++|+..... ....++.+|+++++.+.+ ++|....-++.....
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-------~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARK-------AGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHH-------CCCCCCEEEEEECCC
Confidence 38999999999997 456789999865321 112456789999999854 333333333445667
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+|||||++| +|.+++.... . .++.||+.+|.+||+.|++|+|+||+||+++ .+.++|+|||++..
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~ 138 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKY 138 (199)
T ss_pred CEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcC
Confidence 7999999975 7777664322 0 7899999999999999999999999999995 57899999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.1e-15 Score=152.80 Aligned_cols=138 Identities=23% Similarity=0.252 Sum_probs=103.5
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-----------------------hHHHHHHHHHHHHHHhhhc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-----------------------YYQQALVEVSILTTLNKKY 166 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~-----------------------~~~~~~~Ei~iL~~L~~~~ 166 (820)
.|.+.+.||+|+||.||++... +++.||||+++.... .......|+.++..+.+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE- 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc-
Confidence 4778899999999999999875 799999999764320 011356788888888432
Q ss_pred CCCCCCceeEEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcc
Q 003438 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL 245 (820)
Q Consensus 167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL 245 (820)
...++.+++ ....++||||+.| +|.++.. ......++.+|+.+|.++|+.||+||||||+||+
T Consensus 94 ----~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nil 157 (198)
T cd05144 94 ----GFPVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNIL 157 (198)
T ss_pred ----CCCCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEE
Confidence 113444444 2456899999987 4543321 1346678899999999999999999999999999
Q ss_pred cccccCCCeEEEeecccccccCC
Q 003438 246 LCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 246 l~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
++ +++.++|+|||.+.....
T Consensus 158 l~---~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VD---DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred Ec---CCCcEEEEECCccccCCC
Confidence 95 578999999999965544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.5e-15 Score=171.95 Aligned_cols=135 Identities=20% Similarity=0.274 Sum_probs=105.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEe-C---C-----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-N---Q-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik-~---~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
..|...++||+|+||+||++...... +++|+.. + . ....+.+.+|+++++.+ .|++|+..+.
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~~~~i~~p~~ 403 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-------RRAGVPTPVI 403 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-------cccCCCeeEE
Confidence 45667899999999999998764433 3444321 1 1 11234677899999999 4678887777
Q ss_pred EEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 180 YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
++......++||||+++ +|.+++. ....++.||+++|.+||+.+|+||||||+|||+ .++.++|+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~li 469 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLI 469 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEE
Confidence 77777788999999985 7877764 246789999999999999999999999999999 34679999
Q ss_pred eccccccc
Q 003438 259 DFGSACTE 266 (820)
Q Consensus 259 DFGlA~~~ 266 (820)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99999653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=9.1e-15 Score=147.02 Aligned_cols=137 Identities=25% Similarity=0.272 Sum_probs=97.3
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhH---HH----------------------HHHHHHHHHHHhhhcCC
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQ----------------------ALVEVSILTTLNKKYDR 168 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~---~~----------------------~~~Ei~iL~~L~~~~~~ 168 (820)
.+.||+|+||+||+|.+. +++.||||+++...... .. ...|...+..+...
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--- 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA--- 77 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc---
Confidence 467999999999999886 78999999987532111 11 13456666666431
Q ss_pred CCCCceeEEeEEEeecceeEEEEeccCC-ChH-HHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcc
Q 003438 169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLY-ELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENIL 245 (820)
Q Consensus 169 ~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~-d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNIL 245 (820)
+-.+.+++.+ ...++||||+.+ .+. ..+.... . ...++.++.+++.+|.+||. .+|+|+||||+||+
T Consensus 78 --~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 78 --GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNIL 147 (187)
T ss_pred --CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEE
Confidence 2234455443 246999999987 221 1122111 1 16688999999999999999 99999999999999
Q ss_pred cccccCCCeEEEeecccccccCC
Q 003438 246 LCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 246 l~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
++ ++.++|+|||.+.....
T Consensus 148 i~----~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD----DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE----CCcEEEEECcccccccC
Confidence 95 67899999999965433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-14 Score=164.52 Aligned_cols=143 Identities=22% Similarity=0.334 Sum_probs=120.8
Q ss_pred CCCceeEEeEEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCe-eeccCCCCCcccc
Q 003438 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI-IHCDLKPENILLC 247 (820)
Q Consensus 170 ~HpnIVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gI-VHrDLKPeNILl~ 247 (820)
.|.|+.++++.+.+....++|.+||. |+|.|.+.... ..+++.....+++.|+.||.|||..-| .|+.++..|.+++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd 83 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD 83 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee
Confidence 68999999999999999999999998 89999998754 458888999999999999999998765 9999999999995
Q ss_pred cccCCCeEEEeecccccccCC-----ccccccccccccCccccccc---c----ccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 248 TSVKPAEIKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGY---Q----YTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 248 ~~~~~~~iKL~DFGlA~~~~~-----~~~~~~gt~~Y~APEvl~~~---~----yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
....+||+|||+...... ..........|.|||++... . .+.+.||||+|++++|+++...||..
T Consensus 84 ---~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 84 ---SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred ---eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 789999999999865432 11112234559999999874 1 46789999999999999999999975
Q ss_pred C
Q 003438 316 A 316 (820)
Q Consensus 316 ~ 316 (820)
.
T Consensus 161 ~ 161 (484)
T KOG1023|consen 161 R 161 (484)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.7e-16 Score=183.73 Aligned_cols=200 Identities=27% Similarity=0.377 Sum_probs=158.4
Q ss_pred CceEEEEEeccCCceeEEEeecc-CCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-EMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
..|.+.+.||+|+|+.|-++... .....+|+|.+... ....+....|+.+-+.+. .|.|++++++.....
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s------~h~n~~~~~~~~~~~ 93 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS------KHSNTVHMIEPSSSP 93 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc------ccccccccCCccCCC
Confidence 57888889999999999998764 34556777877643 233344445666655553 389999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc-cCCeeeccCCCCCcccccccCCC-eEEEeecc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLCTSVKPA-EIKIIDFG 261 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~~~~~~~-~iKL~DFG 261 (820)
+..++++++..| ++.+.+........+...+..++.|+..+|.|+| ..++.|+||||+|.+++ ..+ .+++.|||
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~ 170 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFG 170 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCch
Confidence 999999999864 7777663333235788889999999999999999 99999999999999996 444 89999999
Q ss_pred cccccCC------ccccccc-cccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 262 SACTEDR------TVYSYIQ-SRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 262 lA~~~~~------~~~~~~g-t~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
+|..... .....+| ++.|+|||...+..| .+..|+||+|+++..+++|..|+....
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 9954333 2334578 999999999998644 578999999999999999999986443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.7e-14 Score=133.85 Aligned_cols=134 Identities=21% Similarity=0.172 Sum_probs=108.3
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
+++.||.|.++.||++.... ..++||+++.... ...+.+|+.+++.+.+. ..++++++.++...+..++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~-----~~~~p~~~~~~~~~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK-----GLPVPKVLASGESDGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc-----CCCCCeEEEEcCCCCccEEEEE
Confidence 45789999999999998644 6799999876543 45788899999999642 3578888888888889999999
Q ss_pred ccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC---CeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 193 LLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA---GIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 193 y~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~---gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
|+.+.....+ +......++.+++++|++||.. +++|+||+|+||+++ ..+.++|+||+.+..
T Consensus 74 ~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 9986432211 4456677889999999999984 799999999999996 468899999999854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.4e-13 Score=143.78 Aligned_cols=134 Identities=21% Similarity=0.212 Sum_probs=98.5
Q ss_pred EEec-cCCceeEEEeeccCCCeEEEEEEEeCCh--------------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 115 DLLG-HGTFGQVAKCWDAEMNSFVAVKIIKNQP--------------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 115 ~~LG-~G~fG~Vyka~d~~tg~~VAIKiik~~~--------------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
..|| .|+.|+||++... +..+|||.+.... .....+.+|++++..|.+. +..+++.++
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~-----gi~vP~pl~ 109 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEA-----GLPVPRPIA 109 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhC-----CCCCceeEe
Confidence 3566 7788888888553 6779999885311 2234677899999999652 233567777
Q ss_pred EEeecc----eeEEEEeccCC--ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC
Q 003438 180 YFVCQR----HLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 180 ~f~~~~----~l~LVmEy~~g--sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~ 253 (820)
+...+. ..+||||++.| +|.+++... .+++.. +.||+.+|.+||++||+||||||+|||++ .++
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~ 179 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDG 179 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCC
Confidence 654432 23599999985 777776542 355543 57899999999999999999999999996 456
Q ss_pred eEEEeecccccc
Q 003438 254 EIKIIDFGSACT 265 (820)
Q Consensus 254 ~iKL~DFGlA~~ 265 (820)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 899999999854
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-13 Score=156.48 Aligned_cols=195 Identities=26% Similarity=0.251 Sum_probs=157.6
Q ss_pred CceEEEEEecc--CCceeEEEeec--cCCCeEEEEEEEeC--C-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGH--GTFGQVAKCWD--AEMNSFVAVKIIKN--Q-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~--G~fG~Vyka~d--~~tg~~VAIKiik~--~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
..+.+.+.+|. |.+|.||.+.. ..+...+|+|.-+. . ......-.+|+...+.+. .|+|.++.+..+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~------~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID------SHENPVRDSPAW 187 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC------ccccccccCccc
Confidence 67788899999 99999999988 88999999998442 1 222233445665555553 689999999999
Q ss_pred eecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHH----HhhhcccCCeeeccCCCCCcccccccCC-CeEE
Q 003438 182 VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR----GLSLLKDAGIIHCDLKPENILLCTSVKP-AEIK 256 (820)
Q Consensus 182 ~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~----aL~yLHs~gIVHrDLKPeNILl~~~~~~-~~iK 256 (820)
+..+.++|-.|+|+..|..+..... .-+++..++.++.+... ||.++|..+|+|-|+||+||++. .+ ..++
T Consensus 188 e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCK 263 (524)
T ss_pred ccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceee
Confidence 9999999999999988887766543 34889999999999999 99999999999999999999996 44 7889
Q ss_pred EeecccccccCCcc--------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 257 IIDFGSACTEDRTV--------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 257 L~DFGlA~~~~~~~--------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
++|||+........ ....+...|++||++.+ -++.+.||++||.++.+..++..++.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 99999986554332 12245677999999866 68899999999999999998866653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.5e-12 Score=153.46 Aligned_cols=261 Identities=18% Similarity=0.276 Sum_probs=189.1
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
..+.+.+++-+-.|.++.++.+.-..++...++|+....+.....-.+++.--+.+ .....+|-+++..-.+.....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~---~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI---LITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc---cccCCCCceecccCCCCCCCC
Confidence 34778888899999999999998888888888887765432211111111110111 111234566665555667788
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+||++|++ ++|...+.... ..+++-.+..+..+..++++||...++|+|++|.|+|+. ..+..++.||+....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSK 953 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccc
Confidence 999999997 57777666543 577788888999999999999999999999999999995 678889999984310
Q ss_pred cC----------------------------------CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCC
Q 003438 266 ED----------------------------------RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 266 ~~----------------------------------~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
.. .......+|+.|.+||.+.+......+|.|++|++++|.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 00 00123467899999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCcc
Q 003438 312 LFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391 (820)
Q Consensus 312 PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~ 391 (820)
||.........+.|...--
T Consensus 1034 p~na~tpq~~f~ni~~~~~------------------------------------------------------------- 1052 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDI------------------------------------------------------------- 1052 (1205)
T ss_pred CCCCcchhhhhhccccCCC-------------------------------------------------------------
Confidence 9987766554433322100
Q ss_pred ccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHH---HHHcCCccCCCCC
Q 003438 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPF---QASRHPFVTGEPF 458 (820)
Q Consensus 392 ~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~---EaL~HPff~~~~~ 458 (820)
|+... ....+..+.+++.++|..+|.+|..+. ++-.|+||+...+
T Consensus 1053 --------------~~p~g--------~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1053 --------------PWPEG--------PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred --------------CCCCC--------ccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 00000 011346788999999999999999998 9999999998765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.1e-12 Score=146.03 Aligned_cols=150 Identities=15% Similarity=0.255 Sum_probs=95.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------------------------------hhHHHHH
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------------------------------AYYQQAL 153 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-----------------------------------~~~~~~~ 153 (820)
..|+. +.||.|++|+||+|+.+.+|+.||||+++..- ...+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 78999999999999998889999999997431 1111222
Q ss_pred HHH------HHHHHHhhhcCCCCCCceeEEeEEEee-cceeEEEEeccCC-ChHHHHHhhhcC----CCCHHHHHHHHHH
Q 003438 154 VEV------SILTTLNKKYDREDKHHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFR----GLSLSIVQLFSKQ 221 (820)
Q Consensus 154 ~Ei------~iL~~L~~~~~~~~HpnIVkl~d~f~~-~~~l~LVmEy~~g-sL~d~l~~~~~~----~l~e~~i~~I~~Q 221 (820)
+|+ .-+.+++..+. +...+.+-.++.+ ....+|||||+.| .+.++......+ .+.+..+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~---~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFE---DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHcc---CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 333 33333333221 2222333333322 4567899999986 666542211111 2455556666677
Q ss_pred HHHHhhhcccCCeeeccCCCCCcccccc-cCCCeEEEeecccccccCCc
Q 003438 222 ILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTEDRT 269 (820)
Q Consensus 222 Il~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~iKL~DFGlA~~~~~~ 269 (820)
|+ ..|++|+|+||.||+++.+ ...++++++|||++...+..
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 65 4899999999999999632 12248999999999765543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.2e-11 Score=138.34 Aligned_cols=142 Identities=20% Similarity=0.307 Sum_probs=94.0
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHH-------------------------------------------H
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQ-------------------------------------------Q 151 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~-------------------------------------------~ 151 (820)
+.||.|++|+||+|+.+ +|+.||||+.+..- .+ .
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i--~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld 199 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGI--EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD 199 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCc--HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence 57999999999999764 68999999986421 11 1
Q ss_pred HHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHH-Hhhhc
Q 003438 152 ALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR-GLSLL 229 (820)
Q Consensus 152 ~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~-aL~yL 229 (820)
+.+|...+.+++..+.....-.|.+++. ......+|||||++| +|.++..... .... ...++.+++. .+..+
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHH
Confidence 2334444444443322111112333332 223457999999986 6666654332 1222 3445666655 47788
Q ss_pred ccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 230 Hs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
|..|++|+|+||.||++. .++.++|+|||++.....
T Consensus 274 ~~~g~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVL---KDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCCceeCCCCcccEEEC---CCCcEEEEeCCCeeECCH
Confidence 999999999999999995 568899999999976553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.7e-11 Score=121.84 Aligned_cols=138 Identities=16% Similarity=0.186 Sum_probs=101.7
Q ss_pred EEeccCCceeEEEeeccC------CCeEEEEEEEeCC-------------h----------hhHHH----HHHHHHHHHH
Q 003438 115 DLLGHGTFGQVAKCWDAE------MNSFVAVKIIKNQ-------------P----------AYYQQ----ALVEVSILTT 161 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~------tg~~VAIKiik~~-------------~----------~~~~~----~~~Ei~iL~~ 161 (820)
..||.|-=+.||.|.... .+..+|||+.+.. + ...+. ..+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 3578999998520 0 01112 3479999999
Q ss_pred HhhhcCCCCCCceeEEeEEEeecceeEEEEeccCCC-hHH-HHHhhhcCCCCHHHHHHHHHHHHHHhhhc-ccCCeeecc
Q 003438 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN-LYE-LIKINHFRGLSLSIVQLFSKQILRGLSLL-KDAGIIHCD 238 (820)
Q Consensus 162 L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs-L~d-~l~~~~~~~l~e~~i~~I~~QIl~aL~yL-Hs~gIVHrD 238 (820)
+... .-++.+++++ ..-+|||||++++ +.. .++. ..+++.++..++.+++.+|..| |+.||||+|
T Consensus 83 l~~~-----Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD 150 (197)
T cd05146 83 MQKA-----GIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHAD 150 (197)
T ss_pred HHHc-----CCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9753 3456666664 4678999999863 221 2222 1356667788899999999999 899999999
Q ss_pred CCCCCcccccccCCCeEEEeecccccccCC
Q 003438 239 LKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 239 LKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
|++.|||+. ++.++|+|||.+.....
T Consensus 151 Ls~~NIL~~----~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH----DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE----CCcEEEEECCCceeCCC
Confidence 999999994 46799999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.1e-11 Score=118.99 Aligned_cols=128 Identities=19% Similarity=0.095 Sum_probs=94.2
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEec
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL 193 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy 193 (820)
++.|+.|.++.||+++.. ++.|++|+............+|+.+++.+... ..+.+++.+.. ...++|||+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~------~~~P~~~~~~~--~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEA------GIGPKLYYFDP--ETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHh------CCCCceEEEeC--CCCeEEEEe
Confidence 467899999999999754 77899999875532233467899999998643 22455555443 345899999
Q ss_pred cCCC-hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCe-----eeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 194 LDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGI-----IHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 194 ~~gs-L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gI-----VHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++|. +.+. ......++.+++++|+.||..++ +|+|++|.||+++ .+.++|+||+.+..
T Consensus 73 i~G~~l~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 9973 3321 01123467899999999999885 9999999999995 45799999999853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-11 Score=141.07 Aligned_cols=197 Identities=22% Similarity=0.193 Sum_probs=148.8
Q ss_pred CCceEEEEEeccCCceeEEEeecc-CCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-EMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
..+|.++..||.|.|+.|+.+... .++..|++|.+.+.. ......+.|+.+...+. .|.+++.....+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~------~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILG------SHLPSVGKNSSWSQ 337 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhh------cccccCCCCCCccc
Confidence 368899999999999999998654 778899999887542 22233456777776664 57899999998888
Q ss_pred cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 184 ~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.+..||-.|||.+....+-. .....+.+..++++..|++.++.++|+..++|+|+||+||++..+ .+..++.||+++
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCW 414 (524)
T ss_pred cccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhccccccc
Confidence 88888999999753222222 112348888999999999999999999999999999999999632 277899999998
Q ss_pred cccCCcccccccccccc--CccccccccccccchhHhHHHHHHHHHhCCCCC
Q 003438 264 CTEDRTVYSYIQSRYYR--SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~--APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
....-........-++. ++++.....+..++|+++||..+.+.+++.+.-
T Consensus 415 t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 415 TRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred cccceecccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 65333222333333344 555555668889999999999999999987544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-10 Score=124.45 Aligned_cols=138 Identities=21% Similarity=0.268 Sum_probs=104.3
Q ss_pred CCCceeEEeEEEeecc-----eeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccC--CeeeccC
Q 003438 170 DKHHIVRIYEYFVCQR-----HLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDA--GIIHCDL 239 (820)
Q Consensus 170 ~HpnIVkl~d~f~~~~-----~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~--gIVHrDL 239 (820)
.|.|||+++.++.+.+ ...++.||+. |.+..+|++.. .+.+.+...++|+-||+.||.|||+. -|+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 4779999999988654 4788999997 78988887654 24588899999999999999999986 5999999
Q ss_pred CCCCcccccccCCCeEEEeeccccccc-------CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTE-------DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~-------~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~ 310 (820)
..+-|++. .++.|||.--...... ........+-++|.|||.=.....+.++|||++|+...+|..+.
T Consensus 205 Tc~tifiq---~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 205 TCDTIFIQ---HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred chhheeec---CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999996 5566665321111100 00011123457799999876667788999999999999998765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.5e-10 Score=130.01 Aligned_cols=165 Identities=23% Similarity=0.266 Sum_probs=126.5
Q ss_pred EeeccCCCeEEEEEEEeCChh-hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhh
Q 003438 127 KCWDAEMNSFVAVKIIKNQPA-YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKIN 205 (820)
Q Consensus 127 ka~d~~tg~~VAIKiik~~~~-~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~ 205 (820)
.+..+.++.+|.|++++.... ..+.+.+-++-|+.| .||||+++++.++.++.+|||+|.+.. |..+++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-------RHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-------RHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-------cCchhhhhhhhhcccCceEEEeecccc-HHHHHHH-
Confidence 456678888999999986543 345566677777777 589999999999999999999998862 3334433
Q ss_pred hcCCCCHHHHHHHHHHHHHHhhhcc-cCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccc---cccccccccC
Q 003438 206 HFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS 281 (820)
Q Consensus 206 ~~~~l~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~---~~~gt~~Y~A 281 (820)
+....+...+.||+.||.||| +.+++|++|.-+.|+|+ ..+..||.+|..++....... ...---.|..
T Consensus 101 ----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~ 173 (690)
T KOG1243|consen 101 ----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDD 173 (690)
T ss_pred ----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccCCcccccchhhhcccC
Confidence 346778889999999999997 78999999999999996 789999999999865543321 1111223566
Q ss_pred ccccccccccccchhHhHHHHHHHHHhC
Q 003438 282 PEVLLGYQYTTAIDMWSFGCIVAELFLG 309 (820)
Q Consensus 282 PEvl~~~~yt~ksDIWSLG~ILyeLltG 309 (820)
|+.+.... ...|.|-|||+++|++.|
T Consensus 174 P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 174 PEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 76654332 457999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.9e-09 Score=106.65 Aligned_cols=144 Identities=20% Similarity=0.164 Sum_probs=109.4
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeC---------ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---------QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---------~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+..|-+|+-+.|+++. ..|+.+.||.=.. .....++..+|+++|.++... .|.-..-+|.+
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-------GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-------GIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-------CCCCceEEEEe
Confidence 56788899999999985 4577777775321 123345678899999998654 23333334556
Q ss_pred cceeEEEEeccCC--ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 184 QRHLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 184 ~~~l~LVmEy~~g--sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
...-+|+|||++| ++.+++...............++++|=+.|.-||..+|||+||..+||++..+.....+.|+|||
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeec
Confidence 6677899999998 88898887654444444557899999999999999999999999999999866666667999999
Q ss_pred cccc
Q 003438 262 SACT 265 (820)
Q Consensus 262 lA~~ 265 (820)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 9843
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.5e-09 Score=109.59 Aligned_cols=142 Identities=14% Similarity=0.149 Sum_probs=98.9
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---ceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---RHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~~l~L 189 (820)
+.|+.|..+.||++.... ++.+++|+...... ....+..|+++++.+... +..+.+++.+.... +..++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~-----~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGT-----GVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCC-----CCCCCCEEEECCCCCccCCceE
Confidence 578999999999997643 57899999875432 355778899999999652 33466677666553 36789
Q ss_pred EEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-------------------------------------
Q 003438 190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD------------------------------------- 231 (820)
Q Consensus 190 VmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs------------------------------------- 231 (820)
|||+++| ++.+.+.. ..+++.....++.++++.|..||+
T Consensus 78 v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 78 VMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 9999986 34332211 124555555666666666666652
Q ss_pred -------------------CCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 232 -------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 232 -------------------~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
..+||+|+++.||+++.+ ..+.+.|+||+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~g 207 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccccC
Confidence 357999999999999632 1456899999988543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2e-08 Score=101.00 Aligned_cols=129 Identities=22% Similarity=0.237 Sum_probs=92.1
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEe-C--------ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK-N--------QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik-~--------~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..|.+|+=+.|+.+.. -+..+++|.=. + .....++..+|..+|.++... --++..++++ +.+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~-----GV~~P~v~dv--D~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA-----GVPVPIVYDV--DPD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc-----CCCCCeEEEE--cCC
Confidence 3578899999999854 23346666532 1 123345677899999998653 2345555554 456
Q ss_pred eeEEEEeccCCC-hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~gs-L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
...|+|||++|. |.+++... ...+++.+=.-+.-||..||||+||.+.||++. ...+.++|||++.
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~ 139 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGE 139 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccc
Confidence 678999999984 55566544 135666777777889999999999999999995 4459999999986
Q ss_pred c
Q 003438 265 T 265 (820)
Q Consensus 265 ~ 265 (820)
.
T Consensus 140 ~ 140 (204)
T COG3642 140 F 140 (204)
T ss_pred c
Confidence 4
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.9e-08 Score=105.17 Aligned_cols=127 Identities=16% Similarity=0.065 Sum_probs=91.5
Q ss_pred CCeEEEEEEEeCChh--hHH----------HHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-----cceeEEEEeccC
Q 003438 133 MNSFVAVKIIKNQPA--YYQ----------QALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-----QRHLCICFELLD 195 (820)
Q Consensus 133 tg~~VAIKiik~~~~--~~~----------~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-----~~~l~LVmEy~~ 195 (820)
.|+.|.||....... ..+ .+.+|...+..|... + -.+++++.+.+. ...-+||||+++
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~----G-IptP~pVa~~e~~~~~~~~~s~LVte~l~ 118 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEV----G-VDTMTGVAFGERGSNPATRTSFIITEDLA 118 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHc----C-CCCCCeeEEEEecCCCccceeEEEEeeCC
Confidence 456788886643220 111 377899999888653 1 223344444432 235789999998
Q ss_pred C--ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc----cCCCeEEEeeccccc
Q 003438 196 S--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----VKPAEIKIIDFGSAC 264 (820)
Q Consensus 196 g--sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~----~~~~~iKL~DFGlA~ 264 (820)
+ +|.+++........++.....++.+|+..+.-||..||+|+|+++.|||++.+ .....+.|+||+.+.
T Consensus 119 ~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 119 PTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 7 68888764323446677888999999999999999999999999999999731 235789999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-08 Score=102.84 Aligned_cols=127 Identities=28% Similarity=0.305 Sum_probs=81.2
Q ss_pred eEEEeeccCCCeEEEEEEEeCC---------------------------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeE
Q 003438 124 QVAKCWDAEMNSFVAVKIIKNQ---------------------------PAYYQQALVEVSILTTLNKKYDREDKHHIVR 176 (820)
Q Consensus 124 ~Vyka~d~~tg~~VAIKiik~~---------------------------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk 176 (820)
.||.|.. ..++.||||+.+.. ........+|.+.|.++... .-++.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~-----Gv~vP~ 74 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEA-----GVPVPK 74 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCT-----T-SS--
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHC-----CccCCc
Confidence 4888865 45778999998521 01123467799999998643 235677
Q ss_pred EeEEEeecceeEEEEeccC--CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhh-cccCCeeeccCCCCCcccccccCCC
Q 003438 177 IYEYFVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSL-LKDAGIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 177 l~d~f~~~~~l~LVmEy~~--gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~y-LHs~gIVHrDLKPeNILl~~~~~~~ 253 (820)
++++ ..-+|||||++ |.....+.... ++......++.+++..+.. +|+.||||+||.+.|||+. .+
T Consensus 75 p~~~----~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~ 143 (188)
T PF01163_consen 75 PYDY----NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DG 143 (188)
T ss_dssp EEEE----ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TT
T ss_pred EEEE----eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cc
Confidence 7655 24579999998 74333333322 2244567788888885555 5799999999999999995 33
Q ss_pred eEEEeecccccccC
Q 003438 254 EIKIIDFGSACTED 267 (820)
Q Consensus 254 ~iKL~DFGlA~~~~ 267 (820)
.+.|+|||.+....
T Consensus 144 ~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 KVYIIDFGQAVDSS 157 (188)
T ss_dssp CEEE--GTTEEETT
T ss_pred eEEEEecCcceecC
Confidence 89999999986554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.3e-07 Score=107.01 Aligned_cols=167 Identities=16% Similarity=0.149 Sum_probs=124.2
Q ss_pred CceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec----ceeEEEEeccC
Q 003438 121 TFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ----RHLCICFELLD 195 (820)
Q Consensus 121 ~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~----~~l~LVmEy~~ 195 (820)
--.+.|+|....+|..|++|.+.-.+ ....+...-+++++++ .|.|||++.++|... ..+++|++|..
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-------~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-------CHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-------ccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 34578999999999999999994322 1112333456677777 689999999999843 47999999997
Q ss_pred --CChHHHHHhhh-------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 196 --SNLYELIKINH-------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 196 --gsL~d~l~~~~-------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
++|+++.-... ....+|+.+|.++.||..||.++|+.|+..+-|.+.+||++ .+.+|+|...
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C 437 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGC 437 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecc
Confidence 47888764321 13478999999999999999999999999999999999996 4447888877
Q ss_pred ccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCC
Q 003438 261 GSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 261 GlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
|.......... |.+.. -.+-|.=.||.+++.|.||..
T Consensus 438 ~i~Dvl~~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 438 GIMDVLQEDPT-----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cceeeecCCCC-----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 76643332220 11211 235688899999999999953
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1e-08 Score=119.34 Aligned_cols=152 Identities=22% Similarity=0.305 Sum_probs=109.2
Q ss_pred HHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecccccccCCccc------------cccccccccCcccccc
Q 003438 221 QILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY------------SYIQSRYYRSPEVLLG 287 (820)
Q Consensus 221 QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~------------~~~gt~~Y~APEvl~~ 287 (820)
+++.||.|+|. .++||++|.|++|.++ ..+..||+.|+++........ .......|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n---a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN---ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec---cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34499999995 6999999999999995 778899999999854332110 1123556999999999
Q ss_pred ccccccchhHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCC
Q 003438 288 YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGG 366 (820)
Q Consensus 288 ~~yt~ksDIWSLG~ILyeLl-tG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~ 366 (820)
...+.++|++||||++|.+. .|+..+.......... +..... +
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~-------------------------~---------- 227 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLL-------------------------N---------- 227 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhccc-------------------------c----------
Confidence 88899999999999999999 5776665433211111 000000 0
Q ss_pred ccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHH
Q 003438 367 RSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446 (820)
Q Consensus 367 ~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~E 446 (820)
. ........++.++++=|.++|..|+..||++.+
T Consensus 228 -----------------------~-----------------------~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 228 -----------------------A-----------------------GAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred -----------------------c-----------------------ccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 0 000001224577899999999999999999999
Q ss_pred HHcCCccCCCC
Q 003438 447 ASRHPFVTGEP 457 (820)
Q Consensus 447 aL~HPff~~~~ 457 (820)
++..|||.+..
T Consensus 262 l~~~~ff~D~~ 272 (700)
T KOG2137|consen 262 LLSIPFFSDPG 272 (700)
T ss_pred hhcccccCCch
Confidence 99999999854
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.4e-07 Score=93.92 Aligned_cols=109 Identities=24% Similarity=0.206 Sum_probs=84.9
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec----ceeEEEEeccCC--ChHHHHHhhhcCCCCHHHHHHHHHHHH
Q 003438 150 QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ----RHLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQIL 223 (820)
Q Consensus 150 ~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~----~~l~LVmEy~~g--sL~d~l~~~~~~~l~e~~i~~I~~QIl 223 (820)
....+|...+..|... .-.+.+.+.+.+.. ...+||+|++++ +|.+++..... ++......++.+++
T Consensus 56 ~ra~~E~~~~~~L~~~-----Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 56 SRAKREWRNLQRLREA-----GIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALA 128 (206)
T ss_pred hHHHHHHHHHHHHHHc-----CCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHH
Confidence 4677899888888653 22355556655543 245899999986 68888876432 66777889999999
Q ss_pred HHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 224 ~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..++-||.+||+|+|+++.|||+..+.....+.|+||+.+..
T Consensus 129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 129 RLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999999997554456899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.6e-06 Score=89.84 Aligned_cols=139 Identities=13% Similarity=0.091 Sum_probs=102.4
Q ss_pred ccCCceeEEEeeccCCCeEEEEEEEeCC-------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-----c
Q 003438 118 GHGTFGQVAKCWDAEMNSFVAVKIIKNQ-------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-----R 185 (820)
Q Consensus 118 G~G~fG~Vyka~d~~tg~~VAIKiik~~-------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-----~ 185 (820)
|.|+.+-|++.... |+.+-+|.-.+. +.-...+.+|+..|+.|... +-| +.++. ++... -
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~----GvP-VP~pv-f~~~~k~~~~~ 98 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERA----GVI-VPKIV-FGEAVKIEGEW 98 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHc----CCC-CCccc-eeeeeccCCce
Confidence 56888889887432 335777765421 22346788999999999764 333 55555 33211 2
Q ss_pred eeEEEEeccCC--ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 186 HLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 186 ~l~LVmEy~~g--sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.-+||+|-+++ +|.+++......+.++.....++.+|+..|.-||+.|+.|+|+.+.|||++.. ....++++||.-+
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~ 177 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhcc
Confidence 47899998884 88888876554457888889999999999999999999999999999999632 2345999999877
Q ss_pred cc
Q 003438 264 CT 265 (820)
Q Consensus 264 ~~ 265 (820)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 53
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.8e-08 Score=113.41 Aligned_cols=185 Identities=17% Similarity=0.157 Sum_probs=142.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCc-eeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH-IVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~Hpn-IVkl~d~f~~~~~l 187 (820)
+.|...+-++++++++++|.+...+...+ .|.+... ....-++++|.++ +||| .+..++-+..+++.
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~-------n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKV-------NNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHc-------cCCCCcccccccCCccccc
Confidence 55666677899999999999887776655 7777644 3344578888888 6788 77777878888899
Q ss_pred EEEEeccCCC--hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 188 CICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 188 ~LVmEy~~gs--L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+|+++.+. ....+.... -.+.+-+...+++.-+++|++||+.-=+|+| ||+.. ....|+.||+.+..
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----~~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----EEEVKLLDFAVPPQ 380 (829)
T ss_pred chhhhhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----ccccccccccCCcc
Confidence 9999999843 222211111 1244556677888889999999998778998 88884 46789999999977
Q ss_pred cCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 266 EDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 266 ~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
.... ..+..+++.++|||++....+..+.|+|+++.-..+|.-|.+|-.
T Consensus 381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 7665 566789999999999999999999999999987777777776654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.1e-06 Score=93.44 Aligned_cols=139 Identities=20% Similarity=0.216 Sum_probs=99.9
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----------h-------------hhHHHHHHHHHHHHHHhhhcC
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----------P-------------AYYQQALVEVSILTTLNKKYD 167 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----------~-------------~~~~~~~~Ei~iL~~L~~~~~ 167 (820)
+.+..+||-|-=+.||.|.+. .+..+|||.=+.. . .....+.+|.++|++|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~-- 169 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE-- 169 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc--
Confidence 456789999999999999876 5788999985411 1 1123467899999999431
Q ss_pred CCCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccc
Q 003438 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247 (820)
Q Consensus 168 ~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~ 247 (820)
--.|.+.+++ +..++|||+++|..+.-++ ++.+....++..|++-+.-+-..||||+|+.+-||+++
T Consensus 170 ---G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~ 236 (304)
T COG0478 170 ---GVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT 236 (304)
T ss_pred ---CCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe
Confidence 1246666664 5678999999984222111 23445566666677766666689999999999999996
Q ss_pred cccCCCeEEEeecccccccCC
Q 003438 248 TSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 248 ~~~~~~~iKL~DFGlA~~~~~ 268 (820)
+++.+.++||-.+.....
T Consensus 237 ---~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 237 ---EDGDIVVIDWPQAVPISH 254 (304)
T ss_pred ---cCCCEEEEeCcccccCCC
Confidence 678899999988765443
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.20 E-value=9.2e-06 Score=85.68 Aligned_cols=139 Identities=22% Similarity=0.214 Sum_probs=96.2
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhH-------------------------HHHHHHHHHHHHHhhhcCC
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY-------------------------QQALVEVSILTTLNKKYDR 168 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~-------------------------~~~~~Ei~iL~~L~~~~~~ 168 (820)
...|..|--+.||+|.. .++..||||+++...... ....+|..-|+++...
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA--- 128 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA--- 128 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc---
Confidence 34677888889999965 567899999997422111 1234566777776543
Q ss_pred CCCCceeEEeEEEeecceeEEEEeccCCCh--HHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcc
Q 003438 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNL--YELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENIL 245 (820)
Q Consensus 169 ~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL--~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNIL 245 (820)
+-.+.+.+.+. .-.|||||++... .-.|+.- ++...++..+..++++.+.-|-. .++||+||..-|||
T Consensus 129 --GVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL 199 (268)
T COG1718 129 --GVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNIL 199 (268)
T ss_pred --CCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheE
Confidence 34455555543 3579999997431 1111111 23444688888899999988887 89999999999999
Q ss_pred cccccCCCeEEEeecccccccCCc
Q 003438 246 LCTSVKPAEIKIIDFGSACTEDRT 269 (820)
Q Consensus 246 l~~~~~~~~iKL~DFGlA~~~~~~ 269 (820)
+. ++.+.||||+.|.....+
T Consensus 200 ~~----~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 200 VH----DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred EE----CCeEEEEECccccccCCC
Confidence 94 678999999999765543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.6e-06 Score=98.18 Aligned_cols=141 Identities=20% Similarity=0.332 Sum_probs=89.0
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------------------------------hhHH------HHH
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------------------------------AYYQ------QAL 153 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-----------------------------------~~~~------~~~ 153 (820)
+.|+.++-|+||+|+.+. |+.||||+.+..- ...+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999998654 9999999974210 0011 123
Q ss_pred HHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHH-----HHHHHHHHHHHhh
Q 003438 154 VEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSI-----VQLFSKQILRGLS 227 (820)
Q Consensus 154 ~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~-----i~~I~~QIl~aL~ 227 (820)
+|..-+.+++..+. +.++|.-..=+++....-+|+|||++| .+.++..... .+++... +..++.|++
T Consensus 210 ~EA~n~~~~~~nf~--~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~---- 282 (517)
T COG0661 210 REAANAERFRENFK--DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL---- 282 (517)
T ss_pred HHHHHHHHHHHHcC--CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH----
Confidence 34445555544432 333333222223334677899999998 5555532222 3355333 333333333
Q ss_pred hcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc
Q 003438 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269 (820)
Q Consensus 228 yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~ 269 (820)
..|++|+|.+|.||++. .++++.+.|||+....+..
T Consensus 283 ---~dgffHaDpHpGNi~v~---~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 ---RDGFFHADPHPGNILVR---SDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---hcCccccCCCccceEEe---cCCcEEEEcCcceecCCHH
Confidence 38999999999999996 6689999999998665543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.7e-05 Score=82.80 Aligned_cols=137 Identities=15% Similarity=0.179 Sum_probs=89.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHH----------HHHHHHHHHHHhhhcCCCCCCceeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ----------ALVEVSILTTLNKKYDREDKHHIVRI 177 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~----------~~~Ei~iL~~L~~~~~~~~HpnIVkl 177 (820)
..+|++++++-......|.+. ..+++.+++|..+......++ ..+++..+..+... +...+..+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~----g~~~~~~~ 103 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNE----GFTEPADP 103 (229)
T ss_pred hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHc----Cccccccc
Confidence 378999999998888888776 345678999998754322222 22334444444321 22233332
Q ss_pred eEE-----EeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 178 YEY-----FVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 178 ~d~-----f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
+-+ +......+|||||++| .|.++.. +++ .+...|.++|.-||+.|++|+|.+|.|++++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~---- 169 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS---- 169 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----
Confidence 222 2223456799999998 4544422 232 2445677889999999999999999999995
Q ss_pred CCeEEEeeccccc
Q 003438 252 PAEIKIIDFGSAC 264 (820)
Q Consensus 252 ~~~iKL~DFGlA~ 264 (820)
++.++++||+..+
T Consensus 170 ~~~i~iID~~~k~ 182 (229)
T PF06176_consen 170 NNGIRIIDTQGKR 182 (229)
T ss_pred CCcEEEEECcccc
Confidence 4559999997754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.2e-05 Score=89.49 Aligned_cols=190 Identities=13% Similarity=0.203 Sum_probs=126.5
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe------ec-c
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV------CQ-R 185 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~------~~-~ 185 (820)
....||+|+-+.+|-.-... ..+-|++.....-.+.- .+..|.. ..+||-+-.-+.+-. .. .
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq--k~a~la~------~p~~p~~~~rvaWPqa~L~G~~~~~ 83 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ--KVAELAA------TPDAPLLNYRVAWPQATLHGGRRGK 83 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHHHH--HHHHhcc------CCCCcchhhhhcccHHHhhCCCccc
Confidence 34679999999999763222 23458876543222211 1112211 234553332111111 11 2
Q ss_pred eeEEEEeccCC--ChHHHHHh----hhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 HLCICFELLDS--NLYELIKI----NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ~l~LVmEy~~g--sL~d~l~~----~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.+-+.|+.+.| ...+++.- +.+....+..+.++.+.|+.+.+.||..|.+-+|+.++|||+. +...+.|+|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEc
Confidence 36678888875 44444432 2233478899999999999999999999999999999999996 678899988
Q ss_pred ccccc--ccCCccccccccccccCccccc-----cccccccchhHhHHHHHHHHHhC-CCCCCCC
Q 003438 260 FGSAC--TEDRTVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLG-LPLFPGA 316 (820)
Q Consensus 260 FGlA~--~~~~~~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG-~~PF~~~ 316 (820)
-..-. ..+......+|...|.+||.-. +..-+...|.|-||+++++|+.| +.||.+.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 54321 2233344567899999999865 33556789999999999999986 9999764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.2e-05 Score=78.46 Aligned_cols=76 Identities=12% Similarity=0.137 Sum_probs=54.7
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee---cceeEEE
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---QRHLCIC 190 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---~~~l~LV 190 (820)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.|... . ..+.+++..... ....+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~----~-~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEH----G-IPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHT----T-SBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhc----C-CCCceEEeecccccccccceEE
Confidence 4689999999999997655 47899998755 4567788899999999753 1 135566654433 3357999
Q ss_pred EeccCCC
Q 003438 191 FELLDSN 197 (820)
Q Consensus 191 mEy~~gs 197 (820)
|+++.|.
T Consensus 74 ~~~i~g~ 80 (239)
T PF01636_consen 74 MEYIPGR 80 (239)
T ss_dssp EEEESSE
T ss_pred EEEeccc
Confidence 9999873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.05 E-value=5e-05 Score=79.92 Aligned_cols=73 Identities=11% Similarity=0.018 Sum_probs=54.1
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEecc
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL 194 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~ 194 (820)
..||+|..+.||+.. +..+++|+..... ......+|.++++.+... .-.+.+++.+....+...+|||++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~-----glpvP~~~~~~~~~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-DKETIKREFDASRKVFSL-----GIPTPHPFDLVEDGGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHc-----CCCCCceEEEEecCCeeeeeeeec
Confidence 578999999999842 4457789887533 334568899999999642 123567778777777889999999
Q ss_pred CCC
Q 003438 195 DSN 197 (820)
Q Consensus 195 ~gs 197 (820)
+|.
T Consensus 77 ~G~ 79 (226)
T TIGR02172 77 VGK 79 (226)
T ss_pred CCc
Confidence 883
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.03 E-value=6.2e-05 Score=77.74 Aligned_cols=134 Identities=22% Similarity=0.301 Sum_probs=99.3
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----------------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----------------AYYQQALVEVSILTTLNKKYDREDKHHIVRI 177 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-----------------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl 177 (820)
..||+|+.-.||.- .. .....||++.... ...++..+|+.....+.. .....+.+|.++
T Consensus 7 ~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~-~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSL-RRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhh-ccCCcccccccE
Confidence 46899999999975 32 3346789987544 335677888888888863 234467899999
Q ss_pred eEEEeecceeEEEEeccC---C----ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc
Q 003438 178 YEYFVCQRHLCICFELLD---S----NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV 250 (820)
Q Consensus 178 ~d~f~~~~~l~LVmEy~~---g----sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~ 250 (820)
+++.+.+..+-+|+|.+. | +|.++++.. .+++ .++..+ -+-.+||-+.+|+.+||+|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 999999999999999863 3 677887544 3555 444444 3445677888999999999999998765
Q ss_pred CCC-eEEEee
Q 003438 251 KPA-EIKIID 259 (820)
Q Consensus 251 ~~~-~iKL~D 259 (820)
... .+.|+|
T Consensus 156 ~~~~~lvlID 165 (199)
T PF10707_consen 156 SGEFRLVLID 165 (199)
T ss_pred CCceEEEEEe
Confidence 555 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.2e-05 Score=77.18 Aligned_cols=127 Identities=24% Similarity=0.352 Sum_probs=93.7
Q ss_pred CceEEEEEeccCCc-eeEEEeeccCCCeEEEEEEEeC---------------Ch-------hhHHHHHHHHHHHHHHhhh
Q 003438 109 RRYIVKDLLGHGTF-GQVAKCWDAEMNSFVAVKIIKN---------------QP-------AYYQQALVEVSILTTLNKK 165 (820)
Q Consensus 109 ~rY~i~~~LG~G~f-G~Vyka~d~~tg~~VAIKiik~---------------~~-------~~~~~~~~Ei~iL~~L~~~ 165 (820)
..++.++.||.|.- |.||+++ -.|+.+|||+++. .. .+..-+..|.+..-+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68899999999999 9999995 4577999999431 00 2234567788888888654
Q ss_pred cCCCCCCce--eEEeEEEeecc------------------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHH
Q 003438 166 YDREDKHHI--VRIYEYFVCQR------------------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225 (820)
Q Consensus 166 ~~~~~HpnI--Vkl~d~f~~~~------------------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~a 225 (820)
++.++ |++++++.-.. ...||.||+...- .+... -+.+|++-
T Consensus 115 ----~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~d 176 (207)
T PF13095_consen 115 ----GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRD 176 (207)
T ss_pred ----cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHH
Confidence 55567 99999885331 2367888876432 12222 34567778
Q ss_pred hhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 226 L~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
|..+|..||+-+|+|+.|..=. ||+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCccccccCC--------EEEecccC
Confidence 8889999999999999998743 99999975
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.93 E-value=7.4e-05 Score=78.74 Aligned_cols=72 Identities=15% Similarity=0.055 Sum_probs=51.6
Q ss_pred EeccCCc-eeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEecc
Q 003438 116 LLGHGTF-GQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL 194 (820)
Q Consensus 116 ~LG~G~f-G~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~ 194 (820)
.|-.|.. ..||++... +..++||+..... .....+|+++++.+.. +--+.+++.+....+..++|||++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~------~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAG------KLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHh------cCCCCeEEEEEecCCccEEEEEee
Confidence 3455555 789999653 3678889887543 3456789999999863 234667788777667789999999
Q ss_pred CCC
Q 003438 195 DSN 197 (820)
Q Consensus 195 ~gs 197 (820)
.|.
T Consensus 75 ~G~ 77 (244)
T cd05150 75 PGV 77 (244)
T ss_pred CCc
Confidence 873
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=3.3e-05 Score=90.16 Aligned_cols=148 Identities=17% Similarity=0.195 Sum_probs=87.0
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCC--------------------------------hhhHHHHHHHHHHHHH-
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--------------------------------PAYYQQALVEVSILTT- 161 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--------------------------------~~~~~~~~~Ei~iL~~- 161 (820)
+.||.-+.++|++|+.+. |+.||||+-+.. +...+.+..|+..+++
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999998766 999999996421 0011112223322222
Q ss_pred -----HhhhcCCCC---CCceeEEeEEEeecceeEEEEeccCC---ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc
Q 003438 162 -----LNKKYDRED---KHHIVRIYEYFVCQRHLCICFELLDS---NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK 230 (820)
Q Consensus 162 -----L~~~~~~~~---HpnIVkl~d~f~~~~~l~LVmEy~~g---sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH 230 (820)
+++.+.... --.|.+++-. ....-+|+||||+| +-.+.|+.. +++...+..-+.++..-+ |=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~q--If 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQ--IF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHH--HH
Confidence 222111111 0113333322 22467999999997 333455544 366554443333322211 22
Q ss_pred cCCeeeccCCCCCcccccc-cCCCeEEEeecccccccCCcc
Q 003438 231 DAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTEDRTV 270 (820)
Q Consensus 231 s~gIVHrDLKPeNILl~~~-~~~~~iKL~DFGlA~~~~~~~ 270 (820)
..|++|+|-+|.||++..+ ..+..+.|-|||+........
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 4689999999999999743 246889999999987665543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00048 Score=85.11 Aligned_cols=150 Identities=17% Similarity=0.249 Sum_probs=100.4
Q ss_pred HHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee----EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhh
Q 003438 153 LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL----CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227 (820)
Q Consensus 153 ~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l----~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~ 227 (820)
..|+..+..+ .|+|++.++.+-..+... .+..|+|.. ++...+... ..++...++.+..++++||.
T Consensus 230 E~e~~~l~k~-------~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 230 EIELESLSKI-------AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHhh-------ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHH
Confidence 3355555555 588999999887765332 233455654 566555543 35889999999999999999
Q ss_pred hcccCCeeeccCCCCCcccccccCCCeEEEe--ecccccccCCcc--ccccccccccCccccccccccc--cchhHhHHH
Q 003438 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKII--DFGSACTEDRTV--YSYIQSRYYRSPEVLLGYQYTT--AIDMWSFGC 301 (820)
Q Consensus 228 yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~--DFGlA~~~~~~~--~~~~gt~~Y~APEvl~~~~yt~--ksDIWSLG~ 301 (820)
|+|+..+.|.-|...-..-...+..+.+.+. ||+......... .....+..+.++|......++. ..|+|.+|.
T Consensus 301 ~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 301 YLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred HHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 9999866665554442222222345556666 888876554332 2234466688899887776655 479999999
Q ss_pred HHHHHHhCCC
Q 003438 302 IVAELFLGLP 311 (820)
Q Consensus 302 ILyeLltG~~ 311 (820)
.+..+..|..
T Consensus 381 l~~~~~~~~~ 390 (1351)
T KOG1035|consen 381 LLLQLSQGED 390 (1351)
T ss_pred HHhhhhhcCc
Confidence 9988887653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00028 Score=87.69 Aligned_cols=80 Identities=11% Similarity=0.065 Sum_probs=54.7
Q ss_pred EEEeccCCceeEEEeeccCCC--eEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---ce
Q 003438 114 KDLLGHGTFGQVAKCWDAEMN--SFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---RH 186 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg--~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~~ 186 (820)
++.|+.|.+..+|+......+ ..+++|+..... .....+.+|+++|+.|... ..-.+.+++.++.+. +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~----~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEH----TDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhc----CCCCCCcEEEEecCCCcCCC
Confidence 577899999999998654332 457777764321 2234677899999999521 122357777777654 46
Q ss_pred eEEEEeccCCC
Q 003438 187 LCICFELLDSN 197 (820)
Q Consensus 187 l~LVmEy~~gs 197 (820)
.|+|||+++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 78999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00097 Score=69.68 Aligned_cols=73 Identities=18% Similarity=0.220 Sum_probs=48.2
Q ss_pred EEEeccCCceeEEEeeccC-CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 114 KDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~-tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
++.|..|-...||++.... .++.|++|+............+|+.+++.+... .-+++++..+. -.+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~------gl~P~v~~~~~----~~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKH------GLAPKLYATFQ----NGLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhC------CCCCeEEEEeC----CcEEEE
Confidence 4678888889999996543 356788998765432223345799999998642 22455554433 247999
Q ss_pred ccCC
Q 003438 193 LLDS 196 (820)
Q Consensus 193 y~~g 196 (820)
|++|
T Consensus 73 ~i~G 76 (235)
T cd05157 73 FIPG 76 (235)
T ss_pred eeCC
Confidence 9876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00057 Score=71.84 Aligned_cols=72 Identities=11% Similarity=0.011 Sum_probs=44.1
Q ss_pred EEeccCCce-eEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---ceeEEE
Q 003438 115 DLLGHGTFG-QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---RHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG-~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~~l~LV 190 (820)
+.|+.|+.. .||++. ..+++|+.+.. .......+|.++|+.|.... .. -+.++++..... ...++|
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~-~v---~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHL-PL---PVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc-chHHHHHHHHHHHHHHhccC-CC---CCCceeecCCCccCCCcceEE
Confidence 567767666 599862 24677876643 23457888999999986420 11 233444433322 245889
Q ss_pred EeccCC
Q 003438 191 FELLDS 196 (820)
Q Consensus 191 mEy~~g 196 (820)
|++++|
T Consensus 73 ~~~i~G 78 (235)
T cd05155 73 YRWLEG 78 (235)
T ss_pred EEeecC
Confidence 999876
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0021 Score=73.27 Aligned_cols=77 Identities=22% Similarity=0.255 Sum_probs=55.7
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeC------C--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN------Q--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~------~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.+.||.|.+..||++.+...++.|+||.-.. . ....++...|.+.|+.+... .-.++++++.+ +.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~----~p~~VPkV~~~--D~~ 104 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKY----VPDLVPKVYHY--DEE 104 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhh----CCCCCCeEEEE--CCC
Confidence 3679999999999998865446899998431 1 22456777899999988642 22357777776 345
Q ss_pred eeEEEEeccCC
Q 003438 186 HLCICFELLDS 196 (820)
Q Consensus 186 ~l~LVmEy~~g 196 (820)
..++|||++++
T Consensus 105 ~~~lVME~L~~ 115 (401)
T PRK09550 105 LAVTVMEDLSD 115 (401)
T ss_pred CCEEEEecCCC
Confidence 67899999874
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00056 Score=69.00 Aligned_cols=131 Identities=26% Similarity=0.232 Sum_probs=88.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
..-++.+.|++|.++.||++.. .+..+|+|+-+.+ .....+..|.++|+.++-. ---.+++.+ +..+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~------~~~p~vy~y----g~~~ 88 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD-SPRRNLEKEAKILEILAGE------GVTPEVYFY----GEDF 88 (201)
T ss_pred hhhhhhhhhhcccccEEEEeec--cCceEEEEEecCC-cchhhHHHHHHHHHHhhhc------CCCceEEEe----chhh
Confidence 4445667899999999999965 4568999987654 3456788899999998542 123344444 3345
Q ss_pred EEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCC-CC-CcccccccCCCeEEEeecccccc
Q 003438 189 ICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLK-PE-NILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 189 LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLK-Pe-NILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++|||+.| .|.+.-... + ++-+..+++.-.-|-..||-|..|. |. ||++ .+..+.|+||..|..
T Consensus 89 i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 66999998 665543321 1 2334456666556677899999886 44 5555 345899999999963
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0018 Score=70.11 Aligned_cols=140 Identities=15% Similarity=0.109 Sum_probs=81.1
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE------EEeeccee
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE------YFVCQRHL 187 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d------~f~~~~~l 187 (820)
++.|..|....+|++.. .+..+++|+... ........|+++++.|... +. .+.+++. +....+..
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~----g~-~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAER----GL-PVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHC----CC-CCCccccCCCCcEeeeeCCce
Confidence 56777888889999853 334688898875 2345677799999998653 21 2444433 22334567
Q ss_pred EEEEeccCCChH------------HHHHh-hh-cCCC----------CHHH--HH--------HHHHHHHHHhhhccc--
Q 003438 188 CICFELLDSNLY------------ELIKI-NH-FRGL----------SLSI--VQ--------LFSKQILRGLSLLKD-- 231 (820)
Q Consensus 188 ~LVmEy~~gsL~------------d~l~~-~~-~~~l----------~e~~--i~--------~I~~QIl~aL~yLHs-- 231 (820)
++|+++++|... ..+.. +. ...+ .+.. .. .....+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 899999986221 01100 00 0000 0000 00 011112233334332
Q ss_pred -----CCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 232 -----AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 232 -----~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.++||+|+.|.|||++ ++..+.|+||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence 4799999999999996 445568999998854
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.005 Score=67.59 Aligned_cols=78 Identities=5% Similarity=-0.086 Sum_probs=47.0
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe---EEEeecceeEEE
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY---EYFVCQRHLCIC 190 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~---d~f~~~~~l~LV 190 (820)
++.|..|....+|++... ++ .+++|++.. ...+....|+.+++.|... ....|.+++-. .+....+..++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~--glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAAR--GVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHC--CCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 345777888899998643 33 588898862 2234555678888888643 11233333211 122335678999
Q ss_pred EeccCCC
Q 003438 191 FELLDSN 197 (820)
Q Consensus 191 mEy~~gs 197 (820)
+|+++|.
T Consensus 101 ~~~l~G~ 107 (319)
T PRK05231 101 VTFLEGK 107 (319)
T ss_pred EEecCCC
Confidence 9999863
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.002 Score=70.20 Aligned_cols=73 Identities=14% Similarity=0.110 Sum_probs=48.0
Q ss_pred EEEeccCCceeEEEeeccC------CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 114 KDLLGHGTFGQVAKCWDAE------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
++.|..|-...||++.... .++.|++|+............+|.++++.+... --..+++.++..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~------g~~P~~~~~~~~---- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSER------NLGPKLYGIFPN---- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhC------CCCCceEEEeCC----
Confidence 3556677778889886533 257899999876544445667899999999653 123455555432
Q ss_pred EEEEeccCC
Q 003438 188 CICFELLDS 196 (820)
Q Consensus 188 ~LVmEy~~g 196 (820)
.+|+||++|
T Consensus 73 ~~v~e~i~G 81 (302)
T cd05156 73 GRIEEFIPS 81 (302)
T ss_pred CchhheeCC
Confidence 357888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0026 Score=73.10 Aligned_cols=173 Identities=21% Similarity=0.331 Sum_probs=108.2
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhh
Q 003438 150 QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228 (820)
Q Consensus 150 ~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~y 228 (820)
.+++-..++++.+ .|+|...++++-... ....+|||+++.+|++.++..... .. +++
T Consensus 27 ~~ilgr~~~lktl-------~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~---~~-------s~~----- 84 (725)
T KOG1093|consen 27 IQILGRFQYLKSL-------QHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLK---DE-------SLL----- 84 (725)
T ss_pred HHHhhhhHHHHhh-------cCccceeeEeeecCccceEEEEehhhccchHHHHHhcccc---hh-------hhc-----
Confidence 4455566777777 688999988876643 458899999999999988765411 11 111
Q ss_pred cccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHh
Q 003438 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308 (820)
Q Consensus 229 LHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt 308 (820)
.+++.| -||+ +++| .++... |- ...+|+|||++|.|+.++..
T Consensus 85 --~~~~~~-----~~~~----------~~td-~~~t~~---------------~~-----~~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 85 --AHGVLH-----LNII----------YITD-HFLTKY---------------PS-----PIGPKSDVWSLGFIILELYL 126 (725)
T ss_pred --ccccce-----ehhh----------hccc-cccccC---------------CC-----CCCcchhhhhHHHHHHHHHH
Confidence 122222 2222 2333 111000 10 11149999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCC
Q 003438 309 GLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLI 388 (820)
Q Consensus 309 G~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~ 388 (820)
|...+......+.+..+.+..- .+.+...-
T Consensus 127 ~~~l~~~~~~s~~l~~i~k~~~-~d~~~~~~------------------------------------------------- 156 (725)
T KOG1093|consen 127 GISLEAELTESEYLEILLKYYT-DDQELLST------------------------------------------------- 156 (725)
T ss_pred hhHHHHHHHHHHHHHHHHHhcc-CchhHHHH-------------------------------------------------
Confidence 9988876666666665554332 11000000
Q ss_pred CccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 389 GKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 389 ~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..+. ...-.++..+++++.+|+-..|..|+...++++|+-|.+.
T Consensus 157 -----------------------a~e~-~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 157 -----------------------AMEH-LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred -----------------------HHHH-HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 0000 0111245678999999999999999999999999999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.004 Score=69.24 Aligned_cols=139 Identities=22% Similarity=0.242 Sum_probs=95.2
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---------------------------hhhHHHHHHHHHHHHHHhhh
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---------------------------PAYYQQALVEVSILTTLNKK 165 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---------------------------~~~~~~~~~Ei~iL~~L~~~ 165 (820)
|..+|..|--+.||.|.. .+|..+||||++.. ......+..|+.=|++|+..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456788899999999964 56777999998621 01112345677778888654
Q ss_pred cCCCCCCceeEEeEEEeecceeEEEEeccCCChH--HHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc-cCCeeeccCCCC
Q 003438 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLY--ELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPE 242 (820)
Q Consensus 166 ~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~--d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPe 242 (820)
- ..+|--+-| ...+|||++++.+-. -.|+.. .++...+..+-.|++.-+.-|- .+++||.||.--
T Consensus 227 G--IP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEf 294 (520)
T KOG2270|consen 227 G--IPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEF 294 (520)
T ss_pred C--CCCCCceee-------ecceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHHHhceeccchhhh
Confidence 1 122222212 235789999984322 223222 3777778888888888777775 679999999999
Q ss_pred CcccccccCCCeEEEeecccccccCC
Q 003438 243 NILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 243 NILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
|+|+ ..+.+.|+|-+.+...+.
T Consensus 295 N~Ly----hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 295 NLLY----HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred hheE----ECCEEEEEEccccccCCC
Confidence 9999 578999999998865544
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0019 Score=68.76 Aligned_cols=133 Identities=15% Similarity=0.109 Sum_probs=73.0
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCChhhH-HHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccC
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY-QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD 195 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~-~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~ 195 (820)
+..|-...+|++. .+++.+++|+........ -...+|..+++.+... + -..+++.... -++||||++
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~----g--~~P~~i~~~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSAL----G--LAPKPILVNE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhc----C--CCCceEEEeC----CEEEEEecc
Confidence 5567788899885 446678889865432221 2346799999999642 1 1233333322 368999998
Q ss_pred CChH---------------HHHHhhh-c----CCCCH-HHHHHHHH------------HHHHHhhhcc-----cCCeeec
Q 003438 196 SNLY---------------ELIKINH-F----RGLSL-SIVQLFSK------------QILRGLSLLK-----DAGIIHC 237 (820)
Q Consensus 196 gsL~---------------d~l~~~~-~----~~l~e-~~i~~I~~------------QIl~aL~yLH-----s~gIVHr 237 (820)
|... +.+.+-. . ..++. ..+..+.. +++..+.... ...++|+
T Consensus 72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~ 151 (256)
T TIGR02721 72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM 151 (256)
T ss_pred CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence 6211 1111111 0 11111 11112111 1122221111 2358999
Q ss_pred cCCCCCcccccccCCCeEEEeecccccc
Q 003438 238 DLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 238 DLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
|+.|.||+++ +++ ++|+||..|..
T Consensus 152 Dl~~~Nil~~---~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 152 DVHAYNLVVT---PQG-LKLIDWEYASD 175 (256)
T ss_pred CCCcCcEEEe---CCC-CEEEeccccCc
Confidence 9999999996 233 78999998743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.00078 Score=73.58 Aligned_cols=136 Identities=18% Similarity=0.285 Sum_probs=95.1
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----------Chhh-------------HHHHHHHHHHHHHHhhhc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----------QPAY-------------YQQALVEVSILTTLNKKY 166 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----------~~~~-------------~~~~~~Ei~iL~~L~~~~ 166 (820)
-+.+.+.||-|--+.||.+-+. .|+..++|+-+. +..+ .-.+.+|...|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~- 170 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER- 170 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc-
Confidence 4667889999999999999764 467788887431 1111 12346788888888542
Q ss_pred CCCCCCceeEEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcc
Q 003438 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL 245 (820)
Q Consensus 167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL 245 (820)
.--|.+.+++ +..|+|||++.| .|..+.... .+..+...|+.-+.-|-.+|+||+|..-=||+
T Consensus 171 ----gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 171 ----GFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIM 234 (465)
T ss_pred ----CCCCCCcccc----cceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHHcCceecccchheeE
Confidence 1235555554 457899999986 555433221 24455666667777888999999999999999
Q ss_pred cccccCCCeEEEeeccccccc
Q 003438 246 LCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 246 l~~~~~~~~iKL~DFGlA~~~ 266 (820)
+. ++..++++||-.....
T Consensus 235 v~---dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 235 VK---DDDKIVVIDFPQMVST 252 (465)
T ss_pred Ee---cCCCEEEeechHhhcc
Confidence 96 5778999999876443
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.019 Score=62.98 Aligned_cols=142 Identities=15% Similarity=0.153 Sum_probs=79.6
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE------Eeecce
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY------FVCQRH 186 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~------f~~~~~ 186 (820)
.++.|+.|....||++.. .++ .+++|+..... .......|++++..|... +- .+.+++.. ....+.
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~----g~-pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAAR----GL-PVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHC----CC-CCCccccCCCCCeehhcCCe
Confidence 456677888889999853 334 57789876432 134556788888888543 11 23343331 123456
Q ss_pred eEEEEeccCCCh-----HH-------HHHh-hh-cCCC--------CHHH-----HH----------HHHHHHHHHhhhc
Q 003438 187 LCICFELLDSNL-----YE-------LIKI-NH-FRGL--------SLSI-----VQ----------LFSKQILRGLSLL 229 (820)
Q Consensus 187 l~LVmEy~~gsL-----~d-------~l~~-~~-~~~l--------~e~~-----i~----------~I~~QIl~aL~yL 229 (820)
.++||||++|.- .+ .+.. +. ...+ .... .. .....+.+.++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 789999987621 11 1110 00 0001 0000 00 0011122344444
Q ss_pred c-------cCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 230 K-------DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 230 H-------s~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
. ..++||+|+++.||+++ .++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEE---CCceEEEeecccccC
Confidence 3 36899999999999996 344568999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0095 Score=66.71 Aligned_cols=139 Identities=18% Similarity=0.139 Sum_probs=77.2
Q ss_pred EEeccCCceeEEEeeccC----CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEE
Q 003438 115 DLLGHGTFGQVAKCWDAE----MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCIC 190 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~----tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LV 190 (820)
+.|-.|-...+|++.... .++.|++|+........-...+|+.+++.+... .--.++++.+... .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~------gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRH------GQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHc------CCCCceEEEECCc----eE
Confidence 455557788888875322 346789998875433222346799999998643 1233445555322 47
Q ss_pred EeccCC-ChH-----------H---HHHh-hhcC------CCCHHHHHHHHHHHH--------------------HHh--
Q 003438 191 FELLDS-NLY-----------E---LIKI-NHFR------GLSLSIVQLFSKQIL--------------------RGL-- 226 (820)
Q Consensus 191 mEy~~g-sL~-----------d---~l~~-~~~~------~l~e~~i~~I~~QIl--------------------~aL-- 226 (820)
.||+++ .|. . .+++ +... ......+..++.++. ..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 888765 221 0 0110 0000 011223333332211 111
Q ss_pred --hh-cccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 227 --SL-LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 227 --~y-LHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.. .+...++|+|+++.|||++ ..++.++|+||..|..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence 11 2234699999999999996 2346799999988853
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.011 Score=65.66 Aligned_cols=72 Identities=13% Similarity=0.148 Sum_probs=43.1
Q ss_pred EEeccCCceeEEEeeccCC---CeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
+.|..|-...+|++..... ...|++|+........-...+|..+++.+... .--.+++.++. .+ +|.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~------gl~P~~l~~~~-~G---~i~ 89 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAA------GFGAKLLGVFG-NG---MIQ 89 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhc------CCCCceeEEeC-Cc---Eee
Confidence 4455577788888854322 33788998865433233345799999998643 11234555553 22 477
Q ss_pred eccCC
Q 003438 192 ELLDS 196 (820)
Q Consensus 192 Ey~~g 196 (820)
+|+.+
T Consensus 90 ~fi~g 94 (330)
T PLN02421 90 SFINA 94 (330)
T ss_pred hhhcC
Confidence 77764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0051 Score=63.06 Aligned_cols=101 Identities=20% Similarity=0.287 Sum_probs=75.5
Q ss_pred HHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccCC-ChHHHHH-hhhcCCCCHHHHHHHHHHHHHHhhhccc
Q 003438 154 VEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKD 231 (820)
Q Consensus 154 ~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~-~~~~~~l~e~~i~~I~~QIl~aL~yLHs 231 (820)
.|.-+|+.+.. .+++++++++|- .++|.||+.. .+..... .......++..+.+|+.++++.+.+|+.
T Consensus 8 ~E~lll~~l~~------~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 8 NEPLLLQLLQG------SEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred cHHHHHHHcCC------CCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 47888888853 249999999883 3568899883 4432100 0011236899999999999999999997
Q ss_pred ---CCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 232 ---AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 232 ---~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
..+.-+|++++|+.++ +++++|++|...+...+
T Consensus 78 ~~~~~~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVN---DDGRLKLIDLDDVFVED 113 (188)
T ss_pred CCCCcEEEeecchHHeEEe---CCCcEEEEechhcchhH
Confidence 4588899999999996 66889999998875443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.031 Score=62.85 Aligned_cols=73 Identities=22% Similarity=0.261 Sum_probs=50.4
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEe----C---C-hhhHHHHHHHHHHHHHHhhhcCCCCCC-ceeEEeEEEeecce
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----N---Q-PAYYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQRH 186 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik----~---~-~~~~~~~~~Ei~iL~~L~~~~~~~~Hp-nIVkl~d~f~~~~~ 186 (820)
.||-|....||++.+...++-|+||.-. . . +...++...|..+|+.+... .| .+++++.+ +.+.
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~-----~P~~vP~vy~~--D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH-----VPHLVPRIFHF--DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc-----CccccCeEEEE--cccc
Confidence 4799999999999876444679999853 1 1 33455667899999887542 23 45555543 4456
Q ss_pred eEEEEeccC
Q 003438 187 LCICFELLD 195 (820)
Q Consensus 187 l~LVmEy~~ 195 (820)
..+|||++.
T Consensus 75 ~~~vMEdL~ 83 (370)
T TIGR01767 75 AVTVMEDLS 83 (370)
T ss_pred ceehHhhCc
Confidence 679999985
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.068 Score=60.90 Aligned_cols=75 Identities=20% Similarity=0.279 Sum_probs=53.4
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEe----C--C-hhhHHHHHHHHHHHHHHhhhcCCCCCC-ceeEEeEEEeecc
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----N--Q-PAYYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQR 185 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik----~--~-~~~~~~~~~Ei~iL~~L~~~~~~~~Hp-nIVkl~d~f~~~~ 185 (820)
.+.||-|.-..||++.+...++-|+||.-. . + +...++...|.++|+.+... .| ++++++.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~-----~P~~VP~vy~~--D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEEL-----APGLVPKVYLF--DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhh-----CCCcCCeEEEE--CcH
Confidence 577899999999999875445678998753 1 1 34456778899999988653 23 46666553 445
Q ss_pred eeEEEEeccC
Q 003438 186 HLCICFELLD 195 (820)
Q Consensus 186 ~l~LVmEy~~ 195 (820)
...+|||++.
T Consensus 107 ~~~~vMEdL~ 116 (409)
T PRK12396 107 MNCCVMEDLS 116 (409)
T ss_pred HhhHHHHhCc
Confidence 6778999985
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.15 Score=55.48 Aligned_cols=29 Identities=38% Similarity=0.528 Sum_probs=24.7
Q ss_pred CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 232 ~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.++||+|+++.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 5799999999999995 2 568999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.058 Score=58.60 Aligned_cols=47 Identities=21% Similarity=0.098 Sum_probs=31.0
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhh
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~ 164 (820)
..++|-...|+.+.+ ..|+.+++|.-+.. .......+|.++|+.|..
T Consensus 18 ~~~~g~~~~v~~i~~-~~g~~~VlR~p~~~-~~~~~l~rE~~vL~~L~~ 64 (276)
T cd05152 18 LNESGLDFQVVFAKD-TDGVPWVLRIPRRP-DVSERAAAEKRVLALVRK 64 (276)
T ss_pred ecCCcceeEEEEEEc-CCCCeEEEEecCCH-HHHHHHHHHHHHHHHHHh
Confidence 345555566776632 34667888877533 334567899999999964
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.0038 Score=79.05 Aligned_cols=141 Identities=13% Similarity=-0.029 Sum_probs=104.9
Q ss_pred CCCceeEEeEEEee--cceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccC-----CeeeccC
Q 003438 170 DKHHIVRIYEYFVC--QRHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDA-----GIIHCDL 239 (820)
Q Consensus 170 ~HpnIVkl~d~f~~--~~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~-----gIVHrDL 239 (820)
.|+++.....-... ....+++++++. |.+.+.|.+.- ...+.+.-+.....+.+.+..-+|+. -.+|++|
T Consensus 1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~L 1366 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSL 1366 (2724)
T ss_pred hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhh
Confidence 57777765554432 346789999997 78888876543 22345555555555657777777754 2789999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
|+-|.+|. .+..+|+.++|+.+..... .....+++.|+++++.....++.++|||..+|.+|++..|..+|
T Consensus 1367 kf~lpmIV---tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1367 KFTLPMIV---TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhcccee---cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999995 6678999999999833221 23456788899999998889999999999999999988887666
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.024 Score=58.55 Aligned_cols=31 Identities=45% Similarity=0.598 Sum_probs=20.6
Q ss_pred CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 232 ~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.-++|.||.+.|||+. ...+.++|+||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILIN--NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence 3589999999999993 367889999999884
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.19 Score=55.81 Aligned_cols=70 Identities=17% Similarity=0.025 Sum_probs=43.6
Q ss_pred CceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe---E--EEeecceeEEEEeccC
Q 003438 121 TFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY---E--YFVCQRHLCICFELLD 195 (820)
Q Consensus 121 ~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~---d--~f~~~~~l~LVmEy~~ 195 (820)
.-..||++.. .++..+++|+.+........+..|++++..|... +-| |+... + +...++..+.|+++++
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~----gip-v~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA----EIP-VVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC----CCC-CCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 3456888754 3456799999864443456677899999888653 222 22211 1 2233567788999987
Q ss_pred C
Q 003438 196 S 196 (820)
Q Consensus 196 g 196 (820)
|
T Consensus 111 G 111 (325)
T PRK11768 111 G 111 (325)
T ss_pred C
Confidence 5
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.078 Score=58.18 Aligned_cols=106 Identities=11% Similarity=0.093 Sum_probs=73.7
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee---cceeEE
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---QRHLCI 189 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---~~~l~L 189 (820)
-.+.||.|..+.||+..... + .+++|..+.. .....+..|...|+.|... .--.|.++++++.. .+..+|
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~-~~~~~~~~Ea~~L~~L~~~----~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARSF-STPGVAQQEAWKLSMLARS----GTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEeccc-ccchHHHHHHHHHHHHccC----CCCCcCcEEEEeccCCcCCCeEE
Confidence 45679999999999985432 3 4677875531 1235788899999999642 12357778877654 366899
Q ss_pred EEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC
Q 003438 190 CFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232 (820)
Q Consensus 190 VmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~ 232 (820)
|||+++| .+.+. .........+..+++++|+-||+.
T Consensus 91 VmE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 91 LLERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9999987 34331 123445667778889999999975
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.14 Score=56.12 Aligned_cols=76 Identities=11% Similarity=0.061 Sum_probs=51.5
Q ss_pred EEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEE
Q 003438 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICF 191 (820)
Q Consensus 112 ~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVm 191 (820)
+-.+.|+.|....+|+.. .+++.+.||+-.. .....+..|.+-|+.|... .--.+++++.+...++..+|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~----~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEA----NPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHT----TTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhc----CCCCCCeEEEEEeecCCceEEE
Confidence 345678889999999986 6677899999873 3345677899999999543 3446888999888888889999
Q ss_pred eccC
Q 003438 192 ELLD 195 (820)
Q Consensus 192 Ey~~ 195 (820)
||++
T Consensus 92 e~l~ 95 (288)
T PF03881_consen 92 EFLE 95 (288)
T ss_dssp E---
T ss_pred Eeec
Confidence 9986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.17 Score=58.06 Aligned_cols=76 Identities=14% Similarity=0.146 Sum_probs=52.7
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEe-----CCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik-----~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
..+.||.|....||++.+. +..|+||.-. ... ....+...|...|+.+... ...++.+++.++.
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~----~p~~VPkVy~~de-- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRL----CPDHVPEVYHFDR-- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhc----CCCCCCeEEEECC--
Confidence 3578899999999999763 3458898865 111 2345566678888777532 1236778887766
Q ss_pred ceeEEEEeccCC
Q 003438 185 RHLCICFELLDS 196 (820)
Q Consensus 185 ~~l~LVmEy~~g 196 (820)
+..++|||++++
T Consensus 108 d~~vlvME~L~~ 119 (418)
T PLN02756 108 TMALIGMRYLEP 119 (418)
T ss_pred CCCEEEEeecCC
Confidence 557889999965
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.17 Score=57.57 Aligned_cols=74 Identities=14% Similarity=0.047 Sum_probs=43.3
Q ss_pred EEEEeccCCceeEEEeeccCC-C-----eEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 113 VKDLLGHGTFGQVAKCWDAEM-N-----SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~t-g-----~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++.|..|-...+|++..... + +.|.+++........-.-.+|+++++.|.. +..-.++++.|..
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~------~glgP~l~~~f~~--- 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGD------NNFGPKIIGRFGD--- 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHh------CCCCCeEEEecCC---
Confidence 344565688888998864322 1 225555443222222233568999999864 3344566666642
Q ss_pred eEEEEeccCC
Q 003438 187 LCICFELLDS 196 (820)
Q Consensus 187 l~LVmEy~~g 196 (820)
++|.||++|
T Consensus 125 -g~l~efIeG 133 (383)
T PTZ00384 125 -FTIQEWVEG 133 (383)
T ss_pred -EEEEEEecc
Confidence 588888875
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.21 Score=55.76 Aligned_cols=142 Identities=20% Similarity=0.220 Sum_probs=77.9
Q ss_pred eccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE--Eeecc--eeEEEEe
Q 003438 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY--FVCQR--HLCICFE 192 (820)
Q Consensus 117 LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~--f~~~~--~l~LVmE 192 (820)
|.+ .-..||++.... ++ +++|+.... ....++..|+..|+.|...-...--| |..+-+- ..... +.+-|++
T Consensus 34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhhccCCceeEEEEE
Confidence 444 455788885433 33 389999876 55677788999999997651111112 2222111 11224 7788899
Q ss_pred ccCCChHH------HHH----------h--hhc---C-----CCCHH----HH---------HHHHHHHHHHhhhccc--
Q 003438 193 LLDSNLYE------LIK----------I--NHF---R-----GLSLS----IV---------QLFSKQILRGLSLLKD-- 231 (820)
Q Consensus 193 y~~gsL~d------~l~----------~--~~~---~-----~l~e~----~i---------~~I~~QIl~aL~yLHs-- 231 (820)
|++|.... .+. . ... + ...+. .. .....++...+..+.+
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 98873332 110 0 000 0 01111 00 0122333444444432
Q ss_pred ------CC--eeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 232 ------AG--IIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 232 ------~g--IVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+ |||+|+.|.||+++.+ +..+.++||+-++.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~--~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDD--TDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCC--CCeeeEEEcccccc
Confidence 23 9999999999999622 12589999998853
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.52 Score=60.29 Aligned_cols=148 Identities=19% Similarity=0.163 Sum_probs=78.1
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE-----EEee-cc--e
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE-----YFVC-QR--H 186 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d-----~f~~-~~--~ 186 (820)
+.|+ |..-.+|++.. .+++.+++|+.+... .......|.++|..|.........|.+++-.+ .... ++ +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3453 34567777753 456679999998542 23344557778887764311123444444321 1111 22 5
Q ss_pred eEEEEeccCCC-hHHH-------HH-------h-----hhc------CCCCH-----------------HHHHHHHHHHH
Q 003438 187 LCICFELLDSN-LYEL-------IK-------I-----NHF------RGLSL-----------------SIVQLFSKQIL 223 (820)
Q Consensus 187 l~LVmEy~~gs-L~d~-------l~-------~-----~~~------~~l~e-----------------~~i~~I~~QIl 223 (820)
.+-+|+|++|. +.+. +. + ..+ ..+.| ...+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 67889999873 3220 10 0 000 00111 11222333333
Q ss_pred HHhh-----hcc--cCCeeeccCCCCCcccccccCCCeEE-Eeeccccccc
Q 003438 224 RGLS-----LLK--DAGIIHCDLKPENILLCTSVKPAEIK-IIDFGSACTE 266 (820)
Q Consensus 224 ~aL~-----yLH--s~gIVHrDLKPeNILl~~~~~~~~iK-L~DFGlA~~~ 266 (820)
+.+. .|. ..++||+|+++.|||++.+... ++. |+|||-++..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~-~isGiIDFgDa~~~ 237 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGE-RISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCc-ceEEEEECcccccc
Confidence 3322 121 3579999999999999733222 454 9999998543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.94 E-value=0.42 Score=53.13 Aligned_cols=32 Identities=22% Similarity=0.424 Sum_probs=26.1
Q ss_pred CeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 233 gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
.+||+|+++.||+++ ....+=|+||+++..-+
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEeccccccCC
Confidence 599999999999996 34448999999986443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.53 Score=51.67 Aligned_cols=31 Identities=19% Similarity=0.208 Sum_probs=26.5
Q ss_pred CeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 233 gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||+|+.+.|||++ .++.+.|+||..++..
T Consensus 197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD---ETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEc---CCCCEEEEEhhhcccC
Confidence 799999999999995 5567899999988643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.43 Score=55.39 Aligned_cols=74 Identities=15% Similarity=0.056 Sum_probs=46.6
Q ss_pred EEEEeccCCceeEEEeeccC--------CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 113 VKDLLGHGTFGQVAKCWDAE--------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~--------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
-++.|..|-...+|++.... .++.|.+|+.-......-....|..+++.+... .-.| ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~---gi~P---~l~~~f~-- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKY---RIAP---QLLNTFS-- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHC---CCCC---ceEEEeC--
Confidence 56677778888999986432 246799999875443333456688888888653 1122 4455543
Q ss_pred ceeEEEEeccCC
Q 003438 185 RHLCICFELLDS 196 (820)
Q Consensus 185 ~~l~LVmEy~~g 196 (820)
-+.|.||++|
T Consensus 181 --gg~I~efi~g 190 (442)
T PTZ00296 181 --GGRIEEWLYG 190 (442)
T ss_pred --CCEEEEeeCC
Confidence 2346777764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=92.18 E-value=0.74 Score=48.86 Aligned_cols=73 Identities=14% Similarity=0.117 Sum_probs=50.6
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEecc
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL 194 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~ 194 (820)
+.+.-|.--..|.+.+ ....+.||+-. ......+..|+.=|+.+... +--.|.+++.+-...++.||||||+
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n~--~~~~~~f~AEa~gL~~la~s----~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCNQ--REQLSMFTAEADGLELLARS----NTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEecc--hhhHHHHHHHHHHHHHHHhc----CCccccceEEecCCCCeeEEEEeec
Confidence 4455455455555532 23467888744 33456677888888888653 3457888999999999999999998
Q ss_pred C
Q 003438 195 D 195 (820)
Q Consensus 195 ~ 195 (820)
+
T Consensus 94 ~ 94 (286)
T COG3001 94 P 94 (286)
T ss_pred c
Confidence 6
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.32 E-value=0.42 Score=54.36 Aligned_cols=58 Identities=19% Similarity=0.291 Sum_probs=40.9
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc-cCCeeeccCCCCCcccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLC 247 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~ 247 (820)
..||-+|+.| .+..+++.. ..+++..++++.-...||.-+- -.+++|.|++|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 4566667766 666666644 3666677777776666655443 56899999999999995
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.13 E-value=0.37 Score=53.24 Aligned_cols=139 Identities=14% Similarity=0.178 Sum_probs=88.7
Q ss_pred EEEEeccCCceeEEEeec-------cC---CCeEEEEEEEeCC-------h------------------hhHHHHHHHHH
Q 003438 113 VKDLLGHGTFGQVAKCWD-------AE---MNSFVAVKIIKNQ-------P------------------AYYQQALVEVS 157 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d-------~~---tg~~VAIKiik~~-------~------------------~~~~~~~~Ei~ 157 (820)
|..+|..|--+.|+.|.- .. .-+.+|||+++.. . ...-....|-+
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 445788888888888732 11 1345899997521 0 00111222333
Q ss_pred HHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEeccCCC--hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc-cCCe
Q 003438 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGI 234 (820)
Q Consensus 158 iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gs--L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH-s~gI 234 (820)
+....+.......+|-+|.+.. .+|||-|++.+ -.--++.- .|+..+.+..-.|++.++..|- ++-+
T Consensus 336 mhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~v---~l~d~E~~~aY~q~~~~M~~lY~Ec~L 405 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKNV---ELTDDERRNAYDQVQSIMCRLYKECLL 405 (531)
T ss_pred HHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCcccccc---ccChHHHHHHHHHHHHHHHHHHHhhhe
Confidence 3322222223446777887654 46899999732 22222222 3888888888889998888774 6789
Q ss_pred eeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 235 VHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
||.||.--|||.. .+.+-++|...+..
T Consensus 406 VHADlSEyN~Lw~----~gKvw~IDVsQsve 432 (531)
T KOG2269|consen 406 VHADLSEYNLLWT----PGKVWVIDVSQSVE 432 (531)
T ss_pred eecchhhhhheec----CCceEEEechhccC
Confidence 9999999999994 56899999877643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 820 | ||||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-63 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-62 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-62 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-62 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-62 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-62 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-39 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-39 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 8e-39 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-39 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-38 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-38 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-35 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-35 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-31 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-28 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-28 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-28 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-28 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-28 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-27 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-27 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-27 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-27 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-27 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-27 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-27 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-27 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-27 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-27 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-27 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-27 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-27 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-27 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-27 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-27 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-27 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-27 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-27 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-27 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-27 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-27 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-27 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-27 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-27 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-27 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-27 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-27 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-27 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-27 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-27 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-27 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-27 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-27 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-27 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-26 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-26 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-26 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-26 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-26 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-26 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-26 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-26 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-26 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-26 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-26 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-26 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-26 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-26 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-26 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-26 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-26 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-26 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-26 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-26 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-26 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-26 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-26 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-26 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-26 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-26 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-26 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-26 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-26 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-26 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-26 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-26 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-26 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-26 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-25 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-25 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-25 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-25 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-25 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-25 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-25 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-25 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-25 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-25 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-25 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-25 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-25 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-25 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-25 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-25 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-25 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-25 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-25 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-25 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-25 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-25 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-25 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-25 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-25 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-25 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-25 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-24 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-24 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-24 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-24 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-24 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-24 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-24 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-24 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-24 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-24 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-24 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-24 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-24 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-24 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-24 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-24 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-24 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-24 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-24 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-24 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-24 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-24 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-24 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-24 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-24 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-24 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-24 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-24 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-24 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-24 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-24 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-24 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-24 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-24 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-24 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-24 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-24 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-24 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-24 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-24 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-24 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-24 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-24 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-24 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-24 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-24 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-24 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-24 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-24 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-24 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-24 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-24 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-24 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-24 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-24 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-24 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-24 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-24 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-24 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-24 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-24 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-24 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-24 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-24 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-24 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-24 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-24 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-24 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-24 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-24 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-24 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-24 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-24 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-24 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-24 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-24 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-24 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-23 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-23 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-23 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-23 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-23 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-23 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-23 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-23 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-23 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-23 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-23 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-23 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-23 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-22 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-22 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-22 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-22 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-22 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-22 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-21 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-21 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-20 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-19 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-19 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-19 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-18 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-14 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-14 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-14 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-14 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-14 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-14 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-14 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-14 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-14 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-14 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-14 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-14 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-14 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 7e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 9e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-05 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-05 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-04 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-04 |
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 483 bits (1246), Expect = e-165
Identities = 141/405 (34%), Positives = 207/405 (51%), Gaps = 31/405 (7%)
Query: 55 TYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVK 114
+ V NDGYD+ N D I+ ++ RY +
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMD-----RYEID 59
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
L+G G+FGQV K +D +VA+KIIKN+ A+ QA +EV +L +NK D E K++I
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH-DTEMKYYI 118
Query: 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DA 232
V + +F+ + HLC+ FE+L NLY+L++ +FRG+SL++ + F++Q+ L L +
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT 292
IIHCDLKPENILLC + A IKI+DFGS+C + +Y YIQSR+YRSPEVLLG Y
Sbjct: 179 SIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDL 237
Query: 293 AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIG 352
AIDMWS GCI+ E+ G PLF GA+E D + +++ +LG PP ++L +A KFF+
Sbjct: 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG-IPPAHILDQAPKARKFFEK-- 294
Query: 353 SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412
+ L + + RE K P K +
Sbjct: 295 ------------LPDGTWN-LKKTKDGKREYKPP------GTRKLHNILGVETGGPGGRR 335
Query: 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457
+ L D + ++++DP R P+ A +H F
Sbjct: 336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 484 bits (1248), Expect = e-165
Identities = 146/417 (35%), Positives = 211/417 (50%), Gaps = 35/417 (8%)
Query: 54 ETYQICNPLFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIV 113
E ++I + Y LN K+ G N GYD+ + + + RY V
Sbjct: 48 EHHEIFSYPEIYFLGLNAKKRQGMTG-GPNNGGYDDDQGSYVQVPHDHVAY-----RYEV 101
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHH 173
++G G+FGQV K +D +++ VA+K+++N+ +++QA E+ IL L K D+++ +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRK-QDKDNTMN 160
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
++ + E F + H+C+ FELL NLYELIK N F+G SL +V+ F+ IL+ L L
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTA 293
IIHCDLKPENILL + IK+IDFGS+C E + VY+YIQSR+YR+PEV+LG +Y
Sbjct: 221 IIHCDLKPENILLKQQGRS-GIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMP 279
Query: 294 IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGS 353
IDMWS GCI+AEL G PL PG E D L MI +LG P +L +K F
Sbjct: 280 IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG-MPSQKLLDASKRAKNFVS---- 334
Query: 354 VHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413
G Y +T + + L + + P +
Sbjct: 335 ----------SKGYPRYCTVTTLSDGSVVLNGG---------RSRRGKLRGPPESREWGN 375
Query: 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPR 470
+ +DFLK +E+DPA R +P QA RHP++ P R
Sbjct: 376 ALKGCD---DPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 445 bits (1146), Expect = e-151
Identities = 117/402 (29%), Positives = 178/402 (44%), Gaps = 68/402 (16%)
Query: 88 DNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQP 146
D+ L+ + L RY + LG GTFG+V +C D A S VA+KII+N
Sbjct: 3 DDKEGHLVCRIGDWLQE-----RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG 57
Query: 147 AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINH 206
Y + A +E+++L + + D+E+K V + ++F H+CI FELL N +E +K N+
Sbjct: 58 KYREAARLEINVLKKIKE-KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN 116
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----------------V 250
F+ L V+ + Q+ L L + + H DLKPENIL S V
Sbjct: 117 FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 251 KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310
K I++ DFGSA + + + +R+YR PEV+L + D+WS GCI+ E + G
Sbjct: 177 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
Query: 311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAY 370
LF + L M +ILG P +++ + F+K G +
Sbjct: 237 TLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYK----------------GGLVW 279
Query: 371 QALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFL 430
+ +E KPL K Y LE + L D +
Sbjct: 280 DENSSDGRYVKENCKPL--KSYMLQDSLE-----------------------HVQLFDLM 314
Query: 431 KGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVP 472
+ ++EFDPA+R + +A HPF G P + T R P
Sbjct: 315 RRMLEFDPAQRITLAEALLHPFFAGLT---PEERSFHTSRNP 353
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-144
Identities = 106/407 (26%), Positives = 172/407 (42%), Gaps = 70/407 (17%)
Query: 69 LNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKC 128
++ + S L D+ ++L N ++V +G GTFG+V C
Sbjct: 1 MHHHHH-HSSGRENLYFQGDDEIVHFSWKKGMLLNN-----AFLVIRKMGDGTFGRVLLC 54
Query: 129 WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188
+ + AVK+++N Y + A +E IL + D + ++IV+ + F+ H+C
Sbjct: 55 QHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN--DDINNNNIVKYHGKFMYYDHMC 112
Query: 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248
+ FE L +LYE+I N++ G + ++L+ +IL+ L+ L+ + H DLKPENILL
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
Query: 249 S----------------------VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
K IK+IDFG A + S I +R YR+PEV+L
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL 232
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSK 346
+ + DMWSFGC++AEL+ G LF + L M I+ P +L EA T+
Sbjct: 233 NLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQ-PIPKNMLYEATKTNG 291
Query: 347 FFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP 406
Y ++ K + ++
Sbjct: 292 SK-----------------------------YVNKDELKLAWPENASSINSIK------H 316
Query: 407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
+K L + I K DFL +++ DP R SP + +H F+
Sbjct: 317 VKKCLPLYKIIK----HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-143
Identities = 113/384 (29%), Positives = 174/384 (45%), Gaps = 65/384 (16%)
Query: 91 NSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS-FVAVKIIKNQPAYY 149
+ LI VL RY + D LG G FG+V +C D + VAVKI+KN Y
Sbjct: 1 SMHLICQSGDVLSA-----RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC 55
Query: 150 QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRG 209
+ A E+ +L LN D V++ E+F H+CI FELL + Y+ IK N F
Sbjct: 56 EAARSEIQVLEHLNTT-DPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP 114
Query: 210 LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----------------VKPA 253
L ++ + QI + ++ L + H DLKPENIL S +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 254 EIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
+IK++DFGSA +D + + +R+YR+PEV+L ++ D+WS GCI+ E +LG +F
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 314 PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQAL 373
P + L M RILG P +++++ + F ++ E S GR
Sbjct: 235 PTHDSKEHLAMMERILG-PLPKHMIQKTRKRKYFHH-----DRLDWDEHSSAGRY----- 283
Query: 374 TEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGL 433
KPL ++ + +D+ E L D ++ +
Sbjct: 284 ------VSRACKPL--------------------KEFMLSQDVEHE-----RLFDLIQKM 312
Query: 434 VEFDPAKRWSPFQASRHPFVTGEP 457
+E+DPAKR + +A +HPF
Sbjct: 313 LEYDPAKRITLREALKHPFFDLLK 336
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-129
Identities = 108/377 (28%), Positives = 162/377 (42%), Gaps = 62/377 (16%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK---- 164
RYI+ LG G F V D N+ VA+KI++ Y + A E+ +L +N
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 165 KYDREDKHHIVRIYEYFV----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
K D +HI+++ ++F H+ + FE+L NL LIK RG+ L V+ SK
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 221 QILRGLSLL-KDAGIIHCDLKPENILLCTSVKPA---EIKIIDFGSACTEDRTVYSYIQS 276
Q+L GL + + GIIH D+KPEN+L+ P +IKI D G+AC D + IQ+
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILG 330
R YRSPEVLLG + D+WS C++ EL G LF + D + ++I +LG
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
+ P Y+L+ K T FF G + NI
Sbjct: 259 -ELPSYLLRNGKYTRTFFNSRGLLRNISK------------------------------- 286
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
+ +++ E + DFL +++ DP KR H
Sbjct: 287 ------------LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334
Query: 451 PFVTGEPFTCPYQPPPE 467
P++ + P
Sbjct: 335 PWLKDTLGMEEIRVPDR 351
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 7e-68
Identities = 102/402 (25%), Positives = 162/402 (40%), Gaps = 104/402 (25%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY V LG G F V WD + FVA+K++K+ Y + AL E+ +L ++ D
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS-DPN 96
Query: 170 D--KHHIVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
D + +V++ + F H+C+ FE+L +L + I ++++GL L V+ +Q+L
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 224 RGLSLL-KDAGIIHCDLKPENILLC----------------------------------- 247
+GL L IIH D+KPENILL
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 248 -----------TSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDM 296
+ + ++KI D G+AC + IQ+R YRS EVL+G Y T D+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276
Query: 297 WSFGCIVAELFLGLPLFPG------ASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKC 350
WS C+ EL G LF + D + +I +LG + P ++ K + +FF
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG-KVPRKLIVAGKYSKEFFT- 334
Query: 351 IGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410
+ G+ L L E++ +
Sbjct: 335 -------KKGD-------------------------LKHITKLKPWGLFEVLVE---KYE 359
Query: 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
S E+ + DFL ++E P KR + + RHP+
Sbjct: 360 WSQEEAA-------GFTDFLLPMLELIPEKRATAAECLRHPW 394
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 2e-61
Identities = 96/385 (24%), Positives = 153/385 (39%), Gaps = 84/385 (21%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
+ Y ++G+G+FG V + + VA+K + + E+ I+
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIM------ 101
Query: 166 YDREDKH-HIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRG--LSLSIVQ 216
R+ H +IVR+ +F +L + + + +Y + + L + V+
Sbjct: 102 --RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYI 274
L+ Q+ R L+ + GI H D+KP+N+LL A +K+ DFGSA SYI
Sbjct: 160 LYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 275 QSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
SRYYR+PE++ G YT++ID+WS GC++AEL LG P+FPG S D L +I++LG
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG--T 275
Query: 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF 393
P T + + + E K P I +
Sbjct: 276 P---------TREQIREMNP-------------------------NYTEFKFPQIKAHPW 301
Query: 394 HHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
+R E + L+E+ P R +P +A H F
Sbjct: 302 TKV----------FRPRTPPE-----------AIALCSRLLEYTPTARLTPLEACAHSFF 340
Query: 454 TGEPFTCPYQPPPETPRVPVAQNFK 478
+ P P P NF
Sbjct: 341 --DELRDPNVKLPNGRDTPALFNFT 363
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-59
Identities = 88/385 (22%), Positives = 152/385 (39%), Gaps = 81/385 (21%)
Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
+ + R+ V+ + G GTFG V + VA+K + P + E+ I+ L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDL 73
Query: 163 NKKYDREDKHH-IVRIYEYFVCQRH-------LCICFELLDSNLYELIKINHFRGLSLSI 214
H IV++ YF L + E + L+ + + R ++
Sbjct: 74 -----AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128
Query: 215 --VQLFSKQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR 268
+++F Q++R + L + H D+KP N+L+ + +K+ DFGSA +
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKLCDFGSAKKLSPSE 186
Query: 269 TVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+YI SRYYR+PE++ G Q YTTA+D+WS GCI AE+ LG P+F G + L ++R
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246
Query: 328 ILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
+LG P + + + + + +L
Sbjct: 247 VLG--CP---------SREVLRKLNP-----------------------SHTDVDLYN-- 270
Query: 388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQA 447
P+ S + + D L L+++ P +R P++A
Sbjct: 271 --------------SKGIPWSNVFSDHSLKDAKE----AYDLLSALLQYLPEERMKPYEA 312
Query: 448 SRHPFVTGEPFTCPYQPPPETPRVP 472
HP+ + P P +P
Sbjct: 313 LCHPYF--DELHDPATKLPNNKDLP 335
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 8e-58
Identities = 81/267 (30%), Positives = 132/267 (49%), Gaps = 26/267 (9%)
Query: 76 TSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS 135
+P GV + D+ N + + + + + Y ++G+G+FG V + E +
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 136 FVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH-HIVRIYEYFVCQRH------LC 188
VA+K + + E+ I+ R KH ++V + +F L
Sbjct: 67 -VAIKKVLQDKRF---KNRELQIM--------RIVKHPNVVDLKAFFYSNGDKKDEVFLN 114
Query: 189 ICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246
+ E + +Y + + + + +++L+ Q+LR L+ + GI H D+KP+N+LL
Sbjct: 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174
Query: 247 CTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIV 303
+K+IDFGSA SYI SRYYR+PE++ G YTT ID+WS GC++
Sbjct: 175 DPPS--GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 304 AELFLGLPLFPGASEFDLLRRMIRILG 330
AEL G PLFPG S D L +I++LG
Sbjct: 233 AELMQGQPLFPGESGIDQLVEIIKVLG 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 5e-57
Identities = 72/229 (31%), Positives = 117/229 (51%), Gaps = 20/229 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKY 166
+Y +G G++G V KC + + VA+K + AL E+ +L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRML------- 56
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
++ KH ++V + E F +R L + FE D + + + RG+ +V+ + Q L+
Sbjct: 57 -KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD-RYQRGVPEHLVKSITWQTLQA 114
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSP 282
++ IH D+KPENIL+ K + IK+ DFG A + +R+YRSP
Sbjct: 115 VNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 283 EVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
E+L+G QY +D+W+ GC+ AEL G+PL+PG S+ D L + + LG
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 13/78 (16%), Positives = 25/78 (32%), Gaps = 7/78 (8%)
Query: 400 EIVTNYPYRKNLSMEDISKESQIRLAL-------VDFLKGLVEFDPAKRWSPFQASRHPF 452
++ + Y + + D + L + LKG + DP +R + Q HP+
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
Query: 453 VTGEPFTCPYQPPPETPR 470
+ P
Sbjct: 288 FENIREIEDLAKEHDKPA 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 2e-56
Identities = 90/408 (22%), Positives = 156/408 (38%), Gaps = 116/408 (28%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
++Y + LG G+FG V + +D E A+K + P Y E+ I+ L+
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLD----- 58
Query: 169 EDKH-HIVRIYEYFVCQRH--------------------------------------LCI 189
H +I+++ +YF L +
Sbjct: 59 ---HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 190 CFELLDSNLYELIKINHFRGLSLSI--VQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247
E + L++++K G S+ + + ++ Q+ R + + GI H D+KP+N+L+
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 248 TSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVA 304
+ K +K+ DFGSA +YI SR+YR+PE++LG +YT +ID+WS GC+
Sbjct: 176 S--KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 305 ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSI 364
EL LG PLF G + D L R+I+I+G P T + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMG--TP---------TKEQMIRMNP----------- 271
Query: 365 GGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424
Y P + + + P
Sbjct: 272 ------------HYTEVRF--PTLKAKDWRKI--------LPEGTP-------------S 296
Query: 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTG--EPFTCPYQPPPETPR 470
+D L+ ++ ++P R +P++A HPF + + P
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPH 344
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 9e-56
Identities = 69/229 (30%), Positives = 119/229 (51%), Gaps = 20/229 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY---QQALVEVSILTTLNKKY 166
+Y L+G G++G V KC + + VA+K + A+ E+ +L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL------- 78
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
++ +H ++V + E ++ + FE +D + + ++ GL +VQ + QI+ G
Sbjct: 79 -KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIING 136
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSP 282
+ IIH D+KPENIL+ + +K+ DFG A + +R+YR+P
Sbjct: 137 IGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193
Query: 283 EVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
E+L+G +Y A+D+W+ GC+V E+F+G PLFPG S+ D L ++ LG
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG 242
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 13/82 (15%), Positives = 25/82 (30%), Gaps = 7/82 (8%)
Query: 400 EIVTNYPYRKNLSMEDISKESQIRLAL-------VDFLKGLVEFDPAKRWSPFQASRHPF 452
E+ P + + +I + + +D K + DP KR + H F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 453 VTGEPFTCPYQPPPETPRVPVA 474
+ F + + A
Sbjct: 310 FQMDGFAERFSQELQLKVQKDA 331
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-55
Identities = 95/383 (24%), Positives = 155/383 (40%), Gaps = 81/383 (21%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
+RY +G G G V +DA + VA+K + + ++A E+ ++ +
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 163 NKKYDREDKHH--IVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSI 214
N H I+ + F Q+ L I EL+D+NL ++I+ L
Sbjct: 82 N---------HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHER 128
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVY 271
+ Q+L G+ L AGIIH DLKP NI++ C +KI+DFG A T +
Sbjct: 129 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGLARTAGTSFM 182
Query: 272 S--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
Y+ +RYYR+PEV+LG Y +D+WS GCI+ E+ G LFPG D ++I L
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242
Query: 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIG 389
G P+ F K + T +E +
Sbjct: 243 GTPCPE-----------FMKKLQP-----------------TVRTYVENRPKYAGYSF-- 272
Query: 390 KEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASR 449
++ F + + + + D L ++ D +KR S +A +
Sbjct: 273 EKLFPDVLFPADSEHNKLKASQA--------------RDLLSKMLVIDASKRISVDEALQ 318
Query: 450 HPFVTGEPFTCPYQPPPETPRVP 472
HP++ + P + P++P
Sbjct: 319 HPYI--NVWYDPSEAEAPPPKIP 339
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-55
Identities = 98/392 (25%), Positives = 154/392 (39%), Gaps = 102/392 (26%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLN 163
+ +K LLG G +G V VA+K I+ ++P + + L E+ IL
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67
Query: 164 KKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
H +I+ I+ + I EL+ ++L+ +I LS +Q
Sbjct: 68 --------HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQY 116
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS-- 272
F Q LR + +L + +IH DLKP N+L+ C ++K+ DFG A D +
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC------DLKVCDFGLARIIDESAADNS 170
Query: 273 -----------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320
++ +R+YR+PEV+L Y+ A+D+WS GCI+AELFL P+FPG
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEA 380
L + I+G D +CI S A
Sbjct: 231 QLLLIFGIIGTPHSD----------NDLRCIESP------------------------RA 256
Query: 381 RELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAK 440
R E + + P +E + + D L+ ++ FDPAK
Sbjct: 257 R------------------EYIKSLPMYPAAPLEKMFPRVN-PKGI-DLLQRMLVFDPAK 296
Query: 441 RWSPFQASRHPFVTG------EPFTCPYQPPP 466
R + +A HP++ EP P P
Sbjct: 297 RITAKEALEHPYLQTYHDPNDEPEGEPIPPSF 328
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 8e-55
Identities = 83/375 (22%), Positives = 147/375 (39%), Gaps = 89/375 (23%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
E + Y+ +G G +G V D VA+K + + ++A E+ +L +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSIV 215
H +++ + + F L + + ++L +++ + S +
Sbjct: 81 Q--------HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKI 128
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS 272
Q Q+L+GL + AG++H DLKP N+ + C E+KI+DFG A D +
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC------ELKILDFGLARHADAEMTG 182
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
Y+ +R+YR+PEV+L + Y +D+WS GCI+AE+ G LF G D L +++++ G
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
+ F + + A+
Sbjct: 243 PGTE-----------FVQKLNDKA------------------------AK---------- 257
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
+ + P + + A D L+ ++E D KR + QA HP
Sbjct: 258 --------SYIQSLPQTPRKDFTQLFPRAS-PQAA-DLLEKMLELDVDKRLTAAQALTHP 307
Query: 452 FVTGEPFTCPYQPPP 466
F EPF P +
Sbjct: 308 FF--EPFRDPEEETE 320
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-55
Identities = 105/410 (25%), Positives = 162/410 (39%), Gaps = 91/410 (22%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
R+Y + LG G +G V K D VAVK I + Q+ E+ ILT L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65
Query: 163 NKKYDREDKH-HIVRIYEYFVCQ--RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
+ H +IV + R + + F+ ++++L+ +I+ N L Q
Sbjct: 66 SG-------HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI---LEPVHKQYVV 115
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS---- 272
Q+++ + L G++H D+KP NILL C +K+ DFG + +
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAEC------HVKVADFGLSRSFVNIRRVTNNI 169
Query: 273 --------------------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLP 311
Y+ +R+YR+PE+LLG YT IDMWS GCI+ E+ G P
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
Query: 312 LFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQ 371
+FPG+S + L R+I ++ + + I S
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNE-----------DVESIQSP----------------F 262
Query: 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLK 431
A T IE +++ K K ++ P AL D L
Sbjct: 263 AKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE-----------EAL-DLLD 310
Query: 432 GLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDH 481
L++F+P KR S A +HPFV F P + P + + N V H
Sbjct: 311 KLLQFNPNKRISANDALKHPFV--SIFHNPNEEPNCDHIITIPINDNVKH 358
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-54
Identities = 93/391 (23%), Positives = 154/391 (39%), Gaps = 94/391 (24%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
E RY +G G +G V +D + VAVK + + ++ E+ +L +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 163 NKKYDREDKHH--IVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSI 214
H ++ + + F R L + L+ ++L ++K L+
Sbjct: 86 K---------HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDH 133
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVY 271
VQ QILRGL + A IIH DLKP N+ + C E+KI+DFG A +
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC------ELKILDFGLARHTADEMT 187
Query: 272 SYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
Y+ +R+YR+PE++L + Y +D+WS GCI+AEL G LFPG D L+ ++R++G
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
+ K I S AR
Sbjct: 248 TPGAE-----------LLKKISSES------------------------AR--------- 263
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
+ + ++ ++ + LA+ D L+ ++ D KR + QA H
Sbjct: 264 ---------NYIQSLTQMPKMNFANVFIGAN-PLAV-DLLEKMLVLDSDKRITAAQALAH 312
Query: 451 PFVTG------EPFTCPYQPPPETPRVPVAQ 475
+ EP PY E+ + + +
Sbjct: 313 AYFAQYHDPDDEPVADPYDQSLESRDLLIDE 343
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-54
Identities = 85/384 (22%), Positives = 143/384 (37%), Gaps = 104/384 (27%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVK-IIKNQPAYYQQALVEVSILTTLNK 164
+ RY+ LG G G V D + + VA+K I+ P + AL E+ I+ L+
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD- 66
Query: 165 KYDREDKHH--IVRIYEYFVCQRHLC--------------ICFELLDSNLYELIKINHFR 208
H IV+++E I E ++++L +++
Sbjct: 67 --------HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-- 116
Query: 209 GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL----CTSVKPAEIKIIDFGSAC 264
L +LF Q+LRGL + A ++H DLKP N+ + +KI DFG A
Sbjct: 117 -LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL------VLKIGDFGLAR 169
Query: 265 TEDRTVYS------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGAS 317
D + +++YRSP +LL YT AIDMW+ GCI AE+ G LF GA
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 318 EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIE 377
E + ++ ++ + + + + S
Sbjct: 230 ELEQMQLILESIPVVHEE-----------DRQELLS------------------------ 254
Query: 378 YEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD 437
+ N + + + R A+ DFL+ ++ F
Sbjct: 255 -VIPVY------------------IRNDMTEPHKPLTQLLPGIS-REAV-DFLEQILTFS 293
Query: 438 PAKRWSPFQASRHPFVTGEPFTCP 461
P R + +A HP++ ++ P
Sbjct: 294 PMDRLTAEEALSHPYM--SIYSFP 315
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-53
Identities = 86/390 (22%), Positives = 153/390 (39%), Gaps = 92/390 (23%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
E + Y +G G +G V D + VA+K + + ++A E+ +L +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLC------ICFELLDSNLYELIKINHFRGLSLSIV 215
H +++ + + F L + + ++L +L+K L +
Sbjct: 82 R--------HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRI 130
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS 272
Q Q+L+GL + AGIIH DLKP N+ + C E+KI+DFG A D +
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC------ELKILDFGLARQADSEMTG 184
Query: 273 YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
Y+ +R+YR+PEV+L + YT +D+WS GCI+AE+ G LF G+ D L+ ++++ G
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 244
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
P + F + + S A+
Sbjct: 245 PPAE-----------FVQRLQSDE------------------------AK---------- 259
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
+ P + I + LA+ + L+ ++ D +R + +A HP
Sbjct: 260 --------NYMKGLPELEKKDFASILTNAS-PLAV-NLLEKMLVLDAEQRVTAGEALAHP 309
Query: 452 FVTG------EPFTCPYQPPPETPRVPVAQ 475
+ EP Y + + +
Sbjct: 310 YFESLHDTEDEPQVQKYDDSFDDVDRTLDE 339
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-53
Identities = 100/378 (26%), Positives = 157/378 (41%), Gaps = 92/378 (24%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN--QPAYYQQALVEVSILTTLN 163
+ RY +G G +G V +D VA+K I Y Q+ L E+ IL
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 164 KKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQL 217
H +I+ I + + + I +L++++LY+L+K H LS +
Sbjct: 84 --------HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICY 132
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVYS-- 272
F QILRGL + A ++H DLKP N+LL C ++KI DFG A D
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC------DLKICDFGLARVADPDHDHTG 186
Query: 273 ----YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
Y+ +R+YR+PE++L + YT +ID+WS GCI+AE+ P+FPG D L ++
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246
Query: 328 ILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPL 387
ILG+ + CI ++ AR
Sbjct: 247 ILGSPSQE-----------DLNCIINLK------------------------AR------ 265
Query: 388 IGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQA 447
+ + P++ + + + AL D L ++ F+P KR QA
Sbjct: 266 ------------NYLLSLPHKNKVPWNRLFPNAD-SKAL-DLLDKMLTFNPHKRIEVEQA 311
Query: 448 SRHPFVTGEPFTCPYQPP 465
HP++ E + P P
Sbjct: 312 LAHPYL--EQYYDPSDEP 327
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-53
Identities = 86/387 (22%), Positives = 152/387 (39%), Gaps = 100/387 (25%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYY------------QQAL 153
Q Y V+ + G++G V D+E VA+K + N + ++ L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 154 VEVSILTTLNKKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHF 207
E+ +L + H +I+ + + FV L + EL+ ++L ++I
Sbjct: 78 REIRLLNHFH--------HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSA- 263
+S +Q F IL GL +L +AG++H DL P NILL +I I DF A
Sbjct: 130 V-ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN------DITICDFNLAR 182
Query: 264 -CTEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
T D Y+ R+YR+PE+++ ++ +T +DMWS GC++AE+F LF G++ ++
Sbjct: 183 EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242
Query: 322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEAR 381
L +++ ++G + S AR
Sbjct: 243 LNKIVEVVGTPKIE-----------DVVMFSSPS------------------------AR 267
Query: 382 ELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKR 441
+ + + + + + +AL D + ++EF+P +R
Sbjct: 268 DY-----------------LRNSLSNVPARAWTAVVPTAD-PVAL-DLIAKMLEFNPQRR 308
Query: 442 WSPFQASRHPFVTG------EPFTCPY 462
S QA RHP+
Sbjct: 309 ISTEQALRHPYFESLFDPLDLTEGLSE 335
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-52
Identities = 93/382 (24%), Positives = 151/382 (39%), Gaps = 81/382 (21%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
+RY +G G G V +DA ++ VA+K + + ++A E+ ++ +
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 163 NKKYDREDKHH--IVRIYEYFVCQ------RHLCICFELLDSNLYELIKINHFRGLSLSI 214
N H I+ + F Q + + + EL+D+NL ++I+ L
Sbjct: 119 N---------HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHER 165
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFGSACTEDRTVY 271
+ Q+L G+ L AGIIH DLKP NI++ C +KI+DFG A T +
Sbjct: 166 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC------TLKILDFGLARTAGTSFM 219
Query: 272 S--YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
Y+ +RYYR+PEV+LG Y +D+WS GCI+ E+ LFPG D ++I L
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279
Query: 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIG 389
G P+ F K + R +
Sbjct: 280 GTPCPE-----------FMKKLQP-------------------------TVRNYVENRPK 303
Query: 390 KEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASR 449
++ + +L D D L ++ DPAKR S A +
Sbjct: 304 YA---GLTFPKL-----FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355
Query: 450 HPFVTGEPFTCPYQPPPETPRV 471
HP++ + P + P++
Sbjct: 356 HPYI--NVWYDPAEVEAPPPQI 375
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-51
Identities = 79/356 (22%), Positives = 144/356 (40%), Gaps = 75/356 (21%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
Q Y + LG G + +V + + N V VKI+K P ++ E+ IL L
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENL--- 87
Query: 166 YDREDKHH--IVRIYEYF---VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
+ I+ + + V + + + +++ +L + L+ ++ +
Sbjct: 88 -----RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMY 137
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-CTEDRTVYS-YIQSRY 278
+IL+ L GI+H D+KP N+++ + ++++ID+G A Y+ + SRY
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195
Query: 279 YRSPEVLLGYQ-YTTAIDMWSFGCIVAEL-FLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
++ PE+L+ YQ Y ++DMWS GC++A + F P F G +D L R+ ++LG +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255
Query: 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK 396
+ +NIE L K
Sbjct: 256 YID--------------KYNIEL--------------------DPRFNDIL---GRHSRK 278
Query: 397 HLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
E V + + +S E + DFL L+ +D R + +A HP+
Sbjct: 279 RWERFVHSEN-QHLVSPEAL-----------DFLDKLLRYDHQSRLTAREAMEHPY 322
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 5e-50
Identities = 83/232 (35%), Positives = 125/232 (53%), Gaps = 27/232 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
+Y + +G GT+G V K + A+K I+ + P+ + E+SIL
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPS---TTIREISIL---- 54
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+E KH +IV++Y+ ++ L + FE LD +L +L+ GL + F Q+
Sbjct: 55 ----KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQL 109
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
L G++ D ++H DLKP+N+L+ E+KI DFG A R I + +Y
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVRKYTHEIVTLWY 166
Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
R+P+VL+G +Y+T ID+WS GCI AE+ G PLFPG SE D L R+ RILG
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 75/234 (32%), Positives = 121/234 (51%), Gaps = 26/234 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
RY LG GT+G+V K D N VA+K I+ + P A+ EVS+L
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGT---AIREVSLL---- 87
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+E +H +I+ + L + FE +++L + + + +S+ +++ F Q+
Sbjct: 88 ----KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM--DKNPDVSMRVIKSFLYQL 141
Query: 223 LRGLSLLKDAGIIHCDLKPENILL--CTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSR 277
+ G++ +H DLKP+N+LL + + +KI DFG A R I +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 278 YYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
+YR PE+LLG Y+T++D+WS CI AE+ + PLFPG SE D L ++ +LG
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-49
Identities = 78/231 (33%), Positives = 125/231 (54%), Gaps = 25/231 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNK 164
YI D LG GT+ V K ++ VA+K I+ + P A+ EVS+L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC---TAIREVSLL----- 54
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
++ KH +IV +++ ++ L + FE LD +L + + + +++ V+LF Q+L
Sbjct: 55 ---KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD-DCGNIINMHNVKLFLFQLL 110
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYR 280
RGL+ ++H DLKP+N+L+ E+K+ DFG A +T + + + +YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPTKTYDNEVVTLWYR 167
Query: 281 SPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
P++LLG Y+T IDMW GCI E+ G PLFPG++ + L + RILG
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILG 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-49
Identities = 74/232 (31%), Positives = 130/232 (56%), Gaps = 27/232 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
+Y + +G GT+G V K D++ VA+K I+ P+ A+ E+S+L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPS---TAIREISLL---- 73
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+E H +IV + + +R L + FE ++ +L +++ + GL S ++++ Q+
Sbjct: 74 ----KELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLD-ENKTGLQDSQIKIYLYQL 128
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
LRG++ I+H DLKP+N+L+ + +K+ DFG A R+ + + +Y
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLARAFGIPVRSYTHEVVTLWY 185
Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
R+P+VL+G +Y+T++D+WS GCI AE+ G PLFPG ++ D L ++ ILG
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-49
Identities = 79/235 (33%), Positives = 135/235 (57%), Gaps = 28/235 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNK 164
++ + LG+GT+ V K + +VA+K +K P+ A+ E+S++
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS---TAIREISLM----- 57
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIK----INHFRGLSLSIVQLFS 219
+E KH +IVR+Y+ + L + FE +D++L + + N RGL L++V+ F
Sbjct: 58 ---KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQS 276
Q+L+GL+ + I+H DLKP+N+L+ K ++K+ DFG A T S + +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 277 RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
+YR+P+VL+G Y+T+ID+WS GCI+AE+ G PLFPG ++ + L+ + I+G
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-49
Identities = 79/233 (33%), Positives = 123/233 (52%), Gaps = 27/233 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLN 163
+Y + +G GT+G V K + E + VA+K ++ P+ AL E+ +L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLL---- 55
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+E KH +IVR+++ + L + FE D +L + + L IV+ F Q+
Sbjct: 56 ----KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQL 110
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
L+GL ++H DLKP+N+L+ + E+K+ +FG A R + + + +Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILG 330
R P+VL G Y+T+IDMWS GCI AEL G PLFPG D L+R+ R+LG
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-48
Identities = 79/241 (32%), Positives = 112/241 (46%), Gaps = 34/241 (14%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK------NQPAYYQQALVEVSILTTLN 163
RY +G G +G V K D FVA+K ++ + EV++L L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 164 KKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSIVQL 217
+H ++VR+ + R + + FE +D +L + GL ++
Sbjct: 70 -----AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
+Q LRGL L I+H DLKPENIL+ + +K+ DFG A R YS Q
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTVKLADFGLA----RI-YS-YQMA 175
Query: 278 Y--------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
YR+PEVLL Y T +DMWS GCI AE+F PLF G SE D L ++ ++
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 330 G 330
G
Sbjct: 236 G 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 76/233 (32%), Positives = 121/233 (51%), Gaps = 23/233 (9%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQ------ALVEVSILTTL 162
+RY D LG G F V K D N VA+K IK + AL E+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL--- 66
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
+E H +I+ + + F + ++ + F+ ++++L +IK ++ L+ S ++ +
Sbjct: 67 -----QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLM 120
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRY 278
L+GL L I+H DLKP N+LL + +K+ DFG A + +R + +R+
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRW 177
Query: 279 YRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
YR+PE+L G Y +DMW+ GCI+AEL L +P PG S+ D L R+ LG
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-47
Identities = 78/242 (32%), Positives = 121/242 (50%), Gaps = 38/242 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQ------PAYYQQALVEVSILTTL 162
+Y +G G +G+V K D + FVA+K ++ Q P + EV++L L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL---STIREVAVLRHL 68
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSIVQ 216
+H ++VR+++ R L + FE +D +L + G+ ++
Sbjct: 69 E-----TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
Q+LRGL L ++H DLKP+NIL+ +S +IK+ DFG A R YS Q
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLA----RI-YS-FQM 174
Query: 277 RY--------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328
YR+PEVLL Y T +D+WS GCI AE+F PLF G+S+ D L +++ +
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234
Query: 329 LG 330
+G
Sbjct: 235 IG 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-47
Identities = 98/404 (24%), Positives = 160/404 (39%), Gaps = 117/404 (28%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
YI+K L+G G++G V +D VA+K + ++ L E++IL L
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 163 NKKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
+I+R+Y+ + L I E+ DS+L +L K F L+ ++
Sbjct: 83 K--------SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF--LTEEHIK 132
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG---SACTEDRTV 270
+L G + + ++GIIH DLKP N LL C +K+ DFG + +E T
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDC------SVKVCDFGLARTINSEKDTN 186
Query: 271 YS----------------------YIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELF 307
++ +R+YR+PE++L + YT +ID+WS GCI AEL
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 308 LGL-----------PLFPGASEFDLLRRMIRILGAQPPDYV--LKEAKNTSKFFKCIGS- 353
L PLFPG+S F L L F IG+
Sbjct: 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSK-KVHEKSNRDQLN------IIFNIIGTP 299
Query: 354 ----VHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409
+ NI EV +Y + +P+RK
Sbjct: 300 TEDDLKNINKPEV---------------------------IKY---------IKLFPHRK 323
Query: 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453
++++ + + L+ +++F+P KR + QA HP++
Sbjct: 324 PINLKQKYPSIS-DDGI-NLLESMLKFNPNKRITIDQALDHPYL 365
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-45
Identities = 91/411 (22%), Positives = 155/411 (37%), Gaps = 109/411 (26%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
+ RY ++ L+G G++G V + +D VA+K I ++ L E++IL L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 163 NKKYDREDKH-HIVRIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
N H H+V++ + + + L + E+ DS+ +L + L+ ++
Sbjct: 110 N--------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP--VYLTELHIK 159
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILL---CTSVKPAEIKIIDFG------------ 261
+L G+ + AGI+H DLKP N L+ C +K+ DFG
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC------SVKVCDFGLARTVDYPENGN 213
Query: 262 ------------------SACTEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCI 302
R + ++ +R+YR+PE++L + YT AID+WS GCI
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 303 VAELFLGL-----------PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCI 351
AEL + PLFPG+S F L + G + + F +
Sbjct: 274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPD--QKAGNDFKFHTRGNRDQLNVIFNIL 331
Query: 352 GSVHNIENGEVSIGGRSAYQALTEIEYE-ARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410
G+ + + +E E A+ + +E L E
Sbjct: 332 GTPSE--------------EDIEALEKEDAKRYIRIFPKRE---GTDLAERFPASS---- 370
Query: 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCP 461
A+ LK ++ F+P KR + + HPF +
Sbjct: 371 ------------ADAI-HLLKRMLVFNPNKRITINECLAHPFF--KEVRIA 406
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-44
Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 28/227 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
+ V LLG G F QV + DA+ +K+ K E I T L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK------PANPWEFYIGTQLM 118
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDS----NLYELIKINHFRGLSLSIVQLFS 219
++ +H ++ Y + Q + EL N L K + + +V F+
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--------IKIIDFGSACT-----E 266
++L + + D IIH D+KP+N +L + + +ID G + +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313
+ ++ ++ E+L + ID + V + G +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 52/259 (20%), Positives = 103/259 (39%), Gaps = 37/259 (14%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKK 165
R Y + +G G +V + + E A+K + + E++ L L +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
D I+R+Y+Y + +++ + E + +L +K + + + + K +L
Sbjct: 87 SD-----KIIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEA 139
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR----YYR 280
+ + GI+H DLKP N L+ + +K+IDFG + + T S+ Y
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 281 SPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
PE + + + D+WS GCI+ + G F + + ++ I+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAII 253
Query: 330 GAQP----PDYVLKEAKNT 344
PD K+ ++
Sbjct: 254 DPNHEIEFPDIPEKDLQDV 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-41
Identities = 65/255 (25%), Positives = 102/255 (40%), Gaps = 33/255 (12%)
Query: 110 RYIVKDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD 167
+ KD+LGHG G + +D N VAVK I P + A EV +L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD---NRDVAVKRI--LPECFSFADREVQLLRES----- 74
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
D+H +++R + ++ I EL + L E ++ F L L + L +Q GL
Sbjct: 75 --DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLL-QQTTSGL 131
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQ------SRY 278
+ L I+H DLKP NIL+ + I DFG +S+ + +
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 279 YRSPEVLLGYQ---YTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPP 334
+ +PE+L T +D++S GC+ + G F L+R IL
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-----GKSLQRQANILLGACS 246
Query: 335 DYVLKEAKNTSKFFK 349
L K+ +
Sbjct: 247 LDCLHPEKHEDVIAR 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 54/267 (20%), Positives = 104/267 (38%), Gaps = 36/267 (13%)
Query: 99 NLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVE 155
+ V R Y + +G G +V + + E A+K + + E
Sbjct: 2 ECISVK---GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNE 57
Query: 156 VSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIV 215
++ L L + D I+R+Y+Y + +++ + E + +L +K + +
Sbjct: 58 IAYLNKLQQHSD-----KIIRLYDYEITDQYIYMVMECGNIDLNSWLK--KKKSIDPWER 110
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYI 274
+ + K +L + + GI+H DLKP N L+ + +K+IDFG + + T
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK 166
Query: 275 QSR----YYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPG-ASE 318
S+ Y PE + + + D+WS GCI+ + G F ++
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226
Query: 319 FDLLRRMIRILGAQP-PDYVLKEAKNT 344
L +I PD K+ ++
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDV 253
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-40
Identities = 71/245 (28%), Positives = 120/245 (48%), Gaps = 23/245 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALV--EVSILTTLNKKY 166
Y LG G +G+V C D + A+KII K + + + EV++L L+
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD--- 94
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQIL 223
H +I+++Y++F +R+ + E L++ I F + + KQ+L
Sbjct: 95 -----HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF---NEVDAAVIIKQVL 146
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRS 281
G++ L I+H DLKPEN+LL + K A IKI+DFG + + + + + YY +
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYVL 338
PEVL +Y D+WS G I+ L G P F G ++ ++LR++ + + V
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 339 KEAKN 343
+ AK+
Sbjct: 266 EGAKD 270
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-40
Identities = 77/246 (31%), Positives = 121/246 (49%), Gaps = 24/246 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
RY + +LG G+FG+V C D AVK+I Q + L EV +L L+
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-- 84
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQI 222
H +I+++YE+F + + + E+ L++ I F S +Q+
Sbjct: 85 ------HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF---SEVDAARIIRQV 135
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYR 280
L G++ + I+H DLKPEN+LL + K A I+IIDFG + + + I + YY
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYV 337
+PEVL G Y D+WS G I+ L G P F GA+E+D+L+++ + V
Sbjct: 196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV 254
Query: 338 LKEAKN 343
+ AK+
Sbjct: 255 SESAKD 260
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-40
Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 34/256 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--------------NQPAYYQQALVE 155
Y LG G +G+V C + +S A+K+IK N ++++ E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYE-LIKINHFRGLSL 212
+S+L +L H +I+++++ F +++ + E + L+E +I + F
Sbjct: 97 ISLLKSL--------DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF---DE 145
Query: 213 SIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTV 270
KQIL G+ L I+H D+KPENILL IKI+DFG + ++D +
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--- 327
+ + YY +PEVL +Y D+WS G I+ L G P F G ++ D+++++ +
Sbjct: 206 RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264
Query: 328 ILGAQPPDYVLKEAKN 343
+ EAK
Sbjct: 265 YFDFNDWKNISDEAKE 280
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 20/243 (8%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLN 163
Q+ + LGHG++G+V K E AVK P + L EV +
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+ H VR+ + + L + EL +L + + L + V + +
Sbjct: 115 Q-------HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCE-AWGASLPEAQVWGYLRDT 166
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYR 280
L L+ L G++H D+KP NI L K+ DFG Y
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPR---GRCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
+PE+L G Y TA D++S G + E+ + L G + LR+ L + + E
Sbjct: 224 APELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ--GYLPPEFTAGLSSE 280
Query: 341 AKN 343
++
Sbjct: 281 LRS 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 59/295 (20%), Positives = 119/295 (40%), Gaps = 41/295 (13%)
Query: 71 PKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWD 130
++++ SP +G +D + +++ ++V R Y + +G G +V + +
Sbjct: 26 ERQHMDSPDLGTDDDDKASSSANECISVK--------GRIYSILKQIGSGGSSKVFQVLN 77
Query: 131 AEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187
E A+K + + E++ L L + D I+R+Y+Y + +++
Sbjct: 78 -EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD-----KIIRLYDYEITDQYI 131
Query: 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247
+ E + +L +K + + + + K +L + + GI+H DLKP N L+
Sbjct: 132 YMVMECGNIDLNSWLK--KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 189
Query: 248 TSVKPAEIKIIDFGSA-----CTEDRTVYSYIQSRYYRSPEVLLG-----------YQYT 291
+ +K+IDFG A T S + + Y PE + + +
Sbjct: 190 DGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 292 TAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQP-PDYVLKEAKNT 344
D+WS GCI+ + G F ++ L +I PD K+ ++
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-39
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 38/237 (16%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDRED 170
+G GTFG+V K + VA+K + + P AL E+ IL +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI---TALREIKIL--------QLL 73
Query: 171 KH-HIVRIYEYFVCQRHLCIC--------FELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
KH ++V + E + F+ + +L L+ N +LS ++ +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQM 132
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYIQ-- 275
+L GL + I+H D+K N+L+ + +K+ DFG A ++ Y
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 276 -SRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
+ +YR PE+LLG Y ID+W GCI+AE++ P+ G +E L + ++ G
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-39
Identities = 66/360 (18%), Positives = 119/360 (33%), Gaps = 83/360 (23%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
+++ D+LG G V + + A+K+ N + E +L LN
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN---- 65
Query: 168 REDKH-HIVRIYEYF--VCQRHLCICFELLDS-NLYE-LIKINHFRGLSLSIVQLFSKQI 222
H +IV+++ RH + E +LY L + ++ GL S + + +
Sbjct: 66 ----HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
+ G++ L++ GI+H ++KP NI+ + K+ DFG+A +D S + Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 280 RSPEVLLGY--------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
P++ +Y +D+WS G G F + ++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM----- 236
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
T K I V ENG +
Sbjct: 237 --------YKIITGKPSGAISGVQKAENGPI----------------------------- 259
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
+ + P +LS +++ L L ++E D K W Q
Sbjct: 260 --------DWSGDMPVSCSLS-------RGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-39
Identities = 78/245 (31%), Positives = 116/245 (47%), Gaps = 23/245 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
RY + +LG G+FG+V KC D AVK+I + L EV +L L+
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--- 79
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQIL 223
H +I++++E I EL L++ I K F S KQ+
Sbjct: 80 -----HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVF 131
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRS 281
G++ + I+H DLKPENILL + K +IKIIDFG + ++ + I + YY +
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYVL 338
PEVL G Y D+WS G I+ L G P F G +E+D+L+R+ +
Sbjct: 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 339 KEAKN 343
+AK+
Sbjct: 251 DDAKD 255
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-38
Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 38/248 (15%)
Query: 112 IVKDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+G GT+G V AK D + + A+K I+ A E+++L RE
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALL--------RE 74
Query: 170 DKH-HIVRIYEYFVCQRHLCIC--FELLDSNLYELIK-------INHFRGLSLSIVQLFS 219
KH +++ + + F+ + F+ + +L+ +IK L +V+
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSA---CTEDRTVYSYIQ 275
QIL G+ L ++H DLKP NIL+ +KI D G A + + +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 276 S---RYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE---------FDLL 322
+YR+PE+LLG YT AID+W+ GCI AEL P+F E D L
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254
Query: 323 RRMIRILG 330
R+ ++G
Sbjct: 255 DRIFNVMG 262
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 33/249 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDR 168
+I ++LG G F +V A+K IK PA+ +L E+++L +
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI------ 63
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHF--RGLSLSIVQLFSKQ 221
KH +IV + + + H + +L+ EL ++ + + SL I +Q
Sbjct: 64 --KHENIVTLEDIYESTTHYYLVMQLVSGG--ELFDRILERGVYTEKDASLVI-----QQ 114
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYR 280
+L + L + GI+H DLKPEN+L T + ++I I DFG S ++ + + + Y
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYV 174
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ---PPDY- 336
+PEVL Y+ A+D WS G I L G P F +E L +I +
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE---KIKEGYYEFESPFW 231
Query: 337 --VLKEAKN 343
+ + AK+
Sbjct: 232 DDISESAKD 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 25/247 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALV-EVSILTTLNKKYD 167
+I K LG G FG V + +K I K++ + + E+ +L +L+
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD---- 78
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLS--IVQLFSKQIL 223
H +I++I+E F ++ I E + L E I RG +LS V KQ++
Sbjct: 79 ----HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRS 281
L+ ++H DLKPENIL + + IKIIDFG A D + + Y +
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PPDY 336
PEV T D+WS G ++ L G F G S ++ + + +
Sbjct: 195 PEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ---KATYKEPNYAVECRP 250
Query: 337 VLKEAKN 343
+ +A +
Sbjct: 251 LTPQAVD 257
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-37
Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 59/278 (21%)
Query: 108 QRRYIVKDLLGHGTFGQVAKC--WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
+ + + +LG+G+ G V + VAVK + + AL+E+ +LT
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQGSFQGRP---VAVKRM--LIDFCDIALMEIKLLTES--- 65
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFS----- 219
D H +++R Y R L I EL + NL +L++ + +L + + ++
Sbjct: 66 ----DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTS----------VKPAEIKIIDFGSACTEDRT 269
+QI G++ L IIH DLKP+NIL+ TS + I I DFG D
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 270 VYSYIQ-------SRYYRSPEVLLGY-------QYTTAIDMWSFGCIVAE-LFLGLPLFP 314
S+ + +R+PE+L + T +ID++S GC+ L G F
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF- 240
Query: 315 GASEFDLLRRMIRILGAQ---------PPDYVLKEAKN 343
D R I+ ++ EA +
Sbjct: 241 ----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 57/261 (21%), Positives = 92/261 (35%), Gaps = 39/261 (14%)
Query: 103 VNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162
V+ + +L+G G FGQV K +K +K ++A EV L L
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKL 61
Query: 163 NKKYDREDKH-HIVRIYEYFV----------------CQRHLCICFELLDS-NLYELIKI 204
+ H +IV + + L I E D L + I+
Sbjct: 62 D--------HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 205 NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
L + +QI +G+ + +I+ DLKP NI L ++KI DFG
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVT 170
Query: 265 TEDRTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
+ + Y SPE + Y +D+++ G I+AEL F+
Sbjct: 171 SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA-----FETS 225
Query: 323 RRMIRILGAQPPDYVLKEAKN 343
+ + D K+ K
Sbjct: 226 KFFTDLRDGIISDIFDKKEKT 246
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 75/269 (27%), Positives = 114/269 (42%), Gaps = 50/269 (18%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
+ +LG G FGQV K +A + + A+K I++ L EV +L +LN
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN------- 60
Query: 171 KH-HIVRIYEYFVCQRH-------------LCICFELLDSN-LYELIKINHFRGLSLSIV 215
H ++VR Y ++ +R+ L I E ++ LY+LI +
Sbjct: 61 -HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 216 QLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
+LF +QIL LS + GIIH DLKP NI + + +KI DFG A R++
Sbjct: 120 RLF-RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 276 SR-----------------YYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
Y + EVL G Y IDM+S G I E+ P G
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME 233
Query: 318 EFDLLRRMIRILGAQPPDY---VLKEAKN 343
++L+++ + PPD+ +K K
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKK 262
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-37
Identities = 58/233 (24%), Positives = 99/233 (42%), Gaps = 21/233 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKY 166
+Y+ +G G+FG+ E +K I +++ EV++L +
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK--- 81
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
H +IV+ E F L I + + +L++ I + + QI
Sbjct: 82 -----HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRS 281
L + D I+H D+K +NI L K +++ DFG A + TV + I + YY S
Sbjct: 137 ALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
PE+ Y D+W+ GC++ EL F S +L+ ++I G+ PP
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFPP 244
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-37
Identities = 67/353 (18%), Positives = 120/353 (33%), Gaps = 85/353 (24%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
+++ D+LG G V + + A+K+ N + E +L LN
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN---- 65
Query: 168 REDKH-HIVRIYEYF--VCQRHLCICFELLDS-NLYE-LIKINHFRGLSLSIVQLFSKQI 222
H +IV+++ RH + E +LY L + ++ GL S + + +
Sbjct: 66 ----HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
+ G++ L++ GI+H ++KP NI+ + K+ DFG+A +D S + Y
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 280 RSPEVLLGY--------QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR-MIRILG 330
P++ +Y +D+WS G G F + M +I+
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII- 240
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
T K I V ENG +
Sbjct: 241 -------------TGKPSGAISGVQKAENGPI---------------------------- 259
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS 443
+ + P +LS +++ L L ++E D K W
Sbjct: 260 ---------DWSGDMPVSCSLS-------RGLQVLLTPVLANILEADQEKCWG 296
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 18/224 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+Y++ + LG G FG V +C + K +K + E+SIL
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR------ 59
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSKQILRG 225
H +I+ ++E F L + FE + +++E I L+ + + Q+
Sbjct: 60 --HRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEA 114
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPE 283
L L I H D++PENI + + + + IKII+FG A + Y +PE
Sbjct: 115 LQFLHSHNIGHFDIRPENI-IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
V +TA DMWS G +V L G+ F + ++ ++
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 59/245 (24%), Positives = 103/245 (42%), Gaps = 25/245 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
Y +++ +G G++G+V A K I K + E+ I+ +L+
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD----- 64
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQLFSKQIL 223
H +I+R+YE F + + EL EL + F S K +L
Sbjct: 65 ---HPNIIRLYETFEDNTDIYLVMELCTGG--ELFERVVHKRVF---RESDAARIMKDVL 116
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRS 281
++ + H DLKPEN L T + +K+IDFG A + + + + + YY S
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR---ILGAQPPDYVL 338
P+VL G Y D WS G ++ L G P F ++ +++ ++ + V
Sbjct: 177 PQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235
Query: 339 KEAKN 343
+A++
Sbjct: 236 PQAES 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-36
Identities = 70/250 (28%), Positives = 108/250 (43%), Gaps = 32/250 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
Y VK+ LG G F V +C A KII K +Q+ E I L
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL---- 62
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQLFSKQ 221
+H +IVR+++ + + F+L+ EL + + S + +Q
Sbjct: 63 ----QHPNIVRLHDSIQEESFHYLVFDLVTGG--ELFEDIVAREFY---SEADASHCIQQ 113
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
IL ++ GI+H +LKPEN+LL + K A +K+ DFG A + + + + Y
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP 334
SPEVL Y+ +D+W+ G I+ L +G P F + L +I P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAYDYPSPE 230
Query: 335 -DYVLKEAKN 343
D V EAK+
Sbjct: 231 WDTVTPEAKS 240
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 7e-36
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 21/231 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
+ +K+ LG G FG V + + VA+K + + + + E+ I+ LN
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN---- 70
Query: 168 REDKH-HIVRIYEYFVCQRHL------CICFELLDS-NLYELI-KINHFRGLSLSIVQLF 218
H ++V E + L + E + +L + + + + GL ++
Sbjct: 71 ----HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQS 276
I L L + IIH DLKPENI+L + KIID G A + ++ +
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
Y +PE+L +YT +D WSFG + E G F + +R
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-36
Identities = 51/251 (20%), Positives = 83/251 (33%), Gaps = 37/251 (14%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNK 164
+ + +G G FG V KC A+K K Q AL EV L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSK 220
H H+VR + + H+ I E + +L + I N+ ++
Sbjct: 70 -------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTS----------------VKPAEIKIIDFGSAC 264
Q+ RGL + ++H D+KP NI + + KI D G
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 265 TEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
+ + EVL Y + D+++ V PL ++ +R
Sbjct: 183 RISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR 241
Query: 324 RMIRILGAQPP 334
+ G P
Sbjct: 242 Q-----GRLPR 247
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 19/225 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
Y + + LG G FG V +C + K I P E+SI+ L+
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH----- 106
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSKQILR 224
H ++ +++ F + + + E L L++ I +S V + +Q
Sbjct: 107 ---HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACE 160
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
GL + + I+H D+KPENI+ C + K + +KIIDFG A D V + + +P
Sbjct: 161 GLKHMHEHSIVHLDIKPENIM-CETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
E++ DMW+ G + L GL F G + + L+ + R
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 21/222 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALV-EVSILTTLN 163
Y + +++G G F V +C + E AVKI+ + P + L E SI L
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML- 83
Query: 164 KKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELI--KINHFRGLSLSIVQLFS 219
KH HIV + E + L + FE +D ++L I + + S ++ +
Sbjct: 84 -------KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT---EDRTVYSYIQS 276
+QIL L D IIH D+KP +LL + A +K+ FG A + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGT 196
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
++ +PEV+ Y +D+W G I+ L G F G E
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 70/250 (28%), Positives = 108/250 (43%), Gaps = 32/250 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
Y VK+ LG G F V +C A KII K +Q+ E I L
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL---- 85
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQLFSKQ 221
+H +IVR+++ + + F+L+ EL + + S + +Q
Sbjct: 86 ----QHPNIVRLHDSIQEESFHYLVFDLVTGG--ELFEDIVAREFY---SEADASHCIQQ 136
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
IL ++ GI+H +LKPEN+LL + K A +K+ DFG A + + + + Y
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 196
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP 334
SPEVL Y+ +D+W+ G I+ L +G P F + L +I P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAYDYPSPE 253
Query: 335 -DYVLKEAKN 343
D V EAK+
Sbjct: 254 WDTVTPEAKS 263
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 30/237 (12%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKK 165
Y V +G G++G+ K + K + A Q + EV++L L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-- 63
Query: 166 YDREDKH-HIVRIYEYFVCQR--HLCICFELLDS-NLYELIKINHFRGLSLS---IVQLF 218
H +IVR Y+ + + L I E + +L +I L ++++
Sbjct: 64 ------HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 219 SKQILRGLSLL-----KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV--- 270
+ Q+ L ++H DLKP N+ L +K+ DFG A +
Sbjct: 118 T-QLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFA 173
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+++ + YY SPE + Y D+WS GC++ EL +P F S+ +L ++
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 79/248 (31%), Positives = 118/248 (47%), Gaps = 29/248 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
RY + +LG G+FG+V KC D AVK+I + L EV +L L+
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD--- 79
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQIL 223
H +I++++E I EL L++ I K F S KQ+
Sbjct: 80 -----HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF---SEHDAARIIKQVF 131
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRS 281
G++ + I+H DLKPENILL + K +IKIIDFG + ++ + I + YY +
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP-D 335
PEVL G Y D+WS G I+ L G P F G +E+D+L+ R+ + P
Sbjct: 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK---RVETGKYAFDLPQWR 247
Query: 336 YVLKEAKN 343
+ +AK+
Sbjct: 248 TISDDAKD 255
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-35
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 33/251 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALV--EVSILTTLNKKY 166
Y + + LG G F V +C A II + + + E I L
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL---- 67
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELI-KINHF--RGLSLSIVQLFSKQ 221
KH +IVR+++ + H + F+L+ L+E I ++ S I +Q
Sbjct: 68 ----KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-----QQ 118
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRY 278
IL + G++H +LKPEN+LL + +K A +K+ DFG A E + + + +
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG 178
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----P 333
Y SPEVL Y +D+W+ G I+ L +G P F + L + +I P
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ---QIKAGAYDFPSP 235
Query: 334 P-DYVLKEAKN 343
D V EAK+
Sbjct: 236 EWDTVTPEAKD 246
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-35
Identities = 54/225 (24%), Positives = 99/225 (44%), Gaps = 15/225 (6%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKY 166
Y + + LG G FG V + + + A K + + + E+ ++ L
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR--- 212
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILR 224
H +V +++ F + + +E + L+E + H + +S + +Q+ +
Sbjct: 213 -----HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCK 266
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
GL + + +H DLKPENI+ T+ + E+K+IDFG ++V + + +P
Sbjct: 267 GLCHMHENNYVHLDLKPENIM-FTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
EV G DMWS G + L GL F G ++ + LR +
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 370
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 56/251 (22%), Positives = 92/251 (36%), Gaps = 48/251 (19%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
+ LG G FG V + + + A+K I+ N+ ++ + EV L L
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 61
Query: 168 REDKH-HIVRIYEYFV------------CQRHLCICFELLDS-NLYELIKINHFRGLS-- 211
H IVR + ++ + +L I +L NL + +
Sbjct: 62 ----HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV- 270
+ +F QI + L G++H DLKP NI +K+ DFG D+
Sbjct: 118 SVCLHIF-LQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEE 173
Query: 271 --------------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
+ ++ Y SPE + G Y+ +D++S G I+ EL L F
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQ 230
Query: 317 SEFDLLRRMIR 327
E +R
Sbjct: 231 MERVRTLTDVR 241
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-35
Identities = 32/273 (11%), Positives = 74/273 (27%), Gaps = 34/273 (12%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLN 163
+R+ + + L G V D E A+K+ +N + ++ L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 164 KKYDREDKHHIVRIYEYFVCQ-------------------RHLCICFELLDSNLYELIKI 204
+ E + + + + +L L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 205 NHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
F + + + + Q++R + L+ G++H P+N+ + + + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD---GRLMLGD 237
Query: 260 FGSACTEDRTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
+ + Y E L +T A++ W G + ++ F +
Sbjct: 238 VSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 318 E-FDLLRRMIRILGAQPPDYVLKEAKNTSKFFK 349
+ + F K
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK 330
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 25/237 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
+ ++ +G G F +V + VA+K ++ + E+ +L LN
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-- 90
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS---IVQLFSK 220
H ++++ Y F+ L I EL D+ +L +IK + + + + F
Sbjct: 91 ------HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV- 143
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSR 277
Q+ L + ++H D+KP N+ + +K+ D G +S + +
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
YY SPE + Y D+WS GC++ E+ F + +L +I P
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKIEQCDYP 256
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 62/233 (26%), Positives = 92/233 (39%), Gaps = 28/233 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
Y + LG G F V KC + A K IK + + EVSIL +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQL 217
+H +++ ++E + + + + EL+ EL + +
Sbjct: 72 --------QHPNVITLHEVYENKTDVILILELVAGG--ELFDFLAEKESL---TEEEATE 118
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYI 274
F KQIL G+ L I H DLKPENI+L P IKIIDFG A +
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+ + +PE++ DMWS G I L G F G ++ + L +
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 56/224 (25%), Positives = 88/224 (39%), Gaps = 16/224 (7%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKYDR 168
+ LG G F V +C A K + + + L E+++L
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELA------ 85
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
K ++ ++E + + + E ++ L +S + V KQIL G
Sbjct: 86 --KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG 143
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ-SRYYRSPE 283
+ L I+H DLKP+NILL + +IKI+DFG S I + Y +PE
Sbjct: 144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPE 203
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+L TTA DMW+ G I L F G + + +
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 80/349 (22%), Positives = 126/349 (36%), Gaps = 59/349 (16%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
+ LG G G V K +A K+I +PA Q + E+ +L N Y
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-- 92
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLS 227
IV Y F + IC E +D L +++K + I+ S +++GL+
Sbjct: 93 -----IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLT 145
Query: 228 LLKDAG-IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSPEVL 285
L++ I+H D+KP NIL+ + EIK+ DFG S D S++ +R Y SPE L
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 202
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS 345
G Y+ D+WS G + E+ +G P +L + + +
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 346 KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405
K + ++ L I E P + F
Sbjct: 263 PLNKFGMDSR---------PPMAIFELLDYIVNE----PPPKLPSGVF------------ 297
Query: 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454
S E DF+ + +PA+R Q H F+
Sbjct: 298 -----------SLE------FQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 24/231 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
Y + + LG G F V KC + A K IK + ++ EVSIL +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYE-LIKINHFRGLSLSIVQLFS 219
H +++ +++ + + + + EL+ L++ L + S F
Sbjct: 73 L--------HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFI 121
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYIQS 276
KQIL G++ L I H DLKPENI+L P IK+IDFG A + + +
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+ +PE++ DMWS G I L G F G ++ + L +
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS 232
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 53/254 (20%), Positives = 101/254 (39%), Gaps = 31/254 (12%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
E + +G G+FG+V + D + AVK ++ + + E+ L+
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE----ELVACAGLS-- 108
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
IV +Y + I ELL+ +L +LIK L + Q L
Sbjct: 109 ------SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQAL 160
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR----- 277
GL L I+H D+K +N+LL S + + DFG + C + + + +
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLL--SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 278 --YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
+ +PEV++G +D+WS C++ + G + +++ ++I PP
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPPP- 274
Query: 336 YVLKEAKNTSKFFK 349
+ + + +
Sbjct: 275 -IREIPPSCAPLTA 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 54/253 (21%), Positives = 88/253 (34%), Gaps = 37/253 (14%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYD 167
+ Y+ LG G F V F A+K I ++ ++A E + N
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN---- 84
Query: 168 REDKH-HIVRIYEYFVCQR----HLCICFELLDS-NLYELIKINHFRGLSLS---IVQLF 218
H +I+R+ Y + +R + L+ I+ +G L+ I+ L
Sbjct: 85 ----HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR- 277
I RGL + G H DLKP NILL + ++D GS V Q+
Sbjct: 141 L-GICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALT 196
Query: 278 -----------YYRSPEVLLGYQY---TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323
YR+PE+ + D+WS GC++ + G + +
Sbjct: 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
Query: 324 RMIRILGAQPPDY 336
+ P
Sbjct: 257 ALAVQNQLSIPQS 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDR 168
+ +LG GT+G V D +A+K I + + Y Q L E+++ L
Sbjct: 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK----- 77
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRG-LSLSIVQLFSKQILRG 225
H +IV+ F + I E + +L L++ + + ++KQIL G
Sbjct: 78 ---HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSP 282
L L D I+H D+K +N+L+ T +KI DFG++ + ++ + Y +P
Sbjct: 135 LKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
Query: 283 EVLLGYQ--YTTAIDMWSFGCIVAELFLGLP 311
E++ Y A D+WS GC + E+ G P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 55/247 (22%), Positives = 107/247 (43%), Gaps = 29/247 (11%)
Query: 110 RYI-VKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKK 165
R++ +G G+F V K D E VA + K + Q+ E +L L
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL--- 82
Query: 166 YDREDKH-HIVRIYEYFVC----QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFS 219
+H +IVR Y+ + ++ + + EL+ S L +K F+ + + +++ +
Sbjct: 83 -----QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWC 135
Query: 220 KQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQS 276
+QIL+GL L + IIH DLK +NI + + +KI D G + + I +
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFI--TGPTGSVKIGDLGLATLKRASFAKAVIGT 193
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
+ +PE+ +Y ++D+++FG + E+ + SE ++ R + +
Sbjct: 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPA 249
Query: 337 VLKEAKN 343
+
Sbjct: 250 SFDKVAI 256
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 61/233 (26%), Positives = 92/233 (39%), Gaps = 28/233 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
Y + + LG G F V KC A K IK + ++ EV+IL +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHFRGLSLSIVQL 217
H +I+ +++ F + + + EL+ EL + +
Sbjct: 66 R--------HPNIITLHDIFENKTDVVLILELVSGG--ELFDFLAEKESL---TEDEATQ 112
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYI 274
F KQIL G+ L I H DLKPENI+L P IK+IDFG A +
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+ + +PE++ DMWS G I L G F G ++ + L +
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 24/231 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
Y + + LG G F V KC + A K IK + ++ EVSIL +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYE-LIKINHFRGLSLSIVQLFS 219
H +I+ +++ + + + + EL+ L++ L + S F
Sbjct: 73 --------LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEEATSFI 121
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKP-AEIKIIDFGSA--CTEDRTVYSYIQS 276
KQIL G++ L I H DLKPENI+L P IK+IDFG A + + +
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGT 181
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+ +PE++ DMWS G I L G F G ++ + L +
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 66/297 (22%), Positives = 116/297 (39%), Gaps = 73/297 (24%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK------NQPAYYQQALVEVSILTT 161
Q++Y +K +G G++G V + + + A+KI+ P ++ EV ++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 162 LNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD------------------------- 195
L H +I R+YE + ++++C+ EL
Sbjct: 85 L--------HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 196 ------SNLYELIKINHFRGLSLSIVQLFS--------KQILRGLSLLKDAGIIHCDLKP 241
E G S+ + +QI L L + GI H D+KP
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 242 ENILLCTSVKPAEIKIIDFGSA-------CTEDRTVYSYIQSRYYRSPEVLLG--YQYTT 292
EN L T+ K EIK++DFG + E + + + Y+ +PEVL Y
Sbjct: 197 ENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 293 AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ-----PP-DYVLKEAKN 343
D WS G ++ L +G FPG ++ D + ++L + P + + A++
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTIS---QVLNKKLCFENPNYNVLSPLARD 309
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 19/221 (8%)
Query: 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDREDKH 172
++LG G FGQV KC + +A KII ++ E+S++ L+ H
Sbjct: 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD--------H 145
Query: 173 -HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLS--IVQLFSKQILRGLSL 228
+++++Y+ F + + + E +D L++ I +L+ LF KQI G+
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRH 202
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSPEVLL 286
+ I+H DLKPENI LC + +IKIIDFG A + + + +PEV+
Sbjct: 203 MHQMYILHLDLKPENI-LCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+ DMWS G I L GL F G ++ + L ++
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-32
Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 35/250 (14%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+ V+ LG G V +C A+K++K + E+ +L L
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRL------- 105
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHF--RGLSLSIVQLFSKQI 222
H +I+++ E F + + EL+ EL ++ ++ R + ++ KQI
Sbjct: 106 -SHPNIIKLKEIFETPTEISLVLELVTGG--ELFDRIVEKGYYSERDAADAV-----KQI 157
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYR 280
L ++ L + GI+H DLKPEN+L T A +KI DFG + + + + Y
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG-ASEFDLLRRMIRILGAQ-----PP 334
+PE+L G Y +DMWS G I L G F + + R RIL + P
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR---RILNCEYYFISPW 274
Query: 335 -DYVLKEAKN 343
D V AK+
Sbjct: 275 WDEVSLNAKD 284
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDRE 169
+ LG G+F KC + N AVKII K A Q+ E++ L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLC------- 62
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDSNLYEL----IKINHF--RGLSLSIVQLFSKQI 222
+ H +IV+++E F Q H + ELL+ EL K HF S + +++
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGG--ELFERIKKKKHFSETEASYIM-----RKL 115
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYY 279
+ +S + D G++H DLKPEN+L EIKIIDFG A +++ + + + +Y
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329
+PE+L Y + D+WS G I+ + G F + I+
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 68/259 (26%), Positives = 101/259 (38%), Gaps = 51/259 (19%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
+ K +LG G G+V +C+ A+K++ + P Q EV +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHW-------QASG 80
Query: 172 H-HIVRIYEYFVCQRHLCICF----------ELLDSNLYELIKINHFRGLSLSIVQLFS- 219
HIV I + + H C EL +I RG Q F+
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS-------RIQE-RG-----DQAFTE 127
Query: 220 -------KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVY 271
+ I + L I H D+KPEN+L + K A +K+ DFG + T +
Sbjct: 128 REAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILG 330
+ + YY +PEVL +Y + DMWS G I+ L G P F + + M RI
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 331 AQ-----PP-DYVLKEAKN 343
Q P V ++AK
Sbjct: 248 GQYGFPNPEWSEVSEDAKQ 266
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 63/267 (23%), Positives = 93/267 (34%), Gaps = 51/267 (19%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV----------EVS 157
Y K++LG G V +C AVKII A EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHFRGL 210
IL + H +I+++ + + + F EL D L +
Sbjct: 76 ILRKV-------SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----YLTEKVTL--- 121
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR 268
S + + +L + L I+H DLKPENILL IK+ DFG +
Sbjct: 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGE 178
Query: 269 TVYSYIQSRYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322
+ + Y +PE++ Y +DMWS G I+ L G P F + +L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 323 RRMIRILGAQ-----PP-DYVLKEAKN 343
R I+ P D K+
Sbjct: 239 R---MIMSGNYQFGSPEWDDYSDTVKD 262
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 67/258 (25%), Positives = 105/258 (40%), Gaps = 39/258 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---------NQPAYYQQALVEVSILT 160
YI+ LG G G+V ++ + VA+KII + E+ IL
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSI 214
LN H I++I +F + + L EL D +++ +
Sbjct: 71 KLN--------HPCIIKIKNFFDAEDYYIVLELMEGGELFD----KVVGNKRL---KEAT 115
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
+L+ Q+L + L + GIIH DLKPEN+LL + + IKI DFG + E + +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 273 YIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-- 327
+ Y +PEVL+ Y A+D WS G I+ G P F L+ I
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 328 --ILGAQPPDYVLKEAKN 343
+ V ++A +
Sbjct: 236 KYNFIPEVWAEVSEKALD 253
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 35/238 (14%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV---------EVSILT 160
YI+ LG G G+V ++ + VA++II + A E+ IL
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRH-----LCICFELLDSNLYELIKINHFRGLSLSI 214
LN H I++I +F + + L EL D K+ + L +
Sbjct: 196 KLN--------HPCIIKIKNFFDAEDYYIVLELMEGGELFD-------KVVGNKRLKEAT 240
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYS 272
+L+ Q+L + L + GIIH DLKPEN+LL + + IKI DFG + E + +
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 273 YIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+ Y +PEVL+ Y A+D WS G I+ G P F L+ I
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 51/289 (17%), Positives = 88/289 (30%), Gaps = 75/289 (25%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLN-- 163
+ +G G FG V + + + A+K I+ N+ ++ + EV L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 164 ------------------------------------------------KKYDREDKHHIV 175
++ D + V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 176 RIYEYFVCQRHLCICFELLD-SNLYELIK-INHFRGLSLSIVQLFSKQILRGLSLLKDAG 233
+ + +L I +L NL + + + QI + L G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 234 IIHCDLKPENILLCTSVKPAEIKIIDFGSACT---------------EDRTVYSYIQSRY 278
++H DLKP NI +K+ DFG T + ++
Sbjct: 185 LMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
Y SPE + G Y+ +D++S G I+ EL F E + +R
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR 287
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 69/260 (26%), Positives = 106/260 (40%), Gaps = 42/260 (16%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
+ +LG G G+V + ++ A+K++++ P + EV + ++
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQ-- 113
Query: 167 DREDKH-HIVRIYEYF----VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFS- 219
HIVRI + + ++ L I E LD L+ I RG Q F+
Sbjct: 114 -----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRG-----DQAFTE 160
Query: 220 -------KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTV 270
K I + L I H D+KPEN+L + A +K+ DFG A T ++
Sbjct: 161 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220
Query: 271 YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RIL 329
+ + YY +PEVL +Y + DMWS G I+ L G P F + M RI
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 330 GAQ-----PP-DYVLKEAKN 343
Q P V +E K
Sbjct: 281 MGQYEFPNPEWSEVSEEVKM 300
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 62/252 (24%), Positives = 107/252 (42%), Gaps = 30/252 (11%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
+G GT GQV K + +AVK ++ ++ L+++ ++ +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH----- 81
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
D +IV+ + F+ + I EL+ + E +K + I+ + I++ L
Sbjct: 82 -DCPYIVQCFGTFITNTDVFIAMELMGTCA-EKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 229 LKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED---RTVYSYIQSRYYRSPE 283
LK+ G+IH D+KP NILL +IK+ DFG S D + Y +PE
Sbjct: 140 LKEKHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVDDKAKD--RSAGCAAYMAPE 194
Query: 284 VL-----LGYQYTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMIRILGAQPPDYV 337
+ Y D+WS G + EL G P ++F++L ++L +PP +
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT---KVLQEEPP--L 249
Query: 338 LKEAKNTSKFFK 349
L S F+
Sbjct: 250 LPGHMGFSGDFQ 261
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 63/256 (24%), Positives = 106/256 (41%), Gaps = 44/256 (17%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
Y VK+ +G G++ +C N AVKII + E+ IL R
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILL-------RY 72
Query: 170 DKH-HIVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHF--RGLSLSIVQLFSK 220
+H +I+ + + + +++ + ELLD ++++ F R S +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLD----KILRQKFFSEREASAVL-----F 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE-IKIIDFGSAC---TEDRTVYSYIQS 276
I + + L G++H DLKP NIL E I+I DFG A E+ + + +
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT 183
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF---PGASEFDLLRRMIRILGAQ- 332
+ +PEVL Y A D+WS G ++ + G F P + ++L RI +
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIGSGKF 240
Query: 333 ----PP-DYVLKEAKN 343
+ V AK+
Sbjct: 241 SLSGGYWNSVSDTAKD 256
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
V++++G G FG V K W VA+K I+++ + +VE+ L+ +N
Sbjct: 12 VEEVVGRGAFGVVCKAKWR---AKDVAIKQIESES-ERKAFIVELRQLSRVN-------- 59
Query: 172 H-HIVRIYEYFVCQRHLCICFELLDS-NLYELI-KINHFRGLSLSIVQLFSKQILRGLSL 228
H +IV++Y C +C+ E + +LY ++ + + + Q +G++
Sbjct: 60 HPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 229 L---KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
L + +IH DLKP N+LL KI DFG+AC + + S + +PEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVL--KICDFGTACDIQTHMTNNKGSAAWMAPEVF 175
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
G Y+ D++S+G I+ E+ F
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDE 205
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 33/257 (12%)
Query: 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEV 156
VLV+ ++RRY+ LG G F + + DA+ A KI+ K+ P ++ +E+
Sbjct: 7 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 66
Query: 157 SILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSI 214
SI +L H H+V + +F + + EL L EL K + L+
Sbjct: 67 SIHRSL--------AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPE 116
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSY 273
+ + +QI+ G L +IH DLK N+ L E+KI DFG + E
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDG---- 169
Query: 274 IQSRY-------YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326
+ + Y +PEVL ++ +D+WS GCI+ L +G P F + + R I
Sbjct: 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR-I 227
Query: 327 RILGAQPPDYVLKEAKN 343
+ P ++ A +
Sbjct: 228 KKNEYSIPKHINPVAAS 244
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 41/234 (17%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKYDRED 170
+ +D+LG G +V C + + AVKII+ QP + + + EV +L
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG------ 69
Query: 171 KH-HIVRIYEYFVCQRHLCICFE------LLDSNLYELIKINHF--RGLSLSIVQLFSKQ 221
H +++ + E+F + + FE +L + K HF S+ + +
Sbjct: 70 -HRNVLELIEFFEEEDRFYLVFEKMRGGSILS----HIHKRRHFNELEASVVV-----QD 119
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR--- 277
+ L L + GI H DLKPENIL + + +KI DF + + S I +
Sbjct: 120 VASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 278 ------YYRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320
Y +PEV+ + Y D+WS G I+ L G P F G D
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 59/243 (24%), Positives = 102/243 (41%), Gaps = 25/243 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYY---QQALVEVSILTTLNKK 165
+ + LG G FG V + + +A+K++ K Q Q EV I + L
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL--- 66
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
+H +I+R+Y YF + + E +Y ++ + ++
Sbjct: 67 -----RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELA 119
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSP 282
LS +IH D+KPEN+LL ++ E+KI DFG S + Y P
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRTDLCGTLDYLPP 176
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
E++ G + +D+WS G + E +G P F + + + RI + PD+V +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK---RISRVEFTFPDFVTEG 233
Query: 341 AKN 343
A++
Sbjct: 234 ARD 236
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 26/231 (11%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDKH-H 173
LG G +G V K +AVK I+ ++ L+++ I R
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM-------RTVDCPF 67
Query: 174 IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKD 231
V Y + + IC EL+D++L + K +G ++ L + I++ L L
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 232 AG-IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV--YSYIQSRYYRSPEVLLGY 288
+IH D+KP N+L+ ++K+ DFG + V + Y +PE +
Sbjct: 128 KLSVIHRDVKPSNVLINAL---GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE 184
Query: 289 ----QYTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMIRILGAQPP 334
Y+ D+WS G + EL + P + F L+ +++ P
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK---QVVEEPSP 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 62/253 (24%), Positives = 96/253 (37%), Gaps = 43/253 (16%)
Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
NA + +LG G G+V + ++ A+K++++ P + EV + +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68
Query: 164 KKYDREDKH-HIVRIYEYF----VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQL 217
+ HIVRI + + ++ L I E LD L+ I+ + +
Sbjct: 69 Q-------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR 277
K I + L I H D+KPEN+L + A +K+ DFG A
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------- 167
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI-RILGAQ---- 332
E G +Y + DMWS G I+ L G P F + M RI Q
Sbjct: 168 ----KET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222
Query: 333 -PP-DYVLKEAKN 343
P V +E K
Sbjct: 223 NPEWSEVSEEVKM 235
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 27/219 (12%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--------EVSILTTLNK 164
+ +G G FG V K + S VA+K + + + ++ EV I++ LN
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN- 81
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
H +IV++Y + + E + +LY + + + S+ I
Sbjct: 82 -------HPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLL-DKAHPIKWSVKLRLMLDI 131
Query: 223 LRGLSLL--KDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQSRY 278
G+ + ++ I+H DL+ NI L + + A K+ DFG + +V + +
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQ 191
Query: 279 YRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPG 315
+ +PE + YT D +SF I+ + G F
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 65/255 (25%), Positives = 99/255 (38%), Gaps = 31/255 (12%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDR 168
+G G +G V K +AVK I+ +Q L+++ ++ R
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVM-------R 76
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLD---SNLYELIKINHFRGLSLSIVQLFSKQILR 224
+IV+ Y + IC EL+ Y+ + + I+ + ++
Sbjct: 77 SSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 225 GLSLLKDAG-IIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED---RTVYSYIQSRYY 279
L+ LK+ IIH D+KP NILL S IK+ DFG S D +T R Y
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGISGQLVDSIAKT--RDAGCRPY 191
Query: 280 RSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGL-PLFPGASEFDLLRRMIRILGAQPP 334
+PE + Y D+WS G + EL G P S FD L +++ PP
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT---QVVKGDPP 248
Query: 335 DYVLKEAKNTSKFFK 349
E + S F
Sbjct: 249 QLSNSEEREFSPSFI 263
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 70/258 (27%), Positives = 115/258 (44%), Gaps = 35/258 (13%)
Query: 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEV 156
VLV+ ++RRY+ LG G F + + DA+ A KI+ K+ P ++ +E+
Sbjct: 33 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI 92
Query: 157 SILTTLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSI 214
SI +L H H+V + +F + + EL L EL K + L+
Sbjct: 93 SIHRSL--------AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPE 142
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED-----R 268
+ + +QI+ G L +IH DLK N+ L E+KI DFG + E +
Sbjct: 143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYDGERKK 199
Query: 269 TV---YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
+ +YI +PEVL ++ +D+WS GCI+ L +G P F + + R
Sbjct: 200 VLCGTPNYI------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR- 252
Query: 326 IRILGAQPPDYVLKEAKN 343
I+ P ++ A +
Sbjct: 253 IKKNEYSIPKHINPVAAS 270
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 60/252 (23%), Positives = 93/252 (36%), Gaps = 41/252 (16%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKY 166
+ R V+ +L G F V + D A+K + N+ + + EV + L+
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS--- 83
Query: 167 DREDKHHIVRIYEYFVCQRH--------LCICFELLDSNLYELIKINHFRG-LSLSIVQL 217
+IV+ + + EL L E +K RG LS V
Sbjct: 84 ---GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 218 FSKQILRGLSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
Q R + + + IIH DLK EN+LL IK+ DFGSA T
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWS 197
Query: 276 SR---------------YYRSPEVLLGYQ---YTTAIDMWSFGCIVAEL-FLGLPLFPGA 316
++ YR+PE++ Y D+W+ GCI+ L F P F
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-FEDG 256
Query: 317 SEFDLLRRMIRI 328
++ ++ I
Sbjct: 257 AKLRIVNGKYSI 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 62/264 (23%), Positives = 98/264 (37%), Gaps = 50/264 (18%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---------NQPAYYQQALVEVSILT 160
+Y KD++G G V +C AVKI++ + E IL
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHFRGLSLS 213
+ H HI+ + + + + + F EL D L + S
Sbjct: 155 QVAG-------HPHIITLIDSYESSSFMFLVFDLMRKGELFD----YLTEKVAL---SEK 200
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVY 271
+ + +L +S L I+H DLKPENILL +I++ DFG +C +
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLR 257
Query: 272 SYIQSRYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325
+ Y +PE+L Y +D+W+ G I+ L G P F + +LR
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR-- 315
Query: 326 IRILGAQ-----PP-DYVLKEAKN 343
I+ Q P D K+
Sbjct: 316 -MIMEGQYQFSSPEWDDRSSTVKD 338
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 40/262 (15%), Positives = 77/262 (29%), Gaps = 44/262 (16%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTT 161
E R + +LG + D E V + + +Q EV L
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 162 LNK------------------KYDREDKHHIVRIYEYF--VCQRHLCICFELLDSNLYEL 201
L K ++R+ + + + SNL
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 202 IKINHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256
++ L + Q++R L+ L G++H L+P +I+L +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR---GGVF 246
Query: 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQ-----------YTTAIDMWSFGCIVAE 305
+ F + V S + SR + PE+ T + D W+ G ++
Sbjct: 247 LTGFEHLVRDGARVVSSV-SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 306 LFLGLPLFPGASEFDLLRRMIR 327
++ + + R
Sbjct: 306 IWCADLPITKDAALGGSEWIFR 327
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 32/248 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQ---PAYYQQALVEVSILTTLNKK 165
+ V +LLG G+F V + VA+K+I K Q+ EV I L
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL--- 68
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
KH I+ +Y YF ++ + E+ + + +K N + S + + F QI+
Sbjct: 69 -----KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSENEARHFMHQII 122
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRY---- 278
G+ L GI+H DL N+LL + IKI DFG + + + Y
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRN---MNIKIADFGLATQLKMPH-----EKHYTLCG 174
Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
Y SPE+ + D+WS GC+ L +G P F + + L + + + + P
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK-VVLADYEMPS 233
Query: 336 YVLKEAKN 343
++ EAK+
Sbjct: 234 FLSIEAKD 241
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQPAYYQQALV-----EVSILTTLNKKY 166
+++++G G FG+V + W VAVK ++ P + E + L
Sbjct: 11 LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK--- 64
Query: 167 DREDKH-HIVRIYEYFVCQR--HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQI 222
H +I+ + VC + +LC+ E L ++ + + I+ ++ QI
Sbjct: 65 -----HPNIIALRG--VCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQI 114
Query: 223 LRGLSLL---KDAGIIHCDLKPENILLCTSVKPAE-----IKIIDFGSACTEDRTVYSYI 274
RG++ L IIH DLK NIL+ V+ + +KI DFG A RT
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174
Query: 275 QSRY-YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
Y + +PEV+ ++ D+WS+G ++ EL G F G
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
+Y V LLG G FG V N VA+K ++ + + +EV +L +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFSK 220
+ + ++R+ ++F + E + L++ I L + + F
Sbjct: 104 SSGF-----SGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGA-LQEELARSFFW 156
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-SRYY 279
Q+L + + G++H D+K ENIL+ + E+K+IDFGS TVY+ +R Y
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 214
Query: 280 RSPEVLLGYQYT-TAIDMWSFGCI 302
PE + ++Y + +WS G +
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGIL 238
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 40/267 (14%), Positives = 79/267 (29%), Gaps = 42/267 (15%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII----KNQPAYYQQALVEVSILTTLNK 164
R + +LG + D E V + + +Q EV L L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 165 ---------------KYDREDKHHIVRIYEYFVCQRHLCIC-----FELLDSNLYELIKI 204
+D ++ + +R + + + + SNL ++
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 205 NHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
L + Q++R L+ L G++H L+P +I+L + +
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR---GGVFLTG 254
Query: 260 FGSACTEDRTVYSYIQSRY----YRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGL 310
F + + S I + + +L Q T A D W+ G + ++
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 311 PLFPGASEFDLLRRMIRILGAQPPDYV 337
+ + R P V
Sbjct: 315 LPNTDDAALGGSEWIFR-SCKNIPQPV 340
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 20/205 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-----KNQPAYYQQALV--EVSILTTL 162
Y + LLG G FG V VA+K+I EV++L +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSN--LYELIKINHFRGLSLSIVQLFS 219
H ++R+ ++F Q + E L++ I L + F
Sbjct: 92 G----AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGP-LGEGPSRCFF 145
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-SRY 278
Q++ + G++H D+K ENIL+ ++ K+IDFGS Y+ +R
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDEPYTDFDGTRV 203
Query: 279 YRSPEVLLGYQYT-TAIDMWSFGCI 302
Y PE + +QY +WS G +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGIL 228
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDRE 169
V +G G+FG V + + + VAVK++ P Q EV +L
Sbjct: 28 VGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT------- 77
Query: 170 DKH-HIVRIYEYFVCQR-HLCICFELLD-SNLYELIKINHFRGLSLSIVQL--FSKQILR 224
+H +I+ L I + + S+LY + H + +L ++Q R
Sbjct: 78 -RHVNILLFMG--YSTAPQLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTAR 131
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YY 279
G+ L IIH DLK NI L +KI DFG A + R S+ + +
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLATEKSRWSGSHQFEQLSGSILW 188
Query: 280 RSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPG 315
+PEV+ Y+ D+++FG ++ EL G +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 57/243 (23%), Positives = 103/243 (42%), Gaps = 25/243 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYY---QQALVEVSILTTLNKK 165
+ + LG G FG V + + +A+K++ K+Q Q E+ I + L
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-- 72
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
H +I+R+Y YF ++ + + E LY+ ++ F +++
Sbjct: 73 ------HPNILRMYNYFHDRKRIYLMLEFAPRGELYK--ELQKHGRFDEQRSATFMEELA 124
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSRYYRSP 282
L + +IH D+KPEN+L+ E+KI DFG S + + Y P
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPSLRRRTMCGTLDYLPP 181
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
E++ G + +D+W G + E +G+P F S + R RI+ P ++
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR---RIVNVDLKFPPFLSDG 238
Query: 341 AKN 343
+K+
Sbjct: 239 SKD 241
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 26/244 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
Y + +G G F +V VA+KII + P Q+ EV I+ LN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN--- 72
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
H +IV+++E ++ L + E +++ + + H R + + +QI+
Sbjct: 73 -----HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGR-MKEKEARSKFRQIVS 125
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
+ I+H DLK EN+LL + IKI DFG + T + ++ + Y +P
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
Query: 283 EVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA-QPPDYVLK 339
E+ G +Y +D+WS G I+ L G LP F G + +L R++R G + P Y+
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLP-FDGQNLKELRERVLR--GKYRIPFYMST 239
Query: 340 EAKN 343
+ +N
Sbjct: 240 DCEN 243
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDR 168
+K+ +G G+FG V + W S VAVKI+ Q + L EV+I+ L
Sbjct: 41 IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRL------ 91
Query: 169 EDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG-LSLSIVQLFSKQILRG 225
+H +IV +L I E L +LY L+ + R L + + +G
Sbjct: 92 --RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 226 LSLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR---YYR 280
++ L ++ I+H +LK N+L+ +K+ DFG + + T S + +
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
+PEVL D++SFG I+ EL +
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/248 (22%), Positives = 108/248 (43%), Gaps = 25/248 (10%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
+++Y + +G G G V D VA++ + Q ++ ++ E+ ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM------- 71
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
RE+K+ +IV + ++ L + E L +L +++ ++ V ++ L+
Sbjct: 72 -RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQ 127
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS 281
L L +IH D+K +NILL +K+ DFG + + + Y+ +
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
PEV+ Y +D+WS G + E+ G P P +E + LR + I P L+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--PYLNE-NPLRALYLIATNGTP--ELQNP 239
Query: 342 KNTSKFFK 349
+ S F+
Sbjct: 240 EKLSAIFR 247
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/250 (24%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV-EVSILTTLNKKY 166
+ +G G+ G V + VAVK++ + ++ L EV I+
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM------- 96
Query: 167 DREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
R+ +H ++V +Y+ ++ L + E L L +++ ++ V + +L+
Sbjct: 97 -RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV---CEAVLQ 152
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRS 281
L+ L G+IH D+K ++ILL +K+ DFG + V S + + Y+ +
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 209
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLK 339
PEV+ Y T +D+WS G +V E+ G P + F ++ M R+ + PP LK
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPY-----FSDSPVQAMKRLRDSPPP--KLK 262
Query: 340 EAKNTSKFFK 349
+ S +
Sbjct: 263 NSHKVSPVLR 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 75/245 (30%), Positives = 99/245 (40%), Gaps = 23/245 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY +G G FG D VAVK I+ A + E+ +L
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR------ 74
Query: 170 DKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
H +IVR E + HL I E LYE I N R S + F +Q+L G+S
Sbjct: 75 --HPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGR-FSEDEARFFFQQLLSGVS 130
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRSPEVL 285
I H DLK EN LL S P +KI DFG S S + + Y +PEVL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189
Query: 286 LGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMI-RILGAQ----PPDYVL 338
L +Y D+WS G + + +G P F E R+ I RIL + +
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248
Query: 339 KEAKN 343
E +
Sbjct: 249 PECCH 253
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/249 (24%), Positives = 108/249 (43%), Gaps = 27/249 (10%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKK 165
+ + V + LG G++G V K E VA+K + + + E+SI+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK---EISIMQQCDSP 84
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
+ +V+ Y + L I E + ++ ++I++ + + L+ + + L+
Sbjct: 85 H-------VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLK 136
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRYYRS 281
GL L IH D+K NILL T K+ DFG A T+ + I + ++ +
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTE---GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193
Query: 282 PEVLLGYQYTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
PEV+ Y D+WS G I A E+ G P P ++ +R + I PP ++
Sbjct: 194 PEVIQEIGYNCVADIWSLG-ITAIEMAEGKP--P-YADIHPMRAIFMIPTNPPP--TFRK 247
Query: 341 AKNTSKFFK 349
+ S F
Sbjct: 248 PELWSDNFT 256
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 36/263 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYD 167
Y +++++G G V + A VA+K I + + L E+ ++ +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN- 74
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLS------IVQLFSK 220
IV Y FV + L + +LL ++ ++IK +G S + +
Sbjct: 75 ------IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQSR-- 277
++L GL L G IH D+K NILL ++I DFG SA + + R
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGED---GSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 278 -----YYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331
+ +PEV+ Y D+WSFG EL G + ++ ++ ++ L
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 242
Query: 332 QPP-----DYVLKEAKNTSKFFK 349
PP + K K F+
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFR 265
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 65/255 (25%), Positives = 112/255 (43%), Gaps = 32/255 (12%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY-YQQALVEVSILTTLNKKY 166
+ + LG G FG+V K + E + A K+I+ + + +VE+ IL T + Y
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLD----SNLYELIKINHFRGLSLSIVQLFSKQI 222
IV++ + L I E + + RGL+ +Q+ +Q+
Sbjct: 78 -------IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD----RGLTEPQIQVVCRQM 126
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYY 279
L L+ L IIH DLK N+L+ +I++ DFG + +T+ S+I + Y+
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLE---GDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183
Query: 280 RSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
+PEV++ Y D+WS G + E+ P P E + +R +++I + PP
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKIAKSDPP 240
Query: 335 DYVLKEAKNTSKFFK 349
L S F+
Sbjct: 241 --TLLTPSKWSVEFR 253
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 26/248 (10%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKK 165
+ + + +G G+FG+V K D VA+KII + A + E+++L+ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
Y + + Y ++ L I E L + +L++ ++ + ++IL+
Sbjct: 81 Y-------VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI---LREILK 130
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRS 281
GL L IH D+K N+LL E+K+ DFG A T +++ + ++ +
Sbjct: 131 GLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 187
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
PEV+ Y + D+WS G EL G P SE ++ + I PP L+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKNNPP--TLE-- 240
Query: 342 KNTSKFFK 349
N SK K
Sbjct: 241 GNYSKPLK 248
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 69/251 (27%), Positives = 106/251 (42%), Gaps = 39/251 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---------NQPAYYQQALVEVSILT 160
+Y LG G FG V D E N V VK IK + + +E++IL+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS--NLYELIKINHFRGLSLSIVQL 217
+ H +I+++ + F Q + E S +L+ I H R L +
Sbjct: 85 RVE--------HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPR-LDEPLASY 134
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
+Q++ + L+ IIH D+K ENI++ IK+IDFGSA + Y++
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCG 191
Query: 276 SRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA-Q 332
+ Y +PEVL+G Y ++MWS G + L P F L + A
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP-------FCELEETVE--AAIH 242
Query: 333 PPDYVLKEAKN 343
PP V KE +
Sbjct: 243 PPYLVSKELMS 253
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 55/386 (14%), Positives = 123/386 (31%), Gaps = 99/386 (25%)
Query: 110 RYIVKDLLGHGTFGQV--AKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLN 163
Y + L G F ++ + + N F A+K + + + ++ + + +
Sbjct: 32 DYRIIRTLNQGKFNKIILCE----KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 164 KKYDRED------KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHF------RG 209
+ E K+ + + + I +E +++ ++ + +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 210 LSLSIVQLFSKQILRGLSLL-KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED 267
+ + +++ K +L S + + I H D+KP NIL+ + +K+ DFG S D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN---GRVKLSDFGESEYMVD 204
Query: 268 RTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRR 324
+ + + + PE +D+WS G + +F +P F
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-------FS---- 253
Query: 325 MIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELK 384
+ + F NI +
Sbjct: 254 ---------------LKISLVELFN------NIRTKNIEY-------------------- 272
Query: 385 KPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSP 444
PL + + ++ + + +S E DFLK + +PA+R +
Sbjct: 273 -PLDRNHFLYPLTNKKSTCSNNF--------LSNEDI------DFLKLFLRKNPAERITS 317
Query: 445 FQASRHPFVTGEPFTCPYQPPPETPR 470
A +H ++ + E +
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYK 343
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 45/227 (19%), Positives = 82/227 (36%), Gaps = 42/227 (18%)
Query: 113 VKDLLGHGTFGQVAK-CWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDR 168
+ +L+G G FGQV W E VA+++I + + EV
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT------ 86
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
H +V + HL I L LY +++ L ++ + +++I++G
Sbjct: 87 ---RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKG 142
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY------- 278
+ L GI+H DLK +N+ + I DFG + +
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 279 -YRSPEVL---------LGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
+ +PE++ ++ D+++ G I EL F
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 52/361 (14%), Positives = 107/361 (29%), Gaps = 68/361 (18%)
Query: 111 YIVKDLLGHG--TFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKK 165
Y + ++G G V +V V+ I E+ + N
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
IV F+ L + + + +LI + G++ + + +L+
Sbjct: 87 N-------IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTED-----RTVYSYIQSR- 277
L + G +H +K +IL+ ++ + + R V+ + +
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 278 ---YYRSPEVL--LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
+ SPEVL Y D++S G EL G F + + ++ L
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KDMPATQMLLEKLNGT 253
Query: 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY 392
P L + + ++ N +S ++ + +
Sbjct: 254 VPC--LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP------------- 298
Query: 393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
++PY + S F++ ++ +P R S H F
Sbjct: 299 -----------SHPYHRTFSPH-----------FHHFVEQCLQRNPDARPSASTLLNHSF 336
Query: 453 V 453
Sbjct: 337 F 337
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 28/222 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNS-FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKY 166
+Y VK + HG G + D +N V +K + + A+ E L +
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV--- 137
Query: 167 DREDKH-HIVRIYEYFVCQRHLC-----ICFELLD-SNLYELIKINHFRGLSLSIVQLFS 219
H IV+I+ + I E + +L + L ++ +
Sbjct: 138 -----HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYL 188
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
+IL LS L G+++ DLKPENI+L ++K+ID G+ + Y Y + +
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGYLYG-TPGF 243
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
++PE++ T A D+++ G +A L L LP G L
Sbjct: 244 QAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 35/216 (16%), Positives = 73/216 (33%), Gaps = 37/216 (17%)
Query: 117 LGHGTFGQVAK-CWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKH 172
L G++ K W + + VK++K + + E L + H
Sbjct: 18 LNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS--------H 66
Query: 173 -HIVRIYEYFVCQR----HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+++ + CQ H + + +LY ++ + S F+ + RG+
Sbjct: 67 PNVLPVLG--ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 227 SLL--KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT--VYSYIQSRYYRSP 282
+ L + I L ++++ + +I + +Y+ + +P
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGRMYAPA----WVAP 177
Query: 283 EVLLGYQY---TTAIDMWSFGCIVAELFLGLPLFPG 315
E L + DMWSF ++ EL F
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 71/258 (27%), Positives = 119/258 (46%), Gaps = 36/258 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+ + +L+G+GT+GQV K + A+K++ ++ E+++L ++
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINML--------KK 76
Query: 170 DKHH--IVRIYEYFV------CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSK 220
HH I Y F+ L + E + ++ +LIK L + +
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSR 277
+ILRGLS L +IH D+K +N+LL + AE+K++DFG + DRTV ++I +
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFGVSAQLDRTVGRRNTFIGTP 193
Query: 278 YYRSPEVLLGYQ-----YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILGA 331
Y+ +PEV+ + Y D+WS G I A E+ G P + +R + I
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPL---CDMHPMRALFLIPRN 249
Query: 332 QPPDYVLKEAKNTSKFFK 349
P LK K SK F+
Sbjct: 250 PAP--RLKS-KKWSKKFQ 264
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/253 (21%), Positives = 102/253 (40%), Gaps = 35/253 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNK 164
+Y++ DLLG G++G+V + D+E AVKI+K P E+ +L L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR- 64
Query: 165 KYDREDKH-HIVRIYEYFVCQ--RHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSK 220
H +++++ + + + + + E + E++ + R + +
Sbjct: 65 -------HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFC 116
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ---- 275
Q++ GL L GI+H D+KP N+LL T +KI G + +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 276 SRYYRSPEVLLGYQ-YT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA- 331
S ++ PE+ G ++ +D+WS G + + G P F G + + L I
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP-FEGDNIYKLFE---NIGKGS 229
Query: 332 -QPPDYVLKEAKN 343
P +
Sbjct: 230 YAIPGDCGPPLSD 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 49/224 (21%), Positives = 84/224 (37%), Gaps = 32/224 (14%)
Query: 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA-LVEVSILTTLNKKYDRED 170
I ++LG G FGQ K E + +K + Q+ L EV ++ L
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-------- 64
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+H ++++ + L E + L +IK + S F+K I G++
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAY 123
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-------- 280
L IIH DL N L+ + + + DFG A R +
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 281 ---------SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315
+PE++ G Y +D++SFG ++ E+ + P
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 63/245 (25%), Positives = 113/245 (46%), Gaps = 28/245 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
YI+++ LG G+FG+V + VA+K I + + + E+S L L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-- 67
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
H HI+++Y+ + + E L++ I + R ++ + F +QI+
Sbjct: 68 ------HPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKR-MTEDEGRRFFQQIIC 119
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRSP 282
+ I+H DLKPEN+LL ++ +KI DFG S T+ + + S Y +P
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176
Query: 283 EVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQP--PDYVL 338
EV+ G Y +D+WS G ++ + +G LP F +L + ++ PD++
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLP-FDDEFIPNLFK---KVNSCVYVMPDFLS 232
Query: 339 KEAKN 343
A++
Sbjct: 233 PGAQS 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 75/357 (21%), Positives = 128/357 (35%), Gaps = 49/357 (13%)
Query: 2 DEGSPSNGGQVFGASWRPKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNP 61
D P + A P+ F +L + R L L + ++ P
Sbjct: 100 DALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQ-AP 158
Query: 62 LFKYSEELNPKRYLTSPSVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGT 121
++ + L R+L + G D V LG G
Sbjct: 159 FQEFLDSLYFLRFLQWKWLEAQPMGEDWFL---DFRV------------------LGRGG 197
Query: 122 FGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRI 177
FG+V C A K + + YQ A+VE IL ++ ++ IV +
Sbjct: 198 FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF-------IVSL 250
Query: 178 YEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA 232
F + LC+ + + ++Y + + N G ++ QI+ GL L
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVLLGYQ 289
II+ DLKPEN+LL ++I D G A Y + + +PE+LLG +
Sbjct: 309 NIIYRDLKPENVLLDDD---GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 290 YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQP--PDYVLKEAKN 343
Y ++D ++ G + E+ F E + + + +L PD +K+
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 5e-22
Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 28/242 (11%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G FG+V C A K ++ + AL E IL +N ++
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF----- 245
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYEL---IKINHFRGLSLSIVQLFSKQILRGLSL 228
+V + + + LC+ L+ N +L I G + ++ +I GL
Sbjct: 246 --VVSLAYAYETKDALCLVLTLM--NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSAC--TEDRTVYSYIQSRYYRSPEV 284
L I++ DLKPENILL I+I D G A E +T+ + + Y +PEV
Sbjct: 302 LHRERIVYRDLKPENILL-----DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQP--PDYVLKEA 341
+ +YT + D W+ GC++ E+ G F + + R + + +A
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 342 KN 343
++
Sbjct: 417 RS 418
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 57/250 (22%), Positives = 107/250 (42%), Gaps = 27/250 (10%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAY--YQQALVEVSILTTLN 163
++ + +GHG+FG V D + VA+K + + + +Q + EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
++ ++ + + E + +L++++ + L + + L
Sbjct: 113 HPN-------TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGAL 164
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
+GL+ L +IH D+K NILL +K+ DFGSA S++ + Y+ +PE
Sbjct: 165 QGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAPA-NSFVGTPYWMAPE 220
Query: 284 VLLGYQ---YTTAIDMWSFGCIVA-ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
V+L Y +D+WS G I EL P P + + + I + P L+
Sbjct: 221 VILAMDEGQYDGKVDVWSLG-ITCIELAERKP--P-LFNMNAMSALYHIAQNESP--ALQ 274
Query: 340 EAKNTSKFFK 349
+ S++F+
Sbjct: 275 S-GHWSEYFR 283
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 41/247 (16%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
+LG G+F V + + A+KI++ N+ Y E +++ L+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY---VTRERDVMSRLD----- 88
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSN---LYELIKINHFRGLSLSIVQLFSKQIL 223
H V++Y F L N L + KI F + + ++ +I+
Sbjct: 89 ----HPFFVKLYFTFQDDEKLYFGLSYA-KNGELLKYIRKIGSF---DETCTRFYTAEIV 140
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-----CTEDRTVYSYIQSRY 278
L L GIIH DLKPENILL I+I DFG+A ++ S++ +
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDY 336
Y SPE+L + D+W+ GCI+ +L GLP F +E+ + + +I+ + P+
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---KIIKLEYDFPEK 254
Query: 337 VLKEAKN 343
+A++
Sbjct: 255 FFPKARD 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 65/246 (26%), Positives = 101/246 (41%), Gaps = 29/246 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
Y++ D LG GTFG+V VAVKI+ + E+ L
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-- 69
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
H HI+++Y+ + E + L++ I H R + + +QIL
Sbjct: 70 ------HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGR-VEEMEARRLFQQIL 121
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRS 281
+ ++H DLKPEN+LL + KI DFG S ++ + + S Y +
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAA 178
Query: 282 PEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA--QPPDYV 337
PEV+ G Y +D+WS G I+ L G LP F L + +I G P+Y+
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLP-FDDEHVPTLFK---KIRGGVFYIPEYL 234
Query: 338 LKEAKN 343
+
Sbjct: 235 NRSVAT 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 31/258 (12%)
Query: 104 NAETQRRYIVKD-----LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQ 151
N E + D ++G G FG+V C A+ A+K +
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--- 235
Query: 152 ALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGL 210
AL E +L+ ++ IV + F L +L+ N +L ++
Sbjct: 236 ALNERIMLSLVSTGDCP----FIVCMSYAFHTPDKLSFILDLM--NGGDLHYHLSQHGVF 289
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDR 268
S + ++ ++ +I+ GL + + +++ DLKP NILL ++I D G AC ++ +
Sbjct: 290 SEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK 346
Query: 269 TVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
++ + + Y +PEVL G Y ++ D +S GC++ +L G F D
Sbjct: 347 P-HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405
Query: 328 ILGAQP--PDYVLKEAKN 343
L PD E ++
Sbjct: 406 TLTMAVELPDSFSPELRS 423
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 54/268 (20%), Positives = 110/268 (41%), Gaps = 57/268 (21%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-------------KNQPAYYQQALVEV 156
+Y +KD +G G++G V ++ N++ A+K++ + P + A
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 157 SILTTLNKKYDRE-------DKHHIVRIYE--YFVCQRHLCICFELLDSNLYELIKINHF 207
++ +E D ++V++ E + HL + FEL++ ++++
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTL 131
Query: 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT-- 265
+ LS + + + +++G+ L IIH D+KP N+L+ IKI DFG +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED---GHIKIADFGVSNEFK 188
Query: 266 -EDRTVYSYIQSRYYRSPEVLLGYQ--YT-TAIDMWSFGCI---------------VAEL 306
D + + + + + +PE L + ++ A+D+W+ G + L
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 307 FL----GLPLFPGASEF-----DLLRRM 325
FP + DL+ RM
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRM 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 55/247 (22%), Positives = 92/247 (37%), Gaps = 27/247 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYD 167
+ + LG G +G+V + VAVKI+ K + E+ I LN
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN---- 63
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRG 225
H ++V+ Y + + E EL +I G+ Q F Q++ G
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ----SRYYR 280
+ L GI H D+KPEN+LL +KI DFG + + + Y
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 281 SPEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVL 338
+PE+L ++ +D+WS G ++ + G LP + S+ + +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 339 --KEAKN 343
Sbjct: 234 IDSAPLA 240
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY + D LG G V D +N VA+K I P ++ L K+++RE
Sbjct: 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL----------KRFERE 61
Query: 170 DKH-------HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQ 221
+ +IV + + + E ++ L E I+ +H LS+ F+ Q
Sbjct: 62 VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP-LSVDTAINFTNQ 119
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTEDRTVYSYI 274
IL G+ D I+H D+KP+NIL+ ++ +KI DFG ++ T+ V +
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKALSETSLTQTNHV---L 173
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
+ Y SPE G D++S G ++ E+ +G P F G +
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 5e-20
Identities = 66/246 (26%), Positives = 101/246 (41%), Gaps = 29/246 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
YI+ D LG GTFG+V VAVKI+ + E+ L
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-- 74
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQIL 223
H HI+++Y+ + + E + L++ I + R L + +QIL
Sbjct: 75 ------HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGR-LDEKESRRLFQQIL 126
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SAC-TEDRTVYSYIQSRYYRS 281
G+ ++H DLKPEN+LL + KI DFG S ++ + + S Y +
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAA 183
Query: 282 PEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGA--QPPDYV 337
PEV+ G Y +D+WS G I+ L G LP F L + +I P Y+
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLP-FDDDHVPTLFK---KICDGIFYTPQYL 239
Query: 338 LKEAKN 343
+
Sbjct: 240 NPSVIS 245
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 19/213 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY + +G G+FG + D VA+K+ + + Q +E I +
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQGG---- 64
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
I I + + ELL +L +L R SL V L + Q++ + +
Sbjct: 65 --VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYI 121
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------CTEDRTVYSYIQSRYY 279
IH D+KP+N L+ K + IIDFG A R + + Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
S LG + + D+ S G ++ LG LP
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 55/247 (22%), Positives = 92/247 (37%), Gaps = 27/247 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYD 167
+ + LG G +G+V + VAVKI+ K + E+ I LN
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN---- 63
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELI-KINHFRGLSLSIVQLFSKQILRG 225
H ++V+ Y + + E EL +I G+ Q F Q++ G
Sbjct: 64 ----HENVVKFYGHRREGNIQYLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYSYIQ----SRYYR 280
+ L GI H D+KPEN+LL +KI DFG + + + Y
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 281 SPEVLLGYQYT-TAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVL 338
+PE+L ++ +D+WS G ++ + G LP + S+ + +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP-WDQPSDSCQEYSDWKEKKTYLNPWKK 233
Query: 339 --KEAKN 343
Sbjct: 234 IDSAPLA 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 47/245 (19%), Positives = 84/245 (34%), Gaps = 50/245 (20%)
Query: 110 RYIVKDL-----LGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLN 163
R + +D+ +G G +G+V W VAVKI ++ E+ L
Sbjct: 4 RTVARDITLLECVGKGRYGEV---WRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML- 59
Query: 164 KKYDREDKH-HIVRIY----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
+H +I+ L + + +LY+ +++ L
Sbjct: 60 -------RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLR 109
Query: 218 FSKQILRGLSLL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
I GL+ L I H DLK +NIL+ K + I D G A ++
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQS 166
Query: 270 VYSYIQS-------RYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGA 316
+ Y +PEVL + +D+W+FG ++ E+ +
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 317 SEFDL 321
++
Sbjct: 227 EDYKP 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 106 ETQRRYIVK-DLLGHGTFGQVAKC-WDAEM---NSFVAVKIIK-NQPAYYQQALVEVSIL 159
+ + R++ LG G FG V C +D VAVK ++ + + + E+ IL
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 160 TTLNKKYDREDKH-HIVRIYEYFVC----QRHLCICFELLDS-NLYELIKINHFRGLSLS 213
+L +H +IV+ VC +R+L + E L +L + ++ + +
Sbjct: 66 KSL--------QHDNIVKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERID 112
Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
++L ++ QI +G+ L IH DL NIL+ +KI DFG + +
Sbjct: 113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT----KVLP 165
Query: 272 SYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
+++ PE L +++ A D+WSFG ++ ELF
Sbjct: 166 Q--DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 46/248 (18%), Positives = 86/248 (34%), Gaps = 50/248 (20%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV-------AKCWDAEMNSFVAVKIIKNQPAYYQQA-LVEV 156
+ + ++ + LG GTF ++ + + V +K++ Y ++
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 157 SILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLS 211
S+++ L H+V Y VC + E LD+ L +
Sbjct: 64 SMMSKL-------SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK-------NKNC 109
Query: 212 LSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE-----IKIIDFGSAC 264
++I+ +KQ+ + L++ +IH ++ +NILL IK+ D G +
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS- 168
Query: 265 TEDRTVYSYIQSRYYR------SPEVLL-GYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
TV + PE + A D WSFG + E+ G
Sbjct: 169 ---ITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
Query: 317 SEFDLLRR 324
L+
Sbjct: 223 DSQRKLQF 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAE---MNSFVAVKIIKNQPAYYQQALV-EVSIL 159
+ + R++ LG G FG V C +D VAVK +++ + + E+ IL
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 160 TTLNKKYDREDKH-HIVRIYEYFVC----QRHLCICFELLDS-NLYELIKINHFRGLSLS 213
+L +H +IV+ VC +R+L + E L +L + ++ + +
Sbjct: 97 KSL--------QHDNIVKYKG--VCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERID 143
Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
++L ++ QI +G+ L IH DL NIL+ +KI DFG + +
Sbjct: 144 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT----KVLP 196
Query: 272 SYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
YY+ PE L +++ A D+WSFG ++ ELF
Sbjct: 197 Q--DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 43/238 (18%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
E R + + LG G FG+V ++ VAVK +K L E +++ L
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQL- 65
Query: 164 KKYDREDKHHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FS 219
+VR+Y V Q + I E +++ +L + +K G+ L+I +L +
Sbjct: 66 ------QHQRLVRLYA--VVTQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMA 115
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILL-CTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
QI G++ +++ IH DL+ NIL+ T KI DFG A R + + Y
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLS----CKIADFGLA----RLIED---NEY 164
Query: 279 YRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
PE + +T D+WSFG ++ E+ G +PG + ++++
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 47/215 (21%), Positives = 86/215 (40%), Gaps = 21/215 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
Y V +G G+FG + + + N VA+K + + Q E L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGC---- 65
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
I +Y + H + +LL +L +L+ + R S+ V + +KQ+L + +
Sbjct: 66 --TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 122
Query: 230 KDAGIIHCDLKPENILL--CTSVKPAEIKIIDFGSA------CTED----RTVYSYIQSR 277
+ +++ D+KP+N L+ S I ++DFG T+ R + +
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
Y S LG + + D+ + G + G LP
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 43/238 (18%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
E +R I LG G FG V W + + VAVK+IK + E + L
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKL- 60
Query: 164 KKYDREDKHHIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--F 218
+V+ Y VC + + I E + + L ++ + G L QL
Sbjct: 61 ------SHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEM 109
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
+ G++ L+ IH DL N L+ + +K+ DFG R V +Y
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMT----RYVLD---DQY 159
Query: 279 YRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
S PEV ++Y++ D+W+FG ++ E+F LG + + +++ +
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 49/229 (21%)
Query: 106 ETQRRYIVK-DLLGHGTFGQVAKC-WDAEM---NSFVAVKIIKNQPAYYQQA--LVEVSI 158
++R++ + LG G FG+V C +D E VAVK +K + A E+ I
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 159 LTTLNKKYDREDKH-HIVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSL 212
L L H +IV+ +C + + E L S +L E + N +
Sbjct: 77 LRNL--------YHENIVKYKG--ICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKI 123
Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
++ Q ++ QI +G+ L +H DL N+L+ ++KI DFG + +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLT----KAI 176
Query: 271 YSYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
+ YY PE L+ ++ A D+WSFG + EL
Sbjct: 177 ET--DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 47/235 (20%), Positives = 76/235 (32%), Gaps = 45/235 (19%)
Query: 115 DLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH- 172
+G G +G+V W + VAVK+ E+ + +H
Sbjct: 43 KQIGKGRYGEV---WMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM--------RHE 91
Query: 173 HIVRIY----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
+I+ + L + + ++ +LY+ + L + + + GL
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLC 148
Query: 228 LL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS--- 276
L I H DLK +NIL+ K I D G A
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 277 ----RYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321
+ Y PEVL +Q DM+SFG I+ E+ E+ L
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 45/244 (18%), Positives = 89/244 (36%), Gaps = 48/244 (19%)
Query: 110 RYIVKDL-----LGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLN 163
R I + + +G G FG+V W + VAVKI ++ + E I T+
Sbjct: 38 RTIARTIVLQESIGKGRFGEV---WRGKWRGEEVAVKIFSSR--EERSWFREAEIYQTVM 92
Query: 164 KKYDREDKHHIVRIY----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLF 218
+++ +I+ + L + + + +L++ + + +++ +
Sbjct: 93 LRHE-----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKL 144
Query: 219 SKQILRGLSLL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
+ GL+ L I H DLK +NIL+ K I D G A D
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSAT 201
Query: 271 YSYIQSRY-------YRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
+ + Y +PEVL ++ D+++ G + E+ +
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 318 EFDL 321
++ L
Sbjct: 262 DYQL 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 29/221 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKK 165
Y ++ L+G G G V + D VA+K++ P + + E L
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-- 92
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQIL 223
H+V I+++ L + L++ +L +++ L+ +QI
Sbjct: 93 ------EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIG 144
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTEDRTVYSYIQS 276
L AG H D+KPENIL+ ++DFG T+ + +
Sbjct: 145 SALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLGNT---VGT 198
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
YY +PE T D+++ C++ E G P + G
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 47/240 (19%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAYYQQALVEVSILTTL 162
+ +G G FG V + VA+K I+ + + E ++ L
Sbjct: 4 VIDPSELTFVQEIGSGQFGLV---HLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 60
Query: 163 NKKYDREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL- 217
H +V++Y VC Q +C+ E ++ L + ++ RG + L
Sbjct: 61 --------SHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQ--RG-LFAAETLL 107
Query: 218 -FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
+ G++ L++A +IH DL N L+ + IK+ DFG R V
Sbjct: 108 GMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMT----RFVLD---D 157
Query: 277 RYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
+Y S PEV +Y++ D+WSFG ++ E+F G + S +++
Sbjct: 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 48/228 (21%)
Query: 106 ETQRRYIVK-DLLGHGTFGQVAKC-WDAEMNS---FVAVKIIKNQPAYYQQALV-EVSIL 159
+ R++ LG G FG V C +D ++ VAVK +++ Q+ E+ IL
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 160 TTLNKKYDREDKH-HIVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSLS 213
L IV+ V L + E L S L + ++ + L
Sbjct: 79 KAL--------HSDFIVKYRG--VSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLD 125
Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
+L +S QI +G+ L +H DL NIL+ + A +KI DFG A + +
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES---EAHVKIADFGLA----KLLP 178
Query: 272 SYIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
YY PE L ++ D+WSFG ++ ELF
Sbjct: 179 L--DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+ V +G G FG++ + N +VA+K+ + + Q +E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-SRAPQLHLEYRFYKQLGSG---- 64
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
I ++Y + C ++ + ELL +L +L + R SL V + + Q++ + +
Sbjct: 65 --DGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYV 121
Query: 230 KDAGIIHCDLKPENILL--CTSVKPAEIKIIDFGSA----CTEDRTVYSYIQSRY----- 278
+I+ D+KPEN L+ + I IIDF A E + Y + +
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 279 -YRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
Y S LG + + D+ + G + G LP
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 41/238 (17%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
E +R I K LG G +G+V + + + VAVK +K ++ L E +++ +
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-- 66
Query: 165 KYDREDKHHIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FS 219
++V++ VC + I E + NL + ++ +S V L +
Sbjct: 67 -----KHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMA 117
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
QI + L+ IH DL N L+ + +K+ DFG + R + Y
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLS----R----LMTGDTY 166
Query: 280 RS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
+ PE L +++ D+W+FG ++ E+ G+ +PG +
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 1e-17
Identities = 49/213 (23%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
++ + +G G+FG++ + + N VA+K+ + + Q L E I L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKIYRILQGG---- 62
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
I + + V + + +LL +L +L R LSL V + + Q++ + +
Sbjct: 63 --TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFV 119
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRY------Y 279
+H D+KP+N L+ + ++ IIDFG A T Y +++ Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311
S LG + + D+ S G ++ G LP
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 35/234 (14%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
E R + ++ LG G FG+V W+ VA+K +K + L E ++ L
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLR 237
Query: 164 KKYDREDKHHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FS 219
+ +V++Y V + + I E + +L + +K G L + QL +
Sbjct: 238 HE-------KLVQLYA--VVSEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMA 286
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--YIQSR 277
QI G++ ++ +H DL+ NIL+ ++ K+ DFG A R + Y +
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENL---VCKVADFGLA----RLIEDNEYTARQ 339
Query: 278 YYR------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
+ +PE L ++T D+WSFG ++ EL G +PG ++L +
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 55/226 (24%), Positives = 90/226 (39%), Gaps = 33/226 (14%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY + ++LG G +V D + VAVK+++ A ++ RE
Sbjct: 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFY----------LRFRRE 62
Query: 170 DKH-------HIVRIY---EYFVCQRHLC-ICFELLD-SNLYELIKINHFRGLSLSIVQL 217
++ IV +Y E L I E +D L +++ ++
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGP-MTPKRAIE 120
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ-- 275
+ L+ GIIH D+KP NI++ + +K++DFG A + S Q
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISAT---NAVKVMDFGIARAIADSGNSVTQTA 177
Query: 276 ----SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317
+ Y SPE G D++S GC++ E+ G P F G S
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 49/235 (20%), Positives = 94/235 (40%), Gaps = 44/235 (18%)
Query: 112 IVKDLLGHGTFGQVAK-CWDAEMNSF-VAVKIIKN--QPAYYQQALVEVSILTTLNKKYD 167
I LG G FG V + + VA+K++K + A ++ + E I+ L+
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD---- 68
Query: 168 REDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQI 222
+ +IVR+ VCQ L + E+ L++ + + + + Q+
Sbjct: 69 ----NPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQV 119
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS- 281
G+ L++ +H DL N+LL V KI DFG + + + + YY +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLS----KALGA--DDSYYTAR 170
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
PE + ++++ D+WS+G + E G + +++
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 64/252 (25%)
Query: 117 LGHGTFGQVAKC-WDAEMNSF---VAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRED 170
LG G FG V K W E VA+K ++ P ++ L E ++ +++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------- 75
Query: 171 KH-HIVRIYEYFVCQRH-LCICFEL-----LDSNLYELIKINHFRGLSLSIVQL--FSKQ 221
+ H+ R+ +C + + +L L + E ++ L + Q
Sbjct: 76 -NPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQ 125
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
I +G++ L+D ++H DL N+L+ T P +KI DFG A + + + + + Y +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLA----KLLGA--EEKEYHA 176
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR------ 323
E +L YT D+WS+G V EL G + G ++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
Query: 324 RMIRILGAQPPD 335
R+ QPP
Sbjct: 237 RL-----PQPPI 243
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 51/253 (20%), Positives = 99/253 (39%), Gaps = 41/253 (16%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
++G G F +VA + A+KI+ + + + E +L ++++
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF---REERDVLVNGDRRW-- 122
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
I +++ F + +L + E +L L+ + + + + +I+ +
Sbjct: 123 -----ITQLHFAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMAID 176
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY------YRS 281
+ G +H D+KP+NILL I++ DFGS C + R ++S Y S
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC---GHIRLADFGS-CLKLRA-DGTVRSLVAVGTPDYLS 231
Query: 282 PEVLLG-------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL----LRRMIRILG 330
PE+L Y D W+ G E+F G F S + + +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 331 AQPPDYVLKEAKN 343
+ V +EA++
Sbjct: 292 PLVDEGVPEEARD 304
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 53/237 (22%), Positives = 93/237 (39%), Gaps = 45/237 (18%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQPAYYQQALV-EVSILTTL 162
+ + +G G FG V + + VAVK IK QA + E S++T L
Sbjct: 189 ALNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQL 243
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRH---LCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
+H ++V++ V L I E + +L + ++ L L
Sbjct: 244 --------RHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCL 291
Query: 218 --FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
FS + + L+ +H DL N+L+ K+ DFG + S
Sbjct: 292 LKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLT----KEASS--- 341
Query: 276 SRYYR-------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
++ +PE L +++T D+WSFG ++ E++ G +P D++ R
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 35/243 (14%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
LLG GTFG+V + + A+KI++ ++ A+ + E +L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAH---TVTESRVLQNTR----- 63
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRG 225
H + + F LC E N EL ++ R + + + +I+
Sbjct: 64 ----HPFLTALKYAFQTHDRLCFVMEYA--NGGELFFHLSRERVFTEERARFYGAEIVSA 117
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSP 282
L L +++ D+K EN++L IKI DFG ++ T+ ++ + Y +P
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
EVL Y A+D W G ++ E+ G F L IL + P + E
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE---LILMEEIRFPRTLSPE 231
Query: 341 AKN 343
AK+
Sbjct: 232 AKS 234
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 51/253 (20%)
Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIK--------NQPAYYQQALVEVSILTTLNK 164
+LG G +G QV K A A+K++K A+ E +IL +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH---TKAERNILEEVK- 79
Query: 165 KYDREDKHH--IVRIYEYFVCQRHLCICFELLDSNLY----EL-IKINHFRGLSLSIVQL 217
H IV + F L + E Y EL +++
Sbjct: 80 --------HPFIVDLIYAFQTGGKLYLILE------YLSGGELFMQLEREGIFMEDTACF 125
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYS 272
+ +I L L GII+ DLKPENI+L + +K+ DFG + + ++
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIML-----NHQGHVKLTDFGLCKESIHDGTVTHT 180
Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
+ + Y +PE+L+ + A+D WS G ++ ++ G P F G + + +IL +
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID---KILKCK 237
Query: 333 P--PDYVLKEAKN 343
P Y+ +EA++
Sbjct: 238 LNLPPYLTQEARD 250
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 62/243 (25%), Positives = 98/243 (40%), Gaps = 34/243 (13%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
LLG GTFG+V + + A+KI+K ++ A+ L E +L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH---TLTENRVLQNSR----- 206
Query: 169 EDKHH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGL 226
H + + F LC E N EL ++ R S + + +I+ L
Sbjct: 207 ---HPFLTALKYSFQTHDRLCFVMEYA--NGGELFFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 227 SLL-KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSP 282
L + +++ DLK EN++L IKI DFG + T+ ++ + Y +P
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
EVL Y A+D W G ++ E+ G F L IL + P + E
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILMEEIRFPRTLGPE 375
Query: 341 AKN 343
AK+
Sbjct: 376 AKS 378
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 51/252 (20%)
Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKK 165
+LG G+FG V K ++ A+K++K ++ + +E IL +N
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR----VRTKMERDILVEVN-- 84
Query: 166 YDREDKHH--IVRIYEYFVCQRHLCICFELLDSNLY----EL-IKINHFRGLSLSIVQLF 218
H IV+++ F + L + + + +L +++ + V+ +
Sbjct: 85 -------HPFIVKLHYAFQTEGKLYLILD------FLRGGDLFTRLSKEVMFTEEDVKFY 131
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSY 273
++ L L GII+ DLKPENILL E IK+ DFG + ++ YS+
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLD-----EEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 274 IQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333
+ Y +PEV+ +T + D WSFG ++ E+ G F G + + IL A+
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT---MILKAKL 243
Query: 334 --PDYVLKEAKN 343
P ++ EA++
Sbjct: 244 GMPQFLSPEAQS 255
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 66/263 (25%), Positives = 99/263 (37%), Gaps = 60/263 (22%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
E R + LG G FG+V A + ++ VAVK++K ++ + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD---------SNLY 199
+L+ L H +IV + C + E LL+
Sbjct: 79 VLSYLGN-------HMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257
I L+L + L FS Q+ +G++ L IH DL NILL KI
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKI 186
Query: 258 IDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAE 305
DFG A R + + Y +PE + YT D+WS+G + E
Sbjct: 187 CDFGLA----RDIKN---DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 306 LF-LGLPLFPGASEFDLLRRMIR 327
LF LG +PG +MI+
Sbjct: 240 LFSLGSSPYPGMPVDSKFYKMIK 262
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKNQPAYYQQA--LVEVSIL 159
E QR I +G G FG V + + + N VA+K KN + + L E +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFEL-----LDSNLYELIKINHFRGLSLS 213
D HIV++ V + + I EL L S L R SL
Sbjct: 71 RQF-------DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQV-------RKYSLD 114
Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
+ L ++ Q+ L+ L+ +H D+ N+L+ +K+ DFG + R +
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLS----RYME 167
Query: 272 SYIQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
S YY++ PE + ++T+A D+W FG + E+ G+ F G
Sbjct: 168 D---STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224
Query: 320 DLLRR 324
D++ R
Sbjct: 225 DVIGR 229
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 66/251 (26%), Positives = 103/251 (41%), Gaps = 53/251 (21%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LV 154
E R+ I LGHG FG+V ++ +++ VAVK + + + L+
Sbjct: 26 EVPRKNITLIRGLGHGAFGEV---YEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM 82
Query: 155 EVSILTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNLYELIKINHF 207
E I++ + +IVR V + I EL L S L E +
Sbjct: 83 EALIISKF-------NHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRET-RPRPS 132
Query: 208 RGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
+ SL+++ L ++ I G L++ IH D+ N LL KI DFG A
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-- 190
Query: 266 EDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPL 312
R +Y + YYR PE + +T+ D WSFG ++ E+F LG
Sbjct: 191 --RDIYR---ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 313 FPGASEFDLLR 323
+P S ++L
Sbjct: 246 YPSKSNQEVLE 256
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 56/249 (22%), Positives = 101/249 (40%), Gaps = 40/249 (16%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLN 163
+ LG G+FG+V E + A+KI+ Q + L E IL +N
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH---TLNEKRILQAVN 99
Query: 164 KKYDREDKHH--IVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLSLSIVQ 216
+V++ F +L + E + S+L +I F S +
Sbjct: 100 ---------FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRF---SEPHAR 144
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
++ QI+ L +I+ DLKPEN+L+ + I++ DFG A ++ +
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLCGT 201
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--P 334
+PE++L Y A+D W+ G ++ E+ G P F + +I+ + P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE---KIVSGKVRFP 258
Query: 335 DYVLKEAKN 343
+ + K+
Sbjct: 259 SHFSSDLKD 267
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 51/229 (22%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WD---AEMNSFVAVKIIKNQPAYYQQA--LVEVSI 158
+RY+ LG G FG+V+ +D VAVK +K ++ E+ I
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 159 LTTLNKKYDREDKH-HIVRIYEYFVCQRH----LCICFELLDS-NLYELIKINHFRGLSL 212
L TL H HI++ C+ L + E + +L + + + S+
Sbjct: 87 LRTL--------YHEHIIKYKG--CCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SI 131
Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
+ QL F++QI G++ L IH DL N+LL +KI DFG A + V
Sbjct: 132 GLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN---DRLVKIGDFGLA----KAV 184
Query: 271 YSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
YYR +PE L Y++ A D+WSFG + EL
Sbjct: 185 PE--GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 52/238 (21%), Positives = 92/238 (38%), Gaps = 43/238 (18%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
E + + LG G FG V W + + VA+K+IK + + E ++ L
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNL- 76
Query: 164 KKYDREDKHHIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--F 218
+V++Y VC QR + I E + + L ++ QL
Sbjct: 77 ------SHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEM 125
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY 278
K + + L+ +H DL N L+ +K+ DFG + R V Y
Sbjct: 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQG---VVKVSDFGLS----RYVLD---DEY 175
Query: 279 YRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
S PEVL+ ++++ D+W+FG ++ E++ LG + + +
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-17
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 47/238 (19%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALV-EVSILTTL 162
+ + +G G FG V + + VAVK IK QA + E S++T L
Sbjct: 17 ALNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQL 71
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRH---LCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
+H ++V++ V L I E + +L + ++ L L
Sbjct: 72 --------RHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCL 119
Query: 218 --FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI-KIIDFGSACTEDRTVYSYI 274
FS + + L+ +H DL N+L V + K+ DFG + S
Sbjct: 120 LKFSLDVCEAMEYLEGNNFVHRDLAARNVL----VSEDNVAKVSDFGLT----KEASS-- 169
Query: 275 QSRYYR-------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
++ +PE L +++T D+WSFG ++ E++ G +P D++ R
Sbjct: 170 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 56/247 (22%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIK-NQPAYYQQALV-EVS 157
E R + LG G FG+V A + + VAVK++K A ++AL+ E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-----SNLYELIK 203
I++ L +H +IV + C + + E LL+ S + E
Sbjct: 102 IMSHL-------GQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 204 INHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
+ S L FS Q+ +G++ L IH D+ N+LL KI DFG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFG 209
Query: 262 SACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-L 308
A R + + Y +PE + YT D+WS+G ++ E+F L
Sbjct: 210 LA----RDIMN---DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 309 GLPLFPG 315
GL +PG
Sbjct: 263 GLNPYPG 269
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-17
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 40/225 (17%)
Query: 117 LGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIV 175
LG G FG+V ++ VAVK +K + L E +++ TL +V
Sbjct: 196 LGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-------QHDKLV 246
Query: 176 RIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKD 231
+++ V + + I E + +L + +K + G + +L FS QI G++ ++
Sbjct: 247 KLHA--VVTKEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS---------- 281
IH DL+ NIL+ S+ KI DFG A R + + Y
Sbjct: 303 RNYIHRDLRAANILVSASL---VCKIADFGLA----RVIED---NEYTAREGAKFPIKWT 352
Query: 282 -PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
PE + +T D+WSFG ++ E+ G +PG S +++R
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 59/260 (22%), Positives = 106/260 (40%), Gaps = 57/260 (21%)
Query: 106 ETQRRYIVKD-LLGHGTFGQVAKC-WDAEMNSF---VAVKIIKNQPAYYQQA--LVEVSI 158
+ + K +LG G FG V K W E S V +K+I+++ +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 159 LTTLNKKYDREDKH-HIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIV 215
+ +L+ H HIVR+ +C L + + L +L + ++ + RG +L
Sbjct: 69 IGSLD--------HAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQH--RG-ALGPQ 115
Query: 216 QL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSY 273
L + QI +G+ L++ G++H +L N+LL + P+++++ DFG A +
Sbjct: 116 LLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS---PSQVQVADFGVA----DLLPP- 167
Query: 274 IQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDL 321
+ E + +YT D+WS+G V EL G + G ++
Sbjct: 168 -DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
Query: 322 LR------RMIRILGAQPPD 335
R+ AQP
Sbjct: 227 PDLLEKGERL-----AQPQI 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 67/248 (27%), Positives = 100/248 (40%), Gaps = 47/248 (18%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
E R+ I LGHG FG+V + + VAVK + + + L+E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNLYELIKINHFRGL 210
I++ N +IVR V + I EL L S L E + +
Sbjct: 127 IISKFNH-------QNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPS 176
Query: 211 SLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268
SL+++ L ++ I G L++ IH D+ N LL KI DFG A R
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----R 232
Query: 269 TVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPG 315
+Y + YYR PE + +T+ D WSFG ++ E+F LG +P
Sbjct: 233 DIYR---AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 316 ASEFDLLR 323
S ++L
Sbjct: 290 KSNQEVLE 297
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 49/242 (20%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAKCWDAEMNSF---VAVKIIKNQPAYYQQALVEVSILTT 161
E +R I +K LG G +G+V ++ + VAVK +K ++ L E +++
Sbjct: 216 EMERTDITMKHKLGGGQYGEV---YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 272
Query: 162 LNKKYDREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
+ H ++V++ VC + I E + NL + ++ +S V L
Sbjct: 273 IK--------HPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVL 320
Query: 218 --FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275
+ QI + L+ IH +L N L+ + +K+ DFG + R +
Sbjct: 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLS----R----LMT 369
Query: 276 SRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
Y + PE L +++ D+W+FG ++ E+ G+ +PG +
Sbjct: 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429
Query: 323 RR 324
Sbjct: 430 EL 431
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 64/277 (23%)
Query: 103 VNAETQRRYIVKD-----LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQ 150
+N R +D ++G G FG+V A+K++ + A++
Sbjct: 58 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF- 116
Query: 151 QALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLY----ELIKINH 206
E I+ N + +V+++ F R+L + E Y +L+ +
Sbjct: 117 --WEERDIMAFANSPW-------VVQLFYAFQDDRYLYMVME------YMPGGDLVNLMS 161
Query: 207 FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--C 264
+ + ++ +++ L + G IH D+KP+N+LL S +K+ DFG+
Sbjct: 162 NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKM 218
Query: 265 TEDRTVYS--------YIQSRYYRSPEVLLG----YQYTTAIDMWSFGCIVAELFLGLPL 312
++ V YI SPEVL Y D WS G + E+ +G
Sbjct: 219 NKEGMVRCDTAVGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
Query: 313 FPGASEFDLLRRMIRILGAQ-----PPD-YVLKEAKN 343
F S +I+ + P D + KEAKN
Sbjct: 273 FYADSLVGTYS---KIMNHKNSLTFPDDNDISKEAKN 306
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 1e-16
Identities = 60/239 (25%), Positives = 100/239 (41%), Gaps = 26/239 (10%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G+FG+V + AVKI+K Q + +VE +L K
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK------- 400
Query: 172 HH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ +++ F L E + N +L I ++ +I GL L
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYV--NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSPEVLL 286
+ GII+ DLK +N++L + IKI DFG + T ++ + Y +PE++
Sbjct: 459 QSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 515
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKEAKN 343
Y ++D W+FG ++ E+ G F G E +L + I+ P + KEA
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---SIMEHNVAYPKSMSKEAVA 571
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 62/262 (23%), Positives = 95/262 (36%), Gaps = 59/262 (22%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
E R + LG G FGQV + VAVK++K + + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC---QRHLCICFE------LLD-------SNLYE 200
IL + H ++V + C L + E L +
Sbjct: 83 ILIHI-------GHHLNVVNLLG--ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133
Query: 201 LIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258
+ L++ L +S Q+ +G+ L IH DL NILL +KI
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKIC 190
Query: 259 DFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAEL 306
DFG A R +Y Y +PE + YT D+WSFG ++ E+
Sbjct: 191 DFGLA----RDIYK---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 307 F-LGLPLFPGASEFDLLRRMIR 327
F LG +PG + R ++
Sbjct: 244 FSLGASPYPGVKIDEEFCRRLK 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 113 VKDLLGHGTFGQVAKC-WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDK 171
++ LG G FG+V W+ VA+K +K + L E ++ L +
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHE------ 322
Query: 172 HHIVRIYEYFVC-QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQILRGLS 227
+V++Y V + + I E + +L + +K G L + QL + QI G++
Sbjct: 323 -KLVQLYA--VVSEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMA 377
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS--YIQSRYYR----- 280
++ +H DL+ NIL+ ++ K+ DFG A R + Y + +
Sbjct: 378 YVERMNYVHRDLRAANILVGENLV---CKVADFGLA----RLIEDNEYTARQGAKFPIKW 430
Query: 281 -SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
+PE L ++T D+WSFG ++ EL G +PG ++L +
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 42/234 (17%)
Query: 112 IVKDLLGHGTFGQVAK-CWDAEMNSF-VAVKIIKN---QPAYYQQALVEVSILTTLNKKY 166
+ LG G FG V K + + VAVKI+KN PA + L E +++ L+
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD--- 76
Query: 167 DREDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
+ +IVR+ +C+ + E+ + L + ++ N R + + Q+
Sbjct: 77 -----NPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVS 127
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS-- 281
G+ L+++ +H DL N+LL V KI DFG + + + + YY++
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLS----KALRA--DENYYKAQT 178
Query: 282 ----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
PE + Y++++ D+WSFG ++ E F G + G ++
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 57/253 (22%), Positives = 101/253 (39%), Gaps = 43/253 (16%)
Query: 116 LLGHGTFG---QVAKCWDAEMNSFVAVKIIK-----NQPAYYQQALVEVSILTTLNKKYD 167
+LG G +G V K + A+K++K + + E +L +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR---- 116
Query: 168 REDKHH--IVRIYEYFVCQRHLCICFELLDSN----LYELIKINHFRGLSLSIVQLFSKQ 221
+V ++ F + L + + + N L + F + VQ++ +
Sbjct: 117 ----QSPFLVTLHYAFQTETKLHLILDYI--NGGELFTHLSQRERF---TEHEVQIYVGE 167
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG----SACTEDRTVYSYIQ 275
I+ L L GII+ D+K ENILL + + + DFG E Y +
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLD-----SNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 276 SRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQ 332
+ Y +P+++ G + A+D WS G ++ EL G F E + + R IL ++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 333 P--PDYVLKEAKN 343
P P + AK+
Sbjct: 283 PPYPQEMSALAKD 295
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 55/248 (22%), Positives = 94/248 (37%), Gaps = 40/248 (16%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
+G G+FG+V + A+K + N+ E+ I+ L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN---VFKELQIMQGLE----- 73
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSN----LYELIKINHFRGLSLSIVQLFSKQI 222
H +V ++ F + + + +LL Y L + HF V+LF ++
Sbjct: 74 ----HPFLVNLWYSFQDEEDMFMVVDLL--LGGDLRYHLQQNVHF---KEETVKLFICEL 124
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYR 280
+ L L++ IIH D+KP+NILL + I DF A + + + ++ Y
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEH---GHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 281 SPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PD 335
+PE+ G Y+ A+D WS G EL G + S + P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 336 YVLKEAKN 343
+E +
Sbjct: 242 AWSQEMVS 249
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 59/333 (17%), Positives = 116/333 (34%), Gaps = 59/333 (17%)
Query: 19 PKGFSFGPYLVQKDAPSLRVVVRKPLVVRLTKDIVETYQICNPLFKYSEELNPKRYLTSP 78
P G + ++ + + ++V + I ++ L+K + N
Sbjct: 6 PMGHHHHHHGRRRASVAAGILVPRGSPG--LDGICSIEELSTSLYKKAGSENLY----FQ 59
Query: 79 SVGVLNDGYDNVNSDLILAVNLVLVNAETQRRYIV-KDLLGHGTFGQVAKC---WDAEMN 134
++ +N +L+ AV V++ + +++G G FG V +
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVI--GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK 117
Query: 135 SFVAVKIIKNQPAYYQQA--LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH---LCI 189
AVK + + + L E I+ +++ + +C R +
Sbjct: 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLG--ICLRSEGSPLV 168
Query: 190 CFEL-----LDSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPE 242
L + + + ++ L F Q+ +G+ L +H DL
Sbjct: 169 VLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221
Query: 243 NILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR-----------SPEVLLGYQYT 291
N +L +K+ DFG A R +Y + + E L ++T
Sbjct: 222 NCMLDEKFT---VKVADFGLA----RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274
Query: 292 TAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
T D+WSFG ++ EL G P +P + FD+
Sbjct: 275 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 55/262 (20%), Positives = 98/262 (37%), Gaps = 51/262 (19%)
Query: 89 NVNSDLILAVNLVLVNAETQRRYIV-KDLLGHGTFGQVAKC---WDAEMNSFVAVKIIKN 144
+N +L+ AV V++ + +++G G FG V + AVK +
Sbjct: 6 ALNPELVQAVQHVVI--GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 145 QPAYYQQA--LVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH---LCICFELLDS-NL 198
+ + L E I+ +++ + +C R + + +L
Sbjct: 64 ITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDL 114
Query: 199 YELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256
I+ + ++ L F Q+ +G+ L +H DL N +L +K
Sbjct: 115 RNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VK 168
Query: 257 IIDFGSACTEDRTVYSYIQSRYYR--------------SPEVLLGYQYTTAIDMWSFGCI 302
+ DFG A R +Y YY + E L ++TT D+WSFG +
Sbjct: 169 VADFGLA----RDMYD---KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 303 VAELF-LGLPLFPGASEFDLLR 323
+ EL G P +P + FD+
Sbjct: 222 LWELMTRGAPPYPDVNTFDITV 243
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 69/245 (28%), Positives = 110/245 (44%), Gaps = 38/245 (15%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
+LG G+FG+V + N F A+K +K + +VE +L+ +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---TMVEKRVLSLAWE---- 76
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRG 225
H + ++ F + +L E L N +L I LS ++ +I+ G
Sbjct: 77 ----HPFLTHMFCTFQTKENLFFVMEYL--NGGDLMYHIQSCHKFDLSRATFYAAEIILG 130
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSYIQSRYYR 280
L L GI++ DLK +NILL + IKI DFG D ++ + Y
Sbjct: 131 LQFLHSKGIVYRDLKLDNILL-----DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 185
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVL 338
+PE+LLG +Y ++D WSFG ++ E+ +G F G E +L I P P ++
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH---SIRMDNPFYPRWLE 242
Query: 339 KEAKN 343
KEAK+
Sbjct: 243 KEAKD 247
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 52/259 (20%), Positives = 92/259 (35%), Gaps = 63/259 (24%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
E + + LG FG+V K E VA+K +K++ + E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNL--------YELI 202
+ L ++V + V + L + F L L
Sbjct: 65 LRARL-------QHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 203 KINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE---IKI 257
+ +L QI G+ L ++H DL N+L+ + +KI
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV------YDKLNVKI 169
Query: 258 IDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAE 305
D G R VY+ + YY+ +PE ++ +++ D+WS+G ++ E
Sbjct: 170 SDLGLF----REVYA---ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 306 LF-LGLPLFPGASEFDLLR 323
+F GL + G S D++
Sbjct: 223 VFSYGLQPYCGYSNQDVVE 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 68/255 (26%), Positives = 102/255 (40%), Gaps = 56/255 (21%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALV-EVSI 158
+RR IV K LG G FG+V + VAVK +K+ ++ E +
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 159 LTTLNKKYDREDKHHIVRIYEYFVCQRH--LCICFEL-----LDSNL--------YELIK 203
LT L HIV+ Y VC L + FE L+ L +
Sbjct: 71 LTNL-------QHEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 204 INHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261
L + Q+ + QI G+ L +H DL N L+ ++ +KI DFG
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDFG 178
Query: 262 SACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-L 308
+ R VYS + YYR PE ++ ++TT D+WSFG I+ E+F
Sbjct: 179 MS----RDVYS---TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 309 GLPLFPGASEFDLLR 323
G + S +++
Sbjct: 232 GKQPWFQLSNTEVIE 246
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 55/239 (23%), Positives = 101/239 (42%), Gaps = 37/239 (15%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CWDAEMNS--FVAVKIIKNQPAYYQQA--LVEVSIL 159
E + I ++ ++G G G+V VA+K +K Q+ L E SI+
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 160 TTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFELLDS-NLYELIKINHFRGLSLSIV 215
+ H +I+R+ V R I E +++ +L ++ + +I+
Sbjct: 105 GQFD--------HPNIIRLEG--VVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIM 151
Query: 216 QL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-SACTEDRTVYS 272
QL + + G+ L D G +H DL N+L+ K+ DFG S ED +
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAA 208
Query: 273 YIQS------RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
Y + R+ +PE + +++A D+WSFG ++ E+ G + + D++
Sbjct: 209 YTTTGGKIPIRWT-APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 57/244 (23%), Positives = 96/244 (39%), Gaps = 50/244 (20%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF------VAVKIIKNQPAYYQQA--LVEV 156
R +V +LG G FG+V ++ + VAVK K + + E
Sbjct: 8 GIAREDVVLNRILGEGFFGEV---YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEA 64
Query: 157 SILTTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSI 214
I+ L D HIV++ + + I EL L ++ N SL +
Sbjct: 65 VIMKNL-------DHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERN---KNSLKV 112
Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
+ L +S QI + ++ L+ +H D+ NIL+ P +K+ DFG + R +
Sbjct: 113 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLS----RYIED 165
Query: 273 YIQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFD 320
YY++ PE + ++TTA D+W F + E+ G F D
Sbjct: 166 ---EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
Query: 321 LLRR 324
++
Sbjct: 223 VIGV 226
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 66/262 (25%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD-----AEMNSFVAVKIIKNQPAYYQQA--LVE 155
E R + LG G FGQV A+ + VAVK++K+ + + E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-------SNLY 199
+ ++ + KH +I+ + C L + E L + +
Sbjct: 137 MEMMKMI-------GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--- 254
IN ++ L + Q+ RG+ L IH DL N+L+ E
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------TENNV 241
Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCI 302
+KI DFG A R + + YY+ +PE L YT D+WSFG +
Sbjct: 242 MKIADFGLA----RDINN---IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 303 VAELF-LGLPLFPGASEFDLLR 323
+ E+F LG +PG +L +
Sbjct: 295 MWEIFTLGGSPYPGIPVEELFK 316
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 60/244 (24%), Positives = 100/244 (40%), Gaps = 36/244 (14%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
+LG G+FG+V + AVKI+K + +VE +L K
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVEC---TMVEKRVLALPGK---- 79
Query: 169 EDKHH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGL 226
+ +++ F L E + N +L I ++ +I GL
Sbjct: 80 ---PPFLTQLHSCFQTMDRLYFVMEYV--NGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSYIQSRYYRS 281
L+ GII+ DLK +N++L +E IKI DFG + T ++ + Y +
Sbjct: 135 FFLQSKGIIYRDLKLDNVML-----DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 189
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLK 339
PE++ Y ++D W+FG ++ E+ G F G E +L + I+ P + K
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ---SIMEHNVAYPKSMSK 246
Query: 340 EAKN 343
EA
Sbjct: 247 EAVA 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 63/262 (24%), Positives = 100/262 (38%), Gaps = 66/262 (25%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD-----AEMNSFVAVKIIKNQPAYYQQA--LVE 155
E R + LG G FGQV A+ + VAVK++K+ + + E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-------SNLY 199
+ ++ + KH +I+ + C L + E L + +
Sbjct: 91 MEMMKMI-------GKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141
Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--- 254
IN ++ L + Q+ RG+ L IH DL N+L+ E
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------TENNV 195
Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCI 302
+KI DFG A R + + YY+ +PE L YT D+WSFG +
Sbjct: 196 MKIADFGLA----RDINN---IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 303 VAELF-LGLPLFPGASEFDLLR 323
+ E+F LG +PG +L +
Sbjct: 249 MWEIFTLGGSPYPGIPVEELFK 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 65/259 (25%), Positives = 100/259 (38%), Gaps = 60/259 (23%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD-----AEMNSFVAVKIIKNQPAYYQQA--LVE 155
E R +V LG G FGQV A+ + VAVK++K+ + + E
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 156 VSILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD-------SNLY 199
+ ++ + K H +I+ + C L + E L + L
Sbjct: 125 MEMMKMIGK-------HKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175
Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257
+H LS L + Q+ RG+ L IH DL N+L+ +KI
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKI 232
Query: 258 IDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAE 305
DFG A R ++ YY+ +PE L YT D+WSFG ++ E
Sbjct: 233 ADFGLA----RDIHH---IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285
Query: 306 LF-LGLPLFPGASEFDLLR 323
+F LG +PG +L +
Sbjct: 286 IFTLGGSPYPGVPVEELFK 304
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 50/246 (20%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CW---DAEMNSFVAVKIIKNQPAYYQQA--LVEVSI 158
E + + ++G G FG+V K + VA+K +K Q+ L E I
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99
Query: 159 LTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL-----LDSNLYELIKINHFRGLS 211
+ H+I+R+ V + + I E LD L E +
Sbjct: 100 MGQF-------SHHNIIRLEG--VISKYKPMMIITEYMENGALDKFLRE-------KDGE 143
Query: 212 LSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT 269
S++QL + I G+ L + +H DL NIL+ K+ DFG + R
Sbjct: 144 FSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS----RV 196
Query: 270 VYSYIQSRYYRS----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASE 318
+ ++ Y S PE + ++T+A D+WSFG ++ E+ G + S
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256
Query: 319 FDLLRR 324
++++
Sbjct: 257 HEVMKA 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 34/243 (13%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
+LG G+FG+V E AVK++K + + E IL+
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVEC---TMTEKRILSLARN---- 82
Query: 169 EDKHH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRG 225
H + +++ F L E + N +L I R + + ++ +I+
Sbjct: 83 ----HPFLTQLFCCFQTPDRLFFVMEFV--NGGDLMFHIQKSRRFDEARARFYAAEIISA 136
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRYYRSP 282
L L D GII+ DLK +N+LL K+ DFG T ++ + Y +P
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGICNGVTTATFCGTPDYIAP 193
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLKE 340
E+L Y A+D W+ G ++ E+ G F +E DL IL + P ++ ++
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFE---AILNDEVVYPTWLHED 250
Query: 341 AKN 343
A
Sbjct: 251 ATG 253
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 7e-16
Identities = 62/253 (24%), Positives = 100/253 (39%), Gaps = 58/253 (22%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
LG G+FG+V + A+K++K Q + E +L+ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH---TNDERLMLSIVT----- 64
Query: 169 EDKHH--IVRIYEYFVCQRHLCICF------ELLDSNLYELIKINHFRGLSLSIVQLFSK 220
H I+R++ F + + + EL L K F + + ++
Sbjct: 65 ----HPFIIRMWGTFQDAQQIFMIMDYIEGGELF----SLLRKSQRF---PNPVAKFYAA 113
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSACTEDRTVYS------ 272
++ L L II+ DLKPENILL IKI DFG A Y+
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLD-----KNGHIKITDFGFAKYVPDVTYTLCGTPD 168
Query: 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332
YI +PEV+ Y +ID WSFG ++ E+ G F ++ +IL A+
Sbjct: 169 YI------APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE---KILNAE 219
Query: 333 P--PDYVLKEAKN 343
P + ++ K+
Sbjct: 220 LRFPPFFNEDVKD 232
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 56/241 (23%), Positives = 86/241 (35%), Gaps = 45/241 (18%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILT 160
+V + +G G FG+V + VAVK + +A L E IL
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL--VAVKSCRETLPPDLKAKFLQEARILK 167
Query: 161 TLNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL- 217
+ H +IVR+ ++ + I EL+ + ++ G L + L
Sbjct: 168 QYS--------HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLL 216
Query: 218 -FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
G+ L+ IH DL N L+ +KI DFG + R
Sbjct: 217 QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN---VLKISDFGMS----REEA---DG 266
Query: 277 RYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR 323
Y S PE L +Y++ D+WSFG ++ E F LG +P S
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326
Query: 324 R 324
Sbjct: 327 F 327
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 50/252 (19%), Positives = 81/252 (32%), Gaps = 54/252 (21%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF------VAVKIIKNQPAYYQQA---LVE 155
+ +LG G FG V +A++ VAVK++K L E
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSV---REAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 156 VSILTTLNKKYDREDKHHIVRIY------EYFVCQRHLCICFEL-----LDSNLYELIKI 204
+ + D H+ ++ + L + L
Sbjct: 76 AACMKEF-------DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 205 NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
+ L L + F I G+ L IH DL N +L + + + DFG +
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT---VCVADFGLS- 184
Query: 265 TEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLP 311
R +YS YYR + E L YT D+W+FG + E+ G
Sbjct: 185 ---RKIYS---GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238
Query: 312 LFPGASEFDLLR 323
+ G ++
Sbjct: 239 PYAGIENAEIYN 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 57/245 (23%), Positives = 97/245 (39%), Gaps = 49/245 (20%)
Query: 106 ETQRRYI-VKDLLGHGTFGQVAK-CW--DAEMNSFVAVKIIKNQPAYYQQA--LVEVSIL 159
E I + ++G G FG+V ++ VA+K +K Q+ L E SI+
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 160 TTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL-----LDSNLYELIKINHFRGLSL 212
D +I+R+ V + + I E LDS L +
Sbjct: 101 GQF-------DHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSFLRK-------HDAQF 144
Query: 213 SIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV 270
+++QL + I G+ L D G +H DL NIL+ K+ DFG R +
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLG----RVL 197
Query: 271 YSYIQSRYYRS----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
++ Y PE + ++T+A D+WS+G ++ E+ G + S
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 320 DLLRR 324
D+++
Sbjct: 258 DVIKA 262
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 58/255 (22%), Positives = 94/255 (36%), Gaps = 58/255 (22%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWDAEMNSFVAVKIIKNQPAYYQQA--LVEVSILT 160
I +D++G G FGQV A+ + A+K +K + E+ +L
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 161 TLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFEL-----LDSNL--------YELIKI 204
L H +I+ + C + +L + E L L I
Sbjct: 81 KLGH-------HPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 205 NHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262
+ +LS QL F+ + RG+ L IH DL NIL+ + KI DFG
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY---VAKIADFGL 188
Query: 263 ACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LG 309
+ ++ Y + E L YTT D+WS+G ++ E+ LG
Sbjct: 189 SRGQE----------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 238
Query: 310 LPLFPGASEFDLLRR 324
+ G + +L +
Sbjct: 239 GTPYCGMTCAELYEK 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 61/253 (24%), Positives = 95/253 (37%), Gaps = 57/253 (22%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF--------VAVKIIKNQPAYYQQA--LV 154
E R I LG G+FG V ++ VA+K + + ++ L
Sbjct: 21 EVAREKITMSRELGQGSFGMV---YEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 155 EVSILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL---------LDSNLYELIK 203
E S++ + HH+VR+ V + + EL L S +
Sbjct: 78 EASVMKEF-------NCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 128
Query: 204 INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
SLS + + +I G++ L +H DL N ++ +KI DFG
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMT 185
Query: 264 CTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGL 310
R +Y + YYR SPE L +TT D+WSFG ++ E+ L
Sbjct: 186 ----RDIYE---TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
Query: 311 PLFPGASEFDLLR 323
+ G S +LR
Sbjct: 239 QPYQGLSNEQVLR 251
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 50/269 (18%), Positives = 94/269 (34%), Gaps = 64/269 (23%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKCWDAEMNSF------VAVKIIKNQPAYYQQA---LVE 155
R ++ +LG G FG V + + VAVK +K + ++ L E
Sbjct: 30 VIDRNLLILGKILGEGEFGSV---MEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 156 VSILTTLNKKYDREDKHHIVRIY-----EYFVCQRHLCICFELLDS-NLYELIKIN--HF 207
+ + +++R+ + + +L+ + +
Sbjct: 87 AACMKDF-------SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 208 RGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
+ + L F I G+ L + +H DL N +L + + + DFG +
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT---VCVADFGLS-- 194
Query: 266 EDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPL 312
+ +YS YYR + E L YT+ D+W+FG + E+ G+
Sbjct: 195 --KKIYS---GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
Query: 313 FPGASEFDLLR------RMIRILGAQPPD 335
+PG ++ R+ QP D
Sbjct: 250 YPGVQNHEMYDYLLHGHRL-----KQPED 273
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 15/169 (8%)
Query: 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166
++++ +G G FG + + A ++K + E+ + KK
Sbjct: 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKD 94
Query: 167 DREDKHH--------IVRIYEY----FVCQRHLCICFELLDSNLYELIKINHFRGLSLSI 214
+ I Y F + + + E L +L ++ N S
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN--GTFKKST 152
Query: 215 VQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
V ++L L + + +H D+K N+LL P ++ + D+G +
Sbjct: 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLS 200
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 47/227 (20%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIK----NQPAYYQQALVEVS 157
+ + + LG G+FG V + WDA VAVK +K +QP + EV+
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSI 214
+ +L+ H +++R+Y V + + EL +L + ++ + +
Sbjct: 74 AMHSLD--------HRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKH---QGHFLL 120
Query: 215 VQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYS 272
L ++ Q+ G+ L+ IH DL N+LL +KI DFG R +
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLM----RALPQ 173
Query: 273 YIQSRYYRS------------PEVLLGYQYTTAIDMWSFGCIVAELF 307
+Y PE L ++ A D W FG + E+F
Sbjct: 174 --NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 70/257 (27%), Positives = 100/257 (38%), Gaps = 61/257 (23%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALV-EVSI 158
+RR IV K LG G FG+V + VAVK +K +Q E +
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 159 LTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL-----LDSNL-------YELIKI 204
LT L HIVR + VC R L + FE L+ L L
Sbjct: 97 LTML-------QHQHIVRFFG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147
Query: 205 NHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE---IKIID 259
L + QL + Q+ G+ L +H DL N L+ + +KI D
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV------GQGLVVKIGD 201
Query: 260 FGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGCIVAELF 307
FG + R +YS + YYR PE +L ++TT D+WSFG ++ E+F
Sbjct: 202 FGMS----RDIYS---TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 308 -LGLPLFPGASEFDLLR 323
G + S + +
Sbjct: 255 TYGKQPWYQLSNTEAID 271
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 64/252 (25%)
Query: 117 LGHGTFGQVAKC-WDAEMNSF---VAVKIIKN--QPAYYQQALVEVSILTTLNKKYDRED 170
LG G FG V K W E VA+K ++ P ++ L E ++ +++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD------- 75
Query: 171 KH-HIVRIYEYFVC-QRHLCICFEL-----LDSNLYELIKINHFRGLSLSIVQL--FSKQ 221
+ H+ R+ +C + + +L L + E ++ L + Q
Sbjct: 76 -NPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQ 125
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281
I +G++ L+D ++H DL N+L+ T P +KI DFG A + + + + + Y +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKT---PQHVKITDFGLA----KLLGA--EEKEYHA 176
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLR------ 323
E +L YT D+WS+G V EL G + G ++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
Query: 324 RMIRILGAQPPD 335
R+ QPP
Sbjct: 237 RL-----PQPPI 243
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 67/269 (24%), Positives = 105/269 (39%), Gaps = 73/269 (27%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
E R+ +V LG G FG+V A + + VAVK++K + + L E +
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD------------- 195
+L +N H H++++Y C L + E L
Sbjct: 79 VLKQVN--------HPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 196 --SNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251
++H +L++ L F+ QI +G+ L + ++H DL NIL+
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV----- 183
Query: 252 PAE---IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDM 296
AE +KI DFG + R VY Y + E L + YTT D+
Sbjct: 184 -AEGRKMKISDFGLS----RDVYE---EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 297 WSFGCIVAELF-LGLPLFPGASEFDLLRR 324
WSFG ++ E+ LG +PG L
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPERLFNL 264
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 52/245 (21%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAK-CWDAEMNSF--VAVKIIKNQPAYYQQA--LVEVSIL 159
E QR I +G G FG V + + + N VA+K KN + + L E +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRH-LCICFEL-----LDSNLYELIKINHFRGLSLS 213
D HIV++ V + + I EL L S L R SL
Sbjct: 446 RQF-------DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQV-------RKFSLD 489
Query: 214 IVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY 271
+ L ++ Q+ L+ L+ +H D+ N+L+ + +K+ DFG + R +
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS---NDCVKLGDFGLS----RYME 542
Query: 272 SYIQSRYYRS-----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
S YY++ PE + ++T+A D+W FG + E+ G+ F G
Sbjct: 543 D---STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 320 DLLRR 324
D++ R
Sbjct: 600 DVIGR 604
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 58/274 (21%), Positives = 100/274 (36%), Gaps = 52/274 (18%)
Query: 102 LVNAETQRRYIVKD-----LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYY 149
+ Q R +D ++G G FG+VA + A+KI+ + A +
Sbjct: 62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 150 QQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFR 208
E +L + K+ I ++ F +L + + +L L+
Sbjct: 122 ---REERDVLVNGDSKW-------ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS-KFED 170
Query: 209 GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTE 266
L + + + +++ + + +H D+KP+NIL+ I++ DFGS E
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLME 227
Query: 267 DRTVYS--------YIQSRYYRSPEVLLGYQ-----YTTAIDMWSFGCIVAELFLGLPLF 313
D TV S YI SPE+L + Y D WS G + E+ G F
Sbjct: 228 DGTVQSSVAVGTPDYI------SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
Query: 314 PGASEFDL----LRRMIRILGAQPPDYVLKEAKN 343
S + + R V + AK+
Sbjct: 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 63/268 (23%), Positives = 106/268 (39%), Gaps = 65/268 (24%)
Query: 106 ETQRRYIV-KDLLGHGTFGQV--AKCWD---AEMNSFVAVKIIK-NQPAYYQQALV-EVS 157
E R + +LG G FG+V A + ++ VAVK++K + ++AL+ E+
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 158 ILTTLNKKYDREDKH-HIVRIYEYFVC--QRHLCICFE------LLD------------- 195
++T L H +IV + C + + FE LL+
Sbjct: 101 MMTQL-------GSHENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 196 -SNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252
+ L+ L F+ Q+ +G+ L+ +H DL N+L+
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--- 208
Query: 253 AEIKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFG 300
+KI DFG A R + S Y +PE L YT D+WS+G
Sbjct: 209 KVVKICDFGLA----RDIMS---DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261
Query: 301 CIVAELF-LGLPLFPGASEFDLLRRMIR 327
++ E+F LG+ +PG ++I+
Sbjct: 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQ 289
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 51/234 (21%), Positives = 84/234 (35%), Gaps = 48/234 (20%)
Query: 114 KDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
++ G FG V W A++ +VAVKI Q Q EV L + KH
Sbjct: 29 LEVKARGRFGCV---WKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM--------KH 77
Query: 173 -HIVRIYEYFVCQR------HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILR 224
+I++ +R L + + +L + + +S + + ++ + R
Sbjct: 78 ENILQFIGA--EKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMAR 132
Query: 225 GLSLL----------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYI 274
GL+ L I H D+K +N+LL I DFG A + +
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGD 189
Query: 275 QSRY-----YRSPEVL-----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318
Y +PEVL IDM++ G ++ EL G +
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 55/244 (22%), Positives = 98/244 (40%), Gaps = 36/244 (14%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTLNKKYDR 168
++G G+FG+V F AVK+++ + + + E ++L +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH---IMSERNVLL-------K 94
Query: 169 EDKHH-IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGL 226
KH +V ++ F L + + N EL + R + ++ +I L
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYI--NGGELFYHLQRERCFLEPRARFYAAEIASAL 152
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAE--IKIIDFG---SACTEDRTVYSYIQSRYYRS 281
L I++ DLKPENILL ++ I + DFG + T ++ + Y +
Sbjct: 153 GYLHSLNIVYRDLKPENILLD-----SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP--PDYVLK 339
PEVL Y +D W G ++ E+ GLP F + ++ IL +
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD---NILNKPLQLKPNITN 264
Query: 340 EAKN 343
A++
Sbjct: 265 SARH 268
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 33/247 (13%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
++G G++ +V + + A+K++K N E + +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN------- 68
Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSL 228
H +V ++ F + L E + N +L + R L + +S +I L+
Sbjct: 69 -HPFLVGLHSCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEV 284
L + GII+ DLK +N+LL + IK+ D+G C E T ++ + Y +PE+
Sbjct: 126 LHERGIIYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSTFCGTPNYIAPEI 181
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR-----RMIR-ILGAQP--PDY 336
L G Y ++D W+ G ++ E+ G F D + + IL Q P
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 241
Query: 337 VLKEAKN 343
+ +A +
Sbjct: 242 LSVKAAS 248
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 71/267 (26%)
Query: 106 ETQRRYIV-KDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQA--LVEVS 157
E R I +G G FG+V + E + VAVK++K + + QA E +
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 158 ILTTLNKKYDREDKHHIVRIYEYFVC--QRHLCICFEL---------------------L 194
++ D +IV++ VC + +C+ FE
Sbjct: 103 LMAEF-------DNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 195 DSNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252
S+L +++ LS + ++Q+ G++ L + +H DL N L+
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV------ 207
Query: 253 AE---IKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMW 297
E +KI DFG + R +YS + YY+ PE + +YTT D+W
Sbjct: 208 GENMVVKIADFGLS----RNIYS---ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260
Query: 298 SFGCIVAELF-LGLPLFPGASEFDLLR 323
++G ++ E+F GL + G + +++
Sbjct: 261 AYGVVLWEIFSYGLQPYYGMAHEEVIY 287
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 54/247 (21%), Positives = 101/247 (40%), Gaps = 33/247 (13%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKYDREDK 171
++G G++ +V + + A++++K N E + +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN------- 111
Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYEL-IKINHFRGLSLSIVQLFSKQILRGLSL 228
H +V ++ F + L E + N +L + R L + +S +I L+
Sbjct: 112 -HPFLVGLHSCFQTESRLFFVIEYV--NGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE----DRTVYSYIQSRYYRSPEV 284
L + GII+ DLK +N+LL + IK+ D+G C E T ++ + Y +PE+
Sbjct: 169 LHERGIIYRDLKLDNVLLDSE---GHIKLTDYG-MCKEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR-----RMIR-ILGAQP--PDY 336
L G Y ++D W+ G ++ E+ G F D + + IL Q P
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284
Query: 337 VLKEAKN 343
+ +A +
Sbjct: 285 LSVKAAS 291
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 48/235 (20%), Positives = 94/235 (40%), Gaps = 44/235 (18%)
Query: 112 IVKDLLGHGTFGQVAK-CWDAEMNSF-VAVKIIKN--QPAYYQQALVEVSILTTLNKKYD 167
I LG G FG V + + VA+K++K + A ++ + E I+ L+
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD---- 394
Query: 168 REDKH-HIVRIYEYFVCQRH-LCICFELLDS-NLYELIKINHFRGLSLSIVQL--FSKQI 222
+ +IVR+ VCQ L + E+ L++ + + + + Q+
Sbjct: 395 ----NPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQV 445
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRS- 281
G+ L++ +H +L N+LL V KI DFG + + + + YY +
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLS----KALGA--DDSYYTAR 496
Query: 282 -----------PEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRR 324
PE + ++++ D+WS+G + E G + +++
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 66/282 (23%)
Query: 89 NVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKC-WDAEMNSF--VAVKIIKNQ 145
+++S L+ V VL+ E + ++G G FG V + + + A+K +
Sbjct: 2 DLDSALLAEVKDVLIPHE-RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 146 PAYYQQA--LVEVSILTTLNKKYDREDKHHIVRIYEYFVC---QRHLCICFELLDS-NLY 199
Q L E ++ L + +++ + + + + + +L
Sbjct: 61 TEMQQVEAFLREGLLMRGL-------NHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLL 111
Query: 200 ELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE--- 254
+ I+ + ++ L F Q+ RG+ L + +H DL N +L E
Sbjct: 112 QFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML------DESFT 162
Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYR--------------SPEVLLGYQYTTAIDMWSFG 300
+K+ DFG A R + YY + E L Y++TT D+WSFG
Sbjct: 163 VKVADFGLA----RDILD---REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG 215
Query: 301 CIVAELF-LGLPLFPGASEFDLLR------RMIRILGAQPPD 335
++ EL G P + FDL R+ QP
Sbjct: 216 VLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-----PQPEY 252
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 24/170 (14%), Positives = 60/170 (35%), Gaps = 14/170 (8%)
Query: 107 TQRRYIVKDLLGHGTFGQV--------AKCWDAEMNSFVAVKI-IKNQPAYYQQALVEVS 157
+ R++ +K G + C ++K+ K+ + +Q + +
Sbjct: 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99
Query: 158 ILTTLNKKYDREDKHH---IVRIYEYFV-CQRHLCICFELLDSNLYELIKINHFRGLSLS 213
K+ + I + V ++ + L +L + ++ LS
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSER 159
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
V + ++L L L + +H ++ ENI + +++ + +G A
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE-DQSQVTLAGYGFA 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 6e-14
Identities = 79/635 (12%), Positives = 169/635 (26%), Gaps = 222/635 (34%)
Query: 50 KDIVETYQ---ICNPLFKYSEELNPKRYLTSPSVG-VLNDGYDNVNSDLILAVNLVLVNA 105
KDI+ ++ + N K +++ PK L+ + ++ + + +L
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDM-PKSILSKEEIDHIIMSKDAVSGTLRLF--WTLLSKQ 75
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNK 164
E + V+++L +N F+ I + Q +++ + ++
Sbjct: 76 EEMVQKFVEEVL--------------RINYKFLMSPI---KTEQRQPSMMTRMYIEQRDR 118
Query: 165 KY---DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
Y K+++ R+ Y ++ L L + I+ G K
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLE----LRPAKN--VLIDGVLG--------SGKT 164
Query: 222 ILRGLSLLKDAGI-------IH------CDLKPENIL-----LCTSVKPAEIKIIDFGSA 263
+ L + + I C+ PE +L L + P D S
Sbjct: 165 WV-ALDVCLSYKVQCKMDFKIFWLNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSN 222
Query: 264 C------TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGC--IV------------ 303
+ Y VLL Q A + ++ C ++
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLS 282
Query: 304 ---------------------AELFLGLPLFPGASEFDLLRRM-------IRILGAQPPD 335
L L + DL R + + I+
Sbjct: 283 AATTTHISLDHHSMTLTPDEVKSLLL---KYLDCRPQDLPREVLTTNPRRLSIIAES--- 336
Query: 336 YVLKEAKNTSKFFKCIG----------SVHNIENGEVSIGGRSAYQALT----------- 374
+++ T +K + S++ +E E R + L+
Sbjct: 337 --IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY----RKMFDRLSVFPPSAHIPTI 390
Query: 375 --------EIEYEAREL-----KKPLIGKE------YFHHKHLEE-------------IV 402
I+ + + K L+ K+ +LE IV
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV 450
Query: 403 TNYPYRKNLSMEDISKESQIRLALVD-----FLKG--LVEFDPAKRWSPF---------- 445
+Y K +D+ +D + G L + +R + F
Sbjct: 451 DHYNIPKTFDSDDLIPPY------LDQYFYSHI-GHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 446 -QASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHW------FAAGLSPNIS 498
Q RH + ++ + + D+ P F + N+
Sbjct: 504 EQKIRH---DSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL- 559
Query: 499 GRSKFSMHNSPHFQVVPYGYGNSYGSVGSYGSYND 533
S + ++ ++ + +
Sbjct: 560 -------ICSKYTDLLRIALMAEDEAI-----FEE 582
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 43/226 (19%), Positives = 71/226 (31%), Gaps = 50/226 (22%)
Query: 116 LLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174
L+G G +G V + ++ VAVK+ Q + E +I ++D +I
Sbjct: 20 LIGRGRYGAV---YKGSLDERPVAVKVFSFA--NRQNFINEKNIYRVPLMEHD-----NI 69
Query: 175 VRIY-----EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
R + + E + +L + + + + RGL+
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 229 L---------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY- 278
L I H DL N+L+ I DFG +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC---VISDFGLSMRLTGNRLVRPGEEDN 183
Query: 279 ----------YRSPEVLLG-------YQYTTAIDMWSFGCIVAELF 307
Y +PEVL G +DM++ G I E+F
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 29/236 (12%), Positives = 60/236 (25%), Gaps = 53/236 (22%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKK 165
RY + G Q + D ++ VA+ + Q Q+ L L+ ++
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-- 89
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLS----LSIVQLFS 219
+ R+ + + + E + +L E+ S + +Q
Sbjct: 90 ------KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQ--- 136
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
+ AG+ P + + ++ +
Sbjct: 137 -SLAAAADAAHRAGVALSIDHPSRVRVSID---GDVVLAYPA-----------------T 175
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
D+ G + L + P A L R QP +
Sbjct: 176 MPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE 224
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 2e-11
Identities = 36/241 (14%), Positives = 70/241 (29%), Gaps = 59/241 (24%)
Query: 117 LGHGTFGQVAKCWDAEMNSFVAVKII---------KNQPAYYQQALVEVSILTTLNKKYD 167
+G G FG+V + ++ VA+KII + +++ L E+ I L+
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 168 REDKHH--IVRIYEYFVCQ------------------------------RHLCICFELLD 195
+ + Q L I E
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 196 SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL-KDAGIIHCDLKPENILLCTSVKPAE 254
++ + SL+ + Q+ L++ H DL N+LL K +
Sbjct: 146 GG--IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK---KTSL 200
Query: 255 IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314
K+ + + +V + YT + + ++ + LF
Sbjct: 201 KKLHYTLNGKSSTIPSCGL---------QVSII-DYTLSRLERDGIVVFCDVSMDEDLFT 250
Query: 315 G 315
G
Sbjct: 251 G 251
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 41/147 (27%), Positives = 61/147 (41%), Gaps = 25/147 (17%)
Query: 196 SNLYELIKINHFRGLSLSIVQL--FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA 253
S++ E L++ L +S Q+ +G+ L IH DL NILL
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-- 231
Query: 254 EIKIIDFGSACTEDRTVYSYIQSRYYR------------SPEVLLGYQYTTAIDMWSFGC 301
+KI DFG A R +Y Y +PE + YT D+WSFG
Sbjct: 232 -VKICDFGLA----RDIYK---DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283
Query: 302 IVAELF-LGLPLFPGASEFDLLRRMIR 327
++ E+F LG +PG + R ++
Sbjct: 284 LLWEIFSLGASPYPGVKIDEEFCRRLK 310
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 28/172 (16%), Positives = 60/172 (34%), Gaps = 22/172 (12%)
Query: 109 RRYIVKDLLGHGTFGQV-----AKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
+ V +G G FG + ++ VK+ + E+
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD---NGPLFTELKFYQRAA 91
Query: 164 KKYDREDKHH--------IVRIY----EYFVCQRHLCICFELLDSNLYELIKINHFRGLS 211
K + + + + + + + + S+L ++ + N + S
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFS 150
Query: 212 LSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
V S +IL L + + +H D+K N+LL P ++ ++D+G A
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLA 201
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 43/217 (19%)
Query: 116 LLGHGTFGQVAKCW-DAEMNSFVAVKIIKNQPAY-----YQQALVEVSILTTLNKKYDRE 169
+G G FG V K + + N+ VAVK + QQ E+ ++
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC------- 87
Query: 170 DKH-HIVRIYEYFVCQRHLCICFEL-----LDSNLYELIKINHFRGLS----LSIVQLFS 219
+H ++V + + LC+ + L L L LS I Q
Sbjct: 88 -QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP---LSWHMRCKIAQ--- 140
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-- 277
G++ L + IH D+K NILL + KI DFG A ++ + + SR
Sbjct: 141 -GAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLARASEKFAQTVMTSRIV 196
Query: 278 --Y-YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
Y +PE L G + T D++SFG ++ E+ GLP
Sbjct: 197 GTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP 232
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 5e-07
Identities = 58/250 (23%), Positives = 91/250 (36%), Gaps = 22/250 (8%)
Query: 523 GSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMNLHAQSGVSVRGSSPDARKM 582
G G Y++ +GL ++ D FSP+ SG N G + G D +
Sbjct: 1465 GQDGGVTPYSNESGLVNADLDVKDELM----FSPLVDSGSNDAMAGGFTAYGG-ADYGEA 1519
Query: 583 FIQYSQGNGLGVSPSAGMFVPLPLGTSP--SQFTPP-SSYGQVSSGSPGHYGPTSPARS- 638
+ SP G+ P TSP S +P S S + Y PTSP+ S
Sbjct: 1520 TSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSP 1579
Query: 639 -SCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQFIDGASSGQAEWNPQVL 697
S SP + T YS S SP+S + S + +P
Sbjct: 1580 TSPSYSPTSPSYSPTSP------SYSPTSPSY-SPTSPSY-----SPTSPSYSPTSPSYS 1627
Query: 698 GSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPAIAEAAHDKPETSLSVP 757
++ + P++PS + + + + S ++ P+S + P + P S + P
Sbjct: 1628 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSP 1687
Query: 758 DPGDWDPNYS 767
PNYS
Sbjct: 1688 SYSPTSPNYS 1697
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 53/255 (20%), Positives = 75/255 (29%), Gaps = 32/255 (12%)
Query: 438 PAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNI 497
+SP S FT P + PG G + G SP
Sbjct: 1488 DELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVS-SPGFSPTS 1546
Query: 498 SGRSKFSM----------HNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDG 547
S S SP + Y + S T S S
Sbjct: 1547 PTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1606
Query: 548 GNTFAY------FSPVGPS---GMNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSA 598
+ +Y +SP PS ++ + S +SP YS SP+
Sbjct: 1607 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT-----SPAY 1661
Query: 599 GMFVPLPLGTSP--SQFTPPSSYGQV--SSGSPGHYGPTSPARSSCHGSPLGKMTAATHY 654
P TSP S +P S S SP Y PTSP+ S SP + +
Sbjct: 1662 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPN-YSPTSPSYSP--TSPGYSPGSPAYS 1718
Query: 655 NRRKNWGYSGNPQSQ 669
++ ++ N S+
Sbjct: 1719 PKQDEQKHNENENSR 1733
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 67/327 (20%), Positives = 107/327 (32%), Gaps = 83/327 (25%)
Query: 442 WSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHHPGAGHWFAAGLSPNISGRS 501
+SP E F +P V PG F++ +SP S
Sbjct: 1505 FSPLVQG--GSEGREGFGDYGLLGAASPYKGV-------QSPGYTSPFSSAMSPGYGLTS 1555
Query: 502 KFSMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSG 561
+SP GY S + S SY+ SY T +SP PS
Sbjct: 1556 PSYSPSSP-------GYSTSPAYMPSSPSYS---PTSPSYSP------TSPSYSPTSPS- 1598
Query: 562 MNLHAQSGVSVRGSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQ 621
++ + S +SP YS + SP++ + P TSPS ++P S
Sbjct: 1599 ---YSPTSPSYSATSPS-------YSPTSP-SYSPTSPSYSP----TSPS-YSPTS---P 1639
Query: 622 VSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQF 681
S + Y PTSP+ S + YS SP+S +
Sbjct: 1640 SYSPTSPSYSPTSPSYS------------------PTSPSYSPTS-PSYSPTSPSYSPTS 1680
Query: 682 IDGASSGQAEWNPQVLGSASLHLPSNPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGPA 741
S ++P ++ + P++PS + + + + S ++ P+S
Sbjct: 1681 P-SYSPTSPSYSP----TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS------ 1729
Query: 742 IAEAAHDKPETSLSVPDPGDWDPNYSD 768
P S + P P+YS
Sbjct: 1730 --------PSYSPTSPSYSPTSPSYSP 1748
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 59/284 (20%), Positives = 92/284 (32%), Gaps = 23/284 (8%)
Query: 504 SMHNSPHFQVVPYGYGNSYGSVGSYGSYNDGTGLGSSYGSYGDGGNTFAYFSPVGPSGMN 563
+ + G G S G+ Y + S + D FSP+ G
Sbjct: 1459 YSLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAA----FSPLVQGGSE 1514
Query: 564 LHAQSGVSVR--GSSPDARKMFIQYSQGNGLGVSPSAGMFVPLPLGTSPSQFTPPSSYGQ 621
G +SP Y+ +SP G+ P +SP T P+
Sbjct: 1515 GREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAY--- 1571
Query: 622 VSSGSPGHYGPTSPARSSCHGSPLGKMTAATHYNRRKNWGYSGNPQSQESPSSQHWQGQF 681
SP Y PTSP+ S SP T+ ++ ++ + S SPS +
Sbjct: 1572 -MPSSPS-YSPTSPSYSP--TSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSY 1627
Query: 682 IDGASSGQAEWNPQVLGSASLHLPS-NPSATSSKQQRGGSGIAASYSAMPNMPSSLTRGP 740
S ++P S S S + S TS + + S ++ P+S + P
Sbjct: 1628 ----SPTSPSYSPT---SPSYSPTSPSYSPTSPSYSP--TSPSYSPTSPSYSPTSPSYSP 1678
Query: 741 AIAEAAHDKPETSLSVPDPGDWDPNYSDEQLLQEDGSDESSITT 784
+ P S + P P+YS S S T+
Sbjct: 1679 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1722
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-06
Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 39/211 (18%)
Query: 116 LLGHGTFGQV--AKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYDREDK 171
+LG G FG+V + D + VAVK +K Q EV +++
Sbjct: 37 ILGRGGFGKVYKGRLAD---GTLVAVKRLKEERTQGGELQFQTEVEMISMA--------V 85
Query: 172 H-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQL---FSKQIL---- 223
H +++R+ + + + + + + + R S L ++I
Sbjct: 86 HRNLLRLRGFCMTPTERLLVYPYMANGSVA----SCLRERPESQPPLDWPKRQRIALGSA 141
Query: 224 RGLSLLKDAG---IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRY-- 278
RGL+ L D IIH D+K NILL + + DFG A D +++ +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEA---VVGDFGLAKLMDYKD-THVTTAVRG 197
Query: 279 ---YRSPEVLLGYQYTTAIDMWSFGCIVAEL 306
+ +PE L + + D++ +G ++ EL
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 44/217 (20%)
Query: 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQA----LVEVSILTTLNKKYDREDK 171
L+GHG FG+V K + + VA+K + Q E+ L+
Sbjct: 46 LIGHGVFGKVYKGVLRD-GAKVALKRRTPES---SQGIEEFETEIETLSFC--------- 92
Query: 172 HH--IVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL------ 223
H +V + + + + + ++ +++ + H G L + + +Q L
Sbjct: 93 RHPHLVSLIGFCDERNEMILIYKYMENGNLK----RHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 224 -RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG---SACTEDRTVYSYIQSRY- 278
RGL L IIH D+K NILL + P KI DFG D+T ++ +
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVP---KITDFGISKKGTELDQT---HLSTVVK 202
Query: 279 ----YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311
Y PE + + T D++SFG ++ E+
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 820 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.41 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.97 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.88 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.43 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.43 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.38 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.91 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.86 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.69 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.41 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.73 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.01 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=487.18 Aligned_cols=255 Identities=23% Similarity=0.411 Sum_probs=219.9
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++|+.| +|||||+++++|.+++
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-------~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHENVVEMYNSYLVGD 144 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECC
Confidence 3478999999999999999999999999999999997432 3345678999999999 6999999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|||||||.| +|.+++.. ..+++.+++.|++||+.||+|||++|||||||||+||||+ .++.+||+|||+|+
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~ 218 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC---CCCCEEEecCcCce
Confidence 99999999984 88888865 3599999999999999999999999999999999999995 67899999999997
Q ss_pred ccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... ...+.+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+.+..|..... +.
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~------ 289 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PR------ 289 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---CC------
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CC------
Confidence 6533 34567999999999999999999999999999999999999999998888777666544111 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
+.....
T Consensus 290 --------------------------------------------------------------------------~~~~~~ 295 (346)
T 4fih_A 290 --------------------------------------------------------------------------LKNLHK 295 (346)
T ss_dssp --------------------------------------------------------------------------CSCGGG
T ss_pred --------------------------------------------------------------------------CCcccc
Confidence 000112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++++++|||.+||+.||++|||++|||+||||++..
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 457899999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=485.09 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=216.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|++| .|||||+++++|.+++
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-------KHPNIVQYRESFEENG 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-------CCCCCCcEEEEEEECC
Confidence 7999999999999999999999999999999999753 34567789999999999 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|||||||. |+|.+++.......+++.+++.|++||+.||+|||++|||||||||+||||+ .++.+||+|||+|+
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC---TTCCEEECSTTEES
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC---CCCCEEEcccccce
Confidence 9999999997 6999999876656689999999999999999999999999999999999996 67899999999998
Q ss_pred ccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
..... ....+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++.+|.+..- |+
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--~~------- 244 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF--PP------- 244 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--CC-------
T ss_pred eecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC--CC-------
Confidence 76543 3456899999999999999999999999999999999999999999888877776654110 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
. ...
T Consensus 245 -----------------------------------------------------------------~-----------~~~ 248 (350)
T 4b9d_A 245 -----------------------------------------------------------------V-----------SLH 248 (350)
T ss_dssp -----------------------------------------------------------------C-----------CTT
T ss_pred -----------------------------------------------------------------C-----------Ccc
Confidence 0 001
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+++++.+||.+||+.||++|||++|||+||||++.
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 249 YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 34678999999999999999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=475.10 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=220.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+++|++| +|||||+++++|+++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHPFFVKLYFTFQDD 104 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeC
Confidence 6799999999999999999999999999999999753 23456788999999988 699999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. |+|.++++.. +.+++.+++.+++||+.||+|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~---~~g~vKl~DFGla 179 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTA 179 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc---CCCCEEEEEcCCc
Confidence 99999999998 5999999765 4699999999999999999999999999999999999995 6789999999999
Q ss_pred cccC-----CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 264 CTED-----RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 264 ~~~~-----~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+... ....+.+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++.+|.+.-- .
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~------ 252 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-D------ 252 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-C------
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-C------
Confidence 7543 223467899999999999999999999999999999999999999999888777776654110 0
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
+|
T Consensus 253 ------------------------------------------------------------------~p------------ 254 (311)
T 4aw0_A 253 ------------------------------------------------------------------FP------------ 254 (311)
T ss_dssp ------------------------------------------------------------------CC------------
T ss_pred ------------------------------------------------------------------CC------------
Confidence 00
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHH------HHcCCccCCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQ------ASRHPFVTGEPFT 459 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~E------aL~HPff~~~~~~ 459 (820)
..++++++|||++||+.||++|+|++| +++||||++..+.
T Consensus 255 -~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 255 -EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp -TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred -cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 013467899999999999999999988 5899999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-55 Score=465.96 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=204.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+.+.+|+++|+.| +|||||+++++|.++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~~ 85 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-------RHPHIIKLYDVIKSK 85 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-------CCTTBCCEEEEEECS
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-------CCCCCCeEEEEEEEC
Confidence 6899999999999999999999999999999999753 23356788999999999 689999999999999
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+.+|||||||+|+|.+++... +.+++.+++.+++||+.||+|||++|||||||||+||||+ .++.+||+|||+|+
T Consensus 86 ~~~~ivmEy~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 86 DEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD---EHLNVKIADFGLSN 160 (275)
T ss_dssp SEEEEEEECCCEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTCCEEECCSSCC-
T ss_pred CEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC---CCCCEEEeecCCCe
Confidence 999999999999999998765 4699999999999999999999999999999999999995 67899999999997
Q ss_pred ccCC--ccccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... ...+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..+.+..+.+..-
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~----------- 229 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY----------- 229 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 5433 3456789999999999999876 5799999999999999999999998877666555543100
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
+++ ..
T Consensus 230 ----------------------------------------------------------------~~p-----------~~ 234 (275)
T 3hyh_A 230 ----------------------------------------------------------------TLP-----------KF 234 (275)
T ss_dssp ----------------------------------------------------------------CCC-----------TT
T ss_pred ----------------------------------------------------------------CCC-----------CC
Confidence 000 01
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
+++++++||++||+.||++|||++|+|+||||+.
T Consensus 235 ~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 235 LSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 3467899999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=489.10 Aligned_cols=256 Identities=23% Similarity=0.411 Sum_probs=220.4
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
+..++|+++++||+|+||+||+|+++.+++.||||++... ....+.+.+|+.+|+.| .|||||+++++|.++
T Consensus 148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-------~HpnIV~l~~~~~~~ 220 (423)
T 4fie_A 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-------QHENVVEMYNSYLVG 220 (423)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-------CCTTBCCEEEEEEET
T ss_pred ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-------CCCCCCceEEEEEEC
Confidence 3457899999999999999999999999999999999753 23345678999999999 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. |+|.++++.. .+++.+++.|++||+.||+|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~---~~g~vKl~DFGla 294 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFC 294 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC---TTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEecCccc
Confidence 99999999998 5898888653 599999999999999999999999999999999999996 6789999999999
Q ss_pred cccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
+.... .....+||+.|||||++.+..|+.++||||||||+|||++|++||.+.+..+.+..|..... +..
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---~~~---- 367 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PRL---- 367 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCC----
T ss_pred eECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---CCC----
Confidence 76533 34567999999999999999999999999999999999999999998888777766544111 000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
....
T Consensus 368 ----------------------------------------------------------------------------~~~~ 371 (423)
T 4fie_A 368 ----------------------------------------------------------------------------KNLH 371 (423)
T ss_dssp ----------------------------------------------------------------------------SCTT
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0001
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++++++|||.+||+.||++|+|++|||+||||++..
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 2457899999999999999999999999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=481.78 Aligned_cols=281 Identities=30% Similarity=0.528 Sum_probs=229.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+++|+++|+.| .|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-------KHDNIIAIKDILRPT 125 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCCS
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-------CCCCcceEeeeeecc
Confidence 37899999999999999999999999999999999753 34456788999999999 689999999998643
Q ss_pred ------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
+++|||||||+|+|.+++... +.+++.+++.|++||+.||+|||++|||||||||+|||++ ..+.+||+
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~---~~~~~Ki~ 200 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN---ENCELKIG 200 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEEC
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC---CCCCEEEe
Confidence 679999999999999998754 4699999999999999999999999999999999999995 67899999
Q ss_pred ecccccccC-------CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003438 259 DFGSACTED-------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330 (820)
Q Consensus 259 DFGlA~~~~-------~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG 330 (820)
|||+|+... ....+.+||+.|||||++.+. .|+.++||||||||+|||++|++||.+.+..+++..|.+..|
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 999997542 223457999999999999886 569999999999999999999999999999999999999999
Q ss_pred CCCchHHHHhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 331 AQPPDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 331 ~~Pp~~~l~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
.|+...+...... ..++... .......++.+..
T Consensus 281 -~p~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~----- 315 (398)
T 4b99_A 281 -TPSPAVIQAVGAERVRAYIQSL---------------------------------------PPRQPVPWETVYP----- 315 (398)
T ss_dssp -CCCGGGTC-----CHHHHHHSS---------------------------------------CCCCCCCHHHHST-----
T ss_pred -CCChHHhhhhhhhhhhhhhhcC---------------------------------------CCcCCCCHHHhCC-----
Confidence 4443322211100 0000000 0011112223222
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++++++|||++||++||++|+||+|||+||||++..
T Consensus 316 ------------~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 316 ------------GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ------------TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred ------------CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 2457899999999999999999999999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=453.26 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=207.9
Q ss_pred Cce-EEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-
Q 003438 109 RRY-IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC- 183 (820)
Q Consensus 109 ~rY-~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~- 183 (820)
.+| ++.++||+|+||+||+|+++.+++.||||++... ....+.+.+|+++|++| +|||||+++++|..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-------QHPNIVRFYDSWEST 97 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEeec
Confidence 444 7888999999999999999999999999999743 34556788999999999 69999999999975
Q ss_pred ---cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEE
Q 003438 184 ---QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 184 ---~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL 257 (820)
++.+|||||||. |+|.+++... +.+++..++.|++||+.||+|||+++ ||||||||+||||+ ..++.+||
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl 173 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKI 173 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEE
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEE
Confidence 357899999998 5999999765 46999999999999999999999998 99999999999995 24678999
Q ss_pred eecccccccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 258 IDFGSACTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 258 ~DFGlA~~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
+|||+|+.... ...+.+||+.|||||++.+ .|+.++||||||||||||+||++||.+......+.+.+.. + ..|..
T Consensus 174 ~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~-~~~~~ 250 (290)
T 3fpq_A 174 GDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VKPAS 250 (290)
T ss_dssp CCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CCCGG
T ss_pred EeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-C-CCCCC
Confidence 99999975433 3456789999999999875 6999999999999999999999999776544333222110 0 00000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
T Consensus 251 -------------------------------------------------------------------------------- 250 (290)
T 3fpq_A 251 -------------------------------------------------------------------------------- 250 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.....++++.+||.+||+.||++|||++|+|+||||+++
T Consensus 251 -~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 251 -FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 001134678999999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=466.10 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=210.5
Q ss_pred CceEEEEEeccCCceeEEEeec---cCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d---~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|+++++||+|+||+||+|++ ..+++.||||++++.. .....+.+|+++|++| +|||||+++++|.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-------NHPFIVKLHYAFQ 96 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-------CCTTEECEEEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-------CCCCCCeEEEEEE
Confidence 6899999999999999999986 3568899999997532 2234567798888877 7999999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+++.+|||||||. |+|.+++... +.+++.+++.+++||+.||+|||++|||||||||+|||++ .++.+||+|||
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~vKl~DFG 171 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFG 171 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTSCEEEESSE
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc---CCCCEEecccc
Confidence 9999999999998 6999999765 4699999999999999999999999999999999999995 67899999999
Q ss_pred cccccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 262 SACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 262 lA~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+|+... ....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.+|.+..- .
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~------ 244 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-G------ 244 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C------
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-C------
Confidence 997532 334567899999999999999999999999999999999999999999888777776654110 0
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
+|
T Consensus 245 ------------------------------------------------------------------~p------------ 246 (304)
T 3ubd_A 245 ------------------------------------------------------------------MP------------ 246 (304)
T ss_dssp ------------------------------------------------------------------CC------------
T ss_pred ------------------------------------------------------------------CC------------
Confidence 00
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
..++++++|||++||+.||++||| ++|+|+||||++..+
T Consensus 247 -~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 247 -QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 013467899999999999999998 589999999998653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=462.35 Aligned_cols=304 Identities=22% Similarity=0.353 Sum_probs=218.9
Q ss_pred CCceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|+++ .+++.||||++.... ...++.+|+++|+.+. +|||||+++++|..+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~------~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAG------GQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTC------SBTTBCCCSEEEEET
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhc------CCCCCceEEEEEEEC
Confidence 478999999999999999999864 467899999997543 3456788999999884 589999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+++|||||||+ ++|.++++ .+++.+++.+++||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla 165 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLA 165 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCC
Confidence 99999999997 58988873 499999999999999999999999999999999999996 33479999999999
Q ss_pred cccCC-------------------------------ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCC
Q 003438 264 CTEDR-------------------------------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 264 ~~~~~-------------------------------~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
+.... .....+||+.|+|||++.+. .|+.++||||+|||+|||++|++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 64321 12345799999999999876 58999999999999999999998
Q ss_pred CC-CCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCc
Q 003438 312 LF-PGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390 (820)
Q Consensus 312 PF-~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~ 390 (820)
|| .+.++.+++..|.+.+| .++........... ...... ........+. ..........+...
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G-~~~~~~~~~~~~~~--~~~~~~----------~p~~~~~~~~--~~~~~~~~~~p~~~- 309 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRG-SRETIQAAKTFGKS--ILCSKE----------VPAQDLRKLC--ERLRGMDSSTPKLT- 309 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHC-HHHHHHHHHHTTEE--EEESSC----------CCCCCHHHHH--HHHC-----------
T ss_pred CCCCCCCHHHHHHHHHHhcC-Cccchhhhhhcccc--cccccc----------CcchhhhHHH--Hhhccccccccccc-
Confidence 88 56678899999999998 33222211110000 000000 0000000000 00000000000000
Q ss_pred cccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 391 ~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+... .........++++++|||++||++||++|+||+|||+||||++.+
T Consensus 310 --------~~~~~~--------~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 310 --------SDIQGH--------ATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp ----------------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred --------cccccc--------cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000000 001112234668899999999999999999999999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=456.44 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=176.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
+.|++.++||+|+||+||+|+++.+++.||||+++.+.. ..+|+.+|+.| +|||||+++++|.+++.+|
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-------~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-------SSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-------CCTTBCCEEEEEEETTEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-------CCCCCCcEEEEEEECCEEE
Confidence 679999999999999999999999999999999986532 24689988887 6999999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCC-eEEEeeccccccc
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPA-EIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~-~iKL~DFGlA~~~ 266 (820)
||||||+ |+|.++++.. +.+++.+++.|+.||+.||+|||+++||||||||+||||+ .++ .+||+|||+|+..
T Consensus 127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCL 201 (336)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC
T ss_pred EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEc
Confidence 9999998 5999999765 4699999999999999999999999999999999999996 444 6999999999754
Q ss_pred CCc--------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003438 267 DRT--------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 267 ~~~--------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~ 326 (820)
... ....+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+++.+|.
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 269 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 321 123579999999999999999999999999999999999999998766554444443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=436.25 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~- 185 (820)
.+|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|++| +|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-------~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-------EHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEecCc
Confidence 4699999999999999999999999999999999743 34556788999999988 6999999999997654
Q ss_pred -----------eeEEEEeccC-CChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 186 -----------HLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 186 -----------~l~LVmEy~~-gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
++|||||||. |+|.+++.... ....++..++.|+.||++||+|||++|||||||||+||||+ .+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CC
Confidence 4799999997 58999987643 22356677999999999999999999999999999999996 66
Q ss_pred CeEEEeecccccccCCc---------------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 253 AEIKIIDFGSACTEDRT---------------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~---------------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
+.+||+|||+|+..... ....+||+.|||||++.+..|+.++||||||||+|||++ ||..
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-- 229 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-- 229 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--
Confidence 89999999999754321 234579999999999999999999999999999999996 7753
Q ss_pred HHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccch
Q 003438 318 EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKH 397 (820)
Q Consensus 318 ~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~ 397 (820)
..+....+........|.
T Consensus 230 ~~~~~~~~~~~~~~~~p~-------------------------------------------------------------- 247 (299)
T 4g31_A 230 QMERVRTLTDVRNLKFPP-------------------------------------------------------------- 247 (299)
T ss_dssp HHHHHHHHHHHHTTCCCH--------------------------------------------------------------
T ss_pred ccHHHHHHHHHhcCCCCC--------------------------------------------------------------
Confidence 222222222211100000
Q ss_pred hHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 398 LEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 398 L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.....++.+.+||++||+.||++|||++|+|+||||++..+
T Consensus 248 --------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 248 --------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp --------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred --------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 00113356789999999999999999999999999997654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=466.14 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=223.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
++|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|+.| +|||||+++++|.+.+.+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-------~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-------RHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-------CCTTBCCEEEEEECSSEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-------CCCCCCeEEEEEEECCEE
Confidence 7899999999999999999999999999999999864 34566788999999999 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|||||||. |+|.+++.... ..+++.+++.+++||+.||+|||+++||||||||+|||++.+ ..+.+||+|||+|+..
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEEC
T ss_pred EEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEc
Confidence 99999997 59999886543 469999999999999999999999999999999999999632 4578999999999765
Q ss_pred C--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003438 267 D--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344 (820)
Q Consensus 267 ~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~ 344 (820)
. ......+||+.|||||++.+..|+.++||||||||||||++|++||.+.+..+.+..|.+.....++.
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------- 378 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--------- 378 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG---------
T ss_pred cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc---------
Confidence 4 33456789999999999999999999999999999999999999999998887777665422100000
Q ss_pred chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHH
Q 003438 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424 (820)
Q Consensus 345 ~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~ 424 (820)
....+++
T Consensus 379 -------------------------------------------------------------------------~~~~~s~ 385 (573)
T 3uto_A 379 -------------------------------------------------------------------------AFSGISE 385 (573)
T ss_dssp -------------------------------------------------------------------------GGTTSCH
T ss_pred -------------------------------------------------------------------------cccCCCH
Confidence 0012457
Q ss_pred HHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 425 ~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
+++|||++||++||++|||++|||+||||+....
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 7899999999999999999999999999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=443.53 Aligned_cols=333 Identities=41% Similarity=0.729 Sum_probs=262.6
Q ss_pred cCCCccCCCCcceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHH
Q 003438 83 LNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTL 162 (820)
Q Consensus 83 ~n~g~d~~~~d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L 162 (820)
.+.++++....+....++.+. .+|+++++||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~-----~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l 150 (429)
T 3kvw_A 76 NNGGYDDDQGSYVQVPHDHVA-----YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150 (429)
T ss_dssp HHHTTBCTTSCBCCCTTCEET-----TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCccCCCccccCCCccc-----CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHH
Confidence 345566666666555555554 899999999999999999999999999999999998877778889999999999
Q ss_pred hhhcCCCCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCC
Q 003438 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPE 242 (820)
Q Consensus 163 ~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPe 242 (820)
++. ....|+||+++++++...+++||||||+.++|.+++.......+++..++.|+.||+.||+|||+++||||||||+
T Consensus 151 ~~~-~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~ 229 (429)
T 3kvw_A 151 RKQ-DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229 (429)
T ss_dssp HTT-CTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGG
T ss_pred hhc-cccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 764 4557899999999999999999999999999999998877667999999999999999999999999999999999
Q ss_pred CcccccccCCCe--EEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHH
Q 003438 243 NILLCTSVKPAE--IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD 320 (820)
Q Consensus 243 NILl~~~~~~~~--iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d 320 (820)
||||+ ..+. +||+|||+++.........++|+.|+|||++.+..|+.++||||||||+|||++|.+||.+.+..+
T Consensus 230 NILl~---~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 230 NILLK---QQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp GEEES---STTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HeEEc---cCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99996 3444 999999999887777777899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccc-----cCCCccccCCccchhhhhHHHHHHHhhcCCCCCcccccc
Q 003438 321 LLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHN-----IENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHH 395 (820)
Q Consensus 321 ~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~-----~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~ 395 (820)
.+..+++.++ .|+..++........++...+.... ...+........ ..... .......
T Consensus 307 ~l~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~-~~~~~~~ 370 (429)
T 3kvw_A 307 QLACMIELLG-MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR--------------SRRGK-LRGPPES 370 (429)
T ss_dssp HHHHHHHHHC-CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEE--------------CTTCC-EECSTTC
T ss_pred HHHHHHHHcC-CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccc--------------cchhh-ccCCccc
Confidence 9999999999 7777777766666666554331110 000000000000 00000 0000000
Q ss_pred chhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 396 KHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 396 ~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..+...+. ...++.++|||++||++||++|||++|||+||||++.
T Consensus 371 ~~~~~~l~----------------~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 371 REWGNALK----------------GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp SCHHHHTT----------------TCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred hhhHhhcc----------------ccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 11111111 1235789999999999999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=425.98 Aligned_cols=342 Identities=41% Similarity=0.729 Sum_probs=264.7
Q ss_pred ccCCCccCCCCcceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHH
Q 003438 82 VLNDGYDNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTT 161 (820)
Q Consensus 82 ~~n~g~d~~~~d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~ 161 (820)
..++++++...++++..++.+. ++|+++++||+|+||+||+|++..+++.||||+++........+.+|+.+++.
T Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~-----~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~ 106 (382)
T 2vx3_A 32 VYNDGYDDDNYDYIVKNGEKWM-----DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLEL 106 (382)
T ss_dssp CBGGGTBCTTSCBCCCTTCEET-----TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHH
T ss_pred cCcCCcCCCCCcEEeecCCEee-----eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHH
Confidence 3455666667677777777665 89999999999999999999999999999999999877777888899999999
Q ss_pred HhhhcCCCCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc--cCCeeeccC
Q 003438 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDL 239 (820)
Q Consensus 162 L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH--s~gIVHrDL 239 (820)
+.+. ....|++|+++++++...+++||||||++++|.+++.......+++..++.++.||+.||.||| +.|||||||
T Consensus 107 l~~~-~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl 185 (382)
T 2vx3_A 107 MNKH-DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185 (382)
T ss_dssp HHHC-SSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred HHhc-ccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence 8642 2223457999999999999999999999999999998876667999999999999999999999 579999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
||+||||+. +..+.+||+|||+++.........++|+.|+|||++.+..++.++|||||||++|||++|++||.+.+..
T Consensus 186 kp~NIll~~-~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 186 KPENILLCN-PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp SGGGEEESS-TTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CcccEEEec-CCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999953 2467899999999988777777789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCcccc---ccc
Q 003438 320 DLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYF---HHK 396 (820)
Q Consensus 320 d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f---~~~ 396 (820)
+.+..+.+.++ .|+..++........+|...... .+..... ..++..+ ...
T Consensus 265 ~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~-------------------~~~~~~~~~~~~~ 318 (382)
T 2vx3_A 265 DQMNKIVEVLG-IPPAHILDQAPKARKFFEKLPDG------TWNLKKT-------------------KDGKREYKPPGTR 318 (382)
T ss_dssp HHHHHHHHHHC-SCCHHHHTTCTTHHHHEEECTTS------CEEECCC-------------------CTTCCCSCCTTCS
T ss_pred HHHHHHHHHhC-CCCHHHHHhhHHHHHHHHhcccc------ccccccc-------------------cccccccCCcchh
Confidence 99999999998 67776666555555555543211 0000000 0000000 011
Q ss_pred hhHHHHhcCCCCCC-CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 397 HLEEIVTNYPYRKN-LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 397 ~L~~il~~~P~~~~-ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.+.+++........ ....+........+.+++||++||++||++|||++|||+||||++.
T Consensus 319 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred hHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 23333221110000 0000011112244689999999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=464.05 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=212.3
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+.++|+++++||+|+||+||+|+++.+++.||||++++.. .......+|..++..+... +|||||+++++|.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~----~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFH 262 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS----CCTTBCCEEEEEE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC----CCCCEeEEEEEEE
Confidence 4479999999999999999999999999999999997532 2233455666666666443 8999999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+.+.+|||||||. |+|.++|... +.+++..++.++.||+.||+|||++|||||||||+||||+ .++.|||+|||
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld---~~G~vKL~DFG 337 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLG 337 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTSCEEECCCT
T ss_pred ECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe---CCCCEEecccc
Confidence 9999999999998 5999999765 4699999999999999999999999999999999999995 77899999999
Q ss_pred cccccC-CccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 262 SACTED-RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 262 lA~~~~-~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+|+... ....+.+||+.|||||++.. ..|+.++||||||||||||++|++||.+.+..+....+...+. .+
T Consensus 338 lA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~------ 410 (689)
T 3v5w_A 338 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MA------ 410 (689)
T ss_dssp TCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CC------
T ss_pred eeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CC------
Confidence 997654 34456799999999999975 5899999999999999999999999976432211111111000 00
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
..+ .
T Consensus 411 -----------------------------------------------------------------~~~-----------p 414 (689)
T 3v5w_A 411 -----------------------------------------------------------------VEL-----------P 414 (689)
T ss_dssp -----------------------------------------------------------------CCC-----------C
T ss_pred -----------------------------------------------------------------CCC-----------C
Confidence 000 0
Q ss_pred HHhHHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
..++++++|||++||+.||++|++ ++||++||||++..+
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 124578899999999999999998 799999999998765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=423.72 Aligned_cols=210 Identities=26% Similarity=0.370 Sum_probs=180.1
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.++|++.++||+|+||+||+|++. .+++.||||+++.. ....+++.+|+++|++| .|||||++++++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-------~HpnIV~l~g~~ 84 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-------QHEHIVKFYGVC 84 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-------CCCCCccEEEEE
Confidence 378999999999999999999754 46889999999854 34567789999999998 699999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh-----------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH-----------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~-----------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
.+++.+|||||||. |+|.+++.... ...+++.+++.|+.||+.||+|||+++||||||||+||||+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~-- 162 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-- 162 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEEC--
Confidence 99999999999997 69999997642 24699999999999999999999999999999999999996
Q ss_pred cCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 250 VKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
.++.+||+|||+|+..... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+++.
T Consensus 163 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 163 -ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp -GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred -CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 6688999999999754322 123468999999999999999999999999999999998 899999888777766
Q ss_pred HHHH
Q 003438 324 RMIR 327 (820)
Q Consensus 324 ~I~~ 327 (820)
.+.+
T Consensus 242 ~i~~ 245 (299)
T 4asz_A 242 CITQ 245 (299)
T ss_dssp HHHH
T ss_pred HHHc
Confidence 6544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=422.15 Aligned_cols=313 Identities=32% Similarity=0.554 Sum_probs=249.8
Q ss_pred ceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhc-CCCCCC
Q 003438 94 LILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKY-DREDKH 172 (820)
Q Consensus 94 ~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~-~~~~Hp 172 (820)
..+.+++.+. ++|+++++||+|+||+||+|++..+++.||||+++......+.+.+|+.+|+.+++.. ...+|+
T Consensus 27 ~~~~~g~~~~-----~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 101 (397)
T 1wak_A 27 HLVKIGDLFN-----GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101 (397)
T ss_dssp CSSCTTCEET-----TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred eEEehhhhcC-----CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence 3455666654 8999999999999999999999999999999999987777788999999999997641 223488
Q ss_pred ceeEEeEEEe----ecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccc
Q 003438 173 HIVRIYEYFV----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLC 247 (820)
Q Consensus 173 nIVkl~d~f~----~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~ 247 (820)
||++++++|. ...++||||||++++|.+.+.......+++..++.++.||+.||+|||++ |||||||||+||||+
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~ 181 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC
T ss_pred eeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe
Confidence 9999999998 55689999999999999988877656799999999999999999999998 999999999999996
Q ss_pred ccc----------------------------------------------CCCeEEEeecccccccCCccccccccccccC
Q 003438 248 TSV----------------------------------------------KPAEIKIIDFGSACTEDRTVYSYIQSRYYRS 281 (820)
Q Consensus 248 ~~~----------------------------------------------~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~A 281 (820)
.+. ....+||+|||+++.........++|+.|+|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~a 261 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRS 261 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCC
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccC
Confidence 321 1137999999999877766667789999999
Q ss_pred ccccccccccccchhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCcc
Q 003438 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVH 355 (820)
Q Consensus 282 PEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s------~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~ 355 (820)
||++.+..++.++||||||||||||++|+.||...+ ..+.+..+.+.++ .+|..++...+....+|...+.+.
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG-KVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHC-SCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcC-CCChHHhhcccccccccCCccccc
Confidence 999999999999999999999999999999997655 5678888999999 555555555454455554443222
Q ss_pred ccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccc
Q 003438 356 NIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVE 435 (820)
Q Consensus 356 ~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~ 435 (820)
.... .. .....+.+...+. .....+..+++||.+||+
T Consensus 341 ~~~~-------~~-------------------------~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~L~ 377 (397)
T 1wak_A 341 HITK-------LK-------------------------PWGLFEVLVEKYE-----------WSQEEAAGFTDFLLPMLE 377 (397)
T ss_dssp SCCC-------CC-------------------------CCCHHHHHHHTSC-----------CCHHHHHHHHHHHGGGGC
T ss_pred cccc-------cC-------------------------CcchhHhhhhhcc-----------cchhhHHHHHHHHHHHhc
Confidence 2111 00 0000111111111 123456789999999999
Q ss_pred cCcCCCCCHHHHHcCCccCC
Q 003438 436 FDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 436 ~DP~kRpTa~EaL~HPff~~ 455 (820)
+||++|||++|||+||||++
T Consensus 378 ~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 378 LIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SSGGGSCCHHHHHTSGGGGC
T ss_pred cChhhcCCHHHHhhCccccC
Confidence 99999999999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=425.59 Aligned_cols=209 Identities=27% Similarity=0.370 Sum_probs=176.4
Q ss_pred CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|.+.++||+|+||+||+|+.+ .+++.||||+++.. ....+.+.+|+++|++| .|||||+++++|.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-------~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-------QHQHIVRFFGVCT 113 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEC
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEE
Confidence 68899999999999999999753 46889999999854 44567899999999998 6999999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhh-------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINH-------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~-------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~ 248 (820)
+.+.+|||||||. |+|.+++.... ...+++.++..|+.||+.||+|||+++||||||||+||||+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~- 192 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG- 192 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE-
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC-
Confidence 9999999999998 69999987542 23589999999999999999999999999999999999996
Q ss_pred ccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 249 SVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 249 ~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
.++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+
T Consensus 193 --~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 193 --QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp --TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred --CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 6789999999999754322 234578999999999999999999999999999999999 89999988877766
Q ss_pred HHHHH
Q 003438 323 RRMIR 327 (820)
Q Consensus 323 ~~I~~ 327 (820)
..+.+
T Consensus 271 ~~i~~ 275 (329)
T 4aoj_A 271 DCITQ 275 (329)
T ss_dssp HHHHH
T ss_pred HHHHc
Confidence 66543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=418.31 Aligned_cols=313 Identities=31% Similarity=0.543 Sum_probs=245.6
Q ss_pred cceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCC
Q 003438 93 DLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172 (820)
Q Consensus 93 d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~Hp 172 (820)
.+....+.++. ++|+++++||+|+||+||+|++..+++.||||+++......+....|+.+++.+.. ....|+
T Consensus 24 ~~~~~~g~~~~-----~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~--~~~~h~ 96 (360)
T 3llt_A 24 HFSWKKGMLLN-----NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQN--DDINNN 96 (360)
T ss_dssp SCCCCTTCEET-----TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCC--CSTTGG
T ss_pred eeeeecceEec-----CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcc--cCCCCC
Confidence 34445555554 89999999999999999999999999999999999777777788889999999963 233599
Q ss_pred ceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc---
Q 003438 173 HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--- 249 (820)
Q Consensus 173 nIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~--- 249 (820)
||+++++++...+.+||||||++++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++..
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred CeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 99999999999999999999998899999988766679999999999999999999999999999999999999631
Q ss_pred -------------------cCCCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCC
Q 003438 250 -------------------VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310 (820)
Q Consensus 250 -------------------~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~ 310 (820)
...+.+||+|||++..........++|+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 1367899999999987776667778999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccc--hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCC
Q 003438 311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTS--KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLI 388 (820)
Q Consensus 311 ~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~--~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~ 388 (820)
.||...+..+.+..+....+.. |..++....... .++...... ..++
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~p 305 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPI-PKNMLYEATKTNGSKYVNKDELK------------------------------LAWP 305 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCC-CHHHHHHHTTSGGGGGEETTTTE------------------------------ECTT
T ss_pred CCCCCCcHHHHHHHHHHhcCCC-CHHHHhhhhhccCccccCcccce------------------------------ecCc
Confidence 9999999999999999988844 444443322111 111100000 0000
Q ss_pred CccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccC
Q 003438 389 GKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454 (820)
Q Consensus 389 ~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~ 454 (820)
... .....+..+....+ ......++.+.+||++||++||++|||++|||+||||+
T Consensus 306 ~~~-~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 306 ENA-SSINSIKHVKKCLP----------LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp TTC-SCHHHHHHHHTCCC----------HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred ccc-cchhhhhhhhhccc----------ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000 00000111111111 01112347889999999999999999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=408.81 Aligned_cols=283 Identities=31% Similarity=0.537 Sum_probs=226.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|+++++||+|+||+||+|++..+++.||||+++.. ........+|+.+++.+... .||||+++++++.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~niv~~~~~~~ 84 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF----EHPNVVRLMDVCA 84 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH----CCTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc----CCCCeEEeeeeee
Confidence 7999999999999999999999999999999999732 12234667899999888654 6999999999998
Q ss_pred ecc-----eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 183 CQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 183 ~~~-----~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
... .+++||||+.++|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl 161 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKL 161 (308)
T ss_dssp ECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC---TTSCEEE
T ss_pred ccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEE
Confidence 764 68999999999999999877655699999999999999999999999999999999999995 6688999
Q ss_pred eecccccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 258 ~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
+|||++..... .....++|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++..+..
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99999975432 3345688999999999999999999999999999999999999999999999999999998844332
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
.+........ ..+ + ......+..+.
T Consensus 242 ~~~~~~~~~~----------------------~~~---------------~-----~~~~~~~~~~~------------- 266 (308)
T 3g33_A 242 DWPRDVSLPR----------------------GAF---------------P-----PRGPRPVQSVV------------- 266 (308)
T ss_dssp TSCSSCSSCG----------------------GGS---------------C-----CCCCCCHHHHS-------------
T ss_pred hccchhhccc----------------------ccc---------------C-----CCCCCcHHHhC-------------
Confidence 2111000000 000 0 00001112221
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+++.+.+||.+||++||++|||++|+|+||||++..
T Consensus 267 ----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 267 ----PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp ----CSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ----ccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 12457899999999999999999999999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=420.12 Aligned_cols=208 Identities=22% Similarity=0.328 Sum_probs=178.9
Q ss_pred CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
..++++++||+|+||+||+|+. ..+++.||||+++.. ....+.+.+|+.+|++| .|||||++++++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-------~HpNIV~l~g~~ 98 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-------QHPNVVCLLGVV 98 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-------CCCCCCCcceEE
Confidence 6788999999999999999974 356789999999743 34457899999999999 699999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl 246 (820)
...+.+|||||||. |+|.++|.... ...+++.++..|+.||+.||+|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 99999999999997 69999997542 2358999999999999999999999999999999999999
Q ss_pred ccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 247 CTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 247 ~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+ +++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+..+
T Consensus 179 ~---~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 179 Y---DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp C---GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred C---CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 6 6688999999999754322 234578999999999999999999999999999999998 899999988777
Q ss_pred HHHHHH
Q 003438 321 LLRRMI 326 (820)
Q Consensus 321 ~l~~I~ 326 (820)
++..+.
T Consensus 256 ~~~~i~ 261 (308)
T 4gt4_A 256 VVEMIR 261 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 665553
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=416.47 Aligned_cols=202 Identities=27% Similarity=0.395 Sum_probs=170.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
+++++.++||+|+||+||+|+... .||||+++. .....+.+.+|+.+|++| .|||||++++++. ++
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-------~HpNIV~l~g~~~-~~ 104 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-------RHVNILLFMGYMT-KD 104 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEC-SS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEE-CC
Confidence 678899999999999999997643 599999974 345567889999999998 6999999999875 46
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|||||||. |+|.+++.... ..+++.++..|+.||+.||+|||+++||||||||+||||+ +++.+||+|||+|+
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLAT 180 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCB
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCce
Confidence 7899999998 69999987654 4699999999999999999999999999999999999996 67899999999997
Q ss_pred ccCC-----ccccccccccccCccccccc---cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 265 TEDR-----TVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 265 ~~~~-----~~~~~~gt~~Y~APEvl~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
.... .....+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+..+.+..+
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~ 249 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM 249 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence 5432 23456899999999999743 5999999999999999999999999887665554443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=409.83 Aligned_cols=282 Identities=31% Similarity=0.549 Sum_probs=226.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|++. +++.||||+++... ...+.+.+|+++|+.+ .||||+++++++...
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-------HHPNIVSLIDVIHSE 91 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-------CCTTBCCEEEEECCS
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-------CCCCEeeeeeEEccC
Confidence 389999999999999999999985 58899999997532 3346788999999998 689999999999999
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+.+||||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 92 RCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLAR 167 (311)
T ss_dssp SCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCE
T ss_pred CEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC---CCCCEEEccCcCce
Confidence 9999999999999999887654 4599999999999999999999999999999999999996 66889999999997
Q ss_pred ccCC---ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 265 TEDR---TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 265 ~~~~---~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+...++..++..+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~- 246 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ- 246 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG-
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh-
Confidence 6542 2334578999999999987 4689999999999999999999999999999999999999988544433221
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
......+... ....+....+..+...
T Consensus 247 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~---------------- 272 (311)
T 3niz_A 247 VQELPLWKQR--------------------------------------TFQVFEKKPWSSIIPG---------------- 272 (311)
T ss_dssp GTTSHHHHSC--------------------------------------CCCCCCCCCHHHHSTT----------------
T ss_pred hhccchhhhc--------------------------------------ccccccCCcHHHhCcc----------------
Confidence 1111100000 0011112222333222
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+++++++||++||++||++|||++|||+||||++..
T Consensus 273 -~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 273 -FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp -CCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred -cCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 347789999999999999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=405.88 Aligned_cols=322 Identities=34% Similarity=0.583 Sum_probs=254.6
Q ss_pred cCCCCcceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCC-eEEEEEEEeCChhhHHHHHHHHHHHHHHhhhc
Q 003438 88 DNVNSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMN-SFVAVKIIKNQPAYYQQALVEVSILTTLNKKY 166 (820)
Q Consensus 88 d~~~~d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg-~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~ 166 (820)
++..+.+.+.+++.+. ++|+++++||+|+||+||+|++..++ +.||||+++......+.+.+|+.+++.+.+.
T Consensus 3 ~~~~~~~~~~~g~~~~-----~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~- 76 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWLQ-----ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK- 76 (355)
T ss_dssp BCTTSCBCCCTTCEET-----TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHH-
T ss_pred cccCCCcccccCceec-----ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhc-
Confidence 3455667777888775 89999999999999999999988776 7999999998777778888999999999764
Q ss_pred CCCCCCceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccc
Q 003438 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILL 246 (820)
Q Consensus 167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl 246 (820)
....+.+|+.+++++...+++||||||++++|.+.+.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll 156 (355)
T 2eu9_A 77 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF 156 (355)
T ss_dssp CTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred CCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 22345569999999999999999999999999999887765679999999999999999999999999999999999999
Q ss_pred ccc----------------cCCCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCC
Q 003438 247 CTS----------------VKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL 310 (820)
Q Consensus 247 ~~~----------------~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~ 310 (820)
... ...+.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence 532 3568899999999987766666778999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCc
Q 003438 311 PLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390 (820)
Q Consensus 311 ~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~ 390 (820)
.||......+.+..+.+..+ .+|..++...+....++..... +...............+.
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~--- 296 (355)
T 2eu9_A 237 TLFQTHENREHLVMMEKILG-PIPSHMIHRTRKQKYFYKGGLV----------------WDENSSDGRYVKENCKPL--- 296 (355)
T ss_dssp CSCCCSSHHHHHHHHHHHHC-CCCHHHHHHCSCGGGEETTEEC----------------CCTTSHHHHHHHHHCCCG---
T ss_pred CCCCCCCHHHHHHHHHHHcC-CCcHHHhhhccchhhhcccccc----------------cccccchhccccccCCcc---
Confidence 99999999999999999998 5566665554433222221110 000000000000000000
Q ss_pred cccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 391 ~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
. .........+..+.+||++||++||++|||++|+|+||||++..
T Consensus 297 -----------------~-----~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 297 -----------------K-----SYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp -----------------G-----GGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred -----------------c-----ccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 0 00011123467899999999999999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=401.92 Aligned_cols=313 Identities=35% Similarity=0.580 Sum_probs=246.1
Q ss_pred EeeceeeeccccCCceEEEEEeccCCceeEEEeec-cCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCce
Q 003438 96 LAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWD-AEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHI 174 (820)
Q Consensus 96 ~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d-~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnI 174 (820)
...++++. ++|+++++||+|+||+||+|++ ..+++.||||+++......+.+.+|+++++.+++. ....|++|
T Consensus 6 ~~~g~~~~-----~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~~i 79 (339)
T 1z57_A 6 CQSGDVLS-----ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT-DPNSTFRC 79 (339)
T ss_dssp CSTTCEET-----TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHH-CTTCTTCB
T ss_pred eecCCCcc-----CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhc-CCCCceee
Confidence 34455554 7999999999999999999988 56889999999998777778889999999999764 33456789
Q ss_pred eEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC---
Q 003438 175 VRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK--- 251 (820)
Q Consensus 175 Vkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~--- 251 (820)
+++++++...+++||||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 80 VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 99999999999999999999999999998776567999999999999999999999999999999999999963221
Q ss_pred -------------CCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 252 -------------PAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 252 -------------~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
.+.+||+|||++...........+|+.|+|||++.+..++.++|||||||++|||++|..||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5679999999998777666677899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchh
Q 003438 319 FDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL 398 (820)
Q Consensus 319 ~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L 398 (820)
.+.+..+.+..+ .+|..++........+..... ...... ....+.. ....+ +
T Consensus 240 ~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~~----------~~~~~~-----~~~~~~~-~~~~~-----------~ 291 (339)
T 1z57_A 240 KEHLAMMERILG-PLPKHMIQKTRKRKYFHHDRL----------DWDEHS-----SAGRYVS-RACKP-----------L 291 (339)
T ss_dssp HHHHHHHHHHHC-SCCHHHHHHCSCGGGEETTEE----------CCCTTS-----HHHHHHH-HHCCC-----------G
T ss_pred HHHHHHHHHHhC-CCCHHHHhhccchhHHhhccc----------cccccc-----cccchhh-hcCcc-----------h
Confidence 999999999888 555555554332221111100 000000 0000000 00000 0
Q ss_pred HHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 399 ~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
. +........++.+.+||++||+.||++|||++|+|+||||+..
T Consensus 292 ~--------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 292 K--------------EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp G--------------GGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred h--------------hhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 0 0001112356789999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=428.09 Aligned_cols=285 Identities=30% Similarity=0.548 Sum_probs=212.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|+++.+++.||||++... ....+.+.+|+++|+.| .|+|||++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~~~~~~~ 124 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-------NHDHVVKVLDIVIPK 124 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCCS
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-------CCCCCCceEEEEecC
Confidence 47999999999999999999999999999999999753 44567788999999999 689999999999543
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+||||||++++|.+++... ..+++..++.+++||+.||+|||++|||||||||+||||+ .++.+||+|
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~---~~~~~kl~D 199 (458)
T 3rp9_A 125 DVEKFDELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN---QDCSVKVCD 199 (458)
T ss_dssp CTTTCCCEEEEECCCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTCCEEECC
T ss_pred CcccCceEEEEEeccccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC---CCCCEeecc
Confidence 579999999999999998754 4699999999999999999999999999999999999995 678999999
Q ss_pred cccccccCC------------------------------ccccccccccccCccccc-cccccccchhHhHHHHHHHHHh
Q 003438 260 FGSACTEDR------------------------------TVYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFL 308 (820)
Q Consensus 260 FGlA~~~~~------------------------------~~~~~~gt~~Y~APEvl~-~~~yt~ksDIWSLG~ILyeLlt 308 (820)
||+++.... .....++|+.|+|||++. +..|+.++||||||||||||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 999975431 234457899999999874 5579999999999999999998
Q ss_pred -----------CCCCCCCCC--------------------HHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCcccc
Q 003438 309 -----------GLPLFPGAS--------------------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNI 357 (820)
Q Consensus 309 -----------G~~PF~~~s--------------------~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~ 357 (820)
|+++|++.+ ..+++..|.+.+| .|+...+.......
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g-~p~~~~~~~~~~~~------------ 346 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG-TPSEEDIEALEKED------------ 346 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHC-CCCHHHHHTSSCHH------------
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcC-CCCHHHHhhcCCHH------------
Confidence 888887765 3678888888888 55554443321100
Q ss_pred CCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccC
Q 003438 358 ENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD 437 (820)
Q Consensus 358 ~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~D 437 (820)
....+..++........ ......+++++|||++||++|
T Consensus 347 ----------------------------------------~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dLl~~mL~~d 384 (458)
T 3rp9_A 347 ----------------------------------------AKRYIRIFPKREGTDLA--ERFPASSADAIHLLKRMLVFN 384 (458)
T ss_dssp ----------------------------------------HHHHHTTSCCCCCCCGG--GGSTTSCHHHHHHHHHHSCSS
T ss_pred ----------------------------------------HHHHHHhcCCCCCCCHH--HHCCCCCHHHHHHHHHHhccC
Confidence 00000111110000000 011124578999999999999
Q ss_pred cCCCCCHHHHHcCCccCCCCCC
Q 003438 438 PAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 438 P~kRpTa~EaL~HPff~~~~~~ 459 (820)
|++|||++|||+||||++....
T Consensus 385 P~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 385 PNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp TTTSCCHHHHHHSGGGTTTCCG
T ss_pred ccccCCHHHHhcCHhhhhcCCC
Confidence 9999999999999999987653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=431.69 Aligned_cols=289 Identities=30% Similarity=0.528 Sum_probs=226.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
++|+++++||+|+||+||+|++..+++.||||++.+ .....+.+.+|+.+|+.+ .||||++++++|...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIISLLNVFTPQK 134 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEccCC
Confidence 899999999999999999999999999999999985 345567788999999998 689999999999765
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.++||||||++++|.+.+.. .+++..++.+++||+.||+|||++|||||||||+||||+ .++.+||+|
T Consensus 135 ~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~---~~~~~kl~D 207 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 207 (464)
T ss_dssp STTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECC
T ss_pred ccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe---CCCCEEEEE
Confidence 36799999999998887743 489999999999999999999999999999999999996 678999999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||+++..... ....++|+.|+|||++.+..|+.++||||||||+|||++|++||.+.+..+++.+|++.+|.++++.+
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 208 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp CCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred EEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9999765433 34568999999999999999999999999999999999999999999999999999999995555443
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
.........++.... .+....+.+++... +...+..
T Consensus 288 ~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~-----~~~~~~~ 323 (464)
T 3ttj_A 288 KKLQPTVRNYVENRP---------------------------------------KYAGLTFPKLFPDS-----LFPADSE 323 (464)
T ss_dssp TTSCHHHHHHHTTSC---------------------------------------CCCCCCHHHHSCGG-----GSCCSSH
T ss_pred HHcchhhhhHhhccc---------------------------------------ccCCCChHHhCccc-----ccccccc
Confidence 222111111211110 00111111211110 0001112
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.....+++++|||++||++||++|||++|||+||||+.
T Consensus 324 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 324 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred cccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 22335688999999999999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=399.67 Aligned_cols=280 Identities=30% Similarity=0.517 Sum_probs=224.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++++ .|+||+++++++..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-------KHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEETT
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-------CCCCEeeEEeEEEeCC
Confidence 6899999999999999999999999999999999743 33456778899999888 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+||||||++++|.+.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 75 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 75 KLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARA 150 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeccccee
Confidence 999999999999988887654 5699999999999999999999999999999999999996 678899999999975
Q ss_pred cCC---ccccccccccccCcccccccc-ccccchhHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 266 EDR---TVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPL-FPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 266 ~~~---~~~~~~gt~~Y~APEvl~~~~-yt~ksDIWSLG~ILyeLltG~~P-F~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+.+.++ .++...+..
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~-~~~~~~~~~ 229 (292)
T 3o0g_A 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEEQWPS 229 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC-CCCTTTCTT
T ss_pred cCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhhhhh
Confidence 432 234457899999999998775 89999999999999999986555 788888889999999888 333322221
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
......+. +.. .+-....+. ....
T Consensus 230 ~~~~~~~~-------------------------------------~~~--~~~~~~~~~-----------------~~~~ 253 (292)
T 3o0g_A 230 MTKLPDYK-------------------------------------PYP--MYPATTSLV-----------------NVVP 253 (292)
T ss_dssp GGGSTTCC-------------------------------------CCC--CCCTTCCCT-----------------TTST
T ss_pred hccccccc-------------------------------------ccc--cccCCcchh-----------------hccc
Confidence 11110000 000 000000000 0111
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..+..+++||++||++||++|||++|+|+||||++.
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 245788999999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=407.61 Aligned_cols=305 Identities=35% Similarity=0.561 Sum_probs=243.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcC----CCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD----REDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~----~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||+++......+.+.+|+.+++++.+... ...|+||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 79999999999999999999999999999999999877777888999999999975310 11378999999999876
Q ss_pred c----eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccc---cCCCeEE
Q 003438 185 R----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTS---VKPAEIK 256 (820)
Q Consensus 185 ~----~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~---~~~~~iK 256 (820)
+ .+++|||+++++|.+++.......+++..++.++.||+.||+|||++ |||||||||+||||+.+ .....+|
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~k 178 (373)
T 1q8y_A 99 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 178 (373)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred CCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEE
Confidence 5 89999999988999999886656799999999999999999999998 99999999999999633 2345799
Q ss_pred EeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhC
Q 003438 257 IIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILG 330 (820)
Q Consensus 257 L~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s------~~d~l~~I~~~lG 330 (820)
|+|||++...........+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+..+.+.++
T Consensus 179 l~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (373)
T 1q8y_A 179 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258 (373)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcC
Confidence 9999999877766667789999999999999999999999999999999999999998654 5677888889999
Q ss_pred CCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 331 ~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
.+|..++...+....+|........+... ....+.+++..
T Consensus 259 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~------ 298 (373)
T 1q8y_A 259 -ELPSYLLRNGKYTRTFFNSRGLLRNISKL---------------------------------KFWPLEDVLTE------ 298 (373)
T ss_dssp -SCCHHHHHHCTTHHHHBCC--CBSSCCCC---------------------------------CBCCHHHHHHH------
T ss_pred -CCCHHHHhccchhhhhcCCcchhcccccc---------------------------------cccchhhhhhh------
Confidence 66666766666555555543322211110 00112222211
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
........+..+.+||++||++||++|||++|||+||||++..
T Consensus 299 ----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 299 ----KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp ----TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred ----cccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 0111234678899999999999999999999999999999854
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=416.80 Aligned_cols=295 Identities=29% Similarity=0.554 Sum_probs=220.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++..+++.||||++.. .....+...+|+.+|+.+. .|+||+++++++...+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~------~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS------GHENIVNLLNVLRADN 82 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT------TCTTBCCEEEEEECTT
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc------CCCCCCeeeeEEecCC
Confidence 799999999999999999999999999999999864 3455667889999999984 4899999999998654
Q ss_pred --eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 186 --HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 186 --~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.+|||||||+++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||++
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a 156 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN---AECHVKVADFGLS 156 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTC
T ss_pred CCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc---CCCCEEecCCccc
Confidence 78999999999999988764 599999999999999999999999999999999999995 6789999999999
Q ss_pred cccCC------------------------ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 264 CTEDR------------------------TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 264 ~~~~~------------------------~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
+.... .....++|+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 64321 1234589999999999987 5799999999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCchHHHHhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccc
Q 003438 319 FDLLRRMIRILGAQPPDYVLKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHK 396 (820)
Q Consensus 319 ~d~l~~I~~~lG~~Pp~~~l~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~ 396 (820)
.+++..|...++ .|+...+...... ..+++.. ..............| .
T Consensus 237 ~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~--~ 286 (388)
T 3oz6_A 237 MNQLERIIGVID-FPSNEDVESIQSPFAKTMIESL---------------------------KEKVEIRQSNKRDIF--T 286 (388)
T ss_dssp HHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHH---------------------------HHHCC-----CCCCH--H
T ss_pred HHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhC---------------------------cccccccCCCHHHhC--c
Confidence 999999999998 5554433321100 0000000 000000000000001 0
Q ss_pred hhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 397 HLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 397 ~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.+...+.... .....++.++|||++||++||++|||++|||+||||+..
T Consensus 287 ~~~~~~~~~~-----------~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 287 KWKNLLLKIN-----------PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHHHHHHHC-----------TTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred chhhhccccc-----------ccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 1111111111 111245789999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=418.27 Aligned_cols=286 Identities=33% Similarity=0.573 Sum_probs=225.8
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
..++|+++++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|+.+ .|+||+++++++..
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-------KSDYIIRLYDLIIP 96 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-------CCCCcceEEEEEec
Confidence 348999999999999999999999999999999999753 34567788999999999 58999999999987
Q ss_pred c-----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 184 Q-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 184 ~-----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
. ..+||||||++++|.++++.. ..+++..++.+++||+.||+|||++||+||||||+||||+ .++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~---~~~~~kL~ 171 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN---QDCSVKVC 171 (432)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEEC
T ss_pred CCCCcCCeEEEEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC---CCCCEEEc
Confidence 6 579999999999999998754 4599999999999999999999999999999999999995 67899999
Q ss_pred ecccccccCCc-------------------------cccccccccccCccccc-cccccccchhHhHHHHHHHHHh----
Q 003438 259 DFGSACTEDRT-------------------------VYSYIQSRYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFL---- 308 (820)
Q Consensus 259 DFGlA~~~~~~-------------------------~~~~~gt~~Y~APEvl~-~~~yt~ksDIWSLG~ILyeLlt---- 308 (820)
|||+++..... ....++|+.|+|||++. ...|+.++||||||||+|||++
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99999754321 35568899999999874 5579999999999999999997
Q ss_pred -------CCCCCCCCC-----------------HHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCcccc
Q 003438 309 -------GLPLFPGAS-----------------EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSI 364 (820)
Q Consensus 309 -------G~~PF~~~s-----------------~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~ 364 (820)
|.++|.+.+ ..+++..|.+.+| .|+...+.......
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g-~p~~~~~~~~~~~~------------------- 311 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIG-TPTEDDLKNINKPE------------------- 311 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHC-SCCHHHHHTCCCHH-------------------
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcC-CCCHHHHHhccCHH-------------------
Confidence 667776654 4688899999999 56555443321100
Q ss_pred CCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCH
Q 003438 365 GGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSP 444 (820)
Q Consensus 365 ~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa 444 (820)
..+.+...+......... ....+++.++|||++||++||++|||+
T Consensus 312 ---------------------------------~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dLl~~mL~~dP~~R~ta 356 (432)
T 3n9x_A 312 ---------------------------------VIKYIKLFPHRKPINLKQ--KYPSISDDGINLLESMLKFNPNKRITI 356 (432)
T ss_dssp ---------------------------------HHHHHHTSCCCCCCCHHH--HSTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred ---------------------------------HHHHHHhCCCCCCCCHHH--HCCCCCHHHHHHHHHHhcCCcccCCCH
Confidence 000111111111010000 111245789999999999999999999
Q ss_pred HHHHcCCccCCCCCC
Q 003438 445 FQASRHPFVTGEPFT 459 (820)
Q Consensus 445 ~EaL~HPff~~~~~~ 459 (820)
+|||+||||++....
T Consensus 357 ~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 357 DQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHTCGGGTTTCCT
T ss_pred HHHhcChhhhhccCc
Confidence 999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=417.16 Aligned_cols=204 Identities=27% Similarity=0.390 Sum_probs=174.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t-----g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||+||+|++..+ ++.||||+++.. ....+.+.+|+++|.++. +|||||+++++
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~------hhpnIV~l~g~ 136 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA 136 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC------CCCcEEEEEEE
Confidence 37999999999999999999986543 478999999854 344567899999999995 36899999999
Q ss_pred Eeec-ceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 181 FVCQ-RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 181 f~~~-~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
|... +.+|||||||. |+|.++|+... ...+++.++..|+.||++||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 8764 57999999998 69999997643 13489999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ +++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 217 Ll~---~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 217 LLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp EEC---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred eeC---CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 996 6689999999999754322 234578999999999999999999999999999999998 9999987654
Q ss_pred HH
Q 003438 319 FD 320 (820)
Q Consensus 319 ~d 320 (820)
.+
T Consensus 294 ~~ 295 (353)
T 4ase_A 294 DE 295 (353)
T ss_dssp SH
T ss_pred HH
Confidence 33
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=404.40 Aligned_cols=287 Identities=32% Similarity=0.586 Sum_probs=216.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++|+.+ .||||+++++++..++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~~ 77 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-------KHENIVRLYDVIHTENK 77 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-------CBTTBCCEEEEECCTTE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-------CCCCcceEEEEEEECCe
Confidence 78999999999999999999999999999999997532 2346678899999888 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhc----CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 187 LCICFELLDSNLYELIKINHF----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~----~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+||||||++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGL 154 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCSS
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc---CCCCEEECcCcc
Confidence 999999999999999876542 3589999999999999999999999999999999999995 668899999999
Q ss_pred ccccCC---ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 263 ACTEDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 263 A~~~~~---~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+..... .....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .++...+
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~ 233 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG-TPNESLW 233 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SCCTTTC
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCChhHh
Confidence 975432 23345789999999999874 689999999999999999999999999999999999999888 4444333
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
........+..... ......+.+.+... .
T Consensus 234 ~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~------------~ 262 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQ---------------------------------------QRPPRDLRQVLQPH------------T 262 (317)
T ss_dssp GGGGGCTTCCTTCC---------------------------------------CCCCCCSHHHHGGG------------C
T ss_pred hhhhhhhhcccccc---------------------------------------cccchhHHHhhccc------------c
Confidence 32222111110000 00011122222110 0
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....+..+++||++||+.||++|||++|+|+||||++..
T Consensus 263 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 012457899999999999999999999999999998743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=407.39 Aligned_cols=286 Identities=32% Similarity=0.540 Sum_probs=223.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+|+.+ .|+||+++++++...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-------QHRNIIELKSVIHHN 105 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-------CCTTBCCEEEEEEET
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-------CCCCcceEEEEEecC
Confidence 379999999999999999999999999999999997542 2344567899998888 689999999999999
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc--cCCCeEEEeeccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGS 262 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~--~~~~~iKL~DFGl 262 (820)
+.+||||||++++|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+ +..+.+||+|||+
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred CEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999999999999999987653 59999999999999999999999999999999999999633 2456799999999
Q ss_pred ccccC---CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 263 ACTED---RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 263 A~~~~---~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+.... ......++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .|+...+
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-LPDDTTW 262 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTS
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-CCchhhh
Confidence 96543 223445779999999999875 589999999999999999999999999999999999999888 4433322
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
........+... ...+....+...+.
T Consensus 263 ~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~--------------- 288 (329)
T 3gbz_A 263 PGVTALPDWKQS---------------------------------------FPKFRGKTLKRVLG--------------- 288 (329)
T ss_dssp TTGGGSTTCCTT---------------------------------------CCCCCCCCHHHHHG---------------
T ss_pred hhhhhhhhhhhh---------------------------------------hhhhccccHhhhcc---------------
Confidence 211111100000 00111222222221
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..+++++++||++||++||++|||++|||+||||++..+
T Consensus 289 -~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 289 -ALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp -GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred -cccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 124578999999999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=410.69 Aligned_cols=280 Identities=28% Similarity=0.557 Sum_probs=226.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++++.||+|+||+||+|++..+++.||||++.. .....+.+.+|+++|+.+ .|+||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-------RHENVIGLLDVFTPD 96 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-------CBTTBCCCSEEECSC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-------CCcCCCCceeeEecC
Confidence 3899999999999999999999999999999999964 334556788999999998 589999999999876
Q ss_pred c------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 R------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ~------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
. .+||||||++++|.++++.. .+++..++.+++||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~ 170 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKIL 170 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEEC
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc---CCCCEEEE
Confidence 3 46999999988999988763 599999999999999999999999999999999999995 67889999
Q ss_pred ecccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||+++.........++|+.|+|||++.+ ..++.++||||||||+|||++|++||.+.+..+++..|.+..| .|+..+
T Consensus 171 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~~~~~~ 249 (367)
T 1cm8_A 171 DFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG-TPPAEF 249 (367)
T ss_dssp CCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred eeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCCHHH
Confidence 99999887766677789999999999987 6899999999999999999999999999999999999999999 555555
Q ss_pred HHhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 338 LKEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 338 l~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
+...... ..+.+... .. ....+..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~----------------------------------~~-----~~~~~~~~~------------- 277 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLP----------------------------------EL-----EKKDFASIL------------- 277 (367)
T ss_dssp HHTCSCHHHHHHHHHSC----------------------------------CC-----CCCCGGGTC-------------
T ss_pred HHHhhhHHHHHHHHhCC----------------------------------CC-----CCCCHHHHC-------------
Confidence 4432110 11111110 00 000111111
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++.+++||++||++||++|||++|||+||||++..
T Consensus 278 ----~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 278 ----TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp ----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred ----CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12457899999999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=397.55 Aligned_cols=279 Identities=32% Similarity=0.555 Sum_probs=219.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++ .+++.||||+++... ...+.+.+|+++++.+ .||||+++++++...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-------KHSNIVKLYDVIHTKK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-------CCTTBCCEEEEEECSS
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-------CCCCEeeeeeEEccCC
Confidence 6899999999999999999988 678999999997542 2235677899998888 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+|+||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARA 149 (288)
T ss_dssp CEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHH
T ss_pred eEEEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEeECccccc
Confidence 999999999999999887653 4699999999999999999999999999999999999995 678999999999965
Q ss_pred cCC---ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~---~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++..+... +...
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 228 (288)
T 1ob3_A 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN-WPNV 228 (288)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT-STTG
T ss_pred cCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh-chhh
Confidence 432 23345789999999999765 589999999999999999999999999999999999998888333221 1111
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+-.. ...+....++... ..
T Consensus 229 ~~~~~~~~~---------------------------------------~~~~~~~~~~~~~-----------------~~ 252 (288)
T 1ob3_A 229 TELPKYDPN---------------------------------------FTVYEPLPWESFL-----------------KG 252 (288)
T ss_dssp GGSTTCCTT---------------------------------------CCCCCCCCGGGTC-----------------CS
T ss_pred hcccccccc---------------------------------------cccccCccHHHHh-----------------hh
Confidence 000000000 0000000111111 12
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+++.+++||++||+.||++|||++|+|+||||++.
T Consensus 253 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 45788999999999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=403.91 Aligned_cols=283 Identities=31% Similarity=0.511 Sum_probs=220.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh--HHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY--YQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~--~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||+|++..+++.||||+++..... ...+.+|+.+|+.+ .|+||+++++++...+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-------KHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-------CCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-------CCCCCCeeeeEEeeCCE
Confidence 6899999999999999999999999999999999754321 11345688888877 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+||||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 75 LTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN---ERGELKLADFGLARAK 150 (324)
T ss_dssp EEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC---TTCCEEECSSSEEECC
T ss_pred EEEEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC---CCCCEEEccCcccccc
Confidence 99999999999999987654 4699999999999999999999999999999999999996 6678999999999754
Q ss_pred CCc---cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+++.. +....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~ 229 (324)
T 3mtl_A 151 SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET-WPGIL 229 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT-STTGG
T ss_pred cCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh-chhhh
Confidence 322 234578999999999987 4789999999999999999999999999999999999999998443332 22111
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
....+.. .. .+ .+....+ ......+
T Consensus 230 ~~~~~~~-~~--------------------------------~~-----~~~~~~~-----------------~~~~~~~ 254 (324)
T 3mtl_A 230 SNEEFKT-YN--------------------------------YP-----KYRAEAL-----------------LSHAPRL 254 (324)
T ss_dssp GCHHHHH-TC--------------------------------CC-----CCCCCCH-----------------HHHCTTS
T ss_pred cchhhcc-cc--------------------------------cc-----cccchhh-----------------hhhcCCC
Confidence 1100000 00 00 0000011 1111235
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
++.+.+||++||++||++|||++|||+||||.+...
T Consensus 255 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 255 DSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred CHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 578999999999999999999999999999987543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=400.35 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=216.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+++|+.+ .||||+++++++...+
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-------NHPNIVKLFEVIETEK 87 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEECSS
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEECC
Confidence 7899999999999999999999999999999999753 34566788999999998 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~ 162 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD---ADMNIKIADFGFSN 162 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTCCG
T ss_pred EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc---CCCCEEEeeccCce
Confidence 9999999996 6999988765 3699999999999999999999999999999999999995 67889999999996
Q ss_pred ccC--CccccccccccccCcccccccccc-ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TED--RTVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~--~~~~~~~gt~~Y~APEvl~~~~yt-~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+....- .
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~--------- 232 (328)
T 3fe3_A 163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-R--------- 232 (328)
T ss_dssp GGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C---------
T ss_pred ecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-C---------
Confidence 543 334567899999999999988775 799999999999999999999998877666555443100 0
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.| ..
T Consensus 233 ---------------------------------------------------------------~p-------------~~ 236 (328)
T 3fe3_A 233 ---------------------------------------------------------------IP-------------FY 236 (328)
T ss_dssp ---------------------------------------------------------------CC-------------TT
T ss_pred ---------------------------------------------------------------CC-------------CC
Confidence 00 01
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++.+.+||++||.+||++|||++|+|+||||+...
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 346789999999999999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=411.15 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=214.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ....+...+|+.+|+.+. .||||++++++|...
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~------~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR------NHPFLTQLFCCFQTP 96 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT------TCTTBCCEEEEEECS
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc------CCCceeeEEEEEEeC
Confidence 7999999999999999999999999999999999853 234456778999998874 589999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. ++|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||++
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~---~~g~ikL~DFG~a 171 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMC 171 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC---CCCCEEEccccce
Confidence 99999999998 5898888765 3699999999999999999999999999999999999995 6789999999999
Q ss_pred cccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
+... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|....- .
T Consensus 172 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~-------- 242 (353)
T 3txo_A 172 KEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV-V-------- 242 (353)
T ss_dssp BCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C--------
T ss_pred eecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-C--------
Confidence 7532 234456899999999999999999999999999999999999999999888777666654110 0
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
+| .
T Consensus 243 ----------------------------------------------------------------~p-------------~ 245 (353)
T 3txo_A 243 ----------------------------------------------------------------YP-------------T 245 (353)
T ss_dssp ----------------------------------------------------------------CC-------------T
T ss_pred ----------------------------------------------------------------CC-------------C
Confidence 00 0
Q ss_pred HhHHHHHHHHHhccccCcCCCCCH------HHHHcCCccCCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSP------FQASRHPFVTGEPF 458 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa------~EaL~HPff~~~~~ 458 (820)
.++..+.+||++||+.||++|+++ +|+++||||++..+
T Consensus 246 ~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 246 WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 134678999999999999999999 99999999998654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=406.71 Aligned_cols=290 Identities=30% Similarity=0.528 Sum_probs=221.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+ .||||+++++++...+
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-------NHKNIIGLLNVFTPQK 97 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEECSCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-------CCCCccceEEeecccc
Confidence 8999999999999999999999999999999999753 34556788999999988 6899999999998765
Q ss_pred ------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 ------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.+||||||++++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~---~~~~~kl~D 170 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILD 170 (371)
T ss_dssp STTTCCEEEEEEECCSEEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECC
T ss_pred ccccccceEEEEEcCCCCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc---CCCCEEEEE
Confidence 789999999999998885 3489999999999999999999999999999999999995 678899999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++...... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++..+++.+
T Consensus 171 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 171 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp CCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred eecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9999765433 34568899999999999999999999999999999999999999999999999999998884444433
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
.........++.... .+....+++++...... ....
T Consensus 251 ~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~-----~~~~ 286 (371)
T 2xrw_A 251 KKLQPTVRTYVENRP---------------------------------------KYAGYSFEKLFPDVLFP-----ADSE 286 (371)
T ss_dssp TTSCHHHHHHHHSSC---------------------------------------CCCCCCHHHHSCGGGSC-----CSSH
T ss_pred HHhhhHHHHHHhhCc---------------------------------------cccccchhhhcccccCc-----cccc
Confidence 221111111111100 01111122222111100 1111
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.....+..+++||++||++||++|||++|||+||||+..
T Consensus 287 ~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 287 HNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 223356789999999999999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=408.15 Aligned_cols=280 Identities=29% Similarity=0.544 Sum_probs=212.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|+.+ .|+||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-------KHENVIGLLDVFTPAR 101 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSCS
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEecCC
Confidence 8999999999999999999999999999999999753 34556788999999998 689999999999764
Q ss_pred -----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 185 -----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 185 -----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+|+|||+++++|.+++.. ..+++..++.+++||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kL~D 175 (367)
T 2fst_X 102 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILD 175 (367)
T ss_dssp SGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECC
T ss_pred ccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC---CCCCEEEee
Confidence 56899999999999988875 3599999999999999999999999999999999999995 678999999
Q ss_pred cccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 260 FGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 260 FGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
||+++.........++|+.|+|||++.+ ..++.++||||||||+|||++|++||.+.+..+++..|.+.+| .|+...+
T Consensus 176 FG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~p~~~~~ 254 (367)
T 2fst_X 176 FGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-TPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SCCHHHH
T ss_pred ccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHH
Confidence 9999877666667789999999999987 5899999999999999999999999999999999999999999 5555444
Q ss_pred Hhhhcc--chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 339 KEAKNT--SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 339 ~~~~~~--~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
...... ..+..... ......+..+..
T Consensus 255 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~------------- 282 (367)
T 2fst_X 255 KKISSESARNYIQSLT---------------------------------------QMPKMNFANVFI------------- 282 (367)
T ss_dssp TTCCCHHHHHHHHTSC---------------------------------------CCCCCCHHHHTT-------------
T ss_pred HHhhhHHHHHHHhccC---------------------------------------CCCCCCHHHHCC-------------
Confidence 322110 01111000 000111222221
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..++.++|||++||++||++|||++|||+||||++...
T Consensus 283 ----~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 283 ----GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp ----TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred ----CCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 23578999999999999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=399.61 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=221.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.+.||+|+||+||+|++..+++.||+|+++........+.+|+.+|+.+ .||||+++++++...+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-------RHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-------CCTTBCCEEEEEEETTEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-------CCCCCCeEeEEEecCCEE
Confidence 4899999999999999999999999999999999987766677788999999988 689999999999999999
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|||||||.+ +|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeEC
Confidence 999999984 8998886543 459999999999999999999999999999999999999632 3688999999999754
Q ss_pred C--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003438 267 D--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344 (820)
Q Consensus 267 ~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~ 344 (820)
. .......+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+..... .++.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~--------- 224 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-TFDE--------- 224 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCH---------
T ss_pred CCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC-CCCh---------
Confidence 3 333456789999999999998899999999999999999999999998887776666654221 0000
Q ss_pred chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHH
Q 003438 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424 (820)
Q Consensus 345 ~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~ 424 (820)
+ ....++.
T Consensus 225 -------------------------------------------------------~-----------------~~~~~s~ 232 (321)
T 1tki_A 225 -------------------------------------------------------E-----------------AFKEISI 232 (321)
T ss_dssp -------------------------------------------------------H-----------------HHTTSCH
T ss_pred -------------------------------------------------------h-----------------hhccCCH
Confidence 0 0012346
Q ss_pred HHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 425 ~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
++.+||++||..||++|||++|+|+||||++.
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 78999999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=393.85 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=215.7
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..++|+++++||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.+ .||||+++++++...+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-------CCCCCCeEeEEEEECC
Confidence 4489999999999999999999999999999999997432 3356678899999988 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+||||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCA 164 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC---CCCCEEEeeCCCce
Confidence 9999999996 6899888754 499999999999999999999999999999999999995 66789999999986
Q ss_pred ccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... .....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+..... +.
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~------- 235 (297)
T 3fxz_A 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--PE------- 235 (297)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS--CC-------
T ss_pred ecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CC-------
Confidence 5432 23455799999999999999999999999999999999999999988776665554433111 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
+.....
T Consensus 236 --------------------------------------------------------------------------~~~~~~ 241 (297)
T 3fxz_A 236 --------------------------------------------------------------------------LQNPEK 241 (297)
T ss_dssp --------------------------------------------------------------------------CSCGGG
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 000012
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
++..+.+||.+||+.||++|||++|+|+||||+..
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 44678999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=402.40 Aligned_cols=285 Identities=31% Similarity=0.546 Sum_probs=223.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.++|++++.||+|+||+||+|++..+++.||||+++... ...+.+.+|+++++.+ .|+||+++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~ 81 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-------SHPNIIGLLDAF 81 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-------CCCCCCeEEEEE
Confidence 479999999999999999999999999999999997432 1124677899999998 689999999999
Q ss_pred eecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 182 VCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 182 ~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
...+..+|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 82 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg 157 (346)
T 1ua2_A 82 GHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFG 157 (346)
T ss_dssp CCTTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCG
T ss_pred eeCCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc---CCCCEEEEecc
Confidence 9999999999999999988886543 4589999999999999999999999999999999999995 66899999999
Q ss_pred cccccCC---ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 262 SACTEDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 262 lA~~~~~---~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
++..... .....++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+..+++.
T Consensus 158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~- 236 (346)
T 1ua2_A 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ- 236 (346)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT-
T ss_pred cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhh-
Confidence 9975432 23345789999999999765 589999999999999999999999999999999999999888333222
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+........+. ....+....+..+..
T Consensus 237 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~-------------- 262 (346)
T 1ua2_A 237 WPDMCSLPDYV----------------------------------------TFKSFPGIPLHHIFS-------------- 262 (346)
T ss_dssp SSSTTSSTTCC----------------------------------------CCCCCCCCCHHHHCT--------------
T ss_pred hhhhccCcccc----------------------------------------cccccCCCChHHhhc--------------
Confidence 11100000000 000011112222221
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCP 461 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~ 461 (820)
..+..+++||++||+.||++|||++|+|+||||++.+.+.+
T Consensus 263 ---~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 263 ---AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp ---TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred ---cCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 24578999999999999999999999999999998765544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=398.28 Aligned_cols=287 Identities=25% Similarity=0.443 Sum_probs=227.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~- 183 (820)
.++|+++++||+|+||+||+|++..+++.||||++... ......+.+|+.+|+.+ .|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTK 88 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-------CCTTBCCEEEEEEEC
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-------cCCCcccHhheeecc
Confidence 37999999999999999999999999999999998643 22345677899999998 68999999999987
Q ss_pred -------cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEE
Q 003438 184 -------QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 184 -------~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
.+.+||||||++++|.+.+.... ..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~---~~~~~k 164 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLK 164 (351)
T ss_dssp --------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEE
T ss_pred ccccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCCEE
Confidence 34789999999999998887654 4699999999999999999999999999999999999995 668999
Q ss_pred EeecccccccC-------CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003438 257 IIDFGSACTED-------RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 257 L~DFGlA~~~~-------~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~ 328 (820)
|+|||++.... ......++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999996432 122345789999999999864 6899999999999999999999999999999999999999
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
.+..+++. +....... .+....... .....+.+.
T Consensus 245 ~~~~~~~~-~~~~~~~~-~~~~~~~~~-------------------------------------~~~~~~~~~------- 278 (351)
T 3mi9_A 245 CGSITPEV-WPNVDNYE-LYEKLELVK-------------------------------------GQKRKVKDR------- 278 (351)
T ss_dssp HCCCCTTT-STTGGGCG-GGTSSCCCS-------------------------------------SCCCCHHHH-------
T ss_pred hCCCChhh-ccccccch-hhccccccc-------------------------------------ccccCHHHH-------
Confidence 88554433 22211111 011000000 000001111
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
......++.+++||++||++||++|||++|||+||||+..+.+
T Consensus 279 --------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 279 --------LKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp --------HHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred --------hhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 1111235779999999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=402.22 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=215.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ......+.+|+.+|+.+ .||||++++++|...
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-------RHPFLTALKYAFQTH 77 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CCTTBCCEEEEEECS
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-------CCCcCcceEEEEEeC
Confidence 7899999999999999999999999999999999753 23345678899998877 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~a 152 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLC 152 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC---CCCCEEEeeccch
Confidence 99999999997 5888888764 3699999999999999999999999999999999999995 6789999999999
Q ss_pred ccc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
... .......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+....-
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------- 222 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------- 222 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred hhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 753 2334566899999999999999999999999999999999999999988776655554432100
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.+| .
T Consensus 223 ---------------------------------------------------------------~~p-------------~ 226 (337)
T 1o6l_A 223 ---------------------------------------------------------------RFP-------------R 226 (337)
T ss_dssp ---------------------------------------------------------------CCC-------------T
T ss_pred ---------------------------------------------------------------CCC-------------C
Confidence 000 0
Q ss_pred HhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
.+++.+.+||++||+.||++|+ +++|+++||||++..+
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 1346789999999999999999 9999999999998653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=399.52 Aligned_cols=252 Identities=24% Similarity=0.441 Sum_probs=219.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+|+.+ .||||+++++++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-------THPFIIRMWGTFQDA 78 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CBTTBCCEEEEEECS
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-------CCCCCceEeEEEEeC
Confidence 78999999999999999999999999999999998532 2345677888888877 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~Dfg~a 153 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFA 153 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSC
T ss_pred CEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc---CCCCEEEeecCcc
Confidence 99999999997 5899988764 3699999999999999999999999999999999999995 6789999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
..........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+....-
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------- 220 (318)
T 1fot_A 154 KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------- 220 (318)
T ss_dssp EECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-------------
T ss_pred eecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------
Confidence 8777666778999999999999999999999999999999999999999988777666555543100
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.+| ..++
T Consensus 221 ------------------------------------------------------------~~p-------------~~~~ 227 (318)
T 1fot_A 221 ------------------------------------------------------------RFP-------------PFFN 227 (318)
T ss_dssp ------------------------------------------------------------CCC-------------TTSC
T ss_pred ------------------------------------------------------------CCC-------------CCCC
Confidence 000 0134
Q ss_pred HHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
.++.+||++||..||++|+ +++|+++||||++..+
T Consensus 228 ~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 6789999999999999999 9999999999997653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=404.71 Aligned_cols=259 Identities=28% Similarity=0.394 Sum_probs=217.6
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-------hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~-------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
..++|++++.||+|+||+||+|+++.+++.||||++++... ..+.+.+|+.+|+.+ .||||+++++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~ 82 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-------LHPNIITLHD 82 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-------CCTTBCCEEE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-------CCcCCCcEEE
Confidence 34789999999999999999999999999999999985421 346788999999888 6899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC-CCeEEE
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKI 257 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~iKL 257 (820)
+|...+.+||||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+.. ...+||
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 83 VYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 9999999999999996 6999988653 46999999999999999999999999999999999999963211 227999
Q ss_pred eecccccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 258 ~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
+|||++..... .....+||+.|+|||++.+..|+.++||||||||+|+|++|.+||.+.+..+.+..|.......++
T Consensus 161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 239 (361)
T 2yab_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE- 239 (361)
T ss_dssp CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred EecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc-
Confidence 99999975543 234568999999999999989999999999999999999999999988877766665432110000
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
+
T Consensus 240 ----------------------------------------------------------------~--------------- 240 (361)
T 2yab_A 240 ----------------------------------------------------------------E--------------- 240 (361)
T ss_dssp ----------------------------------------------------------------H---------------
T ss_pred ----------------------------------------------------------------h---------------
Confidence 0
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....+++.+++||++||..||++|||++|+|+||||+..
T Consensus 241 --~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 241 --FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp --HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred --hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 001234678999999999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=404.46 Aligned_cols=280 Identities=30% Similarity=0.622 Sum_probs=223.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
.++|+++++||+|+||+||+|++..+++.||||++..+... ..+|+++|+.+ .|+||++++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l-------~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVL-------DHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTC-------CCTTBCCEEEEEEEC---
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHc-------CCCCccchhheeeecCcc
Confidence 47999999999999999999999999999999999865432 23699999888 68999999999854
Q ss_pred ----------------------------------cceeEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhh
Q 003438 184 ----------------------------------QRHLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLS 227 (820)
Q Consensus 184 ----------------------------------~~~l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~ 227 (820)
..+++|||||+.++|.+.+... ....+++..++.++.||+.||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3358999999999988887652 3356999999999999999999
Q ss_pred hcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc--CCccccccccccccCccccccc-cccccchhHhHHHHHH
Q 003438 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE--DRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVA 304 (820)
Q Consensus 228 yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~--~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILy 304 (820)
|||++||+||||||+|||++ ..++.+||+|||++... .......++|+.|+|||++.+. .++.++|||||||++|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 99999999999999999995 35679999999999754 3334456889999999999875 5999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhc
Q 003438 305 ELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELK 384 (820)
Q Consensus 305 eLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~ 384 (820)
||++|++||.+.+..+.+..+++.+|.++.+.+...... +....
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~----~~~~~-------------------------------- 277 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH----YTEVR-------------------------------- 277 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT----C--CC--------------------------------
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc----ccccc--------------------------------
Confidence 999999999999999999999999994444433322111 00000
Q ss_pred CCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 385 KPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 385 ~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
...+....+..++. ...+..+++||.+||++||++|||+.|||+||||++.
T Consensus 278 -----~~~~~~~~~~~~~~----------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 278 -----FPTLKAKDWRKILP----------------EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp -----CCCCCCCCHHHHSC----------------TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred -----CCccCcccHHhhCC----------------CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 00011111222211 1245779999999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=394.90 Aligned_cols=287 Identities=28% Similarity=0.493 Sum_probs=218.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH-- 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~-- 186 (820)
++|++.++||+|+||+||+|++..+++.||||++...........+|++.+..+ .|+||++++++|...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-------~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-------HHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-------CCTTBCCEEEEEEEECSSC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-------CCCCcccHHHhhhcccccc
Confidence 799999999999999999999999999999999987655555566677777777 68999999999976443
Q ss_pred -----eEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcc--cCCeeeccCCCCCcccccccCCCeEEE
Q 003438 187 -----LCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLK--DAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 187 -----l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLH--s~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
++|||||+.++|.+.+... ....+++..++.++.||+.||.||| ++||+||||||+||||+ ..++.+||
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl 173 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKL 173 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEE
Confidence 8999999999988776542 3346899999999999999999999 99999999999999996 23689999
Q ss_pred eecccccccCC--ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 258 ~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
+|||++..... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+.++ .++
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~ 252 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG-CPS 252 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCC
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC-CCC
Confidence 99999975543 23455789999999999765 489999999999999999999999999999999999999999 555
Q ss_pred hHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChh
Q 003438 335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME 414 (820)
Q Consensus 335 ~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e 414 (820)
..++.........+... ......+..++...+
T Consensus 253 ~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~~~-------- 284 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLY----------------------------------------NSKGIPWSNVFSDHS-------- 284 (360)
T ss_dssp HHHHHHHCTTCCCGGGG----------------------------------------CCCCCCHHHHTTTCC--------
T ss_pred HHHHHhcccchhhcccc----------------------------------------ccccCCcccccchhh--------
Confidence 55444322111000000 000111222222211
Q ss_pred hhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 415 ~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...++.+++||.+||++||++|||+.|||+||||++...
T Consensus 285 -----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 285 -----LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp -----CTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred -----ccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 124678999999999999999999999999999998654
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=408.47 Aligned_cols=280 Identities=31% Similarity=0.562 Sum_probs=222.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec----
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---- 184 (820)
.+|+++++||+|+||+||+|++..+++.||||++..... ...+|+++|+.| .|+|||+++++|...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l-------~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-------DHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTC-------CCTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHc-------CCCCccceeeEEeccCCCC
Confidence 589999999999999999999999999999999986532 234699999988 689999999998643
Q ss_pred --ceeEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 --RHLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 --~~l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
.+++|||||+.++|.+++... ....+++..++.++.||+.||+|||++|||||||||+||||+ .+.+.+||+||
T Consensus 124 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DF 201 (420)
T 1j1b_A 124 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDF 201 (420)
T ss_dssp TEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCC
T ss_pred cceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccc
Confidence 247899999999888877642 235699999999999999999999999999999999999996 24467999999
Q ss_pred ccccccC--CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 261 GSACTED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 261 GlA~~~~--~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|+++... ......++|+.|+|||++.+. .|+.++||||||||||||++|++||.+.+..+++.++++.+| .|+...
T Consensus 202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg-~p~~~~ 280 (420)
T 1j1b_A 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG-TPTREQ 280 (420)
T ss_dssp TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-SCCHHH
T ss_pred hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHH
Confidence 9997542 334456889999999999875 799999999999999999999999999999999999999999 554443
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+...... +.... . + ......+..++.
T Consensus 281 ~~~~~~~---~~~~~-----------~---------------------p-----~~~~~~~~~~~~-------------- 306 (420)
T 1j1b_A 281 IREMNPN---YTEFK-----------F---------------------P-----QIKAHPWTKVFR-------------- 306 (420)
T ss_dssp HHHHCSC---CCCCC-----------C---------------------C-----CCCCCCHHHHSC--------------
T ss_pred HHhhChh---hhhhc-----------c---------------------C-----ccCCCCHHHhcC--------------
Confidence 3321100 00000 0 0 001111222110
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...+++++|||++||++||++|||+.|+|+||||++..
T Consensus 307 --~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 307 --PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred --CCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 12457899999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=399.28 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=213.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|++.++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|+.+ .||||+++++++.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~ 96 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-------KHPHIVELLETYS 96 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-------CCCCCCcEEEEEE
Confidence 78999999999999999999999999999999997422 1356788999999998 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQRHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+.+|||||||. ++|.+.+.... ...+++..++.++.||+.||+|||+++||||||||+|||++.+.....+||+|
T Consensus 97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEec
Confidence 9999999999998 58888776543 23489999999999999999999999999999999999997555556799999
Q ss_pred cccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 260 FGlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
||++...... ....++|+.|+|||++.+..++.++||||||||+|+|++|+.||.+.. .+.+..+.+.....++
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~-- 253 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP-- 253 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH--
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc--
Confidence 9999765432 234579999999999999999999999999999999999999998643 2333333221000000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
.
T Consensus 254 ---------------------------------------------------------------~---------------- 254 (351)
T 3c0i_A 254 ---------------------------------------------------------------R---------------- 254 (351)
T ss_dssp ---------------------------------------------------------------H----------------
T ss_pred ---------------------------------------------------------------c----------------
Confidence 0
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....++..+.+||++||..||++|||+.|+|+||||++.
T Consensus 255 -~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 -QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 001244678999999999999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=394.19 Aligned_cols=261 Identities=28% Similarity=0.407 Sum_probs=218.3
Q ss_pred ccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 106 ~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
...++|++.+.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|+.+ .||||++++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~ 80 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-------QHPNVITLH 80 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEE
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-------CCCCCCcEE
Confidence 34478999999999999999999999999999999997532 1356788999999999 689999999
Q ss_pred EEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc-CCCeEE
Q 003438 179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIK 256 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~iK 256 (820)
+++.....+||||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+|
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEE
Confidence 99999999999999996 5999988653 4699999999999999999999999999999999999996322 223799
Q ss_pred EeecccccccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 257 IIDFGSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 257 L~DFGlA~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
|+|||++.... ......++|+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+..... ..+
T Consensus 159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~ 237 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFE 237 (326)
T ss_dssp ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-CCC
T ss_pred EEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-CcC
Confidence 99999997653 333456799999999999988999999999999999999999999998877666655543211 000
Q ss_pred hHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChh
Q 003438 335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME 414 (820)
Q Consensus 335 ~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e 414 (820)
. ..
T Consensus 238 ~----------------------------------------------------------------~~------------- 240 (326)
T 2y0a_A 238 D----------------------------------------------------------------EY------------- 240 (326)
T ss_dssp H----------------------------------------------------------------HH-------------
T ss_pred c----------------------------------------------------------------cc-------------
Confidence 0 00
Q ss_pred hhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 415 ~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....+..+.+||++||+.||++|||++|+|+||||+...
T Consensus 241 ----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 241 ----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp ----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred ----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 011346789999999999999999999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=409.79 Aligned_cols=296 Identities=27% Similarity=0.463 Sum_probs=214.5
Q ss_pred CceEEE-EEeccCCceeEEEeecc--CCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--
Q 003438 109 RRYIVK-DLLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-- 183 (820)
Q Consensus 109 ~rY~i~-~~LG~G~fG~Vyka~d~--~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-- 183 (820)
+.|++. ++||+|+||+||+|+++ .+++.||||+++.... ...+.+|+.+|+.| .||||++++++|..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLREL-------KHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHC-------CCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhc-------CCCCeeeEeeEEecCC
Confidence 567774 57999999999999955 5788999999985432 34678899999999 68999999999965
Q ss_pred cceeEEEEeccCCChHHHHHhhhc-------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc-cCCCeE
Q 003438 184 QRHLCICFELLDSNLYELIKINHF-------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEI 255 (820)
Q Consensus 184 ~~~l~LVmEy~~gsL~d~l~~~~~-------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~i 255 (820)
...+||||||++++|.+++..... ..+++..++.|++||+.||+|||++|||||||||+||||... +..+.+
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 92 DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 678999999999999998875431 249999999999999999999999999999999999999543 356899
Q ss_pred EEeecccccccCC------ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCH---------H
Q 003438 256 KIIDFGSACTEDR------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASE---------F 319 (820)
Q Consensus 256 KL~DFGlA~~~~~------~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~---------~ 319 (820)
||+|||+++.... .....++|+.|+|||++.+. .++.++||||||||+|+|++|++||.+... .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 9999999975442 23346789999999999875 589999999999999999999999987654 4
Q ss_pred HHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhH
Q 003438 320 DLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLE 399 (820)
Q Consensus 320 d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~ 399 (820)
+++..|.+.+| .|+...+........+..... . .....+....+.
T Consensus 252 ~~l~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~-----------------------------~-----~~~~~~~~~~~~ 296 (405)
T 3rgf_A 252 DQLDRIFNVMG-FPADKDWEDIKKMPEHSTLMK-----------------------------D-----FRRNTYTNCSLI 296 (405)
T ss_dssp HHHHHHHHHHC-CCCTTTCGGGGGSTTHHHHHH-----------------------------H-----CCGGGGTTCCHH
T ss_pred HHHHHHHHhhC-CCChhhcchhhcCcchhhhhh-----------------------------h-----ccccCCCcchhh
Confidence 78889999998 444433332222111111000 0 000011111122
Q ss_pred HHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCC
Q 003438 400 EIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTC 460 (820)
Q Consensus 400 ~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~ 460 (820)
+.+.... ...+..+++||++||++||++|||++|||+||||++.+.+.
T Consensus 297 ~~~~~~~-------------~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 297 KYMEKHK-------------VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp HHHHTTT-------------CCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred hhHhhcC-------------CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 2221111 11246789999999999999999999999999999877643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=402.23 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=219.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++++.||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+|+.+ .||||+++++++.+.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~ 113 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-------NFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEcC
Confidence 79999999999999999999999999999999997532 2345677888888877 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFg~a 188 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFA 188 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred CEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC---CCCCEEEcccccc
Confidence 99999999996 6999988765 3599999999999999999999999999999999999995 6789999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
+.........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..|....- .
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~----------- 256 (350)
T 1rdq_E 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-R----------- 256 (350)
T ss_dssp EECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C-----------
T ss_pred eeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-C-----------
Confidence 8777666677999999999999999999999999999999999999999998877666655543100 0
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+| ..++
T Consensus 257 -------------------------------------------------------------~p-------------~~~~ 262 (350)
T 1rdq_E 257 -------------------------------------------------------------FP-------------SHFS 262 (350)
T ss_dssp -------------------------------------------------------------CC-------------TTCC
T ss_pred -------------------------------------------------------------CC-------------CCCC
Confidence 00 0134
Q ss_pred HHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
..+.+||++||+.||++|++ ++|+++||||++..+
T Consensus 263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 67899999999999999998 999999999997654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=397.89 Aligned_cols=281 Identities=27% Similarity=0.537 Sum_probs=224.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.+ .|+||+++++++...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-------QHENVIGLLDVFTPA 113 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-------CCCCchhhhhheecc
Confidence 38999999999999999999999999999999999853 34467788999999998 689999999999987
Q ss_pred cee------EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 RHL------CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ~~l------~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
+.. |+||||+.++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kL~ 186 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKIL 186 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEEC
T ss_pred CCcccceeEEEEEccccccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC---CCCCEEEE
Confidence 654 9999999999887763 3499999999999999999999999999999999999995 67889999
Q ss_pred ecccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||+++.........++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+ .++..+
T Consensus 187 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 265 (371)
T 4exu_A 187 DFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGTEF 265 (371)
T ss_dssp STTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred ecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCcHHH
Confidence 99999877776677789999999999987 6899999999999999999999999999999999999999998 454443
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
........ ...+... ... .....+..+.
T Consensus 266 ~~~~~~~~-----------------------------~~~~~~~--~~~------~~~~~~~~~~--------------- 293 (371)
T 4exu_A 266 VQKLNDKA-----------------------------AKSYIQS--LPQ------TPRKDFTQLF--------------- 293 (371)
T ss_dssp HTTCSCHH-----------------------------HHHHHHH--SCC------CCCCCHHHHS---------------
T ss_pred HHHhhhhh-----------------------------hhhhhhc--cCC------CcchhHHHhc---------------
Confidence 33211000 0000000 000 0001111111
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++.+.+||++||++||++|||++|+|+||||+...
T Consensus 294 --~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 294 --PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp --TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred --cccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 12457899999999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=395.73 Aligned_cols=280 Identities=33% Similarity=0.581 Sum_probs=226.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-- 184 (820)
++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+++|+.+ .|+||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-------CCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-------CCCCCccceeEEecCCc
Confidence 7999999999999999999999999999999999743 34557788999999998 689999999999765
Q ss_pred ---ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 ---RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ---~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
...||||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 100 ~~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg 173 (364)
T 3qyz_A 100 EQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFG 173 (364)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCT
T ss_pred cccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC---CCCCEEEEeCc
Confidence 378999999999999988754 499999999999999999999999999999999999995 67789999999
Q ss_pred cccccCCc------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 262 SACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 262 lA~~~~~~------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
++...... ....++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...++ .|+
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~ 252 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG-SPS 252 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC-SCC
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC-CCC
Confidence 99754432 2345889999999987654 589999999999999999999999999999999999999999 454
Q ss_pred hHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChh
Q 003438 335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME 414 (820)
Q Consensus 335 ~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e 414 (820)
...+........ ..+.. ..+.. ....+..+..
T Consensus 253 ~~~~~~~~~~~~-----------------------------~~~~~---~~~~~-----~~~~~~~~~~----------- 284 (364)
T 3qyz_A 253 QEDLNCIINLKA-----------------------------RNYLL---SLPHK-----NKVPWNRLFP----------- 284 (364)
T ss_dssp HHHHHTCCCHHH-----------------------------HHHHH---TSCCC-----CCCCHHHHCT-----------
T ss_pred HHHHHHhhhhhH-----------------------------HHHHH---hcCCc-----cCCCHHHhCC-----------
Confidence 443332111000 00000 00000 0001111111
Q ss_pred hhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 415 ~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..+..+++||++||++||++|||++|||+||||++.
T Consensus 285 ------~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 285 ------NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp ------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred ------CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 245789999999999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=382.09 Aligned_cols=283 Identities=33% Similarity=0.551 Sum_probs=220.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+++++.+ .|+||+++++++...+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-------KHPNLVNLLEVFRRKR 75 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-------CCCCccchhheeecCC
Confidence 7899999999999999999999999999999998653 23456678899999998 6899999999999999
Q ss_pred eeEEEEeccCCC-hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~gs-L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..++||||+.++ |.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCE
T ss_pred eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc---CCCCEEEeeCCCch
Confidence 999999999975 44444432 4699999999999999999999999999999999999995 67899999999997
Q ss_pred ccCCc---cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 265 TEDRT---VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 265 ~~~~~---~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
..... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+.+.++..++......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 151 LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 54422 234578999999999986 57899999999999999999999999999999999999998885554332111
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
. ...++.... .+. + . ....+... ..
T Consensus 231 -~-~~~~~~~~~-~~~-----------------------------~----~--~~~~~~~~-----------------~~ 255 (311)
T 4agu_A 231 -S-TNQYFSGVK-IPD-----------------------------P----E--DMEPLELK-----------------FP 255 (311)
T ss_dssp -H-TCGGGTTCC-CCC-----------------------------C----S--SCCCHHHH-----------------CT
T ss_pred -c-cccccccCc-CCC-----------------------------c----c--ccchhhhh-----------------cc
Confidence 1 111111110 000 0 0 00001111 11
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.++..+.+||++||.+||++|||++|||+||||++...
T Consensus 256 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 256 NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp TCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 24577999999999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=411.27 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=218.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|+++.+++.||+|++.... ...+.+.+|+.+|+.+ .||||+++++++...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-------KHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-------CBTTBCCEEEEEECS
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCcCCCeEEEEEEEC
Confidence 379999999999999999999999999999999998543 3456688999999998 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..|||||||. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred CEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 99999999997 5898888765 36999999999999999999999999999999999999976556788999999999
Q ss_pred cccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
...... ....+||+.|+|||++.+..|+.++||||||||+|+|++|.+||.+.+..+.+..+.......+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 235 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP----- 235 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-----
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc-----
Confidence 755432 234689999999999999999999999999999999999999999888777766654421100000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
...
T Consensus 236 -----------------------------------------------------------------------------~~~ 238 (444)
T 3soa_A 236 -----------------------------------------------------------------------------EWD 238 (444)
T ss_dssp -----------------------------------------------------------------------------TTT
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.+++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 134678999999999999999999999999999753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=400.38 Aligned_cols=281 Identities=30% Similarity=0.569 Sum_probs=221.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc--
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-- 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-- 185 (820)
..+|+++++||+|+||+||+|++..+++ ||+|++...... ..+|+++|+.+ .|+||++++++|...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l-------~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIV-------KHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTC-------CCTTBCCEEEEEEEESSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhC-------CCCCcceEEEEEEecCCC
Confidence 3789999999999999999999887776 788877654322 23699999888 6899999999996544
Q ss_pred ----eeEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 ----HLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ----~l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.+||||||+.+++.+.+... ....+++..++.+++||+.||+|||++||+||||||+||||+ ...+.+||+|
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~D 185 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLID 185 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECC
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEee
Confidence 48999999999887766532 235699999999999999999999999999999999999995 3578999999
Q ss_pred ccccccc--CCccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 260 FGSACTE--DRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 260 FGlA~~~--~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
||+++.. .......++|+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..+.+.+| .|+..
T Consensus 186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g-~p~~~ 264 (394)
T 4e7w_A 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG-TPSRE 264 (394)
T ss_dssp CTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCHH
T ss_pred CCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHH
Confidence 9999754 3334456889999999999775 599999999999999999999999999999999999999999 55444
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
.+..... .+.. .. . + ......+...+.
T Consensus 265 ~~~~~~~--~~~~-~~-~-------------------------------~-----~~~~~~~~~~~~------------- 291 (394)
T 4e7w_A 265 QIKTMNP--NYME-HK-F-------------------------------P-----QIRPHPFSKVFR------------- 291 (394)
T ss_dssp HHHHHCG--GGSS-SC-C-------------------------------C-----CCCCCCHHHHSC-------------
T ss_pred HHHhhCh--hhhh-hc-c-------------------------------c-----cccCCcHHHhcc-------------
Confidence 3332111 0000 00 0 0 000111111111
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...++++++||.+||++||++|||+.|+|+||||++...
T Consensus 292 ---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 292 ---PRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp ---TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred ---ccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 124578999999999999999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=400.89 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=218.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+.+|+.| .||||+++++++.+.+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-------QHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeCC
Confidence 7899999999999999999999999999999999853 34456788999999998 6899999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..||||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+.....+||+|||++.
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999984 898888654 359999999999999999999999999999999999999755556789999999997
Q ss_pred ccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
..... ....+||+.|+|||++.+..|+.++||||||||+|+|++|.+||.+.+..+.+..+.......+.
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 251 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS-------- 251 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--------
T ss_pred EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc--------
Confidence 65432 33468999999999999989999999999999999999999999988776666555432110000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.....+
T Consensus 252 --------------------------------------------------------------------------~~~~~~ 257 (362)
T 2bdw_A 252 --------------------------------------------------------------------------PEWDTV 257 (362)
T ss_dssp --------------------------------------------------------------------------TGGGGS
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 000123
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 4678999999999999999999999999999763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=394.91 Aligned_cols=193 Identities=21% Similarity=0.250 Sum_probs=158.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--- 185 (820)
++|.+.++||+|+||+||+|++ +++.||||+++...........|+.++..+ .|||||++++++..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-------~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-------RHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-------CCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-------CCCCCCcEEEEEEecCCCc
Confidence 6899999999999999999976 589999999986543222233344444444 7999999999998764
Q ss_pred -eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC--------CeeeccCCCCCcccccccCCCeE
Q 003438 186 -HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--------GIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 186 -~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~--------gIVHrDLKPeNILl~~~~~~~~i 255 (820)
.+|||||||+ |+|.++++.. .++++.+.+++.|++.||+|||++ +||||||||+||||+ .++.+
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~---~~~~~ 147 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC---TTSCE
T ss_pred eEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC---CCCCE
Confidence 6899999998 6999998754 489999999999999999999987 999999999999995 67899
Q ss_pred EEeecccccccCCc-------cccccccccccCccccccc------cccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 256 KIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 256 KL~DFGlA~~~~~~-------~~~~~gt~~Y~APEvl~~~------~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
||+|||+|+..... ....+||+.|||||++.+. .|+.++||||||||||||+||.+||...
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 99999999654321 2235799999999999764 5788999999999999999999888543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=402.71 Aligned_cols=207 Identities=18% Similarity=0.254 Sum_probs=181.5
Q ss_pred CceEEEEEeccC--CceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHG--TFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G--~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++|+++++||+| +||+||+|+++.+++.||||+++.. ....+.+.+|+.+|+.+ .|||||++++++..
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~ 97 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-------NHPNIVPYRATFIA 97 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-------CCCCCCcEeEEEEE
Confidence 799999999999 9999999999999999999999854 34456778899999998 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+|||||||. ++|.+++.......+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~---~~~~~kl~dfg~ 174 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRS 174 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCGGG
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEccccc
Confidence 999999999997 6899998876556799999999999999999999999999999999999995 678999999998
Q ss_pred ccccC----------CccccccccccccCcccccc--ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 263 ACTED----------RTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 263 A~~~~----------~~~~~~~gt~~Y~APEvl~~--~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
+.... ......++|+.|+|||++.+ ..++.++||||||||+|||++|++||.+.+..+.+..+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 84321 11223478999999999988 57999999999999999999999999887665554443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=406.46 Aligned_cols=198 Identities=22% Similarity=0.395 Sum_probs=175.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+|+++. .||||++++++|..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~------~hp~Iv~l~~~~~~ 124 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS------NHPFLVGLHSCFQT 124 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT------TCTTBCCEEEEEEC
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC------CCCCcCeeEEEEEE
Confidence 379999999999999999999999999999999998542 23345778999998874 58999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+|||||||. ++|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFGl 199 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGM 199 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC---CCCCEEEeecce
Confidence 999999999997 5888888765 4699999999999999999999999999999999999995 678999999999
Q ss_pred cccc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 263 A~~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++.. .......+||+.|+|||++.+..|+.++|||||||++|||++|++||...
T Consensus 200 a~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 200 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred eeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 9752 33445678999999999999999999999999999999999999999653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=401.29 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=217.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++.. ...+....|..+|+.+. .||||++++++|..
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~------~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EHPFLTHMFCTFQT 89 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT------TCTTBCCEEEEEEC
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC------CCCCCCcEEEEEEe
Confidence 379999999999999999999999999999999998542 33456778999988763 58999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+||||||+. ++|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~vkL~DFG~ 164 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGM 164 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC---CCCCEEEeEChh
Confidence 999999999997 5899988764 3699999999999999999999999999999999999995 678999999999
Q ss_pred cccc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
++.. .......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..|....-
T Consensus 165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------- 235 (345)
T 1xjd_A 165 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------- 235 (345)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred hhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 9753 2334566899999999999999999999999999999999999999998877666655533100
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.+|
T Consensus 236 ----------------------------------------------------------------~~p------------- 238 (345)
T 1xjd_A 236 ----------------------------------------------------------------FYP------------- 238 (345)
T ss_dssp ----------------------------------------------------------------CCC-------------
T ss_pred ----------------------------------------------------------------CCC-------------
Confidence 000
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHH-HHHcCCccCCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPF-QASRHPFVTGEPF 458 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~-EaL~HPff~~~~~ 458 (820)
..+++.+.+||++||+.||++|||+. |+++||||++..+
T Consensus 239 ~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 239 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 01346789999999999999999998 9999999998654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=395.20 Aligned_cols=197 Identities=22% Similarity=0.400 Sum_probs=176.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+.+|+++. .||||++++++|..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~------~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS------NHPFLVGLHSCFQT 81 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT------TCTTBCCEEEEEEC
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC------CCCccCeEEEEEEe
Confidence 37899999999999999999999999999999999853 344566788999998873 58999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+||||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~g~~kL~DFG~ 156 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGM 156 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCGGG
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEEeccc
Confidence 999999999997 5898888764 3699999999999999999999999999999999999995 678999999999
Q ss_pred cccc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 263 A~~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
++.. .......+||+.|+|||++.+..++.++|||||||++|||++|++||..
T Consensus 157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 157 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 9753 2334566899999999999999999999999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=384.92 Aligned_cols=284 Identities=30% Similarity=0.514 Sum_probs=226.9
Q ss_pred CceEEEEEeccCCceeEEEeecc-CCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-EMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-- 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-- 182 (820)
++|++++.||+|+||+||+|++. .+++.||||+++... .....+.+|+.+++.+... .||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~----~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----EHPNVVRLFDVCTVS 86 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT----CCTTBCCEEEEEEEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhcc----CCCCeEeeeeeeeec
Confidence 79999999999999999999985 678999999997422 2223566889998888653 6999999999997
Q ss_pred ---ecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 ---CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ---~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
....+++||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~---~~~~~kl~D 163 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD 163 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc---CCCCEEEec
Confidence 56789999999999999999876555699999999999999999999999999999999999995 668999999
Q ss_pred cccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|++||.+....+.+..+.+.++..+...+
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 9999765432 33457899999999999999999999999999999999999999999999999999988883333221
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
..........+.. .....+.++
T Consensus 244 ~~~~~~~~~~~~~------------------------------------------~~~~~~~~~---------------- 265 (326)
T 1blx_A 244 PRDVALPRQAFHS------------------------------------------KSAQPIEKF---------------- 265 (326)
T ss_dssp CTTCSSCGGGSCC------------------------------------------CCCCCGGGT----------------
T ss_pred ccccccchhhhcc------------------------------------------cCcchhhhc----------------
Confidence 1100000000000 000001111
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...++..+.+||.+||..||++|||+.|+|+||||++...
T Consensus 266 -~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 266 -VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp -CCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred -cccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 1124578899999999999999999999999999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=393.69 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=219.5
Q ss_pred CceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~-~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|.+. ++||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.+. .||||+++++++...
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK------SCPRVINLHEVYENT 101 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT------TCTTBCCEEEEEECS
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc------CCCCEEEEEEEEEeC
Confidence 788888 8999999999999999999999999999853 234567889999999985 479999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+.+ +|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999985 8888876554467999999999999999999999999999999999999975444689999999999
Q ss_pred cccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 264 CTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 264 ~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+..
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 255 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE------ 255 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------
T ss_pred cccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch------
Confidence 765433 244578999999999999999999999999999999999999999888776666554422200000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
....
T Consensus 256 ----------------------------------------------------------------------------~~~~ 259 (327)
T 3lm5_A 256 ----------------------------------------------------------------------------TFSS 259 (327)
T ss_dssp ----------------------------------------------------------------------------TTTT
T ss_pred ----------------------------------------------------------------------------hhcc
Confidence 0011
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~ 462 (820)
++..+.+||++||+.||++|||++|||+||||++..+....
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence 34678999999999999999999999999999987765443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=406.85 Aligned_cols=258 Identities=21% Similarity=0.374 Sum_probs=217.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++... ..+.+.+|+.+|+.+ .|||||+++++|.+
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-------~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-------NSPWVVQLFYAFQD 140 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-------CCTTBCCEEEEEEC
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEE
Confidence 3799999999999999999999999999999999975321 223467899999888 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+|||||||. |+|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+ ..+.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~---~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC---CCCCEEEeccce
Confidence 999999999996 5899888653 599999999999999999999999999999999999995 678999999999
Q ss_pred ccccCCc----cccccccccccCcccccccc----ccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 263 ACTEDRT----VYSYIQSRYYRSPEVLLGYQ----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 263 A~~~~~~----~~~~~gt~~Y~APEvl~~~~----yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
++..... ....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+...+|.+.....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-- 292 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-- 292 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--
Confidence 9755432 23568999999999998765 8899999999999999999999999888777776665421100
Q ss_pred hHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChh
Q 003438 335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME 414 (820)
Q Consensus 335 ~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e 414 (820)
.+|.
T Consensus 293 ---------------------------------------------------------------------~~p~------- 296 (410)
T 3v8s_A 293 ---------------------------------------------------------------------TFPD------- 296 (410)
T ss_dssp ---------------------------------------------------------------------CCCT-------
T ss_pred ---------------------------------------------------------------------cCCC-------
Confidence 0000
Q ss_pred hhhhhHHhHHHHHHHHHhccccCcCC--CCCHHHHHcCCccCCCCCCC
Q 003438 415 DISKESQIRLALVDFLKGLVEFDPAK--RWSPFQASRHPFVTGEPFTC 460 (820)
Q Consensus 415 ~~~~~~~~s~~l~DLI~kmL~~DP~k--RpTa~EaL~HPff~~~~~~~ 460 (820)
...++..+++||++||..+|++ |++++||++||||++..+..
T Consensus 297 ----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 297 ----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp ----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 0013467899999999999998 99999999999999876543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=382.47 Aligned_cols=283 Identities=30% Similarity=0.490 Sum_probs=218.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe----
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV---- 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~---- 182 (820)
.++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+++++.+ .||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-------DHDNIVKVFEILGPSGS 82 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEECTTSC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-------CCCCeeEEEEecccccc
Confidence 38999999999999999999999999999999999754 44567788999999988 6899999999874
Q ss_pred ----------ecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 183 ----------CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 183 ----------~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
.....||||||+.++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ ..+
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~ 157 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TED 157 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTT
T ss_pred ccccccccccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCC
Confidence 3468899999999999998864 3599999999999999999999999999999999999995 245
Q ss_pred CeEEEeecccccccCC------ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 253 AEIKIIDFGSACTEDR------TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~------~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
+.+||+|||++..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7899999999975432 1234467899999999876 57899999999999999999999999999988888888
Q ss_pred HHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcC
Q 003438 326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405 (820)
Q Consensus 326 ~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~ 405 (820)
.+.......+...+.......+..... . .....+..+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~--------~~~~~~~~~~~-- 276 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDM-------------------------------T--------EPHKPLTQLLP-- 276 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHT-------------------------------T--------SCCCCHHHHST--
T ss_pred HHhcCCCchhhhhhhhhcCcccccccc-------------------------------c--------CCCCChhHhcc--
Confidence 877662222221111111111100000 0 00011112111
Q ss_pred CCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 406 P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.++..+++||++||+.||++|||++|+|+||||+...+
T Consensus 277 ---------------~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 277 ---------------GISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp ---------------TCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred ---------------hhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 24578999999999999999999999999999997654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=399.06 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=215.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+.+|..+|..+. .||||++++++|...
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~------~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG------KPPFLTQLHSCFQTM 93 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT------CCTTBCCEEEEEECS
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC------CCCEEeeEEEEEEcC
Confidence 79999999999999999999999999999999998532 23456677888876653 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||++
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a 168 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMC 168 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc---CCCcEEEEeCCcc
Confidence 99999999997 5899988765 3599999999999999999999999999999999999995 6789999999999
Q ss_pred ccc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
... .......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..|....- .
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~-~-------- 239 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV-A-------- 239 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C--------
T ss_pred cccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-C--------
Confidence 753 2334566899999999999999999999999999999999999999998887766666544100 0
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
+| .
T Consensus 240 ----------------------------------------------------------------~p-------------~ 242 (353)
T 2i0e_A 240 ----------------------------------------------------------------YP-------------K 242 (353)
T ss_dssp ----------------------------------------------------------------CC-------------T
T ss_pred ----------------------------------------------------------------CC-------------C
Confidence 00 0
Q ss_pred HhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
.++..+.+||++||..||++|+ +++|+++||||++..+
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 1346789999999999999999 4799999999997654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=385.96 Aligned_cols=284 Identities=31% Similarity=0.549 Sum_probs=223.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC--ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
.++|++.++||+|+||+||+|++..+++.||||+++. .......+.+|+.+|+.+ .|+||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-------KHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-------cCCCcCCeeeeecccc
Confidence 3899999999999999999999999999999999974 334556778999999998 689999999988764
Q ss_pred ----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 ----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
...|+||||+.++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 83 ~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~---~~~~~kl~Df 156 (353)
T 2b9h_A 83 FENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN---SNCDLKVCDF 156 (353)
T ss_dssp STTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCC
T ss_pred cCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---CCCcEEEEec
Confidence 679999999999999988763 599999999999999999999999999999999999995 6788999999
Q ss_pred ccccccCCc-------------cccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003438 261 GSACTEDRT-------------VYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 261 GlA~~~~~~-------------~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~ 326 (820)
|++...... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus 157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 999654321 123478999999999865 678999999999999999999999999999989888888
Q ss_pred HHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCC
Q 003438 327 RILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP 406 (820)
Q Consensus 327 ~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P 406 (820)
...+..+.......... ....++... . ..+....+..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~---~-----~~~~~~~~~~~~---- 275 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIES-----------------------------PRAREYIKS---L-----PMYPAAPLEKMF---- 275 (353)
T ss_dssp HHHCCCCSTTTTTTCCC-----------------------------HHHHHHHHT---S-----CCCCCCCHHHHS----
T ss_pred HHhCCCchhcccccccc-----------------------------chhhHHhhc---c-----cCCCCcchhhhc----
Confidence 88873332211110000 000000000 0 000111122221
Q ss_pred CCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 407 ~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..+++.+.+||++||..||++|||++|||+||||+....
T Consensus 276 -------------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 276 -------------PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp -------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred -------------ccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 124578999999999999999999999999999997654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=382.57 Aligned_cols=287 Identities=23% Similarity=0.439 Sum_probs=217.7
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--c
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--Q 184 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--~ 184 (820)
..++|+++++||+|+||+||+|++..+++.||||+++... .+.+.+|+.+|+.+. .|+||+++++++.. .
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~------~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR------GGPNIITLADIVKDPVS 105 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHT------TSTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcC------CCCCEEEeeeeeccCCC
Confidence 3489999999999999999999999999999999998543 467889999999995 48999999999998 6
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
...++||||+.+ +|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++ .+...+||+|||++
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLA 178 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCc
Confidence 689999999984 6766653 389999999999999999999999999999999999996 23348999999999
Q ss_pred cccC--CccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 264 CTED--RTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLF-PGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 264 ~~~~--~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF-~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+.+.++. + .+..
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~-~--~~~~ 255 (330)
T 3nsz_A 179 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT-E--DLYD 255 (330)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH-H--HHHH
T ss_pred eEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCC-c--hhhh
Confidence 6543 33345678999999999987 57999999999999999999999888 455677788888777761 1 1111
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.... ... .. ...+.+++...........-.....
T Consensus 256 ~~~~-------~~~---------~~------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (330)
T 3nsz_A 256 YIDK-------YNI---------EL------------------------------DPRFNDILGRHSRKRWERFVHSENQ 289 (330)
T ss_dssp HHHH-------TTC---------CC------------------------------CTHHHHHHCCCCCCCGGGGCCTTTG
T ss_pred HHHH-------hcc---------cc------------------------------ccchhhhhhhccccchhhhcccccc
Confidence 1000 000 00 0000011100000000000000111
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+++.+++||++||++||++|||++|||+||||++..
T Consensus 290 ~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 290 HLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp GGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 23568899999999999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.89 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=218.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.++||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.+ .|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-------QHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-------CCCCcCeEEEEEEcC
Confidence 48999999999999999999999999999999999753 34456778899999998 689999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.+.....+||+|||++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 999999999975 888887765 35999999999999999999999999999999999999976555667999999999
Q ss_pred cccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 264 CTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 264 ~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+.......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T 3kk8_A 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP------ 229 (284)
T ss_dssp EECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------
T ss_pred EEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch------
Confidence 655432 234578999999999999999999999999999999999999998877766655544321100000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
....
T Consensus 230 ----------------------------------------------------------------------------~~~~ 233 (284)
T 3kk8_A 230 ----------------------------------------------------------------------------EWDT 233 (284)
T ss_dssp ----------------------------------------------------------------------------TTTT
T ss_pred ----------------------------------------------------------------------------hhcc
Confidence 0011
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++.+.+||++||+.||++|||++|+|+||||++..
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 346789999999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=388.25 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=206.8
Q ss_pred CceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
++|+++++||+|+||+||+|++. .+++.||||++++.. .....+.+|+.+|+.+ .||||++++++
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~ 89 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-------KHPFIVDLIYA 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-------CCTTBCCEEEE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-------CCCCccceeEE
Confidence 79999999999999999999875 689999999998542 2345577899999998 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+...+.+||||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~D 164 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTD 164 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC---TTSCEEECC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC---CCCcEEEEe
Confidence 999999999999997 5898888764 3589999999999999999999999999999999999995 678999999
Q ss_pred cccccccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 260 FGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 260 FGlA~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.+....
T Consensus 165 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----- 239 (327)
T 3a62_A 165 FGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN----- 239 (327)
T ss_dssp CSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----
T ss_pred CCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 99986432 2234567899999999999999999999999999999999999999988776666555431110
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
+|
T Consensus 240 --------------------------------------------------------------------~p---------- 241 (327)
T 3a62_A 240 --------------------------------------------------------------------LP---------- 241 (327)
T ss_dssp --------------------------------------------------------------------CC----------
T ss_pred --------------------------------------------------------------------CC----------
Confidence 00
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
..++..+.+||++||..||++|| |++|+|+||||++..+
T Consensus 242 ---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 242 ---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp ---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred ---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 01346789999999999999999 8999999999997643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=397.84 Aligned_cols=259 Identities=28% Similarity=0.366 Sum_probs=202.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|+++++||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.+ .||||+++++++...+.+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-------RHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-------CCTTBCCEEEEEECSSEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-------CCCCCCcEEEEEeeCCEE
Confidence 3799999999999999999999999999999999987665567788999999998 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
||||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+ ....+||+|||+++..
T Consensus 92 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-SSCCEEECCCCCC---
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCceEEEeecCccccc
Confidence 99999996 5899888764 369999999999999999999999999999999999999632 2345999999999633
Q ss_pred --CCccccccccccccCcccccccccccc-chhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 --DRTVYSYIQSRYYRSPEVLLGYQYTTA-IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 --~~~~~~~~gt~~Y~APEvl~~~~yt~k-sDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
.......++|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........+.+.+....
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------- 238 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK---------- 238 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC----------
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC----------
Confidence 233345689999999999998887655 9999999999999999999976543222222211110000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
..+| ....++
T Consensus 239 -----------------------------------------------------------~~~~-----------~~~~~s 248 (361)
T 3uc3_A 239 -----------------------------------------------------------YSIP-----------DDIRIS 248 (361)
T ss_dssp -----------------------------------------------------------CCCC-----------TTSCCC
T ss_pred -----------------------------------------------------------CCCC-----------CcCCCC
Confidence 0000 000134
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+.+++||++||+.||++|||++|||+||||...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 678999999999999999999999999999653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=387.57 Aligned_cols=280 Identities=26% Similarity=0.531 Sum_probs=221.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|+.+ .||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-------QHENVIGLLDVFTPAS 96 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSCS
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-------CCCCcccHhheEeccc
Confidence 7999999999999999999999999999999999753 34456788999999998 6899999999998765
Q ss_pred e------eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 H------LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ~------l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
. +|+||||+.++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~D 169 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN---EDCELKILD 169 (353)
T ss_dssp SGGGCCCCEEEEECCSEEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---TTCCEEECS
T ss_pred ccccceeEEEEeccccCCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC---CCCcEEEee
Confidence 4 59999999998887663 3499999999999999999999999999999999999995 668899999
Q ss_pred cccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 260 FGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 260 FGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
||++...........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+ .++..+.
T Consensus 170 fg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~ 248 (353)
T 3coi_A 170 FGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG-VPGTEFV 248 (353)
T ss_dssp TTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC-BCCHHHH
T ss_pred cccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCCHHHH
Confidence 9999877666666788999999999987 5789999999999999999999999999999999999999988 4444433
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
....... ....+...+........ ..
T Consensus 249 ~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~~~--~~ 274 (353)
T 3coi_A 249 QKLNDKA----------------------------------------------------AKSYIQSLPQTPRKDFT--QL 274 (353)
T ss_dssp TTCSCHH----------------------------------------------------HHHHHHTSCBCSSCCTT--TT
T ss_pred HHHhhHH----------------------------------------------------HHHHHHhCcCCCCccHH--Hh
Confidence 3211100 00000000000000000 00
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....++.+.+||.+||..||++|||++|+|+||||+...
T Consensus 275 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 275 FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred cCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 112457899999999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=380.85 Aligned_cols=202 Identities=28% Similarity=0.461 Sum_probs=171.6
Q ss_pred CCceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~-~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++. ++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|+++. .||||+++++++...+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~------~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ------GHRNVLELIEFFEEED 84 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC------CCTTBCCEEEEEEETT
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc------CCCCeeeEEEEEeeCC
Confidence 3789996 78999999999999999999999999997543 34567889999998863 6999999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+||||||+. ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.+.....+||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999997 6999998765 369999999999999999999999999999999999999754444569999999986
Q ss_pred ccCC----------ccccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 265 TEDR----------TVYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 265 ~~~~----------~~~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.... .....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 4321 1223468999999999975 568999999999999999999999997654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=383.67 Aligned_cols=283 Identities=30% Similarity=0.532 Sum_probs=221.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+ .|+||+++++++...+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-------RHENLVNLLEVCKKKK 97 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-------CCCCEeeEEEEeecCC
Confidence 8999999999999999999999999999999998643 33455677899999998 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..||||||+.+.+++.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFART 173 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCTTC--
T ss_pred EEEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc---CCCcEEEEeCCCcee
Confidence 999999999976555544332 4699999999999999999999999999999999999995 667999999999965
Q ss_pred cCC---ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~---~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+..++..... .
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 252 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL-F 252 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH-H
T ss_pred ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH-h
Confidence 432 23445789999999999876 789999999999999999999999999999999999999888555433211 1
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
... ..+.... .+.. -....+... ...
T Consensus 253 ~~~-~~~~~~~--------------------------------~~~~----~~~~~~~~~-----------------~~~ 278 (331)
T 4aaa_A 253 NKN-PVFAGVR--------------------------------LPEI----KEREPLERR-----------------YPK 278 (331)
T ss_dssp HHC-GGGTTCC--------------------------------CCCC----SSCCCHHHH-----------------STT
T ss_pred hhc-ccccccc--------------------------------Cccc----cccchhhhc-----------------ccc
Confidence 110 0000000 0000 000001111 112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus 279 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 279 LSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred hhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 457899999999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=396.97 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=217.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|+++++||+|+||+||+|+++.+++.||+|++... ......+.+|+.+|+.+ .|+||+++++++...+.
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-------HHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-------CSTTBCCEEEEEECSSE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-------CCcCCCeEEEEEEeCCE
Confidence 37899999999999999999999999999999999864 33455778899999887 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+||||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ ..+.+||+|||++..
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATK 200 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEeccccee
Confidence 999999997 58988886543 459999999999999999999999999999999999999632 457899999999976
Q ss_pred cCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 266 EDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 266 ~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... .....++|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~---------- 270 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------- 270 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC----------
T ss_pred cCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------
Confidence 543 23445799999999999999999999999999999999999999998877666655543111000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.. ....++
T Consensus 271 ---------------------------------------------------~~---------------------~~~~~s 278 (387)
T 1kob_A 271 ---------------------------------------------------ED---------------------AFSSVS 278 (387)
T ss_dssp ---------------------------------------------------SS---------------------TTTTSC
T ss_pred ---------------------------------------------------cc---------------------ccccCC
Confidence 00 001134
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+.+.+||++||..||++|||++|+|+||||++..
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 6789999999999999999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=398.21 Aligned_cols=196 Identities=28% Similarity=0.458 Sum_probs=175.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||+||+|++..+++.||||++.+.. .....+.+|+.+|+.+ .||||+++++++...
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~~~~~~ 81 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-------RHPHIIKLYDVITTP 81 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeC
Confidence 79999999999999999999999999999999997532 2234678899999888 689999999999999
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+.+||||||++|+|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 82 ~~~~lv~E~~~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 82 TDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSN 156 (336)
T ss_dssp SEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC---TTCCEEECCSSCTB
T ss_pred CEEEEEEECCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc---CCCCEEEEEeccce
Confidence 999999999999999988765 3699999999999999999999999999999999999995 67889999999997
Q ss_pred ccCC--ccccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 157 IMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp TTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred eccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 5433 3345689999999999998876 68999999999999999999999653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=402.29 Aligned_cols=260 Identities=20% Similarity=0.323 Sum_probs=216.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++... ....+.+|+.+|..+ .|+||++++++|.+
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-------~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-------DSKWITTLHYAFQD 145 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-------CTTTBCCEEEEEEC
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEee
Confidence 3799999999999999999999999999999999975321 122367899999887 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+|||||||. |+|.+++.... ..+++..++.++.||+.||.|||+++||||||||+||||+ .++.+||+|||+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~---~~g~vkL~DFGl 221 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGS 221 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc---CCCCEEEcchhh
Confidence 999999999996 69999987643 4699999999999999999999999999999999999995 678999999999
Q ss_pred ccccCCc----cccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 263 ACTEDRT----VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 263 A~~~~~~----~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
++..... ....+||+.|+|||++. ...|+.++|||||||++|||++|++||.+.+..+.+.+|+......
T Consensus 222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~- 300 (437)
T 4aw2_A 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF- 300 (437)
T ss_dssp CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-
T ss_pred hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-
Confidence 9654322 23358999999999997 4579999999999999999999999999988877777665321100
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
.+| ..
T Consensus 301 ----------------------------------------------------------------------~~p--~~--- 305 (437)
T 4aw2_A 301 ----------------------------------------------------------------------QFP--TQ--- 305 (437)
T ss_dssp ----------------------------------------------------------------------CCC--SS---
T ss_pred ----------------------------------------------------------------------cCC--cc---
Confidence 000 00
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCC--CCCHHHHHcCCccCCCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAK--RWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~k--RpTa~EaL~HPff~~~~~~ 459 (820)
...++++++|||++||..+|++ |++++|+++||||++..+.
T Consensus 306 -----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 306 -----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp -----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred -----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 0013467899999999999998 9999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=381.42 Aligned_cols=249 Identities=25% Similarity=0.307 Sum_probs=202.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++..+++.||||++... .........|+..+..+. .|+||+++++++...+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~------~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG------QHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhc------CCCcEEEEEEEEEeCC
Confidence 7899999999999999999999999999999998753 233344555666665552 6999999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+||||||++++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+|||++..
T Consensus 131 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 131 ILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---GGGCEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---CCCCEEEccceeeee
Confidence 999999999999999887764 5699999999999999999999999999999999999995 567899999999976
Q ss_pred cCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 266 EDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 266 ~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
.... .....||+.|+|||++.+ .++.++|||||||++|||++|..+|..... ...+.+ + ..+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~--~-~~~--------- 270 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ--G-YLP--------- 270 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT--T-CCC---------
T ss_pred cccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc--c-CCC---------
Confidence 5433 234568999999999886 799999999999999999999777644221 111100 0 000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
.++ ...++
T Consensus 271 -------------------------------------------------------~~~-----------------~~~~~ 278 (311)
T 3p1a_A 271 -------------------------------------------------------PEF-----------------TAGLS 278 (311)
T ss_dssp -------------------------------------------------------HHH-----------------HTTSC
T ss_pred -------------------------------------------------------ccc-----------------ccCCC
Confidence 000 11244
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
+.+.+||.+||+.||++|||++|+|+||||++
T Consensus 279 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 77999999999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=387.25 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=206.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|+++++||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++...+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-------NHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-------CCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-------CCCCCCeEEEEEecCC
Confidence 379999999999999999999999999999999997543 2345678899999998 6899999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..||||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~---~~~~~kl~Dfg~a~ 153 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLAT 153 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe---CCCCEEEEEeeccc
Confidence 99999999975 888887544 3599999999999999999999999999999999999995 66889999999996
Q ss_pred ccC-----CccccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 265 TED-----RTVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 265 ~~~-----~~~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.................
T Consensus 154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 225 (323)
T 3tki_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------- 225 (323)
T ss_dssp ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC--------
T ss_pred eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc--------
Confidence 432 12235678999999999988775 7899999999999999999999976543211111000000
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
. ....
T Consensus 226 ----------------------------------------------------~-----------------------~~~~ 230 (323)
T 3tki_A 226 ----------------------------------------------------T-----------------------YLNP 230 (323)
T ss_dssp ----------------------------------------------------T-----------------------TSTT
T ss_pred ----------------------------------------------------c-----------------------cCCc
Confidence 0 0000
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
...++..+.+||++||+.||++|||++|+|+||||++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 11244678999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=377.61 Aligned_cols=257 Identities=28% Similarity=0.379 Sum_probs=210.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++.++||+|+||+||+|++..+++.||||++.... ...+.+.+|+++|+.+ .||||+++++++...+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-------DHPNIIKIFEVFEDYH 93 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECSS
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-------CCchHHhHHHheecCC
Confidence 479999999999999999999999999999999998543 3457788999999988 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 186 HLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..|+||||+. ++|.+.+.... ...+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 9999999997 48998886542 35699999999999999999999999999999999999997555678899999999
Q ss_pred ccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 263 ACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 263 A~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
+..... ......+|+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---~------ 243 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP---N------ 243 (285)
T ss_dssp CCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---C------
T ss_pred ceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc---c------
Confidence 975432 234567899999999986 4789999999999999999999999988776554433322000 0
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
+ +. ...
T Consensus 244 ----------------------------------------------------~------------~~----------~~~ 249 (285)
T 3is5_A 244 ----------------------------------------------------Y------------AV----------ECR 249 (285)
T ss_dssp ----------------------------------------------------C------------CC------------C
T ss_pred ----------------------------------------------------c------------cc----------ccC
Confidence 0 00 000
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
..++.+.+||++||+.||++|||++|+|+||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 13467889999999999999999999999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=390.24 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=200.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.++||+|+||+||+|++..+++.||||+++... ..+.+.+|+++|+++ .|+||+++++++...+.+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-------SHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-------CCTTBCCEEEEEECSSEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-------CCCCCcceeeeEecCCeE
Confidence 378999999999999999999999999999999998653 345677899999998 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+|||||+. ++|.+++... +.+++.+++.++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++...
T Consensus 124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999997 5898888654 35999999999999999999999999999999999999975455789999999999755
Q ss_pred CCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 DRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFD-LLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 ~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d-~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... ....++|+.|+|||++.+..++.++|||||||++|||++|..||......+ .+..+..... .
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~-~----------- 269 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY-Y----------- 269 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC-C-----------
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC-c-----------
Confidence 432 345678999999999999999999999999999999999999997655433 2222211000 0
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+.. + ....++
T Consensus 270 -------------------------------------------------~~~----------~-----------~~~~~~ 279 (349)
T 2w4o_A 270 -------------------------------------------------FIS----------P-----------WWDEVS 279 (349)
T ss_dssp -------------------------------------------------CCT----------T-----------TTTTSC
T ss_pred -------------------------------------------------cCC----------c-----------hhhhCC
Confidence 000 0 001134
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+.+||++||..||++|||++|+|+||||++..
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 6789999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=383.40 Aligned_cols=250 Identities=25% Similarity=0.456 Sum_probs=201.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---------------------------hHHHHHHHHHHHHH
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---------------------------YYQQALVEVSILTT 161 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~---------------------------~~~~~~~Ei~iL~~ 161 (820)
++|++.++||+|+||+||+|++..+++.||||++..... ..+.+.+|+++|+.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 799999999999999999999999999999999975421 13457889999998
Q ss_pred HhhhcCCCCCCceeEEeEEEee--cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeecc
Q 003438 162 LNKKYDREDKHHIVRIYEYFVC--QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCD 238 (820)
Q Consensus 162 L~~~~~~~~HpnIVkl~d~f~~--~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrD 238 (820)
+ .||||+++++++.. .+.+||||||+. ++|.+++. ...+++..++.++.||+.||+|||++||+|||
T Consensus 93 l-------~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 162 (298)
T 2zv2_A 93 L-------DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRD 162 (298)
T ss_dssp C-------CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred C-------CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 8 68999999999987 568999999997 46665432 24699999999999999999999999999999
Q ss_pred CCCCCcccccccCCCeEEEeecccccccCCc---cccccccccccCcccccccc---ccccchhHhHHHHHHHHHhCCCC
Q 003438 239 LKPENILLCTSVKPAEIKIIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPL 312 (820)
Q Consensus 239 LKPeNILl~~~~~~~~iKL~DFGlA~~~~~~---~~~~~gt~~Y~APEvl~~~~---yt~ksDIWSLG~ILyeLltG~~P 312 (820)
|||+|||++ .++.+||+|||++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.|
T Consensus 163 lkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 163 IKPSNLLVG---EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCGGGEEEC---TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEEC---CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999995 6688999999999754332 34457899999999998764 47899999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccc
Q 003438 313 FPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEY 392 (820)
Q Consensus 313 F~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~ 392 (820)
|...........+..... .
T Consensus 240 f~~~~~~~~~~~~~~~~~-~------------------------------------------------------------ 258 (298)
T 2zv2_A 240 FMDERIMCLHSKIKSQAL-E------------------------------------------------------------ 258 (298)
T ss_dssp SCCSSHHHHHHHHHHCCC-C------------------------------------------------------------
T ss_pred CCCccHHHHHHHHhcccC-C------------------------------------------------------------
Confidence 987665444333322000 0
Q ss_pred cccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 393 FHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 393 f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
+|. ...+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 259 ------------~~~-----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 259 ------------FPD-----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp ------------CCS-----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ------------CCC-----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 000 0013467899999999999999999999999999963
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=386.27 Aligned_cols=283 Identities=28% Similarity=0.509 Sum_probs=217.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------------hhhHHHHHHHHHHHHHHhhhcCCCCCCcee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------------PAYYQQALVEVSILTTLNKKYDREDKHHIV 175 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~------------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIV 175 (820)
.++|+++++||+|+||.||+|++.. ++.||||++... ....+.+.+|+++|+.+ .||||+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv 92 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-------HHPNIL 92 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-------CCTTBC
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-------CCcCcc
Confidence 4899999999999999999998865 899999998632 22347788999999999 689999
Q ss_pred EEeEEEeec-----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc
Q 003438 176 RIYEYFVCQ-----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV 250 (820)
Q Consensus 176 kl~d~f~~~-----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~ 250 (820)
++++++... ..+||||||+.++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~--- 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA--- 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---
T ss_pred ceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc---
Confidence 999999543 3689999999999999988653 4699999999999999999999999999999999999995
Q ss_pred CCCeEEEeecccccccCC--ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 003438 251 KPAEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 251 ~~~~iKL~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~ 327 (820)
..+.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp TTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 678899999999974332 2344578999999999987 5799999999999999999999999999999999999999
Q ss_pred HhCCCCchHHHHhhhc-cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCC
Q 003438 328 ILGAQPPDYVLKEAKN-TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYP 406 (820)
Q Consensus 328 ~lG~~Pp~~~l~~~~~-~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P 406 (820)
..+..+.+.+...... ...++.... ..+....+..+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~---- 286 (362)
T 3pg1_A 249 VVGTPKIEDVVMFSSPSARDYLRNSL--------------------------------------SNVPARAWTAVV---- 286 (362)
T ss_dssp HHCCCCHHHHHHTSCHHHHHHTTTCC--------------------------------------CCCCCCCHHHHS----
T ss_pred HcCCCChHHhhhccchhhhHHHHhhc--------------------------------------ccCChhhHHhhC----
Confidence 9984433332211000 000000000 000111111111
Q ss_pred CCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 407 YRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 407 ~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++.+.+||.+||++||++|||++|+|+||||++..
T Consensus 287 -------------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 287 -------------PTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred -------------CCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 12457899999999999999999999999999999753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=406.70 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=206.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|++..+++.||||+++.. ......+.+|+.+|+.+ .||||++++++|..
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-------RHPFLTALKYSFQT 219 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-------SCTTSCCEEEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-------CCCeEeeEEEEEee
Confidence 37899999999999999999999999999999999843 22334556677666655 69999999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.+.+||||||+.+ +|.+++... ..+++..++.++.||+.||+|||+ +|||||||||+||||+ .++.+||+|||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~---~~~~~kl~DFG 294 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFG 294 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC---SSSCEEECCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC---CCCCEEEccCC
Confidence 9999999999974 888888665 369999999999999999999998 9999999999999996 66899999999
Q ss_pred cccccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 262 SACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 262 lA~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..... .
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-~------ 367 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-R------ 367 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-C------
T ss_pred CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-C------
Confidence 997532 234456899999999999999999999999999999999999999988777665555433100 0
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
+|
T Consensus 368 ------------------------------------------------------------------~p------------ 369 (446)
T 4ejn_A 368 ------------------------------------------------------------------FP------------ 369 (446)
T ss_dssp ------------------------------------------------------------------CC------------
T ss_pred ------------------------------------------------------------------CC------------
Confidence 00
Q ss_pred hHHhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
..+++.+.+||.+||+.||++|| |++|+|+||||++..+
T Consensus 370 -~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 370 -RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 01346789999999999999999 9999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.94 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=217.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|++.++||+|+||+||+|++..+++.||+|++... ....+.+.+|+++++.+ .||||+++++++...+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-------DHPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECSSE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-------CCCCEeeEEEEEecCCe
Confidence 37999999999999999999999999999999999753 23456788999999988 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..++..+.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 999999997 4888888765 3599999999999999999999999999999999999996555778999999999965
Q ss_pred cC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 266 ED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 266 ~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
.. .......+|+.|+|||++.+. ++.++|||||||++|+|++|+.||......+....+.+... ..+..
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~------- 229 (277)
T 3f3z_A 159 FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF-TFPEK------- 229 (277)
T ss_dssp CCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CCCHH-------
T ss_pred ccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-CCCch-------
Confidence 43 233456789999999998764 99999999999999999999999998877766665544211 00000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
....++
T Consensus 230 --------------------------------------------------------------------------~~~~~~ 235 (277)
T 3f3z_A 230 --------------------------------------------------------------------------DWLNVS 235 (277)
T ss_dssp --------------------------------------------------------------------------HHTTSC
T ss_pred --------------------------------------------------------------------------hhhcCC
Confidence 001134
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+.+.+||++||+.||++|||+.|+|+||||++.
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 678999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=395.49 Aligned_cols=200 Identities=29% Similarity=0.423 Sum_probs=167.6
Q ss_pred CCceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee---
Q 003438 108 QRRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--- 183 (820)
Q Consensus 108 ~~rY~i~-~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--- 183 (820)
.++|.+. ++||+|+||+||+|+++.+++.||||+++.. ....+|+.++.++. .|+||++++++|..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~------~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS------QCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT------TSTTBCCEEEEEEEEET
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc------CCCCcceEeEEEeeccc
Confidence 3678887 7899999999999999999999999999854 34667888886663 68999999999876
Q ss_pred -cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 184 -QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 184 -~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..++|||||||. ++|.+++.......+++..++.|+.||+.||.|||++|||||||||+|||++.....+.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 678999999997 599999987554569999999999999999999999999999999999999754447899999999
Q ss_pred cccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 262 SACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 262 lA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
+++.... .....++|+.|+|||++.+..|+.++||||||||+|||++|+.||.+..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 9975442 2345688999999999999999999999999999999999999997654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=403.93 Aligned_cols=258 Identities=27% Similarity=0.446 Sum_probs=215.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--------------hhHHHHHHHHHHHHHHhhhcCCCCCCc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--------------AYYQQALVEVSILTTLNKKYDREDKHH 173 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--------------~~~~~~~~Ei~iL~~L~~~~~~~~Hpn 173 (820)
.++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|+.| .|||
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpn 107 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-------DHPN 107 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-------CCTT
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-------CCCC
Confidence 389999999999999999999999999999999998542 2346788899999998 6899
Q ss_pred eeEEeEEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 174 IVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 174 IVkl~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
|+++++++.....+|||||||. ++|.+.+... ..+++..++.+++||+.||+|||++||+||||||+|||++.+...
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCC
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCC
Confidence 9999999999999999999997 5898888765 369999999999999999999999999999999999999754444
Q ss_pred CeEEEeecccccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003438 253 AEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG 330 (820)
..+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+...
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp SSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred ccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 5799999999975443 3345689999999999874 699999999999999999999999999888777666654111
Q ss_pred CCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 331 ~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
..+
T Consensus 265 -~~~---------------------------------------------------------------------------- 267 (504)
T 3q5i_A 265 -YFD---------------------------------------------------------------------------- 267 (504)
T ss_dssp -CCC----------------------------------------------------------------------------
T ss_pred -CCC----------------------------------------------------------------------------
Confidence 000
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
......+++.+++||++||++||++|||++|+|+||||++..
T Consensus 268 -----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 268 -----FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp -----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred -----ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 000112457789999999999999999999999999998743
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=390.08 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=207.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++++.||+|+||+||+|+++.+++.||||++++... ...+|+++|.++. .||||+++++++.+.+.+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~------~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG------QHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT------TSTTBCCEEEEEECSSEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc------CCCCcCeEEEEEEcCCEEE
Confidence 789999999999999999999999999999999986542 2346888888874 5899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc-cCCCeEEEeeccccccc
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~-~~~~~iKL~DFGlA~~~ 266 (820)
||||||. ++|.+.+... +.+++..++.++.||+.||+|||++||+||||||+|||+... .....+||+|||++...
T Consensus 93 lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999997 5899988764 359999999999999999999999999999999999998532 22346999999999754
Q ss_pred CC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCCchHHHHh
Q 003438 267 DR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA---SEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 267 ~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~---s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.. .....++|+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. ...+.+..+....- .
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--~------- 241 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF--S------- 241 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCC--C-------
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCc--c-------
Confidence 32 234568899999999999888999999999999999999999999753 22333333221000 0
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.... ...
T Consensus 242 -----------------------------------------------~~~~--------------------------~~~ 248 (342)
T 2qr7_A 242 -----------------------------------------------LSGG--------------------------YWN 248 (342)
T ss_dssp -----------------------------------------------CCST--------------------------TTT
T ss_pred -----------------------------------------------cCcc--------------------------ccc
Confidence 0000 001
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.+++.+.+||++||..||++|||++|+|+||||.+
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 24577899999999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=403.46 Aligned_cols=258 Identities=32% Similarity=0.506 Sum_probs=218.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|+++.+++.||||++... ......+.+|+++|+++ .||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-------DHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECS
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-------CCCCcCeEEEEEEcC
Confidence 37999999999999999999999999999999999742 23456788999999999 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
..+|+|||||. ++|.+.+... +.+++..++.+++||+.||.|||++|||||||||+|||++.....+.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999997 5898888765 36999999999999999999999999999999999999976556778999999999
Q ss_pred cccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 264 CTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 264 ~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
..... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.......+
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 242 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------- 242 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC--------
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 75432 2345689999999999976 599999999999999999999999999888777666544211000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
......
T Consensus 243 --------------------------------------------------------------------------~~~~~~ 248 (486)
T 3mwu_A 243 --------------------------------------------------------------------------LPQWRT 248 (486)
T ss_dssp --------------------------------------------------------------------------SGGGGG
T ss_pred --------------------------------------------------------------------------CcccCC
Confidence 000112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+++.+++||++||++||++|||+.|||+||||++..
T Consensus 249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 457789999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=392.15 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=211.2
Q ss_pred CceEE--EEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIV--KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i--~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..|++ .++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|++| .||||+++++++...+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-------DHANLIQLYDAFESKN 159 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEECSS
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-------CCCCCCeEEEEEEECC
Confidence 34544 678999999999999999999999999998643 4556788999999888 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+||||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||+.. +..+.+||+|||++.
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLAR 237 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCce
Confidence 9999999997 58988887543 35999999999999999999999999999999999999952 245789999999997
Q ss_pred ccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....++|+.|+|||++.+..++.++||||||||+|||++|+.||.+.+..+.+..+.......++.
T Consensus 238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------- 310 (373)
T 2x4f_A 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE------- 310 (373)
T ss_dssp ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG-------
T ss_pred ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh-------
Confidence 5433 2334578999999999998899999999999999999999999999988877776665422100000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
....+
T Consensus 311 ---------------------------------------------------------------------------~~~~~ 315 (373)
T 2x4f_A 311 ---------------------------------------------------------------------------EFQDI 315 (373)
T ss_dssp ---------------------------------------------------------------------------GGTTS
T ss_pred ---------------------------------------------------------------------------hhccC
Confidence 00113
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++.+++||.+||+.||++|||++|+|+||||++.+
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 46789999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=386.53 Aligned_cols=199 Identities=31% Similarity=0.488 Sum_probs=156.0
Q ss_pred CceEEE---EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVK---DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~---~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++. ++||+|+||+||+|+++.+++.||||++.+. ......+|+.+++.+. +||||+++++++.+..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~------~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE------GHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT------TCTTBCCEEEEEECSS
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc------CCCCeeEEEEEEEcCC
Confidence 567775 7899999999999999999999999999754 3456778999999984 4999999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..||||||+.+ +|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+.....+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999975 899988764 469999999999999999999999999999999999999754444589999999997
Q ss_pred ccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 265 TEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 265 ~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.... .....++|+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 5432 2345678999999999999999999999999999999999999997644
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=396.97 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=215.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+|..+ .|+||++++++|.+
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-------~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-------DRRWITQLHFAFQD 132 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-------CTTTBCCEEEEEEC
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEee
Confidence 379999999999999999999999999999999997532 2223467899998887 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+||||||+. ++|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++ ..+.+||+|||+
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld---~~g~vkL~DFGl 208 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGS 208 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec---CCCCEEEeechh
Confidence 999999999996 69999987643 4699999999999999999999999999999999999995 678999999999
Q ss_pred ccccCCc----cccccccccccCccccc-------cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003438 263 ACTEDRT----VYSYIQSRYYRSPEVLL-------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331 (820)
Q Consensus 263 A~~~~~~----~~~~~gt~~Y~APEvl~-------~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~ 331 (820)
+...... ....+||+.|+|||++. ...|+.++|||||||++|||++|++||.+.+..+.+.+|......
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 9754332 23458999999999997 357999999999999999999999999988877776666531100
Q ss_pred CCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 332 ~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
. .+|.
T Consensus 289 -------------------~----------------------------------------------------~~p~---- 293 (412)
T 2vd5_A 289 -------------------L----------------------------------------------------SLPL---- 293 (412)
T ss_dssp -------------------C----------------------------------------------------CCC-----
T ss_pred -------------------c----------------------------------------------------CCCc----
Confidence 0 0000
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCC---CCHHHHHcCCccCCCCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKR---WSPFQASRHPFVTGEPFTC 460 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kR---pTa~EaL~HPff~~~~~~~ 460 (820)
....+++++++||++||. ||++| ++++|+++||||++..+..
T Consensus 294 ------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 294 ------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp ---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred ------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 001145778999999999 99998 4999999999999876644
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=378.52 Aligned_cols=259 Identities=28% Similarity=0.410 Sum_probs=215.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+.+|+.+ .||||++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~ 83 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-------LHHNVITLHDV 83 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-------CCCCcceEEEE
Confidence 378999999999999999999999999999999997532 1356788999999998 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC-CCeEEEe
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-PAEIKII 258 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-~~~iKL~ 258 (820)
+...+.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+.. ...+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 999999999999996 5999988754 46899999999999999999999999999999999999963211 1279999
Q ss_pred ecccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 259 DFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 259 DFGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+..... ..+.
T Consensus 162 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~- 239 (321)
T 2a2a_A 162 DFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY-DFDE- 239 (321)
T ss_dssp CCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-CCCH-
T ss_pred cCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-ccCh-
Confidence 99999754432 3445789999999999999999999999999999999999999988877666555433111 0000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
++.
T Consensus 240 ---------------------------------------------------------------~~~-------------- 242 (321)
T 2a2a_A 240 ---------------------------------------------------------------EFF-------------- 242 (321)
T ss_dssp ---------------------------------------------------------------HHH--------------
T ss_pred ---------------------------------------------------------------hhh--------------
Confidence 000
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...+..+.+||++||..||++|||++|+|+||||+...
T Consensus 243 ---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 243 ---SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp ---TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ---cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 11346789999999999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=395.35 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=210.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||++++.. ...+.+.+|+.+|+.+ .|||||+++++|...
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-------~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-------EHPFLVNLWYSFQDE 87 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEeC
Confidence 79999999999999999999999999999999997532 3346778899999888 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+ ..+.+||+|||++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~vkL~DFG~a 162 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIA 162 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC---CCCCEEEecccee
Confidence 99999999997 5888888754 3699999999999999999999999999999999999995 6789999999999
Q ss_pred cccC--CccccccccccccCcccccc---ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 264 CTED--RTVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 264 ~~~~--~~~~~~~gt~~Y~APEvl~~---~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
.... ......+||+.|+|||++.. ..|+.++|||||||++|||++|+.||...........+..... ..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~-~~----- 236 (384)
T 4fr4_A 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET-TV----- 236 (384)
T ss_dssp EECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH-CC-----
T ss_pred eeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh-cc-----
Confidence 7543 33456789999999999974 4689999999999999999999999975432111111100000 00
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
..+|
T Consensus 237 ----------------------------------------------------------------~~~p------------ 240 (384)
T 4fr4_A 237 ----------------------------------------------------------------VTYP------------ 240 (384)
T ss_dssp ----------------------------------------------------------------CCCC------------
T ss_pred ----------------------------------------------------------------cCCC------------
Confidence 0000
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCC-HHHHHcCCccCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWS-PFQASRHPFVTGEPF 458 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpT-a~EaL~HPff~~~~~ 458 (820)
..++..+.+||++||..||++||+ ++++++||||++..+
T Consensus 241 -~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 241 -SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 113467899999999999999998 999999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=405.20 Aligned_cols=256 Identities=30% Similarity=0.507 Sum_probs=213.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|+++.+++.||||++++.. .....+.+|+.+|+.+ .||||++++++|....
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-------DHPNIMKLYDFFEDKR 109 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-------CCTTBCCEEEEEECSS
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-------CCCCCCeEEEEEEeCC
Confidence 68999999999999999999999999999999998542 2346778899999888 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|||||||. ++|.+.+... ..+++..++.+++||+.||.|||++|||||||||+|||++.....+.+||+|||++.
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999997 5898888765 359999999999999999999999999999999999999755556789999999996
Q ss_pred ccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+..
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------- 259 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP------- 259 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG-------
T ss_pred ECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch-------
Confidence 5432 3345689999999999864 79999999999999999999999999988877766665421100000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
....+
T Consensus 260 ---------------------------------------------------------------------------~~~~~ 264 (494)
T 3lij_A 260 ---------------------------------------------------------------------------EWKNV 264 (494)
T ss_dssp ---------------------------------------------------------------------------GGTTS
T ss_pred ---------------------------------------------------------------------------hcccC
Confidence 00123
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
++.+.+||++||++||++|||++|||+||||++.
T Consensus 265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 4678999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=376.93 Aligned_cols=195 Identities=25% Similarity=0.375 Sum_probs=166.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~- 185 (820)
++|+++++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|+++ .||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-------EHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-------CCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEEecc
Confidence 6899999999999999999999999999999999743 34567788999999988 6899999999986543
Q ss_pred --------------------------------------------------------eeEEEEeccCC-ChHHHHHhhhc-
Q 003438 186 --------------------------------------------------------HLCICFELLDS-NLYELIKINHF- 207 (820)
Q Consensus 186 --------------------------------------------------------~l~LVmEy~~g-sL~d~l~~~~~- 207 (820)
.++||||||.+ +|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 38999999985 89998876432
Q ss_pred CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc---------------ccc
Q 003438 208 RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT---------------VYS 272 (820)
Q Consensus 208 ~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~---------------~~~ 272 (820)
...++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...... ...
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 2356778999999999999999999999999999999996 6679999999999754432 233
Q ss_pred ccccccccCccccccccccccchhHhHHHHHHHHHhCCCCC
Q 003438 273 YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 273 ~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
.++|+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 46899999999999999999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=393.17 Aligned_cols=254 Identities=22% Similarity=0.404 Sum_probs=207.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++... ....+.+|..++ .....||||++++++|..
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l------l~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL------LKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC------BCCCCCTTBCCEEEEEEC
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH------HHhCCCCCCCCEEEEEEe
Confidence 3789999999999999999999999999999999986432 222333343332 233479999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+||||||+. ++|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~---~~g~ikL~DFG~ 185 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGL 185 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC---CCCCEEEeeCcc
Confidence 999999999997 5898888764 3699999999999999999999999999999999999995 678999999999
Q ss_pred cccc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
++.. .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....|....-
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------- 256 (373)
T 2r5t_A 186 CKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------- 256 (373)
T ss_dssp CGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---------
T ss_pred ccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------
Confidence 9752 2334566899999999999999999999999999999999999999998877666665543100
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.+|
T Consensus 257 ----------------------------------------------------------------~~~------------- 259 (373)
T 2r5t_A 257 ----------------------------------------------------------------QLK------------- 259 (373)
T ss_dssp ----------------------------------------------------------------CCC-------------
T ss_pred ----------------------------------------------------------------CCC-------------
Confidence 000
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCH----HHHHcCCccCCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSP----FQASRHPFVTGEPF 458 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa----~EaL~HPff~~~~~ 458 (820)
..++..+.+||++||+.||++|+++ +|+++||||++..+
T Consensus 260 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 260 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 0134678999999999999999997 69999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=380.39 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=212.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..|+..++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.+ .|+||+++++++...+..
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-------QHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-------CCTTBCCEEEEEEETTEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-------CCCCcceEEEEEEECCEE
Confidence 46888899999999999999999999999999998542 3456788899999888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+|||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 118 ~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQI 191 (321)
T ss_dssp EEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCcEEEeeeeeeeec
Confidence 99999997 578887754 3599999999999999999999999999999999999995 6688999999998654
Q ss_pred CC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 DR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 ~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.... ++.
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~~~-------- 260 (321)
T 2c30_A 192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPK-------- 260 (321)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS---CCC--------
T ss_pred ccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCC--------
Confidence 33 2345578999999999999999999999999999999999999998877665544433210 000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+.....++
T Consensus 261 ------------------------------------------------------------------------~~~~~~~~ 268 (321)
T 2c30_A 261 ------------------------------------------------------------------------LKNSHKVS 268 (321)
T ss_dssp ------------------------------------------------------------------------CTTGGGSC
T ss_pred ------------------------------------------------------------------------cCccccCC
Confidence 00001234
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+.+.+||.+||+.||++|||++|+|+||||.+..
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 6789999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=384.14 Aligned_cols=260 Identities=25% Similarity=0.462 Sum_probs=210.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.++|+++++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+|+.+ .||||+++++++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~ 97 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-------HHPNIARLYEVY 97 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-------CCCCcceeehhh
Confidence 37999999999999999999999999999999999743 24456788999999999 589999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh--------------------------------------cCCCCHHHHHHHHHHH
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH--------------------------------------FRGLSLSIVQLFSKQI 222 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------------------------------------~~~l~e~~i~~I~~QI 222 (820)
...+..|||||||. ++|.+++.... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999996 68988874210 0124678899999999
Q ss_pred HHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC-------ccccccccccccCcccccc--cccccc
Q 003438 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR-------TVYSYIQSRYYRSPEVLLG--YQYTTA 293 (820)
Q Consensus 223 l~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~-------~~~~~~gt~~Y~APEvl~~--~~yt~k 293 (820)
+.||+|||+++|+||||||+|||++.+ ....+||+|||++..... ......+|+.|+|||++.+ ..++.+
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCS-SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecC-CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999999999999999999632 234899999999964322 1345578999999999975 578999
Q ss_pred chhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhh
Q 003438 294 IDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQAL 373 (820)
Q Consensus 294 sDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~ 373 (820)
+|||||||++|||++|+.||.+.+..+.+..+.......+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------------------------------- 296 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE---------------------------------------- 296 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT----------------------------------------
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC----------------------------------------
Confidence 9999999999999999999998887776665544111000
Q ss_pred hHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 374 TEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 374 s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
. .....+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 297 ---------------------~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 297 ---------------------N---------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp ---------------------S---------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred ---------------------C---------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 0 0001134678999999999999999999999999999
Q ss_pred CCCC
Q 003438 454 TGEP 457 (820)
Q Consensus 454 ~~~~ 457 (820)
++..
T Consensus 335 ~~~~ 338 (345)
T 3hko_A 335 SQFS 338 (345)
T ss_dssp HTTS
T ss_pred ccCh
Confidence 8754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=401.45 Aligned_cols=199 Identities=18% Similarity=0.203 Sum_probs=170.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe-----
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY----- 178 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~----- 178 (820)
.++|++.++||+|+||+||+|++..+++.||||+++. .....+.+.+|+.+|+.+... .|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l----~hpniv~~~~~~~~ 147 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI----KNQKQAKVHLRFIF 147 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTC----CSHHHHHHHHCBCC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcccc----CCHHHHHHHhhhhh
Confidence 4799999999999999999999999999999999973 334567788999887777543 799999998
Q ss_pred --EEEeecc-----------------eeEEEEeccCCChHHHHHhhhcCCCC-------HHHHHHHHHHHHHHhhhcccC
Q 003438 179 --EYFVCQR-----------------HLCICFELLDSNLYELIKINHFRGLS-------LSIVQLFSKQILRGLSLLKDA 232 (820)
Q Consensus 179 --d~f~~~~-----------------~l~LVmEy~~gsL~d~l~~~~~~~l~-------e~~i~~I~~QIl~aL~yLHs~ 232 (820)
+++...+ ..||||||++|+|.+++.... .++ +..++.|+.||+.||+|||++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 7766553 389999999999999998653 244 478888999999999999999
Q ss_pred CeeeccCCCCCcccccccCCCeEEEeecccccccCCccccccccccccCccccccc-----------cccccchhHhHHH
Q 003438 233 GIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY-----------QYTTAIDMWSFGC 301 (820)
Q Consensus 233 gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~-----------~yt~ksDIWSLG~ 301 (820)
|||||||||+||||+ .++.+||+|||+++.........+| +.|+|||++.+. .++.++|||||||
T Consensus 226 ~ivHrDikp~NIll~---~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 226 GLVHTYLRPVDIVLD---QRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp TEECSCCCGGGEEEC---TTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEc---CCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999996 6689999999999887776667788 999999999987 8999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 003438 302 IVAELFLGLPLFPGA 316 (820)
Q Consensus 302 ILyeLltG~~PF~~~ 316 (820)
++|||++|+.||.+.
T Consensus 302 il~elltg~~Pf~~~ 316 (377)
T 3byv_A 302 VIYWIWCADLPITKD 316 (377)
T ss_dssp HHHHHHHSSCCC---
T ss_pred HHHHHHHCCCCCccc
Confidence 999999999999643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=373.78 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=216.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|++.++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.+ .||||+++++++...+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-------KHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-------CCTTBCCEEEEEECSSE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-------CCCCeeehhhhcccCCE
Confidence 479999999999999999999999999999999998653 2345678899999998 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+||||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 999999997 5899988765 3699999999999999999999999999999999999996545678999999999975
Q ss_pred cCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003438 266 EDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344 (820)
Q Consensus 266 ~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~ 344 (820)
.... .....+++.|+|||++.+..++.++|||||||++|+|++|..||......+.+..+.+.....+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----------- 227 (304)
T 2jam_A 159 EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE----------- 227 (304)
T ss_dssp CCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC-----------
T ss_pred cCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-----------
Confidence 5432 3345789999999999999999999999999999999999999988777665555443111000
Q ss_pred chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHH
Q 003438 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424 (820)
Q Consensus 345 ~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~ 424 (820)
. + ....++.
T Consensus 228 --------------------------------------------------~----------~-----------~~~~~~~ 236 (304)
T 2jam_A 228 --------------------------------------------------S----------P-----------FWDDISE 236 (304)
T ss_dssp --------------------------------------------------T----------T-----------TTTTSCH
T ss_pred --------------------------------------------------c----------c-----------ccccCCH
Confidence 0 0 0011346
Q ss_pred HHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 425 ~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.+.+||.+||..||++|||++|+|+||||++..
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 789999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=404.05 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=218.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.++||+|+||+||+|+++.+++.||||++... ....+.+.+|+.+|+++ .||||+++++++...
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-------DHPNIMKLYEFFEDK 98 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEeC
Confidence 7999999999999999999999999999999999743 34467788999999888 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+|||||. ++|.+.+... ..+++..++.+++||+.||.|||++|||||||||+|||++.....+.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 99999999997 5898888754 46999999999999999999999999999999999999975556789999999999
Q ss_pred cccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 264 CTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 264 ~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... ......++|+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.+.....+
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 247 (484)
T 3nyv_A 177 THFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE-------- 247 (484)
T ss_dssp HHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred EEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 6543 33445689999999999977 699999999999999999999999999888777766644111000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
......
T Consensus 248 --------------------------------------------------------------------------~~~~~~ 253 (484)
T 3nyv_A 248 --------------------------------------------------------------------------LPQWKK 253 (484)
T ss_dssp --------------------------------------------------------------------------SGGGGG
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 000112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+++.+++||++||++||++|||++|+|+||||+..
T Consensus 254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 45778999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=384.89 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=215.7
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+++|+.+ .||||+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~ 124 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-------RHPNTIQYRGCYL 124 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEE
Confidence 347899999999999999999999999999999999743 23446788999999998 6899999999999
Q ss_pred ecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 183 CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 183 ~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..+..||||||+.|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 125 ~~~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~ 200 (348)
T 1u5q_A 125 REHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGS 200 (348)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTT
T ss_pred ECCeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccC
Confidence 999999999999999999887554 5699999999999999999999999999999999999996 678999999999
Q ss_pred ccccCCccccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTEDRTVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~~~~~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
+...... ...++|+.|+|||++. ...++.++|||||||++|||++|++||...+..+.+..+..... +.
T Consensus 201 a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~--~~----- 272 (348)
T 1u5q_A 201 ASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA----- 272 (348)
T ss_dssp CBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CC-----
T ss_pred ceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CC-----
Confidence 9765433 4568999999999985 45799999999999999999999999988776655544432100 00
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
. ..
T Consensus 273 ------------------------------------------------~-----------------------------~~ 275 (348)
T 1u5q_A 273 ------------------------------------------------L-----------------------------QS 275 (348)
T ss_dssp ------------------------------------------------C-----------------------------CC
T ss_pred ------------------------------------------------C-----------------------------CC
Confidence 0 00
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+++.+.+||.+||+.||++|||++|+|+||||....
T Consensus 276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 01346789999999999999999999999999998654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=370.45 Aligned_cols=252 Identities=23% Similarity=0.415 Sum_probs=211.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+ .||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-------RHPNILRLYGYFHD 80 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEEC
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-------CCCCCcchhheEec
Confidence 379999999999999999999999999999999997532 2245677888888877 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+..++||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGW 155 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC---TTSCEEECSCCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc---CCCCEEEEeccc
Confidence 999999999998 5888888765 3599999999999999999999999999999999999995 678899999999
Q ss_pred ccccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 263 ACTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 263 A~~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
+...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------- 225 (279)
T 3fdn_A 156 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-T--------- 225 (279)
T ss_dssp ESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-C---------
T ss_pred cccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-C---------
Confidence 8654332 3456789999999999999999999999999999999999999988776665554433111 0
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
+| ..
T Consensus 226 ---------------------------------------------------------------~~-------------~~ 229 (279)
T 3fdn_A 226 ---------------------------------------------------------------FP-------------DF 229 (279)
T ss_dssp ---------------------------------------------------------------CC-------------TT
T ss_pred ---------------------------------------------------------------CC-------------Cc
Confidence 00 01
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++.+.+||++||..||++|||++|+|+||||+...
T Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 336788999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=381.94 Aligned_cols=197 Identities=23% Similarity=0.416 Sum_probs=168.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|.+. +++.||||+++.. ....+.+.+|+.+|+.+.+ .|+||+++++++...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-----HSDKIIRLYDYEITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh-----cCCceEEEeeeEeeC
Confidence 378999999999999999999884 5889999999753 3445678899999999964 358999999999999
Q ss_pred ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 185 RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 185 ~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+.+|||||+.+++|.+++... +.+++.+++.++.||+.||+|||+++|+||||||+|||++ ++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIAN 155 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSC
T ss_pred CEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeeccccc
Confidence 999999998888999999864 4699999999999999999999999999999999999994 4689999999997
Q ss_pred ccCCc-----cccccccccccCcccccc-----------ccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 265 TEDRT-----VYSYIQSRYYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 265 ~~~~~-----~~~~~gt~~Y~APEvl~~-----------~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 55332 234578999999999975 57899999999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.10 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=204.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++..+++.||||+++.. ......+.+|+.++..+. .||||+++++++...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~------~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG------QHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC------SCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC------CCCCeeeeeeeeecCC
Confidence 7899999999999999999999999999999999853 344567788888888873 5899999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhc--CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc------------
Q 003438 186 HLCICFELLDS-NLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV------------ 250 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~--~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~------------ 250 (820)
.++|||||+.+ +|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999975 99999876532 5699999999999999999999999999999999999997432
Q ss_pred ----CCCeEEEeecccccccCCccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 251 ----KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 251 ----~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
....+||+|||++....... ...+|+.|+|||++.+. .++.++|||||||++|+|++|.+++..... ...+
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~ 240 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred cccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence 45579999999997665432 34689999999999876 677899999999999999999988754321 1111
Q ss_pred HHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcC
Q 003438 326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405 (820)
Q Consensus 326 ~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~ 405 (820)
.+ + .. + ..
T Consensus 241 ~~--~-~~----------------------------------------------------~-----------------~~ 248 (289)
T 1x8b_A 241 RQ--G-RL----------------------------------------------------P-----------------RI 248 (289)
T ss_dssp HT--T-CC----------------------------------------------------C-----------------CC
T ss_pred Hc--C-CC----------------------------------------------------C-----------------CC
Confidence 10 0 00 0 00
Q ss_pred CCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 406 P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
| ..+++.+.+||++||+.||++|||++|+|+||||++.
T Consensus 249 ~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 249 P-------------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp S-------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred C-------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 0 0134678999999999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=372.44 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=210.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV- 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~- 182 (820)
++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+.+|+++++.+ .|+||+++++++.
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~ 77 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-------RHKNVIQLVDVLYN 77 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEC
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-------CCCCeeEEEEEEEc
Confidence 78999999999999999999999999999999997532 3456788899998888 6899999999984
Q ss_pred -ecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 -CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 -~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.....||||||+.++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg 154 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALG 154 (305)
T ss_dssp C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCT
T ss_pred CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeeccc
Confidence 45689999999998898888876666799999999999999999999999999999999999996 66889999999
Q ss_pred cccccC-----CccccccccccccCcccccccc--ccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCc
Q 003438 262 SACTED-----RTVYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334 (820)
Q Consensus 262 lA~~~~-----~~~~~~~gt~~Y~APEvl~~~~--yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp 334 (820)
++.... .......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.+..-
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---- 230 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY---- 230 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC----
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC----
Confidence 996543 2223456899999999998653 47899999999999999999999988766554444322000
Q ss_pred hHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChh
Q 003438 335 DYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSME 414 (820)
Q Consensus 335 ~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e 414 (820)
+..
T Consensus 231 -----------------------------------------------------------------------~~~------ 233 (305)
T 2wtk_C 231 -----------------------------------------------------------------------AIP------ 233 (305)
T ss_dssp -----------------------------------------------------------------------CCC------
T ss_pred -----------------------------------------------------------------------CCC------
Confidence 000
Q ss_pred hhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 415 DISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 415 ~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...++.+.+||++||..||++|||++|+|+||||++...
T Consensus 234 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 234 -----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 013367889999999999999999999999999987643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=369.65 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=217.8
Q ss_pred eeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeE
Q 003438 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVR 176 (820)
Q Consensus 101 ~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk 176 (820)
++.+....++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.+ .|+||++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~ 79 (294)
T 2rku_A 7 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-------AHQHVVG 79 (294)
T ss_dssp EEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-------CCTTBCC
T ss_pred eeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-------CCCCEee
Confidence 344455668999999999999999999999999999999999753 34556778899999888 6899999
Q ss_pred EeEEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeE
Q 003438 177 IYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 177 l~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~i 255 (820)
+++++...+..++||||+. ++|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~ 154 (294)
T 2rku_A 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEV 154 (294)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCE
T ss_pred eeeeeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc---CCCCE
Confidence 9999999999999999998 5888877654 3699999999999999999999999999999999999995 66889
Q ss_pred EEeecccccccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 256 KIIDFGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 256 KL~DFGlA~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
||+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 232 (294)
T 2rku_A 155 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 232 (294)
T ss_dssp EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--
T ss_pred EEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC--
Confidence 999999996543 223345789999999999998999999999999999999999999987765544333221000
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
..|
T Consensus 233 -----------------------------------------------------------------------~~~------ 235 (294)
T 2rku_A 233 -----------------------------------------------------------------------SIP------ 235 (294)
T ss_dssp -----------------------------------------------------------------------CCC------
T ss_pred -----------------------------------------------------------------------CCc------
Confidence 000
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
...+..+.+||++||+.||++|||++|+|+||||++...
T Consensus 236 -------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 236 -------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -------cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 013367889999999999999999999999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=418.27 Aligned_cols=254 Identities=25% Similarity=0.396 Sum_probs=217.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++.. ...+....|..+|..+. .|++|++++++|..
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~------~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG------KPPFLTQLHSCFQT 413 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT------CCTTBCCEEEECBC
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc------CCCeEEEEEEEEEe
Confidence 478999999999999999999999999999999998532 23455677888877663 58999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+||||||+. ++|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~---~~g~ikL~DFGl 488 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGM 488 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC---SSSCEEECCCTT
T ss_pred CCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc---CCCcEEEeecce
Confidence 999999999997 5898888765 3699999999999999999999999999999999999995 678999999999
Q ss_pred cccc---CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 263 ACTE---DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 263 A~~~---~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
++.. .......+||+.|+|||++.+..|+.++||||||||||||++|++||.+.+..+++..|.+...
T Consensus 489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------- 559 (674)
T 3pfq_A 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------- 559 (674)
T ss_dssp CEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC---------
T ss_pred eeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 9742 2334567899999999999999999999999999999999999999999887777666543110
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
.+|
T Consensus 560 ----------------------------------------------------------------~~p------------- 562 (674)
T 3pfq_A 560 ----------------------------------------------------------------AYP------------- 562 (674)
T ss_dssp ----------------------------------------------------------------CCC-------------
T ss_pred ----------------------------------------------------------------CCC-------------
Confidence 000
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCH-----HHHHcCCccCCCCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSP-----FQASRHPFVTGEPF 458 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa-----~EaL~HPff~~~~~ 458 (820)
..+++++.+||++||+.||++|+++ +||++||||++..+
T Consensus 563 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 0134678999999999999999997 99999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=388.64 Aligned_cols=197 Identities=23% Similarity=0.418 Sum_probs=170.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|.+.. ++.||||+++.. ....+.+.+|+.+|+.|.+ .|+||+++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~-----~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-----HSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT-----TCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc-----CCCeEEEEEEEEecCC
Confidence 679999999999999999998865 889999999753 3456778899999999964 3799999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+|||||+.+++|.+++... ..+++.+++.++.||+.||.|||+++||||||||+||||+ ++.+||+|||++..
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ 203 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCC
T ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCcccc
Confidence 99999997778999998765 3689999999999999999999999999999999999994 47899999999975
Q ss_pred cCCc-----cccccccccccCcccccc-----------ccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 266 EDRT-----VYSYIQSRYYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 266 ~~~~-----~~~~~gt~~Y~APEvl~~-----------~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.... ....+||+.|+|||++.+ ..++.++||||||||||||++|++||....
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 5322 234579999999999975 368899999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=377.51 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=218.4
Q ss_pred eeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeE
Q 003438 101 VLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVR 176 (820)
Q Consensus 101 ~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk 176 (820)
.+.+....++|++.++||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.+ .|+||++
T Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~ 105 (335)
T 2owb_A 33 VLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-------AHQHVVG 105 (335)
T ss_dssp EEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-------CCTTBCC
T ss_pred eecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-------CCCCCCe
Confidence 344445568999999999999999999999999999999999753 34556788899999888 6899999
Q ss_pred EeEEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeE
Q 003438 177 IYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 177 l~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~i 255 (820)
+++++...+.+||||||+. ++|.+++... ..+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~ 180 (335)
T 2owb_A 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEV 180 (335)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCE
T ss_pred EEEEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc---CCCCE
Confidence 9999999999999999998 5888887664 4699999999999999999999999999999999999996 66889
Q ss_pred EEeecccccccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 256 KIIDFGSACTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 256 KL~DFGlA~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
||+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+....-
T Consensus 181 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 258 (335)
T 2owb_A 181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-- 258 (335)
T ss_dssp EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--
T ss_pred EEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--
Confidence 999999997543 223445789999999999998999999999999999999999999987765554433322000
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
.+|
T Consensus 259 -----------------------------------------------------------------------~~~------ 261 (335)
T 2owb_A 259 -----------------------------------------------------------------------SIP------ 261 (335)
T ss_dssp -----------------------------------------------------------------------CCC------
T ss_pred -----------------------------------------------------------------------CCC------
Confidence 000
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
..++..+.+||++||+.||++|||++|+|+||||+....
T Consensus 262 -------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 262 -------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 013356889999999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=395.46 Aligned_cols=258 Identities=30% Similarity=0.501 Sum_probs=200.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
.++|++.++||+|+||+||+|++..+++.||||++.... .....+.+|+.+|+++ .||||++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~l~ 206 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-------NHPCIIKIK 206 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-------CCTTBCCCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-------CCCCEeeEE
Confidence 478999999999999999999999999999999997532 1122467899999999 689999999
Q ss_pred EEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
+++.. +..||||||+. ++|.+++... +.+++..++.++.||+.||+|||+++|+||||||+|||++.+.....+||
T Consensus 207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 207 NFFDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp EEEES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEE
Confidence 99864 45899999997 5888877543 46999999999999999999999999999999999999976555667999
Q ss_pred eecccccccCCc--cccccccccccCcccccc---ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 258 IDFGSACTEDRT--VYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 258 ~DFGlA~~~~~~--~~~~~gt~~Y~APEvl~~---~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
+|||+++..... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||........+........
T Consensus 284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~-- 361 (419)
T 3i6u_A 284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-- 361 (419)
T ss_dssp CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTC--
T ss_pred eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCC--
Confidence 999999765433 345689999999999864 5788999999999999999999999975432211111111000
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
+. ...+.
T Consensus 362 -------------------------------------~~-------------------------~~~~~----------- 368 (419)
T 3i6u_A 362 -------------------------------------YN-------------------------FIPEV----------- 368 (419)
T ss_dssp -------------------------------------CC-------------------------CCHHH-----------
T ss_pred -------------------------------------CC-------------------------CCchh-----------
Confidence 00 00000
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
...+++.+.+||++||++||++|||++|+|+||||++.
T Consensus 369 ------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 369 ------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp ------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred ------hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 11245778999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.16 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=192.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|+++++||+|+||+||+|++..+++.||||+++.... .......|..++ + ....||||+++++++...+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~--~----~~~~h~~iv~~~~~~~~~~ 79 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS--M----RTVDCPFTVTFYGALFREG 79 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHH--H----TTCCCTTBCCEEEEEECSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHH--H----HhCCCCeEEEEeeeeeccC
Confidence 3899999999999999999999999999999999975422 222222233222 1 2237999999999999999
Q ss_pred eeEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 186 HLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
..||||||++++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++ ..+.+||+|||+
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~ 156 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGI 156 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC---TTCCEEBCCC--
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC---CCCCEEEeecCC
Confidence 99999999999998887653 235699999999999999999999998 999999999999995 667999999999
Q ss_pred ccccCCc--cccccccccccCcccc----ccccccccchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCch
Q 003438 263 ACTEDRT--VYSYIQSRYYRSPEVL----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 263 A~~~~~~--~~~~~gt~~Y~APEvl----~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~-s~~d~l~~I~~~lG~~Pp~ 335 (820)
+...... .....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||... .....+..+..... +
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~-- 232 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--P-- 232 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--C--
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--C--
Confidence 9754433 2334789999999996 4557899999999999999999999999753 22222222211000 0
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
. .
T Consensus 233 --------------------------------------------------~------------------------~---- 234 (290)
T 3fme_A 233 --------------------------------------------------Q------------------------L---- 234 (290)
T ss_dssp --------------------------------------------------C------------------------C----
T ss_pred --------------------------------------------------C------------------------c----
Confidence 0 0
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....++..+.+||.+||+.||++|||++|+|+||||+..
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 235 --PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp --CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 000134678999999999999999999999999999853
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=363.74 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=214.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----------AYYQQALVEVSILTTLNKKYDREDKHHIVRI 177 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl 177 (820)
.++|++.++||+|+||.||+|+++.+++.||||+++... ...+.+.+|+.+|+++. +||||+++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~ 89 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS------GHPNIIQL 89 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT------TCTTBCCE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc------CCCCEeee
Confidence 389999999999999999999999999999999997532 23456788999999984 48999999
Q ss_pred eEEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEE
Q 003438 178 YEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 178 ~d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
++++...+..+|||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~k 164 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIK 164 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEE
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc---CCCcEE
Confidence 999999999999999997 5999998765 3699999999999999999999999999999999999995 667899
Q ss_pred EeecccccccCC--ccccccccccccCccccc------cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003438 257 IIDFGSACTEDR--TVYSYIQSRYYRSPEVLL------GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 257 L~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~------~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~ 328 (820)
|+|||++..... ......+++.|+|||++. ...++.++|||||||++|+|++|..||...+..+....+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 999999975432 334557899999999986 346889999999999999999999999887766555544331
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
....+ .
T Consensus 245 ~~~~~-------------------------------------------------------------~------------- 250 (298)
T 1phk_A 245 NYQFG-------------------------------------------------------------S------------- 250 (298)
T ss_dssp CCCCC-------------------------------------------------------------T-------------
T ss_pred CcccC-------------------------------------------------------------c-------------
Confidence 11000 0
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.....++..+.+||.+||..||++|||++|+|+||||++..
T Consensus 251 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 251 --------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp --------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred --------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 00012346789999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=373.01 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=209.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
.++|++++.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++++. .|+||+++++++..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~------~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS------HHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC------CSTTBCCEEEEEEECC--
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc------CCCCeeeeeeEEeeccCc
Confidence 48999999999999999999999999999999999876555678889999999984 58999999999987
Q ss_pred --cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 184 --QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 184 --~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
.+.+||||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~---~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc---CCCCEEEeeC
Confidence 4689999999985 999999876556799999999999999999999999999999999999995 6788999999
Q ss_pred ccccccCCc---cccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 261 GSACTEDRT---VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 261 GlA~~~~~~---~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
|++...... .....+++.|+|||++. +..++.++|||||||++|+|++|..||......+.+..+.+...
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 251 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-- 251 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--
T ss_pred cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--
Confidence 999754432 23457899999999997 45789999999999999999999999987765544433322000
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
+ . +
T Consensus 252 -~----------------------------------------------------~-----~------------------- 254 (326)
T 2x7f_A 252 -P----------------------------------------------------R-----L------------------- 254 (326)
T ss_dssp -C----------------------------------------------------C-----C-------------------
T ss_pred -c----------------------------------------------------c-----C-------------------
Confidence 0 0 0
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....++..+.+||++||..||++|||++|+|+||||++.+
T Consensus 255 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 255 -----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp -----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred -----CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 0001346789999999999999999999999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=381.35 Aligned_cols=204 Identities=29% Similarity=0.451 Sum_probs=178.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||+|++..+++.||+|+++.. ....+.+.+|+.+|+.+ .|+||+++++++...+.
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-------CCTTBCCEEEEEEETTE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-------CCCCEEEEeEEEEECCE
Confidence 7999999999999999999999999999999999864 44556788899988887 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+||||||+.+ +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++.
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~ 180 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 180 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCH
T ss_pred EEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECCCCc
Confidence 9999999975 999988765 3599999999999999999999986 999999999999996 66789999999986
Q ss_pred ccC-CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 003438 265 TED-RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRR 324 (820)
Q Consensus 265 ~~~-~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~ 324 (820)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 181 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 241 (360)
T 3eqc_A 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241 (360)
T ss_dssp HHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred ccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 432 223445789999999999999999999999999999999999999988776554433
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=363.60 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=206.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~- 183 (820)
.+.|++.++||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+|+.+ .||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-------QHPNIVRFYDSWEST 97 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-------CCCCeeeeeeeeccc
Confidence 37899999999999999999999999999999999753 34556788899999888 68999999999876
Q ss_pred ---cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEE
Q 003438 184 ---QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 184 ---~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL 257 (820)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl 173 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKI 173 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEE
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEE
Confidence 467999999997 5999998764 46999999999999999999999999 99999999999995 35678999
Q ss_pred eecccccccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 258 IDFGSACTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 258 ~DFGlA~~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
+|||++...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||........+...... + ..+.
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~-~~~~- 249 (290)
T 1t4h_A 174 GDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VKPA- 249 (290)
T ss_dssp CCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CCCG-
T ss_pred eeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-c-CCcc-
Confidence 999999754433 344578999999998875 5999999999999999999999999765443332221110 0 0000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
T Consensus 250 -------------------------------------------------------------------------------- 249 (290)
T 1t4h_A 250 -------------------------------------------------------------------------------- 249 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
......++.+.+||.+||..||++|||++|+|+||||++.
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 0001123578999999999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.55 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=212.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++++.||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.+ .||||+++++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~ 77 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-------RHPNIITLHDIF 77 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-------CCCCeeehhhee
Confidence 68999999999999999999999999999999997532 1357788999999998 589999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc-CCCeEEEee
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKIID 259 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~iKL~D 259 (820)
...+..++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+. ....+||+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 99999999999996 6999988764 3699999999999999999999999999999999999996322 233899999
Q ss_pred cccccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+..... ..+
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--- 231 (283)
T 3bhy_A 156 FGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY-DFD--- 231 (283)
T ss_dssp CTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-CCC---
T ss_pred cccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-CCc---
Confidence 999975433 23345789999999999988999999999999999999999999988776665544432111 000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
.+..
T Consensus 232 -------------------------------------------------------------~~~~--------------- 235 (283)
T 3bhy_A 232 -------------------------------------------------------------EEYF--------------- 235 (283)
T ss_dssp -------------------------------------------------------------HHHH---------------
T ss_pred -------------------------------------------------------------chhc---------------
Confidence 0000
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
...+..+.+||++||..||++|||++|+|+||||+..
T Consensus 236 --~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 236 --SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp --TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 1134678999999999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=386.82 Aligned_cols=200 Identities=15% Similarity=0.161 Sum_probs=163.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe------
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY------ 178 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~------ 178 (820)
..|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.|.. .||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-----~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-----ESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC---------------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-----cChhhhhhceeEEee
Confidence 5699999999999999999999999999999999873 3445667789888888853 589988765
Q ss_pred -EEEeec-----------------ceeEEEEeccCCChHHHHHhhhcCCCCHHHH------HHHHHHHHHHhhhcccCCe
Q 003438 179 -EYFVCQ-----------------RHLCICFELLDSNLYELIKINHFRGLSLSIV------QLFSKQILRGLSLLKDAGI 234 (820)
Q Consensus 179 -d~f~~~-----------------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i------~~I~~QIl~aL~yLHs~gI 234 (820)
+++... ..+|||||||+++|.+++..... .+.+..+ ..++.||+.||+|||++||
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 555433 34899999999999999987542 3455555 6777999999999999999
Q ss_pred eeccCCCCCcccccccCCCeEEEeecccccccCCccccccccccccCcccccc--ccccccchhHhHHHHHHHHHhCCCC
Q 003438 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPL 312 (820)
Q Consensus 235 VHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~--~~yt~ksDIWSLG~ILyeLltG~~P 312 (820)
|||||||+||||+ .++.+||+|||+++..........+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 216 vHrDikp~NIll~---~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIM---PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEEC---TTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEEC---CCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999996 6688999999999877766556677899999999987 6899999999999999999999999
Q ss_pred CCCCC
Q 003438 313 FPGAS 317 (820)
Q Consensus 313 F~~~s 317 (820)
|.+..
T Consensus 293 f~~~~ 297 (371)
T 3q60_A 293 FGLVT 297 (371)
T ss_dssp TTBCC
T ss_pred CCCcC
Confidence 97643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=364.89 Aligned_cols=252 Identities=23% Similarity=0.435 Sum_probs=213.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+++++.+ .|+||+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-------RHPNILRMYNYFHD 85 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEEC
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-------CCCCEeeEEEEEEc
Confidence 379999999999999999999999999999999997532 2245678899999888 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+..|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGW 160 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC---TTCCEEECCCTT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc---CCCCEEEecccc
Confidence 999999999997 49999887653 599999999999999999999999999999999999995 667899999999
Q ss_pred ccccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 263 ACTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 263 A~~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
+..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||......+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------- 229 (284)
T 2vgo_A 161 SVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL----------- 229 (284)
T ss_dssp CEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------
T ss_pred cccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-----------
Confidence 865433 23455789999999999999999999999999999999999999987766554443322000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+| ..
T Consensus 230 --------------------------------------------------------------~~~-------------~~ 234 (284)
T 2vgo_A 230 --------------------------------------------------------------KFP-------------PF 234 (284)
T ss_dssp --------------------------------------------------------------CCC-------------TT
T ss_pred --------------------------------------------------------------CCC-------------Cc
Confidence 000 01
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++..+.+||.+||..||++|||++|+|+||||+...
T Consensus 235 ~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 235 LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 346789999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=367.64 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=186.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.+ .||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-------KHPSILELYNYFEDS 83 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-------CCTTBCCEEEEEECS
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-------CCCCeEeEEEEEccC
Confidence 78999999999999999999999999999999997532 2235678899888877 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~ 159 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA 159 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC---TTCCEEECCCTTC
T ss_pred CeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEEEeecce
Confidence 99999999997 58888887543 5699999999999999999999999999999999999995 6688999999999
Q ss_pred cccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 226 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------- 226 (278)
T ss_dssp EECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------
Confidence 75432 22345789999999999998999999999999999999999999975442211110000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
. .+.. ..
T Consensus 227 -------------------------------------------------~-------------~~~~-----------~~ 233 (278)
T 3cok_A 227 -------------------------------------------------A-------------DYEM-----------PS 233 (278)
T ss_dssp -------------------------------------------------S-------------CCCC-----------CT
T ss_pred -------------------------------------------------c-------------ccCC-----------cc
Confidence 0 0000 00
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+..+.+||.+||+.||++|||++|+|+||||.+..
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 1346789999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=373.01 Aligned_cols=202 Identities=22% Similarity=0.393 Sum_probs=174.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++.++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|+++ .||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-------NHKNIVKLFAIEEETT 80 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECTT
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-------CCCCcceEEEEeecCC
Confidence 379999999999999999999999999999999998532 3356778999999998 6899999999998765
Q ss_pred --eeEEEEeccC-CChHHHHHhhhc-CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc-ccCCCeEEEeec
Q 003438 186 --HLCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT-SVKPAEIKIIDF 260 (820)
Q Consensus 186 --~l~LVmEy~~-gsL~d~l~~~~~-~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~-~~~~~~iKL~DF 260 (820)
..||||||+. ++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Df 160 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccC
Confidence 7899999997 699999886542 23999999999999999999999999999999999999832 235678999999
Q ss_pred ccccccCC--ccccccccccccCccccc--------cccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 261 GSACTEDR--TVYSYIQSRYYRSPEVLL--------GYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 261 GlA~~~~~--~~~~~~gt~~Y~APEvl~--------~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
|+++.... ......+|+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 161 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99975433 234567899999999986 468899999999999999999999999643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=376.74 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=212.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
++|++.+.||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+++++. +||||+++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~ 167 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA------GHPHIITLID 167 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT------TCTTBCCEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc------CCCCEeEEEE
Confidence 68999999999999999999999999999999997432 22456778999999984 5899999999
Q ss_pred EEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 180 YFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
++......||||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~---~~~~ikl~ 242 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD---DNMQIRLS 242 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEEC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEEE
Confidence 99999999999999985 899988754 4699999999999999999999999999999999999995 67899999
Q ss_pred ecccccccCC--ccccccccccccCcccccc------ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q 003438 259 DFGSACTEDR--TVYSYIQSRYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330 (820)
Q Consensus 259 DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~------~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG 330 (820)
|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999875432 3345689999999999863 3588999999999999999999999988776665555433111
Q ss_pred CCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCC
Q 003438 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKN 410 (820)
Q Consensus 331 ~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ 410 (820)
.++.
T Consensus 323 -~~~~--------------------------------------------------------------------------- 326 (365)
T 2y7j_A 323 -QFSS--------------------------------------------------------------------------- 326 (365)
T ss_dssp -CCCH---------------------------------------------------------------------------
T ss_pred -CCCC---------------------------------------------------------------------------
Confidence 0000
Q ss_pred CChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 411 LSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 411 ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
......+..+.+||++||..||++|||++|+|+||||++
T Consensus 327 ------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 ------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 000113467899999999999999999999999999973
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=396.91 Aligned_cols=250 Identities=27% Similarity=0.413 Sum_probs=212.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+|+.+ .||||+++++++...
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-------~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-------RHPHIIKLYQVISTP 88 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEEC
Confidence 79999999999999999999999999999999997542 2345778899999887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+||||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~---~~~~vkL~DFG~a 163 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLS 163 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC---TTCCEEECCCSSC
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe---cCCCeEEEeccch
Confidence 99999999996 5899988653 4699999999999999999999999999999999999995 6788999999999
Q ss_pred cccCC--ccccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~--~~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+...++..... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~-------- 234 (476)
T 2y94_A 164 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF-Y-------- 234 (476)
T ss_dssp EECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC-C--------
T ss_pred hhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc-C--------
Confidence 75433 3345689999999999998766 6899999999999999999999987766555444432100 0
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.| .
T Consensus 235 ----------------------------------------------------------------~p-------------~ 237 (476)
T 2y94_A 235 ----------------------------------------------------------------TP-------------Q 237 (476)
T ss_dssp ----------------------------------------------------------------CC-------------T
T ss_pred ----------------------------------------------------------------CC-------------c
Confidence 00 0
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.+++.+.+||++||+.||++|||++|+|+||||++.
T Consensus 238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 134678999999999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=372.71 Aligned_cols=259 Identities=30% Similarity=0.488 Sum_probs=205.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
.++|++.+.||+|+||.||+|++..+++.||||++.... .....+.+|+++|+.+ .||||++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~ 81 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-------NHPCIIKIK 81 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-------CCTTBCCEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-------CCCCCceEe
Confidence 378999999999999999999999999999999997532 1223477899999998 689999999
Q ss_pred EEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 179 EYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
+++..+. .|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+.....+||
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEE
Confidence 9987655 8999999975 898887654 46999999999999999999999999999999999999975545567999
Q ss_pred eecccccccCCc--cccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 258 IDFGSACTEDRT--VYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 258 ~DFGlA~~~~~~--~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
+|||++...... .....+|+.|+|||++. ...++.++|||||||++|+|++|..||........+........ .
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~ 237 (322)
T 2ycf_A 159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-Y 237 (322)
T ss_dssp CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC-C
T ss_pred ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc-c
Confidence 999999765443 23457899999999974 45789999999999999999999999975432211111111000 0
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
..+.+..
T Consensus 238 ---------------------------------------------------------------~~~~~~~---------- 244 (322)
T 2ycf_A 238 ---------------------------------------------------------------NFIPEVW---------- 244 (322)
T ss_dssp ---------------------------------------------------------------CCCHHHH----------
T ss_pred ---------------------------------------------------------------ccCchhh----------
Confidence 0000000
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++..+.+||++||..||++|||++|+|+||||++..
T Consensus 245 -------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 245 -------AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp -------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred -------hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 12346789999999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=362.19 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=207.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|++++.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.+ .|+||+++++++...+.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-------NHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-------CCCCceeeeeEEEcCCE
Confidence 7899999999999999999999999999999999743 23456788899999888 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++..
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV 154 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCccc
Confidence 9999999985 888877543 3599999999999999999999999999999999999996 668899999999964
Q ss_pred cCC-----ccccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCchHHH
Q 003438 266 EDR-----TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDL-LRRMIRILGAQPPDYVL 338 (820)
Q Consensus 266 ~~~-----~~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~-l~~I~~~lG~~Pp~~~l 338 (820)
... ......+++.|+|||++.+..+ +.++|||||||++|+|++|+.||........ +..+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~-------- 225 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-K-------- 225 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT-C--------
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc-c--------
Confidence 321 1234578999999999988765 7899999999999999999999976543211 1110000 0
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
. . ...
T Consensus 226 -----------------------------------------------~-----~-----------------------~~~ 230 (276)
T 2yex_A 226 -----------------------------------------------T-----Y-----------------------LNP 230 (276)
T ss_dssp -----------------------------------------------T-----T-----------------------STT
T ss_pred -----------------------------------------------c-----c-----------------------cCc
Confidence 0 0 000
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++..+.+||++||..||++|||++|+|+||||++..
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 012446789999999999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=403.51 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=179.1
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..++|+++++||+|+||+||+|+++.+++.||||++++.. .....+.+|+.+|+.+ .|||||+++++|.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-------~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-------NSRFVVSLAYAYE 254 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-------CCCCEeeEEEEEe
Confidence 3478999999999999999999999999999999997532 2345678899999998 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+.+||||||+. ++|.+++.......+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld---~~g~vKL~DFG 331 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLG 331 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCCT
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe---CCCCeEEEecc
Confidence 9999999999996 6899888766545699999999999999999999999999999999999995 67899999999
Q ss_pred cccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 262 SACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 262 lA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+..
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 9976533 3345689999999999999999999999999999999999999997653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=368.09 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=208.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++++.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.+ .|+||+++++++...+.+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-------DSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-------CCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-------CCCCCccEEEEEEeCCEE
Confidence 489999999999999999999999999999999998653 346678899999988 689999999999999999
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
||||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++...
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccchhh
Confidence 999999985 8988887543 5699999999999999999999999999999999999996 5678999999999654
Q ss_pred CCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... .....+++.|+|||++.+..++.++|||||||++|+|++|..||........+..+.... ++.
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~-------- 244 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP---PPT-------- 244 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CCC--------
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC---Ccc--------
Confidence 332 234578999999999999999999999999999999999999998766544333221100 000
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+ .....++
T Consensus 245 -------------------------------------------------~-----------------------~~~~~~~ 252 (314)
T 3com_A 245 -------------------------------------------------F-----------------------RKPELWS 252 (314)
T ss_dssp -------------------------------------------------C-----------------------SSGGGSC
T ss_pred -------------------------------------------------c-----------------------CCcccCC
Confidence 0 0001134
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+.+||.+||..||++|||++|+|+||||++..
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 6789999999999999999999999999999765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.41 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=205.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|++.++||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.+ .||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-------NHPAIVAVYDTGEA 83 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-------CCTTBCCEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-------CCCCcceEEEeeec
Confidence 38999999999999999999999999999999999853 23345667777777666 79999999999987
Q ss_pred cce----eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 184 QRH----LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 184 ~~~----l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
... .||||||+. ++|.+++... ..+++.+++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~ 158 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVM 158 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEEC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEe
Confidence 654 499999997 5899988765 3699999999999999999999999999999999999996 66889999
Q ss_pred ecccccccCCc------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 259 DFGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 259 DFGlA~~~~~~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+..... .
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~ 237 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-I 237 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-C
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-C
Confidence 99999654322 2234689999999999999999999999999999999999999988877665544433111 0
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
++. .
T Consensus 238 ~~~----------------------------------------------------------------~------------ 241 (311)
T 3ork_A 238 PPS----------------------------------------------------------------A------------ 241 (311)
T ss_dssp CHH----------------------------------------------------------------H------------
T ss_pred Ccc----------------------------------------------------------------c------------
Confidence 000 0
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....++..+.+||.+||+.||++||++.++|+|+|++...
T Consensus 242 -----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 242 -----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0011346789999999999999999999999999998644
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=366.27 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=208.1
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..++|++++.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.+ .||||+++++++...+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-------DHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECC-
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-------CCCCEeeeeeeeeeCC
Confidence 348999999999999999999999999999999999753 33457788999999988 6899999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSA 165 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTSCEEECCCHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC---CCCCEEEEECCCCc
Confidence 99999999985 7777776543 5699999999999999999999999999999999999995 66789999999875
Q ss_pred ccCC---ccccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 265 TEDR---TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 265 ~~~~---~~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
.... ......+++.|+|||++. ...++.++|||||||++|+|++|..||...+..+.+..+..... +.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~- 241 (302)
T 2j7t_A 166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP---PT- 241 (302)
T ss_dssp HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CC-
T ss_pred cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC---cc-
Confidence 3221 223457899999999984 56789999999999999999999999988776555444332100 00
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
.
T Consensus 242 -------------------------------------------------------------------------------~ 242 (302)
T 2j7t_A 242 -------------------------------------------------------------------------------L 242 (302)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.....++..+.+||.+||..||++|||++|+|+||||++..
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00012346789999999999999999999999999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=399.75 Aligned_cols=201 Identities=26% Similarity=0.434 Sum_probs=177.9
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+|+.+ .||||++++++|.
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-------~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HSRFIVSLAYAFE 255 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-------CCCCEeeEEEEEe
Confidence 3479999999999999999999999999999999997532 2345678899999998 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQRHLCICFELLD-SNLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+.+||||||+. ++|.+++.... ...+++..++.++.||+.||.|||++|||||||||+||||+ .++.+||+|
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~---~~g~vkL~D 332 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISD 332 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe---CCCCEEEee
Confidence 9999999999997 58988887543 34599999999999999999999999999999999999995 678999999
Q ss_pred cccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 260 FGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 260 FGlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
||+++..... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+..
T Consensus 333 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred cceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 9999754332 234589999999999999999999999999999999999999997653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=360.02 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=203.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-------RHPHIIKLYQVISTP 83 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-------CCCCEeEEEEEEecC
Confidence 79999999999999999999999999999999997532 2345678899999887 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~ 158 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD---AHMNAKIADFGLS 158 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC---TTSCEEECCCCGG
T ss_pred CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC---CCCCEEEeecccc
Confidence 99999999997 5999998765 3599999999999999999999999999999999999995 6678999999999
Q ss_pred cccCCc--cccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRT--VYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~--~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
...... .....+++.|+|||++.+..+ +.++|||||||++|+|++|+.||......+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 228 (276)
T 2h6d_A 159 NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF---------- 228 (276)
T ss_dssp GCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred cccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------
Confidence 765432 234578999999999988765 6899999999999999999999987665544443322000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
..| .
T Consensus 229 ---------------------------------------------------------------~~~-------------~ 232 (276)
T 2h6d_A 229 ---------------------------------------------------------------YIP-------------E 232 (276)
T ss_dssp ---------------------------------------------------------------CCC-------------T
T ss_pred ---------------------------------------------------------------cCc-------------h
Confidence 000 0
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..+..+.+||.+||+.||++|||++|+|+||||++.
T Consensus 233 ~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 123568899999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=363.14 Aligned_cols=256 Identities=32% Similarity=0.521 Sum_probs=213.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+++++++ .||||+++++++...+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-------DHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECSS
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-------cCCCccEEEEEEeCCC
Confidence 7999999999999999999999999999999999743 23456788999999988 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+++||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.+.....+||+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999997 5888887655 359999999999999999999999999999999999999755556689999999987
Q ss_pred ccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 265 TEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 265 ~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
..... .....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..... .
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--------- 240 (287)
T 2wei_A 173 CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY--A--------- 240 (287)
T ss_dssp TBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--C---------
T ss_pred eecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--C---------
Confidence 54332 234468899999999876 489999999999999999999999988877665554433110 0
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+. ......+
T Consensus 241 --------------------------------------------------~~---------------------~~~~~~~ 249 (287)
T 2wei_A 241 --------------------------------------------------FD---------------------LPQWRTI 249 (287)
T ss_dssp --------------------------------------------------CC---------------------SGGGTTS
T ss_pred --------------------------------------------------CC---------------------chhhhhc
Confidence 00 0000113
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+..+.+||++||..||++|||++|+|+||||++.
T Consensus 250 ~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 4678999999999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=381.61 Aligned_cols=197 Identities=23% Similarity=0.408 Sum_probs=170.1
Q ss_pred CceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
++|+++++||+|+||+||+|++. .+++.||||+++.. ....+.+.+|+++|+.+. .|+||++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~ 127 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR------QSPFLVTLHYA 127 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH------TCTTBCCEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc------CCCceeEEEEE
Confidence 79999999999999999999874 58999999998742 123355677999999995 48999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+...+.+||||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||||+ .++.+||+|
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~D 202 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTD 202 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESC
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCcEEEee
Confidence 999999999999997 5899988765 3699999999999999999999999999999999999995 678999999
Q ss_pred cccccccCC----ccccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 260 FGSACTEDR----TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 260 FGlA~~~~~----~~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
||+++.... .....++|+.|+|||++.+. .++.++||||||||+|||++|+.||...
T Consensus 203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 999965422 22345799999999999863 5789999999999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=378.53 Aligned_cols=197 Identities=29% Similarity=0.503 Sum_probs=173.3
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh---------hHHHHHHHHHHHHHHhhhcCCCCCCceeEE
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA---------YYQQALVEVSILTTLNKKYDREDKHHIVRI 177 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~---------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl 177 (820)
..++|+++++||+|+||+||+|+++.+++.||||+++.... ..+.+.+|+.+|+.+ .|+||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~Iv~~ 94 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-------EHANIIKV 94 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-------CCTTBCCE
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-------CCCCEeeE
Confidence 34799999999999999999999999999999999986421 233566799999888 68999999
Q ss_pred eEEEeecceeEEEEeccC-C-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeE
Q 003438 178 YEYFVCQRHLCICFELLD-S-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 178 ~d~f~~~~~l~LVmEy~~-g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~i 255 (820)
++++...+.+++||||+. + +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~ 169 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTI 169 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCE
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcE
Confidence 999999999999999986 4 888888754 3599999999999999999999999999999999999996 66899
Q ss_pred EEeecccccccCC--ccccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCC
Q 003438 256 KIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 256 KL~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||+|||++..... .....++|+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 170 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp EECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred EEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 9999999975443 2345679999999999998877 7899999999999999999999953
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.34 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=210.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~- 183 (820)
.++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+ .||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-------KHPNIVRYYDRIIDR 77 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEEEG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-------CCCCCCeEEEEEecC
Confidence 37999999999999999999999999999999999853 34556788999999998 58999999998864
Q ss_pred -cceeEEEEeccCC-ChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCC-----eeeccCCCCCcccccccCCCe
Q 003438 184 -QRHLCICFELLDS-NLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAG-----IIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 184 -~~~l~LVmEy~~g-sL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~g-----IVHrDLKPeNILl~~~~~~~~ 254 (820)
...+|+||||+.+ +|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~---~~~~ 154 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQN 154 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC---SSSC
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc---CCCC
Confidence 5689999999975 9999987653 234999999999999999999999999 99999999999995 6788
Q ss_pred EEEeecccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q 003438 255 IKIIDFGSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA 331 (820)
Q Consensus 255 iKL~DFGlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~ 331 (820)
+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~- 233 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF- 233 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-
Confidence 999999999755432 2345789999999999998999999999999999999999999988776555444332100
Q ss_pred CCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCC
Q 003438 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNL 411 (820)
Q Consensus 332 ~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~l 411 (820)
+ ..|
T Consensus 234 -~----------------------------------------------------------------------~~~----- 237 (279)
T 2w5a_A 234 -R----------------------------------------------------------------------RIP----- 237 (279)
T ss_dssp -C----------------------------------------------------------------------CCC-----
T ss_pred -c----------------------------------------------------------------------cCC-----
Confidence 0 000
Q ss_pred ChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 412 SMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 412 s~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++..+.+||.+||..||++|||++|+|+|+|+.+..
T Consensus 238 --------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 --------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred --------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 01346789999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=362.13 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=212.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+ .|+||+++++++....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~ 93 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-------DSPYVTKYYGSYLKDT 93 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-------CCCCEeEEEEEEecCC
Confidence 37899999999999999999999999999999999754 34467788999999988 6899999999999999
Q ss_pred eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAG 167 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC---CCCCEEEeecccce
Confidence 99999999985 88888754 3599999999999999999999999999999999999995 66889999999996
Q ss_pred ccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
..... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||......+.+..+.+.. ++
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~------- 237 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PP------- 237 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CC-------
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC---CC-------
Confidence 54332 234578999999999999999999999999999999999999998766554433322100 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
. + ...
T Consensus 238 ---------------------------------------------~-----~-------------------------~~~ 242 (303)
T 3a7i_A 238 ---------------------------------------------T-----L-------------------------EGN 242 (303)
T ss_dssp ---------------------------------------------C-----C-------------------------CSS
T ss_pred ---------------------------------------------C-----C-------------------------ccc
Confidence 0 0 001
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++..+.+||.+||..||++|||++|+|+||||....
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 336789999999999999999999999999997643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=374.44 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=184.3
Q ss_pred CCceEEEE-EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee---
Q 003438 108 QRRYIVKD-LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--- 183 (820)
Q Consensus 108 ~~rY~i~~-~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--- 183 (820)
.++|++++ +||+|+||+||+|+++.+++.||||++...... .+|+..+.++. .|+||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~e~~~~~~~~------~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA----RQEVDHHWQAS------GGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH----HHHHHHHHHHT------TSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH----HHHHHHHHHhc------CCCChHHHHHHHhhccC
Confidence 37899965 699999999999999999999999999875432 23443333321 68999999999987
Q ss_pred -cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 184 -QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 184 -~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
...++|||||+.+ +|.+++.......+++.+++.++.||+.||.|||++||+||||||+|||++.+...+.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 5569999999975 99999987655579999999999999999999999999999999999999765557789999999
Q ss_pred cccccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 262 SACTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 262 lA~~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...........+.+...
T Consensus 177 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------- 246 (336)
T 3fhr_A 177 FAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR---------- 246 (336)
T ss_dssp TCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh----------
Confidence 99755432 3455789999999999988999999999999999999999999976543222111111000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
. . .. .++. ....
T Consensus 247 --~--------~-------------------------------------~~------------~~~~---------~~~~ 258 (336)
T 3fhr_A 247 --L--------G-------------------------------------QY------------GFPN---------PEWS 258 (336)
T ss_dssp ---------------------------------------------------------------CCCT---------TTST
T ss_pred --c--------c-------------------------------------cc------------ccCc---------hhhc
Confidence 0 0 00 0000 0001
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.++..+.+||++||..||++|||++|+|+||||++.
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 245778999999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.32 Aligned_cols=189 Identities=34% Similarity=0.501 Sum_probs=162.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-----
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC----- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~----- 183 (820)
++|++++.||+|+||+||+|++..+++.||||+++......+.+.+|+.+++.+ .||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-------NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-------CchHHHHHHHHHHhhcchh
Confidence 689999999999999999999999999999999987766777888999999888 68999999998865
Q ss_pred --------cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCe
Q 003438 184 --------QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 184 --------~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
.+.+|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~---~~~~ 154 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRN 154 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc---CCCC
Confidence 467899999997 59999987643 3588999999999999999999999999999999999995 6788
Q ss_pred EEEeecccccccCC-----------------ccccccccccccCccccccc-cccccchhHhHHHHHHHHHh
Q 003438 255 IKIIDFGSACTEDR-----------------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFL 308 (820)
Q Consensus 255 iKL~DFGlA~~~~~-----------------~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLlt 308 (820)
+||+|||++..... ......+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999999965432 12345689999999999865 78999999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=374.68 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=211.2
Q ss_pred CCceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~-----d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|+++++||+|+||+||+|+ +..+++.||||+++.. ......+.+|+.+|+.+ .|+||++++++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~ 142 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-------NHQNIVRCIGV 142 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-------CCCCCCeEEEE
Confidence 4799999999999999999998 5567889999999753 44556788899999998 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhc-----CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCe
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
+......|||||||. ++|.+++..... ..+++.+++.++.||+.||+|||++|||||||||+||||+.+.....
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 999999999999996 599999987542 34899999999999999999999999999999999999975545567
Q ss_pred EEEeecccccccC-----CccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 003438 255 IKIIDFGSACTED-----RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 255 iKL~DFGlA~~~~-----~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~~ 328 (820)
+||+|||+++... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+...
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999996321 22234567899999999999999999999999999999998 99999888776655544321
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
....+
T Consensus 303 ~~~~~--------------------------------------------------------------------------- 307 (367)
T 3l9p_A 303 GRMDP--------------------------------------------------------------------------- 307 (367)
T ss_dssp CCCCC---------------------------------------------------------------------------
T ss_pred CCCCC---------------------------------------------------------------------------
Confidence 10000
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
...++..+.+||++||+.||++|||++|+|+|.++..
T Consensus 308 ----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 308 ----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0013366899999999999999999999999988754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.09 Aligned_cols=202 Identities=29% Similarity=0.398 Sum_probs=175.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|++..+++.||||++.. .....+.+.+|+.+++.+ .||||+++++++...
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-------SHQNIVSMIDVDEED 83 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-------CBTTBCCEEEEEECS
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-------CCCCCceEEEeeeeC
Confidence 899999999999999999999999999999999863 234556788899998888 689999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+.+ +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIA 158 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCSSS
T ss_pred CeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEEeCCCc
Confidence 999999999975 999988765 3699999999999999999999999999999999999995 6688999999999
Q ss_pred cccCCc----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l 322 (820)
...... ....++|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 221 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 755432 23357899999999999999999999999999999999999999887765543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=369.44 Aligned_cols=270 Identities=21% Similarity=0.355 Sum_probs=211.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhh------------------HHHHHHHHHHHHHHhhhcCCCC
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY------------------YQQALVEVSILTTLNKKYDRED 170 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~------------------~~~~~~Ei~iL~~L~~~~~~~~ 170 (820)
++|++++.||+|+||.||+|++ +++.||||++...... .+.+.+|+.+++.+ .
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~ 101 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-------K 101 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-------C
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-------C
Confidence 7999999999999999999988 8999999999743211 17788999999888 6
Q ss_pred CCceeEEeEEEeecceeEEEEeccCC-ChHHH------HHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCC
Q 003438 171 KHHIVRIYEYFVCQRHLCICFELLDS-NLYEL------IKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPE 242 (820)
Q Consensus 171 HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~------l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPe 242 (820)
||||+++++++...+.+|+||||+.+ +|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 89999999999999999999999985 88887 554334579999999999999999999999 99999999999
Q ss_pred CcccccccCCCeEEEeecccccccC-CccccccccccccCccccccc-cccc-cchhHhHHHHHHHHHhCCCCCCCCCH-
Q 003438 243 NILLCTSVKPAEIKIIDFGSACTED-RTVYSYIQSRYYRSPEVLLGY-QYTT-AIDMWSFGCIVAELFLGLPLFPGASE- 318 (820)
Q Consensus 243 NILl~~~~~~~~iKL~DFGlA~~~~-~~~~~~~gt~~Y~APEvl~~~-~yt~-ksDIWSLG~ILyeLltG~~PF~~~s~- 318 (820)
|||++ .++.+||+|||++.... .......+++.|+|||++.+. .++. ++|||||||++|+|++|..||.....
T Consensus 182 Nil~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 182 NILMD---KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GEEEC---TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred hEEEc---CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99995 66899999999997643 334456789999999999887 6776 99999999999999999999987665
Q ss_pred HHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchh
Q 003438 319 FDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL 398 (820)
Q Consensus 319 ~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L 398 (820)
.+.+..+.......|... ..+.. + +.....
T Consensus 259 ~~~~~~i~~~~~~~~~~~--------~~~~~------------------------------------~------~~~~~~ 288 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDR--------NHFLY------------------------------------P------LTNKKS 288 (348)
T ss_dssp HHHHHHHTSCCCCCCCSS--------SSSTT------------------------------------T------TCC---
T ss_pred HHHHHHHhccCcCCccch--------hhhhc------------------------------------c------cccccc
Confidence 444443322110000000 00000 0 000000
Q ss_pred HHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 399 ~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
. .....++..+.+||++||+.||++|||++|+|+||||++..
T Consensus 289 ~-----------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 289 T-----------------CSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp ----------------------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred c-----------------cchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 0 00112457899999999999999999999999999999754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.72 Aligned_cols=201 Identities=21% Similarity=0.278 Sum_probs=175.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+++.+. .|+||+++++++......|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~------~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLA------GCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTT------TCTTCCCEEEEEEETTEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHh------cCCCCCeEEeecCCCceeE
Confidence 79999999999999999999999999999999997543 2345778999999985 4889999999999999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc--cCCCeEEEeeccccccc
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~--~~~~~iKL~DFGlA~~~ 266 (820)
|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ .....+||+|||++...
T Consensus 83 lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999889999997653 459999999999999999999999999999999999999643 12345999999999654
Q ss_pred CCc----------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 267 DRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 267 ~~~----------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 322 234578999999999999999999999999999999999999998743
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=364.02 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=188.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.+ .||||+++++++...+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-------HHPNIVSYYTSFVVKD 86 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-------CCTTBCCEEEEEESSS
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-------CCCCEeeEEEEEeecC
Confidence 38999999999999999999999999999999998753 23345566777776666 6999999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhh------hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 186 HLCICFELLD-SNLYELIKIN------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~------~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
..++||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC---TTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc---CCCCEEEE
Confidence 9999999996 5899988752 224589999999999999999999999999999999999995 66889999
Q ss_pred ecccccccCC--------ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003438 259 DFGSACTEDR--------TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329 (820)
Q Consensus 259 DFGlA~~~~~--------~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~l 329 (820)
|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+.+.....
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 241 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-- 241 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--
Confidence 9999864322 1234578999999999976 4689999999999999999999999987654433322111
Q ss_pred CCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCC
Q 003438 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409 (820)
Q Consensus 330 G~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~ 409 (820)
. .++.. . .. .. ..+
T Consensus 242 ~-~~~~~---------------------~-------------------------------~~-~~---~~~--------- 255 (303)
T 2vwi_A 242 N-DPPSL---------------------E-------------------------------TG-VQ---DKE--------- 255 (303)
T ss_dssp S-SCCCT---------------------T-------------------------------C---------C---------
T ss_pred c-CCCcc---------------------c-------------------------------cc-cc---cch---------
Confidence 0 00000 0 00 00 000
Q ss_pred CCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 410 ~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....++..+.+||.+||..||++|||++|+|+||||++..
T Consensus 256 --------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 256 --------MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp --------CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred --------hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0011346789999999999999999999999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=360.77 Aligned_cols=197 Identities=23% Similarity=0.414 Sum_probs=168.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++++.||+|+||.||+|++. +++.||||++... ....+.+.+|+.+++.+.+ .|+||+++++++...+
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-----HSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG-----GCTTBCCEEEEEECSS
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc-----cCCceEEEEEEeecCC
Confidence 78999999999999999999885 4889999999743 3456778899999999965 3799999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
.+|||||+.+++|.+++... ..+++..++.++.||++||.|||+++|+||||||+|||++ ++.+||+|||++..
T Consensus 102 ~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 102 YIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEECCCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC
T ss_pred EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeecccccc
Confidence 99999998778999998865 3699999999999999999999999999999999999994 37899999999975
Q ss_pred cCCc-----cccccccccccCcccccc-----------ccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 266 EDRT-----VYSYIQSRYYRSPEVLLG-----------YQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 266 ~~~~-----~~~~~gt~~Y~APEvl~~-----------~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 4332 124478999999999976 468889999999999999999999997543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=363.69 Aligned_cols=201 Identities=23% Similarity=0.327 Sum_probs=175.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.++||+|+||+||+|++..+++.||||++..... .+.+.+|+.+++.|. .|+||+++++++...+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~------~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLG------SGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHC------SCTTSCCEEEEEEETTEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhh------CCCCCCEEEEEEecCCccE
Confidence 789999999999999999999999999999999985432 345778999999994 5899999999999999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC--CCeEEEeeccccccc
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK--PAEIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~--~~~iKL~DFGlA~~~ 266 (820)
|||||++++|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.+.. ...+||+|||++...
T Consensus 82 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999889999988653 46999999999999999999999999999999999999963321 122999999999753
Q ss_pred CCc----------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 267 DRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 267 ~~~----------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 221 235678999999999999999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=351.77 Aligned_cols=205 Identities=22% Similarity=0.372 Sum_probs=179.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++++.||+|+||+||+|++. +++.||||+++......+.+.+|+++++++ .||||+++++++.+.+..|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-------SHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-------CCTTBCCEEEEECSSSSEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-------CCCCEeeEEEEEecCCceE
Confidence 79999999999999999999876 467799999997665667889999999998 5899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccc
Confidence 9999997 58888887644 4699999999999999999999999999999999999995 56789999999997554
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~ 220 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 220 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 322 23355778999999998899999999999999999999 99999887766655544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.52 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=207.4
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-------hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~-------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||+||+|++..+++.||||+++.... ..+.+.+|+.+++++.+ .|+||++++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~~~i~~~~~~ 116 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS-----GFSGVIRLLDW 116 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS-----SSCSBCCEEEE
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc-----CCCCceEEEEE
Confidence 3899999999999999999999999999999999975421 22456679999999964 47999999999
Q ss_pred EeecceeEEEEeccC--CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 181 FVCQRHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 181 f~~~~~l~LVmEy~~--gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
+...+..++|||++. ++|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++ ...+.+||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~ 192 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLI 192 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEe
Confidence 999999999999997 6899988764 4699999999999999999999999999999999999995 256789999
Q ss_pred ecccccccCCc-cccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchH
Q 003438 259 DFGSACTEDRT-VYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 259 DFGlA~~~~~~-~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~ 336 (820)
|||++...... .....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||..... +.. + ..
T Consensus 193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~-~~--- 260 (320)
T 3a99_A 193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--G-QV--- 260 (320)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--C-CC---
T ss_pred eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--c-cc---
Confidence 99999765433 334578999999999987765 6889999999999999999999964210 000 0 00
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
.+ .
T Consensus 261 -------------------------------------------------------~~--------------~-------- 263 (320)
T 3a99_A 261 -------------------------------------------------------FF--------------R-------- 263 (320)
T ss_dssp -------------------------------------------------------CC--------------S--------
T ss_pred -------------------------------------------------------cc--------------c--------
Confidence 00 0
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..+++.+.+||++||..||++|||++|+|+||||++..
T Consensus 264 ---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 264 ---QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 01336789999999999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=352.99 Aligned_cols=206 Identities=20% Similarity=0.303 Sum_probs=176.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|+++++||+|+||+||+|.+. ++..||||+++......+.+.+|+++++.+ .|+||+++++++...+.+|
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-------SHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-------CCTTBCCEEEEECSSSSEE
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-------CCCCEeeEEEEEecCCCeE
Confidence 79999999999999999999765 677899999997665667888999999998 5899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTSCEEECSTTGGGGBC
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc---CCCCEEEcccccccccc
Confidence 9999996 68999887643 4599999999999999999999999999999999999995 67789999999997554
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~ 326 (820)
... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 235 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence 322 22345778999999998899999999999999999998 999998877665555443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.60 Aligned_cols=207 Identities=21% Similarity=0.315 Sum_probs=176.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|++.++||+|+||+||+|++..++ ..||||+++.. ....+.+.+|+.+|+.+ .||||+++++++.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~ 120 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-------DHPNIIRLEGVVT 120 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEE
Confidence 489999999999999999999987554 45999999863 44556788999999888 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+..||||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg 196 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFG 196 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCS
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC---CCCCEEECCCC
Confidence 9999999999997 58999886553 4699999999999999999999999999999999999995 67899999999
Q ss_pred cccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 262 SACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 262 lA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+
T Consensus 197 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 267 (325)
T 3kul_A 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267 (325)
T ss_dssp SCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred cccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 997543321 12245678999999998899999999999999999999 99999887776655544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.14 Aligned_cols=206 Identities=22% Similarity=0.320 Sum_probs=178.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++++.||+|+||+||+|++. ++..||||+++......+.+.+|+++++.+ .||||+++++++...+..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-------SHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-------CCCCEeeEEEEEccCCce
Confidence 379999999999999999999765 567899999987766667889999999998 589999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC---TTCCEEECCTTCEEEC
T ss_pred EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC---CCCCEEEccCccceec
Confidence 99999997 57999887654 4599999999999999999999999999999999999995 6788999999999754
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
.... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 218 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred chhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence 3322 22345667999999999899999999999999999999 99999877766554443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=354.93 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=201.2
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
+|....+||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.+ .|+||+++++++...+..+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-------KHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-------CCTTBCCEEEEEEETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-------CCCCEeeEeeEEEeCCcEE
Confidence 333445899999999999999999999999999864 34456788899999988 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 189 ICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++ ...+.+||+|||++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEES
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeeccccccc
Confidence 9999997 68988887653 22467999999999999999999999999999999999996 23678999999999754
Q ss_pred CCc---cccccccccccCcccccccc--ccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 267 DRT---VYSYIQSRYYRSPEVLLGYQ--YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 267 ~~~---~~~~~gt~~Y~APEvl~~~~--yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||................. .
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~--------- 243 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-V--------- 243 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-C---------
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-c---------
Confidence 322 23457899999999997653 88999999999999999999999965332221110000000 0
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+ .. ...
T Consensus 244 -------------------------------------------~~-----------------~~-------------~~~ 250 (295)
T 2clq_A 244 -------------------------------------------HP-----------------EI-------------PES 250 (295)
T ss_dssp -------------------------------------------CC-----------------CC-------------CTT
T ss_pred -------------------------------------------cc-----------------cc-------------ccc
Confidence 00 00 011
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++..+.+||.+||..||++|||++|+|+||||+...
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 346789999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.05 Aligned_cols=206 Identities=25% Similarity=0.397 Sum_probs=176.4
Q ss_pred CCceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
.++|++.+.||+|+||+||+|++. .++..||||+++.. ....+.+.+|+.+|+.+. .||||++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hpnIv~~~ 153 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLL 153 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC------CCTTBCCEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc------CCCCEeeEE
Confidence 379999999999999999999854 35678999999854 345567889999999984 489999999
Q ss_pred EEEeecceeEEEEeccC-CChHHHHHhhhc--------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCC
Q 003438 179 EYFVCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN 243 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN 243 (820)
+++...+.+||||||+. ++|.+++..... ..+++.+++.++.||+.||+|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999997 599999886531 348999999999999999999999999999999999
Q ss_pred cccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 244 ILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 244 ILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
|||+ .++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 234 Ill~---~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVT---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEEC---TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEC---CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9995 6789999999999754322 223456788999999999999999999999999999999 999998765
Q ss_pred HHHHH
Q 003438 318 EFDLL 322 (820)
Q Consensus 318 ~~d~l 322 (820)
..+..
T Consensus 311 ~~~~~ 315 (370)
T 2psq_A 311 VEELF 315 (370)
T ss_dssp GGGHH
T ss_pred HHHHH
Confidence 54433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.21 Aligned_cols=206 Identities=26% Similarity=0.323 Sum_probs=170.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
..+|++.++||+|+||+||+|++ +++.||||++... ....+.+.+|+++|+++ .||||+++++++...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-------RHPNIVLFMGAVTQP 106 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEECST
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEEC
Confidence 37999999999999999999975 5889999999754 34456788999999999 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhc-CCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 RHLCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~-~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
+.++|||||+. ++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~---~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC---TTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe---CCCcEEECCC
Confidence 99999999997 589998875431 23899999999999999999999999 99999999999995 6789999999
Q ss_pred ccccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 261 GSACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 261 GlA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
|+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999754332 33457899999999999999999999999999999999999999887765554443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=360.87 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=189.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~---~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|++.+.||+|+||+||+|++..+++ .||||+++.. ....+.+.+|+++++++ .||||+++++++.
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~ 95 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-------DHPHVAKLVGVSL 95 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-------CCTTBCCCCEEEE
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-------CCCceehhhceee
Confidence 799999999999999999999887775 8999999753 34567788999999888 6899999999998
Q ss_pred eccee------EEEEeccCC-ChHHHHHhhhcC----CCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 183 CQRHL------CICFELLDS-NLYELIKINHFR----GLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 183 ~~~~l------~LVmEy~~g-sL~d~l~~~~~~----~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
..... ++||||+.+ +|.+++...... .+++..++.++.||+.||+|||++||+||||||+|||++ .
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---E 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---T
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---C
Confidence 87655 999999985 899988765422 489999999999999999999999999999999999996 6
Q ss_pred CCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 252 PAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
++.+||+|||+++...... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~ 252 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 6899999999997543221 23345778999999999999999999999999999999 99999876655444433
Q ss_pred HHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcC
Q 003438 326 IRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNY 405 (820)
Q Consensus 326 ~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~ 405 (820)
..... +
T Consensus 253 ~~~~~--~------------------------------------------------------------------------ 258 (323)
T 3qup_A 253 IGGNR--L------------------------------------------------------------------------ 258 (323)
T ss_dssp HTTCC--C------------------------------------------------------------------------
T ss_pred hcCCC--C------------------------------------------------------------------------
Confidence 22000 0
Q ss_pred CCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCC-------HHHHHcCCccCCCC
Q 003438 406 PYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS-------PFQASRHPFVTGEP 457 (820)
Q Consensus 406 P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpT-------a~EaL~HPff~~~~ 457 (820)
+ ....+++.+.+||.+||..||++||| ++++++|||+....
T Consensus 259 ~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 259 K-----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp C-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred C-----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 0 00013467899999999999999999 88899999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=365.63 Aligned_cols=204 Identities=27% Similarity=0.393 Sum_probs=174.5
Q ss_pred CCceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~-----d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.++||+|+||.||+|+ +..+++.||||+++.. ....+.+.+|+++|+++. .||||++++++
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hpniv~~~~~ 94 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA 94 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc------CCcceeeeeee
Confidence 3899999999999999999998 6677899999999864 344567889999999995 58999999999
Q ss_pred Eeecc-eeEEEEeccC-CChHHHHHhhhc---------------------------------------------------
Q 003438 181 FVCQR-HLCICFELLD-SNLYELIKINHF--------------------------------------------------- 207 (820)
Q Consensus 181 f~~~~-~l~LVmEy~~-gsL~d~l~~~~~--------------------------------------------------- 207 (820)
+...+ .++||||||. ++|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 98765 4999999998 499999876532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCCc-----
Q 003438 208 -------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRT----- 269 (820)
Q Consensus 208 -------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~----- 269 (820)
..+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+|||++......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccchh
Confidence 1289999999999999999999999999999999999996 5678999999999754321
Q ss_pred cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 270 VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 270 ~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 303 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence 233467889999999999999999999999999999998 999998765433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.47 Aligned_cols=254 Identities=25% Similarity=0.349 Sum_probs=186.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHH-HHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVS-ILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~-iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++++.||+|+||+||+|++..+++.||||+++... ....+...|+. +++.+ .|+||+++++++...+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-------~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-------DCPYIVQCFGTFITNT 97 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-------TCTTBCCEEEEEECSS
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-------CCCceeeEEEEEecCC
Confidence 79999999999999999999999999999999998642 22233333433 33333 7999999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+||||||+++.+..++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++.
T Consensus 98 ~~~lv~e~~~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~ 173 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISG 173 (318)
T ss_dssp EEEEEECCCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC---TTSCEEECCCTTC-
T ss_pred cEEEEEeccCCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC---CCCCEEEEECCCch
Confidence 9999999996555555443 345699999999999999999999995 999999999999995 66889999999996
Q ss_pred ccCC--ccccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCchH
Q 003438 265 TEDR--TVYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDY 336 (820)
Q Consensus 265 ~~~~--~~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~-s~~d~l~~I~~~lG~~Pp~~ 336 (820)
.... ......+++.|+|||++. ...++.++|||||||++|+|++|+.||... ...+.+..+.... ++.
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~- 249 (318)
T 2dyl_A 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPL- 249 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC---CCC-
T ss_pred hccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC---CCC-
Confidence 5432 233457899999999995 457889999999999999999999999763 3333333332210 000
Q ss_pred HHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 337 VLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 337 ~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
.|.
T Consensus 250 --------------------------------------------------------------------~~~--------- 252 (318)
T 2dyl_A 250 --------------------------------------------------------------------LPG--------- 252 (318)
T ss_dssp --------------------------------------------------------------------CCS---------
T ss_pred --------------------------------------------------------------------CCc---------
Confidence 000
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
...++..+.+||.+||..||.+|||++|+|+||||++.
T Consensus 253 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 253 --HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp --SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred --cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 00134678999999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=353.81 Aligned_cols=203 Identities=21% Similarity=0.346 Sum_probs=181.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.++||+|+||+||+|++..+++.||||+++......+.+.+|+++++.+ .|+||+++++++...+..|
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEccCCCEE
Confidence 799999999999999999999999999999999998777778899999999999 5899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCccceecc
Confidence 9999998 6999999876656799999999999999999999999999999999999995 56789999999997554
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~ 221 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 221 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 322 23356778999999998899999999999999999999 9999987654433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=362.32 Aligned_cols=195 Identities=27% Similarity=0.314 Sum_probs=168.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--- 185 (820)
++|+++++||+|+||+||+|++. ++.||||+++..........+|+.+|+.+ .||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-------KHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-------CCTTBCCEEEEEEEECSSS
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-------CCCCchhhcceeccCCCCC
Confidence 79999999999999999999765 78999999987665556666788777776 6899999999998754
Q ss_pred -eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC----------CeeeccCCCCCcccccccCCC
Q 003438 186 -HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA----------GIIHCDLKPENILLCTSVKPA 253 (820)
Q Consensus 186 -~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~----------gIVHrDLKPeNILl~~~~~~~ 253 (820)
.+||||||+. ++|.++++.. .+++..++.++.||+.||+|||+. +|+||||||+|||++ ..+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---~~~ 168 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNL 168 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC---TTC
T ss_pred ceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC---CCC
Confidence 4799999997 5999998764 499999999999999999999999 999999999999995 678
Q ss_pred eEEEeecccccccCCc-----cccccccccccCcccccc-----ccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 254 EIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLG-----YQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~-----~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
.+||+|||+++..... ....++|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999999999643321 233578999999999987 4677899999999999999999999976543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.41 Aligned_cols=196 Identities=24% Similarity=0.403 Sum_probs=174.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC-ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~-~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
++|++.++||+|+||+||+|++..+++.||||++.. .....+.+.+|+++|+.+ .||||+++++++...+..
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-------EHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEETTEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCcCcccEEEEEecCCee
Confidence 799999999999999999999999999999998865 445667788999999888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
++||||+. ++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC---TTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC---CCCCEEEeecccceec
Confidence 99999997 48999887643 4699999999999999999999999999999999999995 6788999999999654
Q ss_pred CCcc-----------------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 267 DRTV-----------------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 267 ~~~~-----------------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
.... ...+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 3221 145789999999999999999999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=349.17 Aligned_cols=201 Identities=25% Similarity=0.301 Sum_probs=172.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.+.||+|+||+||+|++..+++.||||++..... .+.+.+|+.+++.+.+ +++|..+..++...+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~------~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG------GVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTT------STTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhc------CCCCCccccccCCCCce
Confidence 3899999999999999999999999999999999875432 3457889999999953 34455555556677889
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
++||||++++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++..+.+||+|||++....
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999889999987543 469999999999999999999999999999999999999655567899999999996543
Q ss_pred Cc----------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 268 RT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 268 ~~----------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
.. .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 32 23457899999999999999999999999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.07 Aligned_cols=202 Identities=25% Similarity=0.299 Sum_probs=169.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+.+ +++|..+..++...+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~------~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQG------GVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTT------STTCCCEEEEEEETTEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcC------CCCCCeeeeecCCCCce
Confidence 3799999999999999999999999999999999775432 2457789999999952 34555566666778899
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+...+..+.+||+|||++....
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999889999987543 469999999999999999999999999999999999999544577889999999996543
Q ss_pred Cc----------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 268 RT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 268 ~~----------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.. .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 32 224578999999999999999999999999999999999999997643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=364.49 Aligned_cols=209 Identities=26% Similarity=0.394 Sum_probs=179.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccC-------CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~-------tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
.++|++.++||+|+||+||+|++.. .++.||||+++.. ....+.+.+|+++++.+. .||||++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hpnIv~~~ 141 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG------KHKNIINLL 141 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc------CCchhhhhe
Confidence 3799999999999999999998643 3468999999854 345577889999999994 589999999
Q ss_pred EEEeecceeEEEEeccC-CChHHHHHhhhc--------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCC
Q 003438 179 EYFVCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN 243 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN 243 (820)
+++...+.+||||||+. ++|.+++..... ..+++.+++.++.||+.||+|||+++||||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999997 599999987542 359999999999999999999999999999999999
Q ss_pred cccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 244 ILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 244 ILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
|||+ .++.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 222 Ill~---~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEEC---TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEc---CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9995 6688999999999755422 233456788999999999999999999999999999999 999998877
Q ss_pred HHHHHHHH
Q 003438 318 EFDLLRRM 325 (820)
Q Consensus 318 ~~d~l~~I 325 (820)
..+....+
T Consensus 299 ~~~~~~~~ 306 (382)
T 3tt0_A 299 VEELFKLL 306 (382)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 65554443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.71 Aligned_cols=204 Identities=26% Similarity=0.426 Sum_probs=175.4
Q ss_pred CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.. ....+.+.+|+++|+.+ .||||++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~ 94 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-------NHPHVIKLYGA 94 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEE
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-------CCCceeeEEEE
Confidence 38999999999999999999986 345689999999853 34556788899999888 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhc----------------------CCCCHHHHHHHHHHHHHHhhhcccCCeeec
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHF----------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHC 237 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~----------------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHr 237 (820)
+...+..++||||+. ++|.+++..... ..+++.+++.++.||+.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999997 699999886532 238999999999999999999999999999
Q ss_pred cCCCCCcccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCC
Q 003438 238 DLKPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLP 311 (820)
Q Consensus 238 DLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~ 311 (820)
||||+|||++ .++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVA---EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEE---TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEc---CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999996 6788999999999754322 123356788999999999899999999999999999999 999
Q ss_pred CCCCCCHHHH
Q 003438 312 LFPGASEFDL 321 (820)
Q Consensus 312 PF~~~s~~d~ 321 (820)
||.+....+.
T Consensus 252 p~~~~~~~~~ 261 (314)
T 2ivs_A 252 PYPGIPPERL 261 (314)
T ss_dssp SSTTCCGGGH
T ss_pred CCCCCCHHHH
Confidence 9987655433
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.50 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=197.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-------hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~-------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.++||+|+||+||+|++..+++.||||+++.... ....+.+|+.+++++... ..|+||+++++++
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG---GGHPGVIRLLDWF 107 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS---CCCSSBCCEEEEC
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc---CCCCCeeeEEEEE
Confidence 789999999999999999999999999999999975431 223455799999998532 2699999999999
Q ss_pred eecceeEEEEec-cC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 182 VCQRHLCICFEL-LD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 182 ~~~~~l~LVmEy-~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
...+..++|||+ +. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d 183 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID 183 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence 999999999999 55 6999998765 3599999999999999999999999999999999999995 2567899999
Q ss_pred cccccccCC-ccccccccccccCcccccccccc-ccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDR-TVYSYIQSRYYRSPEVLLGYQYT-TAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~-~~~~~~gt~~Y~APEvl~~~~yt-~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++..... ......++..|+|||++.+..+. .++|||||||++|+|++|+.||.... .+....-
T Consensus 184 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~------- 250 (312)
T 2iwi_A 184 FGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL------- 250 (312)
T ss_dssp CSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC-------
T ss_pred cchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc-------
Confidence 999975543 33455789999999999877664 59999999999999999999996421 0100000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
.++
T Consensus 251 ------------------------------------------------------------------~~~----------- 253 (312)
T 2iwi_A 251 ------------------------------------------------------------------HFP----------- 253 (312)
T ss_dssp ------------------------------------------------------------------CCC-----------
T ss_pred ------------------------------------------------------------------CCc-----------
Confidence 000
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
..++..+.+||.+||+.||++|||++|+|+||||+.....
T Consensus 254 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 254 --AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 0134678999999999999999999999999999986543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=358.30 Aligned_cols=208 Identities=23% Similarity=0.394 Sum_probs=178.1
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++++.||+|+||+||+|++. .+++.||||+++.. ....+.+.+|+.+++.+ .||||++++++
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~ 118 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-------DNPNIVKLLGV 118 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEE
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEE
Confidence 489999999999999999999886 45689999999854 34456788999999998 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhh----------------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeec
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINH----------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHC 237 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~----------------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHr 237 (820)
+...+.+||||||+. ++|.+++.... ...+++.+++.++.||++||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 999999999999997 59999987642 1469999999999999999999999999999
Q ss_pred cCCCCCcccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCC
Q 003438 238 DLKPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLP 311 (820)
Q Consensus 238 DLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~ 311 (820)
||||+|||++ .++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEEC---CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999996 5678999999999643321 233467889999999998899999999999999999999 999
Q ss_pred CCCCCCHHHHHHHH
Q 003438 312 LFPGASEFDLLRRM 325 (820)
Q Consensus 312 PF~~~s~~d~l~~I 325 (820)
||.+....+....+
T Consensus 276 p~~~~~~~~~~~~~ 289 (343)
T 1luf_A 276 PYYGMAHEEVIYYV 289 (343)
T ss_dssp TTTTSCHHHHHHHH
T ss_pred cCCCCChHHHHHHH
Confidence 99887765554443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=367.18 Aligned_cols=205 Identities=25% Similarity=0.407 Sum_probs=177.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++|+.+ .||||+++++++...+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-------SHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-------CCTTBCCEEEEECSSS
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEEecCC
Confidence 37999999999999999999999999999999999854 33445678899999888 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+||||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~---~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGMSR 261 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCGGGCE
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc---CCCcEEECcCCCce
Confidence 9999999997 69999987653 4599999999999999999999999999999999999995 66899999999997
Q ss_pred ccCCcccc-----ccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 265 TEDRTVYS-----YIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 265 ~~~~~~~~-----~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
........ ..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~ 326 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 65433221 234677999999998899999999999999999998 999998877655443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=356.31 Aligned_cols=199 Identities=27% Similarity=0.359 Sum_probs=159.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe-----
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV----- 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~----- 182 (820)
.+|++.++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++++. +|+||+++++++.
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS------GHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT------TSTTBCCEEEEEEECTTT
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc------cCCChhhccccccccccc
Confidence 6999999999999999999999999999999988643 455667889999999994 4899999999994
Q ss_pred ---ecceeEEEEeccCCChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEE
Q 003438 183 ---CQRHLCICFELLDSNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 183 ---~~~~l~LVmEy~~gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iK 256 (820)
....+++||||+.|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+|
T Consensus 102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~~k 178 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIK 178 (337)
T ss_dssp STTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSCEE
T ss_pred cccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCCEE
Confidence 345689999999999999887633 345999999999999999999999999 99999999999996 667899
Q ss_pred EeecccccccCCcc---------------ccccccccccCcccc---ccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 257 IIDFGSACTEDRTV---------------YSYIQSRYYRSPEVL---LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 257 L~DFGlA~~~~~~~---------------~~~~gt~~Y~APEvl---~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
|+|||++....... ....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 99999997554321 134689999999998 5667899999999999999999999999643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.20 Aligned_cols=256 Identities=21% Similarity=0.231 Sum_probs=206.8
Q ss_pred CCceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~-----d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++++.||+|+||+||+|+ +..+++.||||++... ......+.+|+.+++.+ .||||++++++
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~ 101 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-------NHQNIVRCIGV 101 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-------CCCCCCeEEEE
Confidence 3899999999999999999998 5567889999999743 44556788899999998 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhc-----CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCe
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHF-----RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~-----~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
+...+..||||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.+.....
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 999999999999996 699999987542 34899999999999999999999999999999999999975555667
Q ss_pred EEEeecccccccCC-----ccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q 003438 255 IKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 255 iKL~DFGlA~~~~~-----~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~~ 328 (820)
+||+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......+.+..+...
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 99999999863321 2234467889999999998899999999999999999998 99999887765544433221
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
.. + +.
T Consensus 262 ~~--~------------------------------------------------------------------------~~- 266 (327)
T 2yfx_A 262 GR--M------------------------------------------------------------------------DP- 266 (327)
T ss_dssp CC--C------------------------------------------------------------------------CC-
T ss_pred CC--C------------------------------------------------------------------------CC-
Confidence 00 0 00
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
...++..+.+||.+||..||++|||+.|+++|.|+..
T Consensus 267 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 267 ----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0013467899999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=370.93 Aligned_cols=258 Identities=28% Similarity=0.374 Sum_probs=196.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.+.|.+.++||+|+||+||.+ ...+++.||||++..+. .+.+.+|+++|+++. .|||||++++++...+.+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~------~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESD------DHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHT------TSTTBCCEEEEEECSSEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhcc------CCCCcCeEEEEEecCCeE
Confidence 367888899999999999875 45679999999997543 456788999998873 589999999999999999
Q ss_pred EEEEeccCCChHHHHHhhhcCC-----CCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc----------cCC
Q 003438 188 CICFELLDSNLYELIKINHFRG-----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS----------VKP 252 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~-----l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~----------~~~ 252 (820)
|||||||+++|.+++....... .++..++.++.||+.||+|||++|||||||||+|||++.+ ...
T Consensus 85 ~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 85 YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 9999999999999997653211 1333467899999999999999999999999999999643 245
Q ss_pred CeEEEeecccccccCCc-------cccccccccccCcccccc-------ccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 253 AEIKIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~-------~~~~~gt~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
..+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 68999999999755432 224578999999999976 578999999999999999999 999997544
Q ss_pred HHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccch
Q 003438 318 EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKH 397 (820)
Q Consensus 318 ~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~ 397 (820)
..+ ..+.+..- .. ..
T Consensus 245 ~~~--~~i~~~~~-~~---------------------~~----------------------------------------- 259 (434)
T 2rio_A 245 SRE--SNIIRGIF-SL---------------------DE----------------------------------------- 259 (434)
T ss_dssp THH--HHHHHTCC-CC---------------------CC-----------------------------------------
T ss_pred hhH--HHHhcCCC-Cc---------------------cc-----------------------------------------
Confidence 322 11111000 00 00
Q ss_pred hHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 398 LEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 398 L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
...+ ....++.++.+||.+||+.||++|||+.|+|+||||..
T Consensus 260 ----------~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 260 ----------MKCL------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp ----------CTTC------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred ----------cccc------ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 0000 01235678999999999999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.86 Aligned_cols=200 Identities=24% Similarity=0.344 Sum_probs=172.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh----h----HHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----Y----YQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~----~----~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
.++|++.+.||+|+||+||+|++..+++.||||++..... . .+.+.+|+.+++.+ .|+||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~ 90 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-------NHPNIVKLYG 90 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-------CCTTBCCEEE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-------CCCCchhhhe
Confidence 3899999999999999999999999999999999864321 1 15678899999888 6899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCccccccc--CCCe
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSV--KPAE 254 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~--~~~~ 254 (820)
++.... ++||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+. ....
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 987654 79999998 68988887654 46999999999999999999999999 99999999999996321 1224
Q ss_pred EEEeecccccccCCccccccccccccCccccc--cccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 255 IKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL--GYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 255 iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~--~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
+||+|||++...........+|+.|+|||++. ...++.++|||||||++|+|++|+.||....
T Consensus 168 ~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp EEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 99999999987777777778999999999994 4568899999999999999999999997654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.79 Aligned_cols=205 Identities=16% Similarity=0.185 Sum_probs=171.2
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCC-----CeEEEEEEEeCChhhHHHHHHHHHHHHHHhh--------hcCCCCCCc
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQPAYYQQALVEVSILTTLNK--------KYDREDKHH 173 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~t-----g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~--------~~~~~~Hpn 173 (820)
..++|++.++||+|+||+||+|++..+ ++.||||++.... ....+|+++++++.+ ......|+|
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 347999999999999999999988664 5789999998654 245567777776644 123457999
Q ss_pred eeEEeEEEeec----ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 174 IVRIYEYFVCQ----RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 174 IVkl~d~f~~~----~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
|+++++++... .+.||||||++++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+||||+.+
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 99999999875 5689999999779999987643 569999999999999999999999999999999999999632
Q ss_pred cCCCeEEEeecccccccCCc----------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 250 VKPAEIKIIDFGSACTEDRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~~~~----------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
..+.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 189 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 189 -NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp -CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred -CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 5688999999999644321 12345899999999999999999999999999999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.72 Aligned_cols=199 Identities=25% Similarity=0.259 Sum_probs=162.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
.+|++.++||+|+||+|+. ....+++.||||++..... ..+.+|+++|+++. .|||||++++++.....+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~------~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESD------EHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSC------CCTTBCCEEEEEEETTEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhcc------CCCCcCeEEEEEecCCEEE
Confidence 5799999999999999764 3456789999999975422 23567999999873 5999999999999999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc--CCCeEEEeeccccccc
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~iKL~DFGlA~~~ 266 (820)
||||||.++|.+++.... ..+.+..++.++.||+.||+|||++|||||||||+||||+.++ ....+||+|||++...
T Consensus 95 lv~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEEECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EEEECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 999999999999998654 3355666789999999999999999999999999999996432 3346889999999755
Q ss_pred CC------ccccccccccccCcccccc---ccccccchhHhHHHHHHHHHh-CCCCCCCCC
Q 003438 267 DR------TVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFL-GLPLFPGAS 317 (820)
Q Consensus 267 ~~------~~~~~~gt~~Y~APEvl~~---~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s 317 (820)
.. .....+||+.|+|||++.+ ..++.++||||||||+|||++ |..||....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 42 2334579999999999984 467889999999999999999 999996543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=342.01 Aligned_cols=205 Identities=22% Similarity=0.357 Sum_probs=178.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.+.||+|+||.||+|++. +++.||||+++......+.+.+|+++++.+ .||||+++++++...+..+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-------SHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-------CCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-------CCCCEeeEEEEEccCCCeE
Confidence 78999999999999999999876 577899999997665567888999999988 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBC
T ss_pred EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccc
Confidence 9999997 58999887653 4689999999999999999999999999999999999995 56789999999997553
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i 218 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 321 23356778999999998899999999999999999999 89999887765554443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=348.12 Aligned_cols=202 Identities=23% Similarity=0.340 Sum_probs=171.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCC-------eEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg-------~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
.++|++.++||+|+||+||+|++..++ ..||+|+++.. ....+.+.+|+.+++.+ .||||+++++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~ 79 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-------SHKHLVLNYG 79 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-------CCTTBCCEEE
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-------CCCCEeEEEE
Confidence 489999999999999999999988777 57999999754 34567788999999998 6899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC-----CC
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK-----PA 253 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~-----~~ 253 (820)
++...+..+|||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.+.. ..
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 9999999999999998 69999987654 34999999999999999999999999999999999999963321 12
Q ss_pred eEEEeecccccccCCccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhC-CCCCCCCCH
Q 003438 254 EIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLG-LPLFPGASE 318 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG-~~PF~~~s~ 318 (820)
.+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++| .+||.....
T Consensus 159 ~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp EEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 2999999999765443 34467889999999988 6799999999999999999995 555554443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.37 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=151.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++++.||+|+||.||+|+++.+++.||||+++.. ......+..|+..+.+ ...||||+++++++...+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~------~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR------SSDCPYIVQFYGALFREG 94 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHS------SCCCTTBCCEEEEEECSS
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHH------cCCCCcEeeeeeEEEeCC
Confidence 38999999999999999999999999999999999864 2333445555553222 227999999999999999
Q ss_pred eeEEEEeccCCChHHHHHhh---hcCCCCHHHHHHHHHHHHHHhhhcccC-CeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 186 HLCICFELLDSNLYELIKIN---HFRGLSLSIVQLFSKQILRGLSLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~---~~~~l~e~~i~~I~~QIl~aL~yLHs~-gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+|||||+.++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg 171 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCC
Confidence 99999999999988887642 235699999999999999999999998 999999999999996 67899999999
Q ss_pred cccccCCc--cccccccccccCcccc----ccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 262 SACTEDRT--VYSYIQSRYYRSPEVL----LGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 262 lA~~~~~~--~~~~~gt~~Y~APEvl----~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++...... .....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp SSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred CceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99765432 2234789999999999 4557899999999999999999999999754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=369.05 Aligned_cols=201 Identities=22% Similarity=0.399 Sum_probs=173.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++.++||+|+||+||+|++..+++.||||+++... ...+.+.+|+++|+++ .|+||+++++++...+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-------NHKNIVKLFAIEEETT 80 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEECTT
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-------CCCCCCeEEEeeccCC
Confidence 379999999999999999999999999999999998532 3356778899999998 6899999999998765
Q ss_pred --eeEEEEeccC-CChHHHHHhhhc-CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc-ccCCCeEEEeec
Q 003438 186 --HLCICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT-SVKPAEIKIIDF 260 (820)
Q Consensus 186 --~l~LVmEy~~-gsL~d~l~~~~~-~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~-~~~~~~iKL~DF 260 (820)
..|||||||. ++|.+++..... ..+++..++.++.||+.||+|||++|||||||||+|||+.. ++..+.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 7899999997 589998876542 23999999999999999999999999999999999999832 235667999999
Q ss_pred ccccccCCc--cccccccccccCcccccc--------ccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 261 GSACTEDRT--VYSYIQSRYYRSPEVLLG--------YQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 261 GlA~~~~~~--~~~~~gt~~Y~APEvl~~--------~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
|+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999765432 334578999999999875 5788999999999999999999999964
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.30 Aligned_cols=203 Identities=27% Similarity=0.375 Sum_probs=176.0
Q ss_pred CceEEEEEeccCCceeEEEee-----ccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCW-----DAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~-----d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.+.||+|+||+||+|+ +..+++.||||+++... ...+.+.+|+.+|+++. .||||+++++++
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~i~~~~~~~ 96 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG------NHMNIVNLLGAC 96 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc------cCCCeeeEEEEE
Confidence 799999999999999999997 45678899999998542 44577889999999994 589999999999
Q ss_pred eecceeEEEEeccCC-ChHHHHHhhhc----------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 182 VCQRHLCICFELLDS-NLYELIKINHF----------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 182 ~~~~~l~LVmEy~~g-sL~d~l~~~~~----------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
...+..++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 999999999999975 99999886542 1489999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ .++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 177 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 177 LLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEc---CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 996 67899999999997554332 23356788999999999899999999999999999999 9999987654
Q ss_pred HH
Q 003438 319 FD 320 (820)
Q Consensus 319 ~d 320 (820)
..
T Consensus 254 ~~ 255 (313)
T 1t46_A 254 DS 255 (313)
T ss_dssp SH
T ss_pred hh
Confidence 33
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=347.91 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=169.3
Q ss_pred CCceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~----d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|+++++||+|+||+||+|+ +..+++.||||+++.. ....+.+.+|+++|+.+ .||||+++++++.
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-------QHDNIVKYKGVCY 81 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe
Confidence 3899999999999999999998 6778999999999864 44556788999999998 6899999999987
Q ss_pred ec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.. ..++|||||+. ++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~D 157 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGD 157 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEcc
Confidence 54 46899999996 59999987654 3599999999999999999999999999999999999996 668899999
Q ss_pred cccccccCCc------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 260 FGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 260 FGlA~~~~~~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 9999754322 1223467789999999999999999999999999999999999854
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=343.85 Aligned_cols=203 Identities=27% Similarity=0.450 Sum_probs=163.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|++.++||+|+||+||+|++. ++.||||+++... ...+.+.+|+++++.+ .||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-------KHPNIIALRGVCL 76 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-------CCTTBCCEEEEEC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-------CCCCEeeEEEEEe
Confidence 379999999999999999999864 8899999987532 2346778899999998 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC---eeeccCCCCCccccccc-----CCC
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG---IIHCDLKPENILLCTSV-----KPA 253 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g---IVHrDLKPeNILl~~~~-----~~~ 253 (820)
..+..|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++... ..+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred cCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCc
Confidence 9999999999997 577777643 46999999999999999999999999 99999999999996422 267
Q ss_pred eEEEeecccccccCCc-cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHH
Q 003438 254 EIKIIDFGSACTEDRT-VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLL 322 (820)
Q Consensus 254 ~iKL~DFGlA~~~~~~-~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l 322 (820)
.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 154 ~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (271)
T 3dtc_A 154 ILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223 (271)
T ss_dssp CEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH
T ss_pred ceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 8999999999754332 23457899999999999989999999999999999999999999877655443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=356.32 Aligned_cols=204 Identities=24% Similarity=0.383 Sum_probs=173.0
Q ss_pred CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.+.||+|+||+||+|++ ..+++.||||+++.. ....+.+.+|+.+|+++. .||||++++++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~ 117 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG------SHENIVNLLGA 117 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc------CCCCeeeEEEE
Confidence 38999999999999999999986 346778999999753 234467889999999994 58999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhc---------------------CCCCHHHHHHHHHHHHHHhhhcccCCeeecc
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHF---------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCD 238 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~---------------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrD 238 (820)
+...+.+||||||+. ++|.+++..... ..+++..++.++.||+.||+|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999997 599999976532 2379999999999999999999999999999
Q ss_pred CCCCCcccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCC
Q 003438 239 LKPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPL 312 (820)
Q Consensus 239 LKPeNILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~P 312 (820)
|||+|||++ .++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 198 ikp~NIll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 198 LAARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp CSGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CChhhEEEc---CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999996 6789999999999754322 223456788999999999899999999999999999998 9999
Q ss_pred CCCCCHHH
Q 003438 313 FPGASEFD 320 (820)
Q Consensus 313 F~~~s~~d 320 (820)
|.+....+
T Consensus 275 ~~~~~~~~ 282 (344)
T 1rjb_A 275 YPGIPVDA 282 (344)
T ss_dssp STTCCCSH
T ss_pred cccCCcHH
Confidence 98765433
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=352.55 Aligned_cols=207 Identities=25% Similarity=0.335 Sum_probs=176.6
Q ss_pred CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.+.||+|+||+||+|++. .+++.||||++.... .....+.+|+.+++.+ .|+||+++++++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~ 97 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-------NCHHVVRLLGVV 97 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-------CCTTBCCEEEEE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-------CCCCEeeeEEEE
Confidence 79999999999999999999876 467899999997542 3445678899998888 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhc--------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHF--------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~--------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
...+..++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---ED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CC
Confidence 99999999999997 599998876431 3579999999999999999999999999999999999996 66
Q ss_pred CeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 253 AEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 88999999999754322 123356788999999998899999999999999999999 89999877765544433
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=346.29 Aligned_cols=205 Identities=24% Similarity=0.385 Sum_probs=165.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|++.++||+|+||+||+|++..+ +..||||+++.. ....+.+.+|+.+++.+ .||||+++++++.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-------DHPHIVKLIGVIT 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCccceEEEEEc
Confidence 37999999999999999999987653 567999998753 34456788899999888 6899999999984
Q ss_pred ecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
++..|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg 161 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFG 161 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC--
T ss_pred -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccc
Confidence 5678999999985 8999887653 4599999999999999999999999999999999999996 56899999999
Q ss_pred cccccCCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 262 SACTEDRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 262 lA~~~~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
++....... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~ 229 (281)
T 1mp8_A 162 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred cccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH
Confidence 997554321 23356778999999998899999999999999999997 9999987665544433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=377.58 Aligned_cols=205 Identities=20% Similarity=0.341 Sum_probs=181.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..+|++.++||+|+||+||+|+++.+++.||||+++......+.+.+|+.+|+++ .|||||++++++...+.+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-------CCCCEeeEEEEEecCCcE
Confidence 3789999999999999999999999999999999987766678899999999999 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
||||||+. ++|.++++......+++..++.++.||+.||+|||+++||||||||+||||+ .++.+||+|||+++..
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccceec
Confidence 99999998 6999999876556699999999999999999999999999999999999995 5678999999999765
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
.... ....++..|+|||++....++.++|||||||+||||++ |..||.+.+..+..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4322 12345678999999998899999999999999999999 99999876654433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=369.44 Aligned_cols=203 Identities=25% Similarity=0.365 Sum_probs=174.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc-e
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR-H 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~-~ 186 (820)
.++|+++++||+|+||+||++.+. ++.||||+++... ..+.+.+|+.+|+++ .||||+++++++...+ .
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC-------CCTTBCCEEEEEECTTSC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc-------cCCCEEEEEEEEEcCCCc
Confidence 378999999999999999999764 7799999998654 456788999999998 6899999999987765 7
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+||||||+. ++|.+++.......+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC---CCCCEEEeeCCCccc
Confidence 999999997 5999999876544589999999999999999999999999999999999995 678999999999986
Q ss_pred cCCccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 266 EDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 266 ~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
.........++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+.
T Consensus 339 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 339 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp CC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred ccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 6554444567889999999999999999999999999999998 999998765544433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.46 Aligned_cols=242 Identities=26% Similarity=0.385 Sum_probs=190.8
Q ss_pred CceEEE-EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 109 RRYIVK-DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 109 ~rY~i~-~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
++|.++ ++||+|+||.||+|++..+++.||||+++.. ....+|+.++.++. .|+||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~------~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS------QCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT------TSTTBCCEEEEEEEEETT
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc------cCCCchhHHhhhhhhcCC
Confidence 678887 7899999999999999999999999999864 34667888886653 68999999999987
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
...+||||||+.+ +|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 7789999999974 999999876555799999999999999999999999999999999999997544478899999999
Q ss_pred ccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 263 ACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 263 A~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
+.... +..++.++|||||||++|+|++|+.||......+....+..
T Consensus 167 a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~--------------- 212 (299)
T 3m2w_A 167 AKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--------------- 212 (299)
T ss_dssp CEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC---------------
T ss_pred ccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH---------------
Confidence 85432 24678899999999999999999999976443211000000
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
... .. ...+. ......+
T Consensus 213 -------~~~--------------~~---------------------~~~~~---------------------~~~~~~~ 229 (299)
T 3m2w_A 213 -------RIR--------------MG---------------------QYEFP---------------------NPEWSEV 229 (299)
T ss_dssp -------SSC--------------TT---------------------CCSSC---------------------HHHHTTS
T ss_pred -------HHh--------------hc---------------------cccCC---------------------chhcccC
Confidence 000 00 00000 0011224
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++.+.+||.+||..||++|||++|+|+||||++..
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 57899999999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.35 Aligned_cols=192 Identities=27% Similarity=0.353 Sum_probs=171.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-----
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC----- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~----- 183 (820)
.+|++++.||+|+||.||+|++..+++.||||+++... +.+.+|+++++.+ .||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-------~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-------DHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-------CCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-------CCCCEEEEeeeEeccccCc
Confidence 78999999999999999999999999999999998654 3456899999998 68999999999865
Q ss_pred -----------cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 184 -----------QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 184 -----------~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
...+++||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~ 157 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---D 157 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---E
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---C
Confidence 4568999999985 999999876656799999999999999999999999999999999999996 6
Q ss_pred CCeEEEeecccccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCC
Q 003438 252 PAEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
++.+||+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 221 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221 (284)
T ss_dssp TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence 67899999999865433 234457899999999999989999999999999999999998877
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=350.82 Aligned_cols=208 Identities=25% Similarity=0.398 Sum_probs=176.6
Q ss_pred CceEEEEEeccCCceeEEEeecc-------CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-------~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
++|++.+.||+|+||+||+|++. .+++.||||+++.. ....+.+.+|+++++.+. .||||+++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~ 108 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG------KHKNIINLLG 108 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEE
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh------cCCCEeeEEE
Confidence 89999999999999999999865 45778999999854 345567889999999994 5899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhhc--------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~--------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
++...+.+||||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999997 599999886531 2489999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ .++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 189 ll~---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 189 LVT---ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EEC---TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEc---CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 995 6788999999999754432 123356788999999998899999999999999999999 9999988776
Q ss_pred HHHHHHH
Q 003438 319 FDLLRRM 325 (820)
Q Consensus 319 ~d~l~~I 325 (820)
.+....+
T Consensus 266 ~~~~~~~ 272 (334)
T 2pvf_A 266 EELFKLL 272 (334)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5554443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.22 Aligned_cols=205 Identities=25% Similarity=0.406 Sum_probs=176.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++++.||+|+||+||+|++. +++.||||+++......+.+.+|+++|+.+ .|+||+++++++. .+..+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-------QHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEC-SSSCE
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-------CCcCcceEEEEEc-CCCcE
Confidence 79999999999999999999865 567899999987665667889999999998 6899999999986 45689
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc---CCCCEEECCCccccccc
Confidence 9999996 6999998765444699999999999999999999999999999999999995 67889999999997654
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 322 22345778999999998899999999999999999999 99999887766554443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=369.35 Aligned_cols=207 Identities=26% Similarity=0.386 Sum_probs=180.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.++||+|+||+||+|++. ++..||||+++......+.+.+|+.+|+.| .||||+++++++. .+.+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-------QHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-------CCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-------CCCCEeeEEEEEe-CCcc
Confidence 378999999999999999999875 467899999997666678899999999988 6899999999986 6689
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
||||||+. ++|.+++.......+++..++.++.||+.||+|||+++||||||||+||||+ .++.+||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC---TTCCEEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC---CCCcEEEeeCCCceEc
Confidence 99999997 6999999866545689999999999999999999999999999999999995 6789999999999765
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~ 326 (820)
.... ....++..|+|||++....++.++|||||||+||||++ |+.||.+.+..+.+..+.
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 399 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 4322 12345678999999998899999999999999999999 999999887766665543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.78 Aligned_cols=187 Identities=24% Similarity=0.339 Sum_probs=159.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--- 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--- 184 (820)
.++|+++++||+|+||+||+|++ +++.||||++.... .....+|.+++..+. ..||||+++++++...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~-----l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM-----LRHENILGFIASDMTSRHS 77 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC-----CCCTTBCCEEEEEEEEETT
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh-----ccCcCeeeEEEeeccccCC
Confidence 38999999999999999999976 68999999997543 355667888777742 2699999999987653
Q ss_pred -ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc--------cCCeeeccCCCCCcccccccCCCe
Q 003438 185 -RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--------DAGIIHCDLKPENILLCTSVKPAE 254 (820)
Q Consensus 185 -~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH--------s~gIVHrDLKPeNILl~~~~~~~~ 254 (820)
..+||||||+. ++|.++++. ..+++..++.++.||+.||+||| +++|+||||||+|||++ .++.
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~---~~~~ 151 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK---KNGQ 151 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---TTSC
T ss_pred CceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---CCCC
Confidence 56899999998 599999854 35999999999999999999999 99999999999999996 6789
Q ss_pred EEEeecccccccCCc-------cccccccccccCccccccc------cccccchhHhHHHHHHHHHhC
Q 003438 255 IKIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLG 309 (820)
Q Consensus 255 iKL~DFGlA~~~~~~-------~~~~~gt~~Y~APEvl~~~------~yt~ksDIWSLG~ILyeLltG 309 (820)
+||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg 219 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence 999999999643322 1234789999999999877 567899999999999999999
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.91 Aligned_cols=195 Identities=26% Similarity=0.351 Sum_probs=169.1
Q ss_pred CceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~----d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|+++++||+|+||.||+|+ +..+++.||||+++.. ....+.+.+|+++|+.+ .|+||+++++++.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-------YHENIVKYKGICT 93 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-------CCTTBCCEEEEEE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-------CCCCeeeeeeEEe
Confidence 789999999999999999998 6788999999999753 23456788999999998 5899999999998
Q ss_pred ec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.. ..+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~D 169 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGD 169 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECc
Confidence 77 67899999997 49999986654 4699999999999999999999999999999999999996 567999999
Q ss_pred cccccccCCc------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 260 FGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 260 FGlA~~~~~~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
||++...... .....+|..|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 9999754432 223467888999999999999999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=358.28 Aligned_cols=196 Identities=14% Similarity=0.166 Sum_probs=168.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCC--------CeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeE---
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEM--------NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVR--- 176 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~t--------g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVk--- 176 (820)
.++|++.+.||+|+||+||+|++..+ ++.||||++... +.+.+|+++++++ .|+||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-------~h~niv~~~~ 109 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-------AKPLQVNKWK 109 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-------CCHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-------cccchhhhhh
Confidence 48999999999999999999998874 889999999865 3567899999998 4566665
Q ss_pred ------------EeEEEee-cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCC
Q 003438 177 ------------IYEYFVC-QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN 243 (820)
Q Consensus 177 ------------l~d~f~~-~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN 243 (820)
+++++.. .+..||||||++++|.+++.......+++.+++.++.||+.||+|||++||+||||||+|
T Consensus 110 ~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 7788776 678999999998899999987644679999999999999999999999999999999999
Q ss_pred cccccccCCC--eEEEeecccccccCCc----------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCC
Q 003438 244 ILLCTSVKPA--EIKIIDFGSACTEDRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 244 ILl~~~~~~~--~iKL~DFGlA~~~~~~----------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
||++ .++ .+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 190 Il~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 190 IFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp EEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred EEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9996 445 8999999999654322 123478999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 003438 312 LFPGAS 317 (820)
Q Consensus 312 PF~~~s 317 (820)
||....
T Consensus 267 pf~~~~ 272 (352)
T 2jii_A 267 PWTNCL 272 (352)
T ss_dssp TTGGGT
T ss_pred CcccCC
Confidence 997653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.19 Aligned_cols=198 Identities=16% Similarity=0.200 Sum_probs=159.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCChhhH------------HHHHHHHHHHHHHhhhcCCCCCC
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQPAYY------------QQALVEVSILTTLNKKYDREDKH 172 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~---tg~~VAIKiik~~~~~~------------~~~~~Ei~iL~~L~~~~~~~~Hp 172 (820)
.++|++.++||+|+||+||+|++.. ++..||||++....... ..+.+|+.+++.+ .|+
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-------~h~ 108 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-------DYL 108 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-------SCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-------ccc
Confidence 3799999999999999999999887 78899999998653211 1123344444443 799
Q ss_pred ceeEEeEEEee----cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc
Q 003438 173 HIVRIYEYFVC----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248 (820)
Q Consensus 173 nIVkl~d~f~~----~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~ 248 (820)
||+++++++.. ...+||||||++++|.+++.... .+++.+++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 109 ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 109 GIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp CCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES
T ss_pred CcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc
Confidence 99999999988 78999999999779999887654 6999999999999999999999999999999999999963
Q ss_pred ccCCCeEEEeecccccccCCc----------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 249 SVKPAEIKIIDFGSACTEDRT----------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 249 ~~~~~~iKL~DFGlA~~~~~~----------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
+ ..+.+||+|||+++..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 187 ~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 187 K-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp S-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred C-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 2 2238999999999644221 1345789999999999999999999999999999999999999964
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.64 Aligned_cols=200 Identities=24% Similarity=0.388 Sum_probs=164.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeE----EEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~----VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|+++++||+|+||+||+|++..+++. ||+|+++.. ....+.+.+|+.+++++ .||||+++++++.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~ 87 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGICL 87 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-------CBTTBCCEEEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-------CCCCEeEEEEEEe
Confidence 7999999999999999999998877765 577777532 24456788999999999 6899999999998
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
... .++|+|++. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg 162 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFG 162 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTT
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCc
Confidence 765 778888886 68999887654 4699999999999999999999999999999999999996 66889999999
Q ss_pred cccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 262 SACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 262 lA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+++..... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 99654322 123355778999999999999999999999999999999 999998765544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.68 Aligned_cols=203 Identities=16% Similarity=0.188 Sum_probs=173.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~- 184 (820)
++|++.++||+|+||+||+|++. ++.||||+++.. ....+.+.+|+.+++++ .||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-------SHPNVLPVLGACQSPP 80 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-------SCTTEECEEEEECTTT
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-------CCCchhheEEEEccCC
Confidence 79999999999999999999874 889999999854 34455677888887776 699999999999887
Q ss_pred -ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 -RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 -~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
+..++||||+. ++|.+++.......+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~---~~~~~~l~~~ 157 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMA 157 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC---TTSCEEEEGG
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc---CCcceeEEec
Confidence 78999999998 59999998765446999999999999999999999999 99999999999995 6678899988
Q ss_pred ccccccCCccccccccccccCccccccccccc---cchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 261 GSACTEDRTVYSYIQSRYYRSPEVLLGYQYTT---AIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 261 GlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~---ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
+++..... ....+|+.|+|||++.+..++. ++|||||||++|||++|+.||...+..+....+
T Consensus 158 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 158 DVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223 (271)
T ss_dssp GSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred cceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence 88754322 3457899999999998775554 899999999999999999999887766554443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.52 Aligned_cols=199 Identities=26% Similarity=0.361 Sum_probs=165.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec-cee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ-RHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~-~~l 187 (820)
++|++.+.||+|+||+||++++ +++.||||+++... ..+.+.+|+++++.+ .|+||+++++++... +.+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTC-------CCTTBCCEEEEECCC--CC
T ss_pred hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcCCCce
Confidence 7999999999999999999976 48899999998653 456788899999888 689999999997654 579
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|+||||+.+ +|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe---CCCcEEEeeccccccc
Confidence 999999985 999999876544589999999999999999999999999999999999995 6689999999999766
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
........+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred cccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 655555677889999999998899999999999999999998 999997655433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=339.17 Aligned_cols=203 Identities=26% Similarity=0.344 Sum_probs=171.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|++.+.||+|+||+||+|++.. ++..||||+++.. ....+.+.+|+.+++.+ .||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-------DHPHIVKLIGIIE 83 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-------CCTTBCCEEEEEC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-------CCCCcceEEEEEc
Confidence 3799999999999999999998543 4567999999864 34567788999999999 6899999999986
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
. +..|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg 158 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFG 158 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCC
T ss_pred C-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccC
Confidence 5 46789999998 58999887653 4599999999999999999999999999999999999996 56799999999
Q ss_pred cccccCCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 262 SACTEDRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 262 lA~~~~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~ 224 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH
Confidence 997554322 23356788999999998899999999999999999998 99999765554443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=351.03 Aligned_cols=205 Identities=24% Similarity=0.318 Sum_probs=173.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEE--EEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFV--AVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~V--AIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.+.||+|+||.||+|++..+++.+ |||+++.. ....+.+.+|+++|+++. .||||+++++++...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHR 98 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC------CCTTBCCEEEEEEET
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc------CCCchhhhceeeeeC
Confidence 79999999999999999999999888865 99999753 334556788999988873 589999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 185 RHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
+.+||||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-- 176 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-- 176 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc--
Confidence 99999999997 59999987643 23699999999999999999999999999999999999995
Q ss_pred cCCCeEEEeecccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 250 VKPAEIKIIDFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
.++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus 177 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 177 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred -CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 5678999999999644322 223356788999999998899999999999999999998 99999877655443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=346.13 Aligned_cols=202 Identities=27% Similarity=0.398 Sum_probs=172.9
Q ss_pred CCceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.+.||+|+||+||+|++ ..+++.||||+++.. ....+.+.+|+.+++.+. .||||++++++
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~hp~iv~~~~~ 99 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGA 99 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc------cCCCeeeEEEE
Confidence 37999999999999999999983 467789999999864 334567889999999994 48999999999
Q ss_pred Eeecc-eeEEEEeccC-CChHHHHHhhhc--------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 181 FVCQR-HLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 181 f~~~~-~l~LVmEy~~-gsL~d~l~~~~~--------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
+...+ .+++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 88765 5999999998 599999876542 1288999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ ..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 180 l~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EEC---GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EEC---CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 995 5678999999999754322 223466889999999999999999999999999999998 9999976553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.81 Aligned_cols=198 Identities=24% Similarity=0.405 Sum_probs=166.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.+ .||||+++++++..+
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-------QEPHVVPIHDFGEID 106 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEET
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-------CCCCeeEEEEEEeeC
Confidence 7999999999999999999999999999999999753 23346778899998887 689999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIA 181 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC-
T ss_pred CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccC
Confidence 999999999985 999988765 3699999999999999999999999999999999999996 5678999999998
Q ss_pred cccCCc----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 264 CTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 264 ~~~~~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred ccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 654332 2345789999999999999999999999999999999999999987554
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=355.20 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=168.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeE----EEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~----VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.++|+++++||+|+||+||+|++..+++. ||+|++.... ...+.+.+|+.+++.+ .|+||+++++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~ 84 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-------DHAHIVRLLGLC 84 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-------CCTTBCCEEEEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-------CCCCcCeEEEEE
Confidence 47999999999999999999998887765 7777775332 2234566788888887 689999999988
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
. .+..++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+||
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Df 159 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADF 159 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES---SSSCEEECSC
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC---CCCeEEECCC
Confidence 6 567899999997 69999887653 4589999999999999999999999999999999999995 6788999999
Q ss_pred ccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHH
Q 003438 261 GSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLL 322 (820)
Q Consensus 261 GlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l 322 (820)
|+++..... .....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 227 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence 999754322 233466788999999998899999999999999999999 99999876654443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=371.43 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=176.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|+++++||+|+||+||+|++..+++.||||+++.... ...+.+|+++++.|.+ +++|+.+..++...+..
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~------~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQG------GTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTT------STTCCCEEEEEEETTEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcC------CCCCCeEEEEEeeCCEE
Confidence 3899999999999999999999999999999999875432 2457789999999953 56777777788888899
Q ss_pred EEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 188 CICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 188 ~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||||||++++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+||||+..+..+.+||+|||+++...
T Consensus 79 ~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999889999997543 469999999999999999999999999999999999999655577899999999996543
Q ss_pred Ccc----------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 268 RTV----------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 268 ~~~----------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
... ...++|+.|+|||++.+..++.++||||||||||||++|+.||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 321 256789999999999999999999999999999999999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=354.59 Aligned_cols=191 Identities=23% Similarity=0.292 Sum_probs=155.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
.++|+++++||+|+||+||+|++ +++.||||+++.... ..+..|.+++.. ....|+||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~-----~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR--QNFINEKNIYRV-----PLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH--HHHHHHHHHHTS-----TTCCCTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch--hhHHHHHHHHHH-----HhccCcchhhheecccccccC
Confidence 38999999999999999999965 689999999985433 334444444332 12379999999986543
Q ss_pred -cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC---------CeeeccCCCCCcccccccCC
Q 003438 184 -QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA---------GIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 184 -~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~---------gIVHrDLKPeNILl~~~~~~ 252 (820)
...+||||||+. ++|.+++.... +++..++.++.||+.||+|||++ +||||||||+||||+ .+
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~---~~ 156 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK---ND 156 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---TT
T ss_pred CCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---CC
Confidence 246899999996 59999987653 68999999999999999999999 999999999999996 66
Q ss_pred CeEEEeecccccccCC-----------ccccccccccccCcccccc-------ccccccchhHhHHHHHHHHHhCCCCC
Q 003438 253 AEIKIIDFGSACTEDR-----------TVYSYIQSRYYRSPEVLLG-------YQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~-----------~~~~~~gt~~Y~APEvl~~-------~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
+.+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 8999999999965432 1224478999999999987 46778999999999999999996555
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=339.79 Aligned_cols=204 Identities=23% Similarity=0.320 Sum_probs=172.4
Q ss_pred CceEEEE-EeccCCceeEEEeec--cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKD-LLGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~-~LG~G~fG~Vyka~d--~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++|.+.+ .||+|+||+||+|.+ ..+++.||||+++.. ....+.+.+|+++++.+ .||||+++++++ .
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-------DNPYIVRLIGVC-Q 80 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEE-E
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-------CCCCEeEEEEEe-c
Confidence 6788887 999999999999975 356889999999863 45567788999999998 689999999999 5
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~ 156 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGL 156 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccc
Confidence 5679999999985 8888886443 4599999999999999999999999999999999999996 568999999999
Q ss_pred ccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 263 ACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 263 A~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 225 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 97543221 22345788999999998899999999999999999998 9999987766554443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=346.32 Aligned_cols=205 Identities=24% Similarity=0.348 Sum_probs=175.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCe-----EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNS-----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~-----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++.+.||+|+||+||+|.+..+++ .||||+++.. ....+.+.+|+.+|+.+. .||||++++++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~h~~iv~~~~~ 118 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG------QHENIVNLLGA 118 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc------CCCCeeeEEEE
Confidence 3799999999999999999999876654 7999999854 345567889999999994 48999999999
Q ss_pred EeecceeEEEEeccCC-ChHHHHHhhh------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccc
Q 003438 181 FVCQRHLCICFELLDS-NLYELIKINH------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLC 247 (820)
Q Consensus 181 f~~~~~l~LVmEy~~g-sL~d~l~~~~------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~ 247 (820)
+...+.+||||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 9999999999999975 9999987653 23589999999999999999999999999999999999996
Q ss_pred cccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 248 TSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 248 ~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 199 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 199 ---NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp ---GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred ---CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 5678999999999754322 123356778999999999899999999999999999998 9999987654333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.34 Aligned_cols=197 Identities=28% Similarity=0.401 Sum_probs=172.1
Q ss_pred CCceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~----d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|+++++||+|+||+||+|+ +..+++.||||++... ....+.+.+|+++|+.+ .|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~ 94 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-------HSDFIVKYRGVSY 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-------CCCceeEEEEEEe
Confidence 3899999999999999999998 6788999999999864 34456788999999998 6899999999987
Q ss_pred --ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 --CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 --~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
....+||||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~D 170 (327)
T 3lxl_A 95 GPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIAD 170 (327)
T ss_dssp CSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECC
T ss_pred cCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcc
Confidence 4567999999996 68999987654 3599999999999999999999999999999999999996 678899999
Q ss_pred cccccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 260 FGlA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||++....... ....+|..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 99997543221 234577889999999999999999999999999999999999964
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.44 Aligned_cols=203 Identities=27% Similarity=0.405 Sum_probs=172.0
Q ss_pred CceEEEE-EeccCCceeEEEe--eccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKD-LLGHGTFGQVAKC--WDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~-~LG~G~fG~Vyka--~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|++.+ .||+|+||+||+| .+..+++.||||+++.. ....+.+.+|+.+++.+ .||||+++++++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~~- 87 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-------DNPYIVRMIGIC- 87 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-------CCTTBCCEEEEE-
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEE-
Confidence 7899998 9999999999999 45677899999999854 23456788999999988 689999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+..++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg 162 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFG 162 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCT
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCC
Confidence 5678899999998 5899988764 3599999999999999999999999999999999999996 56799999999
Q ss_pred cccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 262 SACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 262 lA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 232 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 996543321 12345688999999998899999999999999999999 9999988776554433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.91 Aligned_cols=208 Identities=22% Similarity=0.314 Sum_probs=171.6
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
...+|++.++||+|+||+||+|++..++ ..||||+++.. ......+.+|+.+++.+ .||||++++++
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~ 114 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-------SHHNIIRLEGV 114 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEE
Confidence 3489999999999999999999876543 46999999853 34455688899999888 68999999999
Q ss_pred EeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 181 FVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 181 f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+...+..+|||||+.+ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kl~D 190 (333)
T 1mqb_A 115 ISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSD 190 (333)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECC
T ss_pred EecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC---CCCcEEECC
Confidence 9999999999999985 8998887643 4699999999999999999999999999999999999995 678999999
Q ss_pred cccccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 260 FGlA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 99997543321 12245778999999998899999999999999999998 99999877765554443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=345.78 Aligned_cols=196 Identities=23% Similarity=0.343 Sum_probs=167.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC-ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~-~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
++|+++++||+|+||.||+|++..+++.||||++.. .....+.+.+|+.+++.+ .||||+++++++..
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-------NHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEEEEEETT
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-------CCCCeeeEEEEEEeccCC
Confidence 799999999999999999999999999999999864 345567788999999888 68999999999973
Q ss_pred cceeEEEEeccCC-ChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 184 QRHLCICFELLDS-NLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
....|+||||+.+ +|.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~---~~~~~kl~df 178 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCCCEEEEec
Confidence 4588999999985 999988764 234699999999999999999999999999999999999995 6688999999
Q ss_pred ccccccCCc------------cccccccccccCcccccccc---ccccchhHhHHHHHHHHHhCCCCCC
Q 003438 261 GSACTEDRT------------VYSYIQSRYYRSPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 261 GlA~~~~~~------------~~~~~gt~~Y~APEvl~~~~---yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
|++...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 998654321 12345699999999997653 7899999999999999999999994
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.78 Aligned_cols=204 Identities=27% Similarity=0.395 Sum_probs=162.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|++.++||+|+||+||+|++.. .||||+++.. ....+.+.+|+.+|+.+ .|+||++++++. ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-------RHVNILLFMGYS-TA 91 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEE-CS
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-------CCCcEEEEEeec-cC
Confidence 3899999999999999999997654 4999999743 34556788899999888 689999999954 56
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
...++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~ 167 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLA 167 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC--
T ss_pred CccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceec
Confidence 67899999998 58888886543 4699999999999999999999999999999999999996 6689999999999
Q ss_pred cccCC-----ccccccccccccCccccc---cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003438 264 CTEDR-----TVYSYIQSRYYRSPEVLL---GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 264 ~~~~~-----~~~~~~gt~~Y~APEvl~---~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~ 326 (820)
..... ......+|+.|+|||++. +..++.++|||||||++|+|++|+.||......+.+..+.
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 64432 223457899999999997 5578899999999999999999999998766655544443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=358.34 Aligned_cols=206 Identities=23% Similarity=0.345 Sum_probs=167.3
Q ss_pred CceEEEEEeccCCceeEEEeecc---CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~---~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+|++.++||+|+||+||+|++. .++..||||+++.. ....+.+.+|+.+|+++ .||||+++++++..
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~~~~~ 117 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-------DHPNIIRLEGVVTK 117 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEECS
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEee
Confidence 78999999999999999999876 56778999999853 34556788999999888 68999999999999
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+||||||+. ++|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kl~Dfg~ 193 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGL 193 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC--
T ss_pred CCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc---CCCCEEECcCcc
Confidence 999999999996 69999987653 4699999999999999999999999999999999999995 678999999999
Q ss_pred ccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 263 ACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 263 A~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
++...... ....+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i 263 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 97543321 11234678999999999899999999999999999998 99999877765554443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=365.37 Aligned_cols=206 Identities=24% Similarity=0.351 Sum_probs=175.0
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.++||+|+||+||+|.+.. +..||||+++......+.+.+|+++|+++ .||||+++++++.. +.+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECS-SSC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-------CCCCEeeEEEEEcC-Cce
Confidence 3789999999999999999998765 46799999987655567889999999999 68999999999876 779
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
||||||+. ++|.+++.......+++..+..++.||+.||+|||+++||||||||+|||++ .++.+||+|||+++..
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI 330 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccceec
Confidence 99999997 5999999765555699999999999999999999999999999999999995 5678999999999755
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
.... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 394 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 3321 22345778999999998899999999999999999999 99999988776655544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.21 Aligned_cols=198 Identities=24% Similarity=0.392 Sum_probs=163.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC----ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN----QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~----~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.++||+|+||.||+|++..+++.||||+++. .....+.+.+|+.+++.+ .|+||+++++++...
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-------NHPNVIKYYASFIED 104 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEET
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEEcC
Confidence 789999999999999999999999999999999974 244566788899999988 689999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhh--cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 185 RHLCICFELLDS-NLYELIKINH--FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~--~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
+..++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~---~~~~~kl~Dfg 181 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLG 181 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCC-
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc---CCCCEEEEecc
Confidence 999999999985 8998887532 34589999999999999999999999999999999999995 67899999999
Q ss_pred cccccCCc---cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 262 SACTEDRT---VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 262 lA~~~~~~---~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
++...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred ceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 98654332 23457899999999999999999999999999999999999999654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=349.21 Aligned_cols=202 Identities=24% Similarity=0.392 Sum_probs=166.2
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEE----EEEEEeC--ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFV----AVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~V----AIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
.++|+++++||+|+||+||+|++..+++.| |+|.++. .....+.+.+|+.+|+.+ .||||+++++++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~ 86 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGIC 86 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-------CBTTBCCCCEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-------CCCCeeEEEEEE
Confidence 389999999999999999999988887654 6666653 234567788999999888 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
.... .++|+|++. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.+||+||
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~Df 161 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDF 161 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCT
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccC
Confidence 8765 778888886 68999887654 4699999999999999999999999999999999999995 6688999999
Q ss_pred ccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 261 GSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 261 GlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
|++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 162 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 228 (327)
T 3lzb_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp TC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred cceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 999754322 122345778999999999999999999999999999999 9999987665443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.59 Aligned_cols=194 Identities=27% Similarity=0.444 Sum_probs=160.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.++||+|+||+||+|++. ++.||||++... ...+.+.+|+++|+++ .||||+++++++. +..|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRV-------NHPNIVKLYGACL--NPVC 75 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHC-------CCTTBCCEEEBCT--TTTE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcC-------CCCCcCeEEEEEc--CCcE
Confidence 79999999999999999999764 788999999754 3456788999999998 6899999999877 4589
Q ss_pred EEEeccC-CChHHHHHhhhc-CCCCHHHHHHHHHHHHHHhhhccc---CCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 189 ICFELLD-SNLYELIKINHF-RGLSLSIVQLFSKQILRGLSLLKD---AGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~-~~l~e~~i~~I~~QIl~aL~yLHs---~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
|||||+. ++|.+++..... ..+++..++.++.||++||+|||+ +||+||||||+|||++ .....+||+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTA 153 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC-
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEcccccc
Confidence 9999997 599999876432 247899999999999999999999 8999999999999996 23335899999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCC
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGA 316 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~ 316 (820)
...........+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 154 CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred cccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 87665555667999999999999999999999999999999999999999753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.41 Aligned_cols=201 Identities=22% Similarity=0.330 Sum_probs=168.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg---~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
-.|++.++||+|+||+||+|++..++ ..||+|+++.. ....+.+.+|+.+++.+ .||||+++++++..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-------NHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEECC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEec
Confidence 57888899999999999999865444 48999999753 34557788999999988 68999999999987
Q ss_pred ccee-EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 184 QRHL-CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 184 ~~~l-~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.+.. ++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~---~~~~~kl~Dfg 169 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFG 169 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECCTT
T ss_pred CCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCcEEeCcCC
Confidence 7655 99999996 69999887643 5689999999999999999999999999999999999995 66799999999
Q ss_pred cccccCCc-------cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 262 lA~~~~~~-------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
++...... .....+++.|+|||++.+..++.++|||||||++|+|++ +.+||...+..+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~ 236 (298)
T 3pls_A 170 LARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236 (298)
T ss_dssp SSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG
T ss_pred CcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH
Confidence 99644322 223466889999999999999999999999999999999 556665544433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.62 Aligned_cols=205 Identities=20% Similarity=0.320 Sum_probs=165.0
Q ss_pred CceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~---tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
++|++.++||+|+||+||+|++.. +++.||||+++.. ....+.+.+|+.+++.+ .||||+++++++.
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~ 106 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-------SHPNVIRLLGVCI 106 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEEE
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-------CCCCeeeeeEEEe
Confidence 799999999999999999997654 5668999999743 34456788899999988 6899999999998
Q ss_pred ecc-----eeEEEEeccC-CChHHHHHhhh----cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 183 CQR-----HLCICFELLD-SNLYELIKINH----FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 183 ~~~-----~l~LVmEy~~-gsL~d~l~~~~----~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
..+ ..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---TT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CC
Confidence 765 4599999998 58999886432 24599999999999999999999999999999999999995 66
Q ss_pred CeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 003438 253 AEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLR 323 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~ 323 (820)
+.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 78999999999654322 223356788999999999999999999999999999999 899998766544433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=353.80 Aligned_cols=201 Identities=21% Similarity=0.314 Sum_probs=171.9
Q ss_pred CCceEEEEEeccCCceeEEEe-----eccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKC-----WDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka-----~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|++.++||+|+||+||+| .+..+++.||||+++... ...+.+|+++++.+... .|+||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~----~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS----MQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGG----GGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhh----hhhhhhhhheeee
Confidence 389999999999999999999 467789999999998653 45678899999888543 6899999999999
Q ss_pred ecceeEEEEeccC-CChHHHHHhhh---cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc--------cc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINH---FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT--------SV 250 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~---~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~--------~~ 250 (820)
..+..|||||||. ++|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+||||+. +.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 9999999999997 69999987532 346999999999999999999999999999999999999963 12
Q ss_pred CCCeEEEeeccccccc-----CCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 251 KPAEIKIIDFGSACTE-----DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 251 ~~~~iKL~DFGlA~~~-----~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
..+.+||+|||+|+.. .......+||+.|+|||++.+..|+.++||||||||+|||++|+.||.
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 2689999999999543 223345679999999999999999999999999999999999999995
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.15 Aligned_cols=202 Identities=22% Similarity=0.330 Sum_probs=168.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV- 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~- 182 (820)
.+|++.++||+|+||+||+|++..+ ...||+|+++.. ....+.+.+|+.+++++ .||||+++++++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLGICLR 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEECC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-------CCCCEeeeeeEEEc
Confidence 6899999999999999999986543 346999998753 34556788999999988 6899999999854
Q ss_pred ecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.++..|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg 173 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFG 173 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSCG
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC---CCCCEEECccc
Confidence 55688999999985 9999987643 5689999999999999999999999999999999999995 67899999999
Q ss_pred cccccCCc-------cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHH
Q 003438 262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDL 321 (820)
Q Consensus 262 lA~~~~~~-------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~ 321 (820)
++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ +.+||......+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 241 (298)
T 3f66_A 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241 (298)
T ss_dssp GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH
T ss_pred ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 99754332 223456788999999999999999999999999999999 6778876554443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=371.43 Aligned_cols=206 Identities=24% Similarity=0.351 Sum_probs=178.8
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.++|++.++||+|+||+||+|++.. +..||||+++......+.+.+|+++|++| .|+||+++++++.. +.+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-------~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECS-SSC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-------CCCCEeeEEEEEee-ccc
Confidence 3789999999999999999998765 46799999987655567889999999999 68999999999876 779
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
||||||+. ++|.+++.......+++.+++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEcccccceec
Confidence 99999997 5999999765555699999999999999999999999999999999999995 5678999999999765
Q ss_pred CCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 267 DRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 267 ~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
.... ....++..|+|||++....++.++|||||||+||||++ |+.||.+....+.+..+
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i 477 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 4322 12345678999999998899999999999999999999 99999888776655544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.87 Aligned_cols=199 Identities=23% Similarity=0.271 Sum_probs=171.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.++|++.+.||+|+||+||+|++. +++.||||++... ....+.+.+|+.+|+.+ .||||+++++++...+.
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC-------RHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-------CCTTBCCEEEECCCTTC
T ss_pred HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEcCCCe
Confidence 378999999999999999999864 6889999998754 34456788899988877 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhc--CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 187 LCICFELLD-SNLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~--~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
.++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC---TTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC---CCCCEEEeecccc
Confidence 999999997 588888765432 2489999999999999999999999999999999999995 6789999999999
Q ss_pred cccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 264 CTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 264 ~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
...... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 653321 233468999999999998899999999999999999999999997543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.95 Aligned_cols=190 Identities=24% Similarity=0.260 Sum_probs=158.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec----
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---- 184 (820)
++|+++++||+|+||+||+|++. ++.||||++..... ....+|.+++..+. ..|+||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~-----~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVL-----MRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTT-----CCCTTBCCEEEEEEESCGGG
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHh-----hcCCCeeeEEEEEccCCCCC
Confidence 79999999999999999999764 89999999975543 34455666555442 2699999999999887
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccC--------CeeeccCCCCCcccccccCCCeE
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDA--------GIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~--------gIVHrDLKPeNILl~~~~~~~~i 255 (820)
..+||||||+. ++|.++++.. .+++..++.++.||+.||+|||++ +||||||||+|||++ .++.+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~---~~~~~ 181 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK---KNGTC 181 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC---TTSCE
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC---CCCCE
Confidence 78999999997 4999998654 499999999999999999999998 999999999999996 66799
Q ss_pred EEeecccccccCCcc-------ccccccccccCcccccccccccc------chhHhHHHHHHHHHhCCCCC
Q 003438 256 KIIDFGSACTEDRTV-------YSYIQSRYYRSPEVLLGYQYTTA------IDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 256 KL~DFGlA~~~~~~~-------~~~~gt~~Y~APEvl~~~~yt~k------sDIWSLG~ILyeLltG~~PF 313 (820)
||+|||++....... ...+||+.|+|||++.+..++.+ +|||||||++|||++|..|+
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 999999996543221 24578999999999987766554 99999999999999995444
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=367.47 Aligned_cols=204 Identities=18% Similarity=0.160 Sum_probs=159.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhc---------CCC------
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKY---------DRE------ 169 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~---------~~~------ 169 (820)
+.|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.+.+.. ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 5699999999999999999999999999999999832 223467788998888875410 000
Q ss_pred CCCceeEEeEEEee-----cceeEEEEeccCCChHHHHHhh-----hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccC
Q 003438 170 DKHHIVRIYEYFVC-----QRHLCICFELLDSNLYELIKIN-----HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL 239 (820)
Q Consensus 170 ~HpnIVkl~d~f~~-----~~~l~LVmEy~~gsL~d~l~~~-----~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL 239 (820)
..+++..+..++.. ...++++|+++.++|.+++... ....+++..++.++.||++||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 00111111122222 2357899999999999988632 1234778899999999999999999999999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCccccccccccccCcccc----------ccccccccchhHhHHHHHHHHHhC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL----------LGYQYTTAIDMWSFGCIVAELFLG 309 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl----------~~~~yt~ksDIWSLG~ILyeLltG 309 (820)
||+||||+ .++.+||+|||+++.........+| +.|+|||++ ....++.++|||||||++|||++|
T Consensus 238 Kp~NILl~---~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 238 RPVDIVLD---QRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp CGGGEEEC---TTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred ccceEEEe---cCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence 99999996 6678999999999877776667788 999999999 555789999999999999999999
Q ss_pred CCCCCCC
Q 003438 310 LPLFPGA 316 (820)
Q Consensus 310 ~~PF~~~ 316 (820)
+.||...
T Consensus 314 ~~Pf~~~ 320 (413)
T 3dzo_A 314 DLPNTDD 320 (413)
T ss_dssp SCCCCTT
T ss_pred CCCCCCc
Confidence 9999654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.08 Aligned_cols=206 Identities=24% Similarity=0.387 Sum_probs=166.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccC-CC--eEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE-MN--SFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~-tg--~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|+++++||+|+||+||+|++.. ++ ..||||+++.. ....+.+.+|+++++.+ .|+||++++++
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i~~~~~~ 89 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-------DHRNLIRLYGV 89 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-------CCTTBCCEEEE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-------CCCCcccEEEE
Confidence 3799999999999999999998543 33 36999998743 34567788999999998 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+.... .++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~D 164 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGD 164 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECC
T ss_pred EccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcc
Confidence 98765 899999997 69999887653 4599999999999999999999999999999999999996 567899999
Q ss_pred cccccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 260 FGlA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+.+..+
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 237 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH
Confidence 99997543321 23356778999999998899999999999999999999 99999887766554443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=340.74 Aligned_cols=194 Identities=28% Similarity=0.377 Sum_probs=166.1
Q ss_pred CceEEEEEeccCCceeEEEe----eccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKC----WDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka----~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
+.|+++++||+|+||+||++ .+..+++.||||+++.. ....+.+.+|+++|+.+ .||||+++++++.
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-------YHEHIIKYKGCCE 103 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-------CCcchhhEEEEEe
Confidence 34499999999999999665 45668999999999864 34456788999999999 5899999999998
Q ss_pred ec--ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQ--RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~--~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.. ..++|||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~---~~~~~kl~D 177 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGD 177 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECC
T ss_pred cCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc---CCCCEEECC
Confidence 84 67899999997 5899888654 499999999999999999999999999999999999995 668899999
Q ss_pred cccccccCCc------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 260 FGSACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 260 FGlA~~~~~~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 9999755432 2234578889999999999999999999999999999999999964
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=348.49 Aligned_cols=196 Identities=25% Similarity=0.310 Sum_probs=168.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh--hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA--YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~--~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.++|++.++||+|+||+||+|++. +++.||||+++.... ....+.+|+++++.+ .|+||+++++++...+
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMA-------VHRNLLRLRGFCMTPT 100 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTC-------CCTTBCCCCEEECCSS
T ss_pred hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhc-------cCCCccceEEEEecCC
Confidence 378999999999999999999754 688999999975421 223577888888777 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhc--CCCCHHHHHHHHHHHHHHhhhcccC---CeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 HLCICFELLD-SNLYELIKINHF--RGLSLSIVQLFSKQILRGLSLLKDA---GIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~--~~l~e~~i~~I~~QIl~aL~yLHs~---gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+|||||+. ++|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~D 177 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGD 177 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC---TTCCEEECC
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC---CCCCEEecc
Confidence 9999999997 499998876532 3499999999999999999999999 999999999999995 668899999
Q ss_pred cccccccCC----ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCC
Q 003438 260 FGSACTEDR----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFP 314 (820)
Q Consensus 260 FGlA~~~~~----~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~ 314 (820)
||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999975432 2233468999999999998899999999999999999999999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=335.63 Aligned_cols=196 Identities=26% Similarity=0.397 Sum_probs=167.9
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.|...++||+|+||+||+|++ +++.||||++... ....+.+.+|+.+++.+ .||||+++++++...
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-------~h~~i~~~~~~~~~~ 102 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-------QHENLVELLGFSSDG 102 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-------CCTTBCCEEEEECSS
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-------CCCCeEEEEEEEecC
Confidence 444558899999999999976 5789999999742 33457788999999998 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 185 RHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+..|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~ 179 (307)
T 2nru_A 103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD---EAFTAKISDFGL 179 (307)
T ss_dssp SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTT
T ss_pred CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc---CCCcEEEeeccc
Confidence 99999999996 69999887543 34599999999999999999999999999999999999995 678999999999
Q ss_pred ccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 263 ACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 263 A~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
+...... .....+|+.|+|||++.+ .++.++|||||||++|+|++|.+||.....
T Consensus 180 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 180 ARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp CEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred ccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 8654322 223478999999999876 589999999999999999999999976543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=351.94 Aligned_cols=201 Identities=22% Similarity=0.328 Sum_probs=161.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.+|++.++||+|+||+||+|++..+ ...||||+++.. ....+.+.+|+.+|+++ .||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-------CCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-------CCCCcceEEEEEEc
Confidence 5789999999999999999986543 346899998753 34567788899988887 68999999998654
Q ss_pred -cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 184 -QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 184 -~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
++..|+||||+. ++|.+++.... ..+++..++.++.||++||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DFG 237 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFG 237 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC-
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC---CCCCEEEeecc
Confidence 568899999998 59999987543 4589999999999999999999999999999999999995 67899999999
Q ss_pred cccccCCc-------cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHH
Q 003438 262 SACTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFD 320 (820)
Q Consensus 262 lA~~~~~~-------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d 320 (820)
+++..... .....+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..+
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~ 304 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304 (373)
T ss_dssp --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred ccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence 99754321 123356788999999999999999999999999999999 788887655433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.23 Aligned_cols=197 Identities=25% Similarity=0.393 Sum_probs=170.2
Q ss_pred CCceEEEEEeccCCceeEEEee----ccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~----d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|+++++||+|+||.||+|+ +..+++.||||+++.. ....+.+.+|+++|+.+ .|+||+++++++.
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-------QHDNIVKYKGVCY 112 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEE
Confidence 3789999999999999999998 5778999999999754 34556788999999988 5899999999987
Q ss_pred ecc--eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 183 CQR--HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 183 ~~~--~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..+ .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~D 188 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGD 188 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEec
Confidence 654 7899999997 59999987653 4599999999999999999999999999999999999996 568999999
Q ss_pred cccccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 260 FGSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 260 FGlA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 99997553321 223567789999999998999999999999999999999998853
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.75 Aligned_cols=186 Identities=23% Similarity=0.302 Sum_probs=161.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--- 185 (820)
++|++.+.||+|+||+||+|++ +++.||||+++... ...+.+|+++++.+. ..||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~-----l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVM-----LRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSC-----CCCTTBCCEEEEEECCCSSC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhh-----cCCCcEEEEEeeecccCCcc
Confidence 7999999999999999999976 58999999997543 456778998888753 26999999999998876
Q ss_pred -eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc--------cCCeeeccCCCCCcccccccCCCeE
Q 003438 186 -HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK--------DAGIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 186 -~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH--------s~gIVHrDLKPeNILl~~~~~~~~i 255 (820)
.+|+||||+.+ +|.+++... .+++..++.++.||+.||.||| +++|+||||||+||||+ .++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~---~~~~~ 186 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTC 186 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC---TTSCE
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC---CCCCE
Confidence 89999999985 999998754 4899999999999999999999 89999999999999995 66789
Q ss_pred EEeecccccccCCc-------cccccccccccCccccccc------cccccchhHhHHHHHHHHHhC
Q 003438 256 KIIDFGSACTEDRT-------VYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLG 309 (820)
Q Consensus 256 KL~DFGlA~~~~~~-------~~~~~gt~~Y~APEvl~~~------~yt~ksDIWSLG~ILyeLltG 309 (820)
||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 99999999654322 2344789999999999875 455799999999999999999
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.32 Aligned_cols=198 Identities=17% Similarity=0.180 Sum_probs=160.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHHhhh--cCCCCCCceeEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKK--YDREDKHHIVRI 177 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~--~~~~~HpnIVkl 177 (820)
++|+++++||+|+||+||+|++ +++.||||+++... ...+.+.+|+.+|++|+.. .....|+|||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 7899999999999999999987 68999999998542 2347788999999999632 112246677766
Q ss_pred eEEEe-----------------e-------------cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHh
Q 003438 178 YEYFV-----------------C-------------QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGL 226 (820)
Q Consensus 178 ~d~f~-----------------~-------------~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL 226 (820)
++++. . .+.+|||||||. |++++.+.. +.+++..++.+++||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 66543 2 678999999997 456665543 4589999999999999999
Q ss_pred hhcc-cCCeeeccCCCCCccccccc-----------------CCCeEEEeecccccccCCccccccccccccCccccccc
Q 003438 227 SLLK-DAGIIHCDLKPENILLCTSV-----------------KPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGY 288 (820)
Q Consensus 227 ~yLH-s~gIVHrDLKPeNILl~~~~-----------------~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~ 288 (820)
+||| ++|||||||||+||||+.+. ....+||+|||+|+..... ..+||+.|+|||++.+.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCCC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcCC
Confidence 9999 99999999999999997332 1128999999999765433 45899999999999876
Q ss_pred cccccchhHhHHHH-HHHHHhCCCCCC
Q 003438 289 QYTTAIDMWSFGCI-VAELFLGLPLFP 314 (820)
Q Consensus 289 ~yt~ksDIWSLG~I-LyeLltG~~PF~ 314 (820)
. +.++|||||+++ .++++.|..||.
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred C-ccceehhhhhCCCCcccccccCCCc
Confidence 6 889999998777 777888999884
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=364.72 Aligned_cols=205 Identities=22% Similarity=0.315 Sum_probs=170.6
Q ss_pred CceEEEE-EeccCCceeEEEeecc--CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKD-LLGHGTFGQVAKCWDA--EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~-~LG~G~fG~Vyka~d~--~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
+++.+.+ +||+|+||+||+|.++ .++..||||+++.. ....+.+.+|+++|+.+ .|+|||++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-------~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-------DNPYIVRLIGVCQA 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-------CCTTBCCEEEEEES
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-------CCCCEeeEEEEecc
Confidence 5666666 8999999999999765 45678999999853 34567889999999888 68999999999876
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+.+|||||||. ++|.+++... ...+++..++.++.||+.||+|||+++||||||||+||||+ .++.+||+|||+
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGl 482 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGL 482 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCST
T ss_pred -CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccC
Confidence 56999999997 5888888654 34699999999999999999999999999999999999996 668999999999
Q ss_pred ccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 263 ACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 263 A~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
++...... ....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+.+..+
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 552 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 97653221 12234678999999998899999999999999999998 99999887766655444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=378.54 Aligned_cols=203 Identities=27% Similarity=0.400 Sum_probs=174.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee---
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC--- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~--- 183 (820)
++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++|+.+ .||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-------~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-------NHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-------CBTTBCCEEECCTTTCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-------CCCCCCceeeeeccccc
Confidence 7899999999999999999999999999999999753 44566788999999999 68999999999765
Q ss_pred ---cceeEEEEeccC-CChHHHHHhhh-cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 184 ---QRHLCICFELLD-SNLYELIKINH-FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 184 ---~~~l~LVmEy~~-gsL~d~l~~~~-~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
.+..|||||||. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+.....+||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 678899999996 69999987643 2358999999999999999999999999999999999999755455569999
Q ss_pred ecccccccCCc--cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCH
Q 003438 259 DFGSACTEDRT--VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASE 318 (820)
Q Consensus 259 DFGlA~~~~~~--~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~ 318 (820)
|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999765432 3445789999999999999999999999999999999999999976543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=364.86 Aligned_cols=205 Identities=26% Similarity=0.408 Sum_probs=170.0
Q ss_pred CceEEE-EEeccCCceeEEEee--ccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVK-DLLGHGTFGQVAKCW--DAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~-~~LG~G~fG~Vyka~--d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..+.+. ++||+|+||+||+|. .+.+++.||||+++.. ....+.+.+|+++|++| .|+|||++++++.
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-------DNPYIVRMIGICE 440 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe
Confidence 344444 489999999999994 4567789999999853 33467889999999999 6899999999986
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
.+..+||||||. ++|.+++... +.+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||
T Consensus 441 -~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFG 514 (635)
T 4fl3_A 441 -AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFG 514 (635)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTT
T ss_pred -cCCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcC
Confidence 456899999997 5899988654 4699999999999999999999999999999999999996 66799999999
Q ss_pred cccccCCc------cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003438 262 SACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 262 lA~~~~~~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~ 326 (820)
+++..... .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+....+.
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99754322 122345788999999999899999999999999999998 999999887766555443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=357.61 Aligned_cols=207 Identities=24% Similarity=0.384 Sum_probs=174.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccC---CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAE---MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~---tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.++|++.+.||+|+||+||+|++.. .+..||||+++.. ....+.+.+|+.+|+.+ .||||+++++++.
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-------DHPHIVKLIGVIT 461 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEe
Confidence 4789999999999999999998754 3568999998753 34456788999999998 6899999999985
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
++.+||||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG 536 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFG 536 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecC
Confidence 567999999998 69999887653 4589999999999999999999999999999999999996 56899999999
Q ss_pred cccccCCcc----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003438 262 SACTEDRTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 262 lA~~~~~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~ 326 (820)
++....... ....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+..+.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~ 606 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 997654322 22356788999999998899999999999999999997 999999887766655543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.84 Aligned_cols=202 Identities=21% Similarity=0.305 Sum_probs=166.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.++||+|+||+||+|++.. .||||+++.. ....+.+.+|+.+++.+ .|+||+++++++...+
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-------~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-------RHENVVLFMGACMSPP 102 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-------CCTTBCCCCEEEECSS
T ss_pred HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-------CCCCEeEEEEEEecCC
Confidence 789999999999999999998754 3999998743 22234566788888777 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFS 177 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC
T ss_pred ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcc
Confidence 9999999997 58888886543 4699999999999999999999999999999999999995 4689999999975
Q ss_pred ccC--------CccccccccccccCcccccc---------ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 003438 265 TED--------RTVYSYIQSRYYRSPEVLLG---------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRM 325 (820)
Q Consensus 265 ~~~--------~~~~~~~gt~~Y~APEvl~~---------~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I 325 (820)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 432 12233468899999999975 35789999999999999999999999887765554443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=360.31 Aligned_cols=190 Identities=26% Similarity=0.363 Sum_probs=163.1
Q ss_pred CceEEEEEeccCCceeEEEeeccC-CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|++.. +++.||||++... ......+.+|+.+|+++ .||||+++++++...+
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-------~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-------VHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-------CCTTBCCEEEEEEEEC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-------CCCCcCeEeeeEeecC
Confidence 899999999999999999999876 7899999998643 34456778899998887 6899999999999876
Q ss_pred e-----eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 186 H-----LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 186 ~-----l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
. .||||||+.+ +|.+++.. .+++.+++.|+.||+.||.|||++|||||||||+||||+ . +.+||+|
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~D 224 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLID 224 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECC
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEe
Confidence 5 7999999985 77776543 599999999999999999999999999999999999996 2 4899999
Q ss_pred cccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 260 FGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 260 FGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||++...... ...+||+.|+|||++.+. ++.++||||||||+|+|++|.+||.+
T Consensus 225 FG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 225 LGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp CTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 9999766544 456799999999998764 48899999999999999999988853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.22 Aligned_cols=171 Identities=15% Similarity=0.128 Sum_probs=150.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.++..+ .|+||+++++++...
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-------~hp~iv~~~~~~~~~ 103 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-------DKPGVARVLDVVHTR 103 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEET
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-------CCCCcceeeEEEEEC
Confidence 7899999999999999999999999999999999854 34457788899988877 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+..||||||+. ++|.++++. .....++..|+.||+.||+|||++||+||||||+|||++ .++.+||++++
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~-- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA-- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC--
T ss_pred CcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc--
Confidence 99999999998 588888743 246667889999999999999999999999999999996 66889998543
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
|++ .++.++|||||||++|||++|+.||.+.+
T Consensus 175 ---------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 ---------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp ---------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred ---------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 333 37899999999999999999999997654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-29 Score=291.27 Aligned_cols=181 Identities=15% Similarity=0.070 Sum_probs=131.1
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEeCC-----------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-----------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-----------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++.|+++.+..++....++.||||++.++ +...+++.+|+++|+++. .|+||++++++++++
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~------~~~~i~~~~~~~ed~ 314 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP------AGFDAPAVLAHGENA 314 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC------TTCCCCCEEEEEECS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC------CCCCeeEEEEEEEEC
Confidence 467888888888888888999999999753 234567889999999984 589999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||+| +|.++|+.. +.+++. .|++||+.||+|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~---~dg~vKL~DFGlA 386 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD---ARQHARLIDFGSI 386 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC---TTSCEEECCCTTE
T ss_pred CEEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC---CCCCEEEeecccC
Confidence 999999999986 899999765 357654 5789999999999999999999999999996 6789999999999
Q ss_pred cccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCC
Q 003438 264 CTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLP 311 (820)
Q Consensus 264 ~~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~ 311 (820)
+.... ...+.+||+.|+|||++.+ .+..++|+|++|+++++|.++..
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred eeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 75543 3455789999999999976 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-24 Score=251.97 Aligned_cols=178 Identities=17% Similarity=0.175 Sum_probs=139.6
Q ss_pred EEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 112 IVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 112 ~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
...++||+|+||+||+| ...++.+|+|+..... ...+++.+|+++|+++ .|+||+++..++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-------~h~nIv~~~~~~~ 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-------KDFGIPAPYIFDV 409 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-------GGGTCCCCCEEEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-------CCCCcCceEEEEE
Confidence 45679999999999999 4456789999865321 1234578999999999 5789996666666
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+..||||||+. ++|.+++.. ++.++.||++||+|||+++|+||||||+|||++ . .+||+|||
T Consensus 410 ~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFG 474 (540)
T 3en9_A 410 DLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFG 474 (540)
T ss_dssp ETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCT
T ss_pred eCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECc
Confidence 7778899999997 689888764 568999999999999999999999999999996 3 89999999
Q ss_pred cccccCCc----------cccccccccccCcccccc--ccccccchhHhHHHHHHHHHhCCCCC
Q 003438 262 SACTEDRT----------VYSYIQSRYYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 262 lA~~~~~~----------~~~~~gt~~Y~APEvl~~--~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
+++..... ....+||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99876542 135689999999999987 57888999999998888888776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-22 Score=211.98 Aligned_cols=144 Identities=24% Similarity=0.300 Sum_probs=115.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------------------hhHHHHHHHHHHHHHHhhhcCCC
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------------------AYYQQALVEVSILTTLNKKYDRE 169 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------------------~~~~~~~~Ei~iL~~L~~~~~~~ 169 (820)
..|.+.+.||+|+||.||+|++ .+++.||||+++... .....+.+|+.+|+.+.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------ 162 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------ 162 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT------
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc------
Confidence 5778889999999999999999 889999999997432 13456889999999983
Q ss_pred CCCceeEEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccc
Q 003438 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCT 248 (820)
Q Consensus 170 ~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~ 248 (820)
| +++.+++. .+..|+||||+.| +|.+ +. ......++.||+.||.|||++|||||||||+|||++
T Consensus 163 ---~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 ---G-LAVPKVYA-WEGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp ---T-SSSCCEEE-EETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred ---C-CCcCeEEe-ccceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-
Confidence 3 44555443 3667999999975 7876 31 123567999999999999999999999999999995
Q ss_pred ccCCCeEEEeecccccccCCccccccccccccCcccccc
Q 003438 249 SVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLG 287 (820)
Q Consensus 249 ~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~ 287 (820)
++.+||+|||+|+. +..++|||++..
T Consensus 228 ---~~~vkl~DFG~a~~----------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 ---EEGIWIIDFPQSVE----------VGEEGWREILER 253 (282)
T ss_dssp ---TTEEEECCCTTCEE----------TTSTTHHHHHHH
T ss_pred ---CCcEEEEECCCCeE----------CCCCCHHHHHHH
Confidence 68899999999953 345789998854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=186.73 Aligned_cols=139 Identities=20% Similarity=0.209 Sum_probs=107.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeE--EEEEEEeCChhh-------------------------HHHHHHHHHHHHH
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSF--VAVKIIKNQPAY-------------------------YQQALVEVSILTT 161 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~--VAIKiik~~~~~-------------------------~~~~~~Ei~iL~~ 161 (820)
.-|++.+.||+|+||.||+|.+..+++. ||||+++..... ...+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3578999999999999999998778999 999998643111 1357889999999
Q ss_pred HhhhcCCCCCCceeEEeEEEeecceeEEEEeccC--C----ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc-cCCe
Q 003438 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD--S----NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGI 234 (820)
Q Consensus 162 L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~~--g----sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH-s~gI 234 (820)
|.+. ..+++.++++ +..||||||++ | .|.++... .++..+..++.||+.+|.||| ++||
T Consensus 127 l~~~-----~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~gi 192 (258)
T 1zth_A 127 AKEA-----GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAEL 192 (258)
T ss_dssp HHHT-----TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCE
T ss_pred HHhC-----CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCE
Confidence 9653 1123334432 46799999995 3 55554321 235568899999999999999 9999
Q ss_pred eeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 235 IHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 235 VHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|||||||+|||++ . .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEES---S--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEc---C--cEEEEECcccccC
Confidence 9999999999995 3 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=6.9e-16 Score=172.09 Aligned_cols=140 Identities=19% Similarity=0.199 Sum_probs=99.1
Q ss_pred ceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh-----------------------hHHHHHHHHHHHHHHhhhc
Q 003438 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA-----------------------YYQQALVEVSILTTLNKKY 166 (820)
Q Consensus 110 rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~-----------------------~~~~~~~Ei~iL~~L~~~~ 166 (820)
-|+|.++||+|+||.||+|.+. +|+.||||+++.... ..-...+|...|.+|...
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~- 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE- 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc-
Confidence 4999999999999999999885 688999999753100 001134577777777432
Q ss_pred CCCCCCceeEEeEEEeecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcc
Q 003438 167 DREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL 245 (820)
Q Consensus 167 ~~~~HpnIVkl~d~f~~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL 245 (820)
.-.+...+++ ...+|||||++| .|.++ ........++.||+.+|.+||++|||||||||.|||
T Consensus 174 ----gv~vp~p~~~----~~~~LVME~i~G~~L~~l--------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 174 ----GFPVPEPIAQ----SRHTIVMSLVDALPMRQV--------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNIL 237 (397)
T ss_dssp ----TCSCCCEEEE----ETTEEEEECCSCEEGGGC--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred ----CCCCCeeeec----cCceEEEEecCCccHhhh--------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence 1123333332 234899999987 44332 122345678999999999999999999999999999
Q ss_pred cccccCC-------CeEEEeecccccccC
Q 003438 246 LCTSVKP-------AEIKIIDFGSACTED 267 (820)
Q Consensus 246 l~~~~~~-------~~iKL~DFGlA~~~~ 267 (820)
++.+.+. ..+.|+||+.+....
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EeCCCCcccccccccceEEEEeCCcccCC
Confidence 9743211 148999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=5.1e-11 Score=124.23 Aligned_cols=138 Identities=14% Similarity=0.055 Sum_probs=106.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..|++...++.|+.+.||++... ++.+++|+..... .....+.+|+.+|+.|.. +..+.++++++...+..
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~------~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG------KLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT------TSCCCCEEEEEEETTEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc------CCCCCeEEEEEecCCce
Confidence 56889999999999999999643 5789999987421 222457889999999953 45688899998888899
Q ss_pred EEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-----------------------------------
Q 003438 188 CICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD----------------------------------- 231 (820)
Q Consensus 188 ~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs----------------------------------- 231 (820)
|+|||+++| +|.+.+ .+......++.+++++|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEEecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999998 555431 1122345778899999999998
Q ss_pred ------------------------CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 232 ------------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 232 ------------------------~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..++|+|++|.|||++ ....+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4599999999999995 33455799998873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=3.9e-10 Score=116.17 Aligned_cols=136 Identities=12% Similarity=-0.037 Sum_probs=95.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
..|.+..+.+.|..+.||++.. .+++.+++|+.... ....+.+|+.+|+.|... .-.+.+++.+....+..+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~-----~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATT-----GVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTT-----TCCBCCEEEEEECSSCEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhC-----CCCCCeEEEeccCCCCCE
Confidence 4556555545667799999964 45677999998754 234567899999999642 123677888888888899
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC-----------------------------------
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG----------------------------------- 233 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g----------------------------------- 233 (820)
+|||+++|.-.+ .. ... ...++.++++.|..||+..
T Consensus 92 ~v~e~i~G~~l~-~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 92 LLLGEVPGQDLL-SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEECCSSEETT-TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEecCCcccC-cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999999873223 11 111 2245566666666666532
Q ss_pred -----------------------eeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 234 -----------------------IIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 234 -----------------------IVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
++|+|++|.|||++ ....++|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999995 33456799999974
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.8e-09 Score=116.67 Aligned_cols=142 Identities=11% Similarity=0.216 Sum_probs=103.3
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEe--CCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec---c
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---R 185 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik--~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---~ 185 (820)
.++.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+|+.|.. .+..+++++.++.+. +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~-----~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAG-----TDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTT-----SSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhc-----CCCCCCcEEEECCCCCccC
Confidence 4578999999999999754 3568888876 322 223467789999999964 244688888888766 4
Q ss_pred eeEEEEeccCCC-hHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc---------------------------------
Q 003438 186 HLCICFELLDSN-LYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD--------------------------------- 231 (820)
Q Consensus 186 ~l~LVmEy~~gs-L~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs--------------------------------- 231 (820)
..|+|||+++|. +.+ .....++..+...++.++++.|..||+
T Consensus 115 ~~~~vme~v~G~~l~~----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWD----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE 190 (359)
T ss_dssp SCEEEEECCCCBCCCC----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred CeEEEEEecCCeecCC----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence 589999999974 322 112347788888999999999999996
Q ss_pred -------------------------CCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 232 -------------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 232 -------------------------~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
..+||+|+++.|||++.+ ....+.|+||+.+...
T Consensus 191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTLG 249 (359)
T ss_dssp CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEEE
T ss_pred CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECccccccC
Confidence 469999999999999632 1234699999998643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.4e-09 Score=114.63 Aligned_cols=183 Identities=22% Similarity=0.197 Sum_probs=117.3
Q ss_pred EEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---eeEEEE
Q 003438 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR---HLCICF 191 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~---~l~LVm 191 (820)
+.|+.|....||++. ..+++|+.... .....+.+|..+|+.|... ..-.+.+++......+ ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~----~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNK----LPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTS----SSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhc----CCCCCCceEeecCCCCCCCcceEEE
Confidence 358899999999984 34889986543 3456788999999998542 1112445555443333 458999
Q ss_pred eccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc---------------------------------------
Q 003438 192 ELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD--------------------------------------- 231 (820)
Q Consensus 192 Ey~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs--------------------------------------- 231 (820)
|+++| .|.+... ..++..+...++.|++..|+.||+
T Consensus 96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99997 4433222 136777777777777777777774
Q ss_pred -------------------CCeeeccCCCCCcccccccCCCeEEEeecccccccCCccccccccccc---cCcccccc--
Q 003438 232 -------------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY---RSPEVLLG-- 287 (820)
Q Consensus 232 -------------------~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~gt~~Y---~APEvl~~-- 287 (820)
..++|+|++|.||+++.+ ....+.|+||+.+...+... .......+ ..|+.+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHH
Confidence 247999999999999621 14567899999985432211 00000111 12222110
Q ss_pred ------------ccccccchhHhHHHHHHHHHhCCCCC
Q 003438 288 ------------YQYTTAIDMWSFGCIVAELFLGLPLF 313 (820)
Q Consensus 288 ------------~~yt~ksDIWSLG~ILyeLltG~~PF 313 (820)
.......+.|+++.++|.+.+|..+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01122368999999999999998766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.6e-06 Score=93.22 Aligned_cols=138 Identities=20% Similarity=0.143 Sum_probs=87.6
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe-ecceeEEEEe
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHLCICFE 192 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~-~~~~l~LVmE 192 (820)
++.++.|....||++ +..+++|+-. .......+.+|.++|+.|.... .-.|.+++.+.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~----~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCV----KVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTC----SSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcC----CCCCCCeEeecccCCCceEEEEe
Confidence 345788999999998 3458888854 3344567889999999996421 123556666653 4456789999
Q ss_pred ccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc-----------------------------------------
Q 003438 193 LLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK----------------------------------------- 230 (820)
Q Consensus 193 y~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH----------------------------------------- 230 (820)
+++| .+.+... ..++..+...++.++.+.|..||
T Consensus 94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9997 4433211 11333333333333333333333
Q ss_pred -------------------cCCeeeccCCCCCcccccccCCCe-EEEeecccccc
Q 003438 231 -------------------DAGIIHCDLKPENILLCTSVKPAE-IKIIDFGSACT 265 (820)
Q Consensus 231 -------------------s~gIVHrDLKPeNILl~~~~~~~~-iKL~DFGlA~~ 265 (820)
...+||+|+++.|||++.+...+. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235799999999999963212344 58999998854
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=6.7e-06 Score=85.58 Aligned_cols=132 Identities=13% Similarity=0.096 Sum_probs=89.6
Q ss_pred EeccCCce-eEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEecc
Q 003438 116 LLGHGTFG-QVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL 194 (820)
Q Consensus 116 ~LG~G~fG-~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~ 194 (820)
.+..|..+ .||+......+..+++|+-... ....+.+|..+|+.|.. +--|.+++.++.+.+..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~------~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA------FMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT------TSCCCCEEEEEEETTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc------CCCcCeEEEEEEECCeEEEEEEee
Confidence 34445554 6999887777888999987643 34567889999999853 223778888888889999999999
Q ss_pred CC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc------------------------------------------
Q 003438 195 DS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD------------------------------------------ 231 (820)
Q Consensus 195 ~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs------------------------------------------ 231 (820)
.| .+.+...... .....+..++...|..||.
T Consensus 103 ~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 87 4444332111 1122333334444443332
Q ss_pred ----------------CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 232 ----------------AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 232 ----------------~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
..++|+|+++.|||++ ..+.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 1379999999999995 44556799999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=9.1e-06 Score=89.96 Aligned_cols=77 Identities=18% Similarity=0.193 Sum_probs=51.1
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.+.||.|..+.||++....+++.|+||...... ........|.++|+.+... ....+.+++.+ +.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~----~~~~vP~~~~~--d~~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH----VPHLVPRVFYS--DTE 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTT----CGGGSCCEEEE--ETT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhh----CCCCcCeEEEE--cCC
Confidence 567999999999999776667889999865321 1234567899999988642 11234455543 345
Q ss_pred eeEEEEeccCC
Q 003438 186 HLCICFELLDS 196 (820)
Q Consensus 186 ~l~LVmEy~~g 196 (820)
..+||||++.+
T Consensus 109 ~~~lvmE~l~g 119 (397)
T 2olc_A 109 MAVTVMEDLSH 119 (397)
T ss_dssp TTEEEECCCTT
T ss_pred ccEEEEEeCCC
Confidence 67899999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=5e-05 Score=81.17 Aligned_cols=76 Identities=18% Similarity=0.196 Sum_probs=44.4
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe-E--EEeecceeEEE
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY-E--YFVCQRHLCIC 190 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~-d--~f~~~~~l~LV 190 (820)
++.|+.|..+.||++... +..+++|+..... .....|+.+++.|...- ...|.++... + +....+..++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g--~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKG--MNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHT--CSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcC--CCCCceeecCCCCEEEEECCEEEEE
Confidence 345666778999998643 3358999998643 34456778888876530 1223333211 0 12345678999
Q ss_pred EeccCC
Q 003438 191 FELLDS 196 (820)
Q Consensus 191 mEy~~g 196 (820)
||+++|
T Consensus 110 ~~~i~G 115 (346)
T 2q83_A 110 YDWIEG 115 (346)
T ss_dssp EECCCC
T ss_pred EEeecC
Confidence 999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=1.9e-05 Score=85.89 Aligned_cols=81 Identities=4% Similarity=-0.000 Sum_probs=55.3
Q ss_pred EEEEEe-ccCCceeEEEeecc--C----CCeEEEEEEEeCChh----hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 112 IVKDLL-GHGTFGQVAKCWDA--E----MNSFVAVKIIKNQPA----YYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 112 ~i~~~L-G~G~fG~Vyka~d~--~----tg~~VAIKiik~~~~----~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
..++.| +.|....+|++... . +++.+++|+...... ....+.+|+.+|+.|... ..-.+.+++.+
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~----~~vpvP~v~~~ 98 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGEL----TDVPVPRVRWI 98 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHH----CCSCCCCEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhc----CCCCCCcEEEE
Confidence 345678 88999999998643 1 256788998764320 124567899999999653 12346777777
Q ss_pred Eeec---ceeEEEEeccCC
Q 003438 181 FVCQ---RHLCICFELLDS 196 (820)
Q Consensus 181 f~~~---~~l~LVmEy~~g 196 (820)
.... +..++|||+++|
T Consensus 99 ~~~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp ECSSTTTSSCEEEEECCCC
T ss_pred ccCCCccCCceEEEEecCC
Confidence 6654 357899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00042 Score=77.37 Aligned_cols=75 Identities=16% Similarity=0.210 Sum_probs=46.2
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeC-------C-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN-------Q-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~-------~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++.||.|..+.||++.. +++.++||.... . .........|.+++..+... ....+.+++.+. .+
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~----~~~~vP~v~~~~--~~ 110 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNL----SPDHVPEVYHFD--RT 110 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHH----SGGGSCCEEEEE--TT
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhh----CCCCCCeEEEEC--CC
Confidence 56789999999999954 466799994321 1 10012233455555544322 123566777665 56
Q ss_pred eeEEEEecc-CC
Q 003438 186 HLCICFELL-DS 196 (820)
Q Consensus 186 ~l~LVmEy~-~g 196 (820)
..++|||++ ++
T Consensus 111 ~~~lv~e~l~~g 122 (420)
T 2pyw_A 111 MALIGMRYLEPP 122 (420)
T ss_dssp TTEEEECCCCTT
T ss_pred ccEEEEeecCCc
Confidence 789999999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00098 Score=72.02 Aligned_cols=76 Identities=24% Similarity=0.205 Sum_probs=59.7
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
-++.|+.|....+|++.. ++..+++|+.... ....+..|...|+.|... ....+++++.+....+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~----~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKT----NSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHT----TSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhh----CCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999965 4567889987743 356678899999999653 23468888888877788999999
Q ss_pred ccCC
Q 003438 193 LLDS 196 (820)
Q Consensus 193 y~~g 196 (820)
+++|
T Consensus 112 ~l~G 115 (312)
T 3jr1_A 112 ALNK 115 (312)
T ss_dssp CCCC
T ss_pred eccC
Confidence 9985
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00031 Score=74.64 Aligned_cols=69 Identities=9% Similarity=-0.051 Sum_probs=44.4
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEec
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFEL 193 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy 193 (820)
++.|+.|....+|++ +.+++|+............+|+.+++.+... +- ..+++.+ +.+.-++|+||
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~----g~--~P~~~~~--~~~~~~~v~e~ 88 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKA----GV--SPEVLHV--DPATGVMVTRY 88 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHT----TS--SCCEEEE--CTTTCCEEEEC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHc----CC--CCceEEE--ECCCCEEEEee
Confidence 567888999999998 3488998875322222235699999888653 11 1445443 33445789999
Q ss_pred c-CC
Q 003438 194 L-DS 196 (820)
Q Consensus 194 ~-~g 196 (820)
+ +|
T Consensus 89 i~~g 92 (301)
T 3dxq_A 89 IAGA 92 (301)
T ss_dssp CTTC
T ss_pred cCCC
Confidence 9 65
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0038 Score=66.59 Aligned_cols=74 Identities=16% Similarity=0.090 Sum_probs=48.1
Q ss_pred EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE-----EeecceeEEE
Q 003438 116 LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY-----FVCQRHLCIC 190 (820)
Q Consensus 116 ~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~-----f~~~~~l~LV 190 (820)
.|+ |....||++.. .+++.+++|+..........+..|..+++.|... +- .+++++.. ....+..++|
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~----g~-~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVND----EV-PVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT----TC-SBCCCCCBTTBSCEEETTEEEEE
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHc----CC-eecceeecCCcEEEEECCEEEEE
Confidence 455 77889998854 3456789999874322345677799999999653 11 23333332 2234567889
Q ss_pred EeccCC
Q 003438 191 FELLDS 196 (820)
Q Consensus 191 mEy~~g 196 (820)
||+++|
T Consensus 106 ~~~i~G 111 (328)
T 1zyl_A 106 FPSVGG 111 (328)
T ss_dssp EECCCC
T ss_pred EEecCC
Confidence 999986
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0033 Score=66.19 Aligned_cols=79 Identities=14% Similarity=0.055 Sum_probs=54.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
.+..-++.+|.|..+.||+++. .+|+.|++|+..... .....+..|...|+.|... .---+++++.+ +.-
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~----~~vpvP~v~~~----~~~ 85 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRS----FGSPVPQVAGW----DDR 85 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCS----TTCCSCCEEEE----ETT
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhh----CCCCcceEEec----cCc
Confidence 4556778999999999999964 568889999876432 2234567899999999542 11124455543 235
Q ss_pred EEEEeccCC
Q 003438 188 CICFELLDS 196 (820)
Q Consensus 188 ~LVmEy~~g 196 (820)
++|||++.+
T Consensus 86 ~lv~e~l~~ 94 (288)
T 3f7w_A 86 TLAMEWVDE 94 (288)
T ss_dssp EEEEECCCC
T ss_pred eEEEEeecc
Confidence 789999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0021 Score=71.39 Aligned_cols=140 Identities=15% Similarity=0.167 Sum_probs=79.5
Q ss_pred EEeccCCceeEEEeeccC-------CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 115 DLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d~~-------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
+.|..|-...+|++.... .++.|++|+............+|..+++.|... .-..+++.++..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~------gv~P~ll~~~~~---- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAER------SLGPQLYGVFPE---- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHT------TSSCCEEEEETT----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhc------CCCCeEEEEcCC----
Confidence 456667778888886532 356799998754322345667899999999753 123566666543
Q ss_pred EEEEeccCC-ChH--------------HHHHh-hhc-----CCC--CHHHHHHHHHHHHHH-------------------
Q 003438 188 CICFELLDS-NLY--------------ELIKI-NHF-----RGL--SLSIVQLFSKQILRG------------------- 225 (820)
Q Consensus 188 ~LVmEy~~g-sL~--------------d~l~~-~~~-----~~l--~e~~i~~I~~QIl~a------------------- 225 (820)
.+||||++| .|. +.+.. +.. +.. -+.++.+++.++...
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 289999985 111 11111 110 111 135566666554321
Q ss_pred hhhcc--------cCCeeeccCCCCCcccccc-cCCCeEEEeeccccc
Q 003438 226 LSLLK--------DAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSAC 264 (820)
Q Consensus 226 L~yLH--------s~gIVHrDLKPeNILl~~~-~~~~~iKL~DFGlA~ 264 (820)
+..|. ...++|+|+.+.|||++.+ +..+.+.|+||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22221 2369999999999999632 123689999999884
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0057 Score=65.03 Aligned_cols=79 Identities=5% Similarity=-0.073 Sum_probs=46.0
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe-E--EEeecceeEE
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIY-E--YFVCQRHLCI 189 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~-d--~f~~~~~l~L 189 (820)
-++.|+.|....||++... ++ .+++|+.... ...+.+..|+.+++.|... ....|.++... + +....+..++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~--g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAK--GLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHT--TCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHC--CCCCCcccCCCCCCEEEEECCEEEE
Confidence 4567888988999998643 33 5789998752 1223456789999988653 11123333211 0 1123466789
Q ss_pred EEeccCC
Q 003438 190 CFELLDS 196 (820)
Q Consensus 190 VmEy~~g 196 (820)
||++++|
T Consensus 101 l~~~l~G 107 (322)
T 2ppq_A 101 LISFLEG 107 (322)
T ss_dssp EEECCCC
T ss_pred EEEeCCC
Confidence 9999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0018 Score=70.74 Aligned_cols=73 Identities=15% Similarity=0.076 Sum_probs=44.5
Q ss_pred EEEeccCCceeEEEeeccC--------CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 114 KDLLGHGTFGQVAKCWDAE--------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~--------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++.|+.|....+|++.... .++.|++|+.............|..+++.|... + -+.+++..+ .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~----g--~~P~~~~~~--~- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKY----K--IAPQLLNTF--N- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHT----T--SSCCEEEEE--T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhc----C--CCCceEEec--C-
Confidence 4567888888999986542 136789998865432222346799999998653 1 144555544 2
Q ss_pred eeEEEEeccCC
Q 003438 186 HLCICFELLDS 196 (820)
Q Consensus 186 ~l~LVmEy~~g 196 (820)
-++||||++|
T Consensus 109 -~~~v~e~i~G 118 (369)
T 3c5i_A 109 -GGRIEEWLYG 118 (369)
T ss_dssp -TEEEEECCCS
T ss_pred -CcEEEEEecC
Confidence 3689999986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0028 Score=68.05 Aligned_cols=35 Identities=29% Similarity=0.429 Sum_probs=27.0
Q ss_pred cCCeeeccCCCCCcccccccC-CCeEEEeecccccc
Q 003438 231 DAGIIHCDLKPENILLCTSVK-PAEIKIIDFGSACT 265 (820)
Q Consensus 231 s~gIVHrDLKPeNILl~~~~~-~~~iKL~DFGlA~~ 265 (820)
...+||+|+.+.|||++.+.. ...+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 457999999999999963110 25789999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0092 Score=67.05 Aligned_cols=73 Identities=19% Similarity=0.164 Sum_probs=49.5
Q ss_pred EEEEeccCCceeEEEeeccC-------CCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 113 VKDLLGHGTFGQVAKCWDAE-------MNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~-------tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
-++.|+.|-...||++.... .++.|++|+..... ....+.+|..+++.|... .-..+++..+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~------g~~P~l~~~~~~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSER------HLGPKLYGIFSG-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHT------TSSSCEEEEETT--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhC------CCCCcEEEEeCC--
Confidence 35678889999999997542 25789999985421 124556799999999653 123556665542
Q ss_pred eeEEEEeccCC
Q 003438 186 HLCICFELLDS 196 (820)
Q Consensus 186 ~l~LVmEy~~g 196 (820)
.+|+||++|
T Consensus 148 --g~v~e~l~G 156 (429)
T 1nw1_A 148 --GRLEEYIPS 156 (429)
T ss_dssp --EEEECCCCE
T ss_pred --CEEEEEeCC
Confidence 289999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.011 Score=67.30 Aligned_cols=74 Identities=16% Similarity=0.157 Sum_probs=47.5
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEe
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFE 192 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmE 192 (820)
-++.|+.|-...+|++.....+..|++|+........-...+|..+|+.|... .-..+++.++. + .+|||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~------gl~P~ll~~~~--~--G~v~e 181 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNK------NIAKKIYVFFT--N--GRIEE 181 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTS------SSBCCEEEEET--T--EEEEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhc------CCCCCEEEEeC--C--eEEEE
Confidence 35678889999999997654457899999854321111125799999999642 22456777663 2 25999
Q ss_pred ccCC
Q 003438 193 LLDS 196 (820)
Q Consensus 193 y~~g 196 (820)
|++|
T Consensus 182 ~I~G 185 (458)
T 2qg7_A 182 FMDG 185 (458)
T ss_dssp CCCS
T ss_pred eeCC
Confidence 9875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.019 Score=62.14 Aligned_cols=68 Identities=12% Similarity=0.085 Sum_probs=44.1
Q ss_pred ccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE------EeecceeEEEE
Q 003438 118 GHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY------FVCQRHLCICF 191 (820)
Q Consensus 118 G~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~------f~~~~~l~LVm 191 (820)
|.|....||++... ++ .+++|+..... ...|+.+++.|... +-+.|++++.. ....+..++||
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~----g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYH-----DEINLSIIRLLHDS----GIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSS-----CCHHHHHHHHHHHT----TCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCcc-----chHHHHHHHHHHhc----CCcccccceecCCCCEEEEECCEEEEEE
Confidence 34446899999643 34 78999887543 14688888888653 22324444422 23356789999
Q ss_pred eccCC
Q 003438 192 ELLDS 196 (820)
Q Consensus 192 Ey~~g 196 (820)
+|++|
T Consensus 101 ~~i~G 105 (339)
T 3i1a_A 101 PFIHA 105 (339)
T ss_dssp ECCCC
T ss_pred eccCC
Confidence 99986
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.05 E-value=0.023 Score=58.16 Aligned_cols=97 Identities=10% Similarity=0.018 Sum_probs=60.8
Q ss_pred ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcc-cCCeeeccCCCCCcccccccCCCeEEEeecccccccCCccccccc
Q 003438 197 NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLK-DAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ 275 (820)
Q Consensus 197 sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLH-s~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~~~~~~~g 275 (820)
+|.++|+... .+++|+++|.++.|.+.+|.-+- .+.-..+=+.|..|+|. .+|.|.+.+ ..+ ...
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s---------~~~ 99 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AAD---------DAG 99 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-ccc---------ccc
Confidence 6888888765 78999999999999999988762 11111233345667774 556665543 111 012
Q ss_pred cccccCccccccccccccchhHhHHHHHHHHHh
Q 003438 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL 308 (820)
Q Consensus 276 t~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt 308 (820)
...+.+||... ...+.+.=|||||+++|..+-
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 33467888763 345678899999999999885
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.19 E-value=0.17 Score=56.74 Aligned_cols=74 Identities=14% Similarity=0.072 Sum_probs=48.0
Q ss_pred EEEEeccCCceeEEEeeccCC-------CeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 113 VKDLLGHGTFGQVAKCWDAEM-------NSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~t-------g~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
-++.|..|-...+|++..... ++.|++|+........-...+|..+++.|... .-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~------gi~P~l~~~~~--- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNI------NIAPNIIADFP--- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHT------TSSCCEEEEET---
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhc------CCCCCEEEEcC---
Confidence 345677788889999875421 57799999764332222345799999998653 12445554332
Q ss_pred eeEEEEeccCC
Q 003438 186 HLCICFELLDS 196 (820)
Q Consensus 186 ~l~LVmEy~~g 196 (820)
-++||||++|
T Consensus 145 -~~~I~efI~G 154 (424)
T 3mes_A 145 -EGRIEEFIDG 154 (424)
T ss_dssp -TEEEEECCCS
T ss_pred -CCEEEEEeCC
Confidence 3789999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.01 E-value=0.25 Score=54.63 Aligned_cols=32 Identities=28% Similarity=0.395 Sum_probs=25.9
Q ss_pred CeeeccCCCCCcccccc---cCCCeEEEeeccccc
Q 003438 233 GIIHCDLKPENILLCTS---VKPAEIKIIDFGSAC 264 (820)
Q Consensus 233 gIVHrDLKPeNILl~~~---~~~~~iKL~DFGlA~ 264 (820)
.++|+|+.+.|||+..+ .+...++|+||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 37899999999999532 356789999999884
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 820 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-56 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-05 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-04 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-50 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-05 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-05 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-49 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-49 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-04 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-04 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-47 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-04 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-04 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-45 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-05 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-04 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 0.002 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 0.003 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 0.002 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-05 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-41 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-40 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-40 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 0.004 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-04 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 0.002 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-32 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-20 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-56
Identities = 75/351 (21%), Positives = 122/351 (34%), Gaps = 59/351 (16%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
+ LG G G V K +A K+I +PA Q + E+ +L N
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN---- 62
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+IV Y F + IC E +D + + + + I+ S +++GL
Sbjct: 63 ----SPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILGKVSIAVIKGL 117
Query: 227 SLLKDA-GIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEV 284
+ L++ I+H D+KP NIL+ + EIK+ DFG + D S++ +R Y SPE
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPER 174
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
L G Y+ D+WS G + E+ +G P +L + + +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
+ L+ IV
Sbjct: 235 RPLSSYGMDSR----------------------------------PPMAIFELLDYIVNE 260
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455
P + L S E DF+ + +PA+R Q H F+
Sbjct: 261 PPPK--LPSGVFSLE------FQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (463), Expect = 9e-52
Identities = 107/376 (28%), Positives = 163/376 (43%), Gaps = 62/376 (16%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNK----K 165
RYI+ LG G F V D N+ VA+KI++ Y + A E+ +L +N K
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 166 YDREDKHHIVRIYEYFVCQR----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
D +HI+++ ++F + H+ + FE+L NL LIK RG+ L V+ SKQ
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 222 ILRGLS-LLKDAGIIHCDLKPENILLCTS---VKPAEIKIIDFGSACTEDRTVYSYIQSR 277
+L GL + + GIIH D+KPEN+L+ +IKI D G+AC D + IQ+R
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------EFDLLRRMIRILGA 331
YRSPEVLLG + D+WS C++ EL G LF + D + ++I +LG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG- 252
Query: 332 QPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKE 391
+ P Y+L+ K T FF G + NI +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLK------------------------------ 282
Query: 392 YFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHP 451
+ +++ E + DFL +++ DP KR HP
Sbjct: 283 -------------FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP 329
Query: 452 FVTGEPFTCPYQPPPE 467
++ + P
Sbjct: 330 WLKDTLGMEEIRVPDR 345
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 63/245 (25%), Positives = 106/245 (43%), Gaps = 21/245 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
+ + LG G FG+V K + E + A K+I + +VE+ IL + +
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP--- 69
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+IV++ + F + +L I E + + + R L+ S +Q+ KQ L L+
Sbjct: 70 ----NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNY 125
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY---SYIQSRYYRSPEVL 285
L D IIH DLK NIL +IK+ DFG + RT+ S+I + Y+ +PEV+
Sbjct: 126 LHDNKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 286 LGYQ-----YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDYVL 338
+ Y D+WS G + E+ P + +L ++ + P
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 339 KEAKN 343
K+
Sbjct: 243 SNFKD 247
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (101), Expect = 7e-05
Identities = 16/70 (22%), Positives = 29/70 (41%), Gaps = 3/70 (4%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
+ H + ++ + ++ S+ S DFLK +E + RW+ Q
Sbjct: 209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS---NFKDFLKKCLEKNVDARWTTSQ 265
Query: 447 ASRHPFVTGE 456
+HPFVT +
Sbjct: 266 LLQHPFVTVD 275
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 54/239 (22%), Positives = 98/239 (41%), Gaps = 17/239 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
+ + LG G FG V + + +A+K++ + Q EV I + L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+I+R+Y YF + + E + + ++
Sbjct: 66 ------PNILRLYGYFHDATRVYLILEYAPLGTVYRE-LQKLSKFDEQRTATYITELANA 118
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEV 284
LS +IH D+KPEN+LL ++ E+KI DFG + + + Y PE+
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 175
Query: 285 LLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
+ G + +D+WS G + E +G P F + + +R+ R+ PD+V + A++
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF-TFPDFVTEGARD 233
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (96), Expect = 3e-04
Identities = 14/69 (20%), Positives = 29/69 (42%), Gaps = 6/69 (8%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
L+GK F +E K +S + + + D + L++ +P++R +
Sbjct: 198 LVGKPPFEANTYQETY------KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 251
Query: 447 ASRHPFVTG 455
HP++T
Sbjct: 252 VLEHPWITA 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-50
Identities = 65/254 (25%), Positives = 106/254 (41%), Gaps = 19/254 (7%)
Query: 104 NAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLN 163
NA + +LG G G+V + ++ A+K++++ P +A EV +
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHW--- 59
Query: 164 KKYDREDKH-HIVRIYEYF----VCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQL 217
R + HIVRI + + ++ L I E LD L+ I+ + +
Sbjct: 60 ----RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 218 FSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQ 275
K I + L I H D+KPEN+L + A +K+ DFG A T ++ +
Sbjct: 116 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 276 SRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
+ YY +PEVL +Y + DMWS G I+ L G P F + M + +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 336 YVLKEAKNTSKFFK 349
+ E S+ K
Sbjct: 236 FPNPEWSEVSEEVK 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-05
Identities = 16/108 (14%), Positives = 32/108 (29%), Gaps = 14/108 (12%)
Query: 364 IGGRSAYQALTEIEYEARELKKPLIGKEYFH--HKHLEEIVTNYPYRKNLSMEDISKESQ 421
+L I Y P I N ++S+E
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE-- 247
Query: 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETP 469
+ ++ L++ +P +R + + HP++ P+TP
Sbjct: 248 ----VKMLIRNLLKTEPTQRMTITEFMNHPWIMQS------TKVPQTP 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (449), Expect = 7e-50
Identities = 53/231 (22%), Positives = 98/231 (42%), Gaps = 13/231 (5%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
Y + + LG G FG V + + + A K + + + E+ ++ L
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP--- 83
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
+V +++ F + + +E + L+E + H + +S + +Q+ +GL
Sbjct: 84 ----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLC 138
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVL 285
+ + +H DLKPENI+ T+ + E+K+IDFG ++V + + +PEV
Sbjct: 139 HMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
G DMWS G + L GL F G ++ + LR +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 46.2 bits (109), Expect = 1e-05
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 2/96 (2%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
L G F ++ +E + N + D S S I DF++ L+ DP R + Q
Sbjct: 219 LSGLSPFGGENDDETLRNV--KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276
Query: 447 ASRHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHH 482
A HP++T P + + + K +
Sbjct: 277 ALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYD 312
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 92/366 (25%), Positives = 154/366 (42%), Gaps = 82/366 (22%)
Query: 115 DLLGHGTFGQVAKCWDAEMNSFVAVKIIK------NQPAYYQQALVEVSILTTLNKKYDR 168
D LG G F V K D N VA+K IK + + AL E+ +L L+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+I+ + + F + ++ + F+ ++++L +IK N L+ S ++ + L+GL
Sbjct: 60 ---PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-LTPSHIKAYMLMTLQGLEY 115
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPEVL 285
L I+H DLKP N+LL + +K+ DFG A + +R + +R+YR+PE+L
Sbjct: 116 LHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 172
Query: 286 LGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344
G + Y +DMW+ GCI+AEL L +P PG S+ D L R+
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI------------------- 213
Query: 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTN 404
F+ +G+ TE ++ + + F L I +
Sbjct: 214 ---FETLGT-------------------PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA 251
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP 464
+ L+D ++GL F+P R + QA + + + P P
Sbjct: 252 -----------AGDD------LLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT---P 291
Query: 465 PPETPR 470
+ PR
Sbjct: 292 GCQLPR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-49
Identities = 76/371 (20%), Positives = 135/371 (36%), Gaps = 84/371 (22%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
+Y +G GTFG+V K + VA+K + + + AL E+ IL L
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH-- 68
Query: 167 DREDKHHIVRIYE--------YFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLF 218
++V + E Y C+ + + F+ + +L L+ N +LS ++
Sbjct: 69 -----ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRV 122
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA-------CTEDRTVY 271
+ +L GL + I+H D+K N+L+ + +K+ DFG A ++
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 272 SYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
+ + + +YR PE+LLG + Y ID+W GCI+AE++ P+ G +E L + ++ G
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 331 AQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGK 390
+ P+ P +
Sbjct: 240 SITPEVW------------------------------------------------PNVDN 251
Query: 391 EYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRH 450
+ K + L +D + L+ DPA+R A H
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPY------ALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 451 PFVTGEPFTCP 461
F +P
Sbjct: 306 DFFWSDPMPSD 316
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-49
Identities = 91/382 (23%), Positives = 153/382 (40%), Gaps = 82/382 (21%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
Y ++G+G+FG V + + VA+K + + + E+ I+ L+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHC---- 73
Query: 170 DKHHIVRIYEYFVC------QRHLCICFELLDSNLYELIK--INHFRGLSLSIVQLFSKQ 221
+IVR+ +F + +L + + + +Y + + + L + V+L+ Q
Sbjct: 74 ---NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
+ R L+ + GI H D+KP+N+LL A +K+ DFGSA SYI SRYY
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYY 188
Query: 280 RSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
R+PE++ G YT++ID+WS GC++AEL LG P+FPG S D L +I++LG + +
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHL 398
+ N ++ F +
Sbjct: 249 EMNPNYTE----------------------------------------------FKFPQI 262
Query: 399 EEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458
+ +R E + L+E+ P R +P +A H F +
Sbjct: 263 KAHPWTKVFRPRTPPE-----------AIALCSRLLEYTPTARLTPLEACAHSFF--DEL 309
Query: 459 TCPYQPPPETPRVPVAQNFKVD 480
P P P NF
Sbjct: 310 RDPNVKLPNGRDTPALFNFTTQ 331
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-49
Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 12/234 (5%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165
E +Y++ + LG G FG V +C + K +K + E+SIL +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILR 224
+I+ ++E F L + FE + +++E I + F L+ + + Q+
Sbjct: 62 -------NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCE 113
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDRTVYSYIQSRYYRSP 282
L L I H D++PENI+ T + + IKII+FG A + Y +P
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 283 EVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
EV +TA DMWS G +V L G+ F + ++ ++ +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (93), Expect = 8e-04
Identities = 16/84 (19%), Positives = 34/84 (40%), Gaps = 2/84 (2%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
L G F + ++I+ N + E+ KE I + +DF+ L+ + R + +
Sbjct: 197 LSGINPFLAETNQQIIENIMNAEYTFDEEAFKE--ISIEAMDFVDRLLVKERKSRMTASE 254
Query: 447 ASRHPFVTGEPFTCPYQPPPETPR 470
A +HP++ + +
Sbjct: 255 ALQHPWLKQKIERVSTKVIRTLKH 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-49
Identities = 85/352 (24%), Positives = 143/352 (40%), Gaps = 73/352 (20%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAE-MNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKK 165
+Y +G G +G+V K D + FVA+K ++ + + EV++L L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 166 YDREDKHHIVRIYEYFVCQR-----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
+ ++VR+++ R L + FE +D +L + G+ ++
Sbjct: 68 ----EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYR 280
Q+LRGL L ++H DLKP+NIL+ TS ++ + + S + + +YR
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILV-TSSGQIKLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 281 SPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340
+PEVLL Y T +D+WS GCI AE+F PLF G+S+ D L +++ ++G
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG------- 235
Query: 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEE 400
E + + ++ FH K +
Sbjct: 236 --------------------------------------EEDWPRDVALPRQAFHSKSAQP 257
Query: 401 IVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
I DI + D L + F+PAKR S + A HP+
Sbjct: 258 IEKFVT--------DIDEL------GKDLLLKCLTFNPAKRISAYSALSHPY 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 1e-48
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 13/231 (5%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKYDR 168
Y + + LG G FG V +C + K I P E+SI+ L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP--- 86
Query: 169 EDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
++ +++ F + + + E L L++ I ++ +S + V + +Q GL
Sbjct: 87 ----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLK 141
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQSRYYRSPEVL 285
+ + I+H D+KPENI+ T K + +KIIDFG A D V + + +PE++
Sbjct: 142 HMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 200
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
DMW+ G + L GL F G + + L+ + R D
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 41.6 bits (97), Expect = 3e-04
Identities = 19/96 (19%), Positives = 37/96 (38%), Gaps = 8/96 (8%)
Query: 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLK 431
A+ + Y P G++ + L+ + + +S E DF+K
Sbjct: 213 AIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDEDAFSSVSPE------AKDFIK 264
Query: 432 GLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPE 467
L++ +P KR + A HP++ G+ + P
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-48
Identities = 83/370 (22%), Positives = 141/370 (38%), Gaps = 65/370 (17%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKK 165
+RY +G G G V +DA ++ VA+K + + ++A E+ ++ +N
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH- 75
Query: 166 YDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFS 219
+I+ + F Q+ + + EL+D+NL ++I++ +
Sbjct: 76 ------KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLL 125
Query: 220 KQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY 279
Q+L G+ L AGIIH DLKP NI++ + + + Y+ +RYY
Sbjct: 126 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL-DFGLARTAGTSFMMTPYVVTRYY 184
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
R+PEV+LG Y +D+WS GCI+ E+ LFPG D ++I LG P+++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLE 399
+ + +P F
Sbjct: 245 LQPTVRNYVE----------------------------------NRPKYAGLTFPK---- 266
Query: 400 EIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459
+ +L D D L ++ DPAKR S A +HP++
Sbjct: 267 ------LFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320
Query: 460 CPYQPPPETP 469
+ PP
Sbjct: 321 AEVEAPPPQI 330
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 87/364 (23%), Positives = 147/364 (40%), Gaps = 79/364 (21%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
+ + +G GT+G V K + VA+K I+ A+ E+S+L LN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-- 60
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+IV++ + + L + FE L +L + + + G+ L +++ + Q+L+GL
Sbjct: 61 -----PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
+ ++H DLKP+N+L+ T IK+ DFG A RT + + +YR+PE
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 284 VLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
+LLG +Y +TA+D+WS GCI AE+ LFPG SE D L
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF------------------- 213
Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
+ F+ +G+ + + + +
Sbjct: 214 ---RIFRTLGTPDEVV---------------------------------WPGVTSMPDYK 237
Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPY 462
++P + + L ++ +DP KR S A HPF F
Sbjct: 238 PSFPKWARQDFSKVVPP--LDEDGRSLLSQMLHYDPNKRISAKAALAHPF-----FQDVT 290
Query: 463 QPPP 466
+P P
Sbjct: 291 KPVP 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-46
Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 22/244 (9%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNK 164
+ + +GHG+FG V D + VA+K + +Q + EV L L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR- 73
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
H + ++ ++ + + E + +L++++ + L + + L
Sbjct: 74 -------HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGAL 125
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPE 283
+GL+ L +IH D+K NILL +P +K+ DFGSA S++ + Y+ +PE
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-NSFVGTPYWMAPE 181
Query: 284 VLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR-ILGAQPPDYVLK 339
V+L QY +D+WS G EL P + L + + A + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241
Query: 340 EAKN 343
+N
Sbjct: 242 YFRN 245
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.3 bits (99), Expect = 2e-04
Identities = 19/93 (20%), Positives = 28/93 (30%), Gaps = 10/93 (10%)
Query: 365 GGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424
G+ +L E E K PL L I N L S+
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPA--LQSGHWSEY----- 242
Query: 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457
+F+ ++ P R + +H FV E
Sbjct: 243 -FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 164 bits (416), Expect = 4e-46
Identities = 92/350 (26%), Positives = 151/350 (43%), Gaps = 76/350 (21%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII---KNQPAYYQQALVEVSILTTLNKKY 166
+Y + +G GT+G V K + A+K I K + E+SIL L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-- 59
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+IV++Y+ ++ L + FE LD +L +L+ + GL + F Q+L G+
Sbjct: 60 -----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGI 113
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
+ D ++H DLKP+N+L+ + E+KI DFG A R I + +YR+P+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170
Query: 284 VLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342
VL+G + Y+T ID+WS GCI AE+ G PLFPG SE D L
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM------------------- 211
Query: 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIV 402
+ F+ +G+ ++ K + + L +
Sbjct: 212 ---RIFRILGTPNS---------------------------------KNWPNVTELPKYD 235
Query: 403 TNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPF 452
N+ + L E K + + +D L +++ DP +R + QA H +
Sbjct: 236 PNFTVYEPLPWESFLK--GLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-46
Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 25/245 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
+ +LG G+F V + + A+KI++ + E +++ L+
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-- 66
Query: 166 YDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQIL 223
H V++Y F L L + I + + ++ +I+
Sbjct: 67 ------HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIV 118
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRY 278
L L GIIH DLKPENILL + I+I DFG+A ++ S++ +
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
Y SPE+L + D+W+ GCI+ +L GLP F +E+ + +++I++ P+
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-DFPEKFF 234
Query: 339 KEAKN 343
+A++
Sbjct: 235 PKARD 239
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 8e-46
Identities = 47/242 (19%), Positives = 93/242 (38%), Gaps = 18/242 (7%)
Query: 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII-KNQPAYYQQALVEVSILTTLNKKY 166
+++Y + +G G G V D VA++ + Q + + E+ ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP- 77
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+IV + ++ L + E L L + + + ++ L+ L
Sbjct: 78 ------NIVNYLDSYLVGDELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
L +IH D+K +NILL +K+ DFG E + + + Y+ +PE
Sbjct: 130 EFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDYVLKEA 341
V+ Y +D+WS G + E+ G P + + L + Q P+ +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 342 KN 343
++
Sbjct: 247 RD 248
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (92), Expect = 9e-04
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 14/98 (14%)
Query: 378 YEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD 437
E E + P + + + L I TN E +S DFL ++ D
Sbjct: 207 IEMIEGEPPYLNEN--PLRALYLIATNGTPELQNP-EKLSAI------FRDFLNRCLDMD 257
Query: 438 PAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRVPVAQ 475
KR S + +H F TP + A+
Sbjct: 258 VEKRGSAKELLQHQF-----LKIAKPLSSLTPLIAAAK 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-45
Identities = 90/374 (24%), Positives = 144/374 (38%), Gaps = 83/374 (22%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK--NQPAYYQQALVEVSILTTLNKKYD 167
RY +G G +G V +D VA+K I Y Q+ L E+ IL +
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE-- 66
Query: 168 REDKHHIVRIYEYFV-----CQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+I+ I + + + + L+ ++LY+L+K + LS + F QI
Sbjct: 67 -----NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQI 118
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC------TEDRTVYSYIQS 276
LRGL + A ++H DLKP N+LL ++KI DFG A + Y+ +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 277 RYYRSPEVLL-GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
R+YR+PE++L YT +ID+WS GCI+AE+ P+FPG D L I + P
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQ 234
Query: 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHH 395
L N +
Sbjct: 235 EDLNCIINLKARNYLL-------------------------------------------- 250
Query: 396 KHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455
+ P++ + + +D L ++ F+P KR QA HP++
Sbjct: 251 --------SLPHKNKVPWNRLFPN--ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE- 299
Query: 456 EPFTCPYQPPPETP 469
+ + +P E P
Sbjct: 300 QYYDPSDEPIAEAP 313
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-45
Identities = 84/377 (22%), Positives = 151/377 (40%), Gaps = 84/377 (22%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTL 162
E + Y +G G +G V D + VA+K + + ++A E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 163 NKKYDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
+ +++ + + F + + ++L +L+K L +Q
Sbjct: 75 RHE-------NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQ 124
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
Q+L+GL + AGIIH DLKP N+ + + E+KI+DFG A D + Y+ +
Sbjct: 125 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVT 181
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
R+YR+PEV+L + YT +D+WS GCI+AE+ G LF G+ D L+ ++++ G P +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHH 395
+V + + +K + G
Sbjct: 242 FVQRLQSDEAKNYMK--------------------------------------GLPELEK 263
Query: 396 KHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455
K I+TN S V+ L+ ++ D +R + +A HP+
Sbjct: 264 KDFASILTN-----------ASPL------AVNLLEKMLVLDAEQRVTAGEALAHPYFE- 305
Query: 456 EPFTCPYQPPPETPRVP 472
+ P+V
Sbjct: 306 -----SLHDTEDEPQVQ 317
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 4e-45
Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 16/233 (6%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALV--EVSILTTLNKKYD 167
Y +D+LG G F +V D VA+K I + ++ + E+++L +
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK---- 65
Query: 168 REDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
H +IV + + + HL + +L+ L++ I + Q+L
Sbjct: 66 ----HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDA 119
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED--RTVYSYIQSRYYRSPE 283
+ L D GI+H DLKPEN+L + + ++I I DFG + ED + + + Y +PE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
VL Y+ A+D WS G I L G P F ++ L ++++ Y
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.8 bits (108), Expect = 1e-05
Identities = 22/100 (22%), Positives = 41/100 (41%), Gaps = 8/100 (8%)
Query: 372 ALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLK 431
++ I Y P + K E+I+ + +DIS DF++
Sbjct: 194 SIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEYEFDSPYWDDISDS------AKDFIR 245
Query: 432 GLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPPPETPRV 471
L+E DP KR++ QA +HP++ G+ + ++
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 162 bits (410), Expect = 7e-45
Identities = 72/373 (19%), Positives = 140/373 (37%), Gaps = 68/373 (18%)
Query: 87 YDNVNSDL---ILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK 143
Y +VN+ +V Q Y + LG G + +V + + N V VKI+K
Sbjct: 10 YTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 144 NQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIK 203
P ++ E+ IL L +I+ + + N + +
Sbjct: 70 --PVKKKKIKREIKILENLR------GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121
Query: 204 INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263
++ L+ ++ + +IL+ L GI+H D+KP N+++ + ++++ID+G A
Sbjct: 122 --LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLA 177
Query: 264 C--TEDRTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLG-LPLFPGASEF 319
+ + SRY++ PE+L+ YQ Y ++DMWS GC++A + P F G +
Sbjct: 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 320 DLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYE 379
D L R+ ++LG + + +
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYN------------------------------------- 260
Query: 380 ARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPA 439
+I+ + ++ + + +DFL L+ +D
Sbjct: 261 ------------IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 440 KRWSPFQASRHPF 452
R + +A HP+
Sbjct: 309 SRLTAREAMEHPY 321
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (406), Expect = 8e-45
Identities = 61/259 (23%), Positives = 99/259 (38%), Gaps = 34/259 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA----------YYQQALVEVSIL 159
Y K++LG G V +C AVKII + L EV IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 160 TTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLF 218
++ +I+++ + + + F+L+ L++ + LS +
Sbjct: 64 RKVS------GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKI 115
Query: 219 SKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC--TEDRTVYSYIQS 276
+ +L + L I+H DLKPENILL IK+ DFG +C + +
Sbjct: 116 MRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGT 172
Query: 277 RYYRSPEVLLGYQ------YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILG 330
Y +PE++ Y +DMWS G I+ L G P F + +LR ++
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--- 229
Query: 331 AQPPDYVLKEAKNTSKFFK 349
+ E + S K
Sbjct: 230 -GNYQFGSPEWDDYSDTVK 247
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 40.1 bits (93), Expect = 7e-04
Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 8/75 (10%)
Query: 378 YEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFD 437
Y P ++ L I++ + +D S + D + +
Sbjct: 206 YTLLAGSPPFWHRK--QMLMLRMIMSGNYQFGSPEWDDYSDT------VKDLVSRFLVVQ 257
Query: 438 PAKRWSPFQASRHPF 452
P KR++ +A HPF
Sbjct: 258 PQKRYTAEEALAHPF 272
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-44
Identities = 93/364 (25%), Positives = 153/364 (42%), Gaps = 82/364 (22%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
+Y + +G GT+G V K + E + VA+K ++ + AL E+ +L L K
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK- 61
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+IVR+++ + L + FE D +L + + L IV+ F Q+L+GL
Sbjct: 62 ------NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGL 114
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYIQSRYYRSPE 283
++H DLKP+N+L+ + E+K+ +FG A R + + + +YR P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPD 171
Query: 284 VLLGYQ-YTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
VL G + Y+T+IDMWS GCI AEL PLFPG D L+R+ R+LG
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT-------- 223
Query: 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEI 401
E + + K K Y + +
Sbjct: 224 -----------------------------------EEQWPSMTKLPDYKPYPMYPATTSL 248
Query: 402 VTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCP 461
V P ++ D L+ L++ +P +R S +A +HP+ +
Sbjct: 249 VNVVP--------KLNAT------GRDLLQNLLKCNPVQRISAEEALQHPYFS------D 288
Query: 462 YQPP 465
+ PP
Sbjct: 289 FCPP 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 69/242 (28%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAY----YQQALVEVSILTTLNKK 165
+I+ +LG G+FG+V + N F A+K +K + +VE +L+
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-- 60
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILR 224
+ + ++ F + +L E L+ +L I+ LS ++ +I+
Sbjct: 61 ----EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIIL 114
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRS 281
GL L GI++ DLK +NILL K IKI DFG D ++ + Y +
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171
Query: 282 PEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341
PE+LLG +Y ++D WSFG ++ E+ +G F G E +L IR+ P ++ KEA
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-HSIRMDNPFYPRWLEKEA 230
Query: 342 KN 343
K+
Sbjct: 231 KD 232
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.002
Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 7/91 (7%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWS-PF 445
LIG+ FH + EE+ + + KE D L L +P KR
Sbjct: 197 LIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE------AKDLLVKLFVREPEKRLGVRG 250
Query: 446 QASRHPFVTGEPFTCPYQPPPETPRVPVAQN 476
+HP + + + P P ++
Sbjct: 251 DIRQHPLFREINWEELERKEIDPPFRPKVKS 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 57/249 (22%), Positives = 95/249 (38%), Gaps = 26/249 (10%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYD 167
Y V +G G++G+ K + K + A Q + EV++L L
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH--- 62
Query: 168 REDKHHIVRIYEYFVCQ--RHLCICFELLD-SNLYELIK--INHFRGLSLSIVQLFSKQI 222
+IVR Y+ + + L I E + +L +I + L V Q+
Sbjct: 63 ----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118
Query: 223 LRGLSLLKDAG-----IIHCDLKPENILLCTSVKPAEIKIIDFGSAC---TEDRTVYSYI 274
L ++H DLKP N+ L +K+ DFG A + +++
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDFGLARILNHDTSFAKAFV 175
Query: 275 QSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPP 334
+ YY SPE + Y D+WS GC++ EL +P F S+ +L ++ + P
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235
Query: 335 DYVLKEAKN 343
E
Sbjct: 236 YRYSDELNE 244
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 53/244 (21%), Positives = 91/244 (37%), Gaps = 21/244 (8%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKII--KNQPAYYQQALVEVSILTTLNKKYD 167
+ + LG G +G+V + VAVKI+ K + E+ I LN +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-- 63
Query: 168 REDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLS 227
++V+ Y + + E +I G+ Q F Q++ G+
Sbjct: 64 -----NVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 228 LLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-----TEDRTVYSYIQSRYYRSP 282
L GI H D+KPEN+LL +KI DFG A +R + + Y +P
Sbjct: 118 YLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 283 EVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGA--QPPDYVLK 339
E+L ++ +D+WS G ++ + G + S+ + P +
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 234
Query: 340 EAKN 343
Sbjct: 235 APLA 238
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-44
Identities = 55/238 (23%), Positives = 96/238 (40%), Gaps = 16/238 (6%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
+ + +G G FG V + VAVK IKN A Q L E S++T L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHS--- 60
Query: 169 EDKHHIVRIYEYFVCQR-HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
++V++ V ++ L I E + +L + ++ L + FS + +
Sbjct: 61 ----NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
L+ +H DL N+L+ K+ DFG T + + +PE L
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR 173
Query: 287 GYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
+++T D+WSFG ++ E++ G +P D++ R+ + PD
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYE 231
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-43
Identities = 58/267 (21%), Positives = 108/267 (40%), Gaps = 35/267 (13%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
+Y V LLG G FG V N VA+K ++ + + +EV +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+ + ++R+ ++F + E + I L + + F Q+
Sbjct: 65 SSGF-----SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVY-SYIQSRYYRS 281
L + + G++H D+K ENIL+ + E+K+IDFGS TVY + +R Y
Sbjct: 120 LEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGALLKDTVYTDFDGTRVYSP 177
Query: 282 PEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEF----------------DLLRR 324
PE + ++Y + +WS G ++ ++ G F E L+R
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 237
Query: 325 MIRILGAQPPDYVLKEAKNTSKFFKCI 351
+ + + P +E +N + + +
Sbjct: 238 CLALRPSDRPT--FEEIQN-HPWMQDV 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (87), Expect = 0.003
Identities = 7/67 (10%), Positives = 23/67 (34%), Gaps = 6/67 (8%)
Query: 405 YPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQP 464
+ + + + + ++ ++ + P+ R + + HP++
Sbjct: 210 FEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL------ 263
Query: 465 PPETPRV 471
P ET +
Sbjct: 264 PQETAEI 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 4e-42
Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 19/238 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
RY + ++LG G +V D ++ VAVK+++ P++Y + E LN
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 166 YDREDKHHIVRIYEYFVCQRH----LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
IV +Y+ + I E +D I ++ ++
Sbjct: 68 -------AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMTPKRAIEVIAD 119
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV---YSYIQSRY 278
+ L+ GIIH D+KP NI++ + + + +V + I +
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
Y SPE G D++S GC++ E+ G P F G S + + +R P
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 6e-42
Identities = 53/237 (22%), Positives = 101/237 (42%), Gaps = 16/237 (6%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKKY 166
+ + LG G+FG+V + A+K++K + + E +L+ +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP- 64
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
I+R++ F + + + + ++ + R + + ++ ++ L
Sbjct: 65 ------FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCLAL 117
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLL 286
L II+ DLKPENILL K IKI DFG A Y+ + Y +PEV+
Sbjct: 118 EYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVS 174
Query: 287 GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
Y +ID WSFG ++ E+ G F ++ +++ + P + ++ K+
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRFPPFFNEDVKD 230
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 38.9 bits (90), Expect = 0.002
Identities = 17/101 (16%), Positives = 31/101 (30%), Gaps = 11/101 (10%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
L G F+ + + + + ++ + D L L+ D ++R Q
Sbjct: 195 LAGYTPFYDSNTMKTY------EKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 248
Query: 447 AS-----RHPFVTGEPFTCPYQPPPETPRVPVAQNFKVDHH 482
HP+ + ETP P Q + D
Sbjct: 249 NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTS 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 1e-41
Identities = 47/254 (18%), Positives = 92/254 (36%), Gaps = 20/254 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
Y V +G G+FG + + + N VA+K + + Q E L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGC---- 60
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
I +Y + H + +LL +L +L+ + R S+ V + +KQ+L + +
Sbjct: 61 --TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI 117
Query: 230 KDAGIIHCDLKPENILLCTSVKPAE--IKIIDFGSA----------CTEDRTVYSYIQSR 277
+ +++ D+KP+N L+ I ++DFG R + +
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
Y S LG + + D+ + G + G + G ++ RI + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 338 LKEAKNTSKFFKCI 351
+ + F
Sbjct: 238 RELCAGFPEEFYKY 251
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-41
Identities = 53/247 (21%), Positives = 104/247 (42%), Gaps = 23/247 (9%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKK 165
R +G G+F V K D E VA ++++ + Q+ E +L L
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH- 67
Query: 166 YDREDKHHIVRIYEYFVC----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
+IVR Y+ + ++ + + EL+ S + + F+ + + +++ + +Q
Sbjct: 68 ------PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY-LKRFKVMKIKVLRSWCRQ 120
Query: 222 ILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTV-YSYIQSRY 278
IL+GL L IIH DLK +NI + +KI D G A + + + I +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKRASFAKAVIGTPE 178
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR--ILGAQPPDY 336
+ +PE+ +Y ++D+++FG + E+ + + R + + A
Sbjct: 179 FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 337 VLKEAKN 343
+ E K
Sbjct: 238 AIPEVKE 244
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 18/237 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK-------NQPAYYQQALVEVSILTTL 162
Y + LG G F V KC + A K IK + + EVSIL +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQI 222
+++ ++E + + + + EL+ L+ F KQI
Sbjct: 71 QHP-------NVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQI 122
Query: 223 LRGLSLLKDAGIIHCDLKPENILLCTS-VKPAEIKIIDFGSA--CTEDRTVYSYIQSRYY 279
L G+ L I H DLKPENI+L V IKIIDFG A + + +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDY 336
+PE++ DMWS G I L G F G ++ + L + + +Y
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (100), Expect = 9e-05
Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 6/84 (7%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
L G F +E + N N ED S DF++ L+ DP KR +
Sbjct: 210 LSGASPFLGDTKQETLANV-SAVNYEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267
Query: 447 ASRHPFVTG----EPFTCPYQPPP 466
+ +HP++ + + + P
Sbjct: 268 SLQHPWIKPKDTQQALSSAWSHPQ 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (381), Expect = 3e-41
Identities = 55/252 (21%), Positives = 90/252 (35%), Gaps = 18/252 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
RY + +G G+FG + D VA+K+ + + Q +E I +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQ------ 60
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
I I + + ELL +L +L R SL V L + Q++ + +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYI 119
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----------CTEDRTVYSYIQSRYY 279
IH D+KP+N L+ K + IIDFG A R + + Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339
S LG + + D+ S G ++ LG + G ++ RI + +
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 340 EAKNTSKFFKCI 351
K F
Sbjct: 240 LCKGYPSEFATY 251
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-40
Identities = 72/254 (28%), Positives = 124/254 (48%), Gaps = 23/254 (9%)
Query: 106 ETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTL 162
E RY +G G +G V +D + VAVK + + ++ E+ +L +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 163 NKKYDREDKHHIVRIYEYFVCQR------HLCICFELLDSNLYELIKINHFRGLSLSIVQ 216
+++ + + F R + + L+ ++L I + L+ VQ
Sbjct: 75 KH-------ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN---IVKCQKLTDDHVQ 124
Query: 217 LFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQS 276
QILRGL + A IIH DLKP N+ + + E+KI+DFG A D + Y+ +
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMTGYVAT 181
Query: 277 RYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
R+YR+PE++L + Y +D+WS GCI+AEL G LFPG D L+ ++R++G +
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 241
Query: 336 YVLKEAKNTSKFFK 349
+ K + +++ +
Sbjct: 242 LLKKISSESARNYI 255
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-40
Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 27/230 (11%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKY 166
+ V +G G+FG V + + + VAVK++ P Q EV +L
Sbjct: 9 QITVGQRIGSGSFGTV---YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV- 64
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+I+ Y L I + + S+LY + I + + + ++Q +G
Sbjct: 65 ------NILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQG 116
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YYR 280
+ L IIH DLK NI L + +KI DFG A + R S+ + +
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 281 SPEVLLGYQ---YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327
+PEV+ Y+ D+++FG ++ EL G + + D + M+
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 4e-39
Identities = 44/240 (18%), Positives = 98/240 (40%), Gaps = 16/240 (6%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+K LG G +G+V + + + VAVK +K ++ L E +++ +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHP---- 73
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
++V++ + I E + NL + ++ + + +S ++ + QI +
Sbjct: 74 ---NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEV 284
L+ IH DL N L+ + +K+ DFG + + +PE
Sbjct: 131 LEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 285 LLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
L +++ D+W+FG ++ E+ G+ +PG + + + + P+ ++
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 2e-38
Identities = 52/238 (21%), Positives = 94/238 (39%), Gaps = 16/238 (6%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKK 165
++ LG G+FG+V E + A+KI+ Q + L E IL +N
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF- 100
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRG 225
+V++ F +L + E + + S + ++ QI+
Sbjct: 101 ------PFLVKLEFSFKDNSNLYMVMEYVAGG-EMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 226 LSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVL 285
L +I+ DLKPEN+L+ I++ DFG A ++ + +PE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTLCGTPEALAPEII 210
Query: 286 LGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
L Y A+D W+ G ++ E+ G P F + I + P + + K+
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-EKIVSGKVRFPSHFSSDLKD 267
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.9 bits (87), Expect = 0.004
Identities = 17/93 (18%), Positives = 27/93 (29%), Gaps = 14/93 (15%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
G F +I K S + L D L+ L++ D KR+ +
Sbjct: 232 AAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD------LKDLLRNLLQVDLTKRFGNLK 285
Query: 447 AS-----RHPFVTGEPFTCPYQ---PPPETPRV 471
H + + YQ P P+
Sbjct: 286 NGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKF 318
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 18/240 (7%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+ + LG G FG+V + ++ VAVK +K L E +++ L +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ---- 68
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSL 228
+VR+Y Q + I E +++ +L + +K L+++ + + QI G++
Sbjct: 69 ---RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 229 LKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEV 284
+++ IH DL+ NIL+ KI DFG A E + +PE
Sbjct: 125 IEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 285 LLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
+ +T D+WSFG ++ E+ G +PG + ++++ + R PD +E
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (363), Expect = 3e-38
Identities = 54/238 (22%), Positives = 102/238 (42%), Gaps = 8/238 (3%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+ V ++G G FG+V C A+ A+K + + +Q +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
D IV + F L +L++ ++ S + ++ ++ +I+ GL +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC-TEDRTVYSYIQSRYYRSPEVLL-G 287
+ +++ DLKP NILL + ++I D G AC + ++ + + Y +PEVL G
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180
Query: 288 YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL--LRRMIRILGAQPPDYVLKEAKN 343
Y ++ D +S GC++ +L G F D + RM + + PD E ++
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-38
Identities = 52/240 (21%), Positives = 93/240 (38%), Gaps = 19/240 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKY 166
+ LLG GTFG+V + + A+KI++ + + E +L
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-- 64
Query: 167 DREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGL 226
+ + F LC E + ++ R + + + +I+ L
Sbjct: 65 -----PFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVFTEERARFYGAEIVSAL 118
Query: 227 SLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA---CTEDRTVYSYIQSRYYRSPE 283
L +++ D+K EN++L IKI DFG ++ T+ ++ + Y +PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 284 VLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
VL Y A+D W G ++ E+ G F L I + + P + EAK+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-ILMEEIRFPRTLSPEAKS 234
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 3e-04
Identities = 19/93 (20%), Positives = 35/93 (37%), Gaps = 14/93 (15%)
Query: 387 LIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQ 446
+ G+ F+++ E + + + ME+I + L GL++ DP +R
Sbjct: 199 MCGRLPFYNQDHERLF------ELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 447 AS-----RHPFVTGEPFTCPYQ---PPPETPRV 471
+ H F + Q PP P+V
Sbjct: 253 SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 16/239 (6%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
++ LG G FG+V + VA+K +K + L E ++ L
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH----- 71
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+V++Y + + + +L + +K + L L + + QI G++ +
Sbjct: 72 --EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA----CTEDRTVYSYIQSRYYRSPEVL 285
+ +H DL+ NIL+ + K+ DFG A E + +PE
Sbjct: 130 ERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
L ++T D+WSFG ++ EL G +PG ++L ++ R P + +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-37
Identities = 45/239 (18%), Positives = 87/239 (36%), Gaps = 18/239 (7%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRED 170
LG G FG V VA+K+IK + + E ++ L+
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMNLS------- 57
Query: 171 KH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
H +V++Y QR + I E + + + K + + L
Sbjct: 58 -HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEVL 285
+ +H DL N L+ +K+ DFG + E + + PEVL
Sbjct: 117 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
+ ++++ D+W+FG ++ E++ LG + + + + + L P ++
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-37
Identities = 46/239 (19%), Positives = 89/239 (37%), Gaps = 16/239 (6%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDRE 169
+G G FG V + VA+K I+ + + E ++ L+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP---- 60
Query: 170 DKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+V++Y + Q +C+ FE ++ + + + G++ L
Sbjct: 61 ---KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSRYYRSPEVL 285
++A +IH DL N L+ + IK+ DFG + + + SPEV
Sbjct: 118 EEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
+Y++ D+WSFG ++ E+F G + S +++ + P
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ 233
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 28/251 (11%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIK----NQPAYYQQALVEVSILTT 161
+ + + LG G+FG V + + VAVK +K +QP + EV+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 162 LNKKYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSK 220
L+ H +++R+Y + + + EL H L + ++
Sbjct: 68 LD--------HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 118
Query: 221 QILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR--- 277
Q+ G+ L+ IH DL N+LL T +KI DFG + Y+
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATR---DLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 278 ---YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQP 333
+ +PE L ++ A D W FG + E+F G + G + +L ++ + P
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 334 -PDYVLKEAKN 343
P+ ++ N
Sbjct: 236 RPEDCPQDIYN 246
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 49/241 (20%), Positives = 97/241 (40%), Gaps = 24/241 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDA---EMNSFVAVKIIK-----NQPAYYQQALVEVSILTT 161
+ + +LG G +G+V + A+K++K + + E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 162 LNKKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQ 221
+ +V ++ F + L + + ++ ++ + VQ++ +
Sbjct: 85 IR------QSPFLVTLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHEVQIYVGE 137
Query: 222 ILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC----TEDRTVYSYIQSR 277
I+ L L GII+ D+K ENILL ++ + + DFG + E Y + +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 278 YYRSPEVLLG--YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335
Y +P+++ G + A+D WS G ++ EL G F E + + R + P
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254
Query: 336 Y 336
Y
Sbjct: 255 Y 255
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (90), Expect = 0.002
Identities = 19/129 (14%), Positives = 35/129 (27%), Gaps = 13/129 (10%)
Query: 353 SVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412
+ + G+ + +L + YE P EI +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG--EKNSQAEISRRILKSEPPY 255
Query: 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQAS-----RHPFVTGEPFTCPYQPPPE 467
+++S D ++ L+ DP KR H F +
Sbjct: 256 PQEMSAL------AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309
Query: 468 TPRVPVAQN 476
P PV ++
Sbjct: 310 APFKPVIRD 318
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 55/271 (20%), Positives = 102/271 (37%), Gaps = 47/271 (17%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSF-----VAVKIIKNQ--PAYYQQALVEVSILTTL 162
+LG G FG+V ++ VAVK++K + + + + E+ ++T L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 163 NKKYDREDKH-HIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG----------- 209
H +IV + + + FE +L ++ +
Sbjct: 98 GS-------HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 210 ----------LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
L+ + F+ Q+ +G+ L+ +H DL N+L+ +KI D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICD 207
Query: 260 FGSAC-----TEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLF 313
FG A + + + +PE L YT D+WS+G ++ E+F LG+ +
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 314 PGASEFDLLRRMIR-ILGAQPPDYVLKEAKN 343
PG ++I+ P Y +E
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYI 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 53/239 (22%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 117 LGHGTFGQVAKCWDA--EMNSFVAVKIIK---NQPAYYQQALVEVSILTTLNKKYDREDK 171
LG G FG V K + ++ VAVKI+K N PA + L E +++ L+
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP------ 68
Query: 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD 231
+IVR+ + + E+ + + R + + Q+ G+ L++
Sbjct: 69 -YIVRMIGICEAE-SWMLVMEMAELGPLNKY-LQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 232 AGIIHCDLKPENILLCTSVKPAEIKIIDFG------SACTEDRTVYSYIQSRYYRSPEVL 285
+ +H DL N+LL T KI DFG + + + +PE +
Sbjct: 126 SNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 286 LGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
Y++++ D+WSFG ++ E F G + G ++ + + P +E +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 4e-34
Identities = 50/245 (20%), Positives = 95/245 (38%), Gaps = 23/245 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSF---VAVKIIKNQ--PAYYQQALVEVSILTTLNK 164
R + +G G FG V + + VA+K KN + ++ L E + +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD- 66
Query: 165 KYDREDKH-HIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
H HIV++ + + I EL L L+ + L++ Q+
Sbjct: 67 -------HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQ----SRYY 279
L+ L+ +H D+ N+L+ +K+ DFG + + + Y +
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
+PE + ++T+A D+W FG + E+ + G+ F G D++ R+ P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 339 KEAKN 343
+
Sbjct: 236 PTLYS 240
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 6e-34
Identities = 43/248 (17%), Positives = 93/248 (37%), Gaps = 24/248 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNK 164
++ ++G G FG+V FVA+K +K+ + L E SI+ +
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
+++ + + I E +++ + + ++ + + I
Sbjct: 87 P-------NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--------CTEDRTVYSYIQS 276
G+ L D +H DL NIL+ ++ K+ DFG + +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSN---LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 277 RYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPD 335
+ +PE + ++T+A D+WS+G ++ E+ G + + D++ + + PP
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 336 YVLKEAKN 343
Sbjct: 257 DCPSALHQ 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 50/267 (18%), Positives = 99/267 (37%), Gaps = 25/267 (9%)
Query: 91 NSDLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIK--NQ 145
N +L+ AV V++ +++G G FG V + + AVK +
Sbjct: 10 NPELVQAVQHVVIGPS-SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68
Query: 146 PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV-CQRHLCICFELLDSNLYELIKI 204
Q L E I+ + +++ + + + + +
Sbjct: 69 IGEVSQFLTEGIIMKDFSH-------PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 205 NHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264
N ++ + F Q+ +G+ L +H DL N +L + +K+ DFG A
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLAR 178
Query: 265 TEDRTVYSYIQSR-------YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGA 316
+ + ++ + + E L ++TT D+WSFG ++ EL G P +P
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 317 SEFDLLRRMIRILGAQPPDYVLKEAKN 343
+ FD+ +++ P+Y
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPDPLYE 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-33
Identities = 55/261 (21%), Positives = 95/261 (36%), Gaps = 33/261 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQ--PAYYQQALVEVSILT 160
R ++ LG G FGQV ++ + VAVK++K+ + E+ ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 161 TLNKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHFRG---------- 209
+ K +I+ + L + E NL E ++ G
Sbjct: 74 MIGKH------KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 210 ----LSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSA 263
LS + + Q+ RG+ L IH DL N+L+ +K A+ +
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLL 322
+ + + +PE L YT D+WSFG ++ E+F LG +PG +L
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 323 RRMIRILGAQPPDYVLKEAKN 343
+ + P E
Sbjct: 248 KLLKEGHRMDKPSNCTNELYM 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 4e-33
Identities = 51/256 (19%), Positives = 93/256 (36%), Gaps = 31/256 (12%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIK----NQPAYYQQALVEVSILTTLNKK 165
+D++G G FGQV K + + I + ++ E+ +L L
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-- 68
Query: 166 YDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINHF--------------RGL 210
+I+ + + +L + E NL + ++ + L
Sbjct: 69 ----HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 211 SLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA--CTEDR 268
S + F+ + RG+ L IH DL NIL+ + KI DFG +
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV 181
Query: 269 TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIR 327
+ + E L YTT D+WS+G ++ E+ LG + G + +L ++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 328 ILGAQPPDYVLKEAKN 343
+ P E +
Sbjct: 242 GYRLEKPLNCDDEVYD 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 8e-33
Identities = 50/270 (18%), Positives = 101/270 (37%), Gaps = 46/270 (17%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIKNQ--PAYYQQALVEVSILTTL 162
+G G FG+V + + + VAVK++K + E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIK------------------ 203
+ +IV++ + +C+ FE + +L E ++
Sbjct: 74 DN-------PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 204 ----INHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259
LS + ++Q+ G++ L + +H DL N L+ ++ +KI D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM---VVKIAD 183
Query: 260 FGSACTEDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLF 313
FG + Y + PE + +YTT D+W++G ++ E+F GL +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 314 PGASEFDLLRRMIRILGAQPPDYVLKEAKN 343
G + +++ + P+ E N
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYN 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 9e-33
Identities = 47/246 (19%), Positives = 92/246 (37%), Gaps = 23/246 (9%)
Query: 110 RYIVKDL-LGHGTFGQVAKCWDAEMNS--FVAVKIIK--NQPAYYQQALVEVSILTTLNK 164
++ D+ LG G FG V + VA+K++K + A ++ + E I+ L+
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
+IVR+ + L + E+ + + +S V Q+
Sbjct: 69 P-------YIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR------Y 278
G+ L++ +H DL N+LL KI DFG + Y
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNR---HYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 279 YRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYV 337
+ +PE + ++++ D+WS+G + E G + +++ + + + P
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237
Query: 338 LKEAKN 343
E
Sbjct: 238 PPELYA 243
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 50/245 (20%), Positives = 90/245 (36%), Gaps = 23/245 (9%)
Query: 111 YIVKDLLGHGTFGQVAKCWDAEMNSF----VAVKIIK--NQPAYYQQALVEVSILTTLNK 164
+ +LG G FG V K VA+K ++ P ++ L E ++ +++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 165 KYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILR 224
H+ R+ + I + L + H + + + QI +
Sbjct: 71 -------PHVCRLLGICLTSTVQLITQLMPFGCLLD-YVREHKDNIGSQYLLNWCVQIAK 122
Query: 225 GLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSR-----YY 279
G++ L+D ++H DL N+L+ T +KI DFG A Y +
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTP---QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 280 RSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338
+ E +L YT D+WS+G V EL G + G ++ + + P
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT 239
Query: 339 KEAKN 343
+
Sbjct: 240 IDVYM 244
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 53/253 (20%), Positives = 92/253 (36%), Gaps = 26/253 (10%)
Query: 110 RYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTL 162
+ + LG G+FG V + E + VA+K + + L E S++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIKINH--------FRGLSLS 213
N HH+VR+ + + EL+ +L ++ SLS
Sbjct: 81 NC-------HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 214 IVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS--VKPAEIKIIDFGSACTEDRTVY 271
+ + +I G++ L +H DL N ++ VK + + R
Sbjct: 134 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 272 SYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILG 330
+ + SPE L +TT D+WSFG ++ E+ L + G S +LR ++
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253
Query: 331 AQPPDYVLKEAKN 343
PD
Sbjct: 254 LDKPDNCPDMLFE 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 40/237 (16%), Positives = 85/237 (35%), Gaps = 41/237 (17%)
Query: 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDR 168
R ++++ +G G FG+V + VAVKI ++ E+ L +
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHE--- 57
Query: 169 EDKHHIVRIYEYFV----CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQIL 223
+I+ L + + + +L++ + + +++ + +
Sbjct: 58 ----NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTA 110
Query: 224 RGLSLL--------KDAGIIHCDLKPENILLCTSVKPAEIKIIDFG-------SACTEDR 268
GL+ L I H DLK +NIL+ + I D G + T D
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIADLGLAVRHDSATDTIDI 167
Query: 269 TVYSYIQSRYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319
+ ++ Y +PEVL ++ D+++ G + E+ + ++
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 4e-31
Identities = 46/247 (18%), Positives = 89/247 (36%), Gaps = 23/247 (9%)
Query: 110 RYIVKDLLGHGTFGQVAKCW----DAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLN 163
+ ++G G FG+V K + VA+K +K L E I+ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 164 KKYDREDKHHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQIL 223
H+I+R+ + + I E +++ + S+ + + I
Sbjct: 68 H-------HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 224 RGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC------TEDRTVYSYIQSR 277
G+ L + +H DL NIL+ K+ DFG + T
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 278 YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEFDLLRRMIRILGAQPPDY 336
+ +PE + ++T+A D+WSFG ++ E+ G + S ++++ + P
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 337 VLKEAKN 343
Sbjct: 238 CPSAIYQ 244
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 59/265 (22%), Positives = 96/265 (36%), Gaps = 40/265 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEM-----NSFVAVKIIK--NQPAYYQQALVEVSILTTL 162
R LG G FG+V + + VAVK++K + + E+ +L+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 163 NKKYDREDKHHIVRIYEYFVCQRHLCICFELLD-SNLYELIK----------------IN 205
+ +IV + + E +L ++ +
Sbjct: 84 G------NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 206 HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
L L + FS Q+ +G++ L IH DL NILL KI DFG A
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARD 194
Query: 266 EDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELF-LGLPLFPGASEF 319
++ + +PE + YT D+WS+G + ELF LG +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 320 DLLRRMIR-ILGAQPPDYVLKEAKN 343
+MI+ P++ E +
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYD 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 9e-26
Identities = 60/265 (22%), Positives = 98/265 (36%), Gaps = 41/265 (15%)
Query: 110 RYIVKDLLGHGTFGQVAKCWDAEMNS-----FVAVKIIKNQ--PAYYQQALVEVSILTTL 162
R + LG G FGQV + ++ VAVK++K + ++ + E+ IL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI-- 71
Query: 163 NKKYDREDKHHIVRIYEYFVCQ--RHLCICFELLD-SNLYELIK--------------IN 205
H V + L + E NL ++
Sbjct: 72 -----HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 206 HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265
+ L+L + +S Q+ +G+ L IH DL NILL + +KI DFG A
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARD 183
Query: 266 EDRTVYSYIQSR-----YYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGL-PLFPGASEF 319
+ + + +PE + YT D+WSFG ++ E+F +PG
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 320 DLLRRMIR-ILGAQPPDYVLKEAKN 343
+ R ++ + PDY E
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQ 268
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 7e-20
Identities = 34/201 (16%), Positives = 58/201 (28%), Gaps = 21/201 (10%)
Query: 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH 172
+ L+G G V C+ + VK K +++ + +
Sbjct: 4 IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKV---KEKRDYGDLHFSVLAIR 59
Query: 173 HIVRIYEYFVCQRHLCICFELLDSNLY---ELIKINHFRGLSLSIVQLFSKQILRGLSLL 229
+ + L + ELI + + IL ++
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 230 KDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDRTVYSYIQSRYY--RSPEVLLG 287
GI+H DL N+L V I IIDF + R R ++
Sbjct: 120 YHRGIVHGDLSQYNVL----VSEEGIWIIDFPQSVEVGEE-----GWREILERDVRNIIT 170
Query: 288 Y---QYTTAIDMWSFGCIVAE 305
Y Y T D+ S + +
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 820 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.1 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.74 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.3 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-54 Score=458.58 Aligned_cols=284 Identities=31% Similarity=0.522 Sum_probs=225.6
Q ss_pred EEEEeccCCceeEEEeeccCCCeEEEEEEEeCChh------hHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 113 VKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPA------YYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 113 i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~------~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.+++||+|+||+||+|+++.+++.||||+++.... ..+.+.+|+.+|+++ .|||||+++++|..+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-------~hpnIv~~~~~~~~~~~ 74 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-------SHPNIIGLLDAFGHKSN 74 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-------CCTTBCCEEEEECCTTC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-------CCCCEeEEEeeeccCCc
Confidence 56899999999999999999999999999974321 234678999999999 68999999999999999
Q ss_pred eEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 187 LCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 187 l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
+|||||||.+++...+... ...+++.+++.+++||+.||+|||++|||||||||+|||++ ..+.+||+|||+|+..
T Consensus 75 ~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~---~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSF 150 (299)
T ss_dssp CEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECCCGGGSTT
T ss_pred eeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec---CCCccccccCcccccc
Confidence 9999999998776665543 35699999999999999999999999999999999999995 6789999999999765
Q ss_pred CC---ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 267 DR---TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 267 ~~---~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.. .....++|+.|+|||++... .|+.++|||||||++|||++|.+||.+.++.+++.+|.+.++ .|+...+....
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~-~~~~~~~~~~~ 229 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG-TPTEEQWPDMC 229 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTSSSTT
T ss_pred CCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC-CCChhhccchh
Confidence 43 23456899999999998755 689999999999999999999999999999999999999998 44332211110
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
.... ......+....+.++.. ..
T Consensus 230 ~~~~----------------------------------------~~~~~~~~~~~~~~~~~-----------------~~ 252 (299)
T d1ua2a_ 230 SLPD----------------------------------------YVTFKSFPGIPLHHIFS-----------------AA 252 (299)
T ss_dssp SSTT----------------------------------------CCCCCCCCCCCHHHHCT-----------------TC
T ss_pred ccch----------------------------------------hhhhccCCCCChHHhcc-----------------cC
Confidence 0000 00000111122222222 24
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCCCCCCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFTCPYQPP 465 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~~~~~~~ 465 (820)
+++++|||++||++||++||||+|||+||||++.+.+.|....
T Consensus 253 s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~ 295 (299)
T d1ua2a_ 253 GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295 (299)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCC
Confidence 5789999999999999999999999999999998876654433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=454.46 Aligned_cols=253 Identities=21% Similarity=0.383 Sum_probs=216.8
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++|+++ .|||||+++++|.+++
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-------KNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEEETT
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-------CCCCEeeEeEEEEECC
Confidence 3478999999999999999999999999999999997532 3456789999999998 6899999999999999
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
++|||||||. |+|.+++.. +.+++.+++.+++||+.||+|||++|||||||||+|||++ .++.+||+|||+|+
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhhe
Confidence 9999999998 588877654 3599999999999999999999999999999999999996 56889999999997
Q ss_pred ccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 265 TED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 265 ~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+..... ++
T Consensus 165 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~------- 235 (293)
T d1yhwa1 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--PE------- 235 (293)
T ss_dssp ECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS--CC-------
T ss_pred eeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--CC-------
Confidence 543 233456899999999999999999999999999999999999999998887766655543211 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
+.....
T Consensus 236 --------------------------------------------------------------------------~~~~~~ 241 (293)
T d1yhwa1 236 --------------------------------------------------------------------------LQNPEK 241 (293)
T ss_dssp --------------------------------------------------------------------------CSSGGG
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 000012
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
+++.+++||++||+.||++|||++|+|+||||+.
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 4577899999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=448.04 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=216.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++++.||+|+||+||+|+++.+++.||||++.+. ....+.+.+|+++|+.+ .|||||++++++.++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-------RHPNILRLYGYFHDA 78 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-------CCCCCCeEEEEEEEC
Confidence 6899999999999999999999999999999999743 23456788899999998 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. |+|.+++... ..+++..++.++.||++||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~~kl~DFG~a 153 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS 153 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEECCCCSC
T ss_pred CEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec---CCCCEeeccccee
Confidence 99999999998 5899988765 3699999999999999999999999999999999999996 6688999999999
Q ss_pred cccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 264 CTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 264 ~~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
..... .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+.+... +
T Consensus 154 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---~-------- 222 (263)
T d2j4za1 154 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---T-------- 222 (263)
T ss_dssp SCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---C--------
T ss_pred eecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---C--------
Confidence 76543 34556899999999999999999999999999999999999999998877666655432100 0
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+| ..+
T Consensus 223 --------------------------------------------------------------~p-------------~~~ 227 (263)
T d2j4za1 223 --------------------------------------------------------------FP-------------DFV 227 (263)
T ss_dssp --------------------------------------------------------------CC-------------TTS
T ss_pred --------------------------------------------------------------CC-------------ccC
Confidence 00 013
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
++++.+||.+||+.||++|||++|+|+||||++
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 467899999999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=450.09 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=207.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++|+++ .|||||++++++.+++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-------~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-------NHENVVKFYGHRREGNI 77 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-------CCTTBCCEEEEEEETTE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-------CCCCEeeEeeeeccCce
Confidence 68999999999999999999999999999999997542 3345688999999998 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|||||||. |+|.+++... ..+++.+++.+++||++||+|||++|||||||||+|||++ .++.+||+|||+|+.
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATV 152 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhhee
Confidence 999999998 5899888643 4699999999999999999999999999999999999995 567899999999975
Q ss_pred cC-----CccccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHH
Q 003438 266 ED-----RTVYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLK 339 (820)
Q Consensus 266 ~~-----~~~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~ 339 (820)
.. ......+||+.|+|||++.+..+ +.++||||||||+|||++|++||....+............ .
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--~------ 224 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--T------ 224 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--T------
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--C------
Confidence 42 12345689999999999998876 5789999999999999999999976543322221111000 0
Q ss_pred hhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhh
Q 003438 340 EAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKE 419 (820)
Q Consensus 340 ~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~ 419 (820)
+ ....
T Consensus 225 -----------------------------------------------------~----------------------~~~~ 229 (271)
T d1nvra_ 225 -----------------------------------------------------Y----------------------LNPW 229 (271)
T ss_dssp -----------------------------------------------------T----------------------STTG
T ss_pred -----------------------------------------------------C----------------------CCcc
Confidence 0 0001
Q ss_pred HHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 420 SQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 420 ~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
..+++++++||++||+.||++|||++|+|+||||++
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 124577899999999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-52 Score=453.96 Aligned_cols=260 Identities=28% Similarity=0.447 Sum_probs=207.3
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh--hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP--AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~--~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
..++|+++++||+|+||+||+|+++.+++.||||++.+.. .....+.+|+.+|+.| +|||||+++++|.++
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-------KHPNIVALDDIYESG 79 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-------CCTTBCCEEEEEECS
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEEC
Confidence 3478999999999999999999999999999999998542 2335677899999988 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. ++|.+++... +.+++.+++.++.||+.||+|||++|||||||||+|||+...++++.+||+|||+|
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred CEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecccee
Confidence 99999999998 6999998764 46999999999999999999999999999999999999976567789999999999
Q ss_pred cccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 264 CTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 264 ~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+....+....+.+... .++
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~~------- 229 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY-EFD------- 229 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC-CCC-------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCC-------
Confidence 75533 34456899999999999999999999999999999999999999998887766665543111 000
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
. + ....
T Consensus 230 -----------------------------------------------------~----------~-----------~~~~ 235 (307)
T d1a06a_ 230 -----------------------------------------------------S----------P-----------YWDD 235 (307)
T ss_dssp -----------------------------------------------------T----------T-----------TTTT
T ss_pred -----------------------------------------------------C----------c-----------cccC
Confidence 0 0 0012
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
+++++++||.+||+.||++|||++|+|+||||++..
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 457789999999999999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.2e-52 Score=455.93 Aligned_cols=260 Identities=26% Similarity=0.400 Sum_probs=223.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
++|+++++||+|+||+||+|+++.+++.||||++... ....+.+.+|+.+|++| .|||||+++++|.+++.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-------RHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-------CCTTBCCEEEEEEETTEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECCEE
Confidence 6899999999999999999999999999999999754 34556788999999999 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|||||||. |+|.+++.... ..+++.+++.|++||+.||+|||++|||||||||+||||+.+ ..+.+||+|||+|+..
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheec
Confidence 99999998 58998886543 469999999999999999999999999999999999999632 4578999999999765
Q ss_pred CC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003438 267 DR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344 (820)
Q Consensus 267 ~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~ 344 (820)
.. .....+||+.|+|||++.+..|+.++||||||||+|||++|+.||.+.+..+.+..|.......++.
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--------- 247 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--------- 247 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG---------
T ss_pred ccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc---------
Confidence 43 3345689999999999999999999999999999999999999999988888777765522200000
Q ss_pred chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHH
Q 003438 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424 (820)
Q Consensus 345 ~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~ 424 (820)
....+++
T Consensus 248 -------------------------------------------------------------------------~~~~~s~ 254 (350)
T d1koaa2 248 -------------------------------------------------------------------------AFSGISE 254 (350)
T ss_dssp -------------------------------------------------------------------------GGGGCCH
T ss_pred -------------------------------------------------------------------------cccCCCH
Confidence 0012456
Q ss_pred HHHHHHHhccccCcCCCCCHHHHHcCCccCCCCCC
Q 003438 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPFT 459 (820)
Q Consensus 425 ~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~~ 459 (820)
.++|||++||++||++|||++|||+||||++...+
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 78999999999999999999999999999986543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=444.21 Aligned_cols=283 Identities=30% Similarity=0.555 Sum_probs=229.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh---hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP---AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~---~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+++|+++ +|||||+++++|.+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-------~Hp~Iv~~~~~~~~~~ 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-------NHPNIVKLLDVIHTEN 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-------CCTTBCCEEEEEEETT
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-------CCCcEEEecccccccc
Confidence 68999999999999999999999999999999997532 2346788999999988 6999999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
++||||||+.+++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+.
T Consensus 75 ~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~---~~~~~kl~DFG~a~~ 151 (298)
T d1gz8a_ 75 KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARA 151 (298)
T ss_dssp EEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSTTHHHH
T ss_pred ceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec---ccCcceeccCCccee
Confidence 99999999999988888777667899999999999999999999999999999999999995 667899999999965
Q ss_pred cC---CccccccccccccCcccccccc-ccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 ED---RTVYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~---~~~~~~~gt~~Y~APEvl~~~~-yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.. ......++|+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+ .+.+..+...
T Consensus 152 ~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 230 (298)
T d1gz8a_ 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVWPGV 230 (298)
T ss_dssp HCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCTTTSTTG
T ss_pred ccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC-CCchhhcccc
Confidence 43 3334558999999999988775 57899999999999999999999999999999999998888 4443332221
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+.... .......+.... ..
T Consensus 231 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~~-----------------~~ 254 (298)
T d1gz8a_ 231 TSMPDYKPSF---------------------------------------PKWARQDFSKVV-----------------PP 254 (298)
T ss_dssp GGSTTCCTTS---------------------------------------CCCCCCCHHHHS-----------------TT
T ss_pred cccccccccc---------------------------------------ccccccchhhhc-----------------cC
Confidence 1110000000 000011111111 12
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
++.+++|||++||++||++|||++|||+||||++...
T Consensus 255 ~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 255 LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 4578999999999999999999999999999987643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=447.73 Aligned_cols=255 Identities=31% Similarity=0.490 Sum_probs=215.6
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
.+.|+++++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|++| +|||||++++++.+++.
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-------DHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-------CCTTBCCEEEEEEETTE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-------CCCCCCeEEEEEeeCCe
Confidence 46899999999999999999999999999999999753 34557788999999998 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|||||||.+ +|.+++.... +.+++.+++.++.||+.||.|||++|||||||||+|||++ .++.+||+|||+|+.
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~ 159 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAK 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhc
Confidence 9999999985 7877766543 5699999999999999999999999999999999999996 668899999999965
Q ss_pred cCCc---cccccccccccCccccc-----cccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLL-----GYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~-----~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
.... ....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.++.+.. ++.
T Consensus 160 ~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~---~~~-- 234 (288)
T d2jfla1 160 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---PPT-- 234 (288)
T ss_dssp CHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC---CCC--
T ss_pred cCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---CCC--
Confidence 4332 34568999999999984 4468999999999999999999999998877766655544310 000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+.
T Consensus 235 ------------------------------------------------------------------------------~~ 236 (288)
T d2jfla1 235 ------------------------------------------------------------------------------LA 236 (288)
T ss_dssp ------------------------------------------------------------------------------CS
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
....+++++++||++||+.||++|||++|||+||||+..
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 011245789999999999999999999999999999854
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=442.38 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=219.6
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC-------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ-------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~-------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
..++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+++|++| +|||||++++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~ 80 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-------QHPNVITLHE 80 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-------CCTTBCCEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-------CCCCCCcEEE
Confidence 447899999999999999999999999999999999742 12357788999999999 6899999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc-CCCeEEE
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV-KPAEIKI 257 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~-~~~~iKL 257 (820)
+|.+.+.+|||||||. |+|.+++... +.+++..++.+++||+.||+|||+++||||||||+|||++.+. ....+||
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEe
Confidence 9999999999999998 5899988765 3699999999999999999999999999999999999997432 2346999
Q ss_pred eecccccccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCch
Q 003438 258 IDFGSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPD 335 (820)
Q Consensus 258 ~DFGlA~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~ 335 (820)
+|||+|.... .......+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+.+... .++.
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~ 237 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFED 237 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-CCCH
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCc
Confidence 9999997653 334456889999999999999999999999999999999999999999888777666544211 0000
Q ss_pred HHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhh
Q 003438 336 YVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMED 415 (820)
Q Consensus 336 ~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~ 415 (820)
.+
T Consensus 238 ----------------------------------------------------------------~~-------------- 239 (293)
T d1jksa_ 238 ----------------------------------------------------------------EY-------------- 239 (293)
T ss_dssp ----------------------------------------------------------------HH--------------
T ss_pred ----------------------------------------------------------------hh--------------
Confidence 00
Q ss_pred hhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 416 ISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 416 ~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++..++|||++||+.||++|||++|+|+||||++..
T Consensus 240 ---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 240 ---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp ---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred ---cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 112457789999999999999999999999999998654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=455.50 Aligned_cols=199 Identities=30% Similarity=0.461 Sum_probs=177.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++|+++++||+|+||+||+|+++.+++.||||+++.. ....+++.+|+.+|+++ +|||||+++++|.++++
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-------NSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-------CCTTBCCEEEEEECSSE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECCE
Confidence 7899999999999999999999999999999999753 44567788999999888 68999999999999999
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
+|||||||.+ +|.+++... +.+++..++.++.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~---~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCH
T ss_pred EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC---CCCCEEEeeCCCcc
Confidence 9999999985 898888765 369999999999999999999997 5999999999999995 67899999999997
Q ss_pred ccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHH
Q 003438 265 TEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEF 319 (820)
Q Consensus 265 ~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~ 319 (820)
.... .....+||+.|+|||++.+..|+.++||||||||+|||++|+.||.+.+..
T Consensus 154 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp HHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 5432 334678999999999999999999999999999999999999999876543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=443.07 Aligned_cols=282 Identities=30% Similarity=0.527 Sum_probs=226.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCC-CeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM-NSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t-g~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~- 183 (820)
++|+++++||+|+||+||+|++..+ ++.||||+++.. ......+.+|+.+|+.|... .||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~----~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----EHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT----CCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhc----CCCCcceeeeeeccc
Confidence 7999999999999999999998655 778999999742 22234567899999988654 79999999999864
Q ss_pred ----cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 184 ----QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 184 ----~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
..++|+|||++.+++..+........+++..++.+++||+.||+|||+++||||||||+|||++ ..+.+||+|
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~---~~~~~kl~d 159 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLAD 159 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEECS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc---CCCCeeecc
Confidence 3579999999998877777666667799999999999999999999999999999999999995 678999999
Q ss_pred cccccccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||++.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+|.+.++ .++...
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEED 238 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCGGG
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC-CCchhc
Confidence 99986543 334466899999999999999999999999999999999999999999999999999999998 343322
Q ss_pred HHhhhccc-hhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhh
Q 003438 338 LKEAKNTS-KFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDI 416 (820)
Q Consensus 338 l~~~~~~~-~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~ 416 (820)
+....... ..+.. .....+..
T Consensus 239 ~~~~~~~~~~~~~~------------------------------------------~~~~~~~~---------------- 260 (305)
T d1blxa_ 239 WPRDVALPRQAFHS------------------------------------------KSAQPIEK---------------- 260 (305)
T ss_dssp SCTTCSSCGGGSCC------------------------------------------CCCCCGGG----------------
T ss_pred ccccccchhhhhcc------------------------------------------ccccchhh----------------
Confidence 11100000 00000 00000000
Q ss_pred hhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 417 SKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 417 ~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
....+++.++|||++||++||++||||+|||+||||++..
T Consensus 261 -~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 261 -FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp -TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred -ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0112457889999999999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=444.15 Aligned_cols=253 Identities=26% Similarity=0.479 Sum_probs=215.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+++|+++ +|||||+++++|.++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-------DHPFFVKLYFTFQDD 80 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-------CSTTBCCEEEEEECS
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-------CCCCeeEEEEEEEEC
Confidence 6799999999999999999999999999999999743 23446788999999998 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. |+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~---~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTA 155 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred CEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC---CCceEEecccccc
Confidence 99999999998 5898887765 4699999999999999999999999999999999999995 6788999999999
Q ss_pred cccCC-----ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHH
Q 003438 264 CTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVL 338 (820)
Q Consensus 264 ~~~~~-----~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l 338 (820)
+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.+..-
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-------- 227 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-------- 227 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--------
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--------
Confidence 75432 22346899999999999999999999999999999999999999998887776665543100
Q ss_pred HhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhh
Q 003438 339 KEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISK 418 (820)
Q Consensus 339 ~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~ 418 (820)
.+|
T Consensus 228 -----------------------------------------------------------------~~p------------ 230 (288)
T d1uu3a_ 228 -----------------------------------------------------------------DFP------------ 230 (288)
T ss_dssp -----------------------------------------------------------------CCC------------
T ss_pred -----------------------------------------------------------------CCC------------
Confidence 000
Q ss_pred hHHhHHHHHHHHHhccccCcCCCCCHHH------HHcCCccCCCCCC
Q 003438 419 ESQIRLALVDFLKGLVEFDPAKRWSPFQ------ASRHPFVTGEPFT 459 (820)
Q Consensus 419 ~~~~s~~l~DLI~kmL~~DP~kRpTa~E------aL~HPff~~~~~~ 459 (820)
..+++.++|||++||+.||++|||++| +++||||++..+.
T Consensus 231 -~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 231 -EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp -TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred -ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 013467899999999999999999988 5889999886543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-51 Score=445.77 Aligned_cols=251 Identities=24% Similarity=0.438 Sum_probs=219.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+.+|+.+ .|||||++++++.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-------THPFIIRMWGTFQDA 76 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CBTTBCCEEEEEECS
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-------cCcChhheeeeEeeC
Confidence 6799999999999999999999999999999999753 23456788999999988 689999999999999
Q ss_pred ceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|+|||||.| +|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~---~~g~vkL~DFG~a 151 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFA 151 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---TTSCEEECCCSSC
T ss_pred CeeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc---CCCCEEEecCccc
Confidence 999999999985 666666554 4689999999999999999999999999999999999995 6789999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
+.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++.+....
T Consensus 152 ~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------------ 219 (316)
T d1fota_ 152 KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR------------ 219 (316)
T ss_dssp EECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC------------
T ss_pred eEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence 88877777889999999999999999999999999999999999999999988877776665441100
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
+| ..++
T Consensus 220 -------------------------------------------------------------~p-------------~~~s 225 (316)
T d1fota_ 220 -------------------------------------------------------------FP-------------PFFN 225 (316)
T ss_dssp -------------------------------------------------------------CC-------------TTSC
T ss_pred -------------------------------------------------------------CC-------------CCCC
Confidence 00 0134
Q ss_pred HHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEP 457 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~ 457 (820)
+++.+||++||+.||.+|+ |++|+|+||||++..
T Consensus 226 ~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 226 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 6789999999999999997 999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-51 Score=452.20 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=220.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
++|+++++||+|+||+||+|+++.+++.||||+++... ...+.+.+|+.+|++| .|||||+++++|.+++.+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-------HHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-------CSTTBCCEEEEEECSSEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-------CCCCCCcEEEEEEECCEE
Confidence 68999999999999999999999999999999998643 4456678899999888 689999999999999999
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
|||||||. |+|.+.+.... ..+++.+++.|++||+.||+|||++|||||||||+||||+.. ..+.+||+|||+|...
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEEC
T ss_pred EEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceec
Confidence 99999998 58888776543 459999999999999999999999999999999999999632 4678999999999765
Q ss_pred CC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhcc
Q 003438 267 DR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKNT 344 (820)
Q Consensus 267 ~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~~ 344 (820)
.. ......+|+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.+.....+..
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--------- 250 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED--------- 250 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS---------
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc---------
Confidence 43 3445689999999999999999999999999999999999999999988888777765522100000
Q ss_pred chhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhHH
Q 003438 345 SKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIRL 424 (820)
Q Consensus 345 ~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s~ 424 (820)
....+++
T Consensus 251 -------------------------------------------------------------------------~~~~~s~ 257 (352)
T d1koba_ 251 -------------------------------------------------------------------------AFSSVSP 257 (352)
T ss_dssp -------------------------------------------------------------------------TTTTSCH
T ss_pred -------------------------------------------------------------------------cccCCCH
Confidence 0011457
Q ss_pred HHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 425 ALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 425 ~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
++.|||++||++||++|||++|||+||||++..
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 789999999999999999999999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=433.03 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=206.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-- 183 (820)
+.|++.++||+|+||+||+|+++.+++.||||++... ....+.+.+|+++|+++ .|||||+++++|..
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-------QHPNIVRFYDSWESTV 81 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEEES
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-------CCCCeeeEEEEEeecc
Confidence 3347888999999999999999999999999999753 34456788999999888 68999999999875
Q ss_pred --cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCC--eeeccCCCCCcccccccCCCeEEEe
Q 003438 184 --QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAG--IIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 184 --~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~g--IVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
+..+|||||||. |+|.+++... ..+++.+++.+++||++||+|||+++ ||||||||+||||+ ++++.+||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~ 157 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIG 157 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEEC
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEe
Confidence 357899999997 5898988765 36999999999999999999999998 99999999999995 346789999
Q ss_pred ecccccccCC-ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDR-TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~-~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||+|+.... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+......+.+.+.. + ..+..
T Consensus 158 DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~-~~~~~- 233 (270)
T d1t4ha_ 158 DLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VKPAS- 233 (270)
T ss_dssp CTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CCCGG-
T ss_pred ecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-C-CCCcc-
Confidence 9999975443 3456689999999999876 6999999999999999999999999765544333221110 0 00000
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
T Consensus 234 -------------------------------------------------------------------------------- 233 (270)
T d1t4ha_ 234 -------------------------------------------------------------------------------- 233 (270)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVT 454 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~ 454 (820)
.....++++.+||.+||+.||++|||++|+|+||||+
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0011346789999999999999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=445.11 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=223.9
Q ss_pred cCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 107 TQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 107 ~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
..++|++++.||+|+||+||+|+++.+++.||||+++........+.+|+++|+.+ .|||||+++++|.++++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~~~~ 75 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-------RHRNILHLHESFESMEE 75 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-------CCTTBCCEEEEEEETTE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-------CCCCCCeEEEEEEECCE
Confidence 34899999999999999999999999999999999998776667788999999998 68999999999999999
Q ss_pred eEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|||||||. ++|.+++.... ..+++.+++.|+.||+.||+|||++|||||||||+|||++.+ ....+||+|||+++.
T Consensus 76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhc
Confidence 999999998 58999886543 359999999999999999999999999999999999999632 456899999999976
Q ss_pred cCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 266 EDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 266 ~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
... ......+|+.|+|||++.+..|+.++||||||||+|+|++|++||.+.+..+.+..|.+... .++..
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~------- 225 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-TFDEE------- 225 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-CCCHH-------
T ss_pred cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCChh-------
Confidence 543 34556889999999999999999999999999999999999999999888887777765221 01100
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
....++
T Consensus 226 --------------------------------------------------------------------------~~~~~s 231 (321)
T d1tkia_ 226 --------------------------------------------------------------------------AFKEIS 231 (321)
T ss_dssp --------------------------------------------------------------------------HHTTSC
T ss_pred --------------------------------------------------------------------------hccCCC
Confidence 001245
Q ss_pred HHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 424 LALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
++++|||++||+.||++|||++|+|+||||++.
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 678999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-51 Score=445.52 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=214.5
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|++| .|||||++++++.+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-------~HpnIv~~~~~~~~ 86 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-------RHPNTIQYRGCYLR 86 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-------CCCCEeeEEEEEEE
Confidence 36799999999999999999999999999999999753 23446788999999988 68999999999999
Q ss_pred cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 184 QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 184 ~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
++.+|||||||.+++.+.+.... +.+++.+++.+++||+.||.|||++|||||||||+||||+ .++.+||+|||+|
T Consensus 87 ~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 87 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 162 (309)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTC
T ss_pred CCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccc
Confidence 99999999999976555544433 5699999999999999999999999999999999999996 6789999999999
Q ss_pred cccCCccccccccccccCcccccc---ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLG---YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~---~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
...... ...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+.+..- ++
T Consensus 163 ~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~--~~------ 233 (309)
T d1u5ra_ 163 SIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--PA------ 233 (309)
T ss_dssp BSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CC------
T ss_pred cccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--CC------
Confidence 765543 45689999999999964 3689999999999999999999999988877666655543110 00
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
+ ...
T Consensus 234 ----------------------------------------------------~------------------------~~~ 237 (309)
T d1u5ra_ 234 ----------------------------------------------------L------------------------QSG 237 (309)
T ss_dssp ----------------------------------------------------C------------------------SCT
T ss_pred ----------------------------------------------------C------------------------CCC
Confidence 0 001
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.+++.+.+||++||+.||++|||++|+|+||||+...
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 1346789999999999999999999999999998643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=448.56 Aligned_cols=251 Identities=23% Similarity=0.395 Sum_probs=217.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+.+|+.+ .|||||+++++|.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-------~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-------RHPFLTALKYAFQTH 77 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-------CCTTBCCEEEEEECS
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-------CCCCEEEEEeeeccc
Confidence 6899999999999999999999999999999999853 23456788999999888 689999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. |+|.+++... +.+++..++.+++||+.||+|||++|||||||||+|||++ .++.+||+|||+|
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~---~~g~vkl~DFG~a 152 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLC 152 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred cccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec---CCCCEEEeecccc
Confidence 99999999998 5888888765 3699999999999999999999999999999999999995 6789999999999
Q ss_pred cccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
+... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....-
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---------- 222 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------- 222 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred cccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC----------
Confidence 7543 334567899999999999999999999999999999999999999999887666655443100
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.+| .
T Consensus 223 ---------------------------------------------------------------~~p-------------~ 226 (337)
T d1o6la_ 223 ---------------------------------------------------------------RFP-------------R 226 (337)
T ss_dssp ---------------------------------------------------------------CCC-------------T
T ss_pred ---------------------------------------------------------------CCC-------------c
Confidence 000 0
Q ss_pred HhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~ 457 (820)
.++++++|||++||++||++|+ |++|+|+||||++..
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 1346789999999999999999 599999999998854
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=436.37 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=202.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee--
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-- 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-- 183 (820)
++|++++.||+|+||+||+|+++.+++.||||+++.. +...+.+.+|+++|+++ .|||||++++++.+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~ 76 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-------KHPNIVRYYDRIIDRT 76 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-------CCTTBCCEEEEEEC--
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-------CCCCEeeEEEEEEeCC
Confidence 6899999999999999999999999999999999753 34456788899998888 69999999999975
Q ss_pred cceeEEEEeccC-CChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCC-----eeeccCCCCCcccccccCCCeE
Q 003438 184 QRHLCICFELLD-SNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAG-----IIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~g-----IVHrDLKPeNILl~~~~~~~~i 255 (820)
.+.+|||||||. |+|.+++... ....+++..++.++.||+.||+|||+++ ||||||||+||||+ .++.+
T Consensus 77 ~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~---~~~~v 153 (269)
T d2java1 77 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNV 153 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC---TTSCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC---CCCcE
Confidence 457899999998 5999988653 2356999999999999999999999876 99999999999996 66899
Q ss_pred EEeecccccccCC---ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q 003438 256 KIIDFGSACTEDR---TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQ 332 (820)
Q Consensus 256 KL~DFGlA~~~~~---~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~ 332 (820)
||+|||+|+.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+.+..-
T Consensus 154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-- 231 (269)
T d2java1 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-- 231 (269)
T ss_dssp EECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--
T ss_pred EEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999999975433 23456899999999999999999999999999999999999999998887766655543100
Q ss_pred CchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCC
Q 003438 333 PPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLS 412 (820)
Q Consensus 333 Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls 412 (820)
++ .|
T Consensus 232 ~~----------------------------------------------------------------------~~------ 235 (269)
T d2java1 232 RR----------------------------------------------------------------------IP------ 235 (269)
T ss_dssp CC----------------------------------------------------------------------CC------
T ss_pred CC----------------------------------------------------------------------CC------
Confidence 00 00
Q ss_pred hhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCcc
Q 003438 413 MEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFV 453 (820)
Q Consensus 413 ~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff 453 (820)
..+++++.+||++||+.||++|||++|+|+|||+
T Consensus 236 -------~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 -------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 0134678999999999999999999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-51 Score=450.12 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=220.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+++|+.+ .|||||+++++|...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~ 113 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-------NFPFLVKLEFSFKDN 113 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-------CCTTBCCEEEEEECS
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-------CCCcEeecccccccc
Confidence 6899999999999999999999999999999999743 23456788999999888 699999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
..+++||||+. |+|.+.+... +.+++..++.++.||+.||.|||+++||||||||+||||+ .++.+||+|||+|
T Consensus 114 ~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~---~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 114 SNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFA 188 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTC
T ss_pred cccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC---CCCCEEeeeceee
Confidence 99999999997 5788887665 3699999999999999999999999999999999999995 6689999999999
Q ss_pred cccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhhc
Q 003438 264 CTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAKN 343 (820)
Q Consensus 264 ~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~~ 343 (820)
+.........+||+.|+|||++.+..|+.++||||||||+|||++|++||.+.+....+.+|..... .+
T Consensus 189 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-~~---------- 257 (350)
T d1rdqe_ 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV-RF---------- 257 (350)
T ss_dssp EECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CC----------
T ss_pred eecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-CC----------
Confidence 8887777788999999999999999999999999999999999999999998887776666544111 00
Q ss_pred cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHhH
Q 003438 344 TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQIR 423 (820)
Q Consensus 344 ~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~s 423 (820)
| ..++
T Consensus 258 --------------------------------------------------------------p-------------~~~s 262 (350)
T d1rdqe_ 258 --------------------------------------------------------------P-------------SHFS 262 (350)
T ss_dssp --------------------------------------------------------------C-------------TTCC
T ss_pred --------------------------------------------------------------C-------------ccCC
Confidence 0 0134
Q ss_pred HHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 424 LALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 424 ~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
+++.+||++||+.||++|+ |++|||+||||++..+
T Consensus 263 ~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 6789999999999999995 9999999999998654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=442.42 Aligned_cols=282 Identities=28% Similarity=0.550 Sum_probs=225.9
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.++|+++++||+|+||+||+|+++.+++.||||++++ .....+.+.+|+++|+.+ .|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-------~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-------RHENVIGLLDVFTPD 89 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-------CBTTBCCCSEEECSC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-------CCCCeeEEEEEeccC
Confidence 4899999999999999999999999999999999974 344567788999999998 689999999999876
Q ss_pred c------eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 R------HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ~------~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
+ ++|||||||+.+|..+++. ..+++..++.+++||+.||+|||++|||||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~---~~~~~kl~ 163 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKIL 163 (346)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEEC
T ss_pred ccccccceEEEEEecccccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc---cccccccc
Confidence 5 5799999998788777654 3599999999999999999999999999999999999995 67899999
Q ss_pred ecccccccCCccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||+|+.........++|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+ .++..+
T Consensus 164 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 242 (346)
T d1cm8a_ 164 DFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG-TPPAEF 242 (346)
T ss_dssp CCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred cccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC-CCcHHH
Confidence 999999888888888999999999999875 578999999999999999999999999999999999999998 555554
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+......... .+.. . .+. +....+..++
T Consensus 243 ~~~~~~~~~~-----------------------------~~~~--~-~~~-----~~~~~~~~~~--------------- 270 (346)
T d1cm8a_ 243 VQRLQSDEAK-----------------------------NYMK--G-LPE-----LEKKDFASIL--------------- 270 (346)
T ss_dssp HHTCSCHHHH-----------------------------HHHH--H-SCC-----CCCCCGGGTC---------------
T ss_pred Hhhhcchhhh-----------------------------hhhc--c-CCc-----ccccchHHhc---------------
Confidence 4432111000 0000 0 000 0001111111
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...++.++|||++||++||++||||+|||+||||++..
T Consensus 271 --~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 271 --TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp --TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred --cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 12457889999999999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-50 Score=425.01 Aligned_cols=254 Identities=27% Similarity=0.425 Sum_probs=216.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----------AYYQQALVEVSILTTLNKKYDREDKHHIVRIY 178 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~ 178 (820)
++|+++++||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.+|++|. .|||||+++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~hpnIv~~~ 76 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS------GHPNIIQLK 76 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT------TCTTBCCEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc------CCCCeEEEE
Confidence 79999999999999999999999999999999997531 22346788999999994 489999999
Q ss_pred EEEeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEE
Q 003438 179 EYFVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKI 257 (820)
Q Consensus 179 d~f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL 257 (820)
++|.+++++|||||||. ++|.++++.. ..+++.+++.++.||++||+|||++|||||||||+||||+ .++.+||
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~---~~~~~kl 151 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKL 151 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEE
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc---CCCCeEE
Confidence 99999999999999997 5999999765 4699999999999999999999999999999999999995 6789999
Q ss_pred eecccccccCC--ccccccccccccCcccccc------ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q 003438 258 IDFGSACTEDR--TVYSYIQSRYYRSPEVLLG------YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRIL 329 (820)
Q Consensus 258 ~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~------~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~l 329 (820)
+|||+++.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+.+..+.+..
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 99999976543 3445679999999999964 257889999999999999999999999988777766655411
Q ss_pred CCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCC
Q 003438 330 GAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRK 409 (820)
Q Consensus 330 G~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~ 409 (820)
- .++ .
T Consensus 232 ~-~~~------------------------------------------------------------~-------------- 236 (277)
T d1phka_ 232 Y-QFG------------------------------------------------------------S-------------- 236 (277)
T ss_dssp C-CCC------------------------------------------------------------T--------------
T ss_pred C-CCC------------------------------------------------------------C--------------
Confidence 1 000 0
Q ss_pred CCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 410 NLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 410 ~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.....++++++|||.+||+.||++|||++|||+||||++
T Consensus 237 -------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 -------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 001124578999999999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-50 Score=429.32 Aligned_cols=278 Identities=32% Similarity=0.559 Sum_probs=220.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|+++ +++.||||+++.. ....+.+.+|+.+|+++ .|||||+++++|...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~hpnIv~~~~~~~~~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-------KHSNIVKLYDVIHTKK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-------CCTTBCCEEEEEECSS
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-------CCCcEEeeeeecccCC
Confidence 69999999999999999999885 7789999999754 23356788999999988 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..|+|||++.+.+...+.... +.+++..++.+++||+.||+|||+++||||||||+|||++ .++.+||+|||.+..
T Consensus 74 ~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~---~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARA 149 (286)
T ss_dssp CEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECCTTHHHH
T ss_pred ceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc---CCCCEEeccccccee
Confidence 999999999988877776544 5699999999999999999999999999999999999995 678999999999965
Q ss_pred cCCc---cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+++.++.+.++. ++...+...
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~ 228 (286)
T d1ob3a_ 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT-PNSKNWPNV 228 (286)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTG
T ss_pred cccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC-CChhhccch
Confidence 4332 3445789999999999865 5789999999999999999999999999999999999998884 332222211
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.....+..... .......... ...
T Consensus 229 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~-----------------~~~ 252 (286)
T d1ob3a_ 229 TELPKYDPNFT---------------------------------------VYEPLPWESF-----------------LKG 252 (286)
T ss_dssp GGSTTCCTTCC---------------------------------------CCCCCCGGGT-----------------CCS
T ss_pred hhhhhcccccc---------------------------------------cccCcchhhh-----------------ccc
Confidence 11110000000 0000000000 112
Q ss_pred hHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.++.++|||++||++||++|||++|||+||||++
T Consensus 253 ~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 4578999999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=440.12 Aligned_cols=260 Identities=26% Similarity=0.392 Sum_probs=211.0
Q ss_pred CceEEEE-EeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee----
Q 003438 109 RRYIVKD-LLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC---- 183 (820)
Q Consensus 109 ~rY~i~~-~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~---- 183 (820)
++|++++ +||+|+||+||+|+++.+++.||||+++.. ..+.+|+.++.++. +|||||+++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~------~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS------QCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT------TSTTBCCEEEEEEEEETT
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc------CCCCCCeEEEEEeecccC
Confidence 7899875 599999999999999999999999999865 34667999877663 69999999999976
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+.++|||||||. |+|.+++.......+++.+++.|++||+.||+|||++|||||||||+|||++.....+.+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 467999999997 5999999875545799999999999999999999999999999999999998665678899999999
Q ss_pred ccccC--CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 263 ACTED--RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 263 A~~~~--~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
|+... ......+||+.|+|||++.+..|+.++||||||||||+|+||++||.+.+..+....+.....
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~---------- 230 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---------- 230 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC----------
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh----------
Confidence 97543 334566899999999999999999999999999999999999999987654333222211100
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.+ ...++. ....
T Consensus 231 ------------------~~-----------------------------~~~~~~---------------------~~~~ 242 (335)
T d2ozaa1 231 ------------------MG-----------------------------QYEFPN---------------------PEWS 242 (335)
T ss_dssp ------------------SC-----------------------------SSSCCT---------------------THHH
T ss_pred ------------------cC-----------------------------CCCCCC---------------------cccc
Confidence 00 000000 0112
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
.++++++|||++||++||++|||++|||+||||.+.
T Consensus 243 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 356789999999999999999999999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=429.36 Aligned_cols=286 Identities=25% Similarity=0.430 Sum_probs=223.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC- 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~- 183 (820)
.++|+++++||+|+||+||+|+++.+++.||||++... ....+.+.+|+++|+++ .|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~h~nii~~~~~~~~~ 81 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-------KHENVVNLIEICRTK 81 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-------CCTTBCCEEEEEEC-
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-------cCCCccceEeeeecc
Confidence 38999999999999999999999999999999998643 33456788999999999 68999999999865
Q ss_pred -------cceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEE
Q 003438 184 -------QRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIK 256 (820)
Q Consensus 184 -------~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iK 256 (820)
++++|+|||||.+++...+... ...+++..++.+++||+.||.|||++|||||||||+|||++ .++.+|
T Consensus 82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~-~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~---~~~~~k 157 (318)
T d3blha1 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLK 157 (318)
T ss_dssp ---------CEEEEEECCCEEHHHHHTCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTSCEE
T ss_pred cccccccCceEEEEEeccCCCccchhhhc-ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec---CCCcEE
Confidence 3578999999998877766544 35699999999999999999999999999999999999996 678999
Q ss_pred EeecccccccCC-------ccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q 003438 257 IIDFGSACTEDR-------TVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRI 328 (820)
Q Consensus 257 L~DFGlA~~~~~-------~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~ 328 (820)
|+|||++..... .....++|+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++.+.+..+.+.
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 999999964332 22345789999999999866 6899999999999999999999999999999999999999
Q ss_pred hCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCC
Q 003438 329 LGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYR 408 (820)
Q Consensus 329 lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~ 408 (820)
++..+++. .........+. ... . .......+.+.+
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~-~~~--------------------------------~-----~~~~~~~~~~~~------ 272 (318)
T d3blha1 238 CGSITPEV-WPNVDNYELYE-KLE--------------------------------L-----VKGQKRKVKDRL------ 272 (318)
T ss_dssp HCCCCTTT-STTCCCC----------------------------------------C-----CSSCCBCHHHHH------
T ss_pred cCCCChhh-ccccchhhhhh-hhc--------------------------------c-----cccccccchhhh------
Confidence 88444332 11111100000 000 0 000001111111
Q ss_pred CCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 409 KNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 409 ~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
.....++.++|||.+||++||++|+||+|||+||||+..+.
T Consensus 273 ---------~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 273 ---------KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp ---------HHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred ---------ccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 12234578899999999999999999999999999997654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-50 Score=443.12 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=210.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh----hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP----AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~----~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++.+.. .....+.+|..+++.+++. +|||||+++++|...
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~----~hpnIv~l~~~~~~~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG----DCPFIVCMSYAFHTP 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS----CCTTBCCEEEEEECS
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC----CCCcEEEEEEEEEEC
Confidence 68999999999999999999999999999999997432 2233456676667666543 799999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. ++|.+++... ..+++..++.+++||+.||+|||++|||||||||+||||+ ..+.+||+|||+|
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~---~~g~iKl~DFGla 154 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLA 154 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---SSSCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc---CCCcEEEeeecee
Confidence 99999999998 6899988765 3689999999999999999999999999999999999995 6789999999999
Q ss_pred cccCC-ccccccccccccCcccccc-ccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 264 CTEDR-TVYSYIQSRYYRSPEVLLG-YQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 264 ~~~~~-~~~~~~gt~~Y~APEvl~~-~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
+.... .....+||+.|+|||++.. ..|+.++|||||||+||||++|+.||.+.+..+....+..... .+
T Consensus 155 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~-------- 225 (364)
T d1omwa3 155 CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MA-------- 225 (364)
T ss_dssp EECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS-CC--------
T ss_pred eecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CC--------
Confidence 76543 3455689999999999975 5799999999999999999999999976543222211111000 00
Q ss_pred hccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHH
Q 003438 342 KNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQ 421 (820)
Q Consensus 342 ~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~ 421 (820)
.+.+ ..
T Consensus 226 ---------------------------------------------------------------~~~~-----------~~ 231 (364)
T d1omwa3 226 ---------------------------------------------------------------VELP-----------DS 231 (364)
T ss_dssp ---------------------------------------------------------------CCCC-----------SS
T ss_pred ---------------------------------------------------------------CCCC-----------CC
Confidence 0000 11
Q ss_pred hHHHHHHHHHhccccCcCCCCC-----HHHHHcCCccCCCCC
Q 003438 422 IRLALVDFLKGLVEFDPAKRWS-----PFQASRHPFVTGEPF 458 (820)
Q Consensus 422 ~s~~l~DLI~kmL~~DP~kRpT-----a~EaL~HPff~~~~~ 458 (820)
+++++++||.+||+.||++||| |+|||+||||++..+
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 4577899999999999999999 899999999998653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=434.03 Aligned_cols=304 Identities=28% Similarity=0.476 Sum_probs=229.1
Q ss_pred cceEeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCC
Q 003438 93 DLILAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDRE 169 (820)
Q Consensus 93 d~~~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~ 169 (820)
.+.+.+++... ...++|+++++||+|+||+||+|+++.+++.||||++++. .....++.+|+.+|+++
T Consensus 3 ~~~~~~~~~~f--~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l------- 73 (355)
T d2b1pa1 3 FYSVEVGDSTF--TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV------- 73 (355)
T ss_dssp EEEEEETTEEE--EEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-------
T ss_pred CEEEEeCCcce--eecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-------
Confidence 34566666321 1227899999999999999999999999999999999854 34456788999999998
Q ss_pred CCCceeEEeEEEeec------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCC
Q 003438 170 DKHHIVRIYEYFVCQ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPEN 243 (820)
Q Consensus 170 ~HpnIVkl~d~f~~~------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeN 243 (820)
+|||||+++++|... .++|+|||||.+++++.+. ..+++..++.+++||+.||+|||++||+||||||+|
T Consensus 74 ~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~N 149 (355)
T d2b1pa1 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_dssp CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccc
Confidence 689999999999743 6899999999998887663 358999999999999999999999999999999999
Q ss_pred cccccccCCCeEEEeecccccccCC--ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHH
Q 003438 244 ILLCTSVKPAEIKIIDFGSACTEDR--TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDL 321 (820)
Q Consensus 244 ILl~~~~~~~~iKL~DFGlA~~~~~--~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~ 321 (820)
||++ .++.+||+|||+++.... .....++|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+....
T Consensus 150 il~~---~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~ 226 (355)
T d2b1pa1 150 IVVK---SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226 (355)
T ss_dssp EEEC---TTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccc---cccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH
Confidence 9996 668899999999865443 33456789999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHH
Q 003438 322 LRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEI 401 (820)
Q Consensus 322 l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~i 401 (820)
+.++.+.++..+++.+.........++..... +.......+
T Consensus 227 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~ 267 (355)
T d2b1pa1 227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK---------------------------------------YAGLTFPKL 267 (355)
T ss_dssp HHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCC---------------------------------------CCCCCHHHH
T ss_pred HHHHHHhccCCCHHHHHHhhhhHHHHhhcCcc---------------------------------------ccccccccc
Confidence 99999999855555443322222222221110 000111111
Q ss_pred HhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 402 VTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 402 l~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
+.... ...+.......+..++|||++||++||++||||+|||+||||++.
T Consensus 268 ~~~~~-----~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 268 FPDSL-----FPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp SCGGG-----SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred ccccc-----ccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 11100 001112233467889999999999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=434.11 Aligned_cols=280 Identities=31% Similarity=0.569 Sum_probs=221.7
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec----
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ---- 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~---- 184 (820)
-+|+.+++||+|+||+||+|+++.+++.||||+++++... ..+|+++|++| +|+|||+++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l-------~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKL-------DHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHC-------CCTTBCCEEEEEEEC--CC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhc-------CCCCCCcEEEEEEecCccC
Confidence 4799999999999999999999999999999999865432 34699999998 689999999999643
Q ss_pred --ceeEEEEeccCCChHHHHHhh--hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 185 --RHLCICFELLDSNLYELIKIN--HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 185 --~~l~LVmEy~~gsL~d~l~~~--~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
.++|||||||++++.+.+... ....+++.+++.+++||+.||+|||++|||||||||+|||++ .+...+||+||
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DF 167 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDF 167 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCC
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecc
Confidence 368999999998877666532 334699999999999999999999999999999999999996 23358999999
Q ss_pred ccccccC--CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 261 GSACTED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 261 GlA~~~~--~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|++.... ......++|+.|+|||++.+. .|+.++|||||||++|||++|++||...+..+.+..+.+.+| .++...
T Consensus 168 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g-~~~~~~ 246 (350)
T d1q5ka_ 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG-TPTREQ 246 (350)
T ss_dssp TTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred cchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC-CChHHh
Confidence 9997543 344566899999999998764 789999999999999999999999999999999999999999 454444
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
+...... +.... . +... ...+.++
T Consensus 247 ~~~~~~~---~~~~~-~-------------------------------~~~~-----~~~~~~~---------------- 270 (350)
T d1q5ka_ 247 IREMNPN---YTEFK-F-------------------------------PQIK-----AHPWTKV---------------- 270 (350)
T ss_dssp HHHHCC------CCC-C-------------------------------CCCC-----CCCGGGT----------------
T ss_pred hhhhccc---hhhcc-c-------------------------------cccc-----cCchhhh----------------
Confidence 4322110 00000 0 0000 0000000
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.....+++++|||++||++||++||||+|||+||||++..
T Consensus 271 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0112457899999999999999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=434.55 Aligned_cols=252 Identities=29% Similarity=0.492 Sum_probs=214.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+.++.+.. +|||||++++++.++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~------~hp~Iv~~~~~~~~~ 75 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EHPFLTHMFCTFQTK 75 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT------TCTTBCCEEEEEECS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC------CCCcEEEEEEEEccC
Confidence 6799999999999999999999999999999999753 233456677777765431 699999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+|||||||. |+|.+++... ..+++.+++.++.||+.||+|||+++||||||||+|||++ ..+.+||+|||++
T Consensus 76 ~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~---~~~~~kl~DFG~a 150 (320)
T d1xjda_ 76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMC 150 (320)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC---TTSCEEECCCTTC
T ss_pred CceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec---CCCceeccccchh
Confidence 99999999998 5899988765 3699999999999999999999999999999999999995 6789999999999
Q ss_pred cccC---CccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 264 CTED---RTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 264 ~~~~---~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
+... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.++.. + .++
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~-~~~------ 221 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--D-NPF------ 221 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--C-CCC------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--C-CCC------
Confidence 7543 233446899999999999999999999999999999999999999999887776666543 1 000
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
+| .
T Consensus 222 ----------------------------------------------------------------~p-------------~ 224 (320)
T d1xjda_ 222 ----------------------------------------------------------------YP-------------R 224 (320)
T ss_dssp ----------------------------------------------------------------CC-------------T
T ss_pred ----------------------------------------------------------------CC-------------c
Confidence 00 0
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHH-HHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPF-QASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~-EaL~HPff~~~~ 457 (820)
.+++.+.|||++||+.||++|||++ |+++||||++..
T Consensus 225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 1346789999999999999999995 899999999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=422.61 Aligned_cols=247 Identities=25% Similarity=0.433 Sum_probs=205.8
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.++||+|+||+||+|+++.+++.||||++++.. ....++.+|+.+|+++++ .|||||+++++|
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~-----~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS-----GFSGVIRLLDWF 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS-----SSCSBCCEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc-----CCCCccEEEEEE
Confidence 78999999999999999999999999999999997432 112345689999999964 489999999999
Q ss_pred eecceeEEEEeccCC--ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 182 VCQRHLCICFELLDS--NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 182 ~~~~~l~LVmEy~~g--sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
.+.+.+|+||||+.+ ++.+++... ..+++.+++.+++||++||+|||++|||||||||+|||++ .+.+.+||+|
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~D 154 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLID 154 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECc
Confidence 999999999999974 677777654 4699999999999999999999999999999999999996 2457899999
Q ss_pred cccccccCCc-cccccccccccCccccccccc-cccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 260 FGSACTEDRT-VYSYIQSRYYRSPEVLLGYQY-TTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 260 FGlA~~~~~~-~~~~~gt~~Y~APEvl~~~~y-t~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
||+|+..... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+ .+.+ + .
T Consensus 155 FG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~--~-~----- 220 (273)
T d1xwsa_ 155 FGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--G-Q----- 220 (273)
T ss_dssp CTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--C-C-----
T ss_pred cccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh--c-c-----
Confidence 9999765433 345689999999999987765 578999999999999999999996421 1111 0 0
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
..+ +
T Consensus 221 -----------------------------------------------------~~~--------------~--------- 224 (273)
T d1xwsa_ 221 -----------------------------------------------------VFF--------------R--------- 224 (273)
T ss_dssp -----------------------------------------------------CCC--------------S---------
T ss_pred -----------------------------------------------------cCC--------------C---------
Confidence 000 0
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGE 456 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~ 456 (820)
..+++++++||++||++||++|||++|||+||||++.
T Consensus 225 --~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 225 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp --SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred --CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0134678999999999999999999999999999874
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=426.89 Aligned_cols=282 Identities=29% Similarity=0.549 Sum_probs=222.7
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
.+||+++++||+|+||+||+|+++.+++.||||++++. ....+.+.+|+++|+.| .|+|||+++++|...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-------~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-------KHENVIGLLDVFTPA 89 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-------CCTTBCCCSEEECSC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-------CCCCeeeEEEEEeec
Confidence 37999999999999999999999999999999999753 34556788999999999 689999999999643
Q ss_pred ------ceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 185 ------RHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 185 ------~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
...++++++++++|.+++.. +.+++.+++.+++||+.||+|||++|||||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~---~~~~~kl~ 163 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKIL 163 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEEC
T ss_pred cccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc---cccccccc
Confidence 34566666666799988854 3599999999999999999999999999999999999995 67899999
Q ss_pred ecccccccCCccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCchHH
Q 003438 259 DFGSACTEDRTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQPPDYV 337 (820)
Q Consensus 259 DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~Pp~~~ 337 (820)
|||++...........+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......|.+..+ .++..+
T Consensus 164 dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~-~~~~~~ 242 (348)
T d2gfsa1 164 DFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG-TPGAEL 242 (348)
T ss_dssp CC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CCCHHH
T ss_pred ccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC-CCChHH
Confidence 999998888877888999999999998776 468899999999999999999999999999999999999888 444433
Q ss_pred HHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhh
Q 003438 338 LKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDIS 417 (820)
Q Consensus 338 l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~ 417 (820)
......... ... .. .. .......+..+.
T Consensus 243 ~~~~~~~~~-----------------------------~~~--~~-~~-----~~~~~~~~~~~~--------------- 270 (348)
T d2gfsa1 243 LKKISSESA-----------------------------RNY--IQ-SL-----TQMPKMNFANVF--------------- 270 (348)
T ss_dssp HTTCCCHHH-----------------------------HHH--HT-TS-----CCCCCCCHHHHS---------------
T ss_pred hhhccchhh-----------------------------hhh--hh-hc-----ccCCCcchhhhc---------------
Confidence 322110000 000 00 00 000111122221
Q ss_pred hhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 418 KESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 418 ~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
...+++++|||++||++||++||||+|||+||||++..
T Consensus 271 --~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 271 --IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp --TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred --CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 12457899999999999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-48 Score=423.74 Aligned_cols=284 Identities=25% Similarity=0.441 Sum_probs=216.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec--ce
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ--RH 186 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~--~~ 186 (820)
++|+++++||+|+||+||+|+++.+++.||||+++... .+++.+|+++|+.+. +||||++++++|... ..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~------~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR------GGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT------TSTTBCCEEEEEECTTTCS
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc------CCCCCcEEEEEEEecCCCc
Confidence 78999999999999999999999999999999998643 467889999999994 589999999999854 57
Q ss_pred eEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 187 LCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 187 l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
+|+|||||.+ +|..+ .+.+++..++.+++||+.||+|||++|||||||||+||||+ .+...+||+|||+|..
T Consensus 107 ~~~v~e~~~~~~L~~~-----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEEEECCCSCBGGGT-----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEE
T ss_pred eeEEEeecCCCcHHHH-----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeeccccccee
Confidence 9999999985 55443 24599999999999999999999999999999999999996 3455799999999975
Q ss_pred cC--CccccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCCchHHHHhh
Q 003438 266 ED--RTVYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGA-SEFDLLRRMIRILGAQPPDYVLKEA 341 (820)
Q Consensus 266 ~~--~~~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~-s~~d~l~~I~~~lG~~Pp~~~l~~~ 341 (820)
.. ......++|+.|+|||++.+. .++.++|||||||++|||++|+.||... +..++...+.+.+|...+.......
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 43 344566889999999998876 5899999999999999999999998654 5666777777777722221111110
Q ss_pred hc-cchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 342 KN-TSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 342 ~~-~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
.. ....+.... .. . ....+..... .....
T Consensus 260 ~~~~~~~~~~~~--------------------------------~~-~-----~~~~~~~~~~------------~~~~~ 289 (328)
T d3bqca1 260 NIELDPRFNDIL--------------------------------GR-H-----SRKRWERFVH------------SENQH 289 (328)
T ss_dssp TCCCCGGGGGTC--------------------------------CC-C-----CCCCGGGGCC------------TTTGG
T ss_pred ccccCcccchhc--------------------------------cc-c-----cccchhhccc------------ccccc
Confidence 00 000000000 00 0 0000000000 00112
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
.++++++|||++||++||++||||+|||+||||++..
T Consensus 290 ~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 290 LVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 3567899999999999999999999999999998753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=423.77 Aligned_cols=282 Identities=33% Similarity=0.571 Sum_probs=220.1
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
..+|+++++||+|+||+||+|+++.+++.||||++++. ....+.+++|+++|+.| .||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-------~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-------CCTTBCCCCEEECCSS
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-------CCCCCCcEEEEEeecc
Confidence 37899999999999999999999999999999999753 45567888999999999 6899999999997653
Q ss_pred -----eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 186 -----HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 186 -----~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
++||||++++++|.+++... .+++..++.+++||+.||+|||++|||||||||+||||+ ..+.+||+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~---~~~~~kl~Df 153 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDF 153 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCC
T ss_pred ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC---CCCCEEEccc
Confidence 46788877778999998754 599999999999999999999999999999999999995 6789999999
Q ss_pred ccccccCCc------cccccccccccCccccccc-cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 261 GSACTEDRT------VYSYIQSRYYRSPEVLLGY-QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 261 GlA~~~~~~------~~~~~gt~~Y~APEvl~~~-~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
|+|...... ....++|+.|+|||++... .++.++||||+||++|+|++|++||.+.+..+....+...+. .+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~-~~ 232 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG-SP 232 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-SC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc-CC
Confidence 999643322 3445789999999998554 678999999999999999999999999999999888888877 44
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
........... . ..... ...+ ......+..++
T Consensus 233 ~~~~~~~~~~~----~-------------------------~~~~~---~~~~-----~~~~~~~~~~~----------- 264 (345)
T d1pmea_ 233 SQEDLNCIINL----K-------------------------ARNYL---LSLP-----HKNKVPWNRLF----------- 264 (345)
T ss_dssp CHHHHHTCCCH----H-------------------------HHHHH---HTSC-----CCCCCCHHHHC-----------
T ss_pred Chhhhhhhhhh----h-------------------------hhccc---ccCC-----ccCCCCHHHhC-----------
Confidence 33322111000 0 00000 0000 00011112221
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEP 457 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~ 457 (820)
..++.++++||.+||++||++||||+|||+||||++..
T Consensus 265 ------~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 265 ------PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp ------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 12457899999999999999999999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=412.32 Aligned_cols=279 Identities=30% Similarity=0.516 Sum_probs=219.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|+++++||+|+||+||+|+++.+++.||||+++.. .....++.+|+.+|+.+ .|+||++++++|....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-------~h~niv~~~~~~~~~~ 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-------KHKNIVRLHDVLHSDK 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEECSS
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-------CcCCEEeecccccccc
Confidence 6899999999999999999999999999999999743 34567888999999888 6899999999999999
Q ss_pred eeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccc
Q 003438 186 HLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACT 265 (820)
Q Consensus 186 ~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~ 265 (820)
..++|+|++.+.+...+... .+.+++..++.+++|+++||+|||++|||||||||+|||++ ..+.+||+|||.+..
T Consensus 75 ~~~iv~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~---~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 75 KLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARA 150 (292)
T ss_dssp EEEEEEECCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred ceeEEeeecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc---cCCceeeeecchhhc
Confidence 99999999997555544433 35799999999999999999999999999999999999996 567899999999976
Q ss_pred cCCc---cccccccccccCcccccccc-ccccchhHhHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCCchHHHHh
Q 003438 266 EDRT---VYSYIQSRYYRSPEVLLGYQ-YTTAIDMWSFGCIVAELFLGLPL-FPGASEFDLLRRMIRILGAQPPDYVLKE 340 (820)
Q Consensus 266 ~~~~---~~~~~gt~~Y~APEvl~~~~-yt~ksDIWSLG~ILyeLltG~~P-F~~~s~~d~l~~I~~~lG~~Pp~~~l~~ 340 (820)
.... .....+++.|+|||++.... ++.++|||||||++|||++|+.| |.+.+..+.+.++....+ .++...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 229 (292)
T d1unla_ 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG-TPTEEQWPS 229 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC-CCCTTTCTT
T ss_pred ccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC-CCChhhhhh
Confidence 5433 23446788899999998764 68999999999999999998876 567777888888888877 333322211
Q ss_pred hhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhH
Q 003438 341 AKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKES 420 (820)
Q Consensus 341 ~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~ 420 (820)
......+... +.... .. .......
T Consensus 230 ~~~~~~~~~~-----------------------------------~~~~~----~~-----------------~~~~~~~ 253 (292)
T d1unla_ 230 MTKLPDYKPY-----------------------------------PMYPA----TT-----------------SLVNVVP 253 (292)
T ss_dssp GGGSTTCCCC-----------------------------------CCCCT----TC-----------------CCTTTST
T ss_pred hhhccccccc-----------------------------------ccccc----cc-----------------hhhhccc
Confidence 1110000000 00000 00 0000111
Q ss_pred HhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCC
Q 003438 421 QIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTG 455 (820)
Q Consensus 421 ~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~ 455 (820)
.+++.++|||++||++||++||||+|||+||||++
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 24578999999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-48 Score=412.19 Aligned_cols=202 Identities=21% Similarity=0.311 Sum_probs=178.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.++||+|+||+||+|+++.+++.||||+++.+....+++.+|+++|++| .|||||+++++|.+.+.++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-------KHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-------CCCCEecCCccEeeCCeeE
Confidence 689999999999999999999999999999999987766778899999999999 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||||||. |+|.+++.......+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||+|+...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---CCCcEEEccccceeecC
Confidence 9999998 6899998876666799999999999999999999999999999999999996 56889999999997654
Q ss_pred Ccc----ccccccccccCccccccccccccchhHhHHHHHHHHHhCCCC-CCCCCHHH
Q 003438 268 RTV----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPL-FPGASEFD 320 (820)
Q Consensus 268 ~~~----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~P-F~~~s~~d 320 (820)
... ....+++.|+|||++.+..|+.++|||||||++|||++|..| |.+.+..+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~ 224 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH
Confidence 322 223578899999999999999999999999999999996555 44444433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-46 Score=412.38 Aligned_cols=315 Identities=32% Similarity=0.503 Sum_probs=240.4
Q ss_pred EeeceeeeccccCCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcC----CCCC
Q 003438 96 LAVNLVLVNAETQRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYD----REDK 171 (820)
Q Consensus 96 ~~l~~~l~~~~~~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~----~~~H 171 (820)
+.+|+.+.+ .||+++++||+|+||+||+|+++.+++.||||+++++....+...+|+++|+.+.+... ...|
T Consensus 4 ~~~g~~~~~----~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~ 79 (362)
T d1q8ya_ 4 AFKGEPYKD----ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79 (362)
T ss_dssp CCTTCEETT----TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred CCCCCCccC----CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCc
Confidence 445666643 67999999999999999999999999999999999887777888999999999976421 1257
Q ss_pred CceeEEeEEEeec--ceeEEEEeccC--CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc-CCeeeccCCCCCccc
Q 003438 172 HHIVRIYEYFVCQ--RHLCICFELLD--SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD-AGIIHCDLKPENILL 246 (820)
Q Consensus 172 pnIVkl~d~f~~~--~~l~LVmEy~~--gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs-~gIVHrDLKPeNILl 246 (820)
+||+++++++... ...++||+++. +.............+++..++.+++||+.||+|||+ .||+||||||+||||
T Consensus 80 ~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 159 (362)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred CceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeee
Confidence 8999999998765 35566666654 455555555556779999999999999999999997 899999999999999
Q ss_pred ccccC---CCeEEEeecccccccCCccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC------
Q 003438 247 CTSVK---PAEIKIIDFGSACTEDRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS------ 317 (820)
Q Consensus 247 ~~~~~---~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s------ 317 (820)
+.+.. ...+||+|||.+..........++|+.|+|||++....|+.++|||||||++++|++|+.||....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred eccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 64322 135899999999877777777899999999999999999999999999999999999999997543
Q ss_pred HHHHHHHHHHHhCCCCchHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccch
Q 003438 318 EFDLLRRMIRILGAQPPDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKH 397 (820)
Q Consensus 318 ~~d~l~~I~~~lG~~Pp~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~ 397 (820)
..+.+..+...+| .++..+.........++........... .....
T Consensus 240 ~~~~~~~~~~~lg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~ 285 (362)
T d1q8ya_ 240 DDDHIAQIIELLG-ELPSYLLRNGKYTRTFFNSRGLLRNISK---------------------------------LKFWP 285 (362)
T ss_dssp HHHHHHHHHHHHC-SCCHHHHHHCTTHHHHBCC--CBSSCCC---------------------------------CCBCC
T ss_pred hhHHHHHHHHHhC-CCCHHHhhcccccccccccchhhhcccc---------------------------------ccCCc
Confidence 4567788888888 5666666665555555544332211111 00011
Q ss_pred hHHHHhcCCCCCCCChhhhhhhHHhHHHHHHHHHhccccCcCCCCCHHHHHcCCccCCCCC
Q 003438 398 LEEIVTNYPYRKNLSMEDISKESQIRLALVDFLKGLVEFDPAKRWSPFQASRHPFVTGEPF 458 (820)
Q Consensus 398 L~~il~~~P~~~~ls~e~~~~~~~~s~~l~DLI~kmL~~DP~kRpTa~EaL~HPff~~~~~ 458 (820)
+...+... .......++.++|||.+||++||++||||+|||+||||++...
T Consensus 286 ~~~~~~~~----------~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 286 LEDVLTEK----------YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp HHHHHHHT----------TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred hhhhcccc----------cccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence 22222110 1122346788999999999999999999999999999996543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=407.79 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=208.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|+++++||+|+||+||+|+++ +++.||||+++......+.+.+|+++|+++ .|||||++++++. ++.+|
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~-~~~~~ 83 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-------QHQRLVRLYAVVT-QEPIY 83 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-------CCCCEeEEEeeec-cCCeE
Confidence 78999999999999999999865 578899999987766677899999999999 6899999999875 46789
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||||||. |+|.+++.......+++..++.|+.||++||+|||+++||||||||+||||+ .++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~---~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee---cccceeeccccceEEcc
Confidence 9999997 6888877666555699999999999999999999999999999999999995 67899999999997654
Q ss_pred Cc----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 268 RT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 268 ~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.. .....+|+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+.+... ++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~--~~-------- 230 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--MV-------- 230 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--CC--------
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--CC--------
Confidence 32 223467899999999998899999999999999999999 5667776666555544432100 00
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
. ...+
T Consensus 231 ----------------------------------------------------------------~-----------p~~~ 235 (272)
T d1qpca_ 231 ----------------------------------------------------------------R-----------PDNC 235 (272)
T ss_dssp ----------------------------------------------------------------C-----------CTTC
T ss_pred ----------------------------------------------------------------C-----------cccC
Confidence 0 0013
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHc--CCccCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASR--HPFVTG 455 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~--HPff~~ 455 (820)
++++.+||.+||+.||++|||++|+++ |+||+.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 467899999999999999999999998 888863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=402.08 Aligned_cols=207 Identities=22% Similarity=0.366 Sum_probs=173.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|+++++||+|+||+||+|+++ +++.||||+++......+++.+|+++++++ .|||||++++++..++.++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-------SHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEECSSSSCE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-------CCCCcccccceeccCCceE
Confidence 68999999999999999999875 567899999987766678899999999999 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
||||||. |+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||||+ .++.+||+|||+++...
T Consensus 77 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---GGGCEEECSCC------
T ss_pred EEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---CCCCeEecccchheecc
Confidence 9999997 68988877653 4689999999999999999999999999999999999996 66889999999997543
Q ss_pred Cc----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003438 268 RT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 268 ~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~ 327 (820)
.. .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+..
T Consensus 153 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 217 (263)
T d1sm2a_ 153 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH
T ss_pred CCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh
Confidence 22 223568999999999999999999999999999999999 6778877776666555443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-47 Score=405.11 Aligned_cols=208 Identities=26% Similarity=0.446 Sum_probs=175.3
Q ss_pred CCceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
.++|++.+.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+++|+.+ +|||||++++++..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-------~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-------NHPAIVAVYDTGEA 78 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-------CCCCCCcccceeee
Confidence 37899999999999999999999999999999999743 34456788999999888 78999999999987
Q ss_pred cc----eeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEe
Q 003438 184 QR----HLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKII 258 (820)
Q Consensus 184 ~~----~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~ 258 (820)
.+ .+|||||||+| +|.+++... +.+++.+++.|++||+.||+|||++|||||||||+|||++ ..+.++|+
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~ 153 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVM 153 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEEC
T ss_pred ccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceee
Confidence 64 48999999984 788777655 4699999999999999999999999999999999999996 67889999
Q ss_pred ecccccccCC------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 003438 259 DFGSACTEDR------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 259 DFGlA~~~~~------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~ 327 (820)
|||.+..... .....+||+.|+|||++.+..|+.++||||||||+|||+||++||.+.+..+.+.++.+
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 9999854322 23456899999999999999999999999999999999999999998887776655543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=398.19 Aligned_cols=207 Identities=20% Similarity=0.305 Sum_probs=182.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|+++++||+|+||+||+|+.+ +++.||||++++.....+.+++|+++++++ .|||||++++++.+++.++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-------~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-------SHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-------CCTTBCCEEEEECCSSSEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-------CCCceeeEEEEEeeCCceE
Confidence 67889999999999999999974 788999999998766678899999999998 6899999999999999999
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+||||+. |+|.+++.... ..+++..+++++.||++||+|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 76 iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~---~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp EEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC---TTCCEEECCCSSCCBCS
T ss_pred EEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc---CCCcEEECcchhheecc
Confidence 9999997 57777766554 4699999999999999999999999999999999999995 67899999999996543
Q ss_pred Cc----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 003438 268 RT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMIR 327 (820)
Q Consensus 268 ~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~~ 327 (820)
.. .....+|+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+.+
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~ 216 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred CCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence 22 223567899999999999999999999999999999998 8999998887776665543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=409.58 Aligned_cols=209 Identities=24% Similarity=0.379 Sum_probs=175.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC-----eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN-----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg-----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.++||+|+||+||+|++..++ ..||||++... ......+.+|+.+|.++. .|||||++++++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------~HpnIv~l~~~~ 110 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG------SHENIVNLLGAC 110 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc------CCCcEeEEEEEE
Confidence 78999999999999999999876554 37999998643 334457889999999984 589999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhc---------------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccC
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHF---------------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDL 239 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~---------------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDL 239 (820)
.+.+.+|||||||+ |+|.++++.... ..+++..++.|+.||++||+|||+++||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999997 699999976431 34899999999999999999999999999999
Q ss_pred CCCCcccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCC
Q 003438 240 KPENILLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLF 313 (820)
Q Consensus 240 KPeNILl~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF 313 (820)
||+|||++ .++.+||+|||+|+..... .....+|+.|+|||++.+..|+.++|||||||+||||++ |++||
T Consensus 191 Kp~Nill~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEE---TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccc---cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999995 6789999999999654322 224567999999999999999999999999999999997 89999
Q ss_pred CCCCHHHHHHHHH
Q 003438 314 PGASEFDLLRRMI 326 (820)
Q Consensus 314 ~~~s~~d~l~~I~ 326 (820)
.+.+..+.+.+++
T Consensus 268 ~~~~~~~~~~~~~ 280 (325)
T d1rjba_ 268 PGIPVDANFYKLI 280 (325)
T ss_dssp TTCCCSHHHHHHH
T ss_pred CCCCHHHHHHHHH
Confidence 8766555444443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-46 Score=402.63 Aligned_cols=207 Identities=21% Similarity=0.336 Sum_probs=169.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe---EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS---FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~---~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++|++.++||+|+||+||+|+++.+++ .||||++... ....+.+.+|+++|++| .|||||++++++..
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-------DHPNVIHLEGVVTK 98 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-------CCTTBCCEEEEECS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-------CCCCCccEEEEEee
Confidence 789999999999999999999876654 6899998753 44566789999999988 69999999999999
Q ss_pred cceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
.+.+|||||||.+ +|.+++.... ..+++.+++.++.||++||+|||+++||||||||+||||+ .++.+||+|||+
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~---~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGL 174 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCC--
T ss_pred CCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC---CCCcEEECCccc
Confidence 9999999999984 7887776543 4699999999999999999999999999999999999995 678999999999
Q ss_pred ccccCCcc--------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003438 263 ACTEDRTV--------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 263 A~~~~~~~--------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~ 326 (820)
|+...... ....+|+.|+|||++.+..|+.++|||||||+||||+| |++||.+.+..+.+..+.
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~ 247 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE 247 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 97543221 12356889999999999999999999999999999998 899999888776665543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=399.40 Aligned_cols=203 Identities=28% Similarity=0.378 Sum_probs=170.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeC---ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKN---QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~---~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
++|++.++||+|+||+||+|+.. ..||||+++. .....+.+.+|+++|+++ .|||||++++++. ++
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~~~~~-~~ 76 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-------RHVNILLFMGYST-AP 76 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-------CCTTBCCEEEEEC-SS
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-------CCCCEeeeeEEEe-cc
Confidence 78999999999999999999754 3599999974 344567888999999988 6899999999865 46
Q ss_pred eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccc
Q 003438 186 HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSAC 264 (820)
Q Consensus 186 ~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~ 264 (820)
.++||||||+ |+|.+++.... ..+++..+..|+.||++||+|||+++||||||||+||||+ .++.+||+|||+|+
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLAT 152 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSC
T ss_pred EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEcccccee
Confidence 7899999998 69999887654 4699999999999999999999999999999999999996 67899999999996
Q ss_pred ccCC-----ccccccccccccCccccccc---cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 003438 265 TEDR-----TVYSYIQSRYYRSPEVLLGY---QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 265 ~~~~-----~~~~~~gt~~Y~APEvl~~~---~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~ 326 (820)
.... ......||+.|+|||++.+. .|+.++|||||||+||||+||+.||.+.+..+.+..+.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 5432 22345789999999999753 58999999999999999999999998876655544443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=398.67 Aligned_cols=205 Identities=22% Similarity=0.336 Sum_probs=174.2
Q ss_pred CceEEEEE-eccCCceeEEEeecc--CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDL-LGHGTFGQVAKCWDA--EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~-LG~G~fG~Vyka~d~--~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++|.+.+. ||+|+||+||+|.++ .++..||||+++.. ....+.+.+|+++|+++ +|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-------DNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-------CCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-------CCCCEeeEeeeecc
Confidence 67888885 999999999999765 34568999999753 45567889999999999 68999999999864
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
+.+|||||||+ |+|.+++.... ..+++.+++.++.||++||+|||+++||||||||+||||+ .++.+||+|||+
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGl 155 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGL 155 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTT
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchh
Confidence 56899999998 58888775443 4699999999999999999999999999999999999996 678999999999
Q ss_pred ccccCCc------cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 263 ACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 263 A~~~~~~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
|+..... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i 225 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9754332 123467899999999999999999999999999999998 99999887766655544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=409.49 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=209.4
Q ss_pred CceEEEEEeccCCceeEEEeec---cCCCeEEEEEEEeCC-----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD---AEMNSFVAVKIIKNQ-----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d---~~tg~~VAIKiik~~-----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
++|+++++||+|+||+||+|++ +.+++.||||++++. ....+.+.+|+++|++++| ||||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h------~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ------SPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT------CTTBCCEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC------CCeEEEeeee
Confidence 7899999999999999999986 457899999998642 2334567889999999963 5899999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEee
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIID 259 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~D 259 (820)
+.+...+++||||+. ++|.+++.... .+++..++.+++||+.||+|||+++||||||||+|||++ .++.+||+|
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~---~~~~vkL~D 172 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTD 172 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTSCEEESC
T ss_pred eccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec---CCCCEEEee
Confidence 999999999999998 58988887654 588999999999999999999999999999999999996 568999999
Q ss_pred cccccccCC----ccccccccccccCccccccc--cccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q 003438 260 FGSACTEDR----TVYSYIQSRYYRSPEVLLGY--QYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLRRMIRILGAQP 333 (820)
Q Consensus 260 FGlA~~~~~----~~~~~~gt~~Y~APEvl~~~--~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~~I~~~lG~~P 333 (820)
||++..... ......+++.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+....+.+.....
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~- 251 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS- 251 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-
Confidence 999965432 23456789999999999765 47789999999999999999999998766544433333211000
Q ss_pred chHHHHhhhccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCCh
Q 003438 334 PDYVLKEAKNTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSM 413 (820)
Q Consensus 334 p~~~l~~~~~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~ 413 (820)
..+.
T Consensus 252 ----------------------------------------------------------------------~~~~------ 255 (322)
T d1vzoa_ 252 ----------------------------------------------------------------------EPPY------ 255 (322)
T ss_dssp ----------------------------------------------------------------------CCCC------
T ss_pred ----------------------------------------------------------------------CCCC------
Confidence 0000
Q ss_pred hhhhhhHHhHHHHHHHHHhccccCcCCCC-----CHHHHHcCCccCCCCC
Q 003438 414 EDISKESQIRLALVDFLKGLVEFDPAKRW-----SPFQASRHPFVTGEPF 458 (820)
Q Consensus 414 e~~~~~~~~s~~l~DLI~kmL~~DP~kRp-----Ta~EaL~HPff~~~~~ 458 (820)
....++++++||++||++||++|+ |++|||+||||++..+
T Consensus 256 -----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 256 -----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp -----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 012457899999999999999999 5999999999998654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=398.01 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=205.2
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|++.+.||+|+||+||+|+++.+ +.||||+++......+.+.+|+.+|+++ +|+|||++++++. ++.++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-------~h~nIv~~~g~~~-~~~~~ 87 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-------RHEKLVQLYAVVS-EEPIY 87 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-------CCTTBCCEEEEEC-SSSCE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-------ccCCEeEEEEEEe-cCCeE
Confidence 6899999999999999999988665 5699999987766678899999999999 6899999999985 45689
Q ss_pred EEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccC
Q 003438 189 ICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTED 267 (820)
Q Consensus 189 LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~ 267 (820)
+|||||. |+|..++.......+++.+++.++.||+.||+|||+++|+||||||+||||+ .++.+||+|||+++...
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIE 164 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC---
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhcc
Confidence 9999998 5788887766556799999999999999999999999999999999999996 56889999999997543
Q ss_pred Cc----cccccccccccCccccccccccccchhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCchHHHHhhh
Q 003438 268 RT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMIRILGAQPPDYVLKEAK 342 (820)
Q Consensus 268 ~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~PF~~~s~~d~l~~I~~~lG~~Pp~~~l~~~~ 342 (820)
.. .....+|+.|+|||++....++.++|||||||++|||++| .++|......+.+..+.+... +
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--~--------- 233 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--M--------- 233 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--C---------
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC--C---------
Confidence 22 2235689999999999999999999999999999999995 666666666555555432110 0
Q ss_pred ccchhhhhcCCccccCCCccccCCccchhhhhHHHHHHHhhcCCCCCccccccchhHHHHhcCCCCCCCChhhhhhhHHh
Q 003438 343 NTSKFFKCIGSVHNIENGEVSIGGRSAYQALTEIEYEARELKKPLIGKEYFHHKHLEEIVTNYPYRKNLSMEDISKESQI 422 (820)
Q Consensus 343 ~~~~~f~~~~~l~~~~~~~~~~~~~~~y~~~s~~e~e~~~~~~p~~~~~~f~~~~L~~il~~~P~~~~ls~e~~~~~~~~ 422 (820)
+.. ..+
T Consensus 234 ---------------------------------------------------------------~~~-----------~~~ 239 (285)
T d1fmka3 234 ---------------------------------------------------------------PCP-----------PEC 239 (285)
T ss_dssp ---------------------------------------------------------------CCC-----------TTS
T ss_pred ---------------------------------------------------------------CCC-----------ccc
Confidence 000 013
Q ss_pred HHHHHHHHHhccccCcCCCCCHHHHHc--CCccCCC
Q 003438 423 RLALVDFLKGLVEFDPAKRWSPFQASR--HPFVTGE 456 (820)
Q Consensus 423 s~~l~DLI~kmL~~DP~kRpTa~EaL~--HPff~~~ 456 (820)
++++.+||.+||+.||++|||++|+++ |+||+..
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 467899999999999999999999988 8999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=394.62 Aligned_cols=198 Identities=27% Similarity=0.423 Sum_probs=166.8
Q ss_pred EEeccCCceeEEEeec--cCCCeEEEEEEEeCC---hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEE
Q 003438 115 DLLGHGTFGQVAKCWD--AEMNSFVAVKIIKNQ---PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCI 189 (820)
Q Consensus 115 ~~LG~G~fG~Vyka~d--~~tg~~VAIKiik~~---~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~L 189 (820)
++||+|+||+||+|.. ..+++.||||+++.. ....+.+.+|+++|++| .|||||++++++.. +..||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-------~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-------DNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-------CCCCCceEEEEecc-CCEEE
Confidence 4699999999999975 445688999999743 33456789999999998 68999999999864 56789
Q ss_pred EEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 190 CFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 190 VmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
|||||+ |+|.+++... ..+++.+++.|+.||+.||+|||+++||||||||+||||+ ..+.+||+|||+++....
T Consensus 85 vmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhccc
Confidence 999998 5898888754 3699999999999999999999999999999999999996 678999999999975432
Q ss_pred c------cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 269 T------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 269 ~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
. .....||+.|+|||++.+..|+.++|||||||++|||++ |++||.+.+..+....+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 2 123468899999999999999999999999999999998 89999988776655444
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=387.88 Aligned_cols=205 Identities=24% Similarity=0.391 Sum_probs=166.4
Q ss_pred CceEEEEEeccCCceeEEEeeccCC---CeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEM---NSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC 183 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~t---g~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~ 183 (820)
++|++.++||+|+||+||+|++..+ +..||||+++.. ....+.+.+|+++|+++ .|||||++++++.
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-------DHPHIVKLIGVIT- 78 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC-
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe-
Confidence 7899999999999999999987654 357899998743 44456788999999998 6999999999986
Q ss_pred cceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccc
Q 003438 184 QRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGS 262 (820)
Q Consensus 184 ~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGl 262 (820)
++.+|||||||. |+|.+++.... ..+++..++.++.||++||.|||+++||||||||+||+++ ..+.+||+|||+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGL 154 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC---
T ss_pred cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchh
Confidence 568999999998 57777766543 5699999999999999999999999999999999999996 668999999999
Q ss_pred ccccCCc----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 003438 263 ACTEDRT----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRM 325 (820)
Q Consensus 263 A~~~~~~----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I 325 (820)
|+..... .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+..+
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i 222 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9754322 234467899999999999999999999999999999998 89999887766655544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=384.95 Aligned_cols=205 Identities=21% Similarity=0.294 Sum_probs=166.3
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC----eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN----SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg----~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
..|++.++||+|+||+||+|+.+.++ ..||||+++.. ......+++|+++|++| .|||||++++++.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-------~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-------SHHNIIRLEGVIS 79 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEEEC
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-------CCCCEeeeeEEEe
Confidence 67999999999999999999876554 47999999753 34456788999999998 6899999999999
Q ss_pred ecceeEEEEeccCC-ChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLDS-NLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~g-sL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
..+.+++|||||.+ .+.+++... ...+++.++..++.||+.||+|||+++||||||||+||||+ .++.+||+|||
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~---~~~~~Kl~DFG 155 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFG 155 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTCCEEECCCC
T ss_pred cCCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC---CCCeEEEcccc
Confidence 99999999999986 566655544 35699999999999999999999999999999999999996 67899999999
Q ss_pred cccccCCc------cccccccccccCccccccccccccchhHhHHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 003438 262 SACTEDRT------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRR 324 (820)
Q Consensus 262 lA~~~~~~------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~PF~~~s~~d~l~~ 324 (820)
+++..... .....||+.|+|||++.+..++.++|||||||++|||+++ .++|...+..+.+..
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~ 225 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH
Confidence 99754322 1234678999999999999999999999999999999995 555655555444433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=392.22 Aligned_cols=204 Identities=24% Similarity=0.376 Sum_probs=167.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCe----EEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEe
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNS----FVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFV 182 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~----~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~ 182 (820)
.+|+++++||+|+||+||+|++..+++ .||||+++.. ....+.+.+|+++|+++ .|||||++++++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-------DNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-------CCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-------CCCCEeeEEEEEe
Confidence 579999999999999999999887776 5888888643 34467889999999999 6899999999998
Q ss_pred ecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecc
Q 003438 183 CQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFG 261 (820)
Q Consensus 183 ~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFG 261 (820)
++. .++|||++. ++|.+.+.... ..+++..++.++.||+.||+|||+++||||||||+||||+ .++.+||+|||
T Consensus 82 ~~~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFG 156 (317)
T d1xkka_ 82 TST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFG 156 (317)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCS
T ss_pred cCC-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccc
Confidence 754 556666665 78988877653 5699999999999999999999999999999999999996 67899999999
Q ss_pred cccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 262 SACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 262 lA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
+|+..... .....+|+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....
T Consensus 157 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~ 225 (317)
T d1xkka_ 157 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 225 (317)
T ss_dssp HHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH
T ss_pred cceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 99754321 223467999999999999999999999999999999998 8999987665554433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=386.41 Aligned_cols=203 Identities=26% Similarity=0.366 Sum_probs=167.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-ccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-QRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-~~~l 187 (820)
++|+++++||+|+||.||+|+. .++.||||+++++. ..+.+.+|+++|+++ .|||||++++++.+ ++.+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQL-------RHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTC-------CCTTBCCEEEEECCC--CC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-HHHHHHHHHHHHHhC-------CCCCEeeEEEEEEecCCcE
Confidence 6899999999999999999987 47789999998653 456788999999888 68999999999865 4678
Q ss_pred EEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeeccccccc
Q 003438 188 CICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTE 266 (820)
Q Consensus 188 ~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~ 266 (820)
||||||+. |+|.+++.......+++..++.|+.||+.||.|||+++||||||||+|||++ .++.+||+|||+++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCEEECCCCC----
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec---CCCCEeecccccceec
Confidence 99999997 6899998766545699999999999999999999999999999999999995 6789999999999887
Q ss_pred CCccccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 003438 267 DRTVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRR 324 (820)
Q Consensus 267 ~~~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~ 324 (820)
........++..|+|||++.+..++.++|||||||++|||+| |++||...+..+.+..
T Consensus 154 ~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~ 212 (262)
T d1byga_ 154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH
T ss_pred CCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 766667788999999999999999999999999999999998 7999977665544443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-44 Score=385.23 Aligned_cols=207 Identities=24% Similarity=0.286 Sum_probs=175.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|+++++||+|+||+||+|++..+++.||||+++.... .+++.+|+++++.+. +|++|+.+..++...+..+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~------~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQ------GGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHST------TSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHcc------CCCcccEEEEEEecCCEEE
Confidence 689999999999999999999999999999999886432 345778999999985 3556777788888889999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccccccCC
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSACTEDR 268 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA~~~~~ 268 (820)
+||||++++|.+.+.... +.+++..++.++.||+.||+|||++|||||||||+|||++..+....+||+|||+|+....
T Consensus 80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999999999888776554 5699999999999999999999999999999999999987666678899999999975432
Q ss_pred ----------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCCHHHHHH
Q 003438 269 ----------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGASEFDLLR 323 (820)
Q Consensus 269 ----------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s~~d~l~ 323 (820)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 1234579999999999999999999999999999999999999998766544433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=386.13 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=164.3
Q ss_pred CceEEEEEeccCCceeEEEeeccC-----CCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-----MNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-----tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|+++++||+|+||+||+|++.. +++.||||+++.. ....+.+.+|+.++.++. +|+|||++++++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~------~h~~iv~~~~~~ 86 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG------HHLNVVNLLGAC 86 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc------CCCeEEEeeeee
Confidence 789999999999999999998643 4578999999753 344567788888888885 588999999988
Q ss_pred eec-ceeEEEEeccC-CChHHHHHhhhc--------------CCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcc
Q 003438 182 VCQ-RHLCICFELLD-SNLYELIKINHF--------------RGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENIL 245 (820)
Q Consensus 182 ~~~-~~l~LVmEy~~-gsL~d~l~~~~~--------------~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNIL 245 (820)
... ..+++|||||+ |+|.+++..... ..+++.+++.++.||++||+|||+++||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 765 47899999998 699999876431 34889999999999999999999999999999999999
Q ss_pred cccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhC-CCCCCCCCHH
Q 003438 246 LCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEF 319 (820)
Q Consensus 246 l~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~PF~~~s~~ 319 (820)
|+ .++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+....
T Consensus 167 l~---~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 167 LS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EC---GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EC---CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 96 6688999999999644322 2345789999999999999999999999999999999986 6788765543
Q ss_pred HH
Q 003438 320 DL 321 (820)
Q Consensus 320 d~ 321 (820)
+.
T Consensus 244 ~~ 245 (299)
T d1ywna1 244 EE 245 (299)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=381.31 Aligned_cols=209 Identities=22% Similarity=0.371 Sum_probs=177.5
Q ss_pred CCceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEE
Q 003438 108 QRRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEY 180 (820)
Q Consensus 108 ~~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~ 180 (820)
.++|++++.||+|+||+||+|+.+ .+++.||||+++.. ....+++.+|+++|+++ .||||++++++
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-------~h~niv~~~~~ 84 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-------DNPNIVKLLGV 84 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-------CCTTBCCEEEE
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-------CCCCcccceee
Confidence 478999999999999999999854 45689999999753 34456789999999998 68999999999
Q ss_pred EeecceeEEEEeccC-CChHHHHHhhh----------------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeec
Q 003438 181 FVCQRHLCICFELLD-SNLYELIKINH----------------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHC 237 (820)
Q Consensus 181 f~~~~~l~LVmEy~~-gsL~d~l~~~~----------------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHr 237 (820)
+...+..++||||+. |+|.+++.... ...+++..++.|++||+.||+|||+++||||
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHr 164 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEee
Confidence 999999999999997 69999886432 1248899999999999999999999999999
Q ss_pred cCCCCCcccccccCCCeEEEeecccccccCC-----ccccccccccccCccccccccccccchhHhHHHHHHHHHhC-CC
Q 003438 238 DLKPENILLCTSVKPAEIKIIDFGSACTEDR-----TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LP 311 (820)
Q Consensus 238 DLKPeNILl~~~~~~~~iKL~DFGlA~~~~~-----~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~ 311 (820)
||||+||||+ .++.+||+|||+|+.... ......+++.|+|||++.+..|+.++|||||||++|||++| .+
T Consensus 165 DlKp~NILld---~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 165 DLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSGGGEEEC---GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEcccceEEC---CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999996 568899999999964322 12345678999999999999999999999999999999998 57
Q ss_pred CCCCCCHHHHHHHHH
Q 003438 312 LFPGASEFDLLRRMI 326 (820)
Q Consensus 312 PF~~~s~~d~l~~I~ 326 (820)
||.+.+..+.+..+.
T Consensus 242 p~~~~~~~e~~~~v~ 256 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVR 256 (301)
T ss_dssp TTTTSCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHH
Confidence 898887777665543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=380.37 Aligned_cols=207 Identities=26% Similarity=0.405 Sum_probs=172.6
Q ss_pred CceEEEEEeccCCceeEEEeeccCCC-------eEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMN-------SFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYE 179 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg-------~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d 179 (820)
++|+++++||+|+||.||+|++..++ ..||||+++.+ .....++.+|+.++.++. .|||||++++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~------~HpnIv~~~~ 86 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG------KHKNIINLLG 86 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEE
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc------CCCeEEeccc
Confidence 79999999999999999999875543 47999999754 345577888999998884 5999999999
Q ss_pred EEeecceeEEEEeccC-CChHHHHHhhh--------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 180 YFVCQRHLCICFELLD-SNLYELIKINH--------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 180 ~f~~~~~l~LVmEy~~-gsL~d~l~~~~--------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
+|.+++.+++|||||. |+|.+++.... ...+++.+++.+++||+.||+|||+++||||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 9999999999999997 68999987553 23589999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ .++.+||+|||+++..... .....+++.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.
T Consensus 167 Ll~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 167 LVT---EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEC---TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eec---CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 995 6788999999999754332 233578899999999999999999999999999999998 7999987776
Q ss_pred HHHHHH
Q 003438 319 FDLLRR 324 (820)
Q Consensus 319 ~d~l~~ 324 (820)
.+....
T Consensus 244 ~~~~~~ 249 (299)
T d1fgka_ 244 EELFKL 249 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 554443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=377.38 Aligned_cols=206 Identities=24% Similarity=0.377 Sum_probs=167.6
Q ss_pred CceEEEEEeccCCceeEEEeeccC-C--CeEEEEEEEeCC----hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAE-M--NSFVAVKIIKNQ----PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~-t--g~~VAIKiik~~----~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++++.||+|+||+||+|+... + ...||||++++. ....+.+.+|+.+|+++ +|||||++++++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-------~H~nIv~~~g~~ 80 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-------DHRNLIRLYGVV 80 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-------CCTTBCCEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-------CCCCEEEEEEEE
Confidence 789999999999999999997543 2 347999998743 34557789999999999 689999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeec
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDF 260 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DF 260 (820)
.+ ..+++|||||. +++.+.+.... ..+++..++.++.||+.||.|||+++|+||||||+||||+ .++.+||+||
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~Df 155 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDF 155 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCC
T ss_pred ee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccc
Confidence 65 57899999997 68887776654 4699999999999999999999999999999999999996 5679999999
Q ss_pred ccccccCCcc------ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 003438 261 GSACTEDRTV------YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASEFDLLRRMI 326 (820)
Q Consensus 261 GlA~~~~~~~------~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~~d~l~~I~ 326 (820)
|+++...... ....++..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.+..+.
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~ 228 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence 9997653321 22356788999999999999999999999999999998 899999888877766554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=384.62 Aligned_cols=208 Identities=24% Similarity=0.309 Sum_probs=173.9
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeE--EEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeec
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSF--VAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQ 184 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~--VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~ 184 (820)
++|++.++||+|+||+||+|+++.++.. ||||+++.. ....+.+.+|+++|+++. +|||||++++++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~------~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPNIINLLGACEHR 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC------CCTTBCCEEEEEEET
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc------CCCCEeeEEEEEecC
Confidence 6899999999999999999999888864 777887643 334567889999999873 489999999999999
Q ss_pred ceeEEEEeccC-CChHHHHHhh--------------hcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccc
Q 003438 185 RHLCICFELLD-SNLYELIKIN--------------HFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTS 249 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~--------------~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~ 249 (820)
+.++|||||+. |+|.+++... ....+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~-- 161 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-- 161 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc--
Confidence 99999999998 6999998654 235699999999999999999999999999999999999996
Q ss_pred cCCCeEEEeecccccccCCcc--ccccccccccCccccccccccccchhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 003438 250 VKPAEIKIIDFGSACTEDRTV--YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRM 325 (820)
Q Consensus 250 ~~~~~iKL~DFGlA~~~~~~~--~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~PF~~~s~~d~l~~I 325 (820)
..+.+||+|||+++...... ....+|..|+|||.+.+..|+.++||||||||+|||++| .+||.+.+..+.+..+
T Consensus 162 -~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 162 -ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp -GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred -CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 66789999999997554332 344689999999999999999999999999999999996 5678877766554443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=376.43 Aligned_cols=209 Identities=27% Similarity=0.378 Sum_probs=177.9
Q ss_pred CceEEEEEeccCCceeEEEeec-----cCCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWD-----AEMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d-----~~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.++||+|+||.||+|+. ..+++.||||+++.. ......+.+|+.+++++. +|||||++++++
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~------~HpnIv~~~g~~ 96 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG------NHMNIVNLLGAC 96 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc------CCCCEEEEEEEE
Confidence 7999999999999999999974 356789999999853 345567889999999984 599999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh----------------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCc
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH----------------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENI 244 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~----------------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNI 244 (820)
...+.+|||||||. |+|.+++.... ...+++..++.++.||+.||+|||+++||||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 99999999999997 58888887543 22589999999999999999999999999999999999
Q ss_pred ccccccCCCeEEEeecccccccCCcc-----ccccccccccCccccccccccccchhHhHHHHHHHHHh-CCCCCCCCCH
Q 003438 245 LLCTSVKPAEIKIIDFGSACTEDRTV-----YSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFL-GLPLFPGASE 318 (820)
Q Consensus 245 Ll~~~~~~~~iKL~DFGlA~~~~~~~-----~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLlt-G~~PF~~~s~ 318 (820)
|++ ..+.+||+|||.++...... ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+.
T Consensus 177 l~~---~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 177 LLT---HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEE---TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccc---ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 996 67899999999997554321 23477999999999999999999999999999999998 7777877665
Q ss_pred HHHHHHHH
Q 003438 319 FDLLRRMI 326 (820)
Q Consensus 319 ~d~l~~I~ 326 (820)
.+.+.+++
T Consensus 254 ~~~~~~~i 261 (311)
T d1t46a_ 254 DSKFYKMI 261 (311)
T ss_dssp SHHHHHHH
T ss_pred HHHHHHHH
Confidence 55544443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-42 Score=371.47 Aligned_cols=201 Identities=21% Similarity=0.277 Sum_probs=176.0
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLC 188 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~ 188 (820)
++|+++++||+|+||+||+|++..+++.||||+++... ....+.+|+++++.|. .|+||+.+++++......|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~------~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLA------GCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTT------TCTTCCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhc------CCCCCCEEEEEeecCCccE
Confidence 79999999999999999999999999999999987543 2345678999999985 3689999999999999999
Q ss_pred EEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCccccccc--CCCeEEEeeccccccc
Q 003438 189 ICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSV--KPAEIKIIDFGSACTE 266 (820)
Q Consensus 189 LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~--~~~~iKL~DFGlA~~~ 266 (820)
+||||++++|.+++.... ..+++.++..++.|++.||+|||++|||||||||+|||++... ..+.+||+|||+|+..
T Consensus 78 ~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999999999887653 5699999999999999999999999999999999999996432 3578999999999643
Q ss_pred CC----------ccccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCCCC
Q 003438 267 DR----------TVYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPGAS 317 (820)
Q Consensus 267 ~~----------~~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~~s 317 (820)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 22 1234579999999999999999999999999999999999999997654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=377.71 Aligned_cols=208 Identities=25% Similarity=0.335 Sum_probs=177.3
Q ss_pred CceEEEEEeccCCceeEEEeecc-----CCCeEEEEEEEeCC--hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEE
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDA-----EMNSFVAVKIIKNQ--PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYF 181 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~-----~tg~~VAIKiik~~--~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f 181 (820)
++|++.++||+|+||+||+|.++ .+++.||||+++.. ......+.+|+++++++ +|||||++++++
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-------~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-------NCHHVVRLLGVV 92 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-------CCTTBCCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-------CCCCEeeeeeEE
Confidence 79999999999999999999864 34678999999853 33445678999999888 789999999999
Q ss_pred eecceeEEEEeccC-CChHHHHHhhh--------cCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCC
Q 003438 182 VCQRHLCICFELLD-SNLYELIKINH--------FRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKP 252 (820)
Q Consensus 182 ~~~~~l~LVmEy~~-gsL~d~l~~~~--------~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~ 252 (820)
..++..++|||||. |+|.+++.... ...+++..+..++.||++||.|||+++||||||||+||||+ .+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld---~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---ED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeec---CC
Confidence 99999999999997 68988876542 13478999999999999999999999999999999999995 77
Q ss_pred CeEEEeecccccccCCc-----cccccccccccCccccccccccccchhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q 003438 253 AEIKIIDFGSACTEDRT-----VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLG-LPLFPGASEFDLLRRMI 326 (820)
Q Consensus 253 ~~iKL~DFGlA~~~~~~-----~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG-~~PF~~~s~~d~l~~I~ 326 (820)
+.+||+|||+|+..... .....+|+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 89999999999754332 2233678999999999999999999999999999999998 58898877776665553
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=366.19 Aligned_cols=192 Identities=22% Similarity=0.276 Sum_probs=158.1
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc---
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR--- 185 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~--- 185 (820)
++|.+.++||+|+||+||+|+. +++.||||+++.... +...+|.+++... ...|||||++++++..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~-----~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTV-----MLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTST-----TCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHh-----hCCCCcCcceEEEEEeCCCcc
Confidence 7899999999999999999974 688999999975543 3444555444322 126999999999998764
Q ss_pred -eeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhccc--------CCeeeccCCCCCcccccccCCCeE
Q 003438 186 -HLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKD--------AGIIHCDLKPENILLCTSVKPAEI 255 (820)
Q Consensus 186 -~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs--------~gIVHrDLKPeNILl~~~~~~~~i 255 (820)
.+|||||||. |+|.++++.. .+++..+..++.|++.||+|||+ ++||||||||+||||+ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~---~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC---TTSCE
T ss_pred eEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc---CCCCe
Confidence 6899999997 6999999764 48999999999999999999996 5999999999999995 67899
Q ss_pred EEeecccccccCC-------ccccccccccccCccccccc------cccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 256 KIIDFGSACTEDR-------TVYSYIQSRYYRSPEVLLGY------QYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 256 KL~DFGlA~~~~~-------~~~~~~gt~~Y~APEvl~~~------~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
||+|||++..... .....+||+.|+|||++.+. .++.++|||||||+||||+||.+||..
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9999999964322 12345789999999998764 378899999999999999999988854
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=366.10 Aligned_cols=194 Identities=20% Similarity=0.266 Sum_probs=162.9
Q ss_pred eEEEEEeccCCceeEEEeeccCCC---eEEEEEEEeC--ChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEee-c
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMN---SFVAVKIIKN--QPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVC-Q 184 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg---~~VAIKiik~--~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~-~ 184 (820)
+.+.++||+|+||+||+|++..++ ..||||++++ .....+++.+|+++|++| .|||||++++++.. +
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-------~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-------SHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-------CCTTBCCCCEEEEETT
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-------CCCCEeEEeEEEEecC
Confidence 344688999999999999876543 4699999974 445567899999999998 68999999999875 4
Q ss_pred ceeEEEEeccC-CChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccCCCeEEEeecccc
Q 003438 185 RHLCICFELLD-SNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVKPAEIKIIDFGSA 263 (820)
Q Consensus 185 ~~l~LVmEy~~-gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~~~~iKL~DFGlA 263 (820)
+.+++|||||. ++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||||+ +.+.+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~---~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTCCEEECSSGGG
T ss_pred CceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC---CCCCEEEecccch
Confidence 68999999998 57777776543 4688899999999999999999999999999999999995 6789999999999
Q ss_pred cccCCc-------cccccccccccCccccccccccccchhHhHHHHHHHHHhCCCCCCC
Q 003438 264 CTEDRT-------VYSYIQSRYYRSPEVLLGYQYTTAIDMWSFGCIVAELFLGLPLFPG 315 (820)
Q Consensus 264 ~~~~~~-------~~~~~gt~~Y~APEvl~~~~yt~ksDIWSLG~ILyeLltG~~PF~~ 315 (820)
+..... .....+|+.|+|||++....++.++|||||||++|||++|..||..
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 754322 1224678999999999999999999999999999999997776654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=7e-23 Score=203.81 Aligned_cols=163 Identities=21% Similarity=0.231 Sum_probs=117.4
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-------------------hhHHHHHHHHHHHHHHhhhcCCCCC
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-------------------AYYQQALVEVSILTTLNKKYDREDK 171 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-------------------~~~~~~~~Ei~iL~~L~~~~~~~~H 171 (820)
+.+.++||+|+||+||+|++. +++.||||+++... .......+|...|.++ .|
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-------~~ 73 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-------QG 73 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-------TT
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-------cC
Confidence 457899999999999999874 68899999975311 1112334567777776 46
Q ss_pred CceeEEeEEEeecceeEEEEeccCCChHHHHHhhhcCCCCHHHHHHHHHHHHHHhhhcccCCeeeccCCCCCcccccccC
Q 003438 172 HHIVRIYEYFVCQRHLCICFELLDSNLYELIKINHFRGLSLSIVQLFSKQILRGLSLLKDAGIIHCDLKPENILLCTSVK 251 (820)
Q Consensus 172 pnIVkl~d~f~~~~~l~LVmEy~~gsL~d~l~~~~~~~l~e~~i~~I~~QIl~aL~yLHs~gIVHrDLKPeNILl~~~~~ 251 (820)
.+++..+++. ..+|||||+++... ..+++..+..++.||+++|+|||++||+||||||+|||++
T Consensus 74 ~~v~~~~~~~----~~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~---- 137 (191)
T d1zara2 74 LAVPKVYAWE----GNAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS---- 137 (191)
T ss_dssp SSSCCEEEEE----TTEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----
T ss_pred CCcceEEEec----CCEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----
Confidence 7888877653 24899999997432 1255666788999999999999999999999999999995
Q ss_pred CCeEEEeecccccccCCccccccccccccCc--c---ccccccccccchhHhHHHH
Q 003438 252 PAEIKIIDFGSACTEDRTVYSYIQSRYYRSP--E---VLLGYQYTTAIDMWSFGCI 302 (820)
Q Consensus 252 ~~~iKL~DFGlA~~~~~~~~~~~gt~~Y~AP--E---vl~~~~yt~ksDIWSLG~I 302 (820)
+..++|+|||+|.......... |... + .+....|+.++||||+.--
T Consensus 138 ~~~~~liDFG~a~~~~~~~~~~-----~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 138 EEGIWIIDFPQSVEVGEEGWRE-----ILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTEEEECCCTTCEETTSTTHHH-----HHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred CCCEEEEECCCcccCCCCCcHH-----HHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 3468999999996654322111 1110 0 0123578999999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.10 E-value=5.7e-06 Score=83.15 Aligned_cols=81 Identities=11% Similarity=0.008 Sum_probs=57.5
Q ss_pred CceEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCCh-hhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeeccee
Q 003438 109 RRYIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQP-AYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHL 187 (820)
Q Consensus 109 ~rY~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~-~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l 187 (820)
..|++++..+-++.+.||++. .+++.++||+..... .....+.+|..+|+.|.. +--+.+++.+...++..
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~------~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG------KLPVPKVLHFERHDGWS 85 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT------TSCCCCEEEEEEETTEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc------cCCCCcEEEEEecCCce
Confidence 567777766556667899984 345567788876432 223356789999988853 23367778888888899
Q ss_pred EEEEeccCCC
Q 003438 188 CICFELLDSN 197 (820)
Q Consensus 188 ~LVmEy~~gs 197 (820)
++||++++|.
T Consensus 86 ~lv~~~l~G~ 95 (263)
T d1j7la_ 86 NLLMSEADGV 95 (263)
T ss_dssp EEEEECCSSE
T ss_pred EEEEEecccc
Confidence 9999999873
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=3.8e-05 Score=82.83 Aligned_cols=77 Identities=19% Similarity=0.225 Sum_probs=50.8
Q ss_pred EEEeccCCceeEEEeeccCCCeEEEEEEEeCC--------hhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecc
Q 003438 114 KDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQ--------PAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQR 185 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~--------~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~ 185 (820)
.+.||.|....||++.+..+++.|+||.-... .....+...|.++|+.+... ....+++++.+ +.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~----~p~~vP~v~~~--d~~ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH----VPHLVPRVFYS--DTE 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTT----CGGGSCCEEEE--ETT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhh----CCCCcceEEEE--cCC
Confidence 45689999999999998888888999975321 11234566799999888542 11245666654 455
Q ss_pred eeEEEEeccCC
Q 003438 186 HLCICFELLDS 196 (820)
Q Consensus 186 ~l~LVmEy~~g 196 (820)
..++|||++.+
T Consensus 105 ~~~lvmE~L~~ 115 (392)
T d2pula1 105 MAVTVMEDLSH 115 (392)
T ss_dssp TTEEEECCCTT
T ss_pred CCEEEEeccCC
Confidence 67899999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.51 E-value=0.0001 Score=73.35 Aligned_cols=73 Identities=10% Similarity=-0.045 Sum_probs=52.4
Q ss_pred EeccCC-ceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecceeEEEEecc
Q 003438 116 LLGHGT-FGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRHLCICFELL 194 (820)
Q Consensus 116 ~LG~G~-fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~l~LVmEy~ 194 (820)
.+..|. -+.||++.. ..+..+++|+..... ...+..|..+|+.|... .-.+.+++.+..+.+..++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~-----gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATT-----GVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTT-----TCCBCCEEEEEECSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhc-----CCCCCceeeecccccceEEEEEee
Confidence 445554 367899865 456668889876543 23467799999988653 223777888888888899999999
Q ss_pred CC
Q 003438 195 DS 196 (820)
Q Consensus 195 ~g 196 (820)
+|
T Consensus 89 ~G 90 (255)
T d1nd4a_ 89 PG 90 (255)
T ss_dssp SS
T ss_pred ec
Confidence 76
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.00089 Score=69.69 Aligned_cols=69 Identities=17% Similarity=0.086 Sum_probs=46.3
Q ss_pred eeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCC--ceeEE--eEEEeecceeEEEEeccCC
Q 003438 123 GQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKH--HIVRI--YEYFVCQRHLCICFELLDS 196 (820)
Q Consensus 123 G~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~Hp--nIVkl--~d~f~~~~~l~LVmEy~~g 196 (820)
..||++.. ++|+.|++|+.+......+++..|+..|..|... +-| ..+.. -..+...+..+.|++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~----gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVND----EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT----TCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhc----CCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 58999965 5678899999986544567788899999999754 112 11111 1123345678889998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.74 E-value=0.0012 Score=70.43 Aligned_cols=72 Identities=18% Similarity=0.175 Sum_probs=49.7
Q ss_pred EEEeccCCceeEEEeecc-------CCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhhcCCCCCCceeEEeEEEeecce
Q 003438 114 KDLLGHGTFGQVAKCWDA-------EMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKKYDREDKHHIVRIYEYFVCQRH 186 (820)
Q Consensus 114 ~~~LG~G~fG~Vyka~d~-------~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~~~~~~HpnIVkl~d~f~~~~~ 186 (820)
++.|+.|-.-.+|++... ...+.|.+++.-.... .....+|..+++.+... .-..+++.++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~idr~~E~~i~~~ls~~------gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-ESHLVAESVIFTLLSER------HLGPKLYGIFSG--- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-HHHHHHHHHHHHHHHHT------TSSSCEEEEETT---
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-hhHHHHHHHHHHHHHhC------CCCCeEEEEcCC---
Confidence 467888889999998754 2346788888764333 34556899999998642 224567777643
Q ss_pred eEEEEeccCC
Q 003438 187 LCICFELLDS 196 (820)
Q Consensus 187 l~LVmEy~~g 196 (820)
.+|+||+.|
T Consensus 117 -g~I~efi~g 125 (395)
T d1nw1a_ 117 -GRLEEYIPS 125 (395)
T ss_dssp -EEEECCCCE
T ss_pred -ceEEEEecc
Confidence 578899875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.30 E-value=0.027 Score=57.27 Aligned_cols=52 Identities=6% Similarity=-0.008 Sum_probs=32.0
Q ss_pred eEEEEEeccCCceeEEEeeccCCCeEEEEEEEeCChhhHHHHHHHHHHHHHHhhh
Q 003438 111 YIVKDLLGHGTFGQVAKCWDAEMNSFVAVKIIKNQPAYYQQALVEVSILTTLNKK 165 (820)
Q Consensus 111 Y~i~~~LG~G~fG~Vyka~d~~tg~~VAIKiik~~~~~~~~~~~Ei~iL~~L~~~ 165 (820)
.+-.+.|..|---+.|+++.. .+ .+++|++.... ..+.+..|+++|..|...
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~ 71 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAK 71 (316)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHT
T ss_pred ceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhc
Confidence 344566778888889998643 34 48899986432 234556688888888764
|